db13-dualityinfo.pdf - American Diabetes Association

AU

THO

R D

ISCL

OSU

RE

A829

PRESENTED AND PUBLISHEDABSTRACTS

DISCLOSURE INFORMATION

All presenters/authors are required to disclose to the program audience any fi nancial relationships related to the subject matter of this program. The intent of this disclosure is not to prevent a presenter or author from being involved in the activity, but rather to provide participants with information on which they may make their own judgments. D

ownloaded from

http://diabetesjournals.org/diabetes/article-pdf/62/Supplement_1/A829/407374/db13-dualityinfo.pdf by guest on 13 Septem

ber 2022

AU

THO

R D

ISCL

OSU

RE

A830

Dow

nloaded from http://diabetesjournals.org/diabetes/article-pdf/62/Supplem

ent_1/A829/407374/db13-dualityinfo.pdf by guest on 13 September 2022

A831

AU

THO

R D

ISCL

OSU

RE

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

Aakhus, Svend ...................................... Disclosed no confl ict of interest. Aalgur, Fusun ........................................ Disclosed no confl ict of interest. Aamidor, Sarah E. ................................. Disclosed no confl ict of interest. Abayomi, Julie ..................................... Disclosed no confl ict of interest. Abbas, Afroze ....................................... Disclosed no confl ict of interest. Abbasi, Fahim ....................................... Disclosed no confl ict of interest. Abbate, Antonio ................................... Disclosed no confl ict of interest. Abbott, Caroline A. ............................... Disclosed no confl ict of interest. Abbott, Scott ........................................ Employee: Valeritas, LLC; Stock/Shareholder: Valeritas, LLC Abcouwer, Steven F. ............................. Disclosed no confl ict of interest. Abdella, A. ............................................ Disclosed no confl ict of interest. Abdella, Nabilla ................................... Disclosed no confl ict of interest. Abdelmoneim, Ahmed .......................... Disclosed no confl ict of interest. Abdel-Rasoul, Mahmoud ..................... Disclosed no confl ict of interest. Abdi, Reza ............................................ Disclosed no conflict of interest. Abdul Karim, Siti Nurhannah ............... Disclosed no confl ict of interest. Abdul Shakoor, Shaikh Abdul ............... Disclosed no confl ict of interest. Abdul-Ghani, Muhammad A. ............... Disclosed no confl ict of interest. Abdul-Hay, Samer O. ............................ Disclosed no confl ict of interest. Abduljalil, Amir .................................... Disclosed no confl ict of interest. Abdulreda, Midhat H. ........................... Disclosed no confl ict of interest. Abe, Hiroko ........................................... Disclosed no confl ict of interest. Abe, Kiwamu ........................................ Disclosed no confl ict of interest. Abe, Yoshimi ........................................ Disclosed no confl ict of interest. Abel, E. Dale ......................................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.,

Merck; Speaker’s Bureau: Merck Aberer, Felix ......................................... Other Relationship: CeQur, Ltd., Menarini, Novo Nordisk A/S Abernethy, Gillian ................................. Disclosed no confl ict of interest. Abiko, Atsuko ....................................... Disclosed no confl ict of interest. Abood, Beth .......................................... Disclosed no confl ict of interest. Abou-Samra, Abdul B. .......................... Disclosed no confl ict of interest. Abraham, Mona A. ............................... Disclosed no confl ict of interest. Abraham, Prakash ................................ Disclosed no confl ict of interest. Abrahamian, Gregory ........................... Disclosed no confl ict of interest. Abrahamson, Martin J. ........................ Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Halozyme Therapeutics, Novo Nordisk, Inc.; Consultant: WebMD

Abramson, Natalie ............................... Disclosed no confl ict of interest. Abreu, Cristina ..................................... Speaker’s Bureau: Bristol-Myers Squibb/AstraZeneca, Eli Lilly

and Company, Novo Nordisk A/S, Sanofi Abreu, Gabriela .................................... Disclosed no confl ict of interest. Abreu, Marconi .................................... Disclosed no confl ict of interest. Absher, Devin ....................................... Disclosed no confl ict of interest. Abt, Markus .......................................... Employee: Hoffman La Roche Abuaysheh, Sanaa ............................... Disclosed no confl ict of interest. Abudukadier, Abulizi ............................ Disclosed no confl ict of interest. Aburatani, Hiroyuki .............................. Disclosed no confl ict of interest. Acar, Ramazan ...................................... Disclosed no confl ict of interest. Accili, Domenico .................................. Consultant: Amgen, Inc., Eli Lilly and Company; Research

Support: AstraZeneca Pharmaceuticals LP, Merck Acerini, Carlo L. .................................... Disclosed no confl ict of interest. Acharya, Nikhil ..................................... Disclosed no confl ict of interest. Achilike, Immculeta U. ......................... Disclosed no confl ict of interest. Ackard, Diann ....................................... Disclosed no confl ict of interest. Ackart, David F. .................................... Disclosed no confl ict of interest. Ackermann, Ronald T. .......................... Disclosed no confl ict of interest. Ackermans, Mariëtte T. ........................ Disclosed no confl ict of interest. Adachi, Chisaki ..................................... Disclosed no confl ict of interest. Adachi, Kei ........................................... Disclosed no confl ict of interest. Adachi, Yusuke ..................................... Disclosed no confl ict of interest. Adam, Karen ......................................... Disclosed no confl ict of interest. Adams, Christopher M. ........................ Disclosed no confl ict of interest. Adams, John ........................................ Disclosed no confl ict of interest. Adams, Joyce W. ................................. Disclosed no confl ict of interest. Adams, Kenneth ................................... Disclosed no confl ict of interest. Adams, Sean H. .................................... Disclosed no confl ict of interest. Adams-Huet, Beverley ......................... Disclosed no confl ict of interest. Adamska, Agnieszka ............................ Disclosed no confl ict of interest. Adamska, Edyta .................................... Disclosed no confl ict of interest. Adamski, Jerzy ..................................... Disclosed no confl ict of interest. Addad, Faouzi ....................................... Disclosed no confl ict of interest. Addison, Augustina .............................. Disclosed no confl ict of interest. Addy, Carol ........................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Adeel, Saira .......................................... Disclosed no confl ict of interest. Adeli, Khosrow ..................................... Disclosed no confl ict of interest. Ades, A.E. ............................................. Disclosed no confl ict of interest. Adesanya, Olu ...................................... Disclosed no confl ict of interest.

Adhami, Anwar .................................... Disclosed no confl ict of interest. Adhami, Mitra ...................................... Disclosed no confl ict of interest. Adhya, Sumona .................................... Employee: Medtronic Adkins, Laura ........................................ Disclosed no confl ict of interest. Adler, Benjamin .................................... Disclosed no confl ict of interest. Adler, Steffen ....................................... Consultant: Sanofi Admane, Karim ..................................... Employee: Sanofi Admiraal, Wanda ................................. Disclosed no confl ict of interest. Adorini, Luciano ................................... Disclosed no confl ict of interest. Adu, Akosua ......................................... Disclosed no confl ict of interest. Advani, Andrew .................................... Disclosed no confl ict of interest. Advani, Suzanne L. ............................... Disclosed no confl ict of interest. Afanasyev, Dmitry E. ............................ Disclosed no confl ict of interest. Afek, Arnon .......................................... Disclosed no confl ict of interest. Affres, Hélène ...................................... Disclosed no confl ict of interest. Afi k, Shaked ......................................... Disclosed no confl ict of interest. Afi nbinder, Yefi m .................................. Disclosed no confl ict of interest. Agarwal, Ulka ....................................... Disclosed no confl ict of interest. Agatsuma, Kumiko ............................... Disclosed no confl ict of interest. Agenor, Keesandra ............................... Disclosed no confl ict of interest. Aggarwal, Sandeep .............................. Disclosed no confl ict of interest. Agha, Amar .......................................... Disclosed no confl ict of interest. Agne, April A. ....................................... Disclosed no confl ict of interest. Agosti, Barbara .................................... Disclosed no confl ict of interest. Agrawal, Pratik ..................................... Employee: Medtronic Ågren, Anna ......................................... Disclosed no confl ict of interest. Aguer, Celine ........................................ Disclosed no confl ict of interest. Aguiar, Carlos ....................................... Disclosed no confl ict of interest. Aguiar, Fernanda M. ............................. Disclosed no confl ict of interest. Aguilar Velazquez, Daniela .................. Disclosed no confl ict of interest. Aguilar, David ....................................... Disclosed no confl ict of interest. Aguilar, Montserrat .............................. Disclosed no confl ict of interest. Aguilar-Diosdado, Manuel ................... Research Support: Amylin Pharmaceuticals, Inc. (Spouse/

Partner) Ah Kioon, Marie Dominique ................. Disclosed no confl ict of interest. Ahdal, Jaishid ...................................... Disclosed no confl ict of interest. Ahima, Rexford S. ................................ Disclosed no confl ict of interest. Ahmad, Jamal ...................................... Disclosed no confl ict of interest. Ahmann, Andrew ................................. Disclosed no confl ict of interest. Ahmeti, Irfan ........................................ Disclosed no confl ict of interest. Ahn, Chul Woo ..................................... Disclosed no confl ict of interest. Ahn, Jae Hee ........................................ Disclosed no confl ict of interest. Ahn, Ki Yong ......................................... Disclosed no confl ict of interest. Ahn, Kyu Jeung .................................... Disclosed no confl ict of interest. Ahn, So-Yeon ........................................ Disclosed no confl ict of interest. Ahn, SunHee ........................................ Disclosed no confl ict of interest. Ahn, Sylvie A. ....................................... Disclosed no confl ict of interest. Ahn, Yu-Bae .......................................... Disclosed no confl ict of interest. Ahrén, Bo .............................................. Advisory Panel: GlaxoSmithKline, Novartis Pharmaceuticals

Corporation, Sanofi ; Speaker’s Bureau: Merck, Novartis Pharmaceuticals Corporation; Stock/Shareholder: Novo Nordisk A/S

Aibiki, Mayo ......................................... Disclosed no confl ict of interest. Aiello, Lloyd P. ...................................... Consultant: Abbott Laboratories, Inc., Genentech, Genzyme

Corporation, KalVista Pharmaceuticals, Ltd., Ophthotec, Pfi zer, Inc., Proteostasis Therapeutics, Inc., Thrombogen-ics, Vantia, Ltd.

Aiello, Vito ............................................ Disclosed no confl ict of interest. Aihara, Ken-ichi .................................... Disclosed no confl ict of interest. Aiken, Monica ...................................... Disclosed no confl ict of interest. Aitchison, Wenda ................................. Disclosed no confl ict of interest. Aitkulov, Aidar M. ................................ Disclosed no confl ict of interest. Aizawa, Toru ......................................... Disclosed no confl ict of interest. Ajani, Andrew E. .................................. Disclosed no confl ict of interest. Ajmera, Mayank ................................... Research Support: Sanofi Akalin, Arzu .......................................... Disclosed no confl ict of interest. Akalin, Sema ........................................ Disclosed no confl ict of interest. Akamatsu, Suguru ................................ Disclosed no confl ict of interest. Akamizu, Takashi .................................. Disclosed no confl ict of interest. Akana, Momi ........................................ Disclosed no confl ict of interest. Akanuma, Yasuo ................................... Disclosed no confl ict of interest. Akerlund, Mikael .................................. Disclosed no confl ict of interest. Akerstrom, Thorbjorn ........................... Disclosed no confl ict of interest. Akhan, Muharrem ................................ Disclosed no confl ict of interest. Akhoundsadegh, Noushin .................... Disclosed no confl ict of interest. Akhtar, Shahid ...................................... Employee: Novo Nordisk, Inc. Aki, Nanako .......................................... Disclosed no confl ict of interest. Akirav, Eitan M. .................................... Disclosed no confl ict of interest.

ABSTRACT AUTHOR DISCLOSURE INFORMATION

Dow



A832


AU

THO

R D

ISCL

OSU

RE

Akiyama, Yoshitaka .............................. Disclosed no confl ict of interest. Akmaev, Viatcheslav R. ........................ Disclosed no confl ict of interest. Al Ansari, Jaber ................................... Disclosed no confl ict of interest. Al Arouj, Monira ................................... Advisory Panel: Novartis Pharma AG Al Awadi, Fatheya ................................ Disclosed no confl ict of interest. Al Gadban, Mohammed ....................... Disclosed no confl ict of interest. Al Madani, Abdulrazzaq A. .................. Disclosed no confl ict of interest. Al Mulla, Fahd ...................................... Disclosed no confl ict of interest. Al Saeed, Abdulghani .......................... Disclosed no confl ict of interest. Al Sayah, Fatima .................................. Disclosed no confl ict of interest. AL-Adsani, Afaf M. .............................. Disclosed no confl ict of interest. Alahmar, Ahmad ................................... Disclosed no confl ict of interest. Al-Ahmar, Ahmed ................................. Disclosed no confl ict of interest. Alam, Uazman ...................................... Disclosed no confl ict of interest. Alarcon, Cristina ................................... Disclosed no confl ict of interest. Alas, Veronica ...................................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Novo

Nordisk, Inc. Alawieh, Mohamad .............................. Disclosed no confl ict of interest. Alazzam, Nissrin ................................... Disclosed no confl ict of interest. Alba, Maria .......................................... Employee: Janssen Research & Development Albanese-O’Neill, Anastasia ................ Disclosed no confl ict of interest. Al-Barazanji, Kamal A. ......................... Disclosed no confl ict of interest. Alberga, Angela S. ............................... Disclosed no confl ict of interest. Albrecht, Kellen .................................... Disclosed no confl ict of interest. Albright, Ann L. .................................... Disclosed no confl ict of interest. Albu, Jeanine ....................................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc., Eli Lilly and Company, Roche Pharmaceuticals, Takeda Pharmaceuticals U.S.A., Inc., Weight Watchers

Al-Daghri, Nasser ................................. Disclosed no confl ict of interest. Alejandro, Rodolfo ............................... Disclosed no confl ict of interest. Aleksandrov, Andrey ............................ Research Support: Novo Nordisk A/S Alemzadeh, Ramin ............................... Disclosed no confl ict of interest. Alepaki, Maria ...................................... Disclosed no confl ict of interest. Alessandroni, Laura ............................. Disclosed no confl ict of interest. Alexander, Charles M. .......................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Alexander, Michael .............................. Disclosed no confl ict of interest. Alexanian, Sara .................................... Disclosed no confl ict of interest. Al-Hasani, Hadi .................................... Disclosed no confl ict of interest. Alhenc-Gelas, François ........................ Disclosed no confl ict of interest. Ali, Asad ............................................... Disclosed no confl ict of interest. Ali, Mohammed K. ............................... Disclosed no confl ict of interest. Ali, Nadia ............................................. Disclosed no confl ict of interest. Ali, Tomader ......................................... Disclosed no confl ict of interest. Alikasifoglu, Ayfer ................................ Disclosed no confl ict of interest. Alina, Asel R. ........................................ Disclosed no confl ict of interest. Alippe, Yael .......................................... Disclosed no confl ict of interest. Aliustaoglu, Mehmet ........................... Disclosed no confl ict of interest. Allamargot, Chantal ............................. Disclosed no confl ict of interest. Allayee, Hooman .................................. Disclosed no confl ict of interest. Allen, Elsie ........................................... Employee: Bristol-Myers Squibb Company Allen, Holley ......................................... Disclosed no confl ict of interest. Allen, Janet M. .................................... Disclosed no confl ict of interest. Allen, Jeffery K. ................................... Employee: Jeffery Allen; Stock/Shareholder: Jeffery Allen Allen, Nancy A. .................................... Disclosed no confl ict of interest. Allen, Norrina ....................................... Disclosed no confl ict of interest. Allen, Sarah .......................................... Disclosed no confl ict of interest. Aller, Rocio ........................................... Disclosed no confl ict of interest. Allison, Matthew ................................. Disclosed no confl ict of interest. Allmeyer, Mary ..................................... Disclosed no confl ict of interest. Alloway, Rita R. .................................... Disclosed no confl ict of interest. Almansouri, Hawaa .............................. Disclosed no confl ict of interest. Almasy, Laura ....................................... Disclosed no confl ict of interest. Almdal, Thomas ................................... Disclosed no confl ict of interest. Almgren, Peter ..................................... Disclosed no confl ict of interest. Almokayyad, Rami M. .......................... Disclosed no confl ict of interest. Alomar, Fadhel ..................................... Disclosed no confl ict of interest. Alon, Tal ............................................... Employee: Insuline Medical Alonso, Laura C. ................................... Disclosed no confl ict of interest. Alperin, Peter ....................................... Disclosed no confl ict of interest. Al-Ramli, Wisam .................................. Disclosed no confl ict of interest. Al-Sabah, Jude ..................................... Disclosed no confl ict of interest. Alsaied, Osama .................................... Disclosed no confl ict of interest. Al-Shabeeb, Ammira ............................ Disclosed no confl ict of interest. Alston, James T. ................................... Employee: Eli Lilly and Company Alt, Marcus ........................................... Disclosed no confl ict of interest. Altaf, Q.A. ............................................. Disclosed no confl ict of interest. Alter, Markus L. .................................... Disclosed no confl ict of interest. Altshuler, David M. .............................. Consultant: Eisai, Inc., MPM Capital; Research Support: Pfi zer,

Inc. Altuntas, Yuksel ................................... Disclosed no confl ict of interest. Alvarez, Andrea .................................... Disclosed no confl ict of interest.

Alvarez-Mercado, Anabel I. ................. Disclosed no confl ict of interest. Al-Zubeidi, Hiba ................................... Disclosed no confl ict of interest. Amam, S.N. .......................................... Disclosed no confl ict of interest. Amano, Hideki ...................................... Disclosed no confl ict of interest. Amatruda, John M. .............................. Advisory Panel: Amgen, Inc., Catabasis, Daiichi-Sankyo, Inc.,

Diamedica, Inc., Ember Therapeutics, Ferring Pharmaceu-ticals, Inc., Forest Pharmaceuticals, Inc., Gilead Sciences, Inc., Johnson & Johnson, Oramed Pharmaceuticals, Rhythm Pharmaceuticals, Zydus Cadila Healthcare Lim-ited; Board Member: Profi l Institute for Clinical Research, Inc.; Consultant: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, CureDM, Inc., Melior Discovery, Inc., Merck, Relapysa, Taisho; Other Relationship: CohBar; Stock/Shareholder: CohBar

Amaya, Marisa ..................................... Disclosed no confl ict of interest. Ambers, Ellen ....................................... Disclosed no confl ict of interest. Ambler, Geoffrey R. .............................. Disclosed no confl ict of interest. Ambrosino, Jodie M. ............................ Disclosed no confl ict of interest. Ambrosius, Walter T. ........................... Disclosed no confl ict of interest. Amed, Shazhan .................................... Disclosed no confl ict of interest. Amiel, Stephanie A. ............................. Disclosed no confl ict of interest. Amin, Nikhil .......................................... Employee: MannKind Corporation; Stock/Shareholder: Mann-

Kind Corporation Amin, Shubarna .................................... Disclosed no confl ict of interest. Aminian, Ali .......................................... Disclosed no confl ict of interest. Aminuddin, Aminuddin ......................... Disclosed no confl ict of interest. Amiri, Azita ........................................... Disclosed no confl ict of interest. Amo, Kikuko ......................................... Disclosed no confl ict of interest. Amodei, Nancy ..................................... Disclosed no confl ict of interest. Amor, Paul A. ........................................ Employee: Pfi zer, Inc. Amorese, Gabriella .............................. Disclosed no confl ict of interest. Amos, Tony ........................................... Disclosed no confl ict of interest. Ampudia-Blasco, Francisco Javier ....... Consultant: Lifescan Animas, Inc.; Research Support: Novo

Nordisk, Inc., Sanofi ; Speaker’s Bureau: Abbott Diabetes Care, Lifescan Animas, Inc., Medtronic MiniMed, Inc., Novo Nordisk, Inc., Sanofi

An, Changlong ...................................... Disclosed no confl ict of interest. An, Ding ................................................ Disclosed no confl ict of interest. An, Hongxia .......................................... Disclosed no confl ict of interest. An, Hyun-Ju .......................................... Disclosed no confl ict of interest. An, Ping ................................................ Disclosed no confl ict of interest. An, So-Yeon .......................................... Disclosed no confl ict of interest. An, Yali ................................................. Disclosed no confl ict of interest. Ananthakrishnan, Kameswari .............. Disclosed no confl ict of interest. Ananthakrishnan, Radha ...................... Disclosed no confl ict of interest. Anavi, Sarit ........................................... Disclosed no confl ict of interest. Anaya, Luis ........................................... Disclosed no confl ict of interest. Ancsin, John B. .................................... Research Support: Bristol-Myers Squibb Company, Novo

Nordisk, Inc. Anders, Matthias ................................. Disclosed no confl ict of interest. Andersen, Birgitte ................................ Employee: Novo Nordisk A/S Andersen, Christian B. ......................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Andersen, Henning ............................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S, Novo Nordisk A/S (Spouse/Partner), Sanofi Andersen, Marianne ............................ Disclosed no confl ict of interest. Andersen, Mette S. .............................. Employee: Zealand Pharma A/S; Research Support: Zealand

Pharma A/S Anderson, Barbara J. ........................... Advisory Panel: Sanofi ; Other Relationship: Bayer Health Care,

LLC; Research Support: NIHAnderson, Beth ..................................... Disclosed no confl ict of interest. Anderson, Ethan J. ............................... Disclosed no confl ict of interest. Anderson, Heather D. ........................... Disclosed no confl ict of interest. Anderson, John E. ................................ Advisory Panel: Abbott Laboratories, Inc., Amylin Pharma-

ceuticals, Inc., Eli Lilly and Company, Sanofi ; Consultant: Amylin Pharmaceuticals, Inc., Sanofi ; Speaker’s Bureau: Amylin Pharmaceuticals, Inc., Boehringer Ingelheim Phar-maceuticals, Inc., Eli Lilly and Company, Novo Nordisk, Inc.

Anderson, Molly A. .............................. Disclosed no confl ict of interest. Anderson, Richard ................................ Disclosed no confl ict of interest. Anderson, Roger ................................... Disclosed no confl ict of interest. Anderson, Stacey M. ............................ Research Support: Animas Corporation Anderson, Wesley ................................ Consultant: Eli Lilly and Company (Spouse/Partner); Employee:

Eli Lilly and Company; Research Support: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner)

Andou, Kiyotaka ................................... Disclosed no confl ict of interest. Andrada, Patricia .................................. Disclosed no confl ict of interest. Andreassen, Kim V. .............................. Employee: Nordic Bioscience A/S Andreozzi, Francesco ............................ Disclosed no confl ict of interest. Andrews, Anne ..................................... Disclosed no confl ict of interest.

Dow



A833


AU

THO

R D

ISCL

OSU

RE

Andrews, Howard F. ............................. Disclosed no confl ict of interest. Andrews, Jeanette S. .......................... Disclosed no confl ict of interest. Andrianesis, Vasileios .......................... Disclosed no confl ict of interest. Andrikopoulos, Sof ............................... Disclosed no confl ict of interest. Andrulli Buccheri, Valentina ................ Disclosed no confl ict of interest. Angeli, Franca S. .................................. Disclosed no confl ict of interest. Anhalt, Henry ....................................... Employee: Animas Corporation; Stock/Shareholder: Johnson

& Johnson Anichini, Roberto .................................. Disclosed no confl ict of interest. Anichini, Sandro ................................... Disclosed no confl ict of interest. Ann, Hee Jung ...................................... Disclosed no confl ict of interest. Annink, Christopher .............................. Disclosed no confl ict of interest. Annunziata, Kathy ................................ Consultant: Janssen Annuzzi, Giovanni ................................. Disclosed no confl ict of interest. Ansani, Nicole T. .................................. Employee: Pfi zer; Stock/Shareholder: Pfi zer Ansarullah, A ........................................ Disclosed no confl ict of interest. Antal, Holly ........................................... Disclosed no confl ict of interest. Anteer, Wissam .................................... Disclosed no confl ict of interest. Antenor-Dorsey, Jo Ann V. ................... Disclosed no confl ict of interest. Antinozzi, Peter A. ................................ Disclosed no confl ict of interest. Antonenko, Viktoriia ............................. Disclosed no confl ict of interest. Antosik, Karolina .................................. Disclosed no confl ict of interest. Antovic, Aleksandra ............................. Disclosed no confl ict of interest. Anyfanti, Panagiota .............................. Disclosed no confl ict of interest. Anzai, Keizo .......................................... Disclosed no confl ict of interest. Anzola, Isabel ....................................... Disclosed no confl ict of interest. Ao, Ziliang ............................................ Disclosed no confl ict of interest. Aoki, Michiko ....................................... Disclosed no confl ict of interest. Apostol, Pompilia ................................. Disclosed no confl ict of interest. Apostolou, Ourania .............................. Disclosed no confl ict of interest. Apovian, Caroline M. ........................... Advisory Panel: Abbott Laboratories, Inc., Allergan, Inc., Amy-

lin Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., Johnson & Johnson, Merck, Novo Nordisk, Inc., Orexigen Therapeutics, Inc., Sanofi , Zafgen, Inc.; Research Support: Amylin Pharmaceuticals, Inc., Dr. Robert C. and Veronica Atkins Foundation, Eli Lilly and Company, MetaProteom-ics, LLC, Orexigen Therapeutics, Inc., Pfi zer, Inc., Sanofi

Appana, Deepa ..................................... Disclosed no confl ict of interest. Appel, Lawrence J. .............................. Disclosed no confl ict of interest. Appelt, Dieter ....................................... Disclosed no confl ict of interest. Arafat, Hwyda A. .................................. Disclosed no confl ict of interest. Araga, Mako ......................................... Employee: Novartis Pharmaceuticals Corporation Aragona, Michele ................................. Disclosed no confl ict of interest. Arai, Yoshinari ...................................... Disclosed no confl ict of interest. Arai, Yusuke ......................................... Disclosed no confl ict of interest. Araia, Mereb ........................................ Disclosed no confl ict of interest. Arakaki, Richard ................................... Consultant: Novo Nordisk, Inc.; Research Support: Eli Lilly and

Company, GSK, Novartis Pharmaceuticals Corporation, Reata Pharmaceuticals, Sanofi ; Speaker’s Bureau: Amylin Pharmaceuticals, Inc.

Araki, Eiichi .......................................... Disclosed no confl ict of interest. Araki, Hisazumi .................................... Disclosed no confl ict of interest. Araki, Kazushi ....................................... Employee: Daiichi-Sankyo, Inc. Araki, Shin-ichi ..................................... Disclosed no confl ict of interest. Aram, Pedram ....................................... Disclosed no confl ict of interest. Aranda, Claudio .................................... Disclosed no confl ict of interest. Araneta, Maria ..................................... Disclosed no confl ict of interest. Arany, Edith J. ...................................... Disclosed no confl ict of interest. Arapostathi, Christina .......................... Disclosed no confl ict of interest. Arase, Yasuji ........................................ Disclosed no confl ict of interest. Arata, Alyssa K. .................................... Disclosed no confl ict of interest. Araujo, Andre B. ................................... Disclosed no confl ict of interest. Araujo, Debora B. ................................. Disclosed no confl ict of interest. Araujo, Denizar V. ................................. Disclosed no confl ict of interest. Arave, Diane ......................................... Disclosed no confl ict of interest. Aravindalochanan, Vigneswari ............ Disclosed no confl ict of interest. Arbelaez, Ana Maria ............................ Disclosed no confl ict of interest. Arbit, Ehud ............................................ Consultant: Oramed Pharmaceuticals Arcori, Leann ........................................ Disclosed no confl ict of interest. Arcury, Thomas ..................................... Disclosed no confl ict of interest. Ardebili, Ranna ..................................... Disclosed no confl ict of interest. Ardicli, Didem ....................................... Disclosed no confl ict of interest. Ardilouze, Jean-Luc .............................. Disclosed no confl ict of interest. Arena, Vincent C. ................................. Disclosed no confl ict of interest. Argiana, Vasiliki ................................... Disclosed no confl ict of interest. Arguello, Vanessa ................................ Disclosed no confl ict of interest. Ariel, Danit ........................................... Disclosed no confl ict of interest. Arima, Hiroshi ...................................... Disclosed no confl ict of interest. Armstrong, David G. ............................. Disclosed no confl ict of interest. Armstrong, Loren L. .............................. Disclosed no confl ict of interest. Armstrong, Matthew ............................ Disclosed no confl ict of interest. Arnett, Donna K. ................................... Disclosed no confl ict of interest.

Arnold, Pamela C. ................................. Speaker’s Bureau: Amylin Pharmaceuticals, Inc., Sanofi Aroda, Vanita R. ................................... Disclosed no confl ict of interest. Aron, David C. ...................................... Disclosed no confl ict of interest. Aronson, Ronnie ................................... Consultant: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi ,

Takeda Pharmaceutical Company, Ltd.; Research Support: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd.

Aroor, Annayya R. ................................. Disclosed no confl ict of interest. Arora, Teresa ........................................ Disclosed no confl ict of interest. Arriga, Roberto ..................................... Disclosed no confl ict of interest. Arrizabalaga Garde, Olatz .................... Disclosed no confl ict of interest. Arrowood, James ................................. Disclosed no confl ict of interest. Arslan, Erol ........................................... Disclosed no confl ict of interest. Arslan, Zekeriya ................................... Disclosed no confl ict of interest. Arslanian, Silva A. ................................ Advisory Panel: Bristol-Myers Squibb Company, Novo Nordisk

A/S; Consultant: Gilead Sciences, Inc., Sanofi ; Other Relationship: Boehringer Ingelheim GmbH & Co. KG, Data Safety Monitoring Board

Artemaki, Fotini .................................... Disclosed no confl ict of interest. Artis, Eunice ......................................... Employee: Janssen Research & Development Arya, Awadhesh K. ............................... Disclosed no confl ict of interest. Asahara, Takashi .................................. Disclosed no confl ict of interest. Asahina, Takayuki ................................ Disclosed no confl ict of interest. Asai, Shiko ........................................... Disclosed no confl ict of interest. Asano, Mai ........................................... Disclosed no confl ict of interest. Asao, Keiko .......................................... Disclosed no confl ict of interest. Asare, Isaac B. ..................................... Disclosed no confl ict of interest. Ascaso, Juan F. ..................................... Disclosed no confl ict of interest. Asche, Steve ........................................ Disclosed no confl ict of interest. Aschemeier, Baerbel ............................ Disclosed no confl ict of interest. Aschner, Pablo ...................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli Lilly

and Company, Janssen Pharmaceuticals, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Sanofi ; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Sanofi

Asenjo, Angel ....................................... Disclosed no confl ict of interest. Asghar, Omar ........................................ Disclosed no confl ict of interest. Asghar, Rabia ....................................... Disclosed no confl ict of interest. Ashaye, Ajibade O. ............................... Consultant: Novo Nordisk, Inc., Sanofi Ashby, Lori ............................................ Disclosed no confl ict of interest. Ashford, Fiona B. .................................. Disclosed no confl ict of interest. Ashford, Michael L. .............................. Disclosed no confl ict of interest. Ashida, Kenji ........................................ Disclosed no confl ict of interest. Ashihara, Jun-ya .................................. Disclosed no confl ict of interest. Ashley, David T. .................................... Employee: Bristol-Myers Squibb Company Ashraf, Muhammad Uwais .................. Disclosed no confl ict of interest. Askari, Hossein .................................... Employee: Janssen Research & Development Askari, Reza .......................................... Disclosed no confl ict of interest. Asleh, Rabea ........................................ Disclosed no confl ict of interest. Aslibekyan, Stella ................................ Disclosed no confl ict of interest. Asnani, Sunil ........................................ Disclosed no confl ict of interest. Asteazarán, Santiago ........................... Disclosed no confl ict of interest. Astiarriaga, Brenno .............................. Disclosed no confl ict of interest. Ata, Ashar ............................................ Disclosed no confl ict of interest. Athanason, Mark G. ............................. Disclosed no confl ict of interest. Atisso, Charles ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Atkinson, Mark ..................................... Disclosed no confl ict of interest. Atlas, Eran ............................................ Speaker’s Bureau: Medtronic MiniMed, Inc. Atlas, Steven J. .................................... Disclosed no confl ict of interest. Atsumi, Tatsuya .................................... Disclosed no confl ict of interest. Attané, Camille .................................... Disclosed no confl ict of interest. Attaoua, Redha .................................... Disclosed no confl ict of interest. Attie, Alan D. ........................................ Disclosed no confl ict of interest. Atzmon, Gil ........................................... Disclosed no confl ict of interest. Au, Dianaly ........................................... Disclosed no confl ict of interest. Aubert, Ronald E. ................................. Employee: Medco Health Solutions, Inc. Augustin, Thomas ................................ Disclosed no confl ict of interest. Aukrust, Pål .......................................... Disclosed no confl ict of interest. Auld, Corinth ........................................ Employee: Mercodia Auster, Michael E. ................................ Disclosed no confl ict of interest. Austin, Erin ........................................... Disclosed no confl ict of interest. Austin, Melissa .................................... Disclosed no confl ict of interest. Autier, Philippe ..................................... Disclosed no confl ict of interest. Avallone, Vincenzo ............................... Disclosed no confl ict of interest. Avalos, Gloria ....................................... Disclosed no confl ict of interest. Avbelj, Magdalena ............................... Disclosed no confl ict of interest. Avignon, Antoine .................................. Board Member: AstraZeneca Pharmaceuticals LP, Bristol-

Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S

Aviles-Santa, Larissa ........................... Disclosed no confl ict of interest.

Dow



A834


AU

THO

R D

ISCL

OSU

RE

Avó, Lucimar R. .................................... Disclosed no confl ict of interest. Avogaro, Angelo ................................... Disclosed no confl ict of interest. Avorn, Jerry .......................................... Research Support: Eli Lilly and Company Avramidis, Iakovos ............................... Disclosed no confl ict of interest. Avron, Ann ............................................ Employee: Andromeda Biotech, Ltd. Awazawa, Motoharu ............................ Disclosed no confl ict of interest. Ay, Seyit Ahmet .................................... Disclosed no confl ict of interest. Aydin, Burcin ........................................ Disclosed no confl ict of interest. Aydin, Cigdem ...................................... Disclosed no confl ict of interest. Aydin, Zeki ............................................ Disclosed no confl ict of interest. Aye, Thwin ........................................... Disclosed no confl ict of interest. Aylor, Kevin W. ..................................... Disclosed no confl ict of interest. Ayyagari, Rajeev .................................. Other Relationship: Sanofi Azak, Alper ........................................... Disclosed no confl ict of interest. Aziz, Riffat ............................................ Disclosed no confl ict of interest. Azmi, Shazli .......................................... Disclosed no confl ict of interest. Azriel, Sharona ..................................... Consultant: Sanofi Azuma, Koichiro ................................... Disclosed no confl ict of interest. Azuma, Yoshihiro .................................. Disclosed no confl ict of interest. Azzi, Jamil R. ........................................ Disclosed no conflict of interest. Baack, Michelle L. ................................ Disclosed no confl ict of interest. Babu, Ambika ....................................... Research Support: Bristol-Myers Squibb Company Babu, Sunanda ..................................... Disclosed no confl ict of interest. Bacci, Simonetta .................................. Disclosed no confl ict of interest. Bacha, Fida ........................................... Disclosed no confl ict of interest. Bachmann, Anette ................................ Disclosed no confl ict of interest. Backlund, Jye-Yu C. .............................. Disclosed no confl ict of interest. Backus, Carey ....................................... Disclosed no confl ict of interest. Bacon, Samantha D. ............................. Disclosed no confl ict of interest. Bacon, Siobhan .................................... Disclosed no confl ict of interest. Baculescu, Nicoleta ............................. Disclosed no confl ict of interest. Badawi, Alaa ........................................ Disclosed no confl ict of interest. Badenhoop, Klaus ................................ Disclosed no confl ict of interest. Bader, Giovanni .................................... Employee: Novartis Pharma AG Badin, Pierre-Marie .............................. Disclosed no confl ict of interest. Badon, Sylvia ........................................ Disclosed no confl ict of interest. Bae, Kwi-Hyun ...................................... Disclosed no confl ict of interest. Bae, Yoo Mi .......................................... Disclosed no confl ict of interest. Baek, Cho ok ......................................... Disclosed no confl ict of interest. Baek, Haeri ........................................... Disclosed no confl ict of interest. Baek, Hong Sun .................................... Disclosed no confl ict of interest. Baek, Ki-Hyun ....................................... Disclosed no confl ict of interest. Baez, Eileen .......................................... Disclosed no confl ict of interest. Baeza, Raymundo ................................. Disclosed no confl ict of interest. Bagchi, Debasis .................................... Disclosed no confl ict of interest. Bagger, Jonatan I. ................................ Speaker’s Bureau: Merck Sharp & Dohme Limited Baginsky, Peter R. ................................. Disclosed no confl ict of interest. Bahceci, Mitat ...................................... Disclosed no confl ict of interest. Bahia, Luciana R. .................................. Disclosed no confl ict of interest. Bahler, Lonneke .................................... Disclosed no confl ict of interest. Bahn, Gideon ........................................ Disclosed no confl ict of interest. Bai, Ge .................................................. Disclosed no confl ict of interest. Bai, Yang .............................................. Disclosed no confl ict of interest. Baier, Leslie J. ...................................... Disclosed no confl ict of interest. Baik, Sei Hyun ...................................... Disclosed no confl ict of interest. Bailbé, Danielle .................................... Disclosed no confl ict of interest. Bailetti, Diego ...................................... Disclosed no confl ict of interest. Bailey, Clifford J. .................................. Consultant: Abbott Laboratories, Inc., AstraZeneca Pharma-

ceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Sanofi , Takeda Pharma-ceuticals U.S.A., Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Merck Sharp & Dohme Limited

Bailey, Kent R. ...................................... Disclosed no confl ict of interest. Bailey, Robert A. ................................... Employee: Janssen Scientifi c Affairs, LLC Bailey, Timothy S. ................................. Consultant: Lifescan Animas, Inc., Medtronic, Novo Nordisk,

Inc., Roche Pharmaceuticals, Sanofi ; Research Support: Abbott Diabetes Care, Animas Corporation, Asante Solu-tions, Bayer Health Care, LLC, BD Medical Diabetes Care, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Cebix, Corcept, Dexcom, Inc., Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline, Ha-lozyme Therapeutics, Insulet Corporation, Lifescan, Inc., MannKind Corporation, Medtronic, Merck, Novo Nordisk, Inc., Orexigen Therapeutics, Inc., ResMed, Sanofi , Tandem Diabetes Care, Versartis, Inc.; Speaker’s Bureau: Novo Nordisk, Inc.

Baimbridge, Charles L. ......................... Disclosed no confl ict of interest. Baimbridge, Susan A. ........................... Disclosed no confl ict of interest. Bajaj, Mandeep .................................... Advisory Panel: Sanofi , Takeda Pharmaceuticals U.S.A.,

Inc.; Research Support: Amylin Pharmaceuticals, Inc.,

AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company

Bajpeyi, Sudip ...................................... Disclosed no confl ict of interest. Baker, Chris .......................................... Disclosed no confl ict of interest. Baker, Dana .......................................... Disclosed no confl ict of interest. Baker, Nathaniel L. ............................... Disclosed no confl ict of interest. Baker, Rocky ......................................... Disclosed no confl ict of interest. Baker, Salah A. ..................................... Disclosed no confl ict of interest. Baker, William ...................................... Disclosed no confl ict of interest. Bakhtiani, Parkash A. ........................... Disclosed no confl ict of interest. Bakker, Wineke .................................... Disclosed no confl ict of interest. Bakris, George L. .................................. Board Member: National Kidney Foundation, American Society

of Hypertension; Consultant: Takeda, Abbott, CVRx, Johnson & Johnson, Eli Lilly and Company, Food and Drug Administration; Other Relationship: Medtronic, Relypsa; Research Support: Forest Labs, Takeda

Balaji, Shruti ......................................... Disclosed no confl ict of interest. Balamurugan, Kandasamy ................... Disclosed no confl ict of interest. Balas, Bogdan ...................................... Disclosed no confl ict of interest. Balasubramanyam, Ashok .................... Disclosed no confl ict of interest. Balcerska, Anna ................................... Disclosed no confl ict of interest. Balci, Mustafa K. .................................. Disclosed no confl ict of interest. Balderramo Gil, Paula .......................... Disclosed no confl ict of interest. Baldi, Rita ............................................. Disclosed no confl ict of interest. Baldi, Simona ....................................... Disclosed no confl ict of interest. Baldivieso Hurtado, Olivia .................... Disclosed no confl ict of interest. Baldwin, Aaron C. ................................ Disclosed no confl ict of interest. Bales, Connie ....................................... Disclosed no confl ict of interest. Balhara, Bharti ..................................... Disclosed no confl ict of interest. Balkau, Beverley ................................... Disclosed no confl ict of interest. Balkir, Tanzer ........................................ Employee: Novo Nordisk A/S Ballantyne, Christie M. ........................ Disclosed no confl ict of interest. Balon, Thomas W. ................................ Disclosed no confl ict of interest. Balta, Sevket ........................................ Disclosed no confl ict of interest. Balthazar, Erick ..................................... Disclosed no confl ict of interest. Baltz, Jean C. ....................................... Disclosed no confl ict of interest. Baluch, Debra P. ................................... Disclosed no confl ict of interest. Bamford, Rosie ..................................... Disclosed no confl ict of interest. Ban, Linda A. ........................................ Disclosed no confl ict of interest. Ban, Woo Ho ........................................ Disclosed no confl ict of interest. Banach, Maciej .................................... Disclosed no confl ict of interest. Banchereau, Jacques ........................... Disclosed no confl ict of interest. Bando, Yukiko ....................................... Disclosed no confl ict of interest. Banerji, Mary Ann ................................ Disclosed no confl ict of interest. Banks, Jaminelli ................................... Disclosed no confl ict of interest. Banks, Kate .......................................... Disclosed no confl ict of interest. Banks, Phillip ........................................ Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Bannister, Christian A. ......................... Disclosed no confl ict of interest. Bannister, Thomas ................................ Disclosed no confl ict of interest. Banno, Ryoichi ...................................... Disclosed no confl ict of interest. Bansal, Kushagra ................................. Disclosed no confl ict of interest. Bantle, John P. ...................................... Disclosed no confl ict of interest. Banton, Tom ......................................... Disclosed no confl ict of interest. Banu, Isabela ........................................ Disclosed no confl ict of interest. Bao, Suqing .......................................... Disclosed no confl ict of interest. Bao, Wei ............................................... Disclosed no confl ict of interest. Bao, Yuqian .......................................... Disclosed no confl ict of interest. Bapputty, Reena ................................... Disclosed no confl ict of interest. Baptista, Carla ...................................... Disclosed no confl ict of interest. Baqai, Najah ......................................... Disclosed no confl ict of interest. Baqar, Sara ........................................... Disclosed no confl ict of interest. Bar Dayan, Yosefa ................................ Disclosed no confl ict of interest. Baraboi, Elena-Dana ............................ Disclosed no confl ict of interest. Baranchuck, Adrian .............................. Disclosed no confl ict of interest. Baratta, Roberto ................................... Disclosed no confl ict of interest. Barb, Diana ........................................... Disclosed no confl ict of interest. Barbaro, Barbara .................................. Disclosed no confl ict of interest. Barber, Thomas M. ............................... Disclosed no confl ict of interest. Barbetti, Fabrizio .................................. Disclosed no confl ict of interest. Barbour, Linda A. .................................. Disclosed no confl ict of interest. Barceló, Sílvia ...................................... Disclosed no confl ict of interest. Barceló-Rico, Fàtima ............................ Disclosed no confl ict of interest. Barcham, Samih ................................... Disclosed no confl ict of interest. Barclay, Alan W. ................................... Other Relationship: Glycemic Index Foundation Barcos, Isabelle .................................... Disclosed no confl ict of interest. Bardenheier, Barbara H. ....................... Disclosed no confl ict of interest. Bargellini, Irene .................................... Disclosed no confl ict of interest. Barker, Lawrence E. .............................. Disclosed no confl ict of interest.

Dow



A835


AU

THO

R D

ISCL

OSU

RE

Barkhof, Frederik .................................. Disclosed no confl ict of interest. Barlovic Pongrac, Drazenka .................. Disclosed no confl ict of interest. Barlow, Allison ..................................... Disclosed no confl ict of interest. Barnard, Katharine ............................... Consultant: Roche Diagnostics Barnard, Maria ..................................... Disclosed no confl ict of interest. Barnard, Neal D. ................................... Disclosed no confl ict of interest. Barnes, Catherine S. ............................ Disclosed no confl ict of interest. Barnett, Anthony H. .............................. Advisory Panel: Boehringer Ingelheim GmbH & Co. KG, Bris-

tol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuti-cals Corporation, Novo Nordisk, Inc., Roche Pharmaceu-ticals, Sanofi Aventis, Takeda Pharmaceutical Company, Ltd.; Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.; Research Support: Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi Aventis, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi Aventis, Takeda Pharmaceutical Company, Ltd.

Barnett, Mitchell .................................. Disclosed no confl ict of interest. Baron, Alain .......................................... Board Member: Elcelyx Therapeutics, Inc.; Employee: Elcelyx

Therapeutics, Inc.; Stock/Shareholder: Elcelyx Therapeu-tics, Inc.

Barone, Bianca ..................................... Disclosed no confl ict of interest. Baronikian, Lillit ................................... Disclosed no confl ict of interest. Barrack, Andrea .................................... Disclosed no confl ict of interest. Barrera, Jerome R. ............................... Disclosed no confl ict of interest. Barreto, Sandhi M. ............................... Disclosed no confl ict of interest. Barrett, David G. ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Barrett, Eugene J. ................................ Disclosed no confl ict of interest. Barrett, Helen L. ................................... Research Support: Cardiovascular Lipid Research Grant, Pfi zer,

Inc. Barrett-Connor, Elizabeth L. ................. Consultant: Eli Lilly and Company, Merck; Speaker’s Bureau:

Eli Lilly and Company, Merck Barrette, Kevin ..................................... Disclosed no confl ict of interest. Barriga, Eduardo S. .............................. Employee: VisionQuest Biomedical Barriga, Kathy ....................................... Disclosed no confl ict of interest. Barrio, Francisco ................................... Disclosed no confl ict of interest. Barros, Luísa ......................................... Disclosed no confl ict of interest. Barsotti, Elisabetta ............................... Disclosed no confl ict of interest. Barsotti, Massimiliano ......................... Disclosed no confl ict of interest. Barstow, Mariah M. ............................. Disclosed no confl ict of interest. Bartha, José L. ..................................... Disclosed no confl ict of interest. Bartlett, Briohny ................................... Disclosed no confl ict of interest. Bartov, Noam ........................................ Disclosed no confl ict of interest. Barufaldi, Laura .................................... Disclosed no confl ict of interest. Barzilai, Nir ........................................... Disclosed no confl ict of interest. Barzilay, Joshua ................................... Disclosed no confl ict of interest. Basantani, Mahesh K. .......................... Disclosed no confl ict of interest. Basaraba, Randall J. ............................ Disclosed no confl ict of interest. Basch, Peter ......................................... Disclosed no confl ict of interest. Baser, Onur ........................................... Disclosed no confl ict of interest. Baskaran, Charu ................................... Disclosed no confl ict of interest. Bass, Joseph T. .................................... Advisory Panel: Reset Therapeutics; Board Member: Janssen

Pharmaceuticals, Vanda Pharmaceuticals; Speaker’s Bu-reau: Gehrson Lehrman Group, Merck; Stock/Shareholder: Reset Therapeutics

Bassi, Roberto ...................................... Disclosed no confl ict of interest. Bassil, Ribal .......................................... Disclosed no confl ict of interest. Bassyouni, A. ........................................ Disclosed no confl ict of interest. Bast, Ingolf ........................................... Disclosed no confl ict of interest. Basu, Ananda ....................................... Disclosed no confl ict of interest. Basu, Rita ............................................. Disclosed no confl ict of interest. Basu, Subhabrata ................................. Disclosed no confl ict of interest. Batayyah, Esam .................................... Disclosed no confl ict of interest. Batchelor, Kim ...................................... Disclosed no confl ict of interest. Bateman, Lori A. ................................... Disclosed no confl ict of interest. Batista Jr., Miguel L. ............................ Disclosed no confl ict of interest. Batra, Manav ........................................ Disclosed no confl ict of interest. Battelino, Tadej .................................... Board Member: Bayer Health Care, LLC, Medtronic, Novo Nor-

disk, Inc., Sanofi ; Consultant: Spring; Research Support: Abbott Diabetes Care, Diamyd Medical AB, GluSense, Medtronic, Novo Nordisk, Inc., Sandoz, Sanofi ; Speaker’s Bureau: Bayer Health Care, LLC, Eli Lilly and Company, Medtronic, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi

Battezzati, Alberto ................................ Disclosed no confl ict of interest. Bauduceau, Bernard ............................. Consultant: AstraZeneca/Bristol-Meyers Squibb, Bayer

Health Care, LLC, BD Medical Diabetes Care, Boehring-er Ingelheim GmbH & Co. KG, Eli Lilly and Company, GSK, IPSEN - Formulation Innovation, Merck, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi, Servier, Takeda Pharmaceuti-cal Company, Ltd.; Research Support: Merck, Novo Nordisk, Inc.

Bauer, Steven M. .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company

Baughman, Robert A. ........................... Employee: MannKind Corporation; Stock/Shareholder: Mann-Kind Corporation

Baumann, Johannes ............................. Disclosed no confl ict of interest. Baumeier, Christian .............................. Disclosed no confl ict of interest. Baumstark, Annette ............................. Disclosed no confl ict of interest. Baus, Adam D. ...................................... Disclosed no confl ict of interest. Baverel, Gabriel .................................... Employee: Metabolys; Stock/Shareholder: Metabolys Baxi, Sunita .......................................... Disclosed no confl ict of interest. Bayatli, Nur .......................................... Disclosed no confl ict of interest. Bayer, Allison L. .................................... Disclosed no confl ict of interest. Bayless, Margaret ................................ Disclosed no confl ict of interest. Baynes, John W. .................................. Disclosed no confl ict of interest. Baynes, Kevin C. ................................... Disclosed no confl ict of interest. Bayrak, Elif S. ....................................... Disclosed no confl ict of interest. Bays, Harold E. ..................................... Advisory Panel: AstraZeneca Pharmaceuticals LP; Speaker’s

Bureau: AstraZeneca Pharmaceuticals LP Baysal, Nihat ........................................ Disclosed no confl ict of interest. Bazarek, Stanley ................................... Disclosed no confl ict of interest. Bazer, Fuller W. .................................... Disclosed no confl ict of interest. Baz-Hecht, Merav ................................. Employee: Daiichi-Sankyo, Inc. Beall, Craig ........................................... Disclosed no confl ict of interest. Beals, Chan R. ...................................... Employee: Merck Sharp & Dohme Limited Beals, John M. ..................................... Advisory Panel: Rose Hulman Institute of Technology;

Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company

Beam, Craig A. ..................................... Disclosed no confl ict of interest. Beamish, Christine A. ........................... Disclosed no confl ict of interest. Beare, Richard ...................................... Disclosed no confl ict of interest. Bearham, Jade ..................................... Employee: Novo Nordisk A/S Beatson, Christie .................................. Disclosed no confl ict of interest. Beatty, Susan ....................................... Disclosed no confl ict of interest. Beaudry, Jacqueline L. ......................... Disclosed no confl ict of interest. Beavers, Daniel P. ................................. Disclosed no confl ict of interest. Beavers, Lisa S. .................................... Employee: Eli Lilly and Company Beavo, Joseph ...................................... Disclosed no confl ict of interest. Bechtold, Andrea .................................. Disclosed no confl ict of interest. Beck, Joni K. ......................................... Disclosed no confl ict of interest. Beck, Peter ........................................... Disclosed no confl ict of interest. Beck, Roy W. ........................................ Advisory Panel: Sanofi ; Consultant: Animas; Research Sup-

port: Novo Nordisk, Inc., Sanofi Beckam, Jenna ..................................... Disclosed no confl ict of interest. Becker, Alexandre D. ............................ Disclosed no confl ict of interest. Becker, Dorothy J. ................................ Disclosed no confl ict of interest. Becker, Matthijs L. ............................... Disclosed no confl ict of interest. Becker, Reinhard H. .............................. Employee: Sanofi Becker, Thomas C. ................................ Disclosed no confl ict of interest. Beckers, Johannes ............................... Disclosed no confl ict of interest. Beckles, Gloria L. .................................. Disclosed no confl ict of interest. Beck-Nielsen, Henning ......................... Disclosed no confl ict of interest. Bee, Yong Mong ................................... Disclosed no confl ict of interest. Beebe, David A. .................................... Employee: Pfi zer, Inc. Beech, Bettina M. ................................ Disclosed no confl ict of interest. Beer-Stolz, Donna ................................ Disclosed no confl ict of interest. Befroy, Douglas E. ................................ Disclosed no confl ict of interest. Beg, Mohd ............................................ Disclosed no confl ict of interest. Begowatz, Paul ..................................... Disclosed no confl ict of interest. Begum, Safi a ........................................ Disclosed no confl ict of interest. Behary, Preeshila .................................. Disclosed no confl ict of interest. Beige, Joachim ..................................... Disclosed no confl ict of interest. Beilman, Gregory J. .............................. Disclosed no confl ict of interest. Bekaert, Marlies ................................... Disclosed no confl ict of interest. Bekker, Pirow ........................................ Employee: ChemoCentryx; Stock/Shareholder: ChemoCentryx Belardinelli, Luiz ................................... Employee: Gilead Sciences, Inc. Belda-Iniesta, Cristobal ........................ Disclosed no confl ict of interest. Belfort De Aguiar, Renata .................... Disclosed no confl ict of interest. Belinova, Lenka .................................... Disclosed no confl ict of interest. Bell, Graeme I. ...................................... Other Relationship: Athena Diagnostics Bell, Kelly ............................................. Employee: Bristol-Myers Squibb Company Bell, Kirstine ......................................... Disclosed no confl ict of interest. Bell, Matthew L. ................................... Disclosed no confl ict of interest. Bell, Ronny A. ....................................... Disclosed no confl ict of interest.

Dow



A836


AU

THO

R D

ISCL

OSU

RE

Bellante, Rosalia .................................. Disclosed no confl ict of interest. Bellia, Alfonso ...................................... Disclosed no confl ict of interest. Bellin, Melena D. ................................. Research Support: Merck Bellomo, Elisa A. .................................. Disclosed no confl ict of interest. Bellows, Brandon K. ............................. Disclosed no confl ict of interest. Belsky, Jennifer .................................... Disclosed no confl ict of interest. Belsley, Scott J. .................................... Disclosed no confl ict of interest. Bembe, Marylou ................................... Disclosed no confl ict of interest. Ben Avraham, Danny ............................ Disclosed no confl ict of interest. Benabbas, Youcef ................................. Advisory Panel: Novo Nordisk A/S; Board Member: Pfi zer, Inc.;

Speaker’s Bureau: Novo Nordisk A/S, Pfi zer, Inc. Benabdallah, Sonia .............................. Disclosed no confl ict of interest. Benamo, Eric ........................................ Disclosed no confl ict of interest. Bender, Diane E. ................................... Disclosed no confl ict of interest. Benhamou, Pierre-Yves ........................ Disclosed no confl ict of interest. Bennett, Peter H. .................................. Disclosed no confl ict of interest. Bennett, Robert G. ................................ Disclosed no confl ict of interest. Bennett, Wendy T. ................................ Disclosed no confl ict of interest. Benninger, Richard K. ........................... Disclosed no confl ict of interest. Benoist, Christophe .............................. Disclosed no confl ict of interest. Benoit, Stephen C. ............................... Disclosed no confl ict of interest. Benoit, Vivian M. .................................. Disclosed no confl ict of interest. Benson, Gretchen ................................. Disclosed no confl ict of interest. Benterki, Isma ...................................... Disclosed no confl ict of interest. Benyamin, Beben ................................. Disclosed no confl ict of interest. Benzinou, Michael ................................ Disclosed no confl ict of interest. Beom, Sun Hee ..................................... Disclosed no confl ict of interest. Bequette, B. Wayne ............................. Disclosed no confl ict of interest. Berahovich, Robert D. .......................... Employee: ChemoCentryx Beren, Ian A. ......................................... Consultant: Genentech Berenguer, Marina ............................... Disclosed no confl ict of interest. Beresford, Shirley ................................. Disclosed no confl ict of interest. Berg, Jonathan ..................................... Disclosed no confl ict of interest. Bergenstal, Richard M. ........................ Advisory Panel: Abbott Diabetes Care, AstraZeneca/Bristol-

Meyers Squibb, Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Halozyme Therapeutics, Hygieia, Inc., Johnson & John-son, Medtronic, Novo Nordisk, Inc., Roche Pharma-ceuticals, Sanofi ; Consultant: Abbott Diabetes Care, AstraZeneca/Bristol-Meyers Squibb, Bayer Health Care, LLC, BD Medical Diabetes Care, Boehringer Ingelheim Pharmaceuticals, Inc., Calibra Medical, Inc., Dexcom, Inc., Eli Lilly and Company, Halozyme Therapeutics, Hygieia, Inc., Johnson & Johnson, Medtronic, Merck, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi ; Other Relationship: All contracts with Park Nicollet Institute; Research Support: AstraZeneca Pharmaceuticals LP, Bayer Health Care, LLC, BD Medical Diabetes Care, Boehringer Ingelheim Pharmaceuticals, Inc., Calibra Medical, Inc., Dexcom, Inc., Eli Lilly and Company, Halozyme Therapeu-tics, Helmsley Charitable Trust, Hygieia, Inc., Johnson & Johnson, Medtronic, Merck, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi ; Stock/Shareholder: Merck

Berger, Matthew .................................. Disclosed no confl ict of interest. Bergeron, Marcy ................................... Disclosed no confl ict of interest. Berggren, Per-Olof ................................ Disclosed no confl ict of interest. Bergis Jurgan, Nikola ........................... Research Support: Berlin Chemie; Speaker’s Bureau: Berlin

Chemie Bergman, Arthur ................................... Employee: Pfi zer, Inc.; Research Support: Pfi zer, Inc.; Stock/

Shareholder: Pfi zer, Inc. Bergman, Bryan C. ................................ Disclosed no confl ict of interest. Bergman, Donald A. ............................. Disclosed no confl ict of interest. Bergman, Richard N. ............................ Advisory Panel: Amylin Pharmaceuticals, Inc.; Board Member:

Tethys; Consultant: Merck, Novo Nordisk A/S, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Merck

Bergmann, Karin ................................... Employee: Sanofi Bergstrom, Colin ................................... Disclosed no confl ict of interest. Berhane, Feven ..................................... Disclosed no confl ict of interest. Berkowitz, Seth A. ................................ Disclosed no confl ict of interest. Berlin, Jesse A. .................................... Employee: Janssen Research & Development; Stock/Share-

holder: Janssen Research & Development Berman, Reena ..................................... Disclosed no confl ict of interest. Bermudez-Millan, Angela .................... Disclosed no confl ict of interest. Bernal-Lopez, Rosa ............................... Disclosed no confl ict of interest. Bernardo, Barbara L. ............................ Employee: Pfi zer, Inc. Bernaud, Fernanda ............................... Disclosed no confl ict of interest. Berndt-Zipfel, Christine ........................ Disclosed no confl ict of interest. Berneir, Angelina .................................. Disclosed no confl ict of interest. Bernier, Michel ..................................... Disclosed no confl ict of interest. Bernini, Arianna ................................... Disclosed no confl ict of interest. Bernsen, Sveinung ............................... Disclosed no confl ict of interest. Bernstein, Richard A. ........................... Disclosed no confl ict of interest.

Berria, Rachele ..................................... Employee: Sanofi Berry, Rodney ....................................... Disclosed no confl ict of interest. Berry, Scott ........................................... Other Relationship: Berry Consultants Bertera, Suzanne .................................. Disclosed no confl ict of interest. Berti, Lucia ........................................... Disclosed no confl ict of interest. Bertola, Adeline ................................... Disclosed no confl ict of interest. Bertola, Susana Carolina ..................... Disclosed no confl ict of interest. Bertoldo, Alessandra ............................ Disclosed no confl ict of interest. Bertoli, Simona ..................................... Disclosed no confl ict of interest. Bertram, Richard .................................. Disclosed no confl ict of interest. Besser, Rachel E. .................................. Disclosed no confl ict of interest. Best, Jennie H. ..................................... Employee: Amylin Pharmaceuticals, Inc.; Stock/Shareholder:

Amylin Pharmaceuticals, Inc. Best, Lyle G. ......................................... Disclosed no confl ict of interest. Bethin, Kathleen ................................... Disclosed no confl ict of interest. Beveridge, Susan ................................. Disclosed no confl ict of interest. Beverly, Elizabeth A. ............................. Disclosed no confl ict of interest. Bevier, Wendy C. .................................. Disclosed no confl ict of interest. Beyer, Andreas M. ................................ Disclosed no confl ict of interest. Beysen, Carine ..................................... Employee: KineMed, Inc.; Stock/Shareholder: KineMed, Inc. Bezy, Olivier .......................................... Disclosed no confl ict of interest. Bharaj, Bhupinder ................................. Disclosed no confl ict of interest. Bhargava, Purvi V. ................................. Disclosed no confl ict of interest. Bhasin, Girish Kumar ............................ Disclosed no confl ict of interest. Bhat, Dattatray S. ................................. Disclosed no confl ict of interest. Bhat, Deepa .......................................... Disclosed no confl ict of interest. Bhat, Sathesh ....................................... Disclosed no confl ict of interest. Bhatnagar, Sushant .............................. Disclosed no confl ict of interest. Bhatt, Deepak L. ................................... Advisory Panel: Medscape, LLC; Board Member: American

Heart Association; Research Support: Amarin, AstraZene-ca/Bristol-Meyers Squibb, Eisai, Inc., Ethicon, Medtronic, Sanofi , The Medicines Company

Bhatt, Shweta ...................................... Disclosed no confl ict of interest. Bhattacharjee, Sandipan ...................... Research Support: Sanofi Bhattacharya, Rituparna ...................... Research Support: Sanofi Bhatti, Rahila S. ................................... Disclosed no confl ict of interest. Bhatwadekar, Ashay D. ........................ Disclosed no confl ict of interest. Bhavna, Bhavna .................................... Disclosed no confl ict of interest. Bhetwal, Bhupal B. ............................... Disclosed no confl ict of interest. Bhonde, Ramesh R. .............................. Disclosed no confl ict of interest. Bhoraskar, Anil ..................................... Disclosed no confl ict of interest. Bhutta, Hina Y. ...................................... Disclosed no confl ict of interest. Bi, Hong Yan ......................................... Disclosed no confl ict of interest. Bi, Jian ................................................. Disclosed no confl ict of interest. Bi, Yan .................................................. Disclosed no confl ict of interest. Bian, Hejiao .......................................... Disclosed no confl ict of interest. Bianchi, Lucio ....................................... Disclosed no confl ict of interest. Bidasee, Keshore R. ............................. Disclosed no confl ict of interest. Biertho, Laurent .................................... Disclosed no confl ict of interest. Biessen, Erik ......................................... Disclosed no confl ict of interest. Biester, Torban ..................................... Disclosed no confl ict of interest. Biggs, Mary Lou ................................... Disclosed no confl ict of interest. Bijl-Oeldrich, Judith ............................. Disclosed no confl ict of interest. Bijos, Pawel .......................................... Disclosed no confl ict of interest. Bilet, Lena ............................................ Disclosed no confl ict of interest. Billilngton, Charles ............................... Disclosed no confl ict of interest. Bilz, Susanne ........................................ Disclosed no confl ict of interest. Binz, Jane G. ........................................ Disclosed no confl ict of interest. Biondi, Giuseppina ............................... Disclosed no confl ict of interest. Biragova, Margarita ............................. Disclosed no confl ict of interest. Birnbaum, Morris J. ............................. Disclosed no confl ict of interest. Birkeland, Kåre I. .................................. Disclosed no confl ict of interest. Birkenfeld, Andreas L. .......................... Disclosed no confl ict of interest. Birnbaum, Howard ............................... Disclosed no confl ict of interest. Birnbaum, Yochai ................................. Research Support: Amylin Pharmaceuticals, Inc., AstraZeneca

Pharmaceuticals LP, Forest Pharmaceuticals, Inc., Merck, Roche Pharmaceuticals

Birnbaumer, Lutz ................................... Disclosed no confl ict of interest. Biron, Simon ......................................... Disclosed no confl ict of interest. Bisceglia, Lucia .................................... Disclosed no confl ict of interest. Bishop, Franziska .................................. Disclosed no confl ict of interest. Bishop, Jonathan S. ............................. Disclosed no confl ict of interest. Bishop, Michael J. ............................... Employee: GlaxoSmithKline Bitovska, Iskra ...................................... Disclosed no confl ict of interest. Bitton, Gabriel ...................................... Employee: Insuline Medical; Stock/Shareholder: Insuline

Medical Bjornstad, Petter .................................. Disclosed no confl ict of interest. Blaak, Ellen ........................................... Disclosed no confl ict of interest. Black, Dawn ......................................... Disclosed no confl ict of interest. Black, Mary Helen ................................ Disclosed no confl ict of interest. Blackburn, Mary Clare .......................... Disclosed no confl ict of interest. Black-Shinn, Jennifer ........................... Disclosed no confl ict of interest.

Dow



A837


AU

THO

R D

ISCL

OSU

RE

Blackwell, Caroline S. .......................... Disclosed no confl ict of interest. Blaesig, Sarah ...................................... Disclosed no confl ict of interest. Blaha, Jan ............................................ Disclosed no confl ict of interest. Blair, Eric C. .......................................... Disclosed no confl ict of interest. Blake, Donald R. ................................... Disclosed no confl ict of interest. Blanco Carrasco, Antonio Jesús .......... Disclosed no confl ict of interest. Blanco, Marta ....................................... Disclosed no confl ict of interest. Blangero, John ..................................... Disclosed no confl ict of interest. Blank, Annika ....................................... Disclosed no confl ict of interest. Blank, Jeffrey ....................................... Disclosed no confl ict of interest. Blase, Erich ........................................... Employee: Amylin Pharmaceuticals, LLC Blaslov, Kristina .................................... Disclosed no confl ict of interest. Blaum, Caroline S. ................................ Disclosed no confl ict of interest. Blebu, Bridgette ................................... Disclosed no confl ict of interest. Blevins, Thomas C. ............................... Research Support: Amylin Pharmaceuticals, Inc., Eli

Lilly and Company, Medtronic MiniMed, Inc., Novo Nordisk, Inc., Sanofi; Speaker’s Bureau: Abbott Labo-ratories, Inc., Amylin Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Medtronic MiniMed, Inc., Merck, Novo Nordisk, Inc., Sanofi

Blickem, Christian ................................ Disclosed no confl ict of interest. Blizzard, Leigh ...................................... Disclosed no confl ict of interest. Blodgett, David M. ............................... Disclosed no confl ict of interest. Blonde, Lawrence ................................. Advisory Panel: Amylin Pharmaceuticals, Inc., GlaxoSmith-

Kline, Janssen Pharmaceuticals, Merck, Novo Nordisk, Inc., sanofi -aventis, Santarus, Inc.; Research Support: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi -Aventis; Speaker’s Bureau: Amylin Pharmaceuticals, Inc., Janssen Pharmaceuticals, Johnson Diabetes Institute, Merck, Novo Nordisk, Inc., Santarus, Inc.

Blossom, Jennifer ................................ Disclosed no confl ict of interest. Blot, William J. .................................... Disclosed no confl ict of interest. Bluck, Les J. ......................................... Disclosed no confl ict of interest. Blueher, Matthias ................................. Disclosed no confl ict of interest. Bluemke, David A. ................................ Disclosed no confl ict of interest. Blüher, Matthias ................................... Disclosed no confl ict of interest. Bluhme, Henrik ..................................... Disclosed no confl ict of interest. Bluhmki, Erich ....................................... Employee: Boehringer Ingelheim GmbH & Co. KG Blum, Hubert E. .................................... Disclosed no confl ict of interest. Blum, Shany ......................................... Disclosed no confl ict of interest. Blumensatt, Marcel .............................. Disclosed no confl ict of interest. Boardman, Marilyn K. .......................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Boaz, Mona .......................................... Disclosed no confl ict of interest. Bocca, Nicola ....................................... Disclosed no confl ict of interest. Bockus, Lee .......................................... Disclosed no confl ict of interest. Bodary, Peter F. ..................................... Disclosed no confl ict of interest. Bode, Bruce W. ..................................... Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S,

Sanofi ; Consultant: Eli Lilly and Company, Novo Nordisk A/S, Sanofi ; Research Support: Eli Lilly and Company, Johnson & Johnson, Merck, Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: Amylin Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck, Novo Nordisk A/S, Sanofi

Bodinham, Caroline .............................. Disclosed no confl ict of interest. Boehm, Anja ......................................... Disclosed no confl ict of interest. Boehm, Bernhard .................................. Disclosed no confl ict of interest. Boehm, Kristi A. ................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Boesch, Chris ........................................ Disclosed no confl ict of interest. Boettcher, Bonniejean .......................... Employee: NeuroMetrix; Stock/Shareholder: NeuroMetrix Bogardus, Clifton .................................. Disclosed no confl ict of interest. Bøgelund, Mette .................................. Consultant: Novo Nordisk A/S Boggi, Ugo ............................................ Disclosed no confl ict of interest. Bognar, Katalin ..................................... Employee: Precision Health Economics Böhm, Anja ........................................... Disclosed no confl ict of interest. Bohnett, Lucas ...................................... Employee: Dexcom, Inc. Boiroux, Dimitri .................................... Disclosed no confl ict of interest. Boivin, Gregory ..................................... Disclosed no confl ict of interest. Bojsen-Møller, Kirstine N. .................... Disclosed no confl ict of interest. Bokvist, Krister B. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Boland, Brandon B. ............................... Disclosed no confl ict of interest. Boldog, Eszter ....................................... Disclosed no confl ict of interest. Bolen, Shari .......................................... Disclosed no confl ict of interest. Boleyn, Karen L. ................................... Employee: Eli Lilly and Company Bolis, Angiola ....................................... Disclosed no confl ict of interest. Bolli, Geremia B. .................................. Advisory Panel: Bristol-Myers Squibb Company, Eli Lilly and

Company, Novartis Pharmaceuticals Corporation, Sanofi ; Research Support: Sanofi

Bollyky, Jennifer B. ............................... Disclosed no confl ict of interest.

Bolo, Nicolas R. .................................... Disclosed no confl ict of interest. Bonadonna, Riccardo C. ....................... Advisory Panel: Eli Lilly and Company, Merck Sharp & Dohme

Limited, Sanofi ; Speaker’s Bureau: Merck Sharp & Dohme Limited

Bonaventura, Aldo ................................ Disclosed no confl ict of interest. Bondia, Jorge ....................................... Disclosed no confl ict of interest. Bone, Robert N. .................................... Disclosed no confl ict of interest. Bonetti, Sara ........................................ Disclosed no confl ict of interest. Bonfanti, Riccardo ................................ Disclosed no confl ict of interest. Bongers, Kale S. ................................... Disclosed no confl ict of interest. Bonilla Islas, Ayeza .............................. Disclosed no confl ict of interest. Bonini, Stefano ..................................... Disclosed no confl ict of interest. Boniol, Mathieu .................................... Disclosed no confl ict of interest. Bonnefond, Amélie ............................... Disclosed no confl ict of interest. Bonner, Caroline ................................... Disclosed no confl ict of interest. Bonner, Jeffrey S. ................................. Disclosed no confl ict of interest. Bonner-Weir, Susan ............................. Consultant: Amylin Pharmaceuticals, Inc. (Spouse/Partner),

Pfi zer, Inc. (Spouse/Partner); Speaker’s Bureau: Merck (Spouse/Partner), Novo Nordisk, Inc. (Spouse/Partner)

Bonnici, François .................................. Consultant: Andromeda Biotech, Ltd. Bonora, Enzo ......................................... Advisory Panel: Abbott Laboratories, Inc., AstraZeneca Phar-

maceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Com-pany, GlaxoSmithKline, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Roche Pharmaceuticals, Takeda Pharmaceutical Company, Ltd.; Research Support: Bruno Farmaceutici, Menarini, Novo Nordisk, Inc., Takeda Pharmaceutical Company, Ltd.; Stock/Shareholder: Eli Lilly and Company, Novo Nordisk, Inc., Pfi zer, Inc.

Boock, Robert ....................................... Employee: Dexcom, Inc. Boodhoo, Amechand ............................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Booij, Jan ............................................. Disclosed no confl ict of interest. Boon, Hanneke ..................................... Disclosed no confl ict of interest. Boran, Gerard ....................................... Disclosed no confl ict of interest. Borchert, Marcus .................................. Disclosed no confl ict of interest. Borch-Johnsen, Knut ............................ Disclosed no confl ict of interest. Bordeleau, Louise ................................. Disclosed no confl ict of interest. Bordin, Silvana ..................................... Disclosed no confl ict of interest. Bordner, Andrew .................................. Disclosed no confl ict of interest. Borecki, Ingrid B. .................................. Disclosed no confl ict of interest. Borelli, María I. .................................... Disclosed no confl ict of interest. Borges, Jorge C. ................................... Disclosed no confl ict of interest. Borges-Yañez, Socorro Aida ................. Disclosed no confl ict of interest. Borgman, Sarah .................................... Disclosed no confl ict of interest. Bornagel, Betty ..................................... Disclosed no confl ict of interest. Bornstein, Stephan ............................... Disclosed no confl ict of interest. Borowiec, Maciej ................................. Disclosed no confl ict of interest. Borschuk, Adrienne P. ........................... Disclosed no confl ict of interest. Bortell, Rita .......................................... Disclosed no confl ict of interest. Bosch, Jackie ....................................... Disclosed no confl ict of interest. Boschem, Elke ...................................... Disclosed no confl ict of interest. Bosco, Domenico .................................. Disclosed no confl ict of interest. Böse, Marlen ........................................ Disclosed no confl ict of interest. Boselli, Linda ........................................ Disclosed no confl ict of interest. Boska, Michael D. ................................ Disclosed no confl ict of interest. Bosma, Madeleen ................................ Disclosed no confl ict of interest. Boss, Anders H. .................................... Employee: MannKind Corporation; Stock/Shareholder: Mann-

Kind Corporation Bostick, Sarah ...................................... Disclosed no confl ict of interest. Boston, Bruce ....................................... Disclosed no confl ict of interest. Bota, Maria .......................................... Disclosed no confl ict of interest. Botta, Julian ......................................... Disclosed no confl ict of interest. Bottino, Rita ......................................... Disclosed no confl ict of interest. Botto, Lorenzo ...................................... Disclosed no confl ict of interest. Botusan, Ileana Ruxandra .................... Disclosed no confl ict of interest. Bouatia-Naji, Nabila ............................ Disclosed no confl ict of interest. Bouby, Nadine ...................................... Disclosed no confl ict of interest. Bouchard, Claude ................................. Disclosed no confl ict of interest. Bouchard, Cynthia ................................ Disclosed no confl ict of interest. Bouchard, Guy F. ................................... Disclosed no confl ict of interest. Bouchard, Jonathan ............................. Employee: Novo Nordisk, Inc.; Stock/Shareholder: Novo

Nordisk, Inc. Boucher, Jackie .................................... Disclosed no confl ict of interest. Boucher, Jeremie ................................. Disclosed no confl ict of interest. Boucher-Berry, Claudia C. .................... Disclosed no confl ict of interest. Boucherie, Beatrix ................................ Disclosed no confl ict of interest. Bouchonville, Matthew ........................ Disclosed no confl ict of interest. Boulton, Andrew J.M. .......................... Disclosed no confl ict of interest. Boulvain, Michel .................................. Disclosed no confl ict of interest. Boulware, David ................................... Disclosed no confl ict of interest. Bound, Michelle ................................... Disclosed no confl ict of interest.

Dow



A838


AU

THO

R D

ISCL

OSU

RE

Bounthavong, Mark .............................. Disclosed no confl ict of interest. Bourlier, Virginie ................................... Disclosed no confl ict of interest. Boursiquot, Ludovic .............................. Disclosed no confl ict of interest. Bousboulas, Stavros ............................. Disclosed no confl ict of interest. Bouskela, Eliete .................................... Disclosed no confl ict of interest. Boutin-Foster, Carla .............................. Disclosed no confl ict of interest. Bouvier, Michel .................................... Disclosed no confl ict of interest. Bouziana, Stella ................................... Disclosed no confl ict of interest. Bowden, Charles H. .............................. Employee: Vivus, Inc. Bowden, Donald W. ............................. Disclosed no confl ict of interest. Bowden, Rita ........................................ Disclosed no confl ict of interest. Bowen, Michael E. ............................... Disclosed no confl ict of interest. Bowen, Sarah ....................................... Disclosed no confl ict of interest. Bower, Julie ......................................... Disclosed no confl ict of interest. Bowers, Katherine ................................ Disclosed no confl ict of interest. Bowes, Anita ........................................ Disclosed no confl ict of interest. Bowker, Weston ................................... Disclosed no confl ict of interest. Bowskill, Bridgit B. ............................... Disclosed no confl ict of interest. Boye, Kristina S. ................................... Board Member: EuroQol Group Foundation; Employee: Eli Lilly

and Company, Eli Lilly and Company (Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner)

Boyer, Bert ............................................ Disclosed no confl ict of interest. Boyko, Edward J. .................................. Other Relationship: Merck Boyle, Kristen E. ................................... Disclosed no confl ict of interest. Boyle, Peter .......................................... Research Support: Sanofi Bozkaya, Duygu .................................... Research Support: Takeda Global Research & Development

Center, Inc. Bozzetto, Lutgarda ................................ Disclosed no confl ict of interest. Bracy, Deanna P. ................................... Disclosed no confl ict of interest. Bradley, Cinnamon ............................... Disclosed no confl ict of interest. Bradley, Eloise ...................................... Disclosed no confl ict of interest. Bradshaw, Elizabeth M. ....................... Disclosed no confl ict of interest. Brady, Ann-Christina ............................ Disclosed no confl ict of interest. Brady, Emer M. ..................................... Disclosed no confl ict of interest. Braendstrup, Jeanett ........................... Disclosed no confl ict of interest. Braffett, Barbara H. .............................. Disclosed no confl ict of interest. Brahmandam, Archana ......................... Disclosed no confl ict of interest. Brake, Julie .......................................... Disclosed no confl ict of interest. Brakoniecki, Katrina ............................. Disclosed no confl ict of interest. Bramlage, Peter .................................... Consultant: Sanofi Brammer, Michael J. ............................ Disclosed no confl ict of interest. Brancati, Frederick L. ............................ Disclosed no confl ict of interest. Brancato, Davide .................................. Disclosed no confl ict of interest. Brandle, Michael .................................. Disclosed no confl ict of interest. Brand-Miller, Jennie C. ........................ Employee: Novo Nordisk A/S (Spouse/Partner) Brandon, Amanda E. ............................. Disclosed no confl ict of interest. Brandslund, Ivan ................................... Disclosed no confl ict of interest. Branoff, Janelle .................................... Disclosed no confl ict of interest. Brath, Helmut ....................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.

Daiichi Sankyo, Eli Lilly and Company, Merck Sharp & Do-hme Limited, Novartis, Novo Nordisk, Inc.Sanofi , Takeda; Other Relationship: Member of EDGE Steering Commitee; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo, Inc., Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis, Novo Nordisk, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd.

Brathwaite, Collin E. ............................ Disclosed no confl ict of interest. Bratina, Natasa .................................... Disclosed no confl ict of interest. Braun, Kathryn ...................................... Disclosed no confl ict of interest. Bray, George A. .................................... Disclosed no confl ict of interest. Brazg, Ronald L. .................................... Research Support: Abbott Diabetes Care, Bayer Health Care,

LLC, Johnson & Johnson, Roche Pharmaceuticals Breccia, Massimo ................................. Other Relationship: Bristol-Myers Squibb Company, Celgene

Corporation, Novartis Pharmaceuticals Corporation Brelje, Kerrin ........................................ Disclosed no confl ict of interest. Bremer, Andrew A. ............................... Consultant: Novo Nordisk, Inc.; Speaker’s Bureau: Pfi zer, Inc. Brenner, Jeffrey .................................... Disclosed no confl ict of interest. Brenner, Martin B. ................................ Employee: AstraZeneca Pharmaceuticals LP Bressler, Neil M. .................................. Research Support: Abbott Medical Optics Inc., Alimera

Sciences, Allergan USA, Inc, Bausch & Lomb, Carl Zeiss Meditec, Inc., DIAGNOS, Inc., ForSight Labs, LLC, Genentech, Genzyme Corporation, Lumenis Inc, Notal Vision, Novartis Pharma AG, Ora, Inc, Pfi zer, Inc., Quark Biotech, Inc., Regeneron Pharmaceuticals, Inc., Research to Prevent Blindness, Steba Biotech S.A., The EMMES Corporation

Brethauer, Stacy ................................... Consultant: Covidien Brewer, Paul Duffi eld ........................... Disclosed no confl ict of interest. Brewster, Lizzy ...................................... Disclosed no confl ict of interest. Breyer, Matthew D. .............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company

Brickey, Sarah R. .................................. Disclosed no confl ict of interest. Brickman, Wendy ................................. Disclosed no confl ict of interest. Bridenstine, Mark ................................. Disclosed no confl ict of interest. Bridges, Dave ....................................... Disclosed no confl ict of interest. Briganti, Silvia Irina .............................. Disclosed no confl ict of interest. Brightwell-Conrad, Angela S. .............. Employee: Metabolic Solutions Development Co. Bril, Fernando ....................................... Disclosed no confl ict of interest. Bril, Vera ............................................... Advisory Panel: Cebix, Inc., Eli Lilly and Company, Grifols USA,

LLC, Pfi zer, Inc. Brillon, David J. .................................... Disclosed no confl ict of interest. Brink Henriksen, Tine ........................... Disclosed no confl ict of interest. Brinton, John T. .................................... Disclosed no confl ict of interest. Brislen, Heather C. ............................... Disclosed no confl ict of interest. Brismar, Kerstin .................................... Disclosed no confl ict of interest. Brissova, Marcela ................................ Disclosed no confl ict of interest. Brits, Tim .............................................. Disclosed no confl ict of interest. Britton, Steve ....................................... Disclosed no confl ict of interest. Britton-Colonnese, Jennifer ................. Disclosed no confl ict of interest. Brix, Johanna M. .................................. Disclosed no confl ict of interest. Brixner, Diana ....................................... Advisory Panel: Novo Nordisk, Inc.; Consultant: Novo

Nordisk, Inc.; Research Support: Bristol-Myers Squibb Company

Brod, Meryl ........................................... Consultant: Novo Nordisk A/S Brodesser, Susanne .............................. Disclosed no confl ict of interest. Brodovicz, Kimberly G. ......................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Broedl, Uli C. ........................................ Employee: Boehringer Ingelheim GmbH & Co. KG Broholm, Christa ................................... Disclosed no confl ict of interest. Brokaw, Sarah ...................................... Disclosed no confl ict of interest. Bron, Morgan ....................................... Employee: Takeda Pharmaceuticals U.S.A., Inc.; Stock/

Shareholder: Takeda Pharmaceuticals U.S.A., Inc. Broniowska, Katarzyna A. .................... Disclosed no confl ict of interest. Bronisz, Agata ...................................... Disclosed no confl ict of interest. Bronisz, Marek ..................................... Disclosed no confl ict of interest. Brøns, Charlotte ................................... Stock/Shareholder: Novo Nordisk A/S Brook, Richard A. .................................. Consultant: Genentech Brooks, Augustin M. ............................. Disclosed no confl ict of interest. Brooks, Belinda A. ................................ Disclosed no confl ict of interest. Brooks, Kelly M. ................................... Disclosed no confl ict of interest. Brooks, Maria M. ................................. Research Support: Sanofi Brophy, Patricia .................................... Disclosed no confl ict of interest. Brosius, Frank ....................................... Disclosed no confl ict of interest. Broussard, Josiane L. ........................... Disclosed no confl ict of interest. Brouwers, Bram .................................... Disclosed no confl ict of interest. Brown, Adrian ...................................... Speaker’s Bureau: Allergan, Inc., Sanofi Brown, Carl O. ...................................... Employee: TWi Biotechnology, Inc; Stock/Shareholder: Amylin

Pharmaceuticals, Inc. Brown, Florence M. .............................. Disclosed no confl ict of interest. Brown, Hilary ........................................ Disclosed no confl ict of interest. Brown, Larry D. ..................................... Disclosed no confl ict of interest. Brown, Nicola ....................................... Disclosed no confl ict of interest. Brown, Susan D. ................................... Disclosed no confl ict of interest. Brown, Talia L. ...................................... Disclosed no confl ict of interest. Browne, Jessica L. ............................... Consultant: Roche Pharmaceuticals; Other Relationship: Roche

Pharmaceuticals Brownlee, Micheal ............................... Disclosed no confl ict of interest. Brubaker, Jamie ................................... Disclosed no confl ict of interest. Brubaker, Patricia ................................. Advisory Panel: Eli Lilly and Company; Consultant: Merck

Sharp & Dohme Limited Bruce, David G. ..................................... Disclosed no confl ict of interest. Bruck-Segal, Dana L. ............................ Disclosed no confl ict of interest. Bruinsma, Christine .............................. Disclosed no confl ict of interest. Brunell, Steven C. ................................. Employee: Amylin Pharmaceuticals, LLC Brunner, Eric J. ..................................... Disclosed no confl ict of interest. Brunner, Martina .................................. Disclosed no confl ict of interest. Bruno, Graziella .................................... Disclosed no confl ict of interest. Bruno, Rosamaria ................................. Disclosed no confl ict of interest. Brusko, Todd M. ................................... Disclosed no confl ict of interest. Bryan, Joseph ....................................... Disclosed no confl ict of interest. Bryant, Priscilla .................................... Disclosed no confl ict of interest. Bryskiewicz, Marta E. ........................... Disclosed no confl ict of interest. Bryzinski, Brian ..................................... Employee: AstraZeneca Pharmaceuticals LP Bu, So Young ........................................ Disclosed no confl ict of interest. Buanes, Trond ....................................... Disclosed no confl ict of interest. Bucala, Richard .................................... Disclosed no confl ict of interest. Bucca, Brian ......................................... Disclosed no confl ict of interest. Bucci, Mariarosaria .............................. Disclosed no confl ict of interest. Buchanan, Thomas A. .......................... Disclosed no confl ict of interest. Buchner, David ..................................... Disclosed no confl ict of interest. Buchner, Klaus ...................................... Employee: Noxxon Buchwald, Peter ................................... Board Member: Converge Biotech, Inc.; Stock/Shareholder:

Converge Biotech, Inc.

Dow



A839


AU

THO

R D

ISCL

OSU

RE

Buckingham, Bruce A. .......................... Advisory Panel: GlySens, Inc., Roche Pharmaceuticals, Sanofi ; Consultant: BD Medical Diabetes Care; Other Relation-ship: Medtronic; Research Support: Medtronic; Speaker’s Bureau: Dexcom, Inc.

Buckloh, Lisa ........................................ Disclosed no confl ict of interest. Buckner, Jane H. .................................. Research Support: Bristol-Myers Squibb Company, Gilead

Sciences, Inc., Novo Nordisk A/S, Pfi zer, Inc. Budak, Ulvi ........................................... Disclosed no confl ict of interest. Buday, Barbara ..................................... Disclosed no confl ict of interest. Budge, Claire ........................................ Disclosed no confl ict of interest. Budnitz, Daniel S. ................................. Disclosed no confl ict of interest. Bueno, Patricia G. ................................. Disclosed no confl ict of interest. Buffi n, Nicholas .................................... Disclosed no confl ict of interest. Bugatto, Fernando ................................ Disclosed no confl ict of interest. Bugliani, Marco .................................... Disclosed no confl ict of interest. Bullard, Kai M. ..................................... Disclosed no confl ict of interest. Bullard, Steven ..................................... Disclosed no confl ict of interest. Bulum, Tomislav ................................... Disclosed no confl ict of interest. Bumol, Stefan ....................................... Disclosed no confl ict of interest. Bumol, Thomas F. ................................. Employee: Lilly Bunker, Clareann H. .............................. Disclosed no confl ict of interest. Burant, Charles ..................................... Disclosed no confl ict of interest. Burch, Miguel ....................................... Disclosed no confl ict of interest. Burdett, Elena ....................................... Disclosed no confl ict of interest. Burdge, Graham C. ............................... Disclosed no confl ict of interest. Burg, Ashley R. ..................................... Disclosed no confl ict of interest. Burge, Mark .......................................... Disclosed no confl ict of interest. Burgess, Candice J. .............................. Other Relationship: Naturally SlimBurgos, Sergio ...................................... Disclosed no confl ict of interest. Burk, David H. ....................................... Disclosed no confl ict of interest. Burkart, Alison ...................................... Disclosed no confl ict of interest. Burkart, Volker ...................................... Disclosed no confl ict of interest. Burke, Gary ........................................... Disclosed no confl ict of interest. Burke, George ....................................... Disclosed no confl ict of interest. Burke, Stuart ........................................ Disclosed no confl ict of interest. Burkhardt, Brant R. ............................... Disclosed no confl ict of interest. Burlina, Silvia ....................................... Disclosed no confl ict of interest. Burns, Colleen ...................................... Employee: Orexigen Therapeutics, Inc.; Stock/Shareholder:

Orexigen Therapeutics, Inc. Burns, Katharina K. .............................. Speaker’s Bureau: Novo Nordisk, Inc. Burns, Stephen A. ................................ Disclosed no confl ict of interest. Burnstein, Rowan ................................. Disclosed no confl ict of interest. Burrows, Nilka R. ................................. Disclosed no confl ict of interest. Burton, Joseph ..................................... Disclosed no confl ict of interest. Burtt, Noel ............................................ Disclosed no confl ict of interest. Buryk, Melissa A. ................................. Disclosed no confl ict of interest. Busch, Stephanie ................................. Disclosed no confl ict of interest. Buse, John B. ....................................... Advisory Panel: Amylin Pharmaceuticals, Inc., Andromeda

Biotech, Ltd., AstraZeneca Pharmaceuticals LP, Bayhill Therapeutics, Inc., BD Research Laboratories, Bristol-Myers Squibb Company, Catabasis, Cebix, Inc., Diartis Pharmaceuticals, Elcelyx Therapeutics, Inc., Eli Lilly and Company, Exsulin, Genentech, GI Dynamics, Halozyme Therapeutics, Hoffman La Roche, Johnson & Johnson, LipoScience, Merck, Metabolic Solutions Development Co., Metabolon, Inc., Novan, Novella, Novo Nordisk, Inc., Orexigen Therapeutics, Inc., Rhythm Pharma-ceuticals, Sanofi , Spherix, Inc., Transpharma, Veritas, Verva; Research Support: Abbott Laboratories, Inc., Amylin Pharmaceuticals, Inc., Andromeda Biotech, Ltd., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GI Dynamics, GlaxoSmithKline, Halozyme Therapeutics, Hoffman La Roche, Johnson & Johnson, Medtronic, Merck, Novo Nordisk, Inc., Orexigen Therapeutics, Inc., Osiris Therapeutics, Inc., Pfi zer, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd., Tolerex

Bush, James F. ...................................... Disclosed no confl ict of interest. Bushong, Eric A. ................................... Disclosed no confl ict of interest. Busjahn, Andreas ................................. Disclosed no confl ict of interest. Bussey-Jones, Jada ............................. Disclosed no confl ict of interest. Butcher, Marcene K. ............................. Disclosed no confl ict of interest. Butler, Anne .......................................... Disclosed no confl ict of interest. Butler, Deborah A. ................................ Disclosed no confl ict of interest. Butler, Lucilla I. ..................................... Disclosed no confl ict of interest. Butte, Atul J. ........................................ Disclosed no confl ict of interest. Buxton, Joanne .................................... Employee: Pfi zer, Inc. Buziashvili, Yuriy .................................. Disclosed no confl ict of interest. Buzzetti, Raffaella ................................ Consultant: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi Bylicki, Olivier ....................................... Disclosed no confl ict of interest. Byrd, Anwar .......................................... Disclosed no confl ict of interest.

Byrd, H.C. Michelle .............................. Disclosed no confl ict of interest. Byrn, Mary ............................................ Disclosed no confl ict of interest. Byrne, Maria M. ................................... Disclosed no confl ict of interest. Byrnes, Michael J. ............................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Novo

Nordisk, Inc., Sanofi Byun, Dongwon .................................... Disclosed no confl ict of interest. Byun, Jeong Ran .................................. Disclosed no confl ict of interest. Byun, Sunghwan .................................. Disclosed no confl ict of interest. Caballero, A. Enrique ........................... Disclosed no confl ict of interest. Caballero, Jaime A. .............................. Disclosed no confl ict of interest. Caballero, Sergio .................................. Disclosed no confl ict of interest. Cabello, Cecilia .................................... Disclosed no confl ict of interest. Cabre, Joan J. ...................................... Disclosed no confl ict of interest. Caccavale, Laura J. .............................. Disclosed no confl ict of interest. Caccioppoli, Cristina ............................ Disclosed no confl ict of interest. Cachia, Elaine ....................................... Disclosed no confl ict of interest. Cacicedo, Jose M. ................................ Disclosed no confl ict of interest. Cadario, Francesco ............................... Disclosed no confl ict of interest. Caeiro, Gabriela ................................... Disclosed no confl ict of interest. Cafazzo, Joseph A. ............................... Speaker’s Bureau: Roche Pharmaceuticals Cahill, Kathleen .................................... Disclosed no confl ict of interest. Cai, Chunyou ........................................ Disclosed no confl ict of interest. Cai, Dehong .......................................... Disclosed no confl ict of interest. Cai, Lu ................................................... Disclosed no confl ict of interest. Cai, Rongrong ....................................... Disclosed no confl ict of interest. Cai, Weijing .......................................... Disclosed no confl ict of interest. Cai, Xiaoling ......................................... Disclosed no confl ict of interest. Caiazzo, Robert ..................................... Disclosed no confl ict of interest. Caires, Jaqueline ................................. Disclosed no confl ict of interest. Cakar, Mustafa ..................................... Disclosed no confl ict of interest. Cakir, Erdinc .......................................... Disclosed no confl ict of interest. Calabuig, Virtu N. ................................. Disclosed no confl ict of interest. Calanna, Salvatore ............................... Disclosed no confl ict of interest. Calderon, Rosanna ............................... Disclosed no confl ict of interest. Caldwell, Bryan D. ................................ Consultant: Janssen Pharmaceuticals, Novartis Pharmaceuti-

cals Corporation, Valeant Pharmaceuticals Caldwell, Karen .................................... Disclosed no confl ict of interest. Cali, Anna ............................................. Employee: Sanofi Callaghan, Brian C. ............................... Disclosed no confl ict of interest. Callaway, Leonie K. .............................. Disclosed no confl ict of interest. Calles, Jorge ........................................ Disclosed no confl ict of interest. Calliari, Luis Eduardo ........................... Disclosed no confl ict of interest. Calogeras, Ellen ................................... Disclosed no confl ict of interest. Calvet, Jean-Henri ............................... Disclosed no confl ict of interest. Calvin, Donna ....................................... Disclosed no confl ict of interest. Camargo, Juliana A. ............................. Disclosed no confl ict of interest. Camastra, Stefania .............................. Disclosed no confl ict of interest. Cameron, Fraser ................................... Disclosed no confl ict of interest. Cameron, Kenzie A. .............................. Disclosed no confl ict of interest. Camilleri, Michael ................................ Disclosed no confl ict of interest. Camillucci, Cecilia ................................ Disclosed no confl ict of interest. Camisasca, Riccardo ............................ Employee: Takeda Global Research & Development Center,

Inc. Camp, Anne .......................................... Disclosed no confl ict of interest. Campbell, Craig R. ................................ Disclosed no confl ict of interest. Campbell, Jonathan D. ......................... Disclosed no confl ict of interest. Campbell-Voytal, Kimberly ................... Disclosed no confl ict of interest. Campos-Alborg, Vicente ...................... Disclosed no confl ict of interest. Can, Ozgur ............................................ Disclosed no confl ict of interest. Canani, Luis .......................................... Disclosed no confl ict of interest. Candela, Joseph ................................... Disclosed no confl ict of interest. Candeloro, Paola .................................. Disclosed no confl ict of interest. Candrilli, Sean ...................................... Employee: RTI Health Solutions; Research Support: sanofi -

aventis US Canipel, Lydie ....................................... Disclosed no confl ict of interest. Cannon, Matthew ................................ Disclosed no confl ict of interest. Cannon, Richard O. ............................... Disclosed no confl ict of interest. Canora, Jesus ....................................... Disclosed no confl ict of interest. Canovatchel, William ........................... Employee: Janssen Research & Development Canturk, Isil C. ...................................... Disclosed no confl ict of interest. Canturk, Zeynep ................................... Disclosed no confl ict of interest. Cao, Bing Y. .......................................... Disclosed no confl ict of interest. Cao, Bingyan ........................................ Disclosed no confl ict of interest. Cao, Mengdie ....................................... Disclosed no confl ict of interest. Cao, Wenhong ...................................... Disclosed no confl ict of interest. Cao, Xiaopei ......................................... Disclosed no confl ict of interest. Cao, Yanan ........................................... Disclosed no confl ict of interest. Cao, Yanli ............................................. Disclosed no confl ict of interest. Cao, Zhun ............................................. Disclosed no confl ict of interest. Capel, Ismael ........................................ Disclosed no confl ict of interest. Capelson, Roberta ................................ Disclosed no confl ict of interest. Caperuto, Luciana C. ............................ Disclosed no confl ict of interest.

Dow



A840


AU

THO

R D

ISCL

OSU

RE

Capobianco, Evangelina ....................... Disclosed no confl ict of interest. Capoccia, Danila .................................. Disclosed no confl ict of interest. Caponigro, Sara .................................... Disclosed no confl ict of interest. Caporale, Joaquín E. ............................ Disclosed no confl ict of interest. Caporarello, Nunzia .............................. Disclosed no confl ict of interest. Cappelletti, Chiara ............................... Disclosed no confl ict of interest. Cappellucci, Laura ................................ Disclosed no confl ict of interest. Cappiello, Darryll .................................. Disclosed no confl ict of interest. Caprio, Sonia ........................................ Disclosed no confl ict of interest. Capuani, Barbara .................................. Disclosed no confl ict of interest. Capuano, George .................................. Employee: Janssen Research & Development Caputo, Maria Paola ............................ Disclosed no confl ict of interest. Caputo, Nicholas .................................. Disclosed no confl ict of interest. Caputo, Salvatore ................................. Consultant: Eli Lilly and Company, Merck Sharp & Dohme

Limited, Novo Nordisk, Inc.; Research Support: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc.; Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc.

Caramori, Luiza ..................................... Disclosed no confl ict of interest. Caratelli, Sara ...................................... Disclosed no confl ict of interest. Carbillon, Lionel ................................... Disclosed no confl ict of interest. Carbonara, Amarynthia ........................ Employee: Institute for Medical and Nursing Education, Inc. Carcoba, Luis M. .................................. Disclosed no confl ict of interest. Cardellini, Marina ................................ Disclosed no confl ict of interest. Cardona, Fernando ............................... Disclosed no confl ict of interest. Cardona, Saumeth ................................ Research Support: Sanofi Careaga, Valeria ................................... Disclosed no confl ict of interest. Carey, Michelle A. ................................ Disclosed no confl ict of interest. Carey, Timothy S. ................................. Disclosed no confl ict of interest. Cariou, Bertrand ................................... Consultant: AstraZeneca Pharmaceuticals LP, Eli Lilly and

Company, Genfi t, GlaxoSmithKline, Merck, Novartis Phar-maceuticals Corporation, Novo Nordisk A/S, Pierre Fabre, Sanofi , Servier, Takeda Pharmaceutical Company, Ltd.; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Genfi t, Johnson & Johnson, Novo Nordisk A/S, Roche Pharmaceuticals; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Genfi t, GlaxoSmithKline, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Pierre Fabre, Sanofi , Servier, Takeda Pharmaceutical Company, Ltd.

Carlson, Edward ................................... Disclosed no confl ict of interest. Carlson, Matthew K. ............................ Disclosed no confl ict of interest. Carlson, Olga D. ................................... Disclosed no confl ict of interest. Carlsson, Annika .................................. Employee: Mercodia Carlström, Mattias ............................... Disclosed no confl ict of interest. Carmody, David .................................... Disclosed no confl ict of interest. Carmody, Louise ................................... Disclosed no confl ict of interest. Carmona Díaz, Elizabeth ...................... Disclosed no confl ict of interest. Carneiro, Glaucia .................................. Disclosed no confl ict of interest. Carnethon, Mercedes R. ...................... Disclosed no confl ict of interest. Carolan, Eirin ........................................ Disclosed no confl ict of interest. Caron Dorval, Dominique ..................... Disclosed no confl ict of interest. Carpenter, Christina ............................. Disclosed no confl ict of interest. Carpentier, André C. ............................. Disclosed no confl ict of interest. Carpentier, Eric ..................................... Disclosed no confl ict of interest. Carpentier, Ken ..................................... Disclosed no confl ict of interest. Carqueja, Teresa .................................. Disclosed no confl ict of interest. Carr, Bernadette ................................... Disclosed no confl ict of interest. Carr, Jeffrey J. ...................................... Disclosed no confl ict of interest. Carr, Molly C. ........................................ Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

Kline Carramiñana-Barrera, Francisco .......... Disclosed no confl ict of interest. Carreras, Maria C. ................................ Disclosed no confl ict of interest. Carria, Lori R. ........................................ Disclosed no confl ict of interest. Carrilho, Francisco ................................ Disclosed no confl ict of interest. Carrion-Petersen, Mary Lou ................. Disclosed no confl ict of interest. Carrobio, Stefania ................................ Disclosed no confl ict of interest. Carroll, Aaron ....................................... Disclosed no confl ict of interest. Carroll, Julie M. ................................... Disclosed no confl ict of interest. Carson, April P. ..................................... Disclosed no confl ict of interest. Carson, Kenneth ................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Carstensen, Maren ............................... Disclosed no confl ict of interest. Cartee, Gregory D. ................................ Disclosed no confl ict of interest. Carter, C. Sue ....................................... Disclosed no confl ict of interest. Caruana, Joseph .................................. Disclosed no confl ict of interest. Caruso, Michael ................................... Disclosed no confl ict of interest. Carvajal-Gonzalez, Santos ................... Employee: Pfi zer, Inc. Carvalheiro, Manuela ........................... Disclosed no confl ict of interest. Carvalho, Bruno M. .............................. Disclosed no confl ict of interest. Carvalho, Carla R. ................................. Disclosed no confl ict of interest.

Carvalho, Davide C. .............................. Disclosed no confl ict of interest. Carvalho, Filipa ..................................... Disclosed no confl ict of interest. Carvalho, Jose A. ................................. Disclosed no confl ict of interest. Casagrande, Viviana ............................ Disclosed no confl ict of interest. Casamitjana Abella, Roser ................... Disclosed no confl ict of interest. Casiraghi, Francesca ............................ Disclosed no confl ict of interest. Casolaro, Arturo ................................... Disclosed no confl ict of interest. Cass, Anna L. ........................................ Disclosed no confl ict of interest. Cassidy, Andrew J. ............................... Disclosed no confl ict of interest. Castano, Luis ........................................ Disclosed no confl ict of interest. Castel, Julien ....................................... Disclosed no confl ict of interest. Castell, Conxa ...................................... Disclosed no confl ict of interest. Castellano-Castillo, Daniel .................. Disclosed no confl ict of interest. Castle, Jessica R. ................................. Research Support: Biodel, Inc.; Speaker’s Bureau: Amylin

Pharmaceuticals, Inc. Castorino, Kristin N. ............................. Disclosed no confl ict of interest. Castrejón-Pérez, Roberto Carlos .......... Disclosed no confl ict of interest. Castro, Ana Valeria B. .......................... Disclosed no confl ict of interest. Castro, Gisele ....................................... Disclosed no confl ict of interest. Catalano, Patrick M. ............................. Disclosed no confl ict of interest. Cataldo, Rita ......................................... Disclosed no confl ict of interest. Caterson, Ian D. .................................... Disclosed no confl ict of interest. Cathey, Brook ....................................... Disclosed no confl ict of interest. Caton, Paul W. ...................................... Other Relationship: Metabolic Solutions Development Co.;

Research Support: EFSD, Eli Lilly and Company Catrina, Anca Irinel .............................. Disclosed no confl ict of interest. Catrina, Sergiu-Bogdan ........................ Disclosed no confl ict of interest. Catteau, Jacki ...................................... Disclosed no confl ict of interest. Cattet, Jennifer .................................... Disclosed no confl ict of interest. Cauchi, Stéphane ................................. Disclosed no confl ict of interest. Caudle, Jane M. ................................... Disclosed no confl ict of interest. Cavallari, Fabrizio ................................. Employee: Novo Nordisk, Inc. Cavan, David A. .................................... Consultant: Roche Diagnostics Cavelti-Weder, Claudia R. .................... Disclosed no confl ict of interest. Cavener, Douglas R. ............................. Disclosed no confl ict of interest. Cavey, Gregory S. ................................. Research Support: Metabolic Solutions Development Co. Cawley, Patrick J. ................................. Disclosed no confl ict of interest. Cayci, Tuncer ........................................ Disclosed no confl ict of interest. Cebada-Aleu, Alberto ........................... Disclosed no confl ict of interest. Cefalu, William T. ................................. Advisory Panel: AstraZeneca; Consultant: Lexicon Pharma-

ceuticals, Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb, sanofi -aventis, Halozyme Therapeutics, Intarcia Therapeutics, Inc; Research Support: Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, MannKind Corporation, GlaxoSmithKline, Lexicon Pharmaceuticals

Celebi, Koray ........................................ Disclosed no confl ict of interest. Céline, Gleizes ...................................... Research Support: Novo Nordisk, Inc. (Spouse/Partner) Cengiz, Eda ........................................... Disclosed no confl ict of interest. Ceriello, Antonio .................................. Consultant: AstraZeneca Pharmaceuticals LP, Bayer Health

Care, LLC, Bristol-Myers Squibb Company, Eli Lilly and Company, Medtronic, Novartis Pharmaceuticals Corpora-tion, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi , Takeda Pharmaceutical Company, Ltd.

Cersosimo, Eugenio .............................. Disclosed no confl ict of interest. Cerutti, Franco ...................................... Disclosed no confl ict of interest. Cetinarslan, Berrin ............................... Disclosed no confl ict of interest. Cha, Bong Soo ...................................... Disclosed no confl ict of interest. Cha, Bong-Yun ...................................... Disclosed no confl ict of interest. Chacko, Shaji K. ................................... Disclosed no confl ict of interest. Chackunkal, Ellen ................................. Disclosed no confl ict of interest. Chacon, Alexander C. ........................... Disclosed no confl ict of interest. Chacon, Ana ......................................... Disclosed no confl ict of interest. Chacon, Jan V. ...................................... Disclosed no confl ict of interest. Chadwick, Maureen E. ......................... Disclosed no confl ict of interest. Chae, Hanjung ...................................... Disclosed no confl ict of interest. Chai, Shangyu ...................................... Disclosed no confl ict of interest. Chai, Weidong ...................................... Disclosed no confl ict of interest. Chaillous, Lucy ..................................... Disclosed no confl ict of interest. Chaix, Amandine .................................. Disclosed no confl ict of interest. Chakkalakal, Rosette J. ........................ Disclosed no confl ict of interest. Chakrabarti, Subrata ............................ Disclosed no confl ict of interest. Chakrabarti, Swarup K. ........................ Disclosed no confl ict of interest. Chakroun, Taher ................................... Disclosed no confl ict of interest. Chalew, Stuart ...................................... Disclosed no confl ict of interest. Chalfant, Charles .................................. Disclosed no confl ict of interest. Challyandra, Lucky ............................... Disclosed no confl ict of interest. Chamany, Shadi .................................... Disclosed no confl ict of interest. Chamarthi, Bindu .................................. Disclosed no confl ict of interest. Chamberlain, James ............................ Consultant: Asante Solutions; Speaker’s Bureau: Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck

Dow



A841


AU

THO

R D

ISCL

OSU

RE

Chambers, Laura C. .............................. Disclosed no confl ict of interest. Chan, Albert K. ..................................... Disclosed no confl ict of interest. Chan, Carol ........................................... Disclosed no confl ict of interest. Chan, Catherine B. ............................... Disclosed no confl ict of interest. Chan, Christine L. ................................. Other Relationship: Bristol-Myers Squibb Company, Daiichi-

Sankyo, Inc., Merck; Research Support: Genentech Chan, Edmund ...................................... Disclosed no confl ict of interest. Chan, Jefferson Y. ................................ Disclosed no confl ict of interest. Chan, Jeremy H. ................................... Disclosed no confl ict of interest. Chan, Julianna ..................................... Consultant: Takeda Global Research & Development Center, Inc. Chan, Kenny L. ...................................... Disclosed no confl ict of interest. Chan, M. Ete ......................................... Disclosed no confl ict of interest. Chan, Meilin ......................................... Disclosed no confl ict of interest. Chan, Owen .......................................... Disclosed no confl ict of interest. Chan, Stanley ....................................... Disclosed no confl ict of interest. Chan, T.M. ............................................ Disclosed no confl ict of interest. Chan, W.B. ............................................ Disclosed no confl ict of interest. Chandni, R. ........................................... Disclosed no confl ict of interest. Chang, Anne ......................................... Disclosed no confl ict of interest. Chang, Baocheng ................................. Disclosed no confl ict of interest. Chang, Chia-Hsuin ................................ Disclosed no confl ict of interest. Chang, Daw-Ming ................................ Disclosed no confl ict of interest. Chang, Hyuk-Jae .................................. Disclosed no confl ict of interest. Chang, Kevin ........................................ Disclosed no confl ict of interest. Chang, Li-Chien .................................... Disclosed no confl ict of interest. Chang, Manchin ................................... Disclosed no confl ict of interest. Chang, Patricia P. .................................. Disclosed no confl ict of interest. Chang, Sang-Ah ................................... Disclosed no confl ict of interest. Chang, Ta-min ...................................... Disclosed no confl ict of interest. Chang, Yen-Jui ..................................... Disclosed no confl ict of interest. Chang, Yi-Cheng ................................... Disclosed no confl ict of interest. Chang, Yih-Hsin .................................... Disclosed no confl ict of interest. Chang, Yi-Ting ...................................... Disclosed no confl ict of interest. Chang, Yuchiao ..................................... Disclosed no confl ict of interest. Chang-ran, Zhang ................................. Disclosed no confl ict of interest. Changyu, Pan ........................................ Disclosed no confl ict of interest. Channabasappa, Shivaprasad .............. Disclosed no confl ict of interest. Chantrel, François ................................ Disclosed no confl ict of interest. Chao, Ariana M. ................................... Disclosed no confl ict of interest. Chapman, Marianne ............................. Disclosed no confl ict of interest. Chapman, William H. ........................... Research Support: Johnson & Johnson Charbonnel, Bernard ............................ Consultant: AstraZeneca/Bristol-Meyers Squibb, Boehringer

Ingelheim GmbH & Co. KG, Eli Lilly and Company, Glaxo-SmithKline, Janssen Biotech, Inc., Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi , Takeda Global Research & Development Center, Inc.; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Glaxo-SmithKline, Janssen Pharmaceuticals, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Roche Pharmaceuti-cals, Sanofi , Takeda Pharmaceutical Company, Ltd.

Charitanski, Didier ................................ Disclosed no confl ict of interest. Charlton, Gerald A. ............................... Disclosed no confl ict of interest. Charpentier, Guillaume ........................ Board Member: Novo Nordisk A/S Charron, Maureen J. ............................ Disclosed no confl ict of interest. Charron-Prochownik, Denise C. ........... Disclosed no confl ict of interest. Chartier-Logan, Catherine .................... Disclosed no confl ict of interest. Charvat, Trevor ..................................... Employee: ChemoCentryx; Stock/Shareholder: ChemoCentryx Chase, Barbara ..................................... Disclosed no confl ict of interest. Chase, H. Peter ..................................... Other Relationship: Dexcom, Inc., Medtronic Chatterjee, Ranee ................................ Disclosed no confl ict of interest. Chatterjee, Somik ................................. Disclosed no confl ict of interest. Chaturvedi, Nishi .................................. Disclosed no confl ict of interest. Chau, Loan ............................................ Disclosed no confl ict of interest. Chaudhuri, Ajay .................................... Disclosed no confl ict of interest. Chaumet, Guillaume ............................. Disclosed no confl ict of interest. Chaussabel, Damien ............................ Disclosed no confl ict of interest. Chavez, Noel ........................................ Disclosed no confl ict of interest. Chawla, Aastha .................................... Disclosed no confl ict of interest. Chawla, Aastik ..................................... Disclosed no confl ict of interest. Chawla, Manoj S. ................................. Advisory Panel: Eli Lilly/BI, Eris Life Sciences, Novartis

Pharma AG; Employee: Piramal Life Sciences (Spouse/Partner); Speaker’s Bureau: Abbott Diabetes Care, Bristol-Meyers Squibb, MSD, Novartis, Novo Nordisk, Inc.

Chawla, Rajeev .................................... Disclosed no confl ict of interest. Chayama, Kazuaki ................................ Disclosed no confl ict of interest. Chaykovska, Lyubov ............................. Disclosed no confl ict of interest. Che, Hailong ......................................... Disclosed no confl ict of interest. Cheah, Yee S. ....................................... Disclosed no confl ict of interest. Cheang, Kai I. ....................................... Disclosed no confl ict of interest. Chechele, Alicia C. ............................... Disclosed no confl ict of interest.

Checklin, Helen .................................... Disclosed no confl ict of interest. Cheetham, Sharon ................................ Disclosed no confl ict of interest. Chekh, Viktor ........................................ Employee: VisionQuest Biomedical Chen, Ailing .......................................... Disclosed no confl ict of interest. Chen, Angela ........................................ Disclosed no confl ict of interest. Chen, Calvin ......................................... Board Member: TWi Pharmaceuticals, Inc.; Employee: Novar-

tis Taiwan (Spouse/Partner), TWi Pharmaceuticals, Inc.; Stock/Shareholder: TWi Pharmaceuticals, Inc.

Chen, Chao H. ....................................... Disclosed no confl ict of interest. Chen, Chu ............................................. Disclosed no confl ict of interest. Chen, Chu-Huang ................................. Disclosed no confl ict of interest. Chen, Danny ......................................... Employee: Pfi zer, Inc.; Stock/Shareholder: Pfi zer, Inc. Chen, Gang ........................................... Disclosed no confl ict of interest. Chen, Guoxun ....................................... Disclosed no confl ict of interest. Chen, Haibing ....................................... Disclosed no confl ict of interest. Chen, Haiyan ........................................ Disclosed no confl ict of interest. Chen, Hanqing ...................................... Disclosed no confl ict of interest. Chen, Hetian ......................................... Disclosed no confl ict of interest. Chen, Hong ........................................... Disclosed no confl ict of interest. Chen, Hong-Chi .................................... Disclosed no confl ict of interest. Chen, Hongjie ....................................... Disclosed no confl ict of interest. Chen, Ida .............................................. Disclosed no confl ict of interest. Chen, Ji ................................................ Disclosed no confl ict of interest. Chen, Jianwen ..................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Chen, Jing ............................................ Disclosed no confl ict of interest. Chen, Jin-Shuen ................................... Disclosed no confl ict of interest. Chen, Kai .............................................. Disclosed no confl ict of interest. Chen, Keyang ....................................... Disclosed no confl ict of interest. Chen, Kong ........................................... Disclosed no confl ict of interest. Chen, Li ................................................. Disclosed no confl ict of interest. Chen, Lieping ........................................ Disclosed no confl ict of interest. Chen, Lihe ............................................. Disclosed no confl ict of interest. Chen, Lihong ......................................... Employee: GlaxoSmithKline Chen, Liming ......................................... Disclosed no confl ict of interest. Chen, Ling ............................................. Disclosed no confl ict of interest. Chen, Miao-Hsueh ............................... Disclosed no confl ict of interest. Chen, Miaoxin ...................................... Disclosed no confl ict of interest. Chen, Michael ...................................... Disclosed no confl ict of interest. Chen, Pan ............................................. Disclosed no confl ict of interest. Chen, Peggy P. ...................................... Disclosed no confl ict of interest. Chen, Ping ............................................ Disclosed no confl ict of interest. Chen, Rong ........................................... Disclosed no confl ict of interest. Chen, Rusan ......................................... Disclosed no confl ict of interest. Chen, Shali ........................................... Disclosed no confl ict of interest. Chen, Sheldon ...................................... Disclosed no confl ict of interest. Chen, Shuchun ..................................... Disclosed no confl ict of interest. Chen, Shu-Hua ..................................... Disclosed no confl ict of interest. Chen, Shuzhen ...................................... Disclosed no confl ict of interest. Chen, Shyh-Huei .................................. Disclosed no conflict of interest. Chen, Steve .......................................... Employee: Amylin Pharmaceuticals, LLC Chen, Timothy ....................................... Disclosed no confl ict of interest. Chen, Vince .......................................... Disclosed no confl ict of interest. Chen, WenBei ...................................... Disclosed no confl ict of interest. Chen, Wen-Hung .................................. Employee: United BioSource Corporation Chen, Xiao Y. ........................................ Disclosed no confl ict of interest. Chen, Xiaoxiao ..................................... Disclosed no confl ict of interest. Chen, Xuanrong .................................... Disclosed no confl ict of interest. Chen, Xue ............................................. Disclosed no confl ict of interest. Chen, Xuequn ....................................... Disclosed no confl ict of interest. Chen, Y. Stefanie .................................. Disclosed no confl ict of interest. Chen, Yanfang ...................................... Disclosed no confl ict of interest. Chen, Yanming ..................................... Disclosed no confl ict of interest. Chen, Yanyan ........................................ Disclosed no confl ict of interest. Chen, Yanyun ........................................ Employee: Eli Lilly and Company Chen, Yao ............................................. Disclosed no confl ict of interest. Chen, Yi-Guang .................................... Disclosed no confl ict of interest. Chen, Yii-Der I. ..................................... Disclosed no confl ict of interest. Chen, Ying ............................................ Disclosed no confl ict of interest. Chen, Yong ........................................... Disclosed no confl ict of interest. Chen, Younan ....................................... Disclosed no confl ict of interest. Chen, Yu-Han ........................................ Disclosed no confl ict of interest. Chen, Yuhong ....................................... Disclosed no confl ict of interest. Chen, Yu-Ju .......................................... Disclosed no confl ict of interest. Chen, Yumay ......................................... Disclosed no confl ict of interest. Chen, Yuqing E. .................................... Disclosed no confl ict of interest. Chen, Zanghua ..................................... Disclosed no confl ict of interest. Chen, Zhanghua ................................... Disclosed no confl ict of interest. Chen, Zheng ......................................... Disclosed no confl ict of interest. Chen, Zhibin ......................................... Disclosed no confl ict of interest. Chen, Zhou ........................................... Disclosed no confl ict of interest. Chen, Zonglan ...................................... Disclosed no confl ict of interest.

Dow



A842


AU

THO

R D

ISCL

OSU

RE

Cheney, Michael C. .............................. Disclosed no confl ict of interest. Cheng, Alan .......................................... Disclosed no confl ict of interest. Cheng, Christopher H. .......................... Disclosed no confl ict of interest. Cheng, David ........................................ Other Relationship: Sanofi Cheng, Emily ......................................... Disclosed no confl ict of interest. Cheng, Hsinlin T. .................................. Disclosed no confl ict of interest. Cheng, Jingqiu ..................................... Disclosed no confl ict of interest. Cheng, John B. ..................................... Employee: Pfi zer, Inc. Cheng, Judy .......................................... Disclosed no confl ict of interest. Cheng, Lei ............................................. Disclosed no confl ict of interest. Cheng, Luo ............................................ Disclosed no confl ict of interest. Cheng, Peiyao ....................................... Disclosed no confl ict of interest. Cheng, Xiaoyun .................................... Disclosed no confl ict of interest. Cheng, Yiling J. .................................... Disclosed no confl ict of interest. Cheng, Yu-Ching ................................... Disclosed no confl ict of interest. Chenji, Suresh ...................................... Employee: Novo Nordisk A/S Cheong, Karey ...................................... Disclosed no confl ict of interest. Cheong, Sami ....................................... Disclosed no confl ict of interest. Cherifi , Blandine ................................... Disclosed no confl ict of interest. Cherney, David Z. ................................. Advisory Panel: Boehringer Ingelheim GmbH & Co. KG, Takeda

Pharmaceutical Company, Ltd.; Consultant: Astellas Pharma US, Inc.; Research Support: Astellas Pharma US, Inc., Boehringer Ingelheim GmbH & Co. KG

Chernova, Tatyana ................................ Disclosed no confl ict of interest. Cherrington, Alan D. ............................. Advisory Panel: Biocon, Bristol-Myers Squibb/Amylin,

Diamedica, Inc., Diasome Pharmaceuticals; Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Fractyl, Merck, Metavention, Novo Nordisk A/S, Pfi zer, Inc., Profi l Institute for Clinical Research, Inc., Sanofi /Aventis, Zafgen, Inc.; Other Relationship: Dia-medica, Inc., Metavention; Research Support: Diamedica, Inc., Metavention, Novo Nordisk A/S, Sensulin, Thermalin Diabetes, LLC, VeroScience; Speaker’s Bureau: Merck; Stock/Shareholder: Biocon, Diamedica, Inc., Fractyl, Merck, Metavention, Novo Nordisk A/S, Sensulin, Zafgen, Inc.

Cherrington, Andrea L. ......................... Research Support: Cities for Life of the American Academy of Family Physicians Foundation supported by Sanofi US

Cherubini, Valentino ............................. Consultant: Eli Lilly and Company, Lifescan Animas, Inc., Merck Sharp & Dohme Limited, Sanofi

Cheruku, Patali S. ................................. Disclosed no confl ict of interest. Cheta, Dan ............................................ Disclosed no confl ict of interest. Cheung, Bernard M. ............................. Disclosed no confl ict of interest. Cheung, Chi Wai .................................. Disclosed no confl ict of interest. Cheung, Lorena .................................... Employee: Nestle Hong Kong Ltd Cheung, Roy K. ..................................... Disclosed no confl ict of interest. Cheung, Susan S. ................................. Disclosed no confl ict of interest. Cheung, Yu ........................................... Disclosed no confl ict of interest. Chevalier, Pierre ................................... Consultant: IMS HEOR Chevalier, Stéphanie ............................ Disclosed no confl ict of interest. Chew, Daniel ........................................ Disclosed no confl ict of interest. Chew, Emily .......................................... Disclosed no confl ict of interest. Chew-Graham, Carolyn ........................ Disclosed no confl ict of interest. Chhabra, Kavaljit H. ............................. Disclosed no confl ict of interest. Chhabra, Pankdeep .............................. Disclosed no confl ict of interest. Chhoun, Jennifer .................................. Disclosed no confl ict of interest. Chiang, Vicky ........................................ Disclosed no confl ict of interest. Chiang, Yu-ting A. ................................ Disclosed no confl ict of interest. Chiarugi, Massimo ............................... Disclosed no confl ict of interest. Chiasson, Jean-Louis ........................... Research Support: AstraZeneca, Bayer, Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, Janssen-Ortho, Merck, Novo Nordisk, Inc. sanofi -aventis, Inc.

Chick, Joel ............................................ Disclosed no confl ict of interest. Chien, Jenny Y. ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Chik, Constance .................................... Disclosed no confl ict of interest. Chimin, Gabby ...................................... Disclosed no confl ict of interest. Chin, Hyoun-Jung ................................. Disclosed no confl ict of interest. Chin, Janice E. ...................................... Employee: Pfi zer, Inc. Chin, LiKang ......................................... Disclosed no confl ict of interest. Chin, Marshall H. ................................. Disclosed no confl ict of interest. Chin, Melissa ....................................... Disclosed no confl ict of interest. Chinchurreta, Laura .............................. Disclosed no confl ict of interest. Chipitsyna, Galina ................................ Disclosed no confl ict of interest. Chiu, Ken C. .......................................... Speaker’s Bureau: Bristol-Myers Squibb/AstraZeneca Chiu, Ya-Lin .......................................... Disclosed no confl ict of interest. Chiu, Yen-Feng ..................................... Disclosed no confl ict of interest. Chlebowski, Rowan .............................. Disclosed no confl ict of interest. Chlup, Rudolf ........................................ Advisory Panel: Bristol-Myers Squibb/AstraZeneca; Research

Support: Medtronic Chmelova, Helena ................................ Disclosed no confl ict of interest. Cho, Alex .............................................. Disclosed no confl ict of interest.

Cho, Jae-Hyoung .................................. Disclosed no confl ict of interest. Cho, Kyu Yong ...................................... Disclosed no confl ict of interest. Cho, Myeong-Chan ............................... Disclosed no confl ict of interest. Cho, Pyone ............................................ Disclosed no confl ict of interest. Cho, Yongin .......................................... Disclosed no confl ict of interest. Cho, Yoon Shin ..................................... Disclosed no confl ict of interest. Cho, Young Min .................................... Disclosed no confl ict of interest. Choe, Eun Yeong .................................. Disclosed no confl ict of interest. Choe, Sun Jung .................................... Disclosed no confl ict of interest. Choi, Byoung-Wook .............................. Disclosed no confl ict of interest. Choi, Dong Seop ................................... Disclosed no confl ict of interest. Choi, Hae Yoon ..................................... Disclosed no confl ict of interest. Choi, Haysook ....................................... Disclosed no confl ict of interest. Choi, Hyung Jin .................................... Disclosed no confl ict of interest. Choi, In Young ...................................... Disclosed no confl ict of interest. Choi, Jin Sun ........................................ Disclosed no confl ict of interest. Choi, Jung Il ......................................... Disclosed no confl ict of interest. Choi, Kyung Mook ................................ Disclosed no confl ict of interest. Choi, Moon-Gi ...................................... Disclosed no confl ict of interest. Choi, Myunghan ................................... Disclosed no confl ict of interest. Choi, Seung A ....................................... Disclosed no confl ict of interest. Choi, Siak Leng ..................................... Employee: Eli Lilly and Company Choi, Soo Bong ..................................... Stock/Shareholder: SOOIL Development Co. Choi, SooMin ........................................ Disclosed no confl ict of interest. Choi, Sung Hee ..................................... Disclosed no confl ict of interest. Choi, Sung-E ......................................... Disclosed no confl ict of interest. Choi, Yeon-Kyung ................................. Disclosed no confl ict of interest. Choi, Yong Jun ..................................... Disclosed no confl ict of interest. Choi, Youn Jeong ................................. Disclosed no confl ict of interest. Choi, Younhee ...................................... Disclosed no confl ict of interest. Choi, Yun Jin ........................................ Disclosed no confl ict of interest. Chonchol, Michel ................................. Disclosed no confl ict of interest. Choo, Theresa ...................................... Disclosed no confl ict of interest. Chou, Chiu-Fang ................................... Disclosed no confl ict of interest. Chou, Cyril ............................................ Disclosed no confl ict of interest. Chou, Danny H. ..................................... Disclosed no confl ict of interest. Chou, Hubert S. .................................... Employee: Daiichi-Sankyo, Inc. Chou, Tzu-Chieh ................................... Disclosed no confl ict of interest. Choudhary, Pratik ................................. Advisory Panel: Cellnovo, Medtronic MiniMed, Inc.; Speaker’s

Bureau: Medtronic Choudhry, Niteesh K. ............................ Research Support: Eli Lilly and Company Chow, Elaine Y. ..................................... Disclosed no confl ict of interest. Chow, Francis C. ................................... Disclosed no confl ict of interest. Chow, Lisa S. ........................................ Disclosed no confl ict of interest. Chow, Wing .......................................... Employee: Janssen Scientifi c Affairs, LLC Chow, Wing Sun ................................... Disclosed no confl ict of interest. Chowdhury, Ak Azad ............................ Disclosed no confl ict of interest. Chowdhury, Sara .................................. Disclosed no confl ict of interest. Choy, Anna M. ...................................... Disclosed no confl ict of interest. Chrelias, Charalambos ......................... Disclosed no confl ict of interest. Christensen, Britt ................................. Disclosed no confl ict of interest. Christensen, Kaare ............................... Disclosed no confl ict of interest. Christensen, Mikkel ............................. Disclosed no confl ict of interest. Christensen, Torsten E. ........................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Christensen, Valerie ............................. Disclosed no confl ict of interest. Christiansen, Claus .............................. Disclosed no confl ict of interest. Christiansen, Erik ................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Christiansen, Jens S. ........................... Advisory Panel: Novo Nordisk A/S; Research Support: Novo

Nordisk A/S Christiansen, Peer ................................ Disclosed no confl ict of interest. Chu, Kwan Yi ........................................ Disclosed no confl ict of interest. Chu, Man Tak ....................................... Disclosed no confl ict of interest. Chu, Nain-Feng ..................................... Disclosed no confl ict of interest. Chu, Ruth .............................................. Employee: Gilead Sciences, Inc. Chuah, Ling L. ....................................... Disclosed no confl ict of interest. Chuang, Lee-Ming ................................ Disclosed no confl ict of interest. Chuang, Pei-Hua ................................... Disclosed no confl ict of interest. Chubb, Barrie ........................................ Employee: Novo Nordisk Ltd Chue, Pierre .......................................... Disclosed no confl ict of interest. Chujo, Daisuke ..................................... Disclosed no confl ict of interest. Chun, Hyun-Ji ....................................... Disclosed no confl ict of interest. Chun, Sung Wan .................................. Disclosed no confl ict of interest. Chung, Bomee ...................................... Disclosed no confl ict of interest. Chung, Choon Hee ................................ Disclosed no confl ict of interest. Chung, Harriet ...................................... Disclosed no confl ict of interest. Chung, Jay H. ....................................... Disclosed no confl ict of interest. Chung, Ping-Chang ............................... Employee: MannKind Corporation; Stock/Shareholder: Mann-

Kind Corporation Chung, Sookja K. .................................. Disclosed no confl ict of interest. Chung, Soon Il ...................................... Disclosed no confl ict of interest.

Dow



A843


AU

THO

R D

ISCL

OSU

RE

Chung, Stephanie T. ............................. Disclosed no confl ict of interest. Chung, Yoon-sok ................................... Disclosed no confl ict of interest. Ciaraldi, Theodore P. ............................ Disclosed no confl ict of interest. Ciborowski, Michal .............................. Disclosed no confl ict of interest. Cibula, Donald ...................................... Disclosed no confl ict of interest. Ciccarone, Annamaria .......................... Disclosed no confl ict of interest. Cid Ruzafa, Javier ................................ Research Support: Allergan, Inc., Amgen, Inc., Bayer Health

Care, LLC, Daiichi-Sankyo, Inc., Eli Lilly and Company, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Shire

Ciecko, Ashley ...................................... Disclosed no confl ict of interest. Cignarelli, Mauro ................................. Disclosed no confl ict of interest. Cigolle, Christine .................................. Disclosed no confl ict of interest. Cimino, Antonino .................................. Disclosed no confl ict of interest. Cimino, Elena ....................................... Disclosed no confl ict of interest. Cimponeriu, Dan ................................... Disclosed no confl ict of interest. Cimponeriu, Danut ............................... Disclosed no confl ict of interest. Cinar, Ali ............................................... Disclosed no confl ict of interest. Cinar, Resat .......................................... Disclosed no confl ict of interest. Cincotta, Anthony H. ............................ Employee: VeroScience Ciociaro, Demetrio ............................... Disclosed no confl ict of interest. Cioli, Patrizia ........................................ Disclosed no confl ict of interest. Cioni, Roberto ....................................... Disclosed no confl ict of interest. Cipriani, Francesco ............................... Disclosed no confl ict of interest. Cipriano, Paola ..................................... Disclosed no confl ict of interest. Ciriacks, Kevin ...................................... Disclosed no confl ict of interest. Cirino, Giuseppe ................................... Disclosed no confl ict of interest. Cisternas, Miriam ................................. Disclosed no confl ict of interest. Citko, Anna ........................................... Disclosed no confl ict of interest. Claggett, Brian ..................................... Disclosed no confl ict of interest. Clancy, Kerri ......................................... Disclosed no confl ict of interest. Clapp, Carmen ...................................... Disclosed no confl ict of interest. Clark, David .......................................... Employee: TransTech Pharma Clark, Dawn .......................................... Disclosed no confl ict of interest. Clark, Jeanne M. .................................. Disclosed no confl ict of interest. Clark, Louise F. ...................................... Disclosed no confl ict of interest. Clark, Noreen M. .................................. Disclosed no confl ict of interest. Clark, Shelley ....................................... Disclosed no confl ict of interest. Clark, Susan ......................................... Disclosed no confl ict of interest. Clarke, Hilda ......................................... Advisory Panel: Amylin/Eli Lilly and Company, Novo Nor-

disk A/S, Sanofi; Speaker’s Bureau: Abbott Diabetes Care, Amylin/Eli Lilly and Company, Novo Nordisk, Inc., Sanofi

Clarke, Pamela ..................................... Disclosed no confl ict of interest. Clarke, Sophie ...................................... Disclosed no confl ict of interest. Clarke, William R. ................................ Disclosed no confl ict of interest. Clarke-Harris, Rebecca ......................... Disclosed no confl ict of interest. Clarson, Cheril L. .................................. Disclosed no confl ict of interest. Clasen, Berthil F. ................................... Disclosed no confl ict of interest. Clausen, Trine R. .................................. Disclosed no confl ict of interest. Clayton, Robert ..................................... Disclosed no confl ict of interest. Cleall, Simon ........................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Cleary, Patricia A. ................................. Disclosed no confl ict of interest. Clee, Susanne M. ................................. Disclosed no confl ict of interest. Clement, Stephen ................................. Disclosed no confl ict of interest. Clemente, Gennaro .............................. Disclosed no confl ict of interest. Clemente-Postigo, Mercedes ............... Disclosed no confl ict of interest. Clements, Mark A. ............................... Disclosed no confl ict of interest. Clements, Scott A. ............................... Disclosed no confl ict of interest. Clergeot, Annie .................................... Disclosed no confl ict of interest. Clermont, Allen .................................... Disclosed no confl ict of interest. Clifton, Peter M. ................................... Other Relationship: Omniblend Nutraceuticals, Australia Cline, Gary W. ...................................... Disclosed no confl ict of interest. Cnop, Miriam ........................................ Disclosed no confl ict of interest. Cobble, Michael E. ............................... Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Eli Lilly

and Company, Novo Nordisk, Inc.; Employee: Atherotech Cardiometabolic Lab; Research Support: Johnson & Johnson; Speaker’s Bureau: Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Forest Pharmaceuticals, Inc., Kowa Pharmaceu-ticals, Vivus, Inc.

Cobelli, Claudio .................................... Research Support: Amylin Pharmaceuticals, Inc., Dexcom, Inc., Insulet Corporation, Tandem Diabetes Care

Cobo-Fernandez, Marta ........................ Disclosed no confl ict of interest. Cobo-Vuilleumier, Nadia ...................... Disclosed no confl ict of interest. Coccaro, Emil ........................................ Disclosed no confl ict of interest. Coccia, Federica ................................... Disclosed no confl ict of interest. Cocco, Patrice M. ................................. Disclosed no confl ict of interest. Cocozza, Sara ....................................... Disclosed no confl ict of interest. Coculescu, Mihai .................................. Disclosed no confl ict of interest. Cody, Declan ......................................... Disclosed no confl ict of interest.

Coelho, Inês C. ..................................... Disclosed no confl ict of interest. Coen, Paul M. ....................................... Disclosed no confl ict of interest. Coester, Hans-Veit ................................ Employee: Profi l Institute for Clinical Research, Inc. Cohen, Daniel ....................................... Disclosed no confl ict of interest. Cohen, Kerryn ....................................... Disclosed no confl ict of interest. Cohen, Marc ......................................... Disclosed no confl ict of interest. Cohen, Marisa ...................................... Disclosed no confl ict of interest. Cohen, Ohad ......................................... Consultant: Medtronic MiniMed, Inc. Cohlmia, Elizabeth ................................ Disclosed no confl ict of interest. Col, Nananda ........................................ Disclosed no confl ict of interest. Colagiuri, Stephen ................................ Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Merck

Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi , Servier; Speaker’s Bureau: Bristol-Myers Squibb/Astra-Zeneca, Merck, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi , Servier

Colberg, Sheri R. .................................. Disclosed no confl ict of interest. Colbran, Roger J. .................................. Disclosed no confl ict of interest. Colca, Jerry R. ...................................... Board Member: Metabolic Solutions Development Co.;

Employee: Metabolic Solutions Development Co.; Stock/Shareholder: Metabolic Solutions Development Co.

Cole, Banumathi K. ............................... Disclosed no confl ict of interest. Cole, Roger ........................................... Disclosed no confl ict of interest. Cole, Serena L. ..................................... Employee: Metabolic Solutions Development Co. Cole, Shelley A. .................................... Disclosed no confl ict of interest. Coletta, Dawn K. .................................. Disclosed no confl ict of interest. Colhoun, Helen M. ............................... Disclosed no confl ict of interest. Colin, Henri ........................................... Disclosed no confl ict of interest. Colin, Ides M. ....................................... Disclosed no confl ict of interest. Collard, Harold ..................................... Disclosed no confl ict of interest. Colle, Bernard ....................................... Disclosed no confl ict of interest. Colleran, Kathleen ................................ Disclosed no confl ict of interest. Collins, Alan R. ..................................... Disclosed no confl ict of interest. Collins, Eileen G. .................................. Disclosed no confl ict of interest. Collins, John ......................................... Disclosed no confl ict of interest. Colman, Peter G. .................................. Disclosed no confl ict of interest. Colman, Shoshana ............................... Employee: Genentech; Stock/Shareholder: Genentech Colombo, Carlo ..................................... Disclosed no confl ict of interest. Colon, Gildred ....................................... Consultant: Eli Lilly and Company, Quintiles, Sanofi Colvin, Scott ......................................... Disclosed no confl ict of interest. Colwell, Christopher S. ........................ Disclosed no confl ict of interest. Comaschi, Marco ................................. Disclosed no confl ict of interest. Comassi, Mario .................................... Disclosed no confl ict of interest. Combest, Travis .................................... Disclosed no confl ict of interest. Comlekci, Abdurrahman ....................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer

Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis Pharmaceuti-cals Corporation, Novo Nordisk A/S, Pfi zer, Inc., Sanofi ; Consultant: Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi , Takeda Pharmaceutical Company, Ltd.

Comment, Nicholas .............................. Disclosed no confl ict of interest. Commissariat, Persis V. ........................ Disclosed no confl ict of interest. Comuzzie, Anthony G. .......................... Disclosed no confl ict of interest. Conard, Scott E. .................................... Consultant: Naturally Slim Condes Areias, Maria Fernanda .......... Disclosed no confl ict of interest. Conget Donlo, Ignacio .......................... Disclosed no confl ict of interest. Conget, Ignacio .................................... Disclosed no confl ict of interest. Conjard-Duplany, Agnès ....................... Stock/Shareholder: Metabolys Conley, Kevin E. .................................... Disclosed no confl ict of interest. Connelly, Kim A. ................................... Disclosed no confl ict of interest. Connelly, Philip W. ............................... Disclosed no confl ict of interest. Connolly, John G. ................................. Disclosed no confl ict of interest. Connor, Crystal ..................................... Disclosed no confl ict of interest. Consoli, Agostino ................................. Board Member: Boehringer Ingelheim Pharmaceuticals, Inc.,

Novo Nordisk, Inc.; Research Support: Novo Nordisk, Inc.

Constable, Todd .................................... Disclosed no confl ict of interest. Constantin, Ciprian ............................... Disclosed no confl ict of interest. Constantin, Georgiana ......................... Disclosed no confl ict of interest. Constantinescu, Andrei A. ................... Research Support: VLM (Association Vaincre la Mucovisci-

dose) Constantino, Maria I. ........................... Disclosed no confl ict of interest. Conte, Francesca .................................. Disclosed no confl ict of interest. Conway, Baqiyyah ................................ Other Relationship: VeraLight, Inc. Conway, Mary-Ellen ............................. Disclosed no confl ict of interest. Cook, David I. ....................................... Disclosed no confl ict of interest. Cook, Gabrielle ..................................... Disclosed no confl ict of interest. Cook, Steven ........................................ Disclosed no confl ict of interest. Cook, William ....................................... Employee: AstraZeneca Pharmaceuticals LP

Dow



A844


AU

THO

R D

ISCL

OSU

RE

Cool, David R. ....................................... Disclosed no confl ict of interest. Coon, Joshua ........................................ Disclosed no confl ict of interest. Cooney, Gregory J. ............................... Disclosed no confl ict of interest. Cooper, Jason ....................................... Disclosed no confl ict of interest. Cooper, Jennifer ................................... Disclosed no confl ict of interest. Cooper, Paige ....................................... Disclosed no confl ict of interest. Cooper, Shawna ................................... Disclosed no confl ict of interest. Copeland, Paul M. ................................ Disclosed no confl ict of interest. Copeman, Christine .............................. Disclosed no confl ict of interest. Copetti, Massimiliano .......................... Disclosed no confl ict of interest. Coppelli, Alberto .................................. Disclosed no confl ict of interest. Coppola, Andrea ................................... Disclosed no confl ict of interest. Corathers, Sarah D. .............................. Disclosed no confl ict of interest. Corbalan, J. Jose ................................. Disclosed no confl ict of interest. Corbin, John A. ..................................... Employee: XOMA Corporation Cordoba-Chacon, Jose ......................... Disclosed no confl ict of interest. Cordova, Jeanine M. ............................ Disclosed no confl ict of interest. Corey, Mark .......................................... Disclosed no confl ict of interest. Corona, Giovanni .................................. Disclosed no confl ict of interest. Coroniti, Roberta .................................. Disclosed no confl ict of interest. Correa, Adolfo ...................................... Disclosed no confl ict of interest. Correig, Xavier ...................................... Disclosed no confl ict of interest. Corriere, Mark D. .................................. Disclosed no confl ict of interest. Cortes-Sempere, María ........................ Disclosed no confl ict of interest. Cos, Xavier ........................................... Disclosed no confl ict of interest. Coskun, Tamer ...................................... Employee: Lilly Coskunpinar, Ender ............................... Disclosed no confl ict of interest. Cosson, Emmanuel ............................... Disclosed no confl ict of interest. Costa, Bernardo .................................... Disclosed no confl ict of interest. Costa, Maria L. ..................................... Disclosed no confl ict of interest. Costabile, Giuseppina .......................... Disclosed no confl ict of interest. Costacou, Tina ...................................... Disclosed no confl ict of interest. Costantini, Federica ............................. Disclosed no confl ict of interest. Coste, Olivier ........................................ Disclosed no confl ict of interest. Coster, Adelle ....................................... Disclosed no confl ict of interest. Costes, Safi a ........................................ Disclosed no confl ict of interest. Costford, Sheila R. ............................... Disclosed no confl ict of interest. Coto, Jeffrey ......................................... Disclosed no confl ict of interest. Cotter, Alexander ................................. Disclosed no confl ict of interest. Couch, Sarah C. .................................... Disclosed no confl ict of interest. Coudriet, Gina M. ................................. Disclosed no confl ict of interest. Coughlan, Kimberly A. .......................... Disclosed no confl ict of interest. Coulter, Kristin R. ................................. Employee: Metabolic Solutions Development Co. Courcoulas, Anita P. ............................. Disclosed no confl ict of interest. Courtade, Jaques ................................. Disclosed no confl ict of interest. Cousineau, Tara M. .............................. Disclosed no confl ict of interest. Cousins, Caroline E. ............................. Disclosed no confl ict of interest. Covington, Jeffrey D. ........................... Disclosed no confl ict of interest. Cowan, Chad A. .................................... Disclosed no confl ict of interest. Cowie, Catherine C. ............................. Disclosed no confl ict of interest. Cox, Amanda J. .................................... Disclosed no confl ict of interest. Cox, Daniel ........................................... Disclosed no confl ict of interest. Cox, Nancy J. ....................................... Disclosed no confl ict of interest. Coy, David ............................................. Disclosed no confl ict of interest. Coyne, Karin ......................................... Employee: United BioSource Corporation Cózar-Castellano, Irene ........................ Disclosed no confl ict of interest. Craciun, Anne Marie ............................ Disclosed no confl ict of interest. Craft, Cheryl E. ..................................... Disclosed no confl ict of interest. Craig, Maria E. ..................................... Disclosed no confl ict of interest. Cramb, Robert ...................................... Disclosed no confl ict of interest. Cramer, Andrea .................................... Disclosed no confl ict of interest. Cramer, Helena ..................................... Disclosed no confl ict of interest. Crandall, Jill P. ...................................... Disclosed no confl ict of interest. Crandell, Jamie L. ................................ Disclosed no confl ict of interest. Crane, Dawn L. ..................................... Disclosed no confl ict of interest. Cranston, Iain ....................................... Consultant: Roche Diagnostics Cranston, Marcus ................................. Disclosed no confl ict of interest. Crean, John K. ...................................... Disclosed no confl ict of interest. Crecelius, Lisa ...................................... Disclosed no confl ict of interest. Cree-Green, Melanie ............................ Disclosed no confl ict of interest. Creissen, Elizabeth ............................... Disclosed no confl ict of interest. Crews, Ryan T. ...................................... Disclosed no confl ict of interest. Crimmins, Nancy A. .............................. Disclosed no confl ict of interest. Crisci, Isabella ...................................... Disclosed no confl ict of interest. Criscitiello, Michael F. .......................... Disclosed no confl ict of interest. Cristaldi, Christina L. ............................ Disclosed no confl ict of interest. Crites, Yvonne ...................................... Disclosed no confl ict of interest. Croteau-Chonka, Damien C. ................. Disclosed no confl ict of interest. Crow, Michael T. .................................. Disclosed no confl ict of interest. Crowley, Stephanie J. .......................... Disclosed no confl ict of interest. Cruciani-Guglielmacci, Céline .............. Disclosed no confl ict of interest. Crume, Tessa L. .................................... Disclosed no confl ict of interest.

Cryer, Philip E. ...................................... Consultant: Novo Nordisk, Inc. Csajbok, Eva A. ..................................... Disclosed no confl ict of interest. Cubbon, Richard ................................... Disclosed no confl ict of interest. Cucinotta, Domenico ............................ Consultant: Novo Nordisk, Inc.; Speaker’s Bureau: Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk, Inc.

Cuddihy, Robert .................................... Employee: Sanofi US, Inc., United Health Group - Optum (Spouse/Partner); Stock/Shareholder: United Health Group - Optum (Spouse/Partner)

Cui, Jinrui ............................................. Disclosed no confl ict of interest. Cui, Jisong ............................................ Disclosed no confl ict of interest. Cui, Ran ................................................ Disclosed no confl ict of interest. Cukierman-Yaffe, Tali ........................... Other Relationship: Sanofi Cullison, Kevin ...................................... Disclosed no confl ict of interest. Cummings, Bethany P. .......................... Disclosed no confl ict of interest. Cummings, David ................................. Disclosed no confl ict of interest. Cummings, Doyle M. ............................ Disclosed no confl ict of interest. Cundy, Timothy F. .................................. Disclosed no confl ict of interest. Cunningham, Glenn R. .......................... Speaker’s Bureau: Merck Cunningham, Solveig A. ....................... Disclosed no confl ict of interest. Curi, Rui ................................................ Disclosed no confl ict of interest. Curran, Joanne E. ................................. Disclosed no confl ict of interest. Currie, Craig J. ..................................... Consultant: Abbott Laboratories, Inc., Bristol-Myers Squibb

Company, Takeda Pharmaceutical Company, Ltd.; Research Support: Takeda Pharmaceutical Company, Ltd.

Cursaru, Adrian .................................... Disclosed no confl ict of interest. Curtis, Bradley H. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Cushman, Samuel W. ........................... Disclosed no confl ict of interest. Cusi, Kenneth ....................................... Research Support: Takeda Pharmaceuticals U.S.A., Inc. Cusumano, Janine ................................ Disclosed no confl ict of interest. Cvitic, Silvija ......................................... Disclosed no confl ict of interest. Cyganek, Katarzyna .............................. Disclosed no confl ict of interest. Cypess, Aaron M. ................................. Research Support: Chugai Pharmaceutical Co., Ltd. Cziraky, Mark J. .................................... Disclosed no confl ict of interest. Czogalla, Jan ........................................ Disclosed no confl ict of interest. Czupryniak, Leszek ............................... Disclosed no confl ict of interest. Da Rosa, Silvina ................................... Disclosed no confl ict of interest. Da Sacco, Letizia .................................. Disclosed no confl ict of interest. da Silva Xavier, Gabriela ...................... Disclosed no confl ict of interest. Dabbous, Omar ..................................... Employee: Takeda Pharmaceutical Company, Ltd. Dabelea, Dana ...................................... Disclosed no confl ict of interest. Daboul, Nour ........................................ Disclosed no confl ict of interest. DaCosta, Christopher ........................... Employee: Lexicon Pharmaceuticals, Inc. Dada, Shirine ........................................ Disclosed no confl ict of interest. D’Addio, Francesca .............................. Disclosed no confl ict of interest. Dadi, Prasanna K. ................................. Disclosed no confl ict of interest. Daemen, Mat ....................................... Disclosed no confl ict of interest. Daffu, Gurdip ........................................ Disclosed no confl ict of interest. Dagan, Shlomo ..................................... Employee: Andromeda Biotech, Ltd. D’Agati, Vivette .................................... Disclosed no confl ict of interest. Dagdeviren, Sezin ................................ Disclosed no confl ict of interest. Dagenais, Gilles ................................... Disclosed no confl ict of interest. Dagogo-Jack, Samuel .......................... Advisory Panel: Amylin Pharmaceuticals, Inc., Merck, Novo

Nordisk, Inc. D’Agostino, Jr., Ralph B. ...................... Disclosed no confl ict of interest. Dagpo, Tenzin ....................................... Disclosed no confl ict of interest. Dahl, Marshall ...................................... Disclosed no confl ict of interest. Dahlerup, Jens Frederik ....................... Disclosed no confl ict of interest. Dahl-Jørgensen, Knut .......................... Disclosed no confl ict of interest. Dahmen, Raphael ................................. Employee: Sanofi Dahmer, Mary K. .................................. Disclosed no confl ict of interest. Dahms, Nancy M. ................................. Disclosed no confl ict of interest. Dai, Chunhua ........................................ Disclosed no confl ict of interest. Dai, Yan-Shan ....................................... Disclosed no confl ict of interest. Daiber, Andreas .................................... Disclosed no confl ict of interest. Dailey, George ...................................... Consultant: Sanofi ; Other Relationship: Amylin Pharmaceu-

ticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Com-pany, GlaxoSmithKline, Halozyme Therapeutics, ITCA, Lexicon Pharmaceuticals, Inc., MannKind Corporation, Merck, Minimed, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi ; Speaker’s Bureau: Amylin Pharmaceuticals, Inc., Boeh-ringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Merck, Sanofi

Dain, Marie-Paule ................................ Employee: Sanofi Dalal, Mehul ......................................... Employee: sanofi -aventis US Dalan, Rinkoo ....................................... Disclosed no confl ict of interest. Dale, William ....................................... Disclosed no confl ict of interest. Dalenbäck, Jan ..................................... Disclosed no confl ict of interest.

Dow



A845


AU

THO

R D

ISCL

OSU

RE

D’Alessio, David A. .............................. Consultant: Amylin Pharmaceuticals, Inc., Eli Lilly and Com-pany, Merck, Novo Nordisk, Inc., Zealand Pharma A/S; Research Support: Ethicon EndoSurgery, Inc.

Daley, Matthew .................................... Disclosed no confl ict of interest. Dalla Man, Chiara ................................ Disclosed no confl ict of interest. Dalley, Jeffrey W. ................................. Disclosed no confl ict of interest. Dalton-Bakes, Cornelia ........................ Disclosed no confl ict of interest. Daly, Rebecca ....................................... Disclosed no confl ict of interest. Damci, Taner ........................................ Advisory Panel: Bilim Pharmaceuticals, Novo Nordisk A/S;

Speaker’s Bureau: Abbott Laboratories, Inc., AstraZeneca/Bristol-Meyers Squibb, Bayer Health Care, LLC, Bilim Pharmaceuticals, Eli Lilly and Company, Novo Nordisk A/S, Pfi zer, Inc., Sanofi

Damgaard, Lars H. ................................ Employee: Novo Nordisk A/S, Novo Zymes A/S (Spouse/Partner)

Damiano, Edward R. ............................. Research Support: Abbott Diabetes Care, Dexcom, Inc., Insulet Corporation, International Biomedical, Medtronic MiniMed, Inc.

Damm, Peter ......................................... Consultant: Novo Nordisk A/S; Research Support: Novo Nordisk A/S; Speaker’s Bureau: Novo Nordisk A/S

Damouni, Rawan .................................. Disclosed no confl ict of interest. Damsbo, Peter ...................................... Consultant: CeQur, Ltd.; Other Relationship: CeQur, Ltd.;

Stock/Shareholder: Novo Nordisk A/S Dan, Olivia ............................................ Disclosed no confl ict of interest. Dandona, Paresh .................................. Advisory Panel: Merck, Novo Nordisk, Inc. Danese, Mark ....................................... Consultant: Genentech; Employee: Outcomes Insights Dang, Ton ............................................. Employee: ChemoCentryx D’Angelo, Angela ................................. Disclosed no confl ict of interest. Daniel, Johnnie .................................... Disclosed no confl ict of interest. Daniel, Louis ......................................... Disclosed no confl ict of interest. Daniele, Giuseppe ................................ Disclosed no confl ict of interest. Daniell, Henry ....................................... Disclosed no confl ict of interest. D’Aniello, Maria ................................... Disclosed no confl ict of interest. Daniels, Linda J. ................................... Disclosed no confl ict of interest. Daniels, Nigel A. .................................. Disclosed no confl ict of interest. Daniels, Stephen R. .............................. Disclosed no confl ict of interest. Danielsen, Inge .................................... Disclosed no confl ict of interest. Danielson, Kirstie K. ............................. Disclosed no confl ict of interest. Dankner, Rachel ................................... Disclosed no confl ict of interest. Danne, Thomas .................................... Consultant: Abbott Diabetes Care, Berlin Chemie AG/

Menarini, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Cellnovo, Eli Lilly and Company, Medtronic MiniMed, Inc., Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi , Unomedical

Danse, Whitney A. ............................... Disclosed no confl ict of interest. Dantas, Diego M. ................................. Disclosed no confl ict of interest. Dantas, Joana ...................................... Disclosed no confl ict of interest. Daoud, Daoud ....................................... Disclosed no confl ict of interest. Daoudi, Ahmed ..................................... Disclosed no confl ict of interest. Daphna-Iken, Dorit ............................... Disclosed no confl ict of interest. Dardano, Angela .................................. Disclosed no confl ict of interest. Dardari, Dured ...................................... Disclosed no confl ict of interest. D’Argenio, David Z. .............................. Disclosed no confl ict of interest. Darland, Celia ....................................... Disclosed no confl ict of interest. Darmon, Patrice .................................... Speaker’s Bureau: Bristol-Myers Squibb Company, Eli Lilly

and Company, GlaxoSmithKline, Merck, Novartis Pharma-ceuticals Corporation, Novo Nordisk A/S, Sanofi , Takeda Pharmaceutical Company, Ltd.

Darnieder, Laura ................................... Disclosed no confl ict of interest. Darpo, Borje ......................................... Consultant: GlaxoSmithKline; Research Support: GlaxoSmith-

Kline Dart, Allison ......................................... Disclosed no confl ict of interest. Das, Ashok K. ....................................... Disclosed no confl ict of interest. Das, Swapan K. .................................... Disclosed no confl ict of interest. Dash, Satya .......................................... Disclosed no confl ict of interest. Daskalova, Ivona K. .............................. Disclosed no confl ict of interest. Dassau, Eyal ......................................... Advisory Panel: Animas Corporation; Consultant: Animas

Corporation; Research Support: Animas Corporation Datz, Nicolin ......................................... Disclosed no confl ict of interest. Dauch, Jacqueline R. ........................... Disclosed no confl ict of interest. Daumit, Gail ......................................... Disclosed no confl ict of interest. Dauriz, Marco ....................................... Disclosed no confl ict of interest. Davalli, Alberto .................................... Disclosed no confl ict of interest. Davato, Francesca ................................ Disclosed no confl ict of interest. Dave, Swapna ...................................... Disclosed no confl ict of interest. Davenport, Colin ................................... Disclosed no confl ict of interest. David, Larry L. ....................................... Disclosed no confl ict of interest. Davidson, Jaime ................................... Advisory Panel: Janssen Davidson, Michael H. ........................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Merck,

Sanofi ; Research Support: Abbott Laboratories, Inc. Davidson, Patricia ................................ Consultant: Columbia University; Other Relationship: Animas,

Medtronics

Davidson, W.S. ..................................... Disclosed no confl ict of interest. Davies, Glenn ....................................... Employee: Merck Davies, Jennifer ................................... Disclosed no confl ict of interest. Davies, Melanie J. ............................... Advisory Panel: Novartis, Novo Nordisk, Inc., sanofi-aven-

tis, Lilly, Merck Sharp & Dohme, Boehringer Ingelheim Pharmaceuticals, Inc., Roche; Consultant: Novartis, Novo Nordisk, Inc., sanofi-aventis, Lilly, Merck Sharp & Dohme, Boehringer Ingelheim Pharmaceuticals, Inc., Roche; Research Support: Novartis, Novo Nordisk, Inc., sanofi-aventis, Lilly, Pfizer, Merck Sharp & Dohme, GlaxoSmithKline; Speaker’s Bureau: Novartis, Novo Nordisk, Inc., sanofi-aventis, Lilly, Merck Sharp & Dohme, Boehringer Ingelheim Pharmaceuticals, Inc., Roche

Davies, Michael J. ............................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder: Merck Sharp & Dohme Limited

Davies, Rhian ....................................... Disclosed no confl ict of interest. Daviglus, Martha .................................. Disclosed no confl ict of interest. Davis, Asa ............................................ Disclosed no confl ict of interest. Davis, Dianne ....................................... Consultant: Abbott Diabetes Care Davis, Elizabeth A. ............................... Disclosed no confl ict of interest. Davis, Ian C. ......................................... Disclosed no confl ict of interest. Davis, James ........................................ Disclosed no confl ict of interest. Davis, Maureen .................................... Disclosed no confl ict of interest. Davis, Meghan L. ................................. Employee: GlaxoSmithKline Davis, Nichola J. .................................. Disclosed no confl ict of interest. Davis, Shain ......................................... Disclosed no confl ict of interest. Davis, Stephen N. ................................ Disclosed no confl ict of interest. Davis, Timothy M. ................................ Advisory Panel: AstraZeneca/Bristol-Meyers Squibb,

Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceuticals, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Research Support: Merck Sharp & Dohme Limited, Novo Nordisk A/S; Speaker’s Bureau: Abbott Laboratories, Inc., AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S

Davis, Wendy A. ................................... Research Support: Novo Nordisk A/S Davis, Wilhelmina I. ............................. Disclosed no confl ict of interest. Daw, Warwick ...................................... Disclosed no confl ict of interest. Dawson, Harry D. ................................. Disclosed no confl ict of interest. Dawson, Neal ....................................... Disclosed no confl ict of interest. Day, Wesley W. .................................... Employee: Vivus, Inc. Dayeh, Tasnim ...................................... Disclosed no confl ict of interest. De Almeida, Jussara C. ........................ Disclosed no confl ict of interest. De Azevedo, Mirela J. .......................... Disclosed no confl ict of interest. De Bellis, Alessandra ........................... Disclosed no confl ict of interest. De Berardis, Giorgia ............................. Disclosed no confl ict of interest. De Block, Christophe ............................ Disclosed no confl ict of interest. De Boer, Ian H. ..................................... Disclosed no confl ict of interest. De Boer, Michiel P. ............................... Disclosed no confl ict of interest. De Bonis, Concetta ............................... Disclosed no confl ict of interest. De Bruin, Tjerk W. ................................ Employee: AstraZeneca Pharmaceuticals LP; Stock/Share-

holder: AstraZeneca Pharmaceuticals LP De Cabo, Rafael ................................... Disclosed no confl ict of interest. De Carli, Elisa ....................................... Disclosed no confl ict of interest. De Chavez, Peter John D. ..................... Disclosed no confl ict of interest. De Cosmo, Salvatore ............................ Disclosed no confl ict of interest. De Courten, Barbora ............................. Disclosed no confl ict of interest. De Courten, Max .................................. Disclosed no confl ict of interest. De Gara, Laura ..................................... Disclosed no confl ict of interest. De Groot, Mary ..................................... Disclosed no confl ict of interest. De Jager, Philip .................................... Disclosed no confl ict of interest. De Jesus, Dario F. ................................. Disclosed no confl ict of interest. De Kleijn, Dominique ........................... Disclosed no confl ict of interest. De Koning, Eelco .................................. Disclosed no confl ict of interest. De Kreutzenberg, Saula ....................... Disclosed no confl ict of interest. De la Fuente, J. .................................... Disclosed no confl ict of interest. De La Houssaye, Becky ........................ Disclosed no confl ict of interest. De Leon, Diva D. ................................... Consultant: Biodel, Inc., XOMA Corporation; Employee:

Merck (Spouse/Partner); Research Support: XOMA Corporation; Stock/Shareholder: Merck

De Luis, Daniel ..................................... Disclosed no confl ict of interest. De Lusignan, Simon ............................. Disclosed no confl ict of interest. De Oliveira, Carolina ............................ Disclosed no confl ict of interest. De Oliveira, Jose Egidio P. ................... Disclosed no confl ict of interest. De Pablos-Velasco, Pedro .................... Disclosed no confl ict of interest. De Simone, Paolo ................................. Disclosed no confl ict of interest. De Souza, Errol ..................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc. De Vries, Daniëlle ................................ Employee: Eli Lilly and Company, Sanofi (Spouse/Partner); Stock/

Shareholder: Eli Lilly and Company, Sanofi (Spouse/Partner)

Dow



A846


AU

THO

R D

ISCL

OSU

RE

De Vries, Liat ........................................ Consultant: Andromeda Biotech, Ltd. De Wit, Maartje ................................... Disclosed no confl ict of interest. Deacon, Carolyn ................................... Advisory Panel: Eli Lilly and Company; Consultant: Merck

Sharp & Dohme Limited; Employee: Merck Sharp & Dohme Limited (Spouse/Partner); Other Relationship: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S; Stock/Shareholder: Merck (Spouse/Partner)

Deal, Dwight ........................................ Disclosed no confl ict of interest. DeAlmeida, Dilhari ............................... Disclosed no confl ict of interest. Dean, Heather J. .................................. Disclosed no confl ict of interest. Deane, Adam M. .................................. Disclosed no confl ict of interest. DeBruin, Tjerk W. ................................. Employee: AstraZeneca Pharmaceuticals LP DeCabo, Rafafel ................................... Disclosed no confl ict of interest. DeFronzo, Ralph A. ............................... Advisory Panel: Amylin Pharmaceuticals, Inc., Boehringer

Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Novo Nordisk, Inc., Takeda Pharmaceutical Company, Ltd.; Other Relationship: Amylin Pharmaceuticals, Inc., Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Novo Nordisk, Inc.

Degismez, Hatice ................................. Disclosed no confl ict of interest. Dehennis, Andrew ................................ Disclosed no confl ict of interest. Dei Tos, Angelo Paolo .......................... Disclosed no confl ict of interest. Deiana, Maria Grazia ........................... Disclosed no confl ict of interest. Deines, Kristin ...................................... Disclosed no confl ict of interest. DeJesus, Stephanie ............................. Disclosed no confl ict of interest. Dejgaard, Anders ................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Dekker Nitert, Marloes ........................ Disclosed no confl ict of interest. Dekker, Jacqueline M. ......................... Disclosed no confl ict of interest. Del Giudice, Marinella ......................... Disclosed no confl ict of interest. Del Prato, Stefano ................................ Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer

Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Com-pany, Eli Lilly and Company, GlaxoSmithKline, Intarcia Therapeutics, Inc., Janssen Pharmaceuticals, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi , Takeda Global Research and Development, Inc.; Research Support: Bristol-Myers Squibb Company, Merck, Novartis Pharmaceuticals Corporation, Takeda Global Research & Development Center, Inc.; Speaker’s Bureau: Novartis Pharmaceuticals Corporation

Del Toro, Rossella ................................ Disclosed no confl ict of interest. Delafont, Bruno .................................... Employee: Boehringer Ingelheim France Delahanty, Linda M. ............................. Advisory Panel: Eli Lilly and Company, Johnson & Johnson;

Consultant: Pfi zer, Inc. DeLany, James P. .................................. Disclosed no confl ict of interest. Deldin, Anthony R. ............................... Disclosed no confl ict of interest. Delfi no von Frankenberg, Anize ........... Disclosed no confl ict of interest. Delghingaro-Augusto, Viviane ............. Disclosed no confl ict of interest. Deliard, Sandra .................................... Disclosed no confl ict of interest. Delin, Ma .............................................. Disclosed no confl ict of interest. Dell’Orfano, Heather ............................ Disclosed no confl ict of interest. Della Corte, Giuseppina ....................... Disclosed no confl ict of interest. Della Pepa, Giuseppe ........................... Disclosed no confl ict of interest. Deller, Sigrid ......................................... Other Relationship: Novo Nordisk A/S Delli, Ahmed ......................................... Disclosed no confl ict of interest. Delong, Thomas ................................... Disclosed no confl ict of interest. DeMarco, Vincent G. ............................ Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc., Takeda Pharmaceutical Company, Ltd. Demarest, Keith ................................... Employee: Janssen Research & Development Deming, James R. ................................ Disclosed no confl ict of interest. Demirbas, Seref ................................... Disclosed no confl ict of interest. Demirci, Ibrahim ................................... Disclosed no confl ict of interest. Demircik, Filiz ....................................... Disclosed no confl ict of interest. Demirkol, Sait ....................................... Disclosed no confl ict of interest. Demirpence, Mustafa .......................... Disclosed no confl ict of interest. Demuth, Dirk ........................................ Consultant: IMS Health, Inc. Deng, Hongrong ................................... Disclosed no confl ict of interest. Deng, Ruifen ......................................... Disclosed no confl ict of interest. Deng, Wanping .................................... Disclosed no confl ict of interest. Deng, Wu ............................................. Disclosed no confl ict of interest. Dengel, Donald R. ................................ Disclosed no confl ict of interest. Deniz, Gunnur ....................................... Disclosed no confl ict of interest. Dennedy, Michael C. ............................ Disclosed no confl ict of interest. Dennis, Michael D. ............................... Disclosed no confl ict of interest. Denny, Kerina ....................................... Disclosed no confl ict of interest. Dent, Robert ......................................... Disclosed no confl ict of interest. Denvir, Jim ........................................... Disclosed no confl ict of interest. Denwood, Geoffrey T. .......................... Disclosed no confl ict of interest. Depis, Fabien ........................................ Disclosed no confl ict of interest. Derazne, Estela .................................... Disclosed no confl ict of interest.

Deroover, Arnaud ................................. Disclosed no confl ict of interest. Derosa, Giuseppe ................................. Disclosed no confl ict of interest. Derwahl, Michael ................................. Research Support: IKFE, Insuline Medical Desai, Jay ............................................. Disclosed no confl ict of interest. Desai, Mayur M. .................................. Disclosed no confl ict of interest. Desai, Mehul ........................................ Employee: Janssen Research & Development Desai, Niraj .......................................... Disclosed no confl ict of interest. Desai, Tejas .......................................... Disclosed no confl ict of interest. Desale, Sameer .................................... Disclosed no confl ict of interest. Desir, Matthew .................................... Disclosed no confl ict of interest. Desouza, Cyrus V. ................................. Disclosed no confl ict of interest. Desoye, Gernot ..................................... Disclosed no confl ict of interest. Dessapt, Cecile .................................... Disclosed no conflict of interest. D’Ettorre, Antonio ................................ Disclosed no confl ict of interest. Devaraj, Sridevi .................................... Disclosed no confl ict of interest. Devarajan, Priyadharshini .................... Disclosed no confl ict of interest. Deville-Almond, Jane ........................... Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk, Inc. Devlin, John T. ...................................... Disclosed no confl ict of interest. DeVore, Stephanie ............................... Employee: AstraZeneca Pharmaceuticals LP DeVries, J. Hans ................................... Board Member: Johnson & Johnson, Novo Nordisk A/S,

Roche Diagnostics; Research Support: Dexcom, Inc., GluMetrics, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: Dexcom, Inc., Eli Lilly and Company, Novo Nordisk A/S

Dewey, Jerry ........................................ Disclosed no confl ict of interest. Dey, Adwitia ......................................... Disclosed no confl ict of interest. Deyneli, Oguzhan ................................. Disclosed no confl ict of interest. Dezaki, Katsuya .................................... Disclosed no confl ict of interest. Dezortova, Monika ............................... Disclosed no confl ict of interest. DeZoysa, Nicole ................................... Disclosed no confl ict of interest. Dhalla, Arvinder K. ............................... Employee: Gilead Sciences, Inc. Dhanoo, Andrew .................................. Disclosed no confl ict of interest. Dharmalingam, Mala ........................... Disclosed no confl ict of interest. Dhatariya, Ketan K. .............................. Disclosed no confl ict of interest. Dhindsa, Sandeep ................................ Disclosed no confl ict of interest. Dhir, Ravindra ....................................... Disclosed no confl ict of interest. Di Mauro, Lazzaro ................................ Disclosed no confl ict of interest. Di Noto, Anna ....................................... Disclosed no confl ict of interest. Di Paola, Rosa ...................................... Disclosed no confl ict of interest. Di Pietro, Cinzia .................................... Employee: Takeda Pharmaceutical Company, Ltd. Di Stasio, Enrico ................................... Disclosed no confl ict of interest. Di Tanna, Gian Luca ............................. Research Support: Eli Lilly and Company Di Tomo, Pamela .................................. Disclosed no confl ict of interest. Di, Chanjuan ......................................... Disclosed no confl ict of interest. Diamant, Michaela ............................... Advisory Panel: Abbott Diabetes Care, Eli Lilly and Company,

Merck Sharp & Dohme Limited, Novo Nordisk A/S, Poxel Pharmaceutical Company, Sanofi ; Consultant: AstraZen-eca/Bristol-Meyers Squibb; Research Support: Amylin Pharmaceuticals, LLC, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi

Diamond, Michael P. ............................ Disclosed no confl ict of interest. Diao, Yalin ............................................ Disclosed no confl ict of interest. Diao, Yanpeng ...................................... Disclosed no confl ict of interest. Dias, Ingrid B. ....................................... Disclosed no confl ict of interest. Dias, Sofi a ............................................ Disclosed no confl ict of interest. Diaz, Ana .............................................. Disclosed no confl ict of interest. Diaz, Monica M. ................................... Disclosed no confl ict of interest. Diaz, Norma .......................................... Disclosed no confl ict of interest. Diaz, Sylvia ........................................... Disclosed no confl ict of interest. DiBonaventura, Marco D. ..................... Consultant: Novartis Pharma AG; Employee: Kantar Health Dick, Edward ........................................ Disclosed no confl ict of interest. Dick, Jonathan J. ................................. Other Relationship: mHealth Solutions Dickens, Jazzmyne T. ........................... Disclosed no confl ict of interest. Dickson, Lorna ...................................... Disclosed no confl ict of interest. Didangelos, Triantafi llos ...................... Disclosed no confl ict of interest. Didier, G. .............................................. Research Support: Boehringer Ingelheim Pharmaceuti-

cals, Inc., Eli Lilly and Company, Johnson & Johnson, Medtronic, Novo Nordisk A/S, Sanofi

Diennet, Marine ................................... Disclosed no conflict of interest. Diepenbroek, Charlene ......................... Disclosed no confl ict of interest. Dierdorff, Jason M. .............................. Disclosed no confl ict of interest. Dietert, Gabriele ................................... Employee: Sanofi Dietrich, Marcelo O. ............................. Disclosed no confl ict of interest. Dieuzeide, Guillermo ............................ Advisory Panel: Novo Nordisk A/S; Speaker’s Bureau:

AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Novo Nordisk A/S

DiGenio, Andres ................................... Employee: sanofi -aventis US Dillingham, Rebecca ............................ Research Support: Bristol-Myers Squibb Company Dillon, James L. .................................... Disclosed no confl ict of interest. DiMarchi, Richard D. ............................ Disclosed no confl ict of interest.

Dow



A847


AU

THO

R D

ISCL

OSU

RE

DiMeglio, Linda A. ............................... Disclosed no confl ict of interest. Dimitriadis, George .............................. Disclosed no confl ict of interest. Dinatale, Emily ..................................... Disclosed no confl ict of interest. Dinc, Mustafa ....................................... Disclosed no confl ict of interest. Dincag, Nevin ....................................... Disclosed no confl ict of interest. Dincer, Fadime ...................................... Disclosed no confl ict of interest. Dineen, Stacey L. ................................. Disclosed no confl ict of interest. Ding, Gui Feng ...................................... Disclosed no confl ict of interest. Ding, Heyuan ........................................ Disclosed no confl ict of interest. Ding, Kai ............................................... Disclosed no confl ict of interest. Ding, Min .............................................. Disclosed no confl ict of interest. Ding, Su-Ann ........................................ Disclosed no confl ict of interest. Ding, Ying ............................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Ding, Yuyan .......................................... Disclosed no confl ict of interest. Ding, Zhi-Ming ..................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Dinh, Thanh .......................................... Disclosed no confl ict of interest. Dinu, Robert ......................................... Disclosed no confl ict of interest. Dinudom, Anuwat ................................ Disclosed no confl ict of interest. Dirani, Riad G. ...................................... Employee: Lifescan Animas, Inc. Dirice, Ercument ................................... Disclosed no confl ict of interest. Dirinck, Eveline L. ................................. Disclosed no confl ict of interest. Dirksen, Carsten ................................... Disclosed no confl ict of interest. Distefano, Giovanna ............................. Disclosed no confl ict of interest. DiTacchio, Luciano ............................... Disclosed no confl ict of interest. diTommaso, Shelley ............................. Employee: Novartis Pharma AG Divani, Maria ........................................ Disclosed no confl ict of interest. Divers, Jasmin ...................................... Disclosed no confl ict of interest. DiVincenzo, Richard ............................. Disclosed no confl ict of interest. Dixon, John .......................................... Advisory Panel: Nestle Health Australia; Consultant: Allergan,

Inc., Bariatric Advantage; Research Support: Allergan, Inc.; Speaker’s Bureau: Eli Lilly and Company, iNova Pharmaceuticals, Merck Sharp & Dohme Limited

Djamali, Arjang .................................... Disclosed no confl ict of interest. Djavelidze, Maya .................................. Disclosed no confl ict of interest. Djousse, Luc ......................................... Disclosed no confl ict of interest. Do Nascimento, Filipe V. ...................... Disclosed no confl ict of interest. Doan, Quan ........................................... Consultant: Genentech; Employee: Outcomes Insights Dobashi, Yuko ....................................... Disclosed no confl ict of interest. Dobbins, Robert L. ................................ Employee: GlaxoSmithKline Dobson, Matthew ................................ Disclosed no confl ict of interest. Dobyszuk, Anita .................................... Disclosed no confl ict of interest. Dodt, Christoph .................................... Disclosed no confl ict of interest. Doecke, Stephanie ............................... Disclosed no confl ict of interest. Doherty, Chris ....................................... Disclosed no confl ict of interest. Dohm, G.L. ............................................ Research Support: Johnson & Johnson Döhring, Carmen .................................. Disclosed no confl ict of interest. Doi, Asako ............................................ Disclosed no confl ict of interest. Doi, Ayano ............................................ Disclosed no confl ict of interest. Dolai, Subhankar .................................. Disclosed no confl ict of interest. Dolan, Chantal M. ................................ Consultant: Genentech Dolan, Lawrence M. ............................. Disclosed no confl ict of interest. Dolasik, Ilhan ........................................ Disclosed no confl ict of interest. Dölek, Devrim ....................................... Disclosed no confl ict of interest. Doliba, Nicolai M. ................................ Disclosed no confl ict of interest. Dölker, Rebecca .................................... Disclosed no confl ict of interest. Domiciano, Mayra ................................ Disclosed no confl ict of interest. Dominkovics, Isabella .......................... Disclosed no confl ict of interest. Donadel, Giulia ..................................... Disclosed no confl ict of interest. Donaghue, Kim C. ................................. Disclosed no confl ict of interest. Donahoo, William T. ............................. Disclosed no confl ict of interest. Donahue, Marina ................................. Disclosed no confl ict of interest. Donahue, Patrick E. .............................. Disclosed no confl ict of interest. Donald, Elizabeth ................................. Disclosed no confl ict of interest. Donaldson, Robert ................................ Disclosed no confl ict of interest. Donath, Marc ....................................... Disclosed no confl ict of interest. Dong, Fran ............................................ Disclosed no confl ict of interest. Dong, Henry .......................................... Disclosed no confl ict of interest. Dong, Shuang ....................................... Disclosed no confl ict of interest. Dong, Yanhu ......................................... Disclosed no confl ict of interest. Dong, Yunzhou ...................................... Disclosed no confl ict of interest. Dong, Zhenhua ..................................... Disclosed no confl ict of interest. Donna, Stolz B. ..................................... Disclosed no confl ict of interest. Donnet, Jean Paul ................................ Disclosed no confl ict of interest. Donsmark, Morten ............................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Dopita, Dana ........................................ Disclosed no confl ict of interest. Dorau, Martina ..................................... Employee: Sanofi Doree, Deon ......................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Dorey, François ..................................... Disclosed no confl ict of interest.

Dorfman, Mauricio D. ........................... Disclosed no confl ict of interest. Doria, Alessandro ................................. Disclosed no confl ict of interest. D’Oria, Rossella .................................... Disclosed no confl ict of interest. Dorian, Randy ....................................... Disclosed no confl ict of interest. Dosch, H. Michael ................................ Disclosed no confl ict of interest. Doshi, Dhaval ....................................... Disclosed no confl ict of interest. Dostalova, Ivana ................................... Disclosed no confl ict of interest. Dou, Jianxin ......................................... Disclosed no confl ict of interest. Doucet, Jean ........................................ Consultant: BD Medical Diabetes Care, Eli Lilly and Company,

Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Research Support: Merck, Novo Nordisk, Inc.

Dougan, Grace C. ................................. Disclosed no confl ict of interest. Dougherty, Erica ................................... Disclosed no confl ict of interest. Dougherty, Sonia .................................. Disclosed no confl ict of interest. Doukas, Loukas .................................... Disclosed no confl ict of interest. Doukelis, Panagiotis ............................. Disclosed no confl ict of interest. Douma, Stella ....................................... Disclosed no confl ict of interest. Doumas, Michael ................................. Disclosed no confl ict of interest. Doumas, Michalis ................................ Disclosed no confl ict of interest. Doupis, Chris ........................................ Disclosed no confl ict of interest. Doupis, John ........................................ Disclosed no confl ict of interest. Dover, Ellen N. ...................................... Disclosed no confl ict of interest. Dowd, Kathy ......................................... Disclosed no confl ict of interest. Downes, Kate ....................................... Disclosed no confl ict of interest. Downey, Maura .................................... Disclosed no confl ict of interest. Doyle III, Francis J. ............................... Advisory Panel: Animas Corporation; Research Support:

Animas Corporation Doyle, Joyce ......................................... Disclosed no confl ict of interest. Doyle, Todd ........................................... Disclosed no confl ict of interest. Draghici, Sorin ...................................... Disclosed no confl ict of interest. Dragomirescu, Liviu .............................. Disclosed no confl ict of interest. Dragut, Ramona Maria ......................... Disclosed no confl ict of interest. Draisma, Harmen H. ............................. Disclosed no confl ict of interest. Drake, Tyler .......................................... Disclosed no confl ict of interest. Drapalova, Jana ................................... Disclosed no confl ict of interest. Draznin, Boris ....................................... Research Support: Sanofi Drews, Kimberly L. ............................... Disclosed no confl ict of interest. Drexel, Heinz ........................................ Disclosed no confl ict of interest. Dridi, Zohra ........................................... Disclosed no confl ict of interest. Driscoll, Henry K. .................................. Disclosed no confl ict of interest. Drossos, Tina ........................................ Disclosed no confl ict of interest. Drury, Paul L. ........................................ Other Relationship: Novo Nordisk, Inc. Drzewoski, Jozef .................................. Consultant: Aventis, Bioton, Novo Nordisk A/S Du, Fenglai ........................................... Disclosed no confl ict of interest. Du, Xiaobing ......................................... Employee: Merck Du, Xinli ................................................ Disclosed no confl ict of interest. Du, Yunpeng ......................................... Disclosed no confl ict of interest. Duan, Yu ............................................... Disclosed no confl ict of interest. Dubb, Kiran ........................................... Disclosed no confl ict of interest. Dubé, John J. ....................................... Disclosed no confl ict of interest. Dube, Simmi ......................................... Disclosed no confl ict of interest. Dubois, Eleonore .................................. Disclosed no confl ict of interest. DuBose, Stephanie ............................... Disclosed no confl ict of interest. Duca, Lindsey M. .................................. Disclosed no confl ict of interest. Ducatman, Alan .................................... Disclosed no confl ict of interest. Duckworth, William C. ......................... Consultant: Caremark, GlaxoSmithKline, Sanofi -Aventis Dufaitre, Lise ........................................ Disclosed no confl ict of interest. Dufaure, Isabelle .................................. Disclosed no confl ict of interest. Dufner, Bianca ...................................... Disclosed no confl ict of interest. Dufour, Ines .......................................... Disclosed no confl ict of interest. Duggirala, Ravindranath ...................... Disclosed no confl ict of interest. Dugi, Klaus ........................................... Employee: Boehringer Ingelheim GmbH & Co. KG Duke, Danny C. ..................................... Disclosed no confl ict of interest. Dumas, Richard .................................... Consultant: Jansen Ortho, Merck,Novo Nordisk, Inc.Lilly,

sanofi -aventis, Boehringer Ingelheim/Astra Zeneca, BMS; Research Support: Jansen Ortho, Merck, Novo Nordisk, Inc., Lilly, sanofi -aventis, Boehringer Ingelheim/Astra Ze-neca, BMS; Speaker’s Bureau: Jansen Ortho, Merck, Novo Nordisk, Inc., Lilly, sanofi -aventis, Boehringer Ingelheim/Astra Zeneca, BMS

Dumont, Julie ....................................... Disclosed no confl ict of interest. Dunbar, James D. ................................. Employee: Lilly Dunford, Emily ...................................... Disclosed no confl ict of interest. Dungan, Kathleen M. ........................... Advisory Panel: Diabetes Technology Management (Spouse/

Partner); Consultant: Eli Lilly and Company (Spouse/Partner); Research Support: Novo Nordisk, Inc. (Spouse/Partner); Speaker’s Bureau: Medikinetics (Spouse/Partner)

Dunger, David B. ................................... Disclosed no confl ict of interest. Dunn, Jennifer C. ................................. Disclosed no confl ict of interest. Dunn, Rodney ....................................... Disclosed no confl ict of interest. Dunn, Ty ................................................ Disclosed no confl ict of interest. Dunne, Fidelma P. ................................. Disclosed no confl ict of interest.

Dow



A848


AU

THO

R D

ISCL

OSU

RE

Dunne, Nancy ....................................... Employee: Bayer Health Care, LLC Dunn-Meyel, Ambrose ......................... Disclosed no confl ict of interest. Dupont, Philippe ................................... Disclosed no confl ict of interest. Dupuy, Olivier ....................................... Disclosed no confl ict of interest. Duranay, Murat .................................... Disclosed no confl ict of interest. Durán-García, Santiago ........................ Other Relationship: Abbott Diabetes Care, AstraZeneca Phar-

maceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Com-pany, Janssen Pharmaceuticals, MannKind Corporation, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Pfi zer, Inc., Roche Pharmaceuticals, Sanofi , Servier, Takeda Pharmaceutical Company, Ltd.

Duranthon, Véronique .......................... Disclosed no confl ict of interest. Duran-Valdez, Elizabeth ....................... Disclosed no confl ict of interest. Durbin, Roy ........................................... Research Support: GlaxoSmithKline Durgin, Jonathan M. ............................ Disclosed no confl ict of interest. Durkan, Maeve C. ................................. Advisory Panel: Amylin/Eli Lilly and Company, Boehringer In-

gelheim GmbH & Co. KG, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi ; Speaker’s Bureau: Amylin/Eli Lilly and Company, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb/AstraZeneca, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation

Durkin, Nowella ................................... Disclosed no confl ict of interest. Dushay, Jody ........................................ Disclosed no confl ict of interest. Dutia, Roxanne ..................................... Disclosed no confl ict of interest. Dutta, Nirjhar ....................................... Disclosed no confl ict of interest. Dutta, Tumpa ........................................ Disclosed no confl ict of interest. Duun-Henriksen, Anne Katrine ............ Disclosed no confl ict of interest. Duvnjak, Lea ......................................... Disclosed no confl ict of interest. Dwinell, Melinda R. ............................. Disclosed no confl ict of interest. Dwivedi, Awanindra ............................. Disclosed no confl ict of interest. Dworak, Markus ................................... Employee: Novartis Pharmaceuticals Corporation Dwyer, Andrea ...................................... Disclosed no confl ict of interest. Dwyer, Peter ......................................... Disclosed no confl ict of interest. Dyal, Leanne ......................................... Disclosed no confl ict of interest. Dyck, Jason R. ...................................... Disclosed no confl ict of interest. Dyck, Roland ......................................... Disclosed no confl ict of interest. Dyer, Alan R. ......................................... Disclosed no confl ict of interest. Dyer, Kelli H. ......................................... Disclosed no confl ict of interest. Dyer, Thomas D. ................................... Disclosed no confl ict of interest. Dyle, Michael C. ................................... Disclosed no confl ict of interest. Dzata, Enyo ........................................... Disclosed no confl ict of interest. Dzida, Grzegorz J. ................................. Advisory Panel: Novo Nordisk A/S; Consultant: Berlin Chemie

AG, Bioton, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Sanofi , Servier

Dziuba, Julia ......................................... Disclosed no confl ict of interest. Ebenezer, Philip J. ................................ Disclosed no confl ict of interest. Ebenibo, Sotonte .................................. Disclosed no confl ict of interest. Eberly, Lynn E. ...................................... Disclosed no confl ict of interest. Ebert, Scott M. ..................................... Disclosed no confl ict of interest. Ebert, Thomas ...................................... Disclosed no confl ict of interest. Eby, Elizabeth ....................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Echouffo-Tcheugui, Justin B. ............... Disclosed no confl ict of interest. Eck, Sarah ............................................. Disclosed no confl ict of interest. Eckardt, Kristin ..................................... Disclosed no confl ict of interest. Eckel, Jürgen ........................................ Disclosed no confl ict of interest. Eckel, Robert H. .................................... Advisory Panel: Amarin, Amylin Pharmaceuticals, Inc.,

Esperion, Genentech, Johnson & Johnson, Novo Nordisk, Inc., Sanofi ; Research Support: GlaxoSmithKline

Ecker, Michelle ..................................... Disclosed no confl ict of interest. Eckfeldt, John H. .................................. Disclosed no confl ict of interest. Edelman, David .................................... Disclosed no confl ict of interest. Edelstein, Sharon L. ............................. Disclosed no confl ict of interest. Edeoga, Chimaroke .............................. Disclosed no confl ict of interest. Edgerton, Dale S. ................................. Disclosed no confl ict of interest. Edidin, Deborah .................................... Disclosed no confl ict of interest. Ediger, Marwood .................................. Employee: VeraLight, Inc. Edwards, Anne ..................................... Employee: VisionQuest Biomedical Edwards, Robert ................................... Employee: Janssen Research & Development Edwin, Bjørn ......................................... Disclosed no confl ict of interest. Eekhoff, Elisabeth M. ........................... Disclosed no confl ict of interest. Efanov, Alexander M. ........................... Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Com-pany, Eli Lilly and Company (Spouse/Partner)

Egan, Anna ........................................... Disclosed no confl ict of interest. Egan, Aoife M. ..................................... Disclosed no confl ict of interest. Egan, Josephine M. ............................. Disclosed no confl ict of interest. Egan, Maria .......................................... Disclosed no confl ict of interest.

Egawa, Katsuya .................................... Disclosed no confl ict of interest. Egesborg, Henrik .................................. Employee: Medtronic Eggels, Leslie ....................................... Disclosed no confl ict of interest. Eggers, Paul W. .................................... Disclosed no confl ict of interest. Eggleston, Emma M. ............................ Disclosed no confl ict of interest. Egidi, Francesca M. .............................. Disclosed no confl ict of interest. Eguchi, Akiko ........................................ Disclosed no confl ict of interest. Eguchi, Hiroshi ..................................... Disclosed no confl ict of interest. Eguchi, Jun ........................................... Disclosed no confl ict of interest. Eguchi, Yuichiro .................................... Disclosed no confl ict of interest. Ehrlich, Jason S. ................................... Employee: Genentech; Stock/Shareholder: Genentech Ehrlich, Samantha F. ............................. Disclosed no confl ict of interest. Ehrmann, David A. ................................ Disclosed no confl ict of interest. Ehrmann, Dominik ................................ Research Support: Berlin Chemie; Speaker’s Bureau: Berlin

Chemie Ehrmann, Markus ................................. Disclosed no confl ict of interest. Eilbracht, Jens ...................................... Employee: Boehringer Ingelheim GmbH & Co. KG Eisenberg, Adva ................................... Disclosed no confl ict of interest. Eisenstat, Stephanie ............................ Disclosed no confl ict of interest. Eizirik, Decio L. ..................................... Disclosed no confl ict of interest. Ejaz, Asma ............................................ Disclosed no confl ict of interest. Ejskjaer, Niels ....................................... Disclosed no confl ict of interest. Ekholm, Ola .......................................... Disclosed no confl ict of interest. Ekinci, Elif I. .......................................... Disclosed no confl ict of interest. Ekstrom, Heidi ...................................... Disclosed no confl ict of interest. El Ebrashy, Ibrahim ............................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Novo

Nordisk A/S, Sanofi , Servier; Speaker’s Bureau: AstraZen-eca/Bristol-Meyers Squibb, Eli Lilly and Company, Merck, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi , Servier

El ghormli, Laure .................................. Disclosed no confl ict of interest. El Hage, Maha ...................................... Employee: Metabolys El Muayed, Malek ................................ Disclosed no confl ict of interest. El Naggar, Nabil K. ............................... Research Support: Novo Nordisk A/S; Speaker’s Bureau:

Bristol-Myers Squibb/AstraZeneca, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation

El Ouaamari, Abdelfattah ..................... Disclosed no confl ict of interest. El Youssef, Joseph ............................... Disclosed no confl ict of interest. Elahi, Dariush ....................................... Disclosed no confl ict of interest. Elased, Khalid M. ................................. Disclosed no confl ict of interest. Elasy, Thomas A. .................................. Disclosed no confl ict of interest. ElAzzouny, Mahmoud ........................... Disclosed no confl ict of interest. Elder, Deborah ...................................... Disclosed no confl ict of interest. Eldor, Roy .............................................. Consultant: Oramed Pharmaceuticals Elefanty, Andrew .................................. Disclosed no confl ict of interest. Eleftheriadou, Ioanna ........................... Disclosed no confl ict of interest. Elgart, Jorge ......................................... Disclosed no confl ict of interest. El-Gohary, Yousef ................................. Disclosed no confl ict of interest. Elian, Viviana I. ..................................... Disclosed no confl ict of interest. Elias, Dana ........................................... Employee: Andromeda Biotech, Ltd. El-Kebbi, Sami ...................................... Disclosed no confl ict of interest. El-Khatib, Firas H. ................................. Disclosed no confl ict of interest. Elleri, Daniela ....................................... Disclosed no confl ict of interest. Elley, C.R. .............................................. Disclosed no confl ict of interest. Elliot, Michael ...................................... Disclosed no confl ict of interest. Elliot-Penry, Lorrie ................................ Disclosed no confl ict of interest. Elliott, Jackie ........................................ Disclosed no confl ict of interest. Elliott, Mary E. ...................................... Disclosed no confl ict of interest. Elliott, Michael ..................................... Disclosed no confl ict of interest. Ellis, James L. ...................................... Employee: GlaxoSmithKline Ellis, Samuel L. ..................................... Disclosed no confl ict of interest. Ellmerer, Martin ................................... Employee: B. Braun Melsungen AG; Stock/Shareholder:

Smart*Med GmbH Ellsiman, Mark H. ................................. Disclosed no confl ict of interest. Ellsworth, Mary L. ................................ Disclosed no confl ict of interest. Elmquist, Joel K. .................................. Disclosed no confl ict of interest. Elpek, Gulsum Ozlem ............................ Disclosed no confl ict of interest. Elrick, Mollisa ....................................... Disclosed no confl ict of interest. Elsayed, Nuha ...................................... Disclosed no confl ict of interest. Elsen, Manuela .................................... Disclosed no confl ict of interest. Elshaw, Ana .......................................... Disclosed no confl ict of interest. Elwyn, Glyn ........................................... Disclosed no confl ict of interest. Elyaman, Wassim ................................. Disclosed no confl ict of interest. Emanuele, Mary Ann ............................ Disclosed no confl ict of interest. Emanuele, Nicholas ............................. Disclosed no confl ict of interest. Emerson, Derek N. ............................... Disclosed no confl ict of interest. Emerson, Jane A. ................................. Research Support: Abbott Laboratories, Inc. Emerson, Sharlene ............................... Disclosed no confl ict of interest. Emirova, Aida ....................................... Employee: Novartis Pharma LLC Emoto, Masanori .................................. Disclosed no confl ict of interest. Emral, Rifat ........................................... Disclosed no confl ict of interest. Endo, Camila ........................................ Disclosed no confl ict of interest.

Dow



A849


AU

THO

R D

ISCL

OSU

RE

Endo, Ginji ............................................ Disclosed no confl ict of interest. Endo, Itsuro .......................................... Disclosed no confl ict of interest. Endo, Takashi ....................................... Disclosed no confl ict of interest. Engel, Samuel S. .................................. Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Engel, Taly ............................................ Employee: Medtronic Engelgau, Michael ............................... Disclosed no confl ict of interest. Engelhardt, John .................................. Disclosed no confl ict of interest. Engelund, Gitte ..................................... Disclosed no confl ict of interest. English, Shane ...................................... Disclosed no confl ict of interest. Enriquez, Fabiola .................................. Disclosed no confl ict of interest. Epps, Juanita A. ................................... Disclosed no confl ict of interest. Eranki, Vijay .......................................... Disclosed no confl ict of interest. Ercan-Fang, Nacide .............................. Disclosed no confl ict of interest. Eren, Rachel ......................................... Employee: Andromeda Biotech, Ltd. Eriksen, Marie ...................................... Disclosed no confl ict of interest. Eriksson, Jan W. ................................... Employee: AstraZeneca Pharmaceuticals LP Eriksson, Karl-Fredrik ........................... Disclosed no confl ict of interest. Eringa, Etto C. ....................................... Disclosed no confl ict of interest. Erion, Derek M. .................................... Employee: Pfi zer, Inc. Erlandsen, Mogens .............................. Disclosed no confl ict of interest. Ernst, Barbara ....................................... Disclosed no confl ict of interest. Ertl, Linda ............................................. Employee: ChemoCentryx Escalada, Javier ................................... Disclosed no confl ict of interest. Escalante, Miguel ................................ Advisory Panel: Abbott, Boehringer Ingelheim Pharmaceuti-

cals, Inc., Eli Lilly and Company, Novo Nordisk, Inc.; Other Relationship: Novo Nordisk A/S

Eschwege, Eveline ............................... Board Member: Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Roche Pharmaceuticals

Escobar-Jimenez, Fernando ................. Disclosed no confl ict of interest. Eshel, Noa ............................................ Disclosed no confl ict of interest. Esko, Tõnu ............................................ Disclosed no confl ict of interest. Esler, William P. .................................... Employee: Pfi zer, Inc. Esliger, Dale ......................................... Disclosed no confl ict of interest. Espinoza, Daniel ................................... Disclosed no confl ict of interest. Esposito, Pasquale ............................... Disclosed no confl ict of interest. Esser, Myrko ......................................... Disclosed no confl ict of interest. Esser, Nathalie ..................................... Disclosed no confl ict of interest. Essers, Yvonne ..................................... Disclosed no confl ict of interest. Esteban, Yaiza ...................................... Disclosed no confl ict of interest. Estépar, Raul San José ........................ Disclosed no confl ict of interest. Esterson, Yonah B. ............................... Disclosed no confl ict of interest. Ettleson, Matthew ............................... Disclosed no confl ict of interest. Eun, Chai Ryoung ................................. Disclosed no confl ict of interest. Eurich, Dean T. ..................................... Disclosed no confl ict of interest. Eury, Elodie ........................................... Disclosed no confl ict of interest. Euyoque, Johanna ................................ Disclosed no confl ict of interest. Evans, Kathryn ...................................... Disclosed no confl ict of interest. Evans, Marc .......................................... Advisory Panel: Eli Lilly and Company, GlaxoSmithKline, MSD,

Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Research Support: Eli Lilly and Company, GlaxoSmithKline, MSD, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: Eli Lilly and Company, GlaxoSmithKline, MSD, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi

Evans, Mark L. ...................................... Advisory Panel: Cellnovo, Medtronic, Roche Pharmaceuticals; Speaker’s Bureau: Abbott Diabetes Care, Animas Corpora-tion

Evans, Megan ....................................... Disclosed no confl ict of interest. Evans, Rhobert ..................................... Disclosed no confl ict of interest. Evans-Molina, Carmella ....................... Disclosed no confl ict of interest. Everrts, Adam ....................................... Disclosed no confl ict of interest. Eversole, Rob R. ................................... Disclosed no confl ict of interest. Evripidou, Polykarpos ........................... Other Relationship: Novartis Pharmaceuticals Corporation,

Novo Nordisk A/S, Remedica Cyprus Ezrokhi, Michael ................................... Employee: VeroScience Fabbrin, Amanda .................................. Disclosed no confl ict of interest. Faber, Jacek ......................................... Disclosed no confl ict of interest. Faber-Heinemann, Gabriele ................. Disclosed no confl ict of interest. Fabian-San Miguel, Guadalupe ........... Disclosed no confl ict of interest. Fabrizi, Marta ....................................... Disclosed no confl ict of interest. Fabsitz, Richard R. ................................ Disclosed no confl ict of interest. Fachado, Alberto .................................. Disclosed no confl ict of interest. Fadavi, Hassan ..................................... Disclosed no confl ict of interest. Fadini, Gianpaolo ................................. Disclosed no confl ict of interest. Færch, Kristine ..................................... Employee: Steno Diabetes Center A/S; Stock/Shareholder:

Novo Nordisk A/S Færch, Louise H. ................................... Disclosed no confl ict of interest. Fagan, Nora .......................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Fagerland, Morten W. .......................... Disclosed no confl ict of interest. Fagour, Cédric ....................................... Disclosed no confl ict of interest. Fahlbusch, Pia ...................................... Disclosed no confl ict of interest.

Fährmann, Elke ..................................... Disclosed no confl ict of interest. Fain, Randi ............................................ Employee: Eisai, Inc. Fainelli, Giulia ...................................... Disclosed no confl ict of interest. Fajmon, Martin ..................................... Disclosed no confl ict of interest. Faleo, Gaetano ..................................... Disclosed no confl ict of interest. Falini, Andrea ....................................... Disclosed no confl ict of interest. Falk Petersen, Kitt ................................ Disclosed no confl ict of interest. Fam, Barbara C. .................................... Disclosed no confl ict of interest. Fan, Bo .................................................. Disclosed no confl ict of interest. Fan, Jiaquan ......................................... Disclosed no confl ict of interest. Fan, Shengjie ........................................ Disclosed no confl ict of interest. Fan, Xiaoning ........................................ Disclosed no confl ict of interest. Fanelli, Carmine G. ............................... Advisory Panel: Sanofi ; Other Relationship: Bristol-Myers

Squibb Company, Menarini, Merck Sharp & Dohme Limited, Sanofi

Fang, Donghong ................................... Disclosed no confl ict of interest. Fang, Hui .............................................. Disclosed no confl ict of interest. Fang, Jingye ......................................... Disclosed no confl ict of interest. Fang, Qichen ......................................... Disclosed no confl ict of interest. Fang, Qijun ........................................... Disclosed no confl ict of interest. Fang, Wang .......................................... Disclosed no confl ict of interest. Fang, Wei-Jin ....................................... Disclosed no confl ict of interest. Fang, Yupeng ........................................ Disclosed no confl ict of interest. Fang, Zhe .............................................. Disclosed no confl ict of interest. Fang, Zhiwei ......................................... Disclosed no confl ict of interest. Farago, Nora ......................................... Disclosed no confl ict of interest. Farb, Thomas B. .................................... Employee: Eli Lilly and Company Farbstein, Dan ...................................... Disclosed no confl ict of interest. Farese, Robert ...................................... Disclosed no confl ict of interest. Farias, Javier M. .................................. Disclosed no confl ict of interest. Faricelli, Barbara .................................. Disclosed no confl ict of interest. Faridbod, Farnoush ............................... Disclosed no confl ict of interest. Farinatti, Paulo D. ................................. Disclosed no confl ict of interest. Farley, Joel F. ........................................ Consultant: Daiichi-Sankyo, Inc. Farmer, Ben .......................................... Disclosed no confl ict of interest. Farmer, Stephen R. ............................... Disclosed no confl ict of interest. Farmer, Tiffany D. ................................. Disclosed no confl ict of interest. Farney, Alan .......................................... Disclosed no confl ict of interest. Farr, Sarah L. ........................................ Disclosed no confl ict of interest. Farrell, Geoff ........................................ Disclosed no confl ict of interest. Farrell, Kaye ......................................... Disclosed no confl ict of interest. Farret, Anne .......................................... Disclosed no confl ict of interest. Farrokhi, Farnoosh ................................ Disclosed no confl ict of interest. Fasano, Dario ....................................... Disclosed no confl ict of interest. Fasano, Matthew J. ............................. Disclosed no confl ict of interest. Faselis, Charles .................................... Disclosed no confl ict of interest. Fasshauer, Mathias .............................. Disclosed no confl ict of interest. Fealy, Ciaran E. ..................................... Disclosed no confl ict of interest. Featherstone, Travis ............................. Disclosed no confl ict of interest. Federici, Massimo ................................ Disclosed no confl ict of interest. Feig, Denice S. ..................................... Disclosed no confl ict of interest. Feigh, Michael J. .................................. Disclosed no confl ict of interest. Feinglos, Mark N. ................................. Advisory Panel: Eli Lilly and Company, Pfi zer, Inc.; Consultant:

Eli Lilly and Company, GlaxoSmithKline, Pfi zer, Inc.; Research Support: Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Medtronic, Merck, Novo Nordisk, Inc., Procter & Gamble, Prodigy Diabetes Care, LLC, Sanofi , Tethys

Feinle-Bisset, Christine ........................ Disclosed no confl ict of interest. Feinn, Richard ....................................... Disclosed no confl ict of interest. Feldman, Dmitry ................................... Employee: Insuline Medical Feldman, Eva L. .................................... Disclosed no confl ict of interest. Feldstein, Jeffrey D. ............................. Disclosed no confl ict of interest. Feldt-Rasmussen, Bo ............................ Board Member: Merck Sharp & Dohme Limited, Novartis Phar-

maceuticals Corporation, Novo Nordisk A/S; Research Support: Novo Nordisk A/S

Felipe, Dania ........................................ Disclosed no confl ict of interest. Felske, David ........................................ Disclosed no confl ict of interest. Felton, Anne M. .................................... Advisory Panel: Bayer Health Care, LLC Felts, Debra .......................................... Disclosed no confl ict of interest. Fenchel, Matthew ................................ Disclosed no confl ict of interest. Fendler, Wojciech ................................. Disclosed no confl ict of interest. Feng, Biao ............................................. Disclosed no confl ict of interest. Feng, Bo ................................................ Disclosed no confl ict of interest. Feng, Jian-Ping ..................................... Disclosed no confl ict of interest. Feng, Kun .............................................. Disclosed no confl ict of interest. Feng, Li ................................................. Disclosed no confl ict of interest. Feng, Nan ............................................. Disclosed no confl ict of interest. Feng, Qiong .......................................... Disclosed no confl ict of interest. Feng, Shiliang ....................................... Disclosed no confl ict of interest. Feng, Wei ............................................. Disclosed no confl ict of interest.

Dow



A850


AU

THO

R D

ISCL

OSU

RE

Feng, Yu X. ............................................ Disclosed no confl ict of interest. Feng, Yuxi ............................................. Disclosed no confl ict of interest. Ferdousi, Maryam ................................ Disclosed no confl ict of interest. Fernandes Quaresma, Paula Gabriele .. Disclosed no confl ict of interest. Fernandez, Francesca ........................... Disclosed no confl ict of interest. Fernandez-Garcia, Diego ...................... Disclosed no confl ict of interest. Fernández-Real, José Manuel ............. Disclosed no confl ict of interest. Ferrannini, Ele ...................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Daiichi-

Sankyo, Inc., Eli Lilly and Company, GlaxoSmithKline, Halozyme Therapeutics, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Sanofi ; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company

Ferrara, Assiamira ................................ Employee: Takeda Global Research and Development, Inc.; Research Support: Takeda Pharmaceutical Company, Ltd.

Ferrara, Lidia ........................................ Disclosed no confl ict of interest. Ferrari, Heitor F. .................................... Disclosed no confl ict of interest. Ferrari, Roberto .................................... Consultant: Boehringer Ingelheim GmbH & Co. KG Ferreira, Teresa .................................... Disclosed no confl ict of interest. Ferrelli, Francesca ................................ Disclosed no confl ict of interest. Ferrer, Jorge ......................................... Disclosed no confl ict of interest. Ferrer, Mariano ..................................... Disclosed no confl ict of interest. Ferretti, Beatrice .................................. Disclosed no confl ict of interest. Ferrier, Bernard ..................................... Employee: Metabolys; Stock/Shareholder: Metabolys Ferris, Heather ...................................... Disclosed no confl ict of interest. Festa, Andreas ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Festuccia, William T. ............................ Disclosed no confl ict of interest. Fiamoncini, Jarlei ................................. Disclosed no confl ict of interest. Fickley, Catherine E. ............................. Disclosed no confl ict of interest. Ficorilli, James V. ................................. Employee: Eli Lilly and Company Figueiredo, Hugo .................................. Disclosed no confl ict of interest. Figueiredo, Roberta .............................. Disclosed no confl ict of interest. Figueroa, Katherine .............................. Employee: Janssen Research & Development Figueroa-Romero, Claudia .................... Disclosed no confl ict of interest. Filipponi, Franco ................................... Disclosed no confl ict of interest. Finan, Brian .......................................... Disclosed no confl ict of interest. Finan, Daniel A. .................................... Employee: Animas Corporation; Stock/Shareholder: Johnson

& Johnson Finch, Joan ........................................... Disclosed no confl ict of interest. Finck, Brian N. ...................................... Disclosed no confl ict of interest. Fine, Jennifer ....................................... Employee: Genentech; Stock/Shareholder: Genentech, Roche

Pharmaceuticals Fine, Lawrence ..................................... Disclosed no confl ict of interest. Fineman, Mark ..................................... Employee: Elcelyx Therapeutics, Inc.; Stock/Shareholder:

Elcelyx Therapeutics, Inc. Fingerlin, Tasha E. ................................ Disclosed no confl ict of interest. Fini, Grazia ............................................ Disclosed no confl ict of interest. Fink, Brian D. ........................................ Disclosed no confl ict of interest. Finkelstein, Jonathan A. ...................... Disclosed no confl ict of interest. Finlay, Allie ........................................... Disclosed no confl ict of interest. Finlayson, Jean .................................... Disclosed no confl ict of interest. Finlin, Brian S. ...................................... Disclosed no confl ict of interest. Finocchietto, Paola V. ........................... Disclosed no confl ict of interest. Finucane, Francis M. ............................ Advisory Panel: Bristol-Myers Squibb Company, Novo Nordisk,

Inc., Sanofi Finzi, Giovanna ..................................... Disclosed no confl ict of interest. Fiorentino, Teresa Vanessa .................. Disclosed no confl ict of interest. Fiori, Jennifer L. ................................... Disclosed no confl ict of interest. Fiorina, Paolo ........................................ Disclosed no confl ict of interest. Fischer, Gabriele ................................... Disclosed no confl ict of interest. Fischer, Jerome S. ................................ Disclosed no confl ict of interest. Fischer, Jonathan D. ............................. Disclosed no confl ict of interest. Fischer, Krista ....................................... Disclosed no confl ict of interest. Fischer, Michael A. ............................... Research Support: Eli Lilly and Company Fish, Jason ........................................... Disclosed no confl ict of interest. Fisher, Edwin B. .................................... Research Support: Bristol-Myers Squibb Foundation, Eli Lilly

and Company Foundation, Sanofi USFisher, Emily A. ..................................... Disclosed no confl ict of interest. Fisher, Kaleigh ...................................... Disclosed no confl ict of interest. Fisher, Maxine D. ................................. Disclosed no confl ict of interest. Fisher, Simon J. .................................... Disclosed no confl ict of interest. Fisher-Wellman, Kelsey ....................... Disclosed no confl ict of interest. Fite, Alemu ........................................... Disclosed no confl ict of interest. Fitzgerald, Shane M. ............................ Disclosed no confl ict of interest. Fitzgerald-Miller, Lisa ........................... Disclosed no confl ict of interest. Fitzpatrick, James A. ............................ Disclosed no confl ict of interest. Fitzpatrick, Stephanie ........................... Disclosed no confl ict of interest. Flacke, Frank ......................................... Employee: Sanofi Flak, Jonathan ...................................... Disclosed no confl ict of interest. Flannick, Jason ..................................... Disclosed no confl ict of interest. Flatt, Shirley W. .................................... Disclosed no confl ict of interest.

Fleck, Penny .......................................... Employee: Takeda Global Research & Development Center, Inc.

Fleitmann, Ann K. ................................. Disclosed no confl ict of interest. Fleming, Thomas H. .............................. Disclosed no confl ict of interest. Fleres, Mattia ....................................... Disclosed no confl ict of interest. Fletcher, Justin ..................................... Disclosed no confl ict of interest. Fletcher, Megrette ................................ Board Member: The Center for Mindful Eating; Other Relation-

ship: Co-author of Eat What You Love, Love What You Eat With Diabetes

Fleury, Dominique ................................. Disclosed no confl ict of interest. Fliers, Eric ............................................. Disclosed no confl ict of interest. Florence, Peter ..................................... Disclosed no confl ict of interest. Flores Meneses, Lilliam ....................... Disclosed no confl ict of interest. Flores, Javier ........................................ Disclosed no confl ict of interest. Flores, Rebecca .................................... Disclosed no confl ict of interest. Flores, Veronica L. ................................ Disclosed no confl ict of interest. Florez, Jose C. ...................................... Disclosed no confl ict of interest. Florindez, Daniella ................................ Disclosed no confl ict of interest. Floyd, Brendan J. .................................. Disclosed no confl ict of interest. Floyd, James S. .................................... Disclosed no confl ict of interest. Flynn, Carly ........................................... Disclosed no confl ict of interest. Focosi, Daniele ..................................... Disclosed no confl ict of interest. Fogari, Elena ......................................... Disclosed no confl ict of interest. Fogari, Roberto ..................................... Disclosed no confl ict of interest. Fogelfeld, Leon ..................................... Research Support: Abbott Laboratories, Inc., Boehringer

Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, ESAI, GlaxoSmithKline, Merck, Sanofi

Fogelman, Alan M. ............................... Other Relationship: Bruin Pharmaceuticals Foghsgaard, Signe ................................ Disclosed no confl ict of interest. Foley, James E. ..................................... Employee: Novartis Pharmaceuticals Corporation; Stock/

Shareholder: Novartis Pharmaceuticals Corporation Folli, Franco .......................................... Disclosed no confl ict of interest. Fonda, Stephanie ................................. Disclosed no confl ict of interest. Fong, Carol ........................................... Disclosed no confl ict of interest. Fonseca, Vivian .................................... Advisory Panel: Abbott Laboratories, Inc., AstraZeneca Pharma-

ceuticals LP, Bristol-Myers Squibb Company, Daiichi-Sankyo, Inc., Eli Lilly and Company, GlaxoSmithKline, Novo Nordisk, Inc., Pamlab, LLC, Sanofi , Takeda Pharmaceuticals U.S.A., Inc., XOMA, Ltd.; Consultant: Abbott Laboratories, Inc., AstraZeneca Pharmaceuticals LP, Daiichi-Sankyo, Inc., Eli Lilly and Company, GlaxoSmithKline, Novo Nordisk, Inc., Pamlab, LLC, Sanofi , Takeda Pharmaceuticals U.S.A., Inc., XOMA, Ltd.; Other Relationship: AstraZeneca Pharmaceuticals LP, Pamlab, LLC, XOMA, Ltd.; Research Support: Abbott Laboratories, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Halozyme Therapeutics, Novo Nordisk, Inc., Pamlab, LLC, Reata Pharmaceuticals, Sanofi , Takeda Pharmaceuticals U.S.A., Inc.; Speaker’s Bureau: Novo Nordisk, Inc., Sanofi

Fontaine, Pierre .................................... Board Member: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi

Fontanillas, Pierre ................................ Disclosed no confl ict of interest. Foos, Volker .......................................... Disclosed no confl ict of interest. Forbes, Angus ....................................... Other Relationship: Abbott Diabetes Care, Roche Pharmaceu-

ticals; Speaker’s Bureau: Abbott Diabetes Care, Eli Lilly and Company

Forbes, Josephine ................................ Disclosed no confl ict of interest. Forbes, Peter ........................................ Disclosed no confl ict of interest. Forbes, Shareen ................................... Disclosed no confl ict of interest. Ford, Daniel M. ..................................... Employee: Daiichi-Sankyo, Inc. Ford, Derek ........................................... Disclosed no confl ict of interest. Ford, G. Charles .................................... Disclosed no confl ict of interest. Forde, Hannah ...................................... Disclosed no confl ict of interest. Forestieri, Pietro ................................... Disclosed no confl ict of interest. Foretz, Marc ......................................... Disclosed no confl ict of interest. Forga, Luis ............................................ Disclosed no confl ict of interest. Forkel, Claudia ...................................... Disclosed no confl ict of interest. Formoso, Gloria .................................... Disclosed no confl ict of interest. Fornaciari, Silvia ................................... Disclosed no confl ict of interest. Fornoni, Alessia .................................... Disclosed no confl ict of interest. Forsberg, Christopher W. ..................... Disclosed no confl ict of interest. Forst, Thomas ....................................... Advisory Panel: Boehringer Ingelheim GmbH & Co. KG, Eli

Lilly and Company, Glenmark Pharmaceuticals, Ltd., Novartis Pharmaceuticals Corporation; Consultant: Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Glenmark Pharmaceuticals, Ltd., Novo Nordisk A/S, Sanofi ; Research Support: AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Glenmark Pharmaceuticals, Ltd., ICON, Novo Nordisk A/S, Sanofi , Unomedical; Speaker’s Bureau: Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Novo Nordisk A/S, Sanofi

Dow



A851


AU

THO

R D

ISCL

OSU

RE

Fort, John G. ......................................... Employee: Pozen, Inc. Fort, Patrice E. ...................................... Disclosed no confl ict of interest. Fortmann, Addie ................................... Disclosed no confl ict of interest. Fortmann, Stephen P. ........................... Disclosed no confl ict of interest. Foster, Charlie ...................................... Disclosed no confl ict of interest. Foster, Clarence E. ................................ Disclosed no confl ict of interest. Foster, Kathleen ................................... Disclosed no confl ict of interest. Foster-Schubert, Karen ........................ Disclosed no confl ict of interest. Fotieo, Gregory G. ................................ Disclosed no confl ict of interest. Fotino, Carmen ..................................... Disclosed no confl ict of interest. Foucat, Emile ........................................ Disclosed no confl ict of interest. Fourcaudot, Marcel .............................. Disclosed no confl ict of interest. Fourlanos, Spiros .................................. Disclosed no confl ict of interest. Fouts, Alexandra R. .............................. Disclosed no confl ict of interest. Fowler, Christine E. .............................. Disclosed no confl ict of interest. Fowler, Samantha ................................ Disclosed no confl ict of interest. Fowler, Sarah ....................................... Disclosed no confl ict of interest. Fox, Daniel C. ....................................... Disclosed no confl ict of interest. Fox, Daniel K. ....................................... Disclosed no confl ict of interest. Fox, Joseph M. ..................................... Disclosed no confl ict of interest. Fox, Kathleen M. .................................. Research Support: AstraZeneca Pharmaceuticals LP Fox, Larry A. .......................................... Disclosed no confl ict of interest. Foxcroft, Roland ................................... Consultant: Novo Nordisk A/S Fraher, Kyle ........................................... Employee: Arena Pharmaceuticals, Inc. Fraile-Gómez, Juana ............................ Disclosed no confl ict of interest. Fraker, Christopher ............................... Stock/Shareholder: Converge Biotech, Inc. Franc, Sylvia ......................................... Disclosed no confl ict of interest. Franceschini, Nora ............................... Disclosed no confl ict of interest. Francesconi, Paolo ............................... Disclosed no confl ict of interest. Francia, Piergiorgio .............................. Disclosed no confl ict of interest. Franciosi, Monica ................................. Disclosed no confl ict of interest. Francisco, Beatriz D. ............................. Disclosed no confl ict of interest. Franco, Felipe O. ................................... Disclosed no confl ict of interest. Franco, Laercio J. ................................. Disclosed no confl ict of interest. Franconi, Flavia .................................... Disclosed no confl ict of interest. Franek, Edward ..................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Eli Lilly and Company, Novo Nordisk, Inc.; Research Support: Bayer, Bioton; Speaker’s Bureau: Bioton, Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, MSD, Novo Nordisk, Inc., Servier

Frangieh, Michael ................................ Disclosed no confl ict of interest. Franklin, Heather .................................. Disclosed no confl ict of interest. Franko, Andras ..................................... Disclosed no confl ict of interest. Franko, Debra L. ................................... Disclosed no confl ict of interest. Frascerra, Silvia .................................... Disclosed no confl ict of interest. Fraser, Iain P. ........................................ Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Fraser, Jonathan ................................... Disclosed no confl ict of interest. Frayling, Timothy M. ............................. Disclosed no confl ict of interest. Frazier, Kenny ....................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Freathy, Rachel M. ............................... Disclosed no confl ict of interest. Freckmann, Guido ................................. Speaker’s Bureau: Abbott Diabetes Care, Bayer Health Care,

LLC, Hoffman La RocheFrederich, Robert .................................. Employee: Bristol-Myers Squibb Company Frederiksen, Brittni N. .......................... Disclosed no confl ict of interest. Frederiksen, Louise .............................. Disclosed no confl ict of interest. Fredholm, Bertil .................................... Disclosed no confl ict of interest. Freeby, Matthew J. .............................. Disclosed no confl ict of interest. Freedman, Barry I. ................................ Disclosed no confl ict of interest. Freeman, Elsie ...................................... Disclosed no confl ict of interest. Freeman, Gordon J. .............................. Disclosed no confl ict of interest. Freeman, Kurt A. .................................. Disclosed no confl ict of interest. Freemantle, Nick .................................. Consultant: Sanofi , Novo Nordisk, Inc., Bristol-Myers Squibb,

Medtronic; Research Support: Sanofi , Novo Nordisk, Inc., Bristol-Myers Squibb, Medtronic

Frei, Thomas ......................................... Employee: Roche Diabetes Care AG Freisinger, Oana ................................... Disclosed no confl ict of interest. Freitas, Valéria C. ................................. Disclosed no confl ict of interest. French, Paul .......................................... Disclosed no confl ict of interest. French, Samuel W. ............................... Disclosed no confl ict of interest. Freudenberg, Johannes ........................ Employee: GlaxoSmithKline Frias, Juan P. ........................................ Employee: Tethys Friborg, Søren ....................................... Disclosed no confl ict of interest. Friderichsen, Anders V. ........................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Fridlyand, Leonid E. .............................. Disclosed no confl ict of interest. Fried, Martin ......................................... Disclosed no confl ict of interest. Friedline, Randall H. ............................. Disclosed no confl ict of interest. Friedman, Jacob E. ............................... Disclosed no confl ict of interest. Friedman, Theodore C. ......................... Disclosed no confl ict of interest.

Friedrichs, Arnd .................................... Consultant: Sanofi Frigè, Francesca ................................... Disclosed no confl ict of interest. Frigerio, Francesca ............................... Disclosed no confl ict of interest. Friis Bak, Jens ...................................... Disclosed no confl ict of interest. Frisbee, Stephanie ............................... Disclosed no confl ict of interest. Frisk, Gun .............................................. Disclosed no confl ict of interest. Fritsch, Maria ....................................... Disclosed no confl ict of interest. Fritsche, Andreas ................................. Disclosed no confl ict of interest. Fritsche, Louise .................................... Disclosed no confl ict of interest. Fritschi, Cynthia .................................... Disclosed no confl ict of interest. Frittitta, Lucia ....................................... Disclosed no confl ict of interest. Frizzell, Norma ...................................... Disclosed no confl ict of interest. Froguel, Philippe ................................... Disclosed no confl ict of interest. Fröhlich-Reiterer, Elke .......................... Disclosed no confl ict of interest. Frøkiær, Jørgen .................................... Disclosed no confl ict of interest. Fronczyk, Aneta .................................... Disclosed no confl ict of interest. Frost, Elizabeth A. ................................ Disclosed no confl ict of interest. Froy, Oren ............................................. Disclosed no confl ict of interest. Fruchter, Eyal ........................................ Disclosed no confl ict of interest. Frühbeck, Gema .................................... Disclosed no confl ict of interest. Fruhwald, Friedrich ............................... Disclosed no confl ict of interest. Frydman, Emily ..................................... Disclosed no confl ict of interest. Fryk, Emanuel ....................................... Disclosed no confl ict of interest. Frykberg, Robert G. ............................... Disclosed no confl ict of interest. Fu, Alex Z. ............................................. Research Support: Merck Fu, Chunmay ......................................... Employee: Merck Fu, Haoda ............................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Fu, Mao ................................................ Research Support: American Diabetes Association, American

Heart Association Fu, Qi .................................................... Disclosed no confl ict of interest. Fu, Yaowen ........................................... Disclosed no confl ict of interest. Fu, Yuchang .......................................... Disclosed no confl ict of interest. Fu, Zhuo ................................................ Disclosed no confl ict of interest. Fuchsberger, Christian .......................... Disclosed no confl ict of interest. Fueger, Patrick T. .................................. Disclosed no confl ict of interest. Fuerst-Recktenwald, Sabine ................ Employee: Hoffman La Roche Fuh, Martin M. ..................................... Disclosed no confl ict of interest. Fujihara, Kazuya ................................... Disclosed no confl ict of interest. Fujii, HItomi .......................................... Disclosed no confl ict of interest. Fujikawa, Jun ....................................... Disclosed no confl ict of interest. Fujimaki, Kyoko .................................... Disclosed no confl ict of interest. Fujimori, Yoshiharu ............................... Disclosed no confl ict of interest. Fujimoto, Kanta .................................... Disclosed no confl ict of interest. Fujimoto, Shimpei ................................ Disclosed no confl ict of interest. Fujimoto, Wilfred Y. ............................. Disclosed no confl ict of interest. Fujimura, Takanori ................................ Disclosed no confl ict of interest. Fujioka, Kei ........................................... Disclosed no confl ict of interest. Fujioka, Ken .......................................... Advisory Panel: Orexigen Therapeutics, Inc.; Consultant:

Arena Pharmaceuticals, Inc., Eisai Co., Ltd., Elcelyx Therapeutics, Inc., Isis Pharmaceuticals, Novo Nordisk, Inc., NPS, Orexigen Therapeutics, Inc., Zafgen, Inc.; Research Support: Eisai Co., Ltd., Elcelyx Therapeutics, Inc., Enteromedics, GI Dynamics, Novo Nordisk, Inc., NPS, Orexigen Therapeutics, Inc., Weight Watchers; Speaker’s Bureau: Abbott Laboratories, Inc., Merck

Fujioka, Toshiki ..................................... Disclosed no confl ict of interest. Fujioka, Youhei ..................................... Disclosed no confl ict of interest. Fujisaka, Shiho ..................................... Disclosed no confl ict of interest. Fujisawa, Reiko .................................... Disclosed no confl ict of interest. Fujita, Masataka .................................. Disclosed no confl ict of interest. Fujita, Yoshihito .................................... Disclosed no confl ict of interest. Fujita, Yukihiro ...................................... Disclosed no confl ict of interest. Fujitani, Yoshio ..................................... Disclosed no confl ict of interest. Fujiwara, Shuichi .................................. Disclosed no confl ict of interest. Fujiwara, Toshimasa ............................ Disclosed no confl ict of interest. Fujiya, Atsushi ...................................... Disclosed no confl ict of interest. Fukazawa, Masanori ............................ Employee: Chugai Pharmaceutical Co., Ltd. Fukuda, Hiroshi ..................................... Disclosed no confl ict of interest. Fukui, Michiaki ..................................... Disclosed no confl ict of interest. Fukumoto, Shinya ................................. Disclosed no confl ict of interest. Fukunaga, Yasutomo ............................ Disclosed no confl ict of interest. Fukushima, Sayaka ............................... Disclosed no confl ict of interest. Fukushima, Toru ................................... Disclosed no confl ict of interest. Fukuta, Akiko ........................................ Disclosed no confl ict of interest. Fukutani, Tomoka ................................. Disclosed no confl ict of interest. Fukuzawa, Taku .................................... Employee: Chugai Pharmaceutical Co., Ltd. Fulcher, Greg ........................................ Advisory Panel: Johnson & Johnson; Other Relationship:

Steering Committee for CANVAS and Chair of the EAC Fuller, Carissa ....................................... Disclosed no confl ict of interest. Fuller, Ryan P. ....................................... Disclosed no confl ict of interest.

Dow



A852


AU

THO

R D

ISCL

OSU

RE

Fuller, Serena M. .................................. Disclosed no confl ict of interest. Fumeron, Frédéric ................................. Disclosed no confl ict of interest. Funahashi, Tohru .................................. Disclosed no confl ict of interest. Funaki, Makoto ..................................... Disclosed no confl ict of interest. Funakoshi, Satoshi ............................... Disclosed no confl ict of interest. Funase, Yoshiko .................................... Disclosed no confl ict of interest. Fung, Albert .......................................... Employee: Janssen Research & Development, LLC Fung, Sze Yuen ..................................... Disclosed no confl ict of interest. Funk, Kristine L. .................................... Research Support: AstraZeneca/Bristol-Meyers Squibb Funke, Klaus ......................................... Research Support: IKFE, Insuline Medical Furlan, Anna ......................................... Disclosed no confl ict of interest. Furukawa, Asami .................................. Disclosed no confl ict of interest. Furukawa, Kazuo .................................. Disclosed no confl ict of interest. Furuta, Hiroto ....................................... Disclosed no confl ict of interest. Furuta, Machi ....................................... Disclosed no confl ict of interest. Furuta, Shinji ........................................ Employee: Sanwa Kagaku Kenkyusho Furuya, Miyuki ...................................... Disclosed no confl ict of interest. Furuzono, Tsutomu ............................... Disclosed no confl ict of interest. Fussman, Chris ..................................... Disclosed no confl ict of interest. Futatsugi, Kentaro ................................ Employee: Pfi zer, Inc. Fysekidis, Marinos ............................... Disclosed no confl ict of interest. Gabi, Alaa ............................................. Disclosed no confl ict of interest. Gaffar, Iljana ......................................... Disclosed no confl ict of interest. Gaffney, Kaitlin C. ................................ Disclosed no confl ict of interest. Gaffney, Peter ....................................... Disclosed no confl ict of interest. Gage, Matthew C. ................................ Disclosed no confl ict of interest. Gaggini, Melania .................................. Disclosed no confl ict of interest. Gagliardino, Juan J. ............................. Disclosed no confl ict of interest. Gagnon, AnneMarie ............................. Disclosed no confl ict of interest. Gahete, Manuel D. ............................... Disclosed no confl ict of interest. Gaich, Gregory ...................................... Employee: Eli Lilly and Company, Eli Lilly and Company


Gaillard, Trudy R. .................................. Disclosed no confl ict of interest. Gaisano, Herbert Y. .............................. Disclosed no confl ict of interest. Gal, Avner ............................................. Employee: Integrity Applications, Ltd. Galan, Manuel ...................................... Employee: Novo Nordisk Pharma S.A.; Stock/Shareholder:

Novo Nordisk, Inc. Galassetti, Pietro R. ............................. Disclosed no confl ict of interest. Galecki, Andrzej T. ................................ Disclosed no confl ict of interest. Galgani, Jose E. ................................... Disclosed no confl ict of interest. Galica, Andrew ..................................... Disclosed no confl ict of interest. Galindo, Cynthia ................................... Disclosed no confl ict of interest. Galindo, Rodolfo J. ............................... Disclosed no confl ict of interest. Gall, Mari-Anne .................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Gall, Walter E. ...................................... Employee: Metabolon, Inc. Gallach, Maria ...................................... Disclosed no confl ict of interest. Gallagher, Emily Jane .......................... Disclosed no confl ict of interest. Gallagher, Mary Pat ............................. Disclosed no confl ict of interest. Galli, Marco .......................................... Disclosed no confl ict of interest. Gallo, Linda .......................................... Disclosed no confl ict of interest. Galloway, Stacey .................................. Disclosed no confl ict of interest. Gallwitz, Baptist ................................... Disclosed no confl ict of interest. Galstyan, Gagik .................................... Disclosed no confl ict of interest. Gamazon, Eric R. .................................. Disclosed no confl ict of interest. Gan, Kexin ............................................ Disclosed no confl ict of interest. Ganda, Anjali ........................................ Disclosed no confl ict of interest. Ganda, Om P. ........................................ Disclosed no confl ict of interest. Gandhi, Rajiv ........................................ Disclosed no confl ict of interest. Gandica, Rachelle G. ............................ Disclosed no confl ict of interest. Ganesan, Goutham ............................... Disclosed no confl ict of interest. Gang, Yuan ........................................... Disclosed no confl ict of interest. Ganguly, Sanjeev .................................. Employee: Nestle India Limited Ganjali, Mohaamadreza ....................... Disclosed no confl ict of interest. Ganjei, Allen ......................................... Disclosed no confl ict of interest. Ganna, Andrea ..................................... Disclosed no confl ict of interest. Gannon, Mary C. .................................. Disclosed no confl ict of interest. Gannon, Maureen A. ............................ Disclosed no confl ict of interest. Gantz, Ira .............................................. Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Ganz, Michael L. ................................... Consultant: Boehringer Ingelheim GmbH & Co. KG, Novo

Nordisk, Inc., Sanofi Gao, Bin ................................................ Disclosed no confl ict of interest. Gao, Chenlin ......................................... Disclosed no confl ict of interest. Gao, Fa Bao .......................................... Disclosed no confl ict of interest. Gao, Haitao .......................................... Employee: Novartis Pharmaceuticals Corporation Gao, Hui ................................................ Disclosed no confl ict of interest. Gao, Jie ................................................ Disclosed no confl ict of interest. Gao, Meifang ....................................... Disclosed no confl ict of interest. Gao, Xiang ............................................ Disclosed no confl ict of interest. Gao, Yan ............................................... Disclosed no confl ict of interest.

Gao, Zhangou ....................................... Disclosed no confl ict of interest. Gao, Zhengnan ..................................... Disclosed no confl ict of interest. Garb, Jane L. ........................................ Disclosed no confl ict of interest. Garber, Manuel .................................... Disclosed no confl ict of interest. Garcia Franco, Renata .......................... Disclosed no confl ict of interest. Garcia, Alicia ........................................ Disclosed no confl ict of interest. Garcia, Arturo ....................................... Employee: Dexcom, Inc. Garcia, Ben ........................................... Disclosed no confl ict of interest. Garcia, Eden ......................................... Disclosed no confl ict of interest. Garcia, Isabel ....................................... Disclosed no confl ict of interest. Garcia, Lorena ...................................... Disclosed no confl ict of interest. García, Marta ....................................... Disclosed no confl ict of interest. Garcia, Pedro ........................................ Advisory Panel: Eli Lilly and Company, MSD, Novo Nordisk,

Inc.; Speaker’s Bureau: Amgen, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, MSD, Novo Nordisk, Inc.

García-García, Fernando ...................... Disclosed no confl ict of interest. García-Sáez, Gema ............................... Disclosed no confl ict of interest. Gardi, Janos ......................................... Disclosed no confl ict of interest. Gardiner, Ann ....................................... Disclosed no confl ict of interest. Gardner, Thomas W. ............................. Disclosed no confl ict of interest. Garduno Garcia, Jesus ......................... Disclosed no confl ict of interest. Garey, Ann ............................................ Disclosed no confl ict of interest. Garg, Rajesh ......................................... Disclosed no confl ict of interest. Garg, Satish K. ....................................Advisory Panel: Dexcom, Inc., Halozyme Therapeutics,

Johnson & Johnson, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi ; Consultant: Novo Nordisk, Inc., Sanofi , Valeritas, LLC; Research Support: Cebix, Inc., Eli Lilly and Company, MannKind Corporation, Medtronic, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi

Garg, Sunny .......................................... Disclosed no confl ict of interest. Garg, Vivek ........................................... Employee: Nestle, Inc. Garhyan, Parag ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Gariani, Karim ...................................... Disclosed no confl ict of interest. Garnero, Theresa .................................. Disclosed no confl ict of interest. Garofolo, Ingrid C. ................................ Disclosed no confl ict of interest. Garofolo, Monia ................................... Disclosed no confl ict of interest. Garrido-Sanchez, Lourdes .................... Disclosed no confl ict of interest. Garro, Mona ......................................... Disclosed no confl ict of interest. Garrow-Sloan, Susan ........................... Disclosed no confl ict of interest. Gärtner, Babette ................................... Research Support: Almased-Wellness-GmbH Garvey, Katharine C. ............................. Disclosed no confl ict of interest. Garvey, W. Timothy .............................. Advisory Panel: Alkermes, Plc., Daiichi-Sankyo, Inc., Janssen

Pharmaceuticals, LipoScience, Tethys, Vivus, Inc.; Other Relationship: Amylin Pharmaceuticals, Inc., Merck, NIH, Weight Watchers; Speaker’s Bureau: Merck; Stock/Shareholder: Bristol-Myers Squibb Company, Eli Lilly and Company, Isis/Genzyme, Merck, Pfi zer, Inc., Vivus, Inc.

Gaspar, Joana M. ................................. Disclosed no confl ict of interest. Gassenhuber, Hans .............................. Employee: Sanofi Gassmann-Mayer, Cristiana ................. Employee: Janssen Research & Development, LLC Gastaldelli, Amalia ............................... Consultant: Roche Pharmaceuticals; Research Support:

Amylin/Eli Lilly, Roche Pharmaceuticals Gatcomb, Patricia ................................. Disclosed no confl ict of interest. Gatt, Elyse ............................................ Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.,

Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk, Inc., Pfi zer, Inc., Sanofi

Gaur, Lakshmi ....................................... Disclosed no confl ict of interest. Gause-Nilsson, Ingrid ........................... Employee: AstraZeneca Pharmaceuticals LP Gauthier, Benoit R. ............................... Disclosed no confl ict of interest. Gautier, Jean Francois ......................... Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Eli

Lilly and Company, GlaxoSmithKline, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi , Servier

Gautreau, Denise ................................. Stock/Shareholder: Pfi zer, Inc. Gavin, Timothy ...................................... Disclosed no confl ict of interest. Gavriilaki, Eleni .................................... Disclosed no confl ict of interest. Gawlik, Melissa ................................... Research Support: Eli Lilly and Company Gaydos, Brenda .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Gaziano, J. Michael ............................. Speaker’s Bureau: Santarus, Inc. Gazioglu, Sema .................................... Disclosed no confl ict of interest. Ge, Jiapu .............................................. Disclosed no confl ict of interest. Ge, Ling ................................................ Disclosed no confl ict of interest. Ge, Yaorong .......................................... Disclosed no confl ict of interest. Geagan, Elizabeth ................................ Disclosed no confl ict of interest. Geary, Michael P. .................................. Disclosed no confl ict of interest. Gebregziabher, Mulugeta ..................... Disclosed no confl ict of interest. Geffner, Mitchell .................................. Board Member: Daiichi-Sankyo, Inc.

Dow



A853


AU

THO

R D

ISCL

OSU

RE

Gehr, Bernhard ..................................... Advisory Panel: Roche Diagnostics GmbH; Research Support: Roche Diagnostics GmbH

Geiger, Kathrin ..................................... Disclosed no confl ict of interest. Geiger, Mary Jane ................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Geiger, Sarah D. ................................... Disclosed no confl ict of interest. Geiser, Jeanne S. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Geiss, Linda S. ...................................... Disclosed no confl ict of interest. Geller, Andrew I. .................................. Disclosed no confl ict of interest. Geller-Rhomberg, Simone .................... Disclosed no confl ict of interest. Genc, Nilgun S. .................................... Disclosed no confl ict of interest. Gendrano, Isaias N. .............................. Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Gentile, Sandro .................................... Disclosed no confl ict of interest. Genuth, Saul M. ................................... Disclosed no confl ict of interest. Georga, Stamatia ................................. Disclosed no confl ict of interest. George, Priya S. .................................... Disclosed no confl ict of interest. Georgopoulos, Angeliki ........................ Disclosed no confl ict of interest. Georgopoulos, Apostolos ..................... Disclosed no confl ict of interest. Geransar, Parnia ................................... Employee: Novartis Pharma AG Gérard, Anne-Catherine ....................... Disclosed no confl ict of interest. Gerasimova, Maria ............................... Disclosed no confl ict of interest. Gerber, Linda M. ................................... Disclosed no confl ict of interest. Gerchman, Fernando ............................ Disclosed no confl ict of interest. Gerlovin, Hanna .................................... Disclosed no confl ict of interest. German, Michael S. ............................. Disclosed no confl ict of interest. Germe, Maeva ...................................... Employee: Sanofi Gerst, Felicia ........................................ Disclosed no confl ict of interest. Gerstein, Hertzel C. .............................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer

Ingelheim Pharmaceuticals, Inc., Bristol-Meyers Squibb, Eli Lilly and Company, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi ; Consultant: Bayer Health Care, LLC, Eli Lilly and Company, Roche Pharmaceuticals, Santarus, Inc., Sanofi ; Research Sup-port: Eli Lilly and Company, Sanofi ; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Meyers Squibb, Sanofi

Gerszten, Robert ................................... Disclosed no confl ict of interest. Gesta, Stephane ................................... Disclosed no confl ict of interest. Gezan, Salvador A. ............................... Disclosed no confl ict of interest. Ghahary, Aziz ........................................ Disclosed no confl ict of interest. Ghai, Kanika ......................................... Disclosed no confl ict of interest. Ghanim, Husam .................................... Disclosed no confl ict of interest. Ghazi, Tara ............................................ Disclosed no confl ict of interest. Ghazizadeh, Ramin ............................... Disclosed no confl ict of interest. Ghiadoni, Lorenzo ................................. Disclosed no confl ict of interest. Ghirlanda, Giovanni .............................. Disclosed no confl ict of interest. Ghori-Javed, Farah Y. ........................... Disclosed no confl ict of interest. Ghosh, Sangeeta .................................. Disclosed no confl ict of interest. Giacca, Adria ........................................ Disclosed no confl ict of interest. Giaccari, Andrea ................................... Disclosed no confl ict of interest. Giaccia, Amato ..................................... Disclosed no confl ict of interest. Giacco, Rosalba .................................... Disclosed no confl ict of interest. Giampatzis, Vasilios ............................. Disclosed no confl ict of interest. Gianchandani, Roma ............................ Disclosed no confl ict of interest. Gianfrancesco, Carla ............................ Disclosed no confl ict of interest. Giannakidou, Fotini .............................. Disclosed no confl ict of interest. Giannarelli, Rosa .................................. Disclosed no confl ict of interest. Giannini, Cosimo .................................. Disclosed no confl ict of interest. Gibbs, Joanna ...................................... Disclosed no confl ict of interest. Gibney, Michael ................................... Employee: BD Medical Diabetes Care Gibson, Jill D. ....................................... Disclosed no confl ict of interest. Gibson, Quince ..................................... Disclosed no confl ict of interest. Giehm, Lise ........................................... Employee: Zealand Pharma A/S; Research Support: Zealand

Pharma A/S Gielen, Charles-Edouard ...................... Disclosed no confl ict of interest. Giesler, Paula D. ................................... Disclosed no confl ict of interest. Gifford, Robert ...................................... Disclosed no confl ict of interest. Gijbels, Marion ..................................... Disclosed no confl ict of interest. Gil, Maria J. ......................................... Disclosed no confl ict of interest. Gilbert, Richard E. ................................ Advisory Panel: Johnson & Johnson, Merck, Bristol-Myers

Squibb, AstraZeneca, Sanofi ; Research Support: Johnson & Johnson, Merck, Bristol-Myers Squibb, AstraZeneca, Sanofi ; Speaker’s Bureau: Johnson & Johnson, Merck, Bristol-Myers Squibb, AstraZeneca, Sanofi

Gilden, Janice L. ................................... Disclosed no confl ict of interest. Giles, Pauline W. .................................. Other Relationship: Novo Nordisk A/S Gilet, Catherine .................................... Disclosed no confl ict of interest. Gilgen, Emily ........................................ Disclosed no confl ict of interest. Gill, Aashna .......................................... Disclosed no confl ict of interest. Gill, Dawn P. ......................................... Disclosed no confl ict of interest.

Gill, G. ................................................... Disclosed no confl ict of interest. Gill, Jasvinder K. .................................. Employee: Sanofi Gill, Shubhroz ....................................... Disclosed no confl ict of interest. Gill, Susan ............................................ Disclosed no confl ict of interest. Gillberg, Linn ........................................ Disclosed no confl ict of interest. Gillespie, Charles ................................. Disclosed no confl ict of interest. Gillespie, Paddy .................................... Disclosed no confl ict of interest. Gilliam, Laura ....................................... Disclosed no confl ict of interest. Gillman, Matthew W. ........................... Disclosed no confl ict of interest. Gil-Lozano, Manuel .............................. Disclosed no confl ict of interest. Gilman, Ronald ..................................... Disclosed no confl ict of interest. Gilmartin, Jocelyn ................................ Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Gimenez, Margarita ............................. Disclosed no confl ict of interest. Gin, Henri ............................................. Disclosed no confl ict of interest. Ginsburg, Geoffrey S. ........................... Disclosed no confl ict of interest. Giorda, Carlo B. .................................... Disclosed no confl ict of interest. Giorgino, Francesco .............................. Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.;

Board Member: AstraZeneca/Bristol-Meyers Squibb; Research Support: AstraZeneca/Bristol-Meyers Squibb; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company

Giraldo, Jaime ...................................... Disclosed no confl ict of interest. Girelli, Angela ...................................... Disclosed no confl ict of interest. Girman, Cynthia J. ................................ Employee: Merck; Stock/Shareholder: Merck Giryes, Sami ......................................... Disclosed no confl ict of interest. Gisler-Limacher, Franziska H. ............... Disclosed no confl ict of interest. Gittes, George K. .................................. Disclosed no confl ict of interest. Giulini Neri, Ilaria ................................. Disclosed no confl ict of interest. Gius, David R. ....................................... Disclosed no confl ict of interest. Giveon, Shmuel M. ............................... Disclosed no confl ict of interest. Giwa, Adebola ...................................... Disclosed no confl ict of interest. Glaser, Benjamin .................................. Disclosed no confl ict of interest. Glazunova, Alexandra .......................... Disclosed no confl ict of interest. Gleeson, Michelle ................................ Consultant: Genentech; Employee: Outcomes Insights Gleizes, Céline ...................................... Disclosed no confl ict of interest. Glerup, Henning ................................... Disclosed no confl ict of interest. Glover, Wiljeana J. ............................... Disclosed no confl ict of interest. Gluud, Lise L. ........................................ Consultant: Merck; Research Support: Merck Gluzman, Israel ..................................... Disclosed no confl ict of interest. Glynn, Liam G. ...................................... Disclosed no confl ict of interest. Gnardellis, Charalambos ...................... Disclosed no confl ict of interest. Gnudi, Luigi .......................................... Disclosed no confl ict of interest. Go, Min Jin ........................................... Disclosed no confl ict of interest. Gobbett, Troy ........................................ Disclosed no confl ict of interest. Gobeil, Fernand J. ................................ Disclosed no confl ict of interest. Goda, Koshi .......................................... Disclosed no confl ict of interest. Goda, Nobuhito .................................... Disclosed no confl ict of interest. Goddard, Giselle ................................... Disclosed no confl ict of interest. Goddu, Anna P. ..................................... Disclosed no confl ict of interest. Godlewski, Grzegorz ............................. Disclosed no confl ict of interest. Godsland, Ian F. .................................... Disclosed no confl ict of interest. Goebel-Fabbri, Ann .............................. Disclosed no confl ict of interest. Goff, David C. ....................................... Disclosed no confl ict of interest. Gohary, Yousef ..................................... Disclosed no confl ict of interest. Goland, Robin S. ................................... Disclosed no confl ict of interest. Goldbach, Alyssa R. ............................. Disclosed no confl ict of interest. Goldberg, Robert J. .............................. Disclosed no confl ict of interest. Goldberg, Ronald B. ............................. Advisory Panel: AstraZeneca/Bristol-Meyers Squibb; Consul-

tant: LipoScience Golden, Lauren H. ................................. Disclosed no confl ict of interest. Golden, Sherita H. ................................ Disclosed no confl ict of interest. Goldenberg, Ronald .............................. Advisory Panel: AstraZeneca; Boehringer Ingelheim

Pharmaceuticals, Inc.; Bristol-Myers Squibb; Eli Lilly and Company; Janssen; Merck; Novo Nordisk, Inc.; Roche; Consultant: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb; Eli Lilly and Company; Janssen; Novo Nordisk, Inc.; Research Support: Abbott; AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb; Eli Lilly and Company; GlaxoSmithKline; Janssen; Medtronic; Merck; Novartis; Novo Nordisk, Inc.; Roche; Sanofi; Takeda; Speaker’s Bureau: Abbott; AstraZeneca; Boeh-ringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb; Eli Lilly and Company; Merck; Novo Nordisk, Inc.

Goldfi eld, Gary S. ................................. Disclosed no confl ict of interest. Goldfi ne, Allison B. ............................... Advisory Panel: Food and Drug Administration Endocrine and

Metabolic Advisory Board Committee; Employee: Joslin Diabetes Center; Research Support: Covidien, Johnson & Johnson, Nestle, NIDDK

Goldfi ne, Ira D. ..................................... Employee: XOMA Corporation

Dow



A854


AU

THO

R D

ISCL

OSU

RE

Goldman, Dana ..................................... Consultant: Bristol-Myers Squibb Company, Sanofi ; Employee: Precision Health Economics

Goldstein, Barry J. ................................ Employee: Merck Sharp & Dohme Limited; Stock/Shareholder: Merck Sharp & Dohme Limited

Goldstein, Jay L. ................................... Consultant: AstraZeneca Pharmaceuticals LP, Pozen, Inc., Takeda Pharmaceutical Company, Ltd.

Goldstein, Neta .................................... Employee: Integrity Applications, Ltd. Golm, Gregory T. ................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Gómez Huelgas, Ricardo ...................... Research Support: Bayer Health Care, LLC, Boehringer

Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline, Menarini, Novartis Pharma-ceuticals Corporation, Novo Nordisk A/S, Pfi zer, Inc., Rovi, Sanofi , Schwarz Biosciences, Inc., Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Abbott Laboratories, Inc., Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi

Gomez Peralta, Tania G. ....................... Disclosed no confl ict of interest. Gomez, Ana M. ..................................... Research Support: Abbott Diabetes Care, Medtronic MiniMed,

Inc., Novartis Pharmaceuticals Corporation, Sanofi ; Speaker’s Bureau: Medtronic MiniMed, Inc., Novo Nordisk, Inc., Sanofi

Gomez, Daniela .................................... Disclosed no confl ict of interest. Gomez-Arbelaez, Diego ........................ Disclosed no confl ict of interest. Gomez-Huelgas, Ricardo ...................... Disclosed no confl ict of interest. Gomez-Peralta, Fernando ..................... Advisory Panel: Novo Nordisk A/S, Sanofi ; Speaker’s Bureau:

AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi

Gomis, Ramon ...................................... Disclosed no confl ict of interest. Gommer, Nadja .................................... Disclosed no confl ict of interest. Gonai, Megumi ..................................... Disclosed no confl ict of interest. Gonc, Nazli ........................................... Disclosed no confl ict of interest. Gonder-Frederick, Linda ....................... Consultant: Dexcom, Inc. Gondhalekar, Ravi ................................ Disclosed no confl ict of interest. Gong, Chun Xiu ..................................... Disclosed no confl ict of interest. Gong, Qiuhong ...................................... Disclosed no confl ict of interest. Gong, Yan ............................................. Employee: Boehringer Ingelheim GmbH & Co. KG Goñi, María José .................................. Disclosed no confl ict of interest. Gonzales, Joseph ................................. Disclosed no confl ict of interest. Gonzalez Perez De Villar, Noemi .......... Disclosed no confl ict of interest. Gonzalez, Amparo ................................ Employee: Johnson & Johnson Gonzalez, Concepcion .......................... Disclosed no confl ict of interest. Gonzalez, Jeffrey S. ............................. Disclosed no confl ict of interest. Gonzalez, Karina N. .............................. Disclosed no confl ict of interest. González, Lorena .................................. Disclosed no confl ict of interest. Gonzalez, Patricia ................................. Disclosed no confl ict of interest. Gonzalez-Jimenez, Amalia ................... Disclosed no confl ict of interest. González-Segura, Diego ....................... Employee: Almirall Gonzalo, Sonia ..................................... Disclosed no confl ict of interest. Goodarzi, Mark O. ................................ Disclosed no confl ict of interest. Gooday, Catherine ................................ Disclosed no confl ict of interest. Gooding, Kimberly A. ........................... Disclosed no confl ict of interest. Goodpaster, Bret H. .............................. Disclosed no confl ict of interest. Goodwin, Nicole ................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Goodyear, Laurie J. .............................. Disclosed no confl ict of interest. Goossens, Gijs ...................................... Disclosed no confl ict of interest. Goovaerts, Wouter ............................... Disclosed no confl ict of interest. Gopalakrishnan, Gopikakrishnan ......... Disclosed no confl ict of interest. Goran, Michael I. .................................. Disclosed no confl ict of interest. Gorbatov, Rostic ................................... Disclosed no confl ict of interest. Gordon, Barak ....................................... Disclosed no confl ict of interest. Gordon, Lavinia .................................... Disclosed no confl ict of interest. Gordon, Scott M. .................................. Disclosed no confl ict of interest. Görgens, Sven W. ................................. Disclosed no confl ict of interest. Goring, Harald H. .................................. Disclosed no confl ict of interest. Gorjão, Renata ..................................... Disclosed no confl ict of interest. Gorlin, Eugenia ..................................... Disclosed no confl ict of interest. Gormsen, Lars C. .................................. Disclosed no confl ict of interest. Gorska, Maria ....................................... Disclosed no confl ict of interest. Gorski, Jack .......................................... Disclosed no confl ict of interest. Goscik, Joanna ..................................... Disclosed no confl ict of interest. Goswami, Devesh ................................ Disclosed no confl ict of interest. Goto, Atsushi ........................................ Disclosed no confl ict of interest. Goto, Chisato ........................................ Employee: Chugai Research Institute for Medical Science, Inc. Goto, Hiromasa .................................... Advisory Panel: Takeda Pharmaceutical Company, Ltd. Goto, Maki ............................................ Disclosed no confl ict of interest. Goto, Rieko ........................................... Disclosed no confl ict of interest. Gottlieb, Peter A. .................................. Advisory Panel: Eli Lilly and Company, Genentech, Sanofi ,

Tolerx, Inc.; Research Support: Bayhill Therapeutics, Inc.,

Diamyd Medical AB, Macrogenics, Inc., Omics Biotechnol-ogy, Inc., Tolerx, Inc.

Gotzamani-Psarakou, Anna .................. Disclosed no confl ict of interest. Goudie, David ....................................... Disclosed no confl ict of interest. Gouet, Didier ........................................ Research Support: Boehringer Ingelheim Pharmaceuti-

cals, Inc., Eli Lilly and Company, Johnson & Johnson, Medtronic, Novo Nordisk A/S, Sanofi

Gougeon, Rejeanne .............................. Disclosed no confl ict of interest. Gough, Stephen C. ............................... Board Member: Eli Lilly and Company, Novo Nordisk A/S;

Research Support: Novo Nordisk A/S, Takeda Pharmaceu-tical Company, Ltd.

Gouldstone, Amy .................................. Disclosed no confl ict of interest. Gourdy, Pierre ....................................... Board Member: Novo Nordisk A/S; Consultant: AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceu-ticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi ; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceu-ticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi

Gouveia, Sofi a ...................................... Disclosed no confl ict of interest. Gozani, Shai ......................................... Employee: NeuroMetrix; Stock/Shareholder: NeuroMetrix Grabner, Michael .................................. Disclosed no confl ict of interest. Grabowska, Marcelina ......................... Disclosed no confl ict of interest. Grabowska-Polanowska, Beata ........... Disclosed no confl ict of interest. Grabowski, Francine ............................. Disclosed no confl ict of interest. Gracheva, Svetlana .............................. Disclosed no confl ict of interest. Graffy, Jonathan ................................... Disclosed no confl ict of interest. Graham, Christopher ............................ Disclosed no confl ict of interest. Graham, Claudia ................................... Employee: Dexcom, Inc.; Stock/Shareholder: Dexcom, Inc. Graham, James L. ................................ Disclosed no confl ict of interest. Graham, Linda ...................................... Disclosed no confl ict of interest. Graham, Wayne D. ............................... Disclosed no confl ict of interest. Grahammer, Florian .............................. Disclosed no confl ict of interest. Grande, Stefania .................................. Disclosed no confl ict of interest. Grandi, Sabrina .................................... Disclosed no confl ict of interest. Grandy, Susan ...................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/Share-

holder: AstraZeneca Pharmaceuticals LP Graninger, Winfried B. ......................... Disclosed no confl ict of interest. Granström, Charlotta ............................ Disclosed no confl ict of interest. Grant, David ......................................... Disclosed no confl ict of interest. Grant, Maria B. ..................................... Disclosed no confl ict of interest. Grant, Richard W. ................................. Disclosed no confl ict of interest. Grant, Struan F.A. ................................. Disclosed no confl ict of interest. Granville, Esther ................................... Disclosed no confl ict of interest. Graph-Barel, Chana .............................. Disclosed no confl ict of interest. Grasso, Valeria ..................................... Disclosed no confl ict of interest. Gray, Laura J. ....................................... Disclosed no confl ict of interest. Gray, Robyn .......................................... Disclosed no confl ict of interest. Gray, Steve ........................................... Disclosed no confl ict of interest. Greeley, Siri Atma W. ........................... Disclosed no confl ict of interest. Green, Danielle .................................... Disclosed no confl ict of interest. Green, Kelly .......................................... Disclosed no confl ict of interest. Green, Robert ....................................... Disclosed no confl ict of interest. Green, Sherri L. .................................... Disclosed no confl ict of interest. Greenaway, Tim ................................... Disclosed no confl ict of interest. Greenbaum, Carla J. ............................ Advisory Panel: Takeda Global Research and Development,

Inc.; Consultant: Andromeda Biotech, Ltd.; Research Sup-port: Novo Nordisk A/S

Greenberg, Ellen ................................... Disclosed no confl ict of interest. Greenfi eld, Yuval .................................. Disclosed no confl ict of interest. Greenspan, Louise C. ........................... Disclosed no confl ict of interest. Greenway, Frank ................................... Disclosed no confl ict of interest. Greenwood, Jeremy ............................. Disclosed no confl ict of interest. Greer, Jennifer ..................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Greer, Nancy ......................................... Disclosed no confl ict of interest. Greevy, Robert ...................................... Disclosed no confl ict of interest. Gregg, Edward W. ................................ Disclosed no confl ict of interest. Gregoire, Francine M. .......................... Disclosed no confl ict of interest. Gregoric, Nadan ................................... Disclosed no confl ict of interest. Gregory, Becky P. .................................. Consultant: Abbott Diabetes Care Gregory, Sarah-Jane ............................ Disclosed no confl ict of interest. Greiner, Dale L. ..................................... Disclosed no confl ict of interest. Grekas, Dimitrios .................................. Disclosed no confl ict of interest. Grempler, Rolf ...................................... Employee: Boehringer Ingelheim GmbH & Co. KG Grenier-Larouche, Thomas ................... Disclosed no confl ict of interest. Grennan, Kerry B. ................................. Disclosed no confl ict of interest. Gretz, Norbert ....................................... Disclosed no confl ict of interest. Greulich, Sabrina .................................. Disclosed no confl ict of interest. Greven, Craig ........................................ Disclosed no confl ict of interest.

Dow



A855


AU

THO

R D

ISCL

OSU

RE

Grey, Margaret ..................................... Disclosed no confl ict of interest. Grice, Brian A. ...................................... Disclosed no confl ict of interest. Grier, Lindsey ........................................ Disclosed no confl ict of interest. Griffey, Susan J. ................................... Disclosed no confl ict of interest. Griffi n, Marie ........................................ Disclosed no confl ict of interest. Griffi n, Timothy ..................................... Disclosed no confl ict of interest. Griffo, Ettore ......................................... Disclosed no confl ict of interest. Grigorescu, Florin ................................. Disclosed no confl ict of interest. Grigoropoulou, Pinelopi ........................ Disclosed no confl ict of interest. Grijalva, Carlos ..................................... Disclosed no confl ict of interest. Grimes, Imogene M. ............................. Employee: TransTech Pharma Grimm, Michael .................................... Employee: Amylin Pharmaceuticals, LLC Grineva, Elena ...................................... Disclosed no confl ict of interest. Grise, Kenneth N. ................................. Disclosed no confl ict of interest. Gritsenko, Marina A. ............................ Disclosed no confl ict of interest. Groener, Jan ......................................... Disclosed no confl ict of interest. Groff, Michelle ..................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Groop, Leif ............................................ Disclosed no confl ict of interest. Groop, Per-Henrik ................................. Advisory Panel: Boehringer Ingelheim GmbH & Co. KG, Eli

Lilly and Company, Novartis Pharmaceuticals Corpora-tion; Other Relationship: Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Genzyme Corporation, Merck Sharp & Dohme Limited, Novartis Pharma-ceuticals Corporation, Novo Nordisk A/S, WebMD; Research Support: Eli Lilly and Company, Roche Pharmaceuticals

Gross, Jorge L. ..................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuti-cals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S

Gross, Myron D. ................................... Disclosed no confl ict of interest. Grossenheider, Tiffani C. ...................... Disclosed no confl ict of interest. Grosser, Ute .......................................... Disclosed no confl ict of interest. Grosshans, David ................................. Disclosed no confl ict of interest. Grossman, Helene ................................ Disclosed no confl ict of interest. Grove, Kaylene ..................................... Disclosed no confl ict of interest. Grove, Kevin L. ..................................... Disclosed no confl ict of interest. Grudziak, Joanna .................................. Disclosed no confl ict of interest. Gruenberger, Jean-Bernard .................. Employee: Novartis Pharmaceuticals Corporation Gruetter, Rolf ........................................ Disclosed no confl ict of interest. Grunberger, George .............................. Consultant: Valeritas, LLC; Research Support: Valeritas, LLC;

Speaker’s Bureau: Valeritas, LLC Grünler, Jacob ...................................... Disclosed no confl ict of interest. Grunwald Jr., William C. ...................... Disclosed no confl ict of interest. Grzelak, Piotr ........................................ Disclosed no confl ict of interest. Grzesik, Wojciech ................................. Disclosed no confl ict of interest. Grzeszczak, Władysław ........................ Advisory Panel: Eli Lilly and Company, Merck; Consultant: Eli

Lilly and Company, Kowa Research Institute, Inc., Merck Sharp & Dohme Limited, Polpharma Pharmaceuticals; Speaker’s Bureau: Bayer Health Care, LLC, Bioton, Merck, Novo Nordisk, Inc., Sanofi

Grzywacz, Joseph ................................. Disclosed no confl ict of interest. Gu, Huimin ............................................ Disclosed no confl ict of interest. Gu, Nan ................................................ Disclosed no confl ict of interest. Gu, Weiqiong ....................................... Disclosed no confl ict of interest. Gu, Yan ................................................. Disclosed no confl ict of interest. Gu, Yi .................................................... Disclosed no confl ict of interest. Gu, Yisu ................................................ Disclosed no confl ict of interest. Gu, Yunjuan .......................................... Disclosed no confl ict of interest. Gu, Zhaoyan ......................................... Disclosed no confl ict of interest. Guadagnini, Dioze ................................ Disclosed no confl ict of interest. Guan, Hongyu ....................................... Disclosed no confl ict of interest. Guan, Meiping ...................................... Disclosed no confl ict of interest. Guarna, Giuliana .................................. Disclosed no confl ict of interest. Gubitosi-Klug, Rose A. ......................... Research Support: Panmira Pharmaceuticals LLC Gudipaty, Lalitha .................................. Disclosed no confl ict of interest. Guelho, Daniela F. ................................ Disclosed no confl ict of interest. Guerci, Bruno ........................................ Advisory Panel: Abbott Laboratories, Inc., Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novartis Pharmaceuticals Corporation; Board Member: Bristol-Myers Squibb/AstraZeneca, GlaxoSmithKline, Novo Nordisk A/S, Roche Diagnostic, Sanofi ; Consultant: Medtronic, Merck Sharp & Dohme Limited, VitalAire; Research Support: Dinno Santé, Eli Lilly and Company, Johnson & Johnson, Medtronic, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi , VitalAire

Guérin, Annie ....................................... Research Support: Takeda Pharmaceutical Company, Ltd. Guérin, Brigitte ..................................... Disclosed no confl ict of interest. Guery, Mattieu ..................................... Employee: Novo Nordisk A/S Guglielmi, Chiara .................................. Disclosed no confl ict of interest. Guida, Piero .......................................... Disclosed no confl ict of interest. Guinness, Mary .................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc. Gujral, Kiranjot ..................................... Disclosed no confl ict of interest. Gujral, Unjali P. ..................................... Disclosed no confl ict of interest. Gulanick, Meg ...................................... Disclosed no confl ict of interest. Gulati, Arti ............................................ Disclosed no confl ict of interest. Gulati, Seema ....................................... Research Support: Nestle, Inc. Gulec, Sadi ........................................... Disclosed no confl ict of interest. Guler, Serdar ........................................ Disclosed no confl ict of interest. Gulisano, Massimo .............................. Disclosed no confl ict of interest. Gullestad, Lars ..................................... Disclosed no confl ict of interest. Gummesson, Anders ............................ Employee: AstraZeneca Pharmaceuticals LP Gumprecht, Janusz ............................... Consultant: Eli Lilly and Company, Kowa Pharmaceuticals,

Merck, Polpharma Pharmaceuticals; Speaker’s Bureau: Bayer Health Care, LLC, Bioton, Eli Lilly and Company, Merck, Merck Sharp & Dohme Limited, Novo Nordisk, Inc.

Gunderson, Erica P. ............................... Disclosed no confl ict of interest. Gundgaard, Jens .................................. Employee: Novo Nordisk A/S Gundo Rao, Nagashree ........................ Disclosed no confl ict of interest. Gunnet, Joseph .................................... Employee: Janssen Research & Development Gunstad, John ...................................... Disclosed no confl ict of interest. Gunton, Jenny ...................................... Disclosed no confl ict of interest. Guo, Aili ................................................ Disclosed no confl ict of interest. Guo, Bingyan ........................................ Disclosed no confl ict of interest. Guo, Deng-Fu ........................................ Disclosed no confl ict of interest. Guo, Fangjian ....................................... Disclosed no confl ict of interest. Guo, Jianjin .......................................... Disclosed no confl ict of interest. Guo, Jie-Feng ....................................... Disclosed no confl ict of interest. Guo, Kaifeng ......................................... Disclosed no confl ict of interest. Guo, Lixin .............................................. Disclosed no confl ict of interest. Guo, Lu ................................................. Disclosed no confl ict of interest. Guo, Ping .............................................. Disclosed no confl ict of interest. Guo, Shaodong ..................................... Disclosed no confl ict of interest. Guo, Wei .............................................. Disclosed no confl ict of interest. Guo, Xiaohui ......................................... Disclosed no confl ict of interest. Guo, Xiuqing ......................................... Disclosed no confl ict of interest. Guo, Zhiguang ...................................... Disclosed no confl ict of interest. Guoqing, Yang ...................................... Disclosed no confl ict of interest. Gupta, Aditi .......................................... Disclosed no confl ict of interest. Gupta, Deepak ...................................... Disclosed no confl ict of interest. Gupta, Dhananjay ................................. Disclosed no confl ict of interest. Gupta, Jyoti .......................................... Disclosed no confl ict of interest. Gupta, Rana K. ..................................... Disclosed no confl ict of interest. Gupta, Sandeep .................................... Disclosed no confl ict of interest. Gupta, Shaloo ....................................... Consultant: Novartis Pharma AG; Employee: Kantar Health Gur, Serap ............................................. Disclosed no confl ict of interest. Gurarie, David ...................................... Disclosed no confl ict of interest. Gurban, Jamala .................................... Disclosed no confl ict of interest. Gurdol, Figen ........................................ Disclosed no confl ict of interest. Gurol, Ali Osman .................................. Disclosed no confl ict of interest. Gus, Miguel .......................................... Disclosed no confl ict of interest. Gustafsson, Stefan ............................... Disclosed no confl ict of interest. Gustavson, Stephanie M. ..................... Employee: Pfi zer, Inc., TransTech Pharma; Stock/Shareholder:

Pfi zer, Inc. Guthridge, Mark A. ............................... Disclosed no confl ict of interest. Guthrie, Robert ..................................... Consultant: Janssen, Lilly/Boehringer Ingelheim Gutierrez, Diana ................................... Disclosed no confl ict of interest. Gutowska, Izabela ................................ Disclosed no confl ict of interest. Guzel, Nil .............................................. Disclosed no confl ict of interest. Guzman, Alfredo L. ............................... Disclosed no confl ict of interest. Guzman, Johanna ................................. Disclosed no confl ict of interest. Gwaltney, Chad .................................... Consultant: Novartis Pharma AG; Employee: ERT Gydesen, Sofi e ..................................... Disclosed no confl ict of interest. Gygi, Steven ......................................... Disclosed no confl ict of interest. Gyllenhammer, Lauren ......................... Disclosed no confl ict of interest. Gylling, Helena ..................................... Disclosed no confl ict of interest. Ha, Connie W. ...................................... Disclosed no confl ict of interest. Ha, Eun Suk .......................................... Disclosed no confl ict of interest. Ha, Hunjoo ............................................ Disclosed no confl ict of interest. Ha, Jinkyung ......................................... Disclosed no confl ict of interest. Ha, Jiyoon ............................................ Disclosed no confl ict of interest. Ha, Joon ............................................... Disclosed no confl ict of interest. Ha, Won Chul ....................................... Disclosed no confl ict of interest. Ha, Yu Mi .............................................. Disclosed no confl ict of interest. Haack, Karin ......................................... Disclosed no confl ict of interest. Haahr, Hanne ........................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S

Dow



A856


AU

THO

R D

ISCL

OSU

RE

Haak, Thomas ....................................... Advisory Panel: Roche, Sanofi Aventis; Research Support: Ber-lin Chemie, Lilly Germany, Roche Diagnostics; Speaker’s Bureau: Berlin Chemie

Haas, Carina ......................................... Disclosed no confl ict of interest. Haas, Jutta ........................................... Disclosed no confl ict of interest. Haastert, Burkhard ............................... Disclosed no confl ict of interest. Habener, Joel F. .................................... Disclosed no confl ict of interest. Habib, Samy L. ..................................... Disclosed no confl ict of interest. Habicht, Antje ...................................... Disclosed no confl ict of interest. Habtemichael, Estifanos N. ................. Disclosed no confl ict of interest. Hacohen, Nir ........................................ Disclosed no confl ict of interest. Haczeyni, Fahrettin ............................... Disclosed no confl ict of interest. Hada, Yusuke ........................................ Disclosed no confl ict of interest. Hadcock, John R. .................................. Employee: Novartis Pharmaceuticals Corporation Haddad, Jihad ...................................... Advisory Panel: Merck Sharp & Dohme Limited, Novo Nordisk

A/S; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Merck Serono, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S

Haddadin, Firas .................................... Disclosed no confl ict of interest. Hadjadj, Samy ...................................... Disclosed no confl ict of interest. Hadjiyannakis, Stasia ........................... Disclosed no confl ict of interest. Haering, Hans-Ulrich ............................ Advisory Panel: Boehringer Ingelheim GmbH & Co. KG, Roche

Pharmaceuticals, Sanofi Haering, Max-Felix ............................... Disclosed no confl ict of interest. Haeusler, Rebecca A. ........................... Disclosed no confl ict of interest. Haffner, Steven M. ............................... Disclosed no confl ict of interest. Haga, Susanne B. ................................. Disclosed no confl ict of interest. Hägg, Sara ............................................ Disclosed no confl ict of interest. Haghiac, Maricela ................................ Disclosed no confl ict of interest. Hahm, Jong Ryeal ................................ Disclosed no confl ict of interest. Hahn, Scott ........................................... Disclosed no confl ict of interest. Hahn-Obercyger, Michal ...................... Disclosed no confl ict of interest. Hai, Chun-xia ........................................ Disclosed no confl ict of interest. Hai, Luo ................................................ Disclosed no confl ict of interest. Haick, Hossam ...................................... Disclosed no confl ict of interest. Haidich, Betina ..................................... Disclosed no confl ict of interest. Haigis, Marcia C. .................................. Disclosed no confl ict of interest. Hajek, Milan ......................................... Disclosed no confl ict of interest. Hajighasemi-Ossareh, Mohammad ..... Disclosed no confl ict of interest. Hajjaji, Issam M. .................................. Disclosed no confl ict of interest. Hajnal, Andras ...................................... Disclosed no confl ict of interest. Hajos, Tibor R. ...................................... Disclosed no confl ict of interest. Hakonarson, Hakon .............................. Disclosed no confl ict of interest. Halama, Anna ....................................... Disclosed no confl ict of interest. Haldane, Diane ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Haldorsson, Thorhallur ......................... Disclosed no confl ict of interest. Hale, Alex ............................................. Disclosed no confl ict of interest. Halff, Glenn .......................................... Disclosed no confl ict of interest. Halko, Michael ..................................... Disclosed no confl ict of interest. Hall, Elin ............................................... Disclosed no confl ict of interest. Hall, Erica ............................................. Disclosed no confl ict of interest. Hall, George ......................................... Disclosed no confl ict of interest. Hall, Katharine E. ................................. Disclosed no confl ict of interest. Haller, Michael J. ................................. Disclosed no confl ict of interest. Haller-Wich, Stacie .............................. Disclosed no confl ict of interest. Halliday, Dana ...................................... Employee: Arena Pharmaceuticals, Inc. Hallinger, Daniel ................................... Disclosed no confl ict of interest. Halm, Ethan .......................................... Disclosed no confl ict of interest. Halperin, Florencia ............................... Disclosed no confl ict of interest. Halpern, Elise M. .................................. Disclosed no confl ict of interest. Halter, Jeffrey B. .................................. Disclosed no confl ict of interest. Haluzik, Martin ..................................... Disclosed no confl ict of interest. Halvatsiotis, Panagiotis ....................... Disclosed no confl ict of interest. Hamada, Yoji ........................................ Disclosed no confl ict of interest. Hamaguchi, Yuriko ............................... Disclosed no confl ict of interest. Hämäläinen, Maija ............................... Disclosed no confl ict of interest. Hamamoto, Kae .................................... Disclosed no confl ict of interest. Hamamoto, Yoshiyuki ........................... Research Support: Eli Lilly and Company Hamano, Kumiko .................................. Disclosed no confl ict of interest. Hamasaki, Akihiro ................................ Disclosed no confl ict of interest. Hamaty, Marwan .................................. Disclosed no confl ict of interest. Hambidge, Bertha ................................ Disclosed no confl ict of interest. Hamdi, Sonia ........................................ Disclosed no confl ict of interest. Hamdouchi, Chafi q ............................... Employee: Eli Lilly and Company Hamdy, Osama ..................................... Advisory Panel: ESAI; Consultant: Abbott Nutrition, Merck Hamel, Frederick G. .............................. Disclosed no confl ict of interest. Hamiel, Uri ........................................... Disclosed no confl ict of interest. Hamilton, D. Lee ................................... Disclosed no confl ict of interest. Hamilton, Jill K. .................................... Disclosed no confl ict of interest. Hammad, Samar M. ............................. Disclosed no confl ict of interest. Hamman, Richard F. ............................. Disclosed no confl ict of interest.

Hammar, Mårten .................................. Employee: AstraZeneca Pharmaceuticals LP Hammer Bech, Bodil ............................. Disclosed no confl ict of interest. Hammes, Hans-Peter ........................... Disclosed no confl ict of interest. Hammoda, Duaa A. .............................. Disclosed no confl ict of interest. Hamo-Tchatchouang, Eliane ................ Disclosed no confl ict of interest. Hampe, Christiane S. ........................... Disclosed no confl ict of interest. Hampton, Lee M. .................................. Disclosed no confl ict of interest. Han, Bok-Ghee ..................................... Disclosed no confl ict of interest. Han, Chunguang ................................... Disclosed no confl ict of interest. Han, Da Woon ...................................... Disclosed no confl ict of interest. Han, Hongling ....................................... Disclosed no confl ict of interest. Han, Hyoil ............................................. Disclosed no confl ict of interest. Han, Je Ho ............................................ Disclosed no confl ict of interest. Han, Jenny ........................................... Employee: Amylin Pharmaceuticals, LLC Han, Jino .............................................. Employee: Medtronic Han, Kyung Ah ...................................... Disclosed no confl ict of interest. Han, Michael ........................................ Disclosed no confl ict of interest. Han, Ping .............................................. Consultant: Takeda Global Research & Development Center,

Inc. Han, Se Jin ........................................... Disclosed no confl ict of interest. Han, Seung Jin ..................................... Disclosed no confl ict of interest. Han, Weiping ....................................... Disclosed no confl ict of interest. Han, Xiaofei .......................................... Disclosed no confl ict of interest. Han, Xueyao ......................................... Disclosed no confl ict of interest. Han, Yuqi .............................................. Disclosed no confl ict of interest. Hanafusa, Toshiaki ............................... Disclosed no confl ict of interest. Hanai, Kou ............................................ Disclosed no confl ict of interest. Hanaki, Keiichi ..................................... Disclosed no confl ict of interest. Hanamoto, Takayuki ............................. Disclosed no confl ict of interest. Hanaoka, Hideki ................................... Disclosed no confl ict of interest. Hanas, Ragnar ...................................... Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S,

Sanofi ; Consultant: Abbott Diabetes Care, Dexcom, Inc., Medtronic; Speaker’s Bureau: Abbott Laboratories, Inc., Dexcom, Inc., Medtronic, Menarini, Roche Pharmaceuti-cals

Hanashita, Junko ................................. Disclosed no confl ict of interest. Hanazawa, Miyuki ................................ Disclosed no confl ict of interest. Handelsman, Yehuda ........................... Consultant: Amarin, Amylin Pharmaceuticals, Inc.,

Daiichi-Sankyo, Inc., Gilead Sciences, Inc., Halozyme Therapeutics, LipoScience, Merck, Novo Nordisk A/S, ResMed, Sanofi , Santarus, Inc., Titus, Vivus; Research Support: Boehringer Ingelheim GmbH & Co. KG, Con-juChem, Daiichi-Sankyo, Inc., GlaxoSmithKline, Lexicon Pharmaceuticals, Inc., Merck, Novo Nordisk A/S, Sanofi , Takeda, ToleRx, XOMA, Ltd.; Speaker’s Bureau: Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Daiichi-Sankyo, Inc., Eli Lilly and Company, GlaxoSmithKline, Novo Nordisk A/S, Santarus, Inc., Vivus, Inc.

Haneda, Masakazu ............................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc., Taisho; Research Support: Astellas Pharma US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Chugai Phar-maceutical Co., Ltd., Taisho, Tanabe-Mitsubishi; Speaker’s Bureau: Astellas Pharma US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Tanabe-Mitsubishi

Hanefeld, Markolf ................................ Advisory Panel: Bristol-Myers Squibb Company, GlaxoSmith-Kline, Sanofi , Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Bayer Health Care, LLC, Eli Lilly and Company, GlaxoSmithKline, Roche Pharmaceuticals, Sanofi , Takeda Pharmaceutical Company, Ltd.

Hang, Jingyu ........................................ Disclosed no confl ict of interest. Hanis, Craig L. ...................................... Disclosed no confl ict of interest. Hankinson, Arlene L. ............................ Disclosed no confl ict of interest. Hanks, Brian C. ..................................... Disclosed no confl ict of interest. Hanley, Anthony J. ............................... Disclosed no confl ict of interest. Han-Markey, Theresa ........................... Disclosed no confl ict of interest. Hannon, Tamara S. ............................... Disclosed no confl ict of interest. Hannun, Yusuf A. .................................. Disclosed no confl ict of interest. Hanseman, Dennis ............................... Disclosed no confl ict of interest. Hansen, Anne-Louise S. ....................... Employee: Steno Diabetes Center; Stock/Shareholder: Novo

Nordisk A/S Hansen, Barbara C. .............................. Advisory Panel: CrownBiosciences, Merck; Consultant:

Altucell, CrownBiosciences, GlaxoSmithKline, Merck, Xoma; Research Support: NIH

Hansen, Dorte L. ................................... Disclosed no confl ict of interest. Hansen, Gitte ....................................... Research Support: Boehringer Ingelheim GmbH & Co. KG Hansen, Henrik ..................................... Research Support: Boehringer Ingelheim GmbH & Co. KG Hansen, Jakob B. ................................. Disclosed no confl ict of interest. Hansen, Morten ................................... Disclosed no confl ict of interest. Hansen, Richard A. ............................... Consultant: Daiichi-Sankyo, Inc.Hansen, Torben .................................... Disclosed no confl ict of interest.

Dow



A857


AU

THO

R D

ISCL

OSU

RE

Hansen, Troels K. ................................. Disclosed no confl ict of interest. Hanson, Robert L. ................................. Disclosed no confl ict of interest. Hanssen, Kristian F. .............................. Disclosed no confl ict of interest. Hanssen, Nordin ................................... Disclosed no confl ict of interest. Hantel, Stefan ...................................... Employee: Boehringer Ingelheim GmbH & Co. KG Hanyu, Osamu ...................................... Disclosed no confl ict of interest. Hao, Jianqiang ..................................... Disclosed no confl ict of interest. Hapil, Fatma Z. ..................................... Disclosed no confl ict of interest. Hara, Akemi .......................................... Disclosed no confl ict of interest. Hara, Fumihiko ..................................... Disclosed no confl ict of interest. Hara, Hidehiko ...................................... Disclosed no confl ict of interest. Hara, Kazuo .......................................... Disclosed no confl ict of interest. Hara, Kenji ............................................ Disclosed no confl ict of interest. Hara, Kento .......................................... Disclosed no confl ict of interest. Hara, Manami ...................................... Disclosed no confl ict of interest. Hara, Masanori .................................... Disclosed no confl ict of interest. Hara, Shigeko ....................................... Disclosed no confl ict of interest. Harada, Nagakatsu .............................. Disclosed no confl ict of interest. Harada, Norio ....................................... Disclosed no confl ict of interest. Harada, Takanari .................................. Disclosed no confl ict of interest. Haraguchi, Kazutoshi ........................... Disclosed no confl ict of interest. Harari, Gil ............................................. Consultant: Andromeda Biotech, Ltd. Harata, Ikue .......................................... Disclosed no confl ict of interest. Hardies, Jean ....................................... Disclosed no confl ict of interest. Hardikar, Anand A. ............................... Disclosed no confl ict of interest. Hardin, Dana S. .................................... Employee: Eli Lilly and Company Harding, Jessica L. ............................... Disclosed no confl ict of interest. Hardy, Elise ........................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/Share-

holder: AstraZeneca Pharmaceuticals LP Hardy, Kevin J. ..................................... Disclosed no confl ict of interest. Hardy, Thomas A. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Hariharan, Meenu ................................ Disclosed no confl ict of interest. Häring, Hans-Ulrich .............................. Advisory Panel: Boehringer Ingelheim GmbH & Co. KG,

Daiichi-Sankyo, Inc., Roche Pharmaceuticals, sanofi -aventis

Haritunians, Talin ................................. Disclosed no confl ict of interest. Harlan, David M. .................................. Board Member: Grove Instruments Harman, Ece ......................................... Disclosed no confl ict of interest. Harman-Boehm, Ilana .......................... Disclosed no confl ict of interest. Haro, Heidi ........................................... Disclosed no confl ict of interest. Harper, Mary-Ellen ............................... Disclosed no confl ict of interest. Harriman, Geraldine ............................. Disclosed no confl ict of interest. Harrington, Kara R. ............................... Disclosed no confl ict of interest. Harrington, T. Michael ......................... Research Support: Sanofi US Harris, Angela ...................................... Employee: Lexicon Pharmaceuticals, Inc. Harris, Cara .......................................... Disclosed no confl ict of interest. Harris, Jonah B. .................................... Disclosed no confl ict of interest. Harris, Michael A. ................................ Disclosed no confl ict of interest. Harris, Robert A. ................................... Disclosed no confl ict of interest. Harris, Stewart B. ................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer

Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Com-pany, Eli Lilly and Company, Janssen Pharmaceuticals, Merck, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi ; Consultant: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Com-pany, Eli Lilly and Company, Janssen Pharmaceuticals, Merck, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi ; Research Support: Merck, Novo Nordisk A/S, Sanofi

Harris, Tamara ...................................... Disclosed no confl ict of interest. Harrisberg, Brian .................................. Disclosed no confl ict of interest. Harrison, Benjamin S. .......................... Disclosed no confl ict of interest. Harrison, Bryce ..................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Harrison, Leonard C. ............................. Disclosed no confl ict of interest. Harrison, Lindsay B. ............................. Disclosed no confl ict of interest. Harrison, Stephen ................................ Disclosed no confl ict of interest. Harry, Abigale ....................................... Disclosed no confl ict of interest. Hart, Peter ............................................ Disclosed no confl ict of interest. Harte, Alison L. ..................................... Disclosed no confl ict of interest. Hartgens, Fred ...................................... Disclosed no confl ict of interest. Hartland, Andrew J. ............................. Speaker’s Bureau: Eli Lilly and Company, Merck Sharp &

Dohme Limited, Novo Nordisk, Inc., Sanofi Hartland, Vickie .................................... Disclosed no confl ict of interest. Hartline, Leona ..................................... Disclosed no confl ict of interest. Hartmann, Bolette ................................ Disclosed no confl ict of interest. Hartmann, Ursula ................................. Disclosed no confl ict of interest. Haruki, Takenori ................................... Disclosed no confl ict of interest. Harvey, Rebecca A. .............................. Disclosed no confl ict of interest. Harwell, Todd S. ................................... Disclosed no confl ict of interest. Harwood, H. James .............................. Disclosed no confl ict of interest. Harzallah, Olfa ...................................... Disclosed no confl ict of interest.

Hasan, Mohammad I. ........................... Advisory Panel: Novo Nordisk A/S; Research Support: Novar-tis Pharmaceuticals Corporation, Roche Pharmaceuticals

Hasan, Sana ......................................... Disclosed no confl ict of interest. Haseda, Fumitaka ................................. Disclosed no confl ict of interest. Hasegawa, Goji .................................... Disclosed no confl ict of interest. Hasegawa, Hiroyuki ............................. Disclosed no confl ict of interest. Hasegawa, Koji .................................... Disclosed no confl ict of interest. Hasegawa, Osamu ............................... Disclosed no confl ict of interest. Hasenour, Clinton M. ........................... Disclosed no confl ict of interest. Hashemi, Mahdi ................................... Employee: AstraZeneca Pharmaceuticals LP Hashemi, Zohre .................................... Disclosed no confl ict of interest. Hashiguchi, Hiroshi .............................. Disclosed no confl ict of interest. Hashimoto, Eriko .................................. Disclosed no confl ict of interest. Hashimoto, Naotake ............................ Disclosed no confl ict of interest. Hashimoto, Takuya ............................... Disclosed no confl ict of interest. Hashinaga, Toshihiko ........................... Disclosed no confl ict of interest. Hashiramoto, Mitsuru .......................... Disclosed no confl ict of interest. Haskins, Kathryn .................................. Disclosed no confl ict of interest. Hassan, Hazem ..................................... Disclosed no confl ict of interest. Hassine, Mohsen ................................. Disclosed no confl ict of interest. Hasslacher, Christoph .......................... Disclosed no confl ict of interest. Hassoun, Ahmed A. .............................. Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Boeh-

ringer Ingelheim Pharmaceuticals, Inc., MerckSerono, MSD, Novartis Pharma AG, NovoNordisk, Inc., sanofi -aventis; Speaker’s Bureau: Eli Lilly and Company, Pfi zer

Hasstedt, Sandra J. .............................. Disclosed no confl ict of interest. Hastings, Stephanie ............................. Disclosed no confl ict of interest. Hastrup, Hanne .................................... Employee: Novo Nordisk A/S Hata, Masaki ........................................ Disclosed no confl ict of interest. Hataji, Yuko .......................................... Disclosed no confl ict of interest. Hatakeyama, Hiroyasu ......................... Disclosed no confl ict of interest. Hatanaka, Masayuki ............................ Disclosed no confl ict of interest. Hatanaka, Takashi ................................ Disclosed no confl ict of interest. Hatano, Masaru ................................... Disclosed no confl ict of interest. Hathway, Joanne ................................. Disclosed no confl ict of interest. Hatori, Megumi .................................... Disclosed no confl ict of interest. Hatten, Alyson ...................................... Disclosed no confl ict of interest. Hattersley, Andrew T. ........................... Disclosed no confl ict of interest. Hatzis, George ...................................... Disclosed no confl ict of interest. Hatzitolios, Apostolos .......................... Disclosed no confl ict of interest. Hauber, A. Brett .................................... Employee: RTI Health Solutions; Research Support: Merck

Sharp & Dohme Limited Haug, Cornelia ...................................... Disclosed no confl ict of interest. Haugen, Jessica ................................... Disclosed no confl ict of interest. Hauguel de-Mouzon, Sylvie ................. Disclosed no confl ict of interest. Hauptman, Jonathan ............................ Employee: Hoffman La Roche; Stock/Shareholder: Hoffmann-

LaRoche Haus, Jacob M. .................................... Disclosed no confl ict of interest. Hausding, Michael ............................... Disclosed no confl ict of interest. Hauser, Robert ...................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc. Havekes, Bas ........................................ Disclosed no confl ict of interest. Havel, Peter J. ...................................... Research Support: Novo Nordisk A/S, Takeda Pharmaceutical

Company, Ltd. Havelund, Svend .................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Haviland, Jo ......................................... Disclosed no confl ict of interest. Haw, Jeehea S. .................................... Disclosed no confl ict of interest. Haw, Sonya .......................................... Disclosed no confl ict of interest. Hawa, Mohammed I. ............................ Disclosed no confl ict of interest. Hawk, Gosia ......................................... Employee: Medco Health Solutions, Inc. Hawkes, Colin P. ................................... Disclosed no confl ict of interest. Hawkins, Matthew ............................... Disclosed no confl ict of interest. Hawkins, Meredith ............................... Disclosed no confl ict of interest. Hayashi, Shinu ..................................... Disclosed no confl ict of interest. Hayashi, Takeshi .................................. Disclosed no confl ict of interest. Hayashi, Tatsuya .................................. Disclosed no confl ict of interest. Hayashi, Tomoshige ............................. Disclosed no confl ict of interest. Hayashi, Yoshio .................................... Disclosed no confl ict of interest. Hayashino, Yasuaki .............................. Disclosed no confl ict of interest. Hayden, Melvin R. ................................ Disclosed no confl ict of interest. Hayden, Michael R. .............................. Disclosed no confl ict of interest. Hayes, Alan .......................................... Disclosed no confl ict of interest. Hayes, Benjamin .................................. Disclosed no confl ict of interest. Hayes, John M. .................................... Disclosed no confl ict of interest. Hayes, M. Geoffrey .............................. Disclosed no confl ict of interest. Haymond, Morey W. ............................ Advisory Panel: Daiichi-Sankyo, Inc., Novo Nordisk, Inc.;

Consultant: Daiichi-Sankyo, Inc.; Other Relationship: Bristol-Myers Squibb Company

Haythorne, Elizabeth A. ........................ Disclosed no confl ict of interest. Hayward, Anthea A. ............................ Disclosed no conflict of interest. Hayward, Rodney ................................. Disclosed no confl ict of interest. Hazarika, Suwagmani .......................... Disclosed no confl ict of interest.

Dow



A858


AU

THO

R D

ISCL

OSU

RE

Hazel-Fernandez, Leslie ....................... Research Support: Novo Nordisk, Inc. Hazlett, Linda J. ................................... Disclosed no confl ict of interest. Hazra, Sugata ....................................... Disclosed no confl ict of interest. He, Fengli ............................................. Disclosed no confl ict of interest. He, Ka ................................................... Disclosed no confl ict of interest. He, Rui .................................................. Disclosed no confl ict of interest. He, Shengqing ...................................... Disclosed no confl ict of interest. He, Sirong ............................................. Disclosed no confl ict of interest. He, Wei ................................................ Disclosed no confl ict of interest. He, Xiaoqing ......................................... Disclosed no confl ict of interest. He, Xiaoying ......................................... Disclosed no confl ict of interest. He, Zhiheng H. ...................................... Disclosed no confl ict of interest. He, Zhi-Min .......................................... Disclosed no confl ict of interest. Headland, Katie .................................... Disclosed no confl ict of interest. Headlee, Stacey ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Heales, Simon ...................................... Disclosed no confl ict of interest. Healey, Erin C. ...................................... Disclosed no confl ict of interest. Healy, Sara J. ....................................... Disclosed no confl ict of interest. Heard, Kevin ......................................... Disclosed no confl ict of interest. Hearon, Christopher ............................. Disclosed no confl ict of interest. Heath, Dennis D. .................................. Disclosed no confl ict of interest. Heather, Alison K. ................................ Disclosed no confl ict of interest. Heathman, Michael .............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Hebda-Szydło, Alicja ............................ Disclosed no confl ict of interest. Hebert, Alexander S. ............................ Disclosed no confl ict of interest. Hecht, Lior ............................................ Disclosed no confl ict of interest. Heckmann, Bradlee L. .......................... Disclosed no confl ict of interest. Hecquet, Carole .................................... Employee: Sanofi Hedbäck, Nora ...................................... Disclosed no confl ict of interest. Hedderson, Monique M. ...................... Disclosed no confl ict of interest. Hedrington, Maka S. ............................ Disclosed no confl ict of interest. Heerey, Adrienne M. ............................ Disclosed no confl ict of interest. Hehnke, Uwe ........................................ Employee: Boehringer Ingelheim GmbH & Co. KG Heianza, Yoriko ..................................... Disclosed no confl ict of interest. Heikkinen, Sami ................................... Disclosed no confl ict of interest. Heilbronn, Leonie ................................. Disclosed no confl ict of interest. Hein, Daniel .......................................... Employee: Sanofi Heine, Robert J. ................................... Board Member: Eli Lilly and Company Heinemann, Lutz ................................... Disclosed no confl ict of interest. Heinrichs, Martin ................................. Employee: Sanofi Heise, Julia .......................................... Disclosed no confl ict of interest. Heise, Tim ............................................. Advisory Panel: Boehringer Ingelheim GmbH & Co. KG, Novo

Nordisk A/S, Nycomed; Other Relationship: Boehringer Ingelheim GmbH & Co. KG, Novo Nordisk A/S; Research Support: Astellas Pharma US, Inc., Becton, Dickinson and Company, Biocon, Boehringer Ingelheim GmbH & Co. KG, Danse Pharmaceuticals, Eli Lilly and Company, Evolva, Hoffman La Roche, Johnson & Johnson, Lundbeck, Inc., Novo Nordisk A/S, Noxxon, Sanofi , SkyePharma; Speaker’s Bureau: Boehringer Ingelheim GmbH & Co. KG, Novo Nordisk A/S

Heiznza, Yoriko ..................................... Disclosed no confl ict of interest. Helbling, Nicole L. ................................ Disclosed no confl ict of interest. Helfand, Stephen L. .............................. Disclosed no confl ict of interest. Helgerson, Steven D. ........................... Disclosed no confl ict of interest. Hellara, Ilham ....................................... Disclosed no confl ict of interest. Hellbach, Katharina .............................. Disclosed no confl ict of interest. Heller, Simon R. .................................... Advisory Panel: Abbott Diabetes Care, Amylin Pharmaceuti-

cals, Inc., Eli Lilly and Company, Lifescan Animas, Inc., Novo Nordisk A/S; Speaker’s Bureau: Abbott Diabetes Care, Eli Lilly and Company, Lifescan Animas, Inc., Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi

Hellerstein, Marc ................................. Consultant: KineMed, Inc.; Stock/Shareholder: KineMed, Inc. Helmrath, Michael ............................... Disclosed no confl ict of interest. Hemmelgarn, Brenda R. ....................... Disclosed no confl ict of interest. Hempe, James ..................................... Disclosed no confl ict of interest. Hempler, Nana F. .................................. Other Relationship: Novo Nordisk A/S Henao-Tamayo, Marcela ...................... Disclosed no confl ict of interest. Hendel, Jakob W. ................................. Disclosed no confl ict of interest. Henderson, James ............................... Disclosed no confl ict of interest. Heneghan, Helen M. ............................ Disclosed no confl ict of interest. Heng, Khai K. ........................................ Disclosed no confl ict of interest. Hengesbach, Carina ............................. Disclosed no confl ict of interest. Heni, Martin ......................................... Disclosed no confl ict of interest. Henkel, Elena ....................................... Disclosed no confl ict of interest. Henkin, Leora ....................................... Disclosed no confl ict of interest. Hennecke, Nadine ................................ Disclosed no confl ict of interest. Hennige, Anita M. ................................ Disclosed no confl ict of interest. Hennink, Monique ................................ Disclosed no confl ict of interest. Henriksen, Erik J. ................................. Disclosed no confl ict of interest.

Henriksen, Kim ..................................... Employee: Nordic Bioscience A/S Henriksen, Rikke K. .............................. Disclosed no confl ict of interest. Henriques, Felipe S. ............................. Disclosed no confl ict of interest. Henry, Robert R. ................................... Advisory Panel: Amgen, Inc., Amylin Pharmaceuticals, Inc.,

AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech, Gilead Sciences, Inc., Intarcia Therapeutics, Inc., Johnson & Johnson, Merck, Novo Nordisk A/S, Roche Pharmaceuticals, Vivus, Inc.; Consul-tant: Amylin Pharmaceuticals, Inc., Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Genentech, Gilead Sciences, Inc., Intarcia Therapeutics, Inc., Isis Pharma-ceuticals, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi ; Research Support: Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Medtronics, Merck, Sanofi ; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company

Henschel, Angela M. ............................ Disclosed no confl ict of interest. Heo, Rok Won ...................................... Disclosed no confl ict of interest. Heptulla, Rubina A. .............................. Disclosed no confl ict of interest. Herder, Christian .................................. Disclosed no confl ict of interest. Herlache, Leah ..................................... Disclosed no confl ict of interest. Herlein, Judith A. ................................. Disclosed no confl ict of interest. Herman, M. A. ...................................... Disclosed no confl ict of interest. Herman, William H. .............................. Disclosed no confl ict of interest. Hermann, Dorota .................................. Disclosed no confl ict of interest. Hermanns, Norbert ............................... Advisory Panel: DAWN 2 International Publication Committe,

Global Diabetes Educator Advisory Board, Eli Lilly; Research Support: Berlin Chemie, E. Lilly Company, Roche Diagnostics; Speaker’s Bureau: Lifescan, Novo Nordisk Germany

Hermans, Michel P. .............................. Disclosed no confl ict of interest. Hermayer, Kathie L. .............................. Research Support: Novo Nordisk, Inc.; Speaker’s Bureau:

Amylin Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Sanofi

Hernández, Cristina .............................. Disclosed no confl ict of interest. Hernández, M. Teresa .......................... Disclosed no confl ict of interest. Hernandez, Manuel J. .......................... Consultant: Lifescan Animas, Inc., Novo Nordisk, Inc., Sanofi ;

Speaker’s Bureau: Novartis Pharmaceuticals Corporation, Roche Pharmaceuticals

Hernandez, Rosalba ............................. Disclosed no confl ict of interest. Hernandez, Teri L. ................................. Disclosed no confl ict of interest. Hernandez-Jimenez, Sergio ................. Disclosed no confl ict of interest. Hernando, M. Elena ............................. Disclosed no confl ict of interest. Herold, Kevan C. ................................... Disclosed no confl ict of interest. Heron, Kristin E. ................................... Disclosed no confl ict of interest. Herrada, Eva ......................................... Disclosed no confl ict of interest. Herrera, Felipe ...................................... Disclosed no confl ict of interest. Herrera, Pedro L. .................................. Disclosed no confl ict of interest. Herrera, Vivian ..................................... Employee: Medco Health Solutions, Inc. Herring, Roselle .................................... Disclosed no confl ict of interest. Herrington, David ................................. Disclosed no confl ict of interest. Herrmann, Kathrin ................................ Employee: Amylin Pharmaceuticals, LLC Hershey, Tamara ................................... Disclosed no confl ict of interest. Hershkop, Karen J. ............................... Disclosed no confl ict of interest. Hershon, Kenneth ................................. Research Support: Valeritas, LLC Hersko, Avram ...................................... Consultant: Oramed Pharmaceuticals Heruc, Gabriella ................................... Disclosed no confl ict of interest. Herz, Matthias ...................................... Employee: F. Hoffmann-La Roche, Ltd.; Stock/Shareholder: Eli

Lilly and Company, F. Hoffmann-La Roche, Ltd. Herzfeld de Wiza, Daniella .................. Disclosed no confl ict of interest. Herzog, Raimund I. ............................... Disclosed no confl ict of interest. Hess, Sibylle ......................................... Disclosed no confl ict of interest. Hesse, Deike ........................................ Disclosed no confl ict of interest. Hesselink, Matthijs K. .......................... Disclosed no confl ict of interest. Hessner, Martin J. ................................ Disclosed no confl ict of interest. Hester, James ...................................... Disclosed no confl ict of interest. Hetherington, Nicola ............................ Disclosed no confl ict of interest. Heywood, Matthew ............................. Disclosed no confl ict of interest. Heywood, Wendy ................................. Disclosed no confl ict of interest. Hickner, Robert ..................................... Disclosed no confl ict of interest. Hidalgo, Bertha .................................... Disclosed no confl ict of interest. Hidalgo, Mariana ................................. Disclosed no confl ict of interest. Hiden, Ursula ........................................ Disclosed no confl ict of interest. Higa, Mariko ......................................... Disclosed no confl ict of interest. Higa, Moritake ..................................... Disclosed no confl ict of interest. Higgins, LeeAnn ................................... Disclosed no confl ict of interest. Higgs, Suzanne ..................................... Disclosed no confl ict of interest. Highland, Heather M. ........................... Disclosed no confl ict of interest. Hightower, R.C. .................................... Disclosed no confl ict of interest.

Dow



A859


AU

THO

R D

ISCL

OSU

RE

Hikita, Yonezo ....................................... Disclosed no confl ict of interest. Hill, David J. ......................................... Disclosed no confl ict of interest. Hill, Martin ........................................... Disclosed no confl ict of interest. Hill, Nathan R. ...................................... Disclosed no confl ict of interest. Hillard, Mallory A. ................................ Disclosed no confl ict of interest. Hill-Briggs, Felicia ................................ Disclosed no confl ict of interest. Himeno, Tatsuhito ................................ Disclosed no confl ict of interest. Himmerick, Katherine ........................... Disclosed no confl ict of interest. Hinchey, Terri ........................................ Stock/Shareholder: Pfi zer, Inc. Hinchliffe, Robert ................................. Disclosed no confl ict of interest. Hinder, Lucy M. .................................... Disclosed no confl ict of interest. Hindmarsh, Peter C. ............................. Disclosed no confl ict of interest. Hinds, Alisha ........................................ Disclosed no confl ict of interest. Hing, Stephen ....................................... Disclosed no confl ict of interest. Hino, Hiroshi ......................................... Employee: Chugai Pharmaceutical Co., Ltd. Hinojosa, Juan ..................................... Disclosed no confl ict of interest. Hinshaw, Ling ....................................... Disclosed no confl ict of interest. Hiort, Line C. ......................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Hirabara, Sandro M. ............................. Disclosed no confl ict of interest. Hirai, Aizan ........................................... Disclosed no confl ict of interest. Hirai, Hiroyuki ....................................... Disclosed no confl ict of interest. Hirai, Keiji ............................................. Disclosed no confl ict of interest. Hiraishi, Kiichirou ................................. Disclosed no confl ict of interest. Hirama, Masayuki ................................ Disclosed no confl ict of interest. Hiramatsu, Mio .................................... Employee: Chugai Research Institute for Medical Science, Inc. Hiramatsu, Yuji ..................................... Disclosed no confl ict of interest. Hiramoto, Masaki ................................. Disclosed no confl ict of interest. Hirao, Mai ............................................ Disclosed no confl ict of interest. Hirata, Ayumu ...................................... Disclosed no confl ict of interest. Hiratsuka, Izumi .................................... Disclosed no confl ict of interest. Hire, Don .............................................. Disclosed no confl ict of interest. Hirning, Beth A. .................................... Disclosed no confl ict of interest. Hiromine, Yoshihisa ............................. Disclosed no confl ict of interest. Hirose, Hiroshi ...................................... Disclosed no confl ict of interest. Hirose, Kenzo ....................................... Disclosed no confl ict of interest. Hirose, Masakazu ................................. Disclosed no confl ict of interest. Hirose, Takahisa ................................... Disclosed no confl ict of interest. Hirsch, Jan D. ....................................... Disclosed no confl ict of interest. Hirsch, Laurence ................................... Employee: BD Medical Diabetes Care Hirschfi eld, Beth ................................... Disclosed no confl ict of interest. Hirschler, Valeria .................................. Disclosed no confl ict of interest. Hirshberg, Boaz .................................... Employee: AstraZeneca Pharmaceuticals LP, Bristol-Myers

Squibb Company Hirshman, Michael F. ........................... Disclosed no confl ict of interest. Hisatake, Shinji .................................... Disclosed no confl ict of interest. Hiss, K. ................................................. Employee: Sanofi Hitomi, Mamiko .................................... Disclosed no confl ict of interest. Hivert, Marie-France ............................ Disclosed no confl ict of interest. Hjelle, Lene .......................................... Disclosed no confl ict of interest. Hjorthaug, Karin ................................... Disclosed no confl ict of interest. Hjuler, Sara T. ....................................... Employee: Nordic Bioscience A/S Ho, George ........................................... Employee: Janssen Research & Development Ho, Janice S. ........................................ Disclosed no confl ict of interest. Ho, Joshua W. ...................................... Disclosed no confl ict of interest. Ho, Maggie M. ..................................... Disclosed no confl ict of interest. Hobbs, Connie ...................................... Disclosed no confl ict of interest. Hobizal, Kimberlee B. ........................... Disclosed no confl ict of interest. Hocher, Berthold ................................... Disclosed no confl ict of interest. Hochhaus, Andreas .............................. Consultant: Ariad, Bristol-Myers Squibb Company, Novartis

Pharmaceuticals Corporation, Pfi zer, Inc.; Other Relation-ship: Ariad, Bristol-Myers Squibb Company, Novartis Pharmaceuticals Corporation, Pfi zer, Inc.; Research Support: Ariad, Bristol-Myers Squibb Company, Novartis Pharmaceuticals Corporation, Pfi zer, Inc.

Hodges, James ..................................... Disclosed no confl ict of interest. Hodson, David J. .................................. Disclosed no confl ict of interest. Hoebaus, Clemens ............................... Disclosed no confl ict of interest. Hoeg-Jensen, Thomas ......................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Hoehn, Dana ......................................... Disclosed no confl ict of interest. Hoehn, Kyle L. ...................................... Disclosed no confl ict of interest. Hoekstra, Joost .................................... Disclosed no confl ict of interest. Hoeller, Evelyne .................................... Disclosed no confl ict of interest. Hoeyem, Pernille .................................. Disclosed no confl ict of interest. Hoffman, Duncan ................................. Disclosed no confl ict of interest. Hoffman, Michelle ............................... Disclosed no confl ict of interest. Hoffmann, Caren .................................. Disclosed no confl ict of interest. Hoffmann, Daniela ............................... Disclosed no confl ict of interest. Hoffmann, Jenny M. ............................ Disclosed no confl ict of interest. Hoffmann, Raymond ............................. Disclosed no confl ict of interest. Hoffmann, Sigrid .................................. Disclosed no confl ict of interest.

Hogan, Andrew .................................... Disclosed no confl ict of interest. Hogan, Patrick ...................................... Disclosed no confl ict of interest. Hogg-Cornejo, Veronica ....................... Disclosed no confl ict of interest. Hohenadel, Maximilian ........................ Disclosed no confl ict of interest. Højlund, Kurt ........................................ Disclosed no confl ict of interest. Hokanson, John E. ................................ Disclosed no confl ict of interest. Holak, Rita ............................................ Disclosed no confl ict of interest. Holewa, Danielle D. ............................. Employee: Metabolic Solutions Development Co. Holgado, Esther .................................... Disclosed no confl ict of interest. Höll, Bernhard ...................................... Disclosed no confl ict of interest. Holl, Katie ............................................. Disclosed no confl ict of interest. Holleman, Frits ..................................... Disclosed no confl ict of interest. Hollern, Douglas A. .............................. Disclosed no confl ict of interest. Hollister-Lock, Jennifer ........................ Disclosed no confl ict of interest. Holman, Dan ......................................... Disclosed no confl ict of interest. Holman, R.W. ....................................... Disclosed no confl ict of interest. Holman, Theodore ................................ Disclosed no confl ict of interest. Holmes, Andrew J. ............................... Disclosed no confl ict of interest. Holmes, Clarissa S. .............................. Disclosed no confl ict of interest. Holmes-Walker, Jane ........................... Speaker’s Bureau: Eli Lilly and Company, Medtronic Holness, Mark J. .................................. Disclosed no confl ict of interest. Holod, Silvia A. ..................................... Disclosed no confl ict of interest. Holst, Jens J. ....................................... Advisory Panel: Merck Sharp & Dohme Limited, Novartis

Pharmaceuticals Corporation, Novo Nordisk A/S, Roche Pharmaceuticals; Other Relationship: Merck Sharp & Dohme Limited, Novo Nordisk A/S; Speaker’s Bureau: GlaxoSmithKline, Merck Sharp & Dohme Limited, Novo Nordisk A/S

Holt, Richard I. ...................................... Advisory Panel: Novo Nordisk A/S; Research Support: Novo Nordisk A/S; Speaker’s Bureau: Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S, Otsuka Pharmaceutical Group, Sanofi

Homa, Katarzyna .................................. Disclosed no confl ict of interest. Home, Philip ......................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Bristol-Myers Squibb/AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Roche Diagnostics, Roche Pharmaceuticals, Sanofi , SkyePharma; Other Relationship: Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi ; Research Support: Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Novo Nordisk A/S, Roche Pharma-ceuticals, Sanofi

Homma, Thais K. .................................. Disclosed no confl ict of interest. Hommel, Eva E. .................................... Other Relationship: Novo Nordisk A/S Hompesch, Marcus .............................. Employee: Profi l Institute for Clinical Research, Inc.; Stock/

Shareholder: Profi l Institute for Clinical Research, Inc. Honda, Kiyofumi ................................... Employee: Chugai Pharmaceutical Co., Ltd. Hong, Eun Shil ...................................... Disclosed no confl ict of interest. Hong, Gregory K. .................................. Disclosed no confl ict of interest. Hong, Ho Cheol .................................... Disclosed no confl ict of interest. Hong, Hu S. .......................................... Disclosed no confl ict of interest. Hong, Jie .............................................. Disclosed no confl ict of interest. Hong, Jing ............................................ Disclosed no confl ict of interest. Hong, Kyeong Hee ................................ Disclosed no confl ict of interest. Hong, Mark I. ........................................ Disclosed no confl ict of interest. Hong, Oak-Kee ..................................... Disclosed no confl ict of interest. Hong, Sangmo ...................................... Disclosed no confl ict of interest. Hong, Seong Bin ................................... Disclosed no confl ict of interest. Hong, Shin Hee .................................... Disclosed no confl ict of interest. Hong, Su Min ....................................... Disclosed no confl ict of interest. Hong, Tianpei ....................................... Disclosed no confl ict of interest. Hong, Xuening ...................................... Employee: Merck Hong, Yu ............................................... Disclosed no confl ict of interest. Hong, Zhenzhen .................................... Disclosed no confl ict of interest. Honjo, Jun ............................................ Disclosed no confl ict of interest. Honjo, Sachiko ..................................... Disclosed no confl ict of interest. Hood, Megan M. .................................. Disclosed no confl ict of interest. Hood, Robert ........................................ Consultant: Eli Lilly and Company Hoogenboom, Wouter S. ...................... Disclosed no confl ict of interest. Hoogwerf, Byron J. .............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Hooshmand, Paria ................................ Disclosed no confl ict of interest. Hooshmand, Payam .............................. Disclosed no confl ict of interest. Hopkins, David ..................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Novo Nordisk A/S, Roche Pharmaceuticals; Research Sup-port: Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly and Company, Novo Nordisk A/S

Hopkins, Scarlett .................................. Disclosed no confl ict of interest. Hopper, Joseph .................................... Other Relationship: Pfi zer, Inc.

Dow



A860


AU

THO

R D

ISCL

OSU

RE

Hora, Israel ........................................... Disclosed no confl ict of interest. Hori, Kennichirou .................................. Disclosed no confl ict of interest. Horikawa, Chika ................................... Disclosed no confl ict of interest. Horikawa, Yukio ................................... Disclosed no confl ict of interest. Horikoshi, Momoko .............................. Disclosed no confl ict of interest. Horki, Vera ............................................ Disclosed no confl ict of interest. Horman, Keren ..................................... Employee: Integrity Applications, Ltd. Hornemann, Silke ................................. Disclosed no confl ict of interest. Horng, Mark ......................................... Employee: Bristol-Myers Squibb Company Hornum, Mads ...................................... Disclosed no confl ict of interest. Hornung, Lindsay .................................. Disclosed no confl ict of interest. Horowitz, Jeffrey F. .............................. Disclosed no confl ict of interest. Horowitz, Michael ................................ Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Meyer Nutraceuticals, Novartis Pharmaceuticals Corpora-tion, Novo Nordisk, Inc., Sanofi , Satiogen Pharmaceu-ticals, Inc.; Research Support: Eli Lilly and Company (Spouse/Partner), Merck (Spouse/Partner)

Horstmann, Annette ............................. Disclosed no confl ict of interest. Horswell, Ronald .................................. Disclosed no confl ict of interest. Horvath, Peter ...................................... Disclosed no confl ict of interest. Horvath, Tamas .................................... Disclosed no confl ict of interest. Hoshina, Sari ........................................ Disclosed no confl ict of interest. Hosking, Joanne ................................... Disclosed no confl ict of interest. Hosoi, Masayuki ................................... Disclosed no confl ict of interest. Hossain, M. Jobayer ............................ Disclosed no confl ict of interest. Hosseini-Araghi, Marzieh .................... Disclosed no confl ict of interest. Hotaling, Jim ........................................ Disclosed no confl ict of interest. Hou, Ningning ...................................... Disclosed no confl ict of interest. Hou, Weikai .......................................... Disclosed no confl ict of interest. Hou, Xiaoli S. ........................................ Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Hou, Xuhong ......................................... Disclosed no confl ict of interest. Houlbert, Dominique ............................ Disclosed no confl ict of interest. Houmard, Joseph A. ............................. Disclosed no confl ict of interest. Houser, Jordon ..................................... Disclosed no confl ict of interest. Houssay, Solange ................................. Disclosed no confl ict of interest. Hovorka, Roman ................................... Advisory Panel: Animas Corporation, Medtronic MiniMed,

Inc.; Consultant: B. Braun Melsungen AG, Becton, Dick-inson and Company, Profi l Institute for Clinical Research, Inc.; Other Relationship: B. Braun Melsungen AG, Becton, Dickinson and Company; Speaker’s Bureau: Lifescan Animas, Inc., Medtronic MiniMed, Inc., Novo Nordisk, Inc.

Howard, Barbara .................................. Disclosed no confl ict of interest. Howard, Campbell ................................ Employee: Novartis Pharmaceuticals Corporation; Stock/

Shareholder: Novartis Pharmaceuticals Corporation Howard, Gabrielle ................................ Disclosed no confl ict of interest. Howard, Neville ................................... Disclosed no confl ict of interest. Howell, Jonathan C. ............................. Disclosed no confl ict of interest. Howell, Mary E. .................................... Disclosed no confl ict of interest. Howell-Stampley, Temple .................... Disclosed no confl ict of interest. Høyem, Pernille H. ................................ Disclosed no confl ict of interest. Hrabe de Angelis, Martin ..................... Disclosed no confl ict of interest. Hresko, Richard C. ................................ Disclosed no confl ict of interest. Hristoskova, Sashka ............................. Employee: Novartis Pharma AG; Stock/Shareholder: Novartis Hruz, Paul W. ........................................ Disclosed no confl ict of interest. Hsia, Daniel S. ...................................... Disclosed no confl ict of interest. Hsia, Stanley H. .................................... Disclosed no confl ict of interest. Hsieh, Albert ........................................ Disclosed no confl ict of interest. Hsieh, An-Tsz ........................................ Consultant: Takeda Global Research & Development Center,

Inc. Hsieh, JuYi ........................................... Disclosed no confl ict of interest. Hsieh, Shiun Dong ................................ Disclosed no confl ict of interest. Hsieh, Wilson ....................................... Disclosed no confl ict of interest. Hsu, Chris ............................................. Disclosed no confl ict of interest. Hsu, Fang-Chi ....................................... Disclosed no confl ict of interest. Hsu, Jing-Fang ..................................... Disclosed no confl ict of interest. Hsueh, Willa ......................................... Research Support: Daiichi-Sankyo, Inc. Hu He, Kaihui ....................................... Disclosed no confl ict of interest. Hu, Changyun ....................................... Disclosed no confl ict of interest. Hu, Cheng ............................................. Disclosed no confl ict of interest. Hu, Dayi ................................................ Disclosed no confl ict of interest. Hu, Fang ............................................... Disclosed no confl ict of interest. Hu, Frank B. .......................................... Disclosed no confl ict of interest. Hu, Gang ............................................... Disclosed no confl ict of interest. Hu, Jiang .............................................. Disclosed no confl ict of interest. Hu, Li .................................................... Disclosed no confl ict of interest. Hu, Ming ............................................... Disclosed no confl ict of interest. Hu, Nan ................................................ Disclosed no confl ict of interest. Hu, Xiaodi ............................................. Disclosed no confl ict of interest. Hu, Xiaoke ............................................ Disclosed no confl ict of interest. Hu, Yinghua .......................................... Disclosed no confl ict of interest.

Hua, Yanyin .......................................... Disclosed no confl ict of interest. Hua, Yu ................................................. Disclosed no confl ict of interest. Huang, Carol ......................................... Disclosed no confl ict of interest. Huang, Cheng ....................................... Disclosed no confl ict of interest. Huang, Chien-Ning ............................... Disclosed no confl ict of interest. Huang, Elbert S. ................................... Disclosed no confl ict of interest. Huang, Gan ........................................... Disclosed no confl ict of interest. Huang, Hazel ........................................ Disclosed no confl ict of interest. Huang, Hu ............................................. Disclosed no confl ict of interest. Huang, Huan ......................................... Research Support: Takeda Global Research & Development

Center, Inc. Huang, Huibin ....................................... Disclosed no confl ict of interest. Huang, Jean ......................................... Disclosed no confl ict of interest. Huang, Jennifer L. ................................ Disclosed no conflict of interest. Huang, Joanna C. ................................. Employee: Novo Nordisk, Inc.; Stock/Shareholder: Novo

Nordisk, Inc. Huang, Ke ............................................. Disclosed no confl ict of interest. Huang, Luqiang .................................... Disclosed no confl ict of interest. Huang, Peiying ..................................... Disclosed no confl ict of interest. Huang, Qingxian ................................... Disclosed no confl ict of interest. Huang, Qi-Ya ........................................ Disclosed no confl ict of interest. Huang, Suiying ..................................... Employee: Medtronic Huang, Tian-Lian .................................. Disclosed no confl ict of interest. Huang, Wei .......................................... Disclosed no confl ict of interest. Huang, Wenying ................................... Employee: Amylin Pharmaceuticals, LLC Huang, Wenyu ...................................... Disclosed no confl ict of interest. Huang, Xu-Feng .................................... Disclosed no confl ict of interest. Huang, Yan ........................................... Disclosed no confl ict of interest. Huang, Yihe .......................................... Disclosed no confl ict of interest. Huang, Yueye ....................................... Disclosed no confl ict of interest. Huang, Zhimin ...................................... Disclosed no confl ict of interest. Huard, Luc ............................................ Disclosed no confl ict of interest. Hubálek, Franta .................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Hubbard, Maddy ................................... Disclosed no confl ict of interest. Hubbard, Rebecca A. ............................ Disclosed no confl ict of interest. Hubbell, Jeffrey A. ............................... Stock/Shareholder: Converge Biotech, Inc. Huber, Jordan ....................................... Disclosed no confl ict of interest. Huber, Tobias ........................................ Disclosed no confl ict of interest. Hübschle, Thomas ................................ Employee: Sanofi Huckfeldt, Peter J. ................................ Consultant: Sanofi Hudson, James I. .................................. Consultant: Genentech, Roche Pharmaceuticals, Shire; Re-

search Support: Eli Lilly and Company, Genentech, Shire Hudson, Margo S. ................................ Consultant: Genentech (Spouse/Partner), Roche Pharmaceu-

ticals (Spouse/Partner), Shire (Spouse/Partner); Research Support: Eli Lilly and Company (Spouse/Partner), Genen-tech (Spouse/Partner), Sanofi -Aventis, Shire (Spouse/Partner)

Huebschmann, Amy G. ......................... Research Support: Amylin Pharmaceuticals, Inc. Huet, Dominique .................................. Board Member: Novartis Pharmaceuticals Corporation, Novo

Nordisk A/S, Sanofi Hughes, Carroll W. ............................... Consultant: Naturally Slim Hughes, Katelyn ................................... Disclosed no confl ict of interest. Hughes, Kristen .................................... Research Support: Abbott Diabetes Care, Bayer Health Care,

LLC, Johnson & Johnson, Roche Pharmaceuticals Hughes, Michael E. .............................. Disclosed no confl ict of interest. Hughes, Nkecha ................................... Disclosed no confl ict of interest. Hughes, Stephen .................................. Disclosed no confl ict of interest. Hughes, Thomas A. .............................. Disclosed no confl ict of interest. Hughes, Timothy P. ............................... Consultant: Ariad, Bristol-Myers Squibb Company, Novartis

Pharmaceuticals Corporation; Other Relationship: Ariad, Bristol-Myers Squibb Company, Novartis Pharmaceuticals Corporation; Research Support: Bristol-Myers Squibb Company, CSL, Novartis Pharmaceuticals Corporation

Hughey, Curtis C. .................................. Disclosed no confl ict of interest. Hugtenburg, Jacqueline G. .................. Disclosed no confl ict of interest. Huh, Ji Hye ........................................... Disclosed no confl ict of interest. Huh, Jin Young ..................................... Disclosed no confl ict of interest. Huh, Joo Young .................................... Disclosed no confl ict of interest. Huh, Kyu Ha .......................................... Disclosed no confl ict of interest. Hui, Elaine ............................................ Disclosed no confl ict of interest. Hui, Vivien ............................................ Disclosed no confl ict of interest. Hui, Xe J. .............................................. Disclosed no confl ict of interest. Huie, Scott ............................................ Employee: Valeritas, LLC Huijberts, Maya .................................... Disclosed no confl ict of interest. Huizenga, Robert .................................. Consultant: “Biggest Loser” program Hujiya, Atsushi ..................................... Disclosed no confl ict of interest. Hull, Rebecca L. .................................... Research Support: Eli Lilly and Company, Merck Huma, Sadia ......................................... Disclosed no confl ict of interest. Humphries, Kenneth ............................. Disclosed no confl ict of interest. Hung, Adriana ...................................... Disclosed no confl ict of interest. Hung, Chi Sang ..................................... Disclosed no confl ict of interest.

Dow



A861


AU

THO

R D

ISCL

OSU

RE

Hunt, Kelly J. ........................................ Disclosed no confl ict of interest. Hunt, Kerry ........................................... Disclosed no confl ict of interest. Hunt, Nicholas H. ................................. Disclosed no confl ict of interest. Hunt, Sharon ........................................ Research Support: Sanofi US Hunter, Chad ......................................... Disclosed no confl ict of interest. Hunter, Steven ...................................... Disclosed no confl ict of interest. Huntgeburth, Michael .......................... Disclosed no confl ict of interest. Hur, Junguk .......................................... Disclosed no confl ict of interest. Hurtado del Pozo, Carmen .................... Disclosed no confl ict of interest. Hurtevent, Jean-François ..................... Disclosed no confl ict of interest. Hussain, Gauhar ................................... Disclosed no confl ict of interest. Hussein, Zanariah ................................ Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli Lilly and

Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S; Research Support: Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Merck Serono, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S

Hussey, Sophie E. ................................. Disclosed no confl ict of interest. Hussien, G. ........................................... Disclosed no confl ict of interest. Hutchinson, Charles E. ......................... Disclosed no confl ict of interest. Hutchinson, John ................................. Disclosed no confl ict of interest. Huth, Cornelia ...................................... Disclosed no confl ict of interest. Hutto, Amy ........................................... Disclosed no confl ict of interest. Hwa Ong, Siew .................................... Employee: Novartis Pharmaceuticals Corporation Hwang, Daniel H. ................................. Disclosed no confl ict of interest. Hwang, In Jae ...................................... Disclosed no confl ict of interest. Hwang, Inah ......................................... Disclosed no confl ict of interest. Hwang, Janice ..................................... Disclosed no confl ict of interest. Hwang, Jessica L. ................................ Disclosed no confl ict of interest. Hwang, Jong-Hee ................................ Disclosed no confl ict of interest. Hwang, Jongnam ................................. Disclosed no confl ict of interest. Hwang, Joo-Yeon ................................. Disclosed no confl ict of interest. Hwang, Wenke ..................................... Disclosed no confl ict of interest. Hwang, Won-Sun ................................. Disclosed no confl ict of interest. Hwang, You-Cheol ................................ Disclosed no confl ict of interest. Hwu, Chii-Min ...................................... Disclosed no confl ict of interest. Hyo, Takanori ........................................ Disclosed no confl ict of interest. Hyogo, Hideyuki ................................... Disclosed no confl ict of interest. Hyöty, Heikki ......................................... Board Member: Vactech Ltd; Stock/Shareholder: Vactech Ltd Hyrc, Krzysztof ...................................... Disclosed no confl ict of interest. Hyslop, Colin ........................................ Disclosed no confl ict of interest. Hyun, Mi Ri ........................................... Disclosed no confl ict of interest. Iacopi, Elisabetta .................................. Disclosed no confl ict of interest. Ianaro, Angela ...................................... Disclosed no confl ict of interest. Ibdah, Jamal ......................................... Disclosed no confl ict of interest. Ichibangase, Akira ................................ Disclosed no confl ict of interest. Ichihara, Kazuo ..................................... Disclosed no confl ict of interest. Ichii, Hirohito ........................................ Disclosed no confl ict of interest. Ichijo, Takamasa ................................... Disclosed no confl ict of interest. Ichimura, Yasuhiko ............................... Disclosed no confl ict of interest. Ida, Atsushi .......................................... Disclosed no confl ict of interest. Ide, Risa ................................................ Disclosed no confl ict of interest. Ido, Yasuo ............................................. Disclosed no confl ict of interest. Idorn, Thomas ....................................... Research Support: Novo Nordisk A/S Idris, Iskandar ....................................... Consultant: Eli Lilly and Company Idzior-Walus, Barbara ........................... Disclosed no confl ict of interest. Ievers-Landis, Carolyn E. ...................... Disclosed no confl ict of interest. Igata, Motoyuki .................................... Disclosed no confl ict of interest. Iglay, Kristy ........................................... Employee: Merck IglayReger, Heidi B. .............................. Disclosed no confl ict of interest. Ihm, Sung-Hee ...................................... Disclosed no confl ict of interest. Iida, Atsushi ......................................... Disclosed no confl ict of interest. Iida, Hitoshi .......................................... Disclosed no confl ict of interest. Iida, Kaoruko T. ..................................... Disclosed no confl ict of interest. Iida, Minoru .......................................... Disclosed no confl ict of interest. Iizuka, Katsumi ..................................... Disclosed no confl ict of interest. Ijzerman, Richard G. ............................. Disclosed no confl ict of interest. Ikayeva, Olga ........................................ Disclosed no confl ict of interest. Ikeda, Fuki ............................................ Disclosed no confl ict of interest. Ikeda, Hiroki ......................................... Disclosed no confl ict of interest. Ikeda, Mitsuru ...................................... Disclosed no confl ict of interest. Ikeda, Nayu .......................................... Disclosed no confl ict of interest. Ikeda, Sachiya ...................................... Disclosed no confl ict of interest. Ikeda, Shin-ichi ..................................... Disclosed no confl ict of interest. Ikeda, Takahide .................................... Disclosed no confl ict of interest. Ikeda, Yukio .......................................... Employee: Sanofi Ikegami, Hiroshi ................................... Disclosed no confl ict of interest. Ikonomov, Ognian ................................. Disclosed no confl ict of interest. Ikramuddin, Sayeed .............................. Disclosed no confl ict of interest. Ikura, Kazuki ......................................... Disclosed no confl ict of interest. Ikushima, Shigeki ................................. Disclosed no confl ict of interest.

Ikutani, Masashi ................................... Disclosed no confl ict of interest. Iliadis, Fotios ........................................ Disclosed no confl ict of interest. Ilias, Anissa .......................................... Disclosed no confl ict of interest. Il’in, Alexander ..................................... Disclosed no confl ict of interest. Iloeje, Uchenna H. ................................ Employee: Bristol-Myers Squibb/AstraZeneca Im, Hae Kyung ...................................... Disclosed no confl ict of interest. Imagawa, Akihisa ................................. Disclosed no confl ict of interest. Imai, Taku ............................................. Disclosed no confl ict of interest. Imai, Tamaki ......................................... Disclosed no confl ict of interest. Imai, Yumi ............................................. Disclosed no confl ict of interest. Imam, Shahnawaz ................................ Disclosed no confl ict of interest. Imamura, Minako ................................. Disclosed no confl ict of interest. Imamura, Satoshi ................................. Disclosed no confl ict of interest. Imamura, Shigeki ................................. Disclosed no confl ict of interest. Imamura, Takeshi ................................. Disclosed no confl ict of interest. Imershein, Sarah G. .............................. Disclosed no confl ict of interest. Imeryuz, Nese ....................................... Disclosed no confl ict of interest. Imhoff, Olivier ....................................... Disclosed no confl ict of interest. Imperatore, Giuseppina ........................ Disclosed no confl ict of interest. Imrie, Helen .......................................... Disclosed no confl ict of interest. Inaba, Masaaki ..................................... Disclosed no confl ict of interest. Inaba, Wataru ...................................... Disclosed no confl ict of interest. Inagaki, Akemi ...................................... Disclosed no confl ict of interest. Inagaki, Nobuya ................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals,

Inc., Chugai Pharmaceutical Co., Ltd., Taisho, Tanabe-Mitsubishi; Research Support: Astellas Pharma US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Chugai Pharmaceutical Co., Ltd., Tanabe-Mitsubishi; Speaker’s Bureau: Astellas Pharma US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Tanabe-Mitsubishi

Incalza, Maria Angela .......................... Disclosed no confl ict of interest. Infanti, Jennifer J. ................................ Disclosed no confl ict of interest. Ingelgård, Anders ................................. Employee: AstraZeneca Pharmaceuticals LP; Stock/Share-

holder: AstraZeneca Pharmaceuticals LP Ingelsson, Erik ...................................... Disclosed no confl ict of interest. Ingenwerth, Marc ................................. Disclosed no confl ict of interest. Ingersoll, Karen .................................... Disclosed no confl ict of interest. Inguva, Anagha .................................... Disclosed no confl ict of interest. Innes, Kim E. ......................................... Disclosed no confl ict of interest. Inomata, Shigeki .................................. Disclosed no confl ict of interest. Inoue, Hideaki ...................................... Disclosed no confl ict of interest. Inoue, Kanako ....................................... Disclosed no confl ict of interest. Inoue, Noboru ....................................... Disclosed no confl ict of interest. Inoue, Satoshi ...................................... Disclosed no confl ict of interest. Inoue, Yuichiro ...................................... Disclosed no confl ict of interest. Inukai, Kouichi ...................................... Disclosed no confl ict of interest. Inukai, Toshihiko ................................... Disclosed no confl ict of interest. Inverardi, Luca ...................................... Board Member: Converge Biotech, Inc., Ophysio; Research

Support: Pfi zer, Inc.; Stock/Shareholder: Converge Biotech, Inc., Ophysio

Inversini, Chiara ................................... Disclosed no confl ict of interest. Inzucchi, Silvio E. .................................. Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Jans-

sen Pharmaceuticals, Merck, Takeda Pharmaceuticals U.S.A., Inc.

Ioannidis, Ioannis ................................. Disclosed no confl ict of interest. Ionescu-Ittu,, Raluca ............................ Research Support: Takeda Pharmaceutical Company, Ltd. Ionut, Viorica ........................................ Research Support: Amylin Pharmaceuticals, Inc. Iorio, Barbara ........................................ Disclosed no confl ict of interest. Iovino, Salvatore .................................. Disclosed no confl ict of interest. Iozzio, Jesse ......................................... Disclosed no confl ict of interest. Ip, Edward ............................................ Disclosed no confl ict of interest. Ip, Wilfred ............................................ Disclosed no confl ict of interest. Ippoliti, Arnaldo .................................... Disclosed no confl ict of interest. Iqbal, Ahmed ........................................ Disclosed no confl ict of interest. Iqbal, Nayyar ........................................ Employee: Bristol-Myers Squibb Company; Stock/Shareholder:

Bristol-Myers Squibb Company Iriarte, Jorge ......................................... Disclosed no confl ict of interest. Irie, Fujiko ............................................. Disclosed no confl ict of interest. Irie, Junichiro ....................................... Disclosed no confl ict of interest. Irino, Ken .............................................. Disclosed no confl ict of interest. Irmler, Martin ....................................... Disclosed no confl ict of interest. Irvin, Marguerite Ryan ......................... Disclosed no confl ict of interest. Isganaitis, Elvira M. ............................. Disclosed no confl ict of interest. Ishani, Areef ......................................... Disclosed no confl ict of interest. Ishibashi, Shun ..................................... Disclosed no confl ict of interest. Ishibashi, Tatsuya ................................. Disclosed no confl ict of interest. Ishida, Hitoshi ...................................... Disclosed no confl ict of interest. Ishida, Yuko .......................................... Disclosed no confl ict of interest. Ishiguro, Kimiko .................................... Disclosed no confl ict of interest. Ishihara, Hisamitsu .............................. Advisory Panel: Ajinomoto Group; Consultant: Sanofi ;

Research Support: Boehringer Ingelheim GmbH & Co. KG, Daiichi-Sankyo, Inc., Dainippon Sumitomo Pharma Co.,

Dow



A862


AU

THO

R D

ISCL

OSU

RE

Ltd., Eli Lilly and Company, Mitsubishi Tanabe Pharmaceu-tical Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Banyu Pharmaceutical Co., Ltd., Boehringer Ingelheim GmbH & Co. KG, Mitsubishi Tanabe Pharmaceutical Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi

Ishii, Hitoshi ......................................... Disclosed no confl ict of interest. Ishii, Isao .............................................. Disclosed no confl ict of interest. Ishikado, Atsushi .................................. Disclosed no confl ict of interest. Ishikawa, Kenji ..................................... Disclosed no confl ict of interest. Ishikawa, Ko ......................................... Disclosed no confl ict of interest. Ishikawa, Kouta .................................... Disclosed no confl ict of interest. Ishimaru, Naozumi ............................... Disclosed no confl ict of interest. Ishino, Tetsuya ..................................... Employee: Pfi zer, Inc. Ishizaka, Yuko ....................................... Disclosed no confl ict of interest. Ishizaki, Masao .................................... Disclosed no confl ict of interest. Ishizawa, Keisuke ................................. Disclosed no confl ict of interest. Ishizawa, Masahiro .............................. Disclosed no confl ict of interest. Ishizawa, Sho ....................................... Disclosed no confl ict of interest. Ishizeki, Kanaki ..................................... Disclosed no confl ict of interest. Ishizuka, Naoki ..................................... Disclosed no confl ict of interest. Ishizuka, Tatsuo .................................... Disclosed no confl ict of interest. Ismail-Beigi, Faramarz E. ..................... Consultant: Novo Nordisk, Inc.; Research Support: Novo

Nordisk, Inc.; Stock/Shareholder: Thermalin Diabetes, LLCIsobe, Ken-ichi ...................................... Disclosed no confl ict of interest. Isom, Scott P. ........................................ Disclosed no confl ict of interest. Isshiki, Keiji .......................................... Disclosed no confl ict of interest. Itaya-Hironaka, Asako .......................... Disclosed no confl ict of interest. Ito, Hideki ............................................. Disclosed no confl ict of interest. Ito, Sachiko ........................................... Disclosed no confl ict of interest. Ito, Tomoko ........................................... Disclosed no confl ict of interest. Itoh, Arata ............................................ Disclosed no confl ict of interest. Itoh, Hiroshi .......................................... Disclosed no confl ict of interest. Itoh, Mitsuyasu .................................... Disclosed no confl ict of interest. Iuchi, Hiroyuki ....................................... Disclosed no confl ict of interest. Ivanova, Jasmina ................................. Disclosed no confl ict of interest. Ivey, Rasheed ....................................... Disclosed no confl ict of interest. Ivie, Elizabeth ....................................... Research Support: Sanofi Ivovic, Alexander .................................. Disclosed no confl ict of interest. Iwabu, Masato ..................................... Disclosed no confl ict of interest. Iwabu, Miki O. ...................................... Disclosed no confl ict of interest. Iwai, Rie ............................................... Disclosed no confl ict of interest. Iwamoto, Taku ...................................... Disclosed no confl ict of interest. Iwane, Aya ........................................... Disclosed no confl ict of interest. Iwano, Masayuki .................................. Disclosed no confl ict of interest. Iwasaki, Hideaki ................................... Disclosed no confl ict of interest. Iwasaki, Hirotaka ................................. Disclosed no confl ict of interest. Iwasaki, Masahiro ................................ Disclosed no confl ict of interest. Iwasaki, Naoko ..................................... Disclosed no confl ict of interest. Iwasaki, Yasuo ..................................... Disclosed no confl ict of interest. Iwata, Minoru ....................................... Disclosed no confl ict of interest. Ix, Joachim ........................................... Disclosed no confl ict of interest. Iyer, Dinakar ......................................... Disclosed no confl ict of interest. Iyer, Malini S. ....................................... Disclosed no confl ict of interest. Iyer, Shridhar ........................................ Disclosed no confl ict of interest. Izaola, Olatz .......................................... Disclosed no confl ict of interest. Izawa, Shoichiro ................................... Disclosed no confl ict of interest. Izumi, Kazuo ......................................... Disclosed no confl ict of interest. Izumi, Kenichi ....................................... Disclosed no confl ict of interest. Izumoto, Takako .................................... Disclosed no confl ict of interest. Izuora, Kenneth .................................... Research Support: NIH, Sanofi Jaacks, Lindsay M. ............................... Disclosed no confl ict of interest. Jabbour, Serge ..................................... Consultant: Amylin Pharmaceuticals, Inc., AstraZeneca

Pharmaceuticals LP, Bristol-Myers Squibb Company Jaber, Yaya ........................................... Disclosed no confl ict of interest. Jackman, Matthew .............................. Disclosed no confl ict of interest. Jackman, Michelle ............................... Stock/Shareholder: GlaxoSmithKline Jackson, Chandra L. ............................. Disclosed no confl ict of interest. Jackson, Jeffrey A. .............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Jackson, Leila W. ................................. Research Support: Case Western Reserve University Jackson, Marilyn .................................. Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc. Jackson, Nicola .................................... Disclosed no confl ict of interest. Jackson, Penny ..................................... Disclosed no confl ict of interest. Jackson, Richard A. .............................. Disclosed no confl ict of interest. Jackson, Sandra L. ............................... Disclosed no confl ict of interest. Jacob, Howard ..................................... Disclosed no confl ict of interest. Jacob, Robert F. .................................... Disclosed no confl ict of interest. Jacober, Scott J. .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Jacobs, David R. ................................... Disclosed no confl ict of interest.

Jacobs, Peter G. ................................... Disclosed no confl ict of interest. Jacobs, Sol ........................................... Disclosed no confl ict of interest. Jacobsen, Siv H. ................................... Disclosed no confl ict of interest. Jacobsen, Steven J. ............................. Disclosed no confl ict of interest. Jacobson, Alan M. ............................... Advisory Panel: Novo Nordisk, Inc. Jacobson, David A. .............................. Disclosed no confl ict of interest. Jacoby, Monique .................................. Disclosed no confl ict of interest. Jacovetti, Cécile ................................... Disclosed no confl ict of interest. Jacquier, Jennifer ................................ Disclosed no confl ict of interest. Jadhav, Ajit .......................................... Disclosed no confl ict of interest. Jaeckle Santos, Lane ........................... Disclosed no confl ict of interest. Jaen, Juan ............................................ Employee: ChemoCentryx; Stock/Shareholder: Chemo-

Centryx Jaffe, Anat ........................................... Disclosed no confl ict of interest. Jäger, Christina .................................... Disclosed no confl ict of interest. Jagielski, Alison C. ............................... Disclosed no confl ict of interest. Jahn, Linda A. ...................................... Disclosed no confl ict of interest. Jain, Abhinav ....................................... Disclosed no confl ict of interest. Jain, Asha ............................................ Disclosed no confl ict of interest. Jain, Maneesh ..................................... Disclosed no confl ict of interest. Jain, Summit ........................................ Disclosed no confl ict of interest. Jain, Sushil K. ...................................... Disclosed no confl ict of interest. Jaishy, Bharat ....................................... Disclosed no confl ict of interest. Jaiswal, Mamta ................................... Disclosed no confl ict of interest. Jakaitis, Daniel .................................... Disclosed no confl ict of interest. Jakoby, Michael G. ............................... Speaker’s Bureau: Merck, Sanofi Jakubowicz, Daniela ............................ Disclosed no confl ict of interest. Jalal, Diana .......................................... Disclosed no confl ict of interest. Jalou, Hasnaa ...................................... Disclosed no confl ict of interest. James, David ........................................ Disclosed no confl ict of interest. James, Freyja D. ................................... Disclosed no confl ict of interest. James, Sean ......................................... Disclosed no confl ict of interest. James, Tim J. ....................................... Disclosed no confl ict of interest. Jameson, Stephanie ............................ Disclosed no confl ict of interest. James-Todd, Tamarra ........................... Disclosed no confl ict of interest. Jamnik, Veronica .................................. Disclosed no confl ict of interest. Jan, Asad ............................................. Disclosed no confl ict of interest. Janardanan, Jyothi .............................. Disclosed no confl ict of interest. Janas, Izabela ...................................... Disclosed no confl ict of interest. Janas, John .......................................... Disclosed no confl ict of interest. Jancsik, Veronika Á. ............................. Disclosed no confl ict of interest. Janez, Andrej ....................................... Disclosed no confl ict of interest. Jang, Eun-Hee ...................................... Disclosed no confl ict of interest. Jang, Hak Chul ..................................... Disclosed no confl ict of interest. Jang, Hyun-Ju ...................................... Disclosed no confl ict of interest. Jang, Jin Young .................................... Disclosed no confl ict of interest. Jankovec, Zdenek ................................. Disclosed no confl ict of interest. Jankowiak, Frank ................................. Disclosed no confl ict of interest. Janmey, Paul A. .................................... Disclosed no confl ict of interest. Jansen, Danielle .................................. Disclosed no confl ict of interest. Jansen, Rachel ..................................... Disclosed no confl ict of interest. Janssen, Ann ........................................ Employee: Pfi zer, Inc. Janssen, Rachel C. ............................... Disclosed no confl ict of interest. Jansson, Leif ........................................ Disclosed no confl ict of interest. Jansson, Per-Anders ............................ Disclosed no confl ict of interest. Januszewicz, Andrzej ........................... Research Support: Janssen Research & Development Janz, Kathleen ...................................... Disclosed no confl ict of interest. Jaschke, Alexander .............................. Disclosed no confl ict of interest. Jaser, Sarah ......................................... Disclosed no confl ict of interest. Jasien, Christine .................................. Disclosed no confl ict of interest. Jastreboff, Ania M. .............................. Disclosed no confl ict of interest. Jaume, Juan ......................................... Disclosed no confl ict of interest. Javed, Amjad ....................................... Disclosed no confl ict of interest. Javlekar, Ashwini ................................. Disclosed no confl ict of interest. Jawerbaum, Alicia ............................... Disclosed no confl ict of interest. Jax, Thomas ......................................... Disclosed no confl ict of interest. Jayatillake, Harsha .............................. Disclosed no confl ict of interest. Jefferson, Leonard S. ........................... Disclosed no confl ict of interest. Jeffery, Alison N. ................................. Disclosed no confl ict of interest. Jelaska, Ante ....................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Jelenik, Tomas ..................................... Disclosed no confl ict of interest. Jenkins, Alicia J. .................................. Disclosed no confl ict of interest. Jenkins-Jones, Sara ............................. Consultant: Abbott Laboratories, Inc., Bristol-Myers Squibb

Company, Novo Nordisk A/S Jennings, Aaron ................................... Disclosed no confl ict of interest. Jensen, David H. .................................. Disclosed no confl ict of interest. Jensen, Henrik H. ................................. Consultant: Novo Nordisk A/S Jensen, Klaus H. .................................. Employee: Novo Nordisk A/S, Novo Nordisk, Inc. (Spouse/

Partner); Stock/Shareholder: Novo Nordisk A/S, Novo Nordisk A/S (Spouse/Partner)

Jensen, Lene ........................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo Nordisk A/S

Dow



A863


AU

THO

R D

ISCL

OSU

RE

Jensen, Michael D. .............................. Disclosed no confl ict of interest. Jensen, Troels M. ................................. Other Relationship: Novo Nordisk A/S; Stock/Shareholder:

Novo Norkisk A/S Jensen, Ulrich S. .................................. Disclosed no confl ict of interest. Jensterle, Mojca .................................. Disclosed no confl ict of interest. Jenum, Anne K. .................................... Disclosed no confl ict of interest. Jeon, Byeong Tak ................................. Disclosed no confl ict of interest. Jeon, Eun-kyoung ................................. Disclosed no confl ict of interest. Jeon, Hyun Jeong ................................ Disclosed no confl ict of interest. Jeon, Ja Young ..................................... Disclosed no confl ict of interest. Jeon, Jae Han ...................................... Disclosed no confl ict of interest. Jeon, Jeong Yong ................................. Disclosed no confl ict of interest. Jeon, Jongmin ...................................... Disclosed no confl ict of interest. Jeon, Justin Y. ...................................... Disclosed no confl ict of interest. Jeon, Sangchoon .................................. Disclosed no confl ict of interest. Jeon, Sungwaan .................................. Disclosed no confl ict of interest. Jeon, Yun Kyung ................................... Disclosed no confl ict of interest. Jeong, In-Kyung ................................... Disclosed no confl ict of interest. Jeong, Jackson .................................... Disclosed no confl ict of interest. Jeong, Ji Yun ........................................ Disclosed no confl ict of interest. Jeoung, Nam Ho .................................. Disclosed no confl ict of interest. Jermendy, Adam L. ............................... Disclosed no confl ict of interest. Jermendy, György ................................. Disclosed no confl ict of interest. Jerome, Gerald ..................................... Disclosed no confl ict of interest. Jerums, George .................................... Disclosed no confl ict of interest. Jessen, Niels ........................................ Disclosed no confl ict of interest. Jeter-Jones, Sabrina ............................ Employee: Lexicon Pharmaceuticals, Inc. Jethi, Krishan G. ................................... Disclosed no confl ict of interest. Jetton, Thomas .................................... Disclosed no confl ict of interest. Jeziorsky, Michael C. ........................... Disclosed no confl ict of interest. Jhala, Gaurang ..................................... Disclosed no confl ict of interest. Jhummon, Navina P. ............................. Disclosed no confl ict of interest. Ji, Linong .............................................. Advisory Panel: Bristol-Myers Squibb/AstraZeneca; Con-

sultant: Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, GlaxoSmithKline, Guangzhou Zhongyi Pharmaceutical, Johnson & Johnson, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi , Takeda Pharmaceutical Company, Ltd.

Ji, Qiuhe ............................................... Consultant: Takeda Global Research & Development Center, Inc.

Ji, Wang Y. ........................................... Disclosed no confl ict of interest. Ji, Yang H. ............................................ Disclosed no confl ict of interest. Jia, Shuang .......................................... Disclosed no confl ict of interest. Jia, Wei ................................................ Disclosed no confl ict of interest. Jia, Weiping ......................................... Disclosed no confl ict of interest. Jia, Wen-Jung ...................................... Disclosed no confl ict of interest. Jialal, Ishwarlal .................................... Disclosed no confl ict of interest. Jianchang, Chi ...................................... Disclosed no confl ict of interest. Jian-Cong, Lin ...................................... Disclosed no confl ict of interest. Jiang, Chunlei ...................................... Disclosed no confl ict of interest. Jiang, Guozhi ........................................ Disclosed no confl ict of interest. Jiang, Jenny ......................................... Disclosed no confl ict of interest. Jiang, Joel ............................................ Employee: Janssen Research & Development Jiang, John ........................................... Disclosed no confl ict of interest. Jiang, Lin .............................................. Disclosed no confl ict of interest. Jiang, Lu-Lin ......................................... Disclosed no confl ict of interest. Jiang, Mao ........................................... Disclosed no confl ict of interest. Jiang, Wei ............................................ Disclosed no confl ict of interest. Jiang, Wenyu ....................................... Disclosed no confl ict of interest. Jiang, Xia ............................................. Disclosed no confl ict of interest. Jiang, Xiaoting ..................................... Disclosed no confl ict of interest. Jiang, Xiaowan .................................... Disclosed no confl ict of interest. Jiang, Yawen ........................................ Disclosed no confl ict of interest. Jiang, Yayun ......................................... Disclosed no confl ict of interest. Jiang, Zhaoshun ................................... Disclosed no confl ict of interest. Jianming, Ba ........................................ Disclosed no confl ict of interest. Jian-Qiang, Feng .................................. Disclosed no confl ict of interest. Jianwen, Cai ........................................ Disclosed no confl ict of interest. Jiao, Hongxiao ..................................... Disclosed no confl ict of interest. Jie, Zhuye ............................................. Disclosed no confl ict of interest. Jiménez Pineda, Amanda ..................... Disclosed no confl ict of interest. Jimenez-Corona, Aida .......................... Disclosed no confl ict of interest. Jimenez-Corona, Leonardo .................. Disclosed no confl ict of interest. Jimenez-Corona, Maria E. .................... Disclosed no confl ict of interest. Jimenez-Moreno, Carmen M. .............. Disclosed no confl ict of interest. Jimeno, Cecilia A. ................................ Disclosed no confl ict of interest. Jin, Heung Yong ................................... Disclosed no confl ict of interest. Jin, Jin .................................................. Employee: Allergan, Inc. Jin, Junfei ............................................ Disclosed no confl ict of interest. Jin, Litai ................................................ Disclosed no confl ict of interest. Jin, Ping ................................................ Disclosed no confl ict of interest.

Jin, Tianru ............................................. Disclosed no confl ict of interest. Jin, Xi ................................................... Disclosed no confl ict of interest. Jin, Ying ............................................... Disclosed no confl ict of interest. Jin, Zhu-Qiu .......................................... Disclosed no confl ict of interest. Jing, Enxuan ......................................... Disclosed no confl ict of interest. jingtao, Dou .......................................... Disclosed no confl ict of interest. Jinka, Madhavi ..................................... Disclosed no confl ict of interest. Jiroutek, Michael ................................. Disclosed no confl ict of interest. Jishage, Kou-ichi .................................. Employee: Chugai Pharmaceutical Co., Ltd. Jo, Dong Hyeuk .................................... Disclosed no confl ict of interest. Jo, Emmanuel ....................................... Disclosed no confl ict of interest. Jo, Jaemin ............................................ Disclosed no confl ict of interest. Joannides, Christos N. ......................... Disclosed no confl ict of interest. Jocken, Johan ...................................... Disclosed no confl ict of interest. Jodar, Esteban ...................................... Advisory Panel: Novo Nordisk, Inc., Bristol-Myers Squibb,

FAES; Research Support: Novo Nordisk, Inc., Eli Lilly and Company, Boehringer Ingelheim Pharmaceuticals, Inc., MSD, Janssen; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk, Inc., MSD

Joens, Matthew ................................... Disclosed no confl ict of interest. Joensen, Lene E. .................................. Other Relationship: Novo Nordisk A/S Joergensen, Sine W. ............................ Disclosed no confl ict of interest. Joglekar, Mugdha V. ............................. Disclosed no confl ict of interest. Joh, Takashi ......................................... Disclosed no confl ict of interest. Johannsen, Darcy L. ............................. Disclosed no confl ict of interest. Johansen, Clea B. ................................ Other Relationship: Novo Nordisk A/S Johansen, Nanna B. ............................. Employee: Steno Diabetes Center; Stock/Shareholder: Novo

Nordisk A/S Johansen, Odd Erik .............................. Employee: Boehringer Ingelheim GmbH & Co. KG Johansen, Pierre .................................. Consultant: Janssen; Research Support: Janssen Johansen, Rakel F. ................................ Disclosed no confl ict of interest. Johansen, Thue .................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Johansson, Rolf .................................... Disclosed no confl ict of interest. John, Priya M. ...................................... Disclosed no confl ict of interest. Johnson, Cathryn ................................. Disclosed no confl ict of interest. Johnson, Geoffrey ................................ Disclosed no confl ict of interest. Johnson, Ginger ................................... Disclosed no confl ict of interest. Johnson, James D. ............................... Research Support: Novo Nordisk A/SJohnson, Jeffrey A. .............................. Disclosed no confl ict of interest. Johnson, Jolene ................................... Disclosed no confl ict of interest. Johnson, Joshua A. .............................. Disclosed no confl ict of interest. Johnson, Justin S. ................................ Disclosed no confl ict of interest. Johnson, Mary L. .................................. Research Support: Calibra, Eli Lilly and Company, NIH, Novo

Nordisk, Inc., Roche Pharmaceuticals, Sanofi Johnson, Matthew E. ........................... Disclosed no confl ict of interest. Johnson, Matthew L. ........................... Disclosed no confl ict of interest. Johnson, Megan S. .............................. Disclosed no confl ict of interest. Johnson, Nicole ................................... Disclosed no confl ict of interest. Johnson, Patria .................................... Disclosed no confl ict of interest. Johnson, Patricia .................................. Disclosed no confl ict of interest. Johnson, Paul E. ................................... Disclosed no confl ict of interest. Johnson, Paul R. ................................... Disclosed no confl ict of interest. Johnson, Richard .................................. Disclosed no confl ict of interest. Johnson, Susan L. ................................ Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

Kline Johnsson, Eva ...................................... Employee: AstraZeneca Pharmaceuticals LP Johnston, Luke W. ................................ Disclosed no confl ict of interest. Johnston, Peter .................................... Employee: Sanofi Johnstone, Bryan ................................. Employee: Sanofi US, Inc. Jolly, Stacey ......................................... Disclosed no confl ict of interest. Joly, Erik ............................................... Disclosed no confl ict of interest. Jonassen, Ib ......................................... Employee: Novo Nordisk A/S Jonassen, Thomas ............................... Disclosed no confl ict of interest. Jones, Angus G. ................................... Disclosed no confl ict of interest. Jones, Barton ....................................... Disclosed no confl ict of interest. Jones, Elizabeth ................................... Disclosed no confl ict of interest. Jones, John G. ..................................... Disclosed no confl ict of interest. Jones, Karen L. ..................................... Advisory Panel: AstraZeneca Pharmaceuticals LP (Spouse/

Partner), Boehringer Ingelheim Pharmaceuticals, Inc. (Spouse/Partner), Eli Lilly and Company (Spouse/Partner), Meyer Nutraceuticals (Spouse/Partner), Novartis Phar-maceuticals Corporation (Spouse/Partner), Novo Nordisk, Inc. (Spouse/Partner), Sanofi (Spouse/Partner), Satiogen Pharmaceuticals, Inc. (Spouse/Partner); Research Support: Eli Lilly and Company, Merck

Jones, Lisa M. ...................................... Disclosed no confl ict of interest. Jones, Marie ........................................ Disclosed no confl ict of interest. Jones, Michael R. ................................ Employee: Daiichi-Sankyo, Inc. Jones, Richard ...................................... Disclosed no confl ict of interest. Jones, Robert ....................................... Disclosed no confl ict of interest. Jones, Russell ...................................... Employee: Boehringer Ingelheim UK Ltd

Dow



A864


AU

THO

R D

ISCL

OSU

RE

Jones, Simon ........................................ Disclosed no confl ict of interest. Jones, Terence A. ................................. Disclosed no confl ict of interest. Jones, Timothy W. ................................ Speaker’s Bureau: Eli Lilly and Company, Medtronic, Novo

Nordisk, Inc., sanofi -aventis Jones-Leone, Angela R. ....................... Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

Kline Joo, Erina ............................................. Disclosed no confl ict of interest. Joost, Hans-Georg ............................... Disclosed no confl ict of interest. Jordan, Jens ......................................... Disclosed no confl ict of interest. Jordan, Kevin ....................................... Disclosed no confl ict of interest. Jorgensen, Jens O. .............................. Disclosed no confl ict of interest. Jørgensen, John B. .............................. Disclosed no confl ict of interest. Jørgensen, Marit E. .............................. Employee: Steno Diabetes Center; Stock/Shareholder: Novo

Nordisk A/S Jorgensen, Nils B. ................................ Disclosed no confl ict of interest. Jørgensen, Sine ................................... Disclosed no confl ict of interest. Jorgensen, William .............................. Disclosed no confl ict of interest. Jornayvaz, Francois R. .......................... Disclosed no confl ict of interest. Jörneskog, Gun .................................... Disclosed no confl ict of interest. Joseph, Stonny E. ................................. Disclosed no confl ict of interest. Joseraj, Mg .......................................... Disclosed no confl ict of interest. Joshi, Shashank R. ............................... Disclosed no confl ict of interest. Joshipura, Kaumudi ............................. Disclosed no confl ict of interest. Jothydev, Sunitha ................................. Disclosed no confl ict of interest. Joubert, Michael .................................. Disclosed no confl ict of interest. Jourdan, Tony ....................................... Disclosed no confl ict of interest. Jovanovic, Lois ..................................... Advisory Panel: Eli Lilly and Company, Insulet Corporation,

Lifescan Animas, Inc.; Consultant: Disetronic Medical Systems; Research Support: Dexcom, Inc., Eli Lilly and Company, Lifescan Animas, Inc.; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk A/S

Jovanovska, Biljana ............................. Disclosed no confl ict of interest. Joy, Nino G. .......................................... Disclosed no confl ict of interest. Joy, Scott V. .......................................... Disclosed no confl ict of interest. Jozwiak, Jacek ..................................... Disclosed no confl ict of interest. Ju, Cynthia ........................................... Disclosed no confl ict of interest. Juang, Jyuhn-Huarng ........................... Disclosed no confl ict of interest. Juárez, Isela ......................................... Disclosed no confl ict of interest. Juarez, Magaly ..................................... Disclosed no confl ict of interest. Jude, Edward B. ................................... Disclosed no confl ict of interest. Judge, Heather M. ............................... Disclosed no confl ict of interest. Juhl, Claus B. ....................................... Employee: HypoSafe A/S Juming, Lu ............................................ Disclosed no confl ict of interest. Jun, Liu ................................................. Disclosed no confl ict of interest. Jun, Zhang X. ....................................... Disclosed no confl ict of interest. Jung, Chan Hee .................................... Disclosed no confl ict of interest. Jung, Chang Hee .................................. Disclosed no confl ict of interest. Jung, Chan-hyeon ................................ Disclosed no confl ict of interest. Jung, Dae Young .................................. Disclosed no confl ict of interest. Jung, Dong Ho ...................................... Disclosed no confl ict of interest. Jung, Hye Seung .................................. Disclosed no confl ict of interest. Jung, Inji ............................................... Disclosed no confl ict of interest. Jung, Jung Hwa ................................... Disclosed no confl ict of interest. Jung, Seung-Hyun ................................ Disclosed no confl ict of interest. Jung, Su Jin ......................................... Disclosed no confl ict of interest. Jung, Sung Yeob .................................. Disclosed no confl ict of interest. Jung, Tae Sik ........................................ Disclosed no confl ict of interest. Junik, Roman ........................................ Disclosed no confl ict of interest. Junkang, Wang .................................... Disclosed no confl ict of interest. Junker, Anders E. ................................. Disclosed no confl ict of interest. Jurado, Jesus A. .................................. Disclosed no confl ict of interest. Juretschke, Hans-Paul ......................... Employee: Sanofi Juscinska, Jolanta ............................... Disclosed no confl ict of interest. Just Kukurova, Ivica ............................. Disclosed no confl ict of interest. Justice, Anne ....................................... Disclosed no confl ict of interest. Juul Holst, Jens ................................... Disclosed no confl ict of interest. Juy, Odile .............................................. Disclosed no confl ict of interest. K., Sreehari G. ...................................... Disclosed no confl ict of interest. Kaakinen, Marika ................................. Disclosed no confl ict of interest. Kabagambe, Edmond K. ....................... Disclosed no confl ict of interest. Kabir, Morvarid ..................................... Disclosed no confl ict of interest. Kachboura, Salem ................................ Disclosed no confl ict of interest. Kachoria, Rashmi ................................. Disclosed no confl ict of interest. Kachroo, Sumesh ................................. Employee: Bristol-Myers Squibb Company; Stock/Shareholder:

Bristol-Myers Squibb Company Kaczmarek, Przemyslaw ....................... Research Support: Noxxon Kadakia, Rachel .................................... Disclosed no confl ict of interest. Kadota, Yuko ........................................ Disclosed no confl ict of interest. Kadowaki, Takashi ............................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Chugai Pharmaceutical Co., Ltd., Tanabe-Mitsubishi; Research Support: Astellas Pharma US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Chugai Pharmaceutical

Co., Ltd., Tanabe-Mitsubishi; Speaker’s Bureau: Astellas Pharma US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Chugai Pharmaceutical Co., Ltd., Tanabe-Mitsubishi

Kadwa, Mahomed Y. ............................ Employee: Novartis Pharma AG; Stock/Shareholder: Novartis Kafanas, Antonios ................................ Disclosed no confl ict of interest. Kageyama, Takahiro ............................. Disclosed no confl ict of interest. Kahl, Sabine ......................................... Disclosed no confl ict of interest. Kahleova, Hana .................................... Disclosed no confl ict of interest. Kahlig, Kris ........................................... Employee: Gilead Sciences, Inc. Kahn, Barbara ....................................... Disclosed no confl ict of interest. Kahn, C. Ronald .................................... Advisory Panel: Catabasis, Dicerna, Ember Therapeutics, Five

Price Therapeutics; Consultant: Sanofi ; Research Support: Eli Lilly and Company, Sanofi ; Speaker’s Bureau: Merck; Stock/Shareholder: Ember Therapeutics

Kahn, Henry S. ...................................... Disclosed no confl ict of interest. Kahn, Steven ........................................ Consultant: Boehringer Ingelheim GmbH & Co. KG Kaholokula, Joseph K. .......................... Disclosed no confl ict of interest. Kahraman, Sevim ................................. Disclosed no confl ict of interest. Kahya, Nihan ........................................ Disclosed no confl ict of interest. Kai, Katsuya ......................................... Disclosed no confl ict of interest. Kai, Toshiharu ....................................... Disclosed no confl ict of interest. Kai, Yuji ................................................ Disclosed no confl ict of interest. Kaihara, Kelly ....................................... Disclosed no confl ict of interest. Kainth, Sonika ...................................... Disclosed no confl ict of interest. Kaiser, Daniel ....................................... Disclosed no confl ict of interest. Kaiser, Gabriele .................................... Disclosed no confl ict of interest. Kajita, Kazuo ........................................ Disclosed no confl ict of interest. Kakefuda, Mami ................................... Employee: Chugai Research Institute for Medical Science, Inc. Kakehi, Saori ........................................ Disclosed no confl ict of interest. Kakei, Masafumi .................................. Disclosed no confl ict of interest. Käkelä, Pirjo ......................................... Disclosed no confl ict of interest. Kakino, Satomi ..................................... Disclosed no confl ict of interest. Kaku, Kohei .......................................... Consultant: Astellas Pharma US, Inc., AstraZeneca/Bristol-

Meyers Squibb, Chugai Pharmaceutical Co., Ltd., Novo Nordisk, Inc., Taisho, Takeda Pharmaceutical Company, Ltd.; Research Support: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Dainippon Sumitomo Pharma Co., Ltd., Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd.

Kaldunski, Mary ................................... Disclosed no confl ict of interest. Kalko, Susana ....................................... Disclosed no confl ict of interest. Kalmus, Ellis ......................................... Disclosed no confl ict of interest. Kalopita, Stavroula ............................... Disclosed no confl ict of interest. Kalousova, Marta ................................. Disclosed no confl ict of interest. Kalra, Sanjay ........................................ Speaker’s Bureau: Novo Nordisk, Inc. Kalsbeek, Andries ................................ Disclosed no confl ict of interest. Kaltenboeck, Anna ............................... Disclosed no confl ict of interest. Kaltheuner, Matthias ........................... Disclosed no confl ict of interest. Kalyani, Rita R. ..................................... Disclosed no confl ict of interest. Kamada, Chiemi ................................... Disclosed no confl ict of interest. Kamata, Kohsuke ................................. Disclosed no confl ict of interest. Kamata, Kosuke ................................... Disclosed no confl ict of interest. Kamath, Subhash ................................. Disclosed no confl ict of interest. Kamei, Nozomu .................................... Disclosed no confl ict of interest. Kameo, Junko ....................................... Disclosed no confl ict of interest. Kamerow, Douglas ............................... Disclosed no confl ict of interest. Kaminska, Dorota ................................. Disclosed no confl ict of interest. Kaminski-Graham, Rose ....................... Disclosed no confl ict of interest. Kaminskyi, Oleksiy V. ........................... Disclosed no confl ict of interest. Kamiya, Hideki ..................................... Disclosed no confl ict of interest. Kamiyama, Hiroshi ............................... Disclosed no confl ict of interest. Kampmann, Ulla ................................... Disclosed no confl ict of interest. Kanasaki, Keizo .................................... Disclosed no confl ict of interest. Kanasaki, Megumi ............................... Disclosed no confl ict of interest. Kanatani, Yukiko ................................... Disclosed no confl ict of interest. Kanatsuka, Azuma ................................ Disclosed no confl ict of interest. Kanatsuna, Norio ................................. Disclosed no confl ict of interest. Kanaya, Alka M. ................................... Disclosed no confl ict of interest. Kanazawa, Akio .................................... Speaker’s Bureau: Novartis Pharmaceuticals Corporation,

Novo Nordisk, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd.

Kanazawa, Yasushi .............................. Disclosed no confl ict of interest. Kandadi, Machender R. ........................ Disclosed no confl ict of interest. Kandeel, Fouad ..................................... Disclosed no confl ict of interest. Kandemir, Nurgun ................................ Disclosed no confl ict of interest. Kandula, Namratha .............................. Disclosed no confl ict of interest. Kane, Constance .................................. Disclosed no confl ict of interest.

Dow



A865


AU

THO

R D

ISCL

OSU

RE

Kane, Daniel ......................................... Disclosed no confl ict of interest. Kaneki, Kentaro .................................... Disclosed no confl ict of interest. Kaneko, Masanori ................................ Disclosed no confl ict of interest. Kaneko, Shizuka ................................... Disclosed no confl ict of interest. Kaneko, Shuichi .................................... Disclosed no confl ict of interest. Kaneto, Hideaki .................................... Disclosed no confl ict of interest. Kang, Eun Seok .................................... Disclosed no confl ict of interest. Kang, Hyeji ........................................... Disclosed no confl ict of interest. Kang, Hyeon-Ji ..................................... Disclosed no confl ict of interest. Kang, Jahoon ....................................... Disclosed no confl ict of interest. Kang, Li ................................................. Disclosed no confl ict of interest. Kang, Shinae ........................................ Disclosed no confl ict of interest. Kang, Sona ........................................... Disclosed no confl ict of interest. kang, Wang J. ...................................... Disclosed no confl ict of interest. Kang, Youhou ....................................... Disclosed no confl ict of interest. Kang, Yup ............................................. Disclosed no confl ict of interest. Kanmaz-Ozer, Muge ............................. Disclosed no confl ict of interest. Kanna, Balavenkatesh .......................... Disclosed no confl ict of interest. Kannan, Subramanian .......................... Disclosed no confl ict of interest. Kanno, Kazuo ........................................ Disclosed no confl ict of interest. Kannt, Aimo .......................................... Disclosed no confl ict of interest. Kantarjian, Hagop M. ........................... Consultant: Novartis Pharmaceuticals Corporation; Research

Support: Bristol-Myers Squibb Company, Novartis Pharmaceuticals Corporation, Pfi zer, Inc.

Kantartzis, Konstantinos ...................... Disclosed no confl ict of interest. Kanter, Justin ....................................... Research Support: Sanofi Kanthimathi, Sekar ............................... Disclosed no confl ict of interest. Kanz, Lothar .......................................... Disclosed no confl ict of interest. Kanzaki, Makoto ................................... Disclosed no confl ict of interest. Kao, Linda ............................................. Disclosed no confl ict of interest. Kapeller, Rosana .................................. Disclosed no confl ict of interest. Kapitza, Christoph ................................ Other Relationship: Novo Nordisk A/S; Research Support: As-

tellas Pharma US, Inc., Becton, Dickinson and Company, Biocon, Boehringer Ingelheim GmbH & Co. KG, Dance Pharmaceuticals, Eli Lilly and Company, Evolva, Hoffman La Roche, Johnson & Johnson, Lundbeck, Inc., Novo Nordisk A/S, Noxxon, Sanofi , SkyePharma

Kaplan, Joan ........................................ Disclosed no confl ict of interest. Kaplan, Robert ...................................... Disclosed no confl ict of interest. Kapoor, Shiv ......................................... Disclosed no confl ict of interest. Kapur, Anil ............................................ Disclosed no confl ict of interest. Kapur, Rahul ......................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Karabayraktar, Tulay ............................. Disclosed no confl ict of interest. Karaca, Melis ....................................... Disclosed no confl ict of interest. Karádi, István ....................................... Disclosed no confl ict of interest. Karakitsos, Petros ................................ Disclosed no confl ict of interest. Karalliedde, Janaka ............................. Disclosed no confl ict of interest. Karamagkiolis, Spyros .......................... Disclosed no confl ict of interest. Karaman, Murat ................................... Disclosed no confl ict of interest. Karamihos, Eleni .................................. Employee: Mercodia Karandikar, Mahesh S. ......................... Disclosed no confl ict of interest. Karczewska-Kupczewska, Monika ....... Disclosed no confl ict of interest. Kardara, Marina ................................... Disclosed no confl ict of interest. Karhunen, Leila .................................... Disclosed no confl ict of interest. Kariyawasam, Dulmini ......................... Disclosed no confl ict of interest. Karnchanasorn, Rudruidee ................... Disclosed no confl ict of interest. Karnieli, Eddy ....................................... Advisory Panel: Novo Nordisk A/S; Speaker’s Bureau: Novo

Nordisk A/S Karns, Shawn ....................................... Disclosed no confl ict of interest. Karpefors, Martin ................................. Employee: AstraZeneca Pharmaceuticals LP Karsdal, Morten A. ............................... Employee: Nordic Bioscience A/S; Stock/Shareholder: Nordic

Bioscience A/S Karsenty, Gerard ................................... Disclosed no confl ict of interest. Karsidag, Kubilay ................................. Disclosed no confl ict of interest. Karter, Andrew J. ................................. Disclosed no confl ict of interest. Karunakaran, Subashini ....................... Disclosed no confl ict of interest. Karve, Sudeep ...................................... Employee: RTI Health Solutions; Research Support: sanofi -

aventis US Kasai, Takatoshi ................................... Disclosed no confl ict of interest. Kaser, Susanne ..................................... Disclosed no confl ict of interest. Kashiwagi, Atsunori ............................. Disclosed no confl ict of interest. Kashmiri, Himala .................................. Disclosed no confl ict of interest. Kashyap, Sangeeta R. .......................... Research Support: Ethicon EndoSurgery, Inc. Kaspers, Stefan .................................... Employee: Boehringer Ingelheim GmbH & Co. KG Kassanos, Dimitrios ............................. Disclosed no confl ict of interest. Kassis, Nadim ...................................... Disclosed no confl ict of interest. Kastelein, John J. ................................ Consultant: Boehringer Ingelheim GmbH & Co. KG Kasumov, Takhar .................................. Disclosed no confl ict of interest. Kasznicki, Jacek ................................... Disclosed no confl ict of interest. Kaszynski, Katie ................................... Disclosed no confl ict of interest. Katagiri, Naoko .................................... Disclosed no confl ict of interest.

Kataoka, Nobuhiko ............................... Disclosed no confl ict of interest. Katayama, Shigehiro ............................ Disclosed no confl ict of interest. Katayama, Takafumi ............................. Disclosed no confl ict of interest. Kato, Jiro .............................................. Disclosed no confl ict of interest. Kato, Mari ............................................ Disclosed no confl ict of interest. Kato, Masahiko .................................... Disclosed no confl ict of interest. Kato, Masayuki .................................... Disclosed no confl ict of interest. Kato, Mitsutoshi ................................... Disclosed no confl ict of interest. Kato, Noriko ......................................... Disclosed no confl ict of interest. Kato, Sotoshi ........................................ Disclosed no confl ict of interest. Katon, Wayne J. ................................... Speaker’s Bureau: Eli Lilly and Company, Forest Laboratories,

Inc., Pfi zer, Inc. Katra, Barbara ...................................... Disclosed no confl ict of interest. Katsanos, Ioannis ................................. Disclosed no confl ict of interest. Katsilambros, Nicholas ........................ Disclosed no confl ict of interest. Katsu, Hiroki ......................................... Disclosed no confl ict of interest. Katsukawa, Fuminori ............................ Disclosed no confl ict of interest. Katsuki, Tatsuo ..................................... Disclosed no confl ict of interest. Katsuragi, Kiyonori ............................... Disclosed no confl ict of interest. Katsuta, Hidenori ................................. Disclosed no confl ict of interest. Katsuta, Hitoshi .................................... Disclosed no confl ict of interest. Katula, Jeffrey A. ................................. Disclosed no confl ict of interest. Katz, Andrew ........................................ Disclosed no confl ict of interest. Katz, Laurence B. .................................. Employee: Lifescan Animas, Inc. Katz, Lorraine ....................................... Disclosed no confl ict of interest. Katz, Michelle L. ................................... Disclosed no confl ict of interest. Katzmarzyk, Peter T. ............................. Disclosed no confl ict of interest. Kauffman, Audra L. .............................. Employee: Eli Lilly and Company Kaufman, Francine R. ........................... Employee: Medtronic MiniMed, Inc. Kaufman, Keith D. ................................ Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Kaufman, Steven .................................. Disclosed no confl ict of interest. Kauka, Iris ............................................. Disclosed no confl ict of interest. Kaul, Kirti .............................................. Disclosed no confl ict of interest. Kaul, Padma ......................................... Disclosed no confl ict of interest. Kaur, Achint .......................................... Disclosed no confl ict of interest. Kaur, Gagandeep .................................. Disclosed no confl ict of interest. Kautzky, Mira ........................................ Disclosed no confl ict of interest. Kautzky-Willer, Alexandra .................... Speaker’s Bureau: Astra Zeneca, Bayer Healthcare, Bristol-

Myers Squibb Company, Eli Lilly and Company, GlaxoS-mithKline, Merck Sharp & Dohme Limited, Novartis, Novo Nordisk, Inc., Roche Pharmaceuticals, sanofi -aventis

Kavalkova, Petra ................................... Disclosed no confl ict of interest. Kavanagh, David H. .............................. Disclosed no confl ict of interest. Kawabata, Yumiko ............................... Disclosed no confl ict of interest. Kawabe, Yoshiki ................................... Employee: Chugai Pharmaceutical Co., Ltd. Kawachi, Ichiro ..................................... Disclosed no confl ict of interest. Kawada, Ryo ........................................ Disclosed no confl ict of interest. Kawaguchi, Miho ................................. Disclosed no confl ict of interest. Kawaguchi, Minako ............................. Disclosed no confl ict of interest. Kawaguchi, Yasushi ............................. Disclosed no confl ict of interest. Kawai, Toshihide .................................. Disclosed no confl ict of interest. Kawakami, Masanobu ......................... Disclosed no confl ict of interest. Kawakami, Yuka ................................... Disclosed no confl ict of interest. Kawakami, Yuko ................................... Disclosed no confl ict of interest. Kawalec-Carroll, Jill S. ........................ Consultant: Ogenix Corporation Kawamori, Dan ..................................... Disclosed no confl ict of interest. Kawamori, Ryuzo .................................. Disclosed no confl ict of interest. Kawamoto, Manabu ............................. Disclosed no confl ict of interest. Kawamura, Ryoichi .............................. Disclosed no confl ict of interest. Kawamura, Tomoyuki ........................... Disclosed no confl ict of interest. Kawanabe, Haruka ............................... Employee: Ajinomoto Group Kawanami, Daiji ................................... Disclosed no confl ict of interest. Kawanami, Takako ............................... Disclosed no confl ict of interest. Kawanishi, Misato ............................... Disclosed no confl ict of interest. Kawano, Naoya .................................... Disclosed no confl ict of interest. Kawasaki, Aya ...................................... Disclosed no confl ict of interest. Kawasaki, Maki .................................... Disclosed no confl ict of interest. Kawasaki, Satsuki ................................ Disclosed no confl ict of interest. Kawasaki, Yukiko ................................. Disclosed no confl ict of interest. Kawase, Ryota ..................................... Disclosed no confl ict of interest. Kawase, Yosuke ................................... Employee: Chugai Research Institute for Medical Science,

Inc. Kawashima, Junji ................................. Disclosed no confl ict of interest. Kawata, Ariane .................................... Employee: United BioSource Corporation Kawata, Nozomi ................................... Disclosed no confl ict of interest. Kawazu, Shoji ....................................... Disclosed no confl ict of interest. Kay, Thomas W. .................................... Disclosed no confl ict of interest. Kayaniyil, Sheena ................................. Disclosed no confl ict of interest. Kayemba-Kays, Simon ......................... Disclosed no confl ict of interest. Kazda, Christof ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company

Dow



A866


AU

THO

R D

ISCL

OSU

RE

Kazdova, Ludmila ................................. Disclosed no confl ict of interest. Kazierad, David J. ................................ Employee: Pfi zer, Inc.; Research Support: Pfi zer, Inc.; Stock/

Shareholder: Pfi zer, Inc. Ke, Weijian ........................................... Disclosed no confl ict of interest. Kearney, Edward .................................. Disclosed no confl ict of interest. Kearney, Mark T. .................................. Disclosed no confl ict of interest. Kearney, Monica .................................. Disclosed no confl ict of interest. Kebede, Melkam .................................. Disclosed no confl ict of interest. Kedar, Asaf ........................................... Disclosed no confl ict of interest. Kee, Hyun Chul ..................................... Disclosed no confl ict of interest. Keenan, Barry ....................................... Employee: Medtronic MiniMed, Inc. Keenan, Hillary A. ................................ Disclosed no confl ict of interest. Kehlenbrink, Sylvia ............................... Disclosed no confl ict of interest. Keidar, Andrei ....................................... Disclosed no confl ict of interest. Keil, Rudolf ........................................... Consultant: Almased-Wellness-GmbH Keith, Steven ........................................ Employee: Becton, Dickinson and Company; Research Support:

Becton, Dickinson and Company Kelemen, Skyler ................................... Disclosed no confl ict of interest. Keli, Heval M. ....................................... Disclosed no confl ict of interest. Kelleher, Donna .................................... Disclosed no confl ict of interest. Keller, Peter J. ...................................... Disclosed no confl ict of interest. Kelley, David E. ..................................... Employee: Merck Sharp & Dohme Limited Kelly, Aaron S. ...................................... Disclosed no confl ict of interest. Kelly, Mike ............................................ Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Kelly, Ronan P. ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Kelly, Zachary A. ................................... Disclosed no confl ict of interest. Kelly-Sullivan, Dawn ............................ Employee: Novartis Pharmaceuticals Corporation Kelsey, Megan M. ................................ Other Relationship: Bristol-Myers Squibb Company, Daiichi-

Sankyo, Inc., Merck Kemmerer, Terri .................................... Disclosed no confl ict of interest. Kemp, Charisse .................................... Employee: Novartis Pharmaceuticals Corporation Kempf, Kerstin ...................................... Research Support: Almased-Wellness-GmbH, Boehringer

Ingelheim GmbH & Co. KG, gbo Medizintechnik AG, Novartis Pharma GmbH

Kempthorne-Rawson, Joan .................. Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Kendall, David M. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Kenna, Lauren A. .................................. Disclosed no confl ict of interest. Kennedy, Laurence ............................... Disclosed no confl ict of interest. Kennedy, Robert ................................... Disclosed no confl ict of interest. Kennedy, Anne ..................................... Disclosed no confl ict of interest. Kenny, Glen P. ....................................... Disclosed no confl ict of interest. Képénékian, Lori ................................... Disclosed no confl ict of interest. Kern, David M. ..................................... Disclosed no confl ict of interest. Kern, Matthias ..................................... Disclosed no confl ict of interest. Kern, Philip A. ....................................... Disclosed no confl ict of interest. Kern, Timothy S. ................................... Disclosed no confl ict of interest. Kerr, David ............................................ Advisory Panel: Novo Nordisk A/S; Consultant: Abbott Diabe-

tes Care; Stock/Shareholder: Cellnovo Kerr-Conte, Julie .................................. Disclosed no confl ict of interest. Kershaw, Erin E. ................................... Disclosed no confl ict of interest. Kerwin, Bill ........................................... Stock/Shareholder: VP Diagnostics Kesavadev, Jothydev ............................ Disclosed no confl ict of interest. Keske, Michelle A. ............................... Disclosed no confl ict of interest. Kesselheim, Aaron S. ........................... Disclosed no confl ict of interest. Kessler, Laurence ................................. Disclosed no confl ict of interest. Ketterer, Caroline ................................. Disclosed no confl ict of interest. Keutzer, Joan ........................................ Disclosed no confl ict of interest. Khaja, Shamim ..................................... Disclosed no confl ict of interest. Khalil, Nofal M. .................................... Disclosed no confl ict of interest. Khaliqdina, Shoheera ........................... Disclosed no confl ict of interest. Khamaisi, Mogher ................................ Disclosed no confl ict of interest. Khambatta, Cyrus F. ............................. Disclosed no confl ict of interest. Khan, Ainy ............................................ Disclosed no confl ict of interest. Khan, Ilvira ........................................... Disclosed no confl ict of interest. Khan, Salmaan Ahmed ......................... Disclosed no confl ict of interest. Khanna, Ish ........................................... Disclosed no confl ict of interest. Kharbanda, Elyse .................................. Disclosed no confl ict of interest. Kharitonenkov, Alexei .......................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Khazrai, Yeganeh Manon ..................... Disclosed no confl ict of interest. Kheav, Oun ........................................... Disclosed no confl ict of interest. Kheirbek, Raya ..................................... Disclosed no confl ict of interest. Kheyami, Ahmad .................................. Disclosed no confl ict of interest. khitan, Zeid ........................................... Disclosed no confl ict of interest. Khochtali, Ines ...................................... Disclosed no confl ict of interest. Khoo, Chin Meng .................................. Disclosed no confl ict of interest. Khorsand, Fahimeh ............................... Disclosed no confl ict of interest. Khosla, Shikha ...................................... Disclosed no confl ict of interest. Khosravanipour, Marjan ....................... Disclosed no confl ict of interest.

Khoury, Jane C. .................................... Disclosed no confl ict of interest. Khoury, Marina ..................................... Disclosed no confl ict of interest. Khoury, Nadia ....................................... Disclosed no confl ict of interest. Khoury, Samia ...................................... Disclosed no confl ict of interest. Khouzam, Sally ..................................... Disclosed no confl ict of interest. Khuder, Saja ......................................... Disclosed no confl ict of interest. Khunti, Kamlesh ................................... Advisory Panel: Bristol-Myers Squibb Company, Eli Lilly and

Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Roche Pharmaceuticals; Research Support: UK National Health Service

Khurana, Reena .................................... Disclosed no confl ict of interest. Kichler, Jessica C. ................................ Disclosed no confl ict of interest. Kida, Yasuo ........................................... Disclosed no confl ict of interest. Kidambi, Srividya ................................. Disclosed no confl ict of interest. Kido, Teruhiko ....................................... Disclosed no confl ict of interest. Kidron, Miriam ..................................... Employee: Oramed Pharmaceuticals Kiec-Wilk, Beata .................................. Disclosed no confl ict of interest. Kiefer-Schmidt, Isabelle ....................... Disclosed no confl ict of interest. Kiehling, Claus ..................................... Advisory Panel: Roche Diagnostics GmbH; Research Support:

Roche Diagnostics GmbH Kienesberger, Petra C. .......................... Disclosed no confl ict of interest. Kieswich, Julius ................................... Disclosed no confl ict of interest. Kievit, Paul ........................................... Disclosed no confl ict of interest. Kikimbaeva, Ausulu A. ......................... Disclosed no confl ict of interest. Kikuchi, Takeshi .................................... Disclosed no confl ict of interest. Kil, Alyson M. ....................................... Disclosed no confl ict of interest. Kilbride, Sean ....................................... Disclosed no confl ict of interest. Kilicarslan, M. ...................................... Disclosed no confl ict of interest. Kilkuskie, Peter M. ............................... Employee: Metabolic Solutions Development Co. Kilpatrick, Rachel ................................. Disclosed no confl ict of interest. Kim, Bhumsoo ...................................... Disclosed no confl ict of interest. Kim, Bo Hyun ........................................ Disclosed no confl ict of interest. Kim, Bo Kyung ...................................... Disclosed no confl ict of interest. Kim, Bu Kyung ...................................... Disclosed no confl ict of interest. Kim, Catherine ...................................... Disclosed no confl ict of interest. Kim, Charles ......................................... Disclosed no confl ict of interest. Kim, Chong Hwa ................................... Disclosed no confl ict of interest. Kim, Chul Hoon ..................................... Disclosed no confl ict of interest. Kim, Chul Sik ........................................ Disclosed no confl ict of interest. Kim, Chun Hwa ..................................... Disclosed no confl ict of interest. Kim, Dae Hyun ...................................... Disclosed no confl ict of interest. Kim, Dae Jung ...................................... Disclosed no confl ict of interest. Kim, Doo Man ...................................... Disclosed no confl ict of interest. Kim, Eui Hyun ....................................... Disclosed no confl ict of interest. Kim, Eun Ky .......................................... Disclosed no confl ict of interest. Kim, Eun Mi .......................................... Disclosed no confl ict of interest. Kim, Eun Sook ...................................... Disclosed no confl ict of interest. Kim, Eunmi ........................................... Disclosed no confl ict of interest. Kim, Francis .......................................... Disclosed no confl ict of interest. Kim, Gabriel .......................................... Employee: Boehringer Ingelheim GmbH & Co. KG Kim, Grace ............................................ Disclosed no confl ict of interest. Kim, Hae Jin ......................................... Disclosed no confl ict of interest. Kim, Hae-Suk ........................................ Disclosed no confl ict of interest. Kim, Hail ............................................... Disclosed no confl ict of interest. Kim, Hee Young .................................... Disclosed no confl ict of interest. Kim, Hong Min ..................................... Disclosed no confl ict of interest. Kim, Hong-Kyu ...................................... Disclosed no confl ict of interest. Kim, Hun Sung ...................................... Disclosed no confl ict of interest. Kim, Hyo Cheol ..................................... Disclosed no confl ict of interest. Kim, Hyun Min ...................................... Disclosed no confl ict of interest. Kim, Hyunji ........................................... Disclosed no confl ict of interest. Kim, Hyunok ......................................... Disclosed no confl ict of interest. Kim, In Joo ........................................... Disclosed no confl ict of interest. Kim, Jae Bum ....................................... Disclosed no confl ict of interest. Kim, Jae Woo ....................................... Disclosed no confl ict of interest. Kim, Jason K. ....................................... Disclosed no confl ict of interest. Kim, Jennifer ........................................ Employee: AstraZeneca Pharmaceuticals LP; Stock/Share-

holder: AstraZeneca Pharmaceuticals LP Kim, Jeong-a ........................................ Disclosed no confl ict of interest. Kim, Ji M. ............................................. Disclosed no confl ict of interest. Kim, Ji Ryang ....................................... Disclosed no confl ict of interest. Kim, Ji Woon ........................................ Disclosed no confl ict of interest. Kim, Ji Yeon ......................................... Disclosed no confl ict of interest. Kim, Ji Young ....................................... Disclosed no confl ict of interest. Kim, Jin Sook ....................................... Disclosed no confl ict of interest. Kim, Jin Sun ......................................... Disclosed no confl ict of interest. Kim, Jinhee .......................................... Disclosed no confl ict of interest. Kim, Ji-Won ......................................... Disclosed no confl ict of interest. Kim, Jiwoon ......................................... Disclosed no confl ict of interest. Kim, Jong Dai ....................................... Disclosed no confl ict of interest. Kim, Jong In ......................................... Disclosed no confl ict of interest. Kim, Jong-Seo ...................................... Disclosed no confl ict of interest.

Dow



A867


AU

THO

R D

ISCL

OSU

RE

Kim, Jong-Yeon .................................... Disclosed no confl ict of interest. Kim, Joon Young .................................. Disclosed no confl ict of interest. Kim, Judy E. .......................................... Disclosed no confl ict of interest. Kim, Jun Ho .......................................... Disclosed no confl ict of interest. Kim, Jung Hee ...................................... Disclosed no confl ict of interest. Kim, Jung-Guk ...................................... Disclosed no confl ict of interest. Kim, Kiwon ........................................... Disclosed no confl ict of interest. Kim, Kwang Joon ................................. Disclosed no confl ict of interest. Kim, Kyoung-Ah .................................... Disclosed no confl ict of interest. Kim, Kyung Rae .................................... Disclosed no confl ict of interest. Kim, Kyung-Jin ..................................... Disclosed no confl ict of interest. Kim, Kyungjoo ...................................... Disclosed no confl ict of interest. Kim, Mee-Kyoung ................................. Disclosed no confl ict of interest. Kim, Mi Kyung ...................................... Disclosed no confl ict of interest. Kim, Min Joo ........................................ Disclosed no confl ict of interest. Kim, Min Kyeong .................................. Disclosed no confl ict of interest. Kim, Min Kyung .................................... Disclosed no confl ict of interest. Kim, Myung K. ...................................... Disclosed no confl ict of interest. Kim, Myung Soo ................................... Disclosed no confl ict of interest. Kim, Nam Hoon .................................... Disclosed no confl ict of interest. Kim, Nan Hee ....................................... Disclosed no confl ict of interest. Kim, S. Joseph ..................................... Disclosed no confl ict of interest. Kim, Sang Jin ....................................... Disclosed no confl ict of interest. Kim, Sang Mi ........................................ Disclosed no confl ict of interest. Kim, Sang Soo ...................................... Disclosed no confl ict of interest. Kim, Seirhan ......................................... Disclosed no confl ict of interest. Kim, Seong Yeon .................................. Disclosed no confl ict of interest. Kim, Shin Y. .......................................... Disclosed no confl ict of interest. Kim, Sin Gon ......................................... Disclosed no confl ict of interest. Kim, So Hun .......................................... Disclosed no confl ict of interest. Kim, Sohee ........................................... Disclosed no confl ict of interest. Kim, Soo Hyun ...................................... Disclosed no confl ict of interest. Kim, Soo Kyoung .................................. Disclosed no confl ict of interest. Kim, Soohyun P. .................................... Disclosed no confl ict of interest. Kim, Soon Ae ........................................ Disclosed no confl ict of interest. Kim, Soon Il .......................................... Disclosed no confl ict of interest. Kim, Stella P. ........................................ Disclosed no confl ict of interest. Kim, Sun ............................................... Disclosed no confl ict of interest. Kim, Sun Hwa ....................................... Disclosed no confl ict of interest. Kim, Sung Rae ...................................... Disclosed no confl ict of interest. Kim, Sung-Hoon ................................... Disclosed no confl ict of interest. Kim, Sung-Rae ...................................... Disclosed no confl ict of interest. Kim, Sungsu ......................................... Disclosed no confl ict of interest. Kim, SunHee ......................................... Disclosed no confl ict of interest. Kim, Tae Ho .......................................... Disclosed no confl ict of interest. Kim, Tae Nyun ...................................... Disclosed no confl ict of interest. Kim, Terri .............................................. Employee: Elcelyx Therapeutics, Inc. Kim, Won Ho ........................................ Disclosed no confl ict of interest. Kim, Won Jin ........................................ Disclosed no confl ict of interest. Kim, Won Y. .......................................... Disclosed no confl ict of interest. Kim, Wook ............................................ Disclosed no confl ict of interest. Kim, Yeo Joo ........................................ Disclosed no confl ict of interest. Kim, Yeon Ji ......................................... Disclosed no confl ict of interest. Kim, Yong Ki ......................................... Disclosed no confl ict of interest. Kim, Yong Seong .................................. Disclosed no confl ict of interest. Kim, Yong Tae ....................................... Disclosed no confl ict of interest. Kim, Yong-Woon .................................. Disclosed no confl ict of interest. Kim, Yoojin ........................................... Disclosed no confl ict of interest. Kim, Yoon Ji ......................................... Disclosed no confl ict of interest. Kim, Yoon Jung .................................... Disclosed no confl ict of interest. Kim, Young Hoon .................................. Disclosed no confl ict of interest. Kim, Young Il ........................................ Disclosed no confl ict of interest. Kim, Young Ree .................................... Disclosed no confl ict of interest. Kim, Young Seol ................................... Disclosed no confl ict of interest. Kim, Young Sook .................................. Disclosed no confl ict of interest. Kim, Young-Bum ................................... Disclosed no confl ict of interest. Kim, Yu Seun ........................................ Disclosed no confl ict of interest. Kim, Yu Sik ........................................... Disclosed no confl ict of interest. Kim, Yuri ............................................... Disclosed no confl ict of interest. Kimball, Scot R. .................................... Disclosed no confl ict of interest. Kimler, Tracy ......................................... Disclosed no confl ict of interest. Kimura, Mari ........................................ Disclosed no confl ict of interest. Kimura, Masayo ................................... Disclosed no confl ict of interest. Kimura, Moritsugu ............................... Disclosed no confl ict of interest. Kimura, Yuki ......................................... Disclosed no confl ict of interest. Kimura, Yukiko ...................................... Disclosed no confl ict of interest. Kincaid, Edward S. ............................... Disclosed no confl ict of interest. Kindo, Masumi ..................................... Disclosed no confl ict of interest. Kinduryte, Ona ...................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Kineish, Omer ....................................... Disclosed no confl ict of interest. Kineman, Rhonda D. ............................. Disclosed no confl ict of interest.

King, Allen B. ........................................ Advisory Panel: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi ; Consultant: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi ; Research Support: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi ; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk, Inc.

King, Bruce R. ....................................... Disclosed no confl ict of interest. King, George L. ..................................... Research Support: Sanofi King, Irena B. ........................................ Disclosed no confl ict of interest. King, Mackie ........................................ Disclosed no confl ict of interest. King, Scott ............................................ Disclosed no confl ict of interest. Kinney, Gregory L. ................................ Disclosed no confl ict of interest. Kinoshita, Hiroshi ................................. Employee: Sanwa Kagaku Kenkyusho Kinoshita, Jun ...................................... Disclosed no confl ict of interest. Kinsley, Brendan T. ............................... Disclosed no confl ict of interest. Kiosh Katashima, Carlos ...................... Disclosed no confl ict of interest. Kipke, Michele ..................................... Disclosed no confl ict of interest. Kipnes, Mark S. .................................... Consultant: Gilead Sciences, Inc., Versartis /Diartis Pharma Kircher, Robert ...................................... Employee: Dose Safety Company; Stock/Shareholder: Dose

Safety Company Kirk, Julienne ....................................... Disclosed no confl ict of interest. Kirk, Lynne ............................................ Disclosed no confl ict of interest. Kirkman, Erlinda L. ............................... Disclosed no confl ict of interest. Kirkman, Sue ........................................ Disclosed no confl ict of interest. Kirkpatrick, Clare .................................. Disclosed no confl ict of interest. Kirtland, Karen A. ................................. Disclosed no confl ict of interest. Kirwan, Breda ....................................... Disclosed no confl ict of interest. Kirwan, John P. ..................................... Research Support: Nestle, Inc. Kishi, Akio ............................................ Disclosed no confl ict of interest. Kishida, Ken ......................................... Disclosed no confl ict of interest. Kishimoto, Ichiro .................................. Disclosed no confl ict of interest. Kishore, Preeti ...................................... Disclosed no confl ict of interest. Kisioglu, Savas V. ................................. Disclosed no confl ict of interest. Kispert, Andreas ................................... Disclosed no confl ict of interest. Kiss, Zoltán ........................................... Employee: Merck Sharp & Dohme Limited Kissner, Thomas ................................... Employee: Sanofi Kitabchi, Abbas E. ................................ Disclosed no confl ict of interest. Kitada, Yoshihiko .................................. Disclosed no confl ict of interest. Kitahara, Yoshiro .................................. Employee: Ajinomoto Group Kitamura, Kumiko ................................. Disclosed no confl ict of interest. Kitamura, Tadahiro ............................... Disclosed no confl ict of interest. Kitaoka, Takafumi ................................. Disclosed no confl ict of interest. Kitatani, Masako .................................. Disclosed no confl ict of interest. Kitatani, Naomi .................................... Disclosed no confl ict of interest. Kito, Aki ................................................ Employee: Chugai Pharmaceutical Co., Ltd. Kitsis, Richard N. .................................. Disclosed no confl ict of interest. Kitsunai, Hiroya .................................... Disclosed no confl ict of interest. Kittelsrud, Julie .................................... Disclosed no confl ict of interest. Kitzmiller, John ..................................... Disclosed no confl ict of interest. Kivimäki, Mika ...................................... Disclosed no confl ict of interest. Kiyomi, Fumiaki .................................... Employee: Novo Nordisk Pharma Ltd; Stock/Shareholder:

Novo Nordisk A/S Kiyosue, Arihiro .................................... Disclosed no confl ict of interest. Kizer, Jorge ........................................... Disclosed no confl ict of interest. Kjær, Troels W. ..................................... Disclosed no confl ict of interest. Klaff, Leslie J. ...................................... Research Support: Abbott Diabetes Care, Bayer Health Care,

LLC, Johnson & Johnson Klamp, Inga .......................................... Disclosed no confl ict of interest. Klassen, Preston ................................... Employee: Orexigen Therapeutics, Inc.; Stock/Shareholder:

Orexigen Therapeutics, Inc. Klassmann, Lucas P. ............................. Disclosed no confl ict of interest. Klaus, Katherine ................................... Disclosed no confl ict of interest. Kleffel, Sonja ........................................ Disclosed no confl ict of interest. Klefortova, Inna .................................... Disclosed no confl ict of interest. Klein, Barbara E. ................................... Disclosed no confl ict of interest. Klein, David J. ...................................... Consultant: Novo Nordisk, Inc. Klein, Kerenaftali ................................. Disclosed no confl ict of interest. Klein, Martin ........................................ Disclosed no confl ict of interest. Klein, Oana L. ....................................... Disclosed no confl ict of interest. Klein, Richard L. ................................... Disclosed no confl ict of interest. Klein, Ronald ........................................ Disclosed no confl ict of interest. Klein, Thomas ....................................... Employee: Boehringer Ingelheim GmbH & Co. KG Kleinman, Nathan L. ............................. Consultant: Genentech Kleinridders, Andre .............................. Disclosed no confl ict of interest. Kletzien, Rolf F. ..................................... Board Member: Metabolic Solutions Development Co.;

Employee: Metabolic Solutions Development Co.; Stock/Shareholder: Metabolic Solutions Development Co.

Klingensmith, Georgeanna ................... Consultant: Eli Lilly and Company, Novo Nordisk, Inc.; Research Support: Novo Nordisk, Inc.

Klip, Amira ............................................ Disclosed no confl ict of interest. Klompas, Michael ................................ Disclosed no confl ict of interest. Klonoff, David C. .................................. Advisory Panel: Sanofi ; Consultant: Sanofi ; Research Support:

Sanofi

Dow



A868


AU

THO

R D

ISCL

OSU

RE

Klöting, Nora ........................................ Disclosed no confl ict of interest. Klussmann, Sven .................................. Employee: Noxxon Kluth, Oliver .......................................... Disclosed no confl ict of interest. Knebel, Birgit ........................................ Disclosed no confl ict of interest. Knee, Alex ............................................ Disclosed no confl ict of interest. Knight, Bridget A. ................................. Disclosed no confl ict of interest. Knight, Tara K. ...................................... Disclosed no confl ict of interest. Knoefel, Wolfram Trudo ....................... Disclosed no confl ict of interest. Knop, Filip K. ........................................ Advisory Panel: Bristol-Myers Squibb Company, Eli Lilly and

Company, Zealand Pharma A/S; Consultant: AstraZeneca/Bristol-Meyers Squibb, Gilead Sciences, Inc., Ono Pharmaceutical Co., Ltd., Zealand Pharma A/S; Speaker’s Bureau: Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi

Knotts, Trina A. ..................................... Disclosed no confl ict of interest. Knowler, William C. ............................. Disclosed no confl ict of interest. Knudsen, Lotte B. ................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Knutson, Kristen L. ............................... Disclosed no confl ict of interest. Knutsson, Mikael ................................. Employee: AstraZeneca Pharmaceuticals LP Ko, Jocelyn ........................................... Disclosed no confl ict of interest. Ko, Kyung Soo ...................................... Disclosed no confl ict of interest. Ko, Sangbong ....................................... Disclosed no confl ict of interest. Ko, Seung-Hyun .................................... Disclosed no confl ict of interest. Kobayashi, Hironori .............................. Disclosed no confl ict of interest. Kobayashi, Kazuaki .............................. Disclosed no confl ict of interest. Kobayashi, Kazuki ................................ Disclosed no confl ict of interest. Kobayashi, Masatoshi .......................... Disclosed no confl ict of interest. Kobayashi, Naoki ................................. Disclosed no confl ict of interest. Kobayashi, Satoru ................................ Disclosed no confl ict of interest. Kobayashi, Takuya ................................ Disclosed no confl ict of interest. Kobayashi, Yasuko ............................... Disclosed no confl ict of interest. Kobayashi, Yumiko ............................... Disclosed no confl ict of interest. Kobes, Sayuko ...................................... Disclosed no confl ict of interest. Kocak, Gulay ......................................... Disclosed no confl ict of interest. Kocalis, Heidi E. ................................... Disclosed no confl ict of interest. Koch, Lauren ......................................... Disclosed no confl ict of interest. Kocher, Jean-Pierre .............................. Disclosed no confl ict of interest. Kochi, Cristiane .................................... Disclosed no confl ict of interest. Kocjan, Tomaz ...................................... Disclosed no confl ict of interest. Kocsis, Agnes K. ................................... Disclosed no confl ict of interest. Kodama, Keiichi ................................... Disclosed no confl ict of interest. Kodama, Mai ........................................ Disclosed no confl ict of interest. Kodama, Satoru .................................... Disclosed no confl ict of interest. Koechlin, Alice ..................................... Disclosed no confl ict of interest. Koehler, Carsta ..................................... Disclosed no confl ict of interest. Koehler, Walter .................................... Consultant: Roche Diagnostics Koepp, Gabriel ...................................... Disclosed no confl ict of interest. Koezuka, Ryo ........................................ Disclosed no confl ict of interest. Koh, Gwanpyo ...................................... Disclosed no confl ict of interest. Koh, Hideo ............................................ Disclosed no confl ict of interest. Koh, Woon-Puay ................................... Disclosed no confl ict of interest. Kohm, Kevin C. ..................................... Disclosed no confl ict of interest. Kohn, Nina ............................................ Disclosed no confl ict of interest. Kohnen, Laurent ................................... Disclosed no confl ict of interest. Kohrt, Wendy M. .................................. Disclosed no confl ict of interest. Koide, Misao ........................................ Disclosed no confl ict of interest. Koiwai, Kazuki ...................................... Employee: Boehringer Ingelheim Co., Ltd. Kojima, Itaru ......................................... Disclosed no confl ict of interest. Kojima, Motoyasu ................................ Disclosed no confl ict of interest. Kojzar, Harald ....................................... Disclosed no confl ict of interest. Kokkinos, Alexander ............................. Disclosed no confl ict of interest. Kokkinos, Peter F. ................................. Disclosed no confl ict of interest. Kokolaki, Anthi ..................................... Disclosed no confl ict of interest. Kokoszka, Andrzej ................................ Advisory Panel: Novo Nordisk A/S; Other Relationship: Dainip-

pon Sumitomo Pharma Co., Ltd., Otsuka Pharmaceutical Group; Research Support: Novo Nordisk A/S; Speaker’s Bureau: Novo Nordisk A/S

Kolatsi-Joannou, Maria ....................... Disclosed no conflict of interest. Kolb, Hubert ......................................... Disclosed no confl ict of interest. Koliaki, Chrysi ....................................... Disclosed no confl ict of interest. Kolka, Cathryn M. ................................. Disclosed no confl ict of interest. Koller, Jonathan M. .............................. Disclosed no confl ict of interest. Koller, Kathyrn ...................................... Disclosed no confl ict of interest. Kollman, Craig ...................................... Disclosed no confl ict of interest. Kolodny, Gerald M. ............................... Disclosed no confl ict of interest. Kolodziejski, Pawel .............................. Disclosed no confl ict of interest. Kolotkin, Ronette L. .............................. Consultant: Department of Veteran Affairs, Vivus, Inc.; Other

Relationship: Duke University Kolterman, Orville ................................ Employee: Amylin Pharmaceuticals, Inc. Komada, Tohru ..................................... Disclosed no confl ict of interest. Komitopoulos, Nikolaos ....................... Disclosed no confl ict of interest.

Komiya, Koji ......................................... Speaker’s Bureau: Takeda Pharmaceutical Company, Ltd. Komuro, Issei ........................................ Disclosed no confl ict of interest. Kondo, Hiroko ....................................... Disclosed no confl ict of interest. Kondo, Keiko ........................................ Disclosed no confl ict of interest. Kondo, Kunikazu ................................... Disclosed no confl ict of interest. Kondo, Masaki ..................................... Disclosed no confl ict of interest. Kondo, Mizuho ..................................... Disclosed no confl ict of interest. Kondo, Satomi ...................................... Disclosed no confl ict of interest. Kondo, Takeshi ..................................... Disclosed no confl ict of interest. Kondo, Takuma ..................................... Disclosed no confl ict of interest. Kondo, Tatsuya ..................................... Disclosed no confl ict of interest. Kondo, Teruki ........................................ Disclosed no confl ict of interest. Kondo, Toshikazu .................................. Disclosed no confl ict of interest. Kondo, Yoshinobu ................................. Disclosed no confl ict of interest. Kong, Alice P.S. .................................... Disclosed no confl ict of interest. Kong, Dexian ........................................ Disclosed no confl ict of interest. Kong, Dong ........................................... Disclosed no confl ict of interest. Kong, Jason .......................................... Disclosed no confl ict of interest. Kong, Shengchun ................................. Disclosed no confl ict of interest. Kong, Stephanie M. ............................. Disclosed no confl ict of interest. Kong, Xuan ........................................... Employee: NeuroMetrix; Stock/Shareholder: NeuroMetrix Kongoji, Mayumi .................................. Disclosed no confl ict of interest. Königsrainer, Alfred ............................. Disclosed no confl ict of interest. Könner, Jürgen ..................................... Disclosed no confl ict of interest. Kono, Mai ............................................. Disclosed no confl ict of interest. Kono, Shigeo ........................................ Disclosed no confl ict of interest. Kono, Tatsuyoshi M. ............................. Disclosed no confl ict of interest. Konyashin, Alexander .......................... Disclosed no confl ict of interest. Koo, Bo Kyung ...................................... Disclosed no confl ict of interest. Koontz, Michaela B. ............................. Research Support: Case Western Reserve University, NIH Koopman, Karin E. ................................ Disclosed no confl ict of interest. Kooy, Adriaan ....................................... Disclosed no confl ict of interest. Kopecky, Petr ........................................ Disclosed no confl ict of interest. Kopp, Hans P. ........................................ Disclosed no confl ict of interest. Kopp, Jeffrey ........................................ Disclosed no confl ict of interest. Kopp, Richard ....................................... Disclosed no confl ict of interest. Koppaka, Sudha ................................... Disclosed no confl ict of interest. Koppensteiner, Renate ......................... Disclosed no confl ict of interest. Koranyi, Laszlo ..................................... Disclosed no confl ict of interest. Kordonouri, Olga .................................. Disclosed no confl ict of interest. Korenblat Donato, Bonnie M. .............. Employee: Bristol-Myers Squibb Company Korger, Volker ....................................... Employee: Sanofi Korkmaz, Ugur ...................................... Disclosed no confl ict of interest. Kornelius, Edy ....................................... Disclosed no confl ict of interest. Korner, Judith ....................................... Disclosed no confl ict of interest. Koro, Carol E. ........................................ Employee: Carol Koro; Stock/Shareholder: Carol Koro Korol, Ellen E. ....................................... Disclosed no confl ict of interest. Korsatko, Stefan ................................... Other Relationship: CeQur, Ltd., Menarini, Novo Nordisk A/S Korshak, Lauren .................................... Disclosed no confl ict of interest. Korte, Jeffrey E. ................................... Disclosed no confl ict of interest. Korytkowski, Mary T. ............................ Consultant: Regeneron Pharmaceuticals, Inc.; Research Sup-

port: Sanofi Koshinsky, Janice ................................. Consultant: Healthy Interactions, Merck Koshiyama, Hiroyuki ............................. Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc., Eli Lilly and Company, Kissei Pharmaceutical Co., Ltd., Merck Sharp & Dohme Limited, Mitsubishi Tanabe Pharmaceutical Corporation, Novo Nordisk, Inc.

Kosi, Lana ............................................. Disclosed no confl ict of interest. Koska, Juraj .......................................... Research Support: Amylin/Eli Lilly Kosmalski, Marcin ................................ Disclosed no confl ict of interest. Kostareva, Anna ................................... Disclosed no confl ict of interest. Kotak, Bhavesh ..................................... Employee: Ranbaxy Laboratories Limited Kotani, Kazuhiko ................................... Disclosed no confl ict of interest. Kothiwale, Shaila V. ............................. Disclosed no confl ict of interest. Kothiwale, Veerappa A. ....................... Disclosed no confl ict of interest. Kothny, Wolfgang ................................. Employee: Novartis Pharmaceuticals Corporation; Stock/

Shareholder: Novartis Pharmaceuticals Corporation Kotzka, Jörg .......................................... Disclosed no confl ict of interest. Koukoui, François ................................. Disclosed no confl ict of interest. Koulajian, Khajag ................................. Disclosed no confl ict of interest. Koutsides, Panayiotis ........................... Other Relationship: Novartis Pharmaceuticals Corporation,

Novo Nordisk A/S, Sanofi Kovacova, Zuzana ................................. Disclosed no confl ict of interest. Kovacs Burns, Katharina ...................... Advisory Panel: Novo Nordisk A/S; Speaker’s Bureau: Novo

Nordisk, Inc. Kovacs, Christopher ............................. Research Support: Boehringer Ingelheim GmbH & Co. KG Kovacs, Peter ........................................ Disclosed no confl ict of interest. Kovalenko, Oleksandr N. ...................... Disclosed no confl ict of interest. Kovatchev, Boris P. ............................... Advisory Panel: Animas Corporation; Other Relationship: John-

son & Johnson; Research Support: Amylin Pharmaceuticals, Inc., Animas Corporation, Dexcom, Inc., Insulet Corporation, Sanofi , Tandem Diabetes Care

Dow



A869


AU

THO

R D

ISCL

OSU

RE

Koves, Timothy R. ................................. Disclosed no confl ict of interest. Kowalska, Irina ..................................... Disclosed no confl ict of interest. Kowdley, Kris V. .................................... Disclosed no confl ict of interest. Koya, Daisuke ....................................... Disclosed no confl ict of interest. Kozek, Elzbieta ..................................... Disclosed no confl ict of interest. Kozinski, Marek .................................... Disclosed no confl ict of interest. Kozuka, Chisayo ................................... Disclosed no confl ict of interest. Kraegen, Edward W. ............................ Disclosed no confl ict of interest. Kraemer-Aguiar, Luiz Guilherme .......... Disclosed no confl ict of interest. Kraft, Guillaume ................................... Disclosed no confl ict of interest. Kraft, Thomas ....................................... Disclosed no confl ict of interest. Kraftson, Andrew T. ............................. Disclosed no confl ict of interest. Kragh, Nana ......................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Kraja, Aldi ............................................. Disclosed no confl ict of interest. Krakoff, Jonathan ................................. Disclosed no confl ict of interest. Kralisch, Susan ..................................... Disclosed no confl ict of interest. Krall, Jodi ............................................. Disclosed no confl ict of interest. Kramer, Caroline K. .............................. Disclosed no confl ict of interest. Kramer, M. Kaye ................................... Disclosed no confl ict of interest. Kramer, Mark H. ................................... Disclosed no confl ict of interest. Kramer, Michael R. ............................... Disclosed no confl ict of interest. Krarup, Thure ........................................ Disclosed no confl ict of interest. Krasner, Alan ........................................ Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc. Krasner, Nadia M. ................................ Disclosed no confl ict of interest. Kratzsch, Jurgen ................................... Disclosed no confl ict of interest. Kraus, William E. .................................. Research Support: Pfi zer, Inc. Krausch, Markus .................................. Disclosed no confl ict of interest. Kreidberg, Jordan ................................. Disclosed no confl ict of interest. Kren, Kari .............................................. Employee: Academy of Nutrition and Dietetics Krentz, Andrew J. ................................. Employee: Profi l Institute for Clinical Research, Inc. Kretowski, Adam .................................. Disclosed no confl ict of interest. Kretschmer, Karsten ............................. Disclosed no confl ict of interest. Kreul, Courtney ..................................... Disclosed no confl ict of interest. Kriauciunas, Kristina ............................ Disclosed no confl ict of interest. Kripalani, Sunil ..................................... Disclosed no confl ict of interest. Krischer, Jeffrey P. ................................ Disclosed no confl ict of interest. Krishna, Rajesh .................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Krishnamoorthy, Ezhilarasi ................... Disclosed no confl ict of interest. Krishnan, Rahul .................................... Disclosed no confl ict of interest. Krishnaswami, Shanthi ........................ Disclosed no confl ict of interest. Kriska, Andrea M. ................................ Disclosed no confl ict of interest. Kristensen, Holly D. .............................. Disclosed no confl ict of interest. Kristensen, Jonas M. ........................... Disclosed no confl ict of interest. Kristiansson, Kati ................................. Disclosed no confl ict of interest. Krivanek, Roland .................................. Employee: Eyesense GmbH Kroeber, Stefan M. ............................... Disclosed no confl ict of interest. Kroehl, Miranda ................................... Disclosed no confl ict of interest. Krogvold, Lars ....................................... Disclosed no confl ict of interest. Krol, Silke ............................................. Disclosed no confl ict of interest. Krolewski, Andrzej S. ........................... Disclosed no confl ict of interest. Kröller-Schön, Swenja ......................... Disclosed no confl ict of interest. Krowlikowski, Jacek ............................ Employee: Arena Pharmaceuticals, Inc. Kruger, Davida F. ................................... Research Support: Amylin Pharmaceutical; Speaker’s Bureau:

Amylin Pharmaceutical Krumholz, Harlan M. ............................ Research Support: Medtronic Krummel, Thierry .................................. Disclosed no confl ict of interest. Kruse, Michael ..................................... Disclosed no confl ict of interest. Krusenstjerna- Hafstrøm, Thomas ....... Disclosed no confl ict of interest. Krzizek, Eva C. ...................................... Disclosed no confl ict of interest. Krzywy, Henry J. ................................... Disclosed no confl ict of interest. Kuang, Jian .......................................... Disclosed no confl ict of interest. Kubat, Jessica ...................................... Disclosed no confl ict of interest. Kubica, Jacek ....................................... Disclosed no confl ict of interest. Kubota, Naoto ...................................... Disclosed no confl ict of interest. Kubota, Tetsuya .................................... Disclosed no confl ict of interest. Kuchroo, Vijay K. .................................. Disclosed no confl ict of interest. Kudlova, Pavla ...................................... Disclosed no confl ict of interest. Kudo, Yasusei ....................................... Disclosed no confl ict of interest. Kudo-Fujimaki, Kyoko ........................... Disclosed no confl ict of interest. Kudoh, Akihiro ...................................... Disclosed no confl ict of interest. Kudva, Yogish C. ................................... Disclosed no confl ict of interest. Kuhadiya, Nitesh .................................. Disclosed no confl ict of interest. Kuharenko, Svetlana ............................ Research Support: Novo Nordisk A/S Kuhn, Norine S. .................................... Disclosed no confl ict of interest. Kuhstoss, Debra ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Kuipers, Allison L. ................................ Disclosed no confl ict of interest. Kujath, Amber S. .................................. Disclosed no confl ict of interest. Kuk, Jennifer L. .................................... Disclosed no confl ict of interest. Kulich, Karoly ....................................... Employee: Novartis Pharmaceuticals Corporation

Kulkarni, Hemant .................................. Disclosed no confl ict of interest. Kulkarni, Rohit N. ................................. Research Support: AstraZeneca Pharmaceuticals LP, AstraZen-

eca/Bristol-Meyers Squibb Kuller, Lewis ......................................... Disclosed no confl ict of interest. Kulozik, Felix ......................................... Disclosed no confl ict of interest. Kulzer, Bernhard ................................... Advisory Panel: DAWN 2; Advisory Board: Roche Diagnostics,

sanofi -aventis; Research Support: Berlin Chemie, Eli Lilly and Company, Roche Diagnostics; Speaker’s Bureau: Berlin Chemie, Lifescan, Novo Nordisk, Inc.

Kumah-Crystal, Yaa .............................. Disclosed no confl ict of interest. Kumar, Ajay .......................................... Disclosed no confl ict of interest. Kumar, Anil ........................................... Disclosed no confl ict of interest. Kumar, Anjali ........................................ Disclosed no confl ict of interest. Kumar, Monica ..................................... Disclosed no confl ict of interest. Kumar, Prasanna .................................. Disclosed no confl ict of interest. Kumar, Sandeep ................................... Disclosed no confl ict of interest. Kumar, Sudhesh ................................... Disclosed no confl ict of interest. Kumareswaran, Kavita ......................... Disclosed no confl ict of interest. Kume, Shinji ......................................... Disclosed no confl ict of interest. Kumpatla, Satyavani ............................ Disclosed no confl ict of interest. Kunach, Margaret ................................ Disclosed no confl ict of interest. Kunkel, Steven D. ................................. Disclosed no confl ict of interest. Kunos, George ...................................... Disclosed no confl ict of interest. Kuntz, Martha ....................................... Disclosed no confl ict of interest. Kunze, Alexander ................................. Disclosed no confl ict of interest. Kuo, Calvin ........................................... Disclosed no confl ict of interest. Kuo, Chien-Hung .................................. Disclosed no confl ict of interest. Kuo, Hsiao-Mei .................................... Disclosed no confl ict of interest. Kuo, Ming-Shang ................................. Disclosed no confl ict of interest. Kuo, Shih Chen ..................................... Research Support: Sanofi Kupfer, Rosane ..................................... Disclosed no confl ict of interest. Kuppusamy, Selvan .............................. Disclosed no confl ict of interest. Kuribayashi, Nobuichi .......................... Disclosed no confl ict of interest. Kurioka, Soichi ..................................... Disclosed no confl ict of interest. Kurisaki, Hironori .................................. Disclosed no confl ict of interest. Kurita, Yayoi ......................................... Disclosed no confl ict of interest. Kuroda, Akio ......................................... Disclosed no confl ict of interest. Kuroda, Masashi .................................. Disclosed no confl ict of interest. Kuroha, Masanori ................................. Employee: Daiichi-Sankyo, Inc. Kurose, Takeshi .................................... Speaker’s Bureau: Eli Lilly and Company, Novartis Pharmaceu-

ticals Corporation, Novo Nordisk, Inc. Kurt, Omer ............................................ Disclosed no confl ict of interest. Kurtz, Melisa ........................................ Disclosed no confl ict of interest. Kurtz, Natalie ....................................... Employee: Medtronic Kuruvilla, Jes ........................................ Disclosed no confl ict of interest. Kusada, Noriko ..................................... Disclosed no confl ict of interest. Kushiyama, Akifumi ............................. Disclosed no confl ict of interest. Kushner, Robert .................................... Advisory Panel: GI Dynamics, Retrofi t, Vivus, Inc.; Board Mem-

ber: Obesity Action Coalition (OAC); Other Relationship: Novo Nordisk, Inc., Weight Watchers

Kusumoto, Yukie ................................... Disclosed no confl ict of interest. Kusunoki, Masataka ............................. Disclosed no confl ict of interest. Kutoh, Eiji ............................................. Disclosed no confl ict of interest. Kuwata, Hirohito .................................. Disclosed no confl ict of interest. Kuwata, Hitoshi .................................... Disclosed no confl ict of interest. Kuzuya, Hideshi .................................... Disclosed no confl ict of interest. Kvasnicka, Jan ..................................... Disclosed no confl ict of interest. Kwak, Soo Heon ................................... Disclosed no confl ict of interest. Kwitek, Anne ........................................ Disclosed no confl ict of interest. Kwon, Eun-Jeong ................................. Disclosed no confl ict of interest. Kwon, Eunjin ........................................ Disclosed no confl ict of interest. Kwon, Hee Sun ..................................... Disclosed no confl ict of interest. Kwon, Hyuk-Sang ................................. Disclosed no confl ict of interest. Kwon, Obin ........................................... Disclosed no confl ict of interest. Kwon, Se Chang ................................... Disclosed no confl ict of interest. Kyaw Tun, Tommy ................................ Disclosed no confl ict of interest. Kyithar, Ma P. ....................................... Disclosed no confl ict of interest. Kyriakidou-Himonas, Marinella ........... Other Relationship: Novartis Pharmaceuticals Corporation,

Sanofi Kyung, Chanhee ................................... Disclosed no confl ict of interest. La Fleur, Susanne E. ............................. Disclosed no confl ict of interest. La Hausse de Lalouviere, Veronique M. .. Disclosed no confl ict of interest. La Spina, Nadia .................................... Disclosed no confl ict of interest. Laakso, Markku .................................... Advisory Panel: Merck; Consultant: Boehringer Ingelheim GmbH

& Co. KG, Eli Lilly and Company, Novartis Pharmaceuticals Corporation; Research Support: Novo Nordisk A/S

Labarbuta, Rossella .............................. Disclosed no confl ict of interest. Labbé, Sébastien M. ............................ Disclosed no confl ict of interest. Labonville, Stephanie ........................... Disclosed no confl ict of interest. Lacadie, Cheryl M. ............................... Disclosed no confl ict of interest. Lacapa, Rochelle .................................. Disclosed no confl ict of interest. Lache, Orit ............................................ Disclosed no confl ict of interest.

Dow



A870


AU

THO

R D

ISCL

OSU

RE

Lachin, John M. .................................... Consultant: Boehringer Ingelheim GmbH & Co. KG Lachmann, Robin H. ............................. Disclosed no confl ict of interest. Lacinova, Zdenka .................................. Disclosed no confl ict of interest. LaCruz, Debby M. ................................. Research Support: Sanofi US Ladenvall, Claes ................................... Disclosed no confl ict of interest. Laferrere, Blandine ............................... Disclosed no confl ict of interest. Laffel, Lori M. ....................................... Advisory Panel: Bristol-Myers Squibb Company, Sanofi ;

Consultant: Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Lifescan Animas, Inc., Menarini, Sanofi

Lafi ta, Francisco Javier ........................ Disclosed no confl ict of interest. Lafrance, Jean-Philippe ....................... Disclosed no confl ict of interest. Lage, Maureen J. ................................. Consultant: Eli Lilly and Company; Research Support: Eli Lilly

and Company Lagou, Vasiliki ...................................... Disclosed no confl ict of interest. Lahti, Jari ............................................. Disclosed no confl ict of interest. Lai, Chien C. ......................................... Disclosed no confl ict of interest. Lai, Mei-Shu ......................................... Disclosed no confl ict of interest. Lai, Olive ............................................... Disclosed no confl ict of interest. Lai, Vesta .............................................. Disclosed no confl ict of interest. Lai, Xiaoyang ........................................ Disclosed no confl ict of interest. Lai, Ying-Chuen .................................... Disclosed no confl ict of interest. Lainez, Elden ........................................ Employee: GlaxoSmithKline Laiteerapong, Neda .............................. Disclosed no confl ict of interest. Lakdawalla, Darius ............................... Other Relationship: Precision Health Economics Lake, Kristin .......................................... Disclosed no confl ict of interest. Lake, Samuel ........................................ Disclosed no confl ict of interest. Lakey, Jonathan R. ............................... Disclosed no confl ict of interest. Lakshmanan, Mark ............................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Lalia, Antigoni ...................................... Disclosed no confl ict of interest. Lally, Jayasree ...................................... Disclosed no confl ict of interest. Lam, Karen Siu Ling ............................. Disclosed no confl ict of interest. Lam, Loretta ......................................... Disclosed no confl ict of interest. Lam, Que .............................................. Disclosed no confl ict of interest. Lam, Tai Hing ........................................ Disclosed no confl ict of interest. Lam, Tony K. ......................................... Disclosed no confl ict of interest. Lam, Vincent K. .................................... Disclosed no confl ict of interest. Lam, Yan Y. ........................................... Disclosed no confl ict of interest. Lamacchia, Olga ................................... Disclosed no confl ict of interest. Lamarche, Marie .................................. Disclosed no confl ict of interest. Lamb, Molly M. .................................... Disclosed no confl ict of interest. Lamb, Morgan ...................................... Disclosed no confl ict of interest. Lamendola, Cindy ................................. Disclosed no confl ict of interest. Lamichhane, Archana P. ....................... Disclosed no confl ict of interest. Lammer, Jan ......................................... Disclosed no confl ict of interest. Lammers, Reiner .................................. Disclosed no confl ict of interest. Lamontagne, Julien .............................. Disclosed no confl ict of interest. Lamotte, Mark ...................................... Consultant: IMS HEOR Lamprinou, Apostolia ........................... Disclosed no confl ict of interest. Lanas, Angel ......................................... Consultant: Pozen, Inc. Landau, Zohar ....................................... Consultant: Andromeda Biotech, Ltd. Landau-Rabbi, Moran ........................... Disclosed no confl ict of interest. Landgraf, Wolfgang ............................. Employee: Sanofi Landis, Carolyn ..................................... Disclosed no confl ict of interest. Landry, Anne ......................................... Disclosed no confl ict of interest. Landsbaugh, Jill R. ............................... Disclosed no confl ict of interest. Lane, James T. ..................................... Research Support: Andromeda Biotech, Ltd., Boeh-

ringer Ingelheim Pharmaceuticals, Inc., Corcept, EMD Serono, GlaxoSmithKline, Merck, Novo Nordisk, Inc., PhaseBiopPharmacuticals, Inc., sanofi, Tranzyme, VMBiopharma

Lanes, Stephan ..................................... Research Support: Eli Lilly and Company Lang, Jiangming ................................... Disclosed no confl ict of interest. Lang, Leonie ......................................... Disclosed no confl ict of interest. Lange, Kylie .......................................... Disclosed no confl ict of interest. Langefeld, Carl D. ................................. Disclosed no confl ict of interest. Langermann, Solomon ......................... Disclosed no confl ict of interest. Langin, Dominique ............................... Disclosed no confl ict of interest. Langkilde, AnnaMaria .......................... Employee: AstraZeneca Pharmaceuticals LP; Stock/Share-

holder: AstraZeneca Pharmaceuticals LP Langlais, Paul R. ................................... Disclosed no confl ict of interest. Langlois, Valerie ................................... Disclosed no confl ict of interest. Langwell, Kathy .................................... Disclosed no confl ict of interest. Lansang, Cecilia ................................... Disclosed no confl ict of interest. Lansang, Maria C. ................................ Disclosed no confl ict of interest. Lantier, Louise ...................................... Disclosed no confl ict of interest. Lantieri, Olivier ..................................... Disclosed no confl ict of interest. Lanuti, Paola ......................................... Disclosed no confl ict of interest. Lanza, Ian ............................................. Disclosed no confl ict of interest. Lao, Julie .............................................. Employee: Merck Lapice, Emanuela ................................. Disclosed no confl ict of interest.

Lapolla, Annunziata .............................. Disclosed no confl ict of interest. LaPorte, Ronald .................................... Disclosed no confl ict of interest. Lappas, Martha .................................... Disclosed no confl ict of interest. Lapuerta, Pablo .................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Larbig, Martin ....................................... Employee: Boehringer Ingelheim GmbH & Co. KG Largajolli, Anna .................................... Disclosed no confl ict of interest. Largay, Joseph ..................................... Disclosed no confl ict of interest. Larijani, Bagher .................................... Disclosed no confl ict of interest. Lark, Daniel .......................................... Disclosed no confl ict of interest. Larkin, Mary E. ..................................... Disclosed no confl ict of interest. LaRosa, Stefano ................................... Disclosed no confl ict of interest. Larsen, Anine ....................................... Employee: HypoSafe A/S Larsen, Tricia ........................................ Disclosed no confl ict of interest. Larson, Richard A. ................................ Consultant: Ariad, Bristol-Myers Squibb Company, Novartis

Pharmaceuticals Corporation, Pfi zer, Inc.; Other Relation-ship: Novartis Pharmaceuticals Corporation; Research Support: Ariad, Bristol-Myers Squibb Company, Novartis Pharmaceuticals Corporation

Larsson, Helena .................................... Disclosed no confl ict of interest. Larter, Claire ......................................... Disclosed no confl ict of interest. Laselva, Claudia R. ............................... Disclosed no confl ict of interest. Lassance, Luciana ................................ Disclosed no confl ict of interest. Lassance, Marcio ................................. Disclosed no confl ict of interest. Laston, Sandra ..................................... Disclosed no confl ict of interest. Lastoria, Giusi ...................................... Employee: Novo Nordisk, Inc. Lastra, Guido ........................................ Disclosed no confl ict of interest. Lathouris, Panagiotis ............................ Research Support: VeraLight, Inc. Latif, Zafar A. ....................................... Disclosed no confl ict of interest. Latremouille-Viau, Dominick ................ Research Support: Takeda Pharmaceutical Company, Ltd. Laturnus, Donna ................................... Disclosed no confl ict of interest. Lau, Eric S. ............................................ Disclosed no confl ict of interest. Lau, Kam Piu ......................................... Disclosed no confl ict of interest. Lau, Raymond G. .................................. Disclosed no confl ict of interest. Laubner, Katharina ............................... Disclosed no confl ict of interest. Lauf, Ryan ............................................. Disclosed no confl ict of interest. Laufs, Alessandra ................................. Disclosed no confl ict of interest. Laugenour, Kelly ................................... Disclosed no confl ict of interest. Laugesen, Esben .................................. Disclosed no confl ict of interest. Lauria, Angelo ...................................... Disclosed no confl ict of interest. Lauritzen, Torsten ................................. Stock/Shareholder: Novo Nordisk A/S Lauro, Davide ....................................... Disclosed no confl ict of interest. Lauro, Renato ....................................... Disclosed no confl ict of interest. Lautz, David B. ...................................... Research Support: Covidien Lautz, Margaret .................................... Disclosed no confl ict of interest. Lavalle González, Fernando J. .............. Advisory Panel: Merck Sharpe and Dohme, Sanofi , Novo

Nordisk, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Janssen, Eli Lilly and Company, Novartis; Research Support: MSD, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, Sanofi , Pfi zer, Inc., Janssen, Novo Nordisk, Inc.; Speaker’s Bureau: Merck Sharpe and Dohme, Sanofi , Novo Nordisk, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Janssen, Eli Lilly and Company, Novartis

Lavietes, Sylvia .................................... Disclosed no confl ict of interest. Laviola, Luigi ........................................ Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb,

Boehringer Ingelheim Pharmaceuticals, Inc. Law, Jennie H. ...................................... Disclosed no confl ict of interest. Lawlor, Michael S. ............................... Disclosed no confl ict of interest. Lawrence, Jean M. .............................. Disclosed no confl ict of interest. Lazartigues, Eric ................................... Disclosed no confl ict of interest. Le Berre, Jean-Philippe ........................ Disclosed no confl ict of interest. Le Floch, Jean-Pierre ............................ Consultant: Abbott Diabetes Care, BD Medical Diabetes Care,

Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi

Le Foll, Christelle .................................. Disclosed no confl ict of interest. Le Roux, Carel W. ................................. Disclosed no confl ict of interest. Le, Aimee ............................................. Disclosed no confl ict of interest. Le, Yun-Zheng ....................................... Disclosed no confl ict of interest. Leahy, Jack L. ....................................... Advisory Panel: Adventis, Janssen Pharmaceuticals, Novartis,

Merck, Valeritas Leahy, John L. ....................................... Advisory Panel: Aventis, Janssen Pharmaceuticals, Merck,

Novo Nordisk, Inc., Valeritas, LLC; Research Support: Takeda Pharmaceuticals U.S.A., Inc.

Leal, Angela M. .................................... Disclosed no confl ict of interest. Lebel, Stephane ................................... Disclosed no confl ict of interest. LeBlanc, Erin S. .................................... Research Support: Amgen, Inc., AstraZeneca/Bristol-Meyers

Squibb Leblanc, Mathias .................................. Disclosed no confl ict of interest. Lebovitz, Harold E. ................................ Consultant: Metacure LeCaire, Tamara J. ............................... Disclosed no confl ict of interest. LeCates, Robert .................................... Disclosed no confl ict of interest.

Dow



A871


AU

THO

R D

ISCL

OSU

RE

Lechuga, Rodrigo .................................. Disclosed no confl ict of interest. Leclair, Erwan ....................................... Disclosed no confl ict of interest. Lecomte, Roger .................................... Disclosed no confl ict of interest. Lecoultre, Virgile .................................. Disclosed no confl ict of interest. Lecube, Albert ...................................... Disclosed no confl ict of interest. Ledur, Priscila S. ................................... Disclosed no confl ict of interest. Lee, Alana ............................................ Disclosed no confl ict of interest. Lee, Amy S. .......................................... Disclosed no confl ict of interest. Lee, Augustine M. ................................ Disclosed no confl ict of interest. Lee, Brian ............................................. Disclosed no confl ict of interest. Lee, Byung-Wan ................................... Disclosed no confl ict of interest. Lee, Chia-lin ......................................... Disclosed no confl ict of interest. Lee, Choogon ........................................ Disclosed no confl ict of interest. Lee, Chris .............................................. Employee: Takeda Pharmaceutical Company, Ltd. Lee, Christine C. ................................... Disclosed no confl ict of interest. Lee, Dae-Ho .......................................... Disclosed no confl ict of interest. Lee, Darwin V. ...................................... Employee: Pfi zer, Inc. Lee, Dong Hoon .................................... Disclosed no confl ict of interest. Lee, Dong-Hwa ..................................... Disclosed no confl ict of interest. Lee, Eun Soo ......................................... Disclosed no confl ict of interest. Lee, Eun Young ..................................... Disclosed no confl ict of interest. Lee, Eunjung ......................................... Disclosed no confl ict of interest. Lee, Gyu Hwang ................................... Disclosed no confl ict of interest. Lee, Hak Mo ......................................... Disclosed no confl ict of interest. Lee, Hangkyu ........................................ Disclosed no confl ict of interest. Lee, Heung Man ................................... Disclosed no confl ict of interest. Lee, Hong Seok .................................... Disclosed no confl ict of interest. Lee, Hyejin ............................................ Disclosed no confl ict of interest. Lee, Hye-Kyoung .................................. Disclosed no confl ict of interest. Lee, Hyoung Woo ................................. Disclosed no confl ict of interest. Lee, Hyun Chul ..................................... Disclosed no confl ict of interest. Lee, Hyunjeong ..................................... Disclosed no confl ict of interest. Lee, I-Fang ............................................ Disclosed no confl ict of interest. Lee, In-Kyu ............................................ Disclosed no confl ict of interest. Lee, I-Te ................................................ Disclosed no confl ict of interest. Lee, James ........................................... Disclosed no confl ict of interest. Lee, JeongKyung .................................. Disclosed no confl ict of interest. Lee, Jeong-Sang .................................. Disclosed no confl ict of interest. Lee, Ji-Hye ........................................... Disclosed no confl ict of interest. Lee, Jin-sook ........................................ Disclosed no confl ict of interest. Lee, Jongsoon ...................................... Disclosed no confl ict of interest. Lee, Jong-Young ................................... Disclosed no confl ict of interest. Lee, Joon Bok ....................................... Disclosed no confl ict of interest. Lee, Jo-Ping .......................................... Disclosed no confl ict of interest. Lee, Joseph .......................................... Disclosed no confl ict of interest. Lee, Joyce M. ....................................... Disclosed no confl ict of interest. Lee, Joyce Y. ......................................... Disclosed no confl ict of interest. Lee, Julie .............................................. Disclosed no confl ict of interest. Lee, Jung-Min ...................................... Disclosed no confl ict of interest. Lee, Justin ............................................ Employee: Dose Safety Company Lee, Kevin Y. ......................................... Disclosed no confl ict of interest. Lee, Ki Won .......................................... Disclosed no confl ict of interest. Lee, Kwan Woo .................................... Disclosed no confl ict of interest. Lee, Kyoung Bun ................................... Disclosed no confl ict of interest. Lee, Kyu Hang ...................................... Disclosed no confl ict of interest. Lee, KyuMin ......................................... Disclosed no confl ict of interest. Lee, Kyung Ae ...................................... Disclosed no confl ict of interest. Lee, Mi Young ...................................... Disclosed no confl ict of interest. Lee, Michael ......................................... Disclosed no confl ict of interest. Lee, Michael Y. ..................................... Disclosed no confl ict of interest. Lee, Michelle L. .................................... Disclosed no confl ict of interest. Lee, Min Jeong .................................... Disclosed no confl ict of interest. Lee, Min Suk ........................................ Disclosed no confl ict of interest. Lee, Min-Young .................................... Disclosed no confl ict of interest. Lee, MyungShik .................................... Disclosed no confl ict of interest. Lee, Pearl G. ......................................... Disclosed no confl ict of interest. Lee, Ronald D. ...................................... Employee: Takeda Global Research & Development Center,

Inc. Lee, Sang Ah ........................................ Disclosed no confl ict of interest. Lee, Sang-Il .......................................... Disclosed no confl ict of interest. Lee, Sarah ............................................ Disclosed no confl ict of interest. Lee, Scott W. ........................................ Employee: Medtronic Lee, Seong Su ...................................... Disclosed no confl ict of interest. Lee, Seung Hwan ................................. Disclosed no confl ict of interest. Lee, Seung Ku ...................................... Disclosed no confl ict of interest. Lee, Seunghun P. .................................. Employee: Janssen Research & Development Lee, Seung-Hwan ................................. Disclosed no confl ict of interest. Lee, Sojin .............................................. Disclosed no confl ict of interest. Lee, SoJung .......................................... Disclosed no confl ict of interest. Lee, Sunghwa ....................................... Disclosed no confl ict of interest. Lee, Susi ............................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited

Lee, Won Young ................................... Disclosed no confl ict of interest. Lee, Woo Je ......................................... Disclosed no confl ict of interest. Lee, Yenna ............................................ Disclosed no confl ict of interest. Lee, Yong Hee ...................................... Disclosed no confl ict of interest. Lee, Yong-ho ......................................... Disclosed no confl ict of interest. Lee, Young Mi ...................................... Disclosed no confl ict of interest. Lee, Young Ran ..................................... Disclosed no confl ict of interest. Lee, Youn-Kyoung ................................. Disclosed no confl ict of interest. Lee, Yu L. .............................................. Disclosed no confl ict of interest. Lee, Yuan-Chi ....................................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Novo

Nordisk, Inc. Lee, Yu-Ri ............................................. Disclosed no confl ict of interest. Leelarathna, Lalantha .......................... Disclosed no confl ict of interest. Leem, Jaechan ..................................... Disclosed no confl ict of interest. Lefai, Etienne ....................................... Disclosed no confl ict of interest. Lefevre, Cinira ...................................... Employee: Eli Lilly and Company Lefkovits, Jeffrey .................................. Disclosed no confl ict of interest. Lefl och, Jean-Pierre ............................. Disclosed no confl ict of interest. Legato, Lauren J. .................................. Disclosed no confl ict of interest. Legrand, Sylvie ..................................... Disclosed no confl ict of interest. Lehert, Philippe .................................... Consultant: Merck Lehki, Barbara ...................................... Disclosed no confl ict of interest. Lehmann, Anne .................................... Employee: Sanofi Lei, Xiaoyong ........................................ Disclosed no confl ict of interest. Leibiger, Ingo ........................................ Disclosed no confl ict of interest. Leibovitz, Eyal ....................................... Disclosed no confl ict of interest. Leibson, Cynthia L. ............................... Research Support: Abbott Laboratories, Inc. Leiherer, Andreas ................................. Disclosed no confl ict of interest. Leinwand, Leslie A. .............................. Disclosed no confl ict of interest. Leiria, Liana F. ....................................... Disclosed no confl ict of interest. Leissring, Malcolm A. .......................... Disclosed no confl ict of interest. Leitão, Cristiane B. ............................... Disclosed no confl ict of interest. Leiter, Lawrence A. .............................. Advisory Panel: GlaxoSmithKline; Consultant: GlaxoSmithKline Leitner, Miriam ..................................... Disclosed no confl ict of interest. Lellis-Santos, Camilo ........................... Disclosed no confl ict of interest. Leng, Lin ............................................... Disclosed no confl ict of interest. Lenhard, M. James .............................. Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc.,

Merck, Sanofi Lennerz, Belinda S. ............................... Disclosed no confl ict of interest. Lennon, James ..................................... Disclosed no confl ict of interest. Leon, Ben .............................................. Disclosed no confl ict of interest. Leon, Lina ............................................. Disclosed no confl ict of interest. Leonardini, Anna .................................. Research Support: Eli Lilly and Company Leon-Chi, Lucero ................................... Disclosed no confl ict of interest. Leone, Alessandro ................................ Disclosed no confl ict of interest. Leone, Angela F. ................................... Disclosed no confl ict of interest. Leone-Jones, Angela ........................... Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

Kline Leonetti, Donna L. ................................ Disclosed no confl ict of interest. Leonetti, Frida ...................................... Disclosed no confl ict of interest. Leong, Amanda .................................... Disclosed no confl ict of interest. Leong, Wen Bun ................................... Disclosed no confl ict of interest. Leonte, Laura ........................................ Disclosed no confl ict of interest. Lepore, Vito .......................................... Disclosed no confl ict of interest. Lerin, Carles ......................................... Disclosed no confl ict of interest. Lerner-Geva, Liat .................................. Disclosed no confl ict of interest. Lernmark, Åke ...................................... Disclosed no confl ict of interest. LeRoith, Derek ...................................... Consultant: AstraZeneca/Bristol-Meyers Squibb, Merck, Novo

Nordisk, Inc., Sanofi ; Research Support: Sanofi Leroy, Clara ........................................... Disclosed no confl ict of interest. Lertwattanarak, Raweewan ................. Disclosed no confl ict of interest. Lervang, Hans Henrik ........................... Disclosed no confl ict of interest. Leslie, Daniel ........................................ Disclosed no confl ict of interest. Leslie, Richard-David G. ....................... Disclosed no confl ict of interest. Leslie, Simon J. .................................... Disclosed no confl ict of interest. Lesser, Martin L. ................................... Disclosed no confl ict of interest. Leu, Hsin-Bang ..................................... Disclosed no confl ict of interest. Leung, Gigi ........................................... Disclosed no confl ict of interest. Leung, Man-Fuk .................................... Disclosed no confl ict of interest. Levetan, Claresa S. .............................. Stock/Shareholder: CureDM, Inc. Levi, Moshe .......................................... Disclosed no confl ict of interest. Levin, Barry E. ....................................... Disclosed no confl ict of interest. Levin, Nancy ......................................... Disclosed no confl ict of interest. Levin, Susan ......................................... Disclosed no confl ict of interest. Levine, Elizabeth .................................. Disclosed no confl ict of interest. Levine, James A. .................................. Disclosed no confl ict of interest. Levitsky, Lynne ..................................... Disclosed no confl ict of interest. Levy, Adrian R. ...................................... Disclosed no confl ict of interest. Levy, Andrew P. .................................... Consultant: Haptocure; Other Relationship: Rappaport

Institute Levy, Hara ............................................. Disclosed no confl ict of interest. Levy, Nina S. ......................................... Disclosed no confl ict of interest.

Dow



A872


AU

THO

R D

ISCL

OSU

RE

Lewin, Andrew ..................................... Research Support: Akros Pharma, Inc., Amylin Pharmaceu-ticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Gilead Sciences, Inc., Merck, Metabolic Solutions Development Co., N-Gene, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfi zer, Inc., PhaseBio Pharmaceuticals, Inc., Shionogi, Inc., Theracos, TransTech Pharma, TWI Bio, XOMA, Ltd.

Lewis, Alfor G. ...................................... Disclosed no confl ict of interest. Lewis, Cora E. ....................................... Disclosed no confl ict of interest. Lewis, Gary F. ....................................... Disclosed no confl ict of interest. Lewis, Megan A. .................................. Disclosed no confl ict of interest. Lewis, Monique K. ............................... Disclosed no confl ict of interest. Lewis-Schroeder, Nina F. ...................... Disclosed no confl ict of interest. Leya, Marysa ........................................ Disclosed no confl ict of interest. Lhomme, Laurent .................................. Disclosed no confl ict of interest. Li, Bonnie H. ......................................... Disclosed no confl ict of interest. Li, Can ................................................... Disclosed no confl ict of interest. Li, Changhong ....................................... Disclosed no confl ict of interest. Li, Chendi .............................................. Disclosed no confl ict of interest. Li, Chengjiang ....................................... Consultant: Takeda Global Research & Development Center,

Inc. Li, Chia-Ing ........................................... Disclosed no confl ict of interest. Li, Ching -Lu .......................................... Disclosed no confl ict of interest. Li, Chunlin ............................................. Disclosed no confl ict of interest. Li, Chunyan ........................................... Disclosed no confl ict of interest. Li, Daliang ............................................ Disclosed no confl ict of interest. Li, Di ..................................................... Disclosed no confl ict of interest. Li, Diancheng ........................................ Disclosed no confl ict of interest. Li, Elizabeth .......................................... Disclosed no confl ict of interest. Li, Fei .................................................... Disclosed no confl ict of interest. Li, Feng ................................................. Disclosed no confl ict of interest. Li, Gang ................................................ Employee: Lifescan Animas, Inc. Li, Guangwei ........................................ Disclosed no confl ict of interest. Li, GuoDong .......................................... Disclosed no confl ict of interest. Li, Hai ................................................... Disclosed no confl ict of interest. Li, Heng ................................................ Disclosed no confl ict of interest. Li, Hong ................................................ Disclosed no confl ict of interest. Li, Hongmei .......................................... Employee: Bristol-Myers Squibb Company Li, Huating ............................................ Disclosed no confl ict of interest. Li, Hui ................................................... Disclosed no confl ict of interest. Li, Ji ...................................................... Disclosed no confl ict of interest. Li, Jianping ........................................... Disclosed no confl ict of interest. Li, Jianwei ............................................ Disclosed no confl ict of interest. Li, Jie .................................................... Disclosed no confl ict of interest. Li, Jin .................................................... Disclosed no confl ict of interest. Li, Jing .................................................. Disclosed no confl ict of interest. Li, Jingming .......................................... Disclosed no confl ict of interest. Li, Kathy ................................................ Disclosed no confl ict of interest. Li, Lan ................................................... Disclosed no confl ict of interest. Li, Lianxi ............................................... Disclosed no confl ict of interest. Li, Licheng ............................................ Disclosed no confl ict of interest. Li, Ling .................................................. Disclosed no confl ict of interest. Li, Liwu ................................................. Disclosed no confl ict of interest. Li, Mei .................................................. Disclosed no confl ict of interest. Li, Mengyao .......................................... Disclosed no confl ict of interest. Li, Min-Dian .......................................... Disclosed no confl ict of interest. Li, Ming ................................................ Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc. Li, Mingshan ......................................... Disclosed no confl ict of interest. Li, Mingzi .............................................. Disclosed no confl ict of interest. Li, Pengqiu ............................................ Disclosed no confl ict of interest. Li, Qian ................................................. Consultant: Eli Lilly and Company, Novo Nordisk, Inc. Li, Qiang ............................................... Disclosed no confl ict of interest. Li, Qifu .................................................. Disclosed no confl ict of interest. Li, Qiuhong ........................................... Disclosed no confl ict of interest. Li, Quanmin .......................................... Disclosed no confl ict of interest. Li, Renyuan ........................................... Disclosed no confl ict of interest. Li, Rui .................................................... Disclosed no confl ict of interest. Li, Samantha K. .................................... Disclosed no confl ict of interest. Li, Shaoqing .......................................... Disclosed no confl ict of interest. Li, Sheng ............................................... Disclosed no confl ict of interest. Li, Shiri ................................................. Disclosed no confl ict of interest. Li, Shuying ............................................ Disclosed no confl ict of interest. Li, Sierra M. .......................................... Disclosed no confl ict of interest. Li, Song-Pei .......................................... Disclosed no confl ict of interest. Li, Tsai-Chung ....................................... Disclosed no confl ict of interest. Li, Wei .................................................. Disclosed no confl ict of interest. Li, Weida .............................................. Disclosed no confl ict of interest. Li, Wei-Dong ........................................ Disclosed no confl ict of interest. Li, Wen-hong ........................................ Disclosed no confl ict of interest. Li, Wenhui ............................................ Consultant: Takeda Global Research & Development Center, Inc. Li, Wenjing ........................................... Disclosed no confl ict of interest.

Li, Wenjun ............................................ Disclosed no confl ict of interest. Li, Wenqing .......................................... Disclosed no confl ict of interest. Li, Xiaofeng .......................................... Disclosed no confl ict of interest. Li, Xiaohong .......................................... Disclosed no confl ict of interest. Li, Xiaokun ............................................ Disclosed no confl ict of interest. Li, Xiaolong ........................................... Employee: Medtronic Li, Xiaoming .......................................... Disclosed no confl ict of interest. Li, Xiaoqian ........................................... Disclosed no confl ict of interest. Li, Xiaowen ........................................... Disclosed no confl ict of interest. Li, Xilong ............................................... Disclosed no confl ict of interest. Li, Xinli .................................................. Disclosed no confl ict of interest. Li, Xiujiang ............................................ Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Li, Xiujun ............................................... Disclosed no confl ict of interest. Li, Xuehai .............................................. Disclosed no confl ict of interest. Li, Xuejun .............................................. Disclosed no confl ict of interest. Li, Xuezheng ......................................... Disclosed no confl ict of interest. Li, Yabin ................................................ Disclosed no confl ict of interest. Li, Yajun ................................................ Disclosed no confl ict of interest. Li, Yan ................................................... Employee: Amylin Pharmaceuticals, LLC Li, Yan F. ................................................ Disclosed no confl ict of interest. Li, Yanbing ............................................ Disclosed no confl ict of interest. Li, Yanchun ........................................... Disclosed no confl ict of interest. Li, YanFeng ........................................... Disclosed no confl ict of interest. Li, Yang ................................................. Disclosed no confl ict of interest. Li, Yangyang ......................................... Disclosed no confl ict of interest. Li, Yiming .............................................. Disclosed no confl ict of interest. Li, Ying .................................................. Disclosed no confl ict of interest. Li, YouYou ............................................. Disclosed no confl ict of interest. Li, Yu ..................................................... Disclosed no confl ict of interest. Li, Yu feng ............................................. Disclosed no confl ict of interest. Li, Yun ................................................... Disclosed no confl ict of interest. Li, Yunxiang .......................................... Disclosed no confl ict of interest. Li, Yupeng ............................................. Disclosed no confl ict of interest. Li, Yuxiu ................................................ Speaker’s Bureau: Eli Lilly and Company, Merck, Novo Nordisk

A/S, Pfi zer, Inc. Li, Zhao ................................................. Disclosed no confl ict of interest. Li, Zhipeng ............................................ Disclosed no confl ict of interest. Li, Zhonggang ....................................... Disclosed no confl ict of interest. Li, Zhuo ................................................. Disclosed no confl ict of interest. Li, Zhuokai ............................................ Disclosed no confl ict of interest. Li, Zibo .................................................. Disclosed no confl ict of interest. Lian, Jean F. .......................................... Employee: Novo Nordisk, Inc. Liang, Bradley C. .................................. Employee: Medtronic Liang, Da-Li .......................................... Disclosed no confl ict of interest. Liang, Guang ........................................ Disclosed no confl ict of interest. Liang, Hanyu ......................................... Disclosed no confl ict of interest. Liang, Hua ............................................ Disclosed no confl ict of interest. Liang, Juan ........................................... Disclosed no confl ict of interest. Liang, Junxing ...................................... Disclosed no confl ict of interest. Liang, Miranda ..................................... Disclosed no confl ict of interest. Liang, Qiangrong .................................. Disclosed no confl ict of interest. Liang, Shi .............................................. Employee: GlaxoSmithKline Liang, Sitai ........................................... Disclosed no confl ict of interest. Liang, Tao ............................................. Disclosed no confl ict of interest. Liang, Weiwei ...................................... Disclosed no confl ict of interest. Liang, Weiwen ..................................... Disclosed no confl ict of interest. Liang, Xinyun ........................................ Disclosed no confl ict of interest. Liang, Yin .............................................. Employee: Janssen Research & Development Liang, Ying ............................................ Disclosed no confl ict of interest. Liang, Yuanjie ....................................... Consultant: Novo Nordisk, Inc. Liao, Guangneng .................................. Disclosed no confl ict of interest. Liaskos, Christos .................................. Disclosed no confl ict of interest. Liatis, Stavros ....................................... Disclosed no confl ict of interest. Libby, Anne M. ..................................... Disclosed no confl ict of interest. Liberman, Joshua ................................. Disclosed no confl ict of interest. Libetta, Carmelo ................................... Disclosed no confl ict of interest. Libianto, Renata ................................... Disclosed no confl ict of interest. Libman, Ingrid M. ................................. Disclosed no confl ict of interest. Licata, Angelo ...................................... Disclosed no confl ict of interest. Lichtenberg, Artur ................................ Disclosed no confl ict of interest. Lieberman, Rachel ................................ Disclosed no confl ict of interest. Liebl, Andreas ...................................... Advisory Panel: Roche Diagnostics GmbH; Research Support:

Roche Diagnostics GmbH Lien, Lillian ........................................... Consultant: Eli Lilly and Company, Merck, Sanofi Liese, Angela D. ................................... Disclosed no confl ict of interest. Lieske, Stefanie .................................... Disclosed no confl ict of interest. Lievre, Michel ....................................... Board Member: Abbott, AstraZeneca Pharmaceuticals LP,

Bard, Boston Scientifi c, Cordis, Johnson & Johnson, Medtronics, Merck-Serono, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Takeda Pharmaceutical Company, Ltd., Terumo Medical

Dow



A873


AU

THO

R D

ISCL

OSU

RE

Liew, Chong Wee ................................. Disclosed no confl ict of interest. Liggins, Richard .................................... Disclosed no confl ict of interest. Ligory, Christopher ............................... Disclosed no confl ict of interest. Ligthart, Symen .................................... Disclosed no confl ict of interest. Liljenquist, David R. ............................. Disclosed no confl ict of interest. Lilly, Leslie C. ........................................ Employee: CeQur, Ltd. Lillycrop, Karen A. ................................ Disclosed no confl ict of interest. Lim, Chang Ki ....................................... Disclosed no confl ict of interest. Lim, Ee Lin ............................................ Disclosed no confl ict of interest. Lim, Ee Mun ......................................... Disclosed no confl ict of interest. Lim, Gareth E. ....................................... Disclosed no confl ict of interest. Lim, Jung Soo ....................................... Disclosed no confl ict of interest. Lim, MinJung ....................................... Disclosed no confl ict of interest. Lim, Sai Kiang ...................................... Disclosed no confl ict of interest. Lim, Soo ................................................ Disclosed no confl ict of interest. Lima, Fabio B. ....................................... Disclosed no confl ict of interest. Lima, Ines S. ......................................... Disclosed no confl ict of interest. Lima, Joao A. ....................................... Disclosed no confl ict of interest. Lima, Thaís M. ...................................... Disclosed no confl ict of interest. Limacher, Franziska H. .......................... Disclosed no confl ict of interest. Limesand, Sean W. .............................. Disclosed no confl ict of interest. Lin, Chia-Hung ...................................... Disclosed no confl ict of interest. Lin, Chien-Te ......................................... Disclosed no confl ict of interest. Lin, Emily .............................................. Employee: TWi Biotechnology, Inc.; Stock/Shareholder: TWi

Pharmaceuticals, Inc. Lin, Jay ................................................. Employee: Novosys Health; Research Support: Sanofi Lin, Jiang .............................................. Employee: GlaxoSmithKline Lin, Jie .................................................. Disclosed no confl ict of interest. Lin, Jing ................................................ Disclosed no confl ict of interest. Lin, Jingna ............................................ Disclosed no confl ict of interest. Lin, Jou-Wei ......................................... Disclosed no confl ict of interest. Lin, Kun D. ............................................ Disclosed no confl ict of interest. Lin, Lixiang ........................................... Disclosed no confl ict of interest. Lin, Meng ............................................. Disclosed no confl ict of interest. Lin, Michael M. .................................... Disclosed no confl ict of interest. Lin, Mingzhu ......................................... Disclosed no confl ict of interest. Lin, Shaoda ........................................... Disclosed no confl ict of interest. Lin, Shih-Yi ........................................... Disclosed no confl ict of interest. Lin, Shuo ............................................... Disclosed no confl ict of interest. Lin, Tsu-Kung ........................................ Disclosed no confl ict of interest. Lin, Xianguang ...................................... Disclosed no confl ict of interest. Lin, Xiu-hong ........................................ Disclosed no confl ict of interest. Lin, Yajun .............................................. Disclosed no confl ict of interest. Lin, Yu-Cheng ....................................... Disclosed no confl ict of interest. Lin, Yu-Tze ............................................ Disclosed no confl ict of interest. Linder, Katarzyna .................................. Disclosed no confl ict of interest. Lindgren, Cecilia M. ............................. Disclosed no confl ict of interest. Lindner, Jaroslav .................................. Disclosed no confl ict of interest. Ling, Chao ............................................. Disclosed no confl ict of interest. Ling, Charlotte ...................................... Disclosed no confl ict of interest. Ling, John ............................................. Employee: Sanofi Ling, Shukuan ....................................... Disclosed no confl ict of interest. Lingvay, Ildiko ....................................... Advisory Panel: Novo Nordisk, Inc. Linjawi, Sultan ..................................... Advisory Panel: Novo Nordisk Australia Link, Manuela ....................................... Disclosed no confl ict of interest. Linn, Thomas ........................................ Consultant: Andromeda Biotech, Ltd. Lins, Per-Eric ......................................... Disclosed no confl ict of interest. Liou, Chia-Wei ...................................... Disclosed no confl ict of interest. Lipari, Genni ......................................... Disclosed no confl ict of interest. Lipinska, Danuta ................................... Disclosed no confl ict of interest. Lips, Michal .......................................... Disclosed no confl ict of interest. Lipscomb, Joseph ................................. Disclosed no confl ict of interest. Lipscombe, Lorraine L. ......................... Disclosed no confl ict of interest. Lipska, Kasia J. .................................... Disclosed no confl ict of interest. Lipton, Rebecca .................................... Disclosed no confl ict of interest. Lisowski, Mark ..................................... Disclosed no confl ict of interest. List, James F. ........................................ Employee: Bristol-Myers Squibb Company; Stock/Shareholder:

Bristol-Myers Squibb Company Literati-Nagy, Botond ........................... Disclosed no confl ict of interest. Little, Megan E. .................................... Employee: Medtronic Little, Tanya .......................................... Research Support: Novartis Pharmaceuticals Corporation Littlejohn, Elizabeth .............................. Disclosed no confl ict of interest. Littlewood, Kerry .................................. Disclosed no confl ict of interest. Littvay, Levente .................................... Disclosed no confl ict of interest. Litvin, Marina ....................................... Disclosed no confl ict of interest. Litwak, León E. ..................................... Board Member: Bristol-Myers Squibb/AstraZeneca, Eli Lilly

and Company, GlaxoSmithKline, Latin American Board, National Boards, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Pfi zer,

Inc., PPD Development, LP, Sanofi , Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Pfi zer, Inc., PPD Development, LP, Roche Pharmaceuticals, Sanofi , Takeda Pharmaceutical Company, Ltd.

Liu, Alice ............................................... Disclosed no confl ict of interest. Liu, Amy W. .......................................... Disclosed no confl ict of interest. Liu, An-Bang ......................................... Disclosed no confl ict of interest. Liu, Bin .................................................. Disclosed no confl ict of interest. Liu, Chao ............................................... Disclosed no confl ict of interest. Liu, Chengyang ..................................... Disclosed no confl ict of interest. Liu, Ching-Ti .......................................... Disclosed no confl ict of interest. Liu, Chune ............................................. Disclosed no confl ict of interest. Liu, Cyuan-Cin ...................................... Disclosed no confl ict of interest. Liu, Dan ................................................ Disclosed no confl ict of interest. Liu, Emily .............................................. Disclosed no confl ict of interest. Liu, Fang ............................................... Disclosed no confl ict of interest. Liu, Feng ............................................... Disclosed no confl ict of interest. Liu, Gaigai ............................................ Disclosed no confl ict of interest. Liu, George ........................................... Research Support: United Health Group Liu, Hong .............................................. Disclosed no confl ict of interest. Liu, Hongtao ......................................... Disclosed no confl ict of interest. Liu, Hongxia .......................................... Disclosed no confl ict of interest. Liu, Hua ................................................ Disclosed no confl ict of interest. Liu, James ............................................ Disclosed no confl ict of interest. Liu, Jason ............................................. Disclosed no confl ict of interest. Liu, Jay ................................................. Employee: Takeda Global Research & Development Center,

Inc. Liu, Jeff ................................................ Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Liu, Jianbin ........................................... Disclosed no confl ict of interest. Liu, Jiang .............................................. Disclosed no confl ict of interest. Liu, Jianjun ........................................... Disclosed no confl ict of interest. Liu, Jie .................................................. Disclosed no confl ict of interest. Liu, Jingping ......................................... Disclosed no confl ict of interest. Liu, Juan ............................................... Disclosed no confl ict of interest. Liu, Jun ................................................. Research Support: Eli Lilly and Company Liu, Kiang .............................................. Disclosed no confl ict of interest. Liu, Lenna L. ......................................... Disclosed no confl ict of interest. Liu, Li .................................................... Disclosed no confl ict of interest. Liu, Liegang .......................................... Disclosed no confl ict of interest. Liu, Liehua ............................................ Disclosed no confl ict of interest. Liu, Limei .............................................. Disclosed no confl ict of interest. Liu, Linda .............................................. Disclosed no confl ict of interest. Liu, Liping ............................................. Employee: Nordic Bioscience A/S Liu, Meng-Ju ........................................ Disclosed no confl ict of interest. Liu, Ming .............................................. Disclosed no confl ict of interest. Liu, Qian ............................................... Disclosed no confl ict of interest. Liu, Qing ............................................... Disclosed no confl ict of interest. Liu, Qinglan .......................................... Disclosed no confl ict of interest. Liu, Shanying ........................................ Disclosed no confl ict of interest. Liu, Shiping ........................................... Disclosed no confl ict of interest. Liu, Suhuan ........................................... Disclosed no confl ict of interest. Liu, Ting ................................................ Disclosed no confl ict of interest. Liu, Tzu-Wen ........................................ Disclosed no confl ict of interest. Liu, Xiaoming ........................................ Disclosed no confl ict of interest. Liu, Xing Yu ........................................... Disclosed no confl ict of interest. Liu, Xulei ............................................... Disclosed no confl ict of interest. Liu, Yanjun ............................................ Disclosed no confl ict of interest. Liu, Yaping J. ........................................ Employee: GlaxoSmithKline Liu, Yongmei ......................................... Disclosed no confl ict of interest. Liu, Yongxue ......................................... Disclosed no confl ict of interest. Liu, Yu ................................................... Employee: Burg Simpson Liu, Yunzi .............................................. Disclosed no confl ict of interest. Liu, Zhenqi ............................................ Disclosed no confl ict of interest. Liu, Zhiwen ........................................... Employee: Merck; Stock/Shareholder: Merck Liu, Zhong-Wu ...................................... Disclosed no confl ict of interest. Livingtsone, Roshan S. ......................... Disclosed no confl ict of interest. Lizunov, Vladimir A. .............................. Disclosed no confl ict of interest. Lloyd, Adam .......................................... Disclosed no confl ict of interest. Lo Presti, Donatella .............................. Disclosed no confl ict of interest. Lo, Joan ................................................ Disclosed no confl ict of interest. Loader, Cameron .................................. Disclosed no confl ict of interest. Loba, Jerzy ........................................... Disclosed no confl ict of interest. Lobbens, Stéphane ............................... Disclosed no confl ict of interest. Lobley, Gerald E. ................................... Disclosed no confl ict of interest. Locatelli, Maelle .................................. Disclosed no conflict of interest. Lo-Ciganic, Wei Hsuan ......................... Research Support: Sanofi Lock, John P. ......................................... Disclosed no confl ict of interest.

Dow



A874


AU

THO

R D

ISCL

OSU

RE

Lock, Patricia ........................................ Disclosed no confl ict of interest. Locke, Adam E. ..................................... Disclosed no confl ict of interest. Loehr, Laura R. ...................................... Disclosed no confl ict of interest. Loeken, Mary R. ................................... Disclosed no confl ict of interest. Löffl er, Andreas .................................... Disclosed no confl ict of interest. Logan, Brent J. ..................................... Disclosed no confl ict of interest. Lohr, Lisa .............................................. Employee: ChemoCentryx; Stock/Shareholder: ChemoCentryx Loizou, Theodoros ................................ Advisory Panel: Novartis Pharmaceuticals Corporation; Other

Relationship: Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi

Lombardero, Manuel ............................ Disclosed no confl ict of interest. Lomonaco, Romina ............................... Disclosed no confl ict of interest. Londou, Stauroula ................................ Disclosed no confl ict of interest. Long, David A. ...................................... Disclosed no conflict of interest. Long, Jonathan Z. ................................. Disclosed no confl ict of interest. Long, Liu Z. ........................................... Disclosed no confl ict of interest. Long, Qi ................................................ Research Support: NIH, Veterans Administration Long, S. Alice ....................................... Disclosed no confl ict of interest. Long, Yang ............................................ Disclosed no confl ict of interest. Long-yi, Zeng ........................................ Disclosed no confl ict of interest. Loni Ekali, Gabriel ................................ Disclosed no confl ict of interest. Lopes-Virella, Maria F. ......................... Disclosed no confl ict of interest. Lopez Gonzalez, Eva ............................. Disclosed no confl ict of interest. Lopez Star, Ellery .................................. Disclosed no confl ict of interest. Lopez, Angel F. ...................................... Disclosed no confl ict of interest. Lopez, Claudia ...................................... Employee: Takeda Global Research & Development Center,

Inc.; Stock/Shareholder: Takeda Global Research & Development Center, Inc.

Lopez, Janice ........................................ Employee: Janssen Scientifi c Affairs, LLC Lopez, Lilia ............................................ Disclosed no confl ict of interest. Lopez, Prudence ................................... Disclosed no confl ict of interest. Lopez-Acosta, Jose F. ........................... Disclosed no confl ict of interest. Lopez-Jaramillo, Patricio ...................... Disclosed no confl ict of interest. Lord, Katherine ..................................... Disclosed no confl ict of interest. Lorenz, Carrie ....................................... Disclosed no confl ict of interest. Lorenzi, G. ............................................. Disclosed no confl ict of interest. Lorenzo, Carlos ..................................... Disclosed no confl ict of interest. Lorenzo, Petra I. .................................... Disclosed no confl ict of interest. Loria, Catherine .................................... Disclosed no confl ict of interest. Lorsignol, Anne .................................... Disclosed no confl ict of interest. Losiewicz, Mandy K. ............................ Disclosed no confl ict of interest. Loskutova, Natalia ............................... Research Support: Sanofi US, Shire Lossner, Ulrike ...................................... Disclosed no confl ict of interest. Lotan, Rachel ........................................ Disclosed no confl ict of interest. Lottenberg, Simão A. ........................... Disclosed no confl ict of interest. Lotti, Giuseppe ..................................... Disclosed no confl ict of interest. Lou, Jesse ............................................ Disclosed no confl ict of interest. Louche, Katie ........................................ Disclosed no confl ict of interest. Loudovaris, Thomas ............................. Disclosed no confl ict of interest. Louis, Thomas A. .................................. Disclosed no confl ict of interest. Loutseiko, Mikhail ................................ Employee: Medtronic Lovas, Sandor ....................................... Disclosed no confl ict of interest. Lovblom, Leif E. .................................... Disclosed no confl ict of interest. Lovegrove, Maribeth C. ........................ Disclosed no confl ict of interest. Lowe, Julia ........................................... Disclosed no confl ict of interest. Lowe, Lynn P. ........................................ Disclosed no confl ict of interest. Lowe, William L. .................................. Disclosed no confl ict of interest. Lowell, Bradford B. ............................... Disclosed no confl ict of interest. Lowery, Jolene ..................................... Disclosed no confl ict of interest. Lown-Hecht, Rachel N. ........................ Disclosed no confl ict of interest. Lozano, Maria Eugenia ......................... Disclosed no confl ict of interest. Lu, Binbin .............................................. Disclosed no confl ict of interest. Lu, Hongyun .......................................... Disclosed no confl ict of interest. Lu, Hui J. .............................................. Disclosed no confl ict of interest. Lu, Huijuan ........................................... Disclosed no confl ict of interest. Lu, Jonathan ......................................... Disclosed no confl ict of interest. Lu, Ju M. .............................................. Disclosed no confl ict of interest. Lu, Juming ............................................ Consultant: Takeda Global Research & Development Center,

Inc. Lu, Junxi ............................................... Disclosed no confl ict of interest. Lu, L.J. .................................................. Disclosed no confl ict of interest. Lu, Mei ................................................. Consultant: Daiichi-Sankyo, Inc. Lu, Ran .................................................. Disclosed no confl ict of interest. Lu, Shih-Jen ......................................... Disclosed no confl ict of interest. Lu, Wei ................................................. Disclosed no confl ict of interest. Lu, Weishu ........................................... Employee: TWi Biotechnology, Inc; Stock/Shareholder: TWi

Pharmaceuticals, Inc Lu, Wenshen ........................................ Disclosed no confl ict of interest. Lu, Yang ................................................ Disclosed no confl ict of interest. Lu, Yanrong ........................................... Disclosed no confl ict of interest. Lu, Ying-Li ............................................. Disclosed no confl ict of interest. Lu, Yiyang ............................................. Disclosed no confl ict of interest.

Lu, Zhigang ........................................... Disclosed no confl ict of interest. Lu, Zhongyang ...................................... Disclosed no confl ict of interest. Lubach, Caroline H. .............................. Disclosed no confl ict of interest. Lubina Solomon, Alexandra ................. Disclosed no confl ict of interest. Lucaites, Virginia .................................. Disclosed no confl ict of interest. Lucas, Joseph ....................................... Disclosed no confl ict of interest. Lucchesi, Daniela ................................. Disclosed no confl ict of interest. Lucidi, Paola ......................................... Other Relationship: Menarini, Sanofi Lucisano, Giuseppe .............................. Disclosed no confl ict of interest. Ludovico, Ornella .................................. Disclosed no confl ict of interest. Ludvigsson, Johnny .............................. Disclosed no confl ict of interest. Ludwig, David ....................................... Disclosed no confl ict of interest. Lugar, Heather M. ................................ Disclosed no confl ict of interest. Luger, Anton ......................................... Disclosed no confl ict of interest. Lui, Jen Bon .......................................... Disclosed no confl ict of interest. Luippold, Gerd ...................................... Disclosed no confl ict of interest. Luk, Andrea O. ...................................... Disclosed no confl ict of interest. Lukas, Christina .................................... Disclosed no confl ict of interest. Lukashevich, Valentina ........................ Employee: Novartis Pharmaceuticals Corporation; Stock/

Shareholder: Novartis Pharmaceuticals Corporation Lum, Helen ........................................... Disclosed no confl ict of interest. Lumeng, Julie ....................................... Disclosed no confl ict of interest. Luna-Lopez, Victoria ............................. Disclosed no confl ict of interest. Lundberg, Rachel .................................. Disclosed no confl ict of interest. Lundh, Morten ...................................... Disclosed no confl ict of interest. Lundy, Steven K. ................................... Disclosed no confl ict of interest. Luo, Connie ........................................... Disclosed no confl ict of interest. Luo, Guochun ........................................ Disclosed no confl ict of interest. Luo, Juhua ............................................ Disclosed no confl ict of interest. Luo, Junxiang ....................................... Employee: Eli Lilly and Company, Eli Lilly and Company


Luo, Moulun ......................................... Disclosed no confl ict of interest. Luo, Ruihua ........................................... Disclosed no confl ict of interest. Luo, Shunkui ......................................... Disclosed no confl ict of interest. Luo, Shuqin ........................................... Employee: VeroScience Luo, Wen-Lin ........................................ Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Luo, Yan ................................................ Disclosed no confl ict of interest. Luo, Yingying ........................................ Disclosed no confl ict of interest. Luo, Yong .............................................. Disclosed no confl ict of interest. Luo, Yuqi ............................................... Disclosed no confl ict of interest. Luongo, Angela .................................... Disclosed no confl ict of interest. Luque, Raul M. ..................................... Disclosed no confl ict of interest. Luquet, Serge ....................................... Disclosed no confl ict of interest. Luscombe-Marsh, Natalie D. ............... Disclosed no confl ict of interest. Lussier, Roxane .................................... Disclosed no confl ict of interest. Lustig, Mary E. ..................................... Disclosed no confl ict of interest. Lutes, Lesley ......................................... Disclosed no confl ict of interest. Luthra, Kalpana .................................... Disclosed no confl ict of interest. Luthra, Rakesh ...................................... Disclosed no confl ict of interest. Lutz, Sharon .......................................... Disclosed no confl ict of interest. Lutz, Stefan Z. ...................................... Disclosed no confl ict of interest. Luzio, Stephen D. ................................. Disclosed no confl ict of interest. Lv, Chao ................................................ Disclosed no confl ict of interest. Lv, Jia ................................................... Disclosed no confl ict of interest. Lv, Qiuju ................................................ Disclosed no confl ict of interest. Lv, Wenlong .......................................... Disclosed no confl ict of interest. Ly, Trang T. ............................................ Disclosed no confl ict of interest. Lyles, Shannon ..................................... Disclosed no confl ict of interest. Lynch, John .......................................... Disclosed no confl ict of interest. Lynch, Ronald M. .................................. Disclosed no confl ict of interest. Lyon, Christopher J. ............................. Disclosed no confl ict of interest. Lyon, Kristin L. ...................................... Disclosed no confl ict of interest. Lyon-Callo, Sarah ................................. Disclosed no confl ict of interest. Lysak, Pauline ....................................... Disclosed no confl ict of interest. Lyssenko, Valeriya ................................ Disclosed no confl ict of interest. M., Joseph L. ........................................ Disclosed no confl ict of interest. Ma, Danjun ........................................... Disclosed no confl ict of interest. Ma, Delin .............................................. Disclosed no confl ict of interest. Ma, Huijuan .......................................... Disclosed no confl ict of interest. Ma, Huijuanma ..................................... Disclosed no confl ict of interest. Ma, Jianhua J. ..................................... Disclosed no confl ict of interest. Ma, Jinhui ............................................ Disclosed no confl ict of interest. Ma, Johnny .......................................... Disclosed no confl ict of interest. Ma, Ke .................................................. Disclosed no confl ict of interest. Ma, Lijun .............................................. Disclosed no confl ict of interest. Ma, Man Chun John ............................ Disclosed no confl ict of interest. Ma, Qiang ............................................. Disclosed no confl ict of interest. Ma, Ronald C. ....................................... Board Member: Eli Lilly and Company; Other Relationship: Danone,

Inc.; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd.

Dow



A875


AU

THO

R D

ISCL

OSU

RE

Ma, Wenzhen ....................................... Employee: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner); Stock/Shareholder: Eli Lilly and Com-pany, Eli Lilly and Company (Spouse/Partner)

Ma, Xiaojing ......................................... Disclosed no confl ict of interest. Ma, Xiaowei ......................................... Disclosed no confl ict of interest. Ma, Zhongmin A. .................................. Disclosed no confl ict of interest. Maahs, David M. .................................. Research Support: Abbott Diabetes Care, Eli Lilly and Com-

pany, Novo Nordisk, Inc. Maas, Richard ...................................... Disclosed no confl ict of interest. Maasch, Christian ................................ Employee: Noxxon Maccallini, Gustavo ............................. Disclosed no confl ict of interest. Macchi, Francesca ............................... Employee: Zealand Pharma A/S; Research Support: Zealand

Pharma A/S MacConell, Leigh ................................. Employee: Amylin Pharmaceuticals, LLC Macedo, Maria P. ................................. Disclosed no confl ict of interest. Macey, Laurel ....................................... Disclosed no confl ict of interest. Macfarlane, David P. ............................ Disclosed no confl ict of interest. Machado, Fernanda C. ......................... Disclosed no confl ict of interest. Machann, Juergen ............................... Disclosed no confl ict of interest. Machicao, Fausto ................................. Disclosed no confl ict of interest. Machida, Yui ........................................ Disclosed no confl ict of interest. Macias, Hector ..................................... Disclosed no confl ict of interest. Macias-Gonzalez, Manuel ................... Disclosed no confl ict of interest. Maciejewski, Matthew L. .................... Consultant: Daiichi-Sankyo, Inc.; Employee: Amgen, Inc.

(Spouse/Partner); Stock/Shareholder: Amgen, Inc. (Spouse/Partner)

MacIsaac, Richard J. ............................ Disclosed no confl ict of interest. Mackenzie, Charles D. ......................... Disclosed no confl ict of interest. Mackey, Eleanor ................................... Disclosed no confl ict of interest. Mackie, Alasdair .................................. Disclosed no confl ict of interest. MacKinney, Erin ................................... Disclosed no confl ict of interest. MacLean, Paul ...................................... Disclosed no confl ict of interest. Maclean, Ross ...................................... Employee: Bristol-Myers Squibb Company Macotela, Yazmin ................................. Disclosed no confl ict of interest. MacRenaris, Keith ................................ Disclosed no confl ict of interest. Madani, Suliya ..................................... Disclosed no confl ict of interest. Madar, Zecharia ................................... Disclosed no confl ict of interest. Maddaloni, Ernesto .............................. Disclosed no confl ict of interest. Mader, Julia K. ..................................... Other Relationship: CeQur, Ltd., Eli Lilly and Company, Me-

narini, Novo Nordisk A/S; Speaker’s Bureau: Novo Nordisk A/S

Mader, Michael .................................... Disclosed no confl ict of interest. Madiraju, S.R. Murthy .......................... Disclosed no confl ict of interest. Madsbad, Sten ..................................... Disclosed no confl ict of interest. Madsen, Henrik .................................... Disclosed no confl ict of interest. Madsen, Lars D. ................................... Disclosed no confl ict of interest. Madsen, Tim J. ..................................... Disclosed no confl ict of interest. Maechler, Pierre ................................... Disclosed no confl ict of interest. Maeda, Hiromi ..................................... Disclosed no confl ict of interest. Maeda, Isseki ....................................... Disclosed no confl ict of interest. Maeda, Shiro ........................................ Disclosed no confl ict of interest. Maedler, Kathrin .................................. Disclosed no confl ict of interest. Maegawa, Hiroshi ................................ Disclosed no confl ict of interest. Maffeis, Claudio ................................... Disclosed no confl ict of interest. Maffi , Paola .......................................... Disclosed no confl ict of interest. Maffi oli, Pamela ................................... Disclosed no confl ict of interest. Maganti, Aarthi .................................... Disclosed no confl ict of interest. Maganti, Lata ....................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Magargee, Mary .................................. Disclosed no confl ict of interest. Magenheimer, Elizabeth ...................... Disclosed no confl ict of interest. Maggs, David ....................................... Employee: Amylin Pharmaceuticals, Inc.; Stock/Shareholder:

Amylin Pharmaceuticals, Inc. Maghrabi, Adam H. .............................. Disclosed no confl ict of interest. Magi, Reedik ........................................ Disclosed no confl ict of interest. Magid, David ........................................ Disclosed no confl ict of interest. Magielski, Przemyslaw ........................ Disclosed no confl ict of interest. Maginley, Roger ................................... Disclosed no confl ict of interest. Magliano, Dianna J. ............................. Disclosed no confl ict of interest. Magliano, Lynne A. .............................. Disclosed no confl ict of interest. Magnan, Christophe ............................. Disclosed no confl ict of interest. Magny-Normilus, Cherlie ..................... Disclosed no confl ict of interest. Maguire, David ..................................... Disclosed no confl ict of interest. Magyar, Kendra L. ................................ Disclosed no confl ict of interest. Mahadevan, Jana ................................ Disclosed no confl ict of interest. Mahaffey, Kenneth W. ......................... Consultant: Adolor, Amgen, Inc., AstraZeneca, Bayer Health-

Care, Biotronik, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly and Company, Elsevier, Exeter Group, Forest, Genentech, GlaxoSmithKline, Gilead Science, Haemonetics, John Hopkins University, Johnson & Johnson, Medtronic, Inc., Merck, Novartis Pharmaceutical Company, Orexigen,

Ortho/McNeill, Pfi zer, Inc., Polymedix, Sanofi , South East Area Health Education Center, Springer Publishing, St. Jude Medical, Sun Pharma, WebMD; Research Support: Abbott Vascular Business, Amgen, Inc., Amylin, Inc., AstraZeneca, Baxter, Boehringer Ingelheim Pharmaceu-ticals, Inc., Cordis, Cubist, Daiichi-Sankyo, Inc., Edwards Lifesciences, Eli Lilly and Company, GlaxoSmithKline, Guidant Corporation, Ikaria, Johnson & Johnson, Luitpold Pharmaceuticals, Inc., Medtronic, Inc., Merck, Novartis Pharmaceutical Company, Portola Pharmaceutical, POZEN Pharmaceutical, Regado Biosciences, Inc., Roche Diag-nostic, Sanofi , The Medicines Company, Schering-Plough Corporation

Mahajan, Anubha ................................. Disclosed no confl ict of interest. Mahaney, Michael C. ........................... Disclosed no confl ict of interest. Mahbod, Parinaz .................................. Disclosed no confl ict of interest. Maher, Jacquelyn J. ............................. Disclosed no confl ict of interest. Maher, Kathryn E. ................................. Disclosed no confl ict of interest. Mahfouz, A. .......................................... Disclosed no confl ict of interest. Mahgoub, Yahya .................................. Disclosed no confl ict of interest. Mahjoub, Sylvia ................................... Disclosed no confl ict of interest. Mahmood, Arshad ................................ Disclosed no confl ict of interest. Mahmoud, Abeer M. ............................ Disclosed no confl ict of interest. Mahmud, Farid H. ................................. Disclosed no confl ict of interest. Mahon, Jeffrey ..................................... Disclosed no confl ict of interest. Mahoney, Sara E. ................................. Disclosed no confl ict of interest. Mahony, Chris ...................................... Disclosed no confl ict of interest. Mai, Lifang ........................................... Disclosed no confl ict of interest. Mai, Zhi-Ming ...................................... Disclosed no confl ict of interest. Maier, Bernhard ................................... Disclosed no confl ict of interest. Maier, Marta ........................................ Disclosed no confl ict of interest. Maiguel, Dony ...................................... Disclosed no confl ict of interest. Maione, Maria ..................................... Disclosed no confl ict of interest. Mairal, Aline ........................................ Disclosed no confl ict of interest. Maiti, Pranab ........................................ Research Support: Eli Lilly and Company Maiztegui, Bárbara ............................... Disclosed no confl ict of interest. Majidi, Shideh ...................................... Disclosed no confl ict of interest. Majima, Masataka ............................... Disclosed no confl ict of interest. Majithia, Amit ...................................... Disclosed no confl ict of interest. Majithiaon, Amit .................................. Disclosed no confl ict of interest. Majkowska, Lilianna ............................ Disclosed no confl ict of interest. Majsterek, Ireneusz .............................. Disclosed no confl ict of interest. Majumdar, Kalpita ................................ Disclosed no confl ict of interest. Majumdar, Sumit R. ............................. Disclosed no confl ict of interest. Makary, Martin ..................................... Disclosed no confl ict of interest. Makdissi, Antoine ................................ Disclosed no confl ict of interest. Makedou, Areti .................................... Disclosed no confl ict of interest. Makhline, Rolan ................................... Disclosed no confl ict of interest. Makino, Hirofumi ................................. Disclosed no confl ict of interest. Makino, Hisashi ................................... Disclosed no confl ict of interest. Makino, Masaki ................................... Disclosed no confl ict of interest. Makino, Taketoshi ................................ Disclosed no confl ict of interest. Makino, Yuichi ...................................... Disclosed no confl ict of interest. Makizaki, Yutaka .................................. Disclosed no confl ict of interest. Makrilakis, Konstantinos ..................... Disclosed no confl ict of interest. Malachowska, Beata ........................... Disclosed no confl ict of interest. Malcolm, Janine .................................. Disclosed no confl ict of interest. Malecki, Maciej T. ................................ Disclosed no confl ict of interest. Malek, Rachid ...................................... Advisory Panel: Novo Nordisk A/S, Sanofi ; Board Member:

Novo Nordisk A/S, Sanofi ; Research Support: Novo Nordisk A/S, Study Coordinator; Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Pfi zer, Inc., Sanofi

Malerbi, Domingos A. .......................... Disclosed no confl ict of interest. Malhi, Tavleen ...................................... Disclosed no confl ict of interest. Malhotra, Keya ..................................... Disclosed no confl ict of interest. Malik, Abida ......................................... Disclosed no confl ict of interest. Malik, Rayaz A. .................................... Disclosed no confl ict of interest. Malin, Cornelia ..................................... Disclosed no confl ict of interest. Malin, Steven K. ................................... Disclosed no confl ict of interest. Malinska, Hana .................................... Disclosed no confl ict of interest. Malinski, Tadeusz ................................. Disclosed no confl ict of interest. Maliszewska, Katarzyna ...................... Disclosed no confl ict of interest. Malkani, Samir ..................................... Disclosed no confl ict of interest. Mallad, Ashwini ................................... Disclosed no confl ict of interest. Malloy, Jaret ........................................ Employee: Amylin Pharmaceuticals, LLC Malmberg, Klas .................................... Employee: F. Hoffmann-La Roche, Ltd. Malmegrin, Kelen R. ............................ Disclosed no confl ict of interest. Malone, James .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Maloney, David .................................... Disclosed no confl ict of interest. Malpique, Rita ...................................... Disclosed no confl ict of interest.

Dow



A876


AU

THO

R D

ISCL

OSU

RE

Maltese, Giuseppe ............................... Disclosed no confl ict of interest. Mamtani, Manju .................................. Disclosed no confl ict of interest. Manassie, Jenny .................................. Employee: Boehringer Ingelheim UK Ltd Manchenko, Oksana ............................. Disclosed no confl ict of interest. Mancini, Arturo .................................... Disclosed no confl ict of interest. Mandarino, Lawrence J. ...................... Disclosed no confl ict of interest. Manders, Irene G. ................................ Disclosed no confl ict of interest. Mandrup-Poulsen, Thomas .................. Disclosed no confl ict of interest. Manes, Christos ................................... Disclosed no confl ict of interest. Maney, Miriam ..................................... Disclosed no confl ict of interest. Manfrini, Silvia ..................................... Disclosed no confl ict of interest. Mangat, Jasdip .................................... Disclosed no confl ict of interest. Manghi, Federico P. .............................. Disclosed no confl ict of interest. Mangiacotti, Davide ............................. Disclosed no confl ict of interest. Mangiafi co, Salvatore P. ...................... Disclosed no confl ict of interest. Mangino, Massimo .............................. Disclosed no confl ict of interest. Mangione, Anna ................................... Disclosed no confl ict of interest. Manhanini, Diogo P. ............................. Disclosed no confl ict of interest. Manigrasso, Michaele B. ..................... Disclosed no confl ict of interest. Manley, Susan E. .................................. Disclosed no confl ict of interest. Manna, Prasenjit .................................. Disclosed no confl ict of interest. Mannalithara, Ajitha ............................ Disclosed no confl ict of interest. Manner, David H. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Manning, Alisa ..................................... Disclosed no confl ict of interest. Manns, Braden J. ................................. Disclosed no confl ict of interest. Mannucci, Edoardo .............................. Consultant: Eli Lilly and Company, Novo Nordisk, Inc.; Re-

search Support: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi ; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk, Inc.

Manor, Brad .......................................... Disclosed no confl ict of interest. Manseau, Katherine ............................. Disclosed no confl ict of interest. Mansfi eld, Traci A. ............................... Employee: Bristol-Myers Squibb Company; Stock/Shareholder:

Bristol-Myers Squibb Company Manso, M. Conceição .......................... Disclosed no confl ict of interest. Mansuri, Owaise .................................. Disclosed no confl ict of interest. Mantegazza, Ermanno .......................... Disclosed no confl ict of interest. Mantzoros, Christos S. ......................... Disclosed no confl ict of interest. Manuel, Allison .................................... Disclosed no confl ict of interest. Manwaring, Victoria ............................ Disclosed no confl ict of interest. Manzato, Enzo ...................................... Disclosed no confl ict of interest. Manzoli, Vita ........................................ Disclosed no confl ict of interest. Mao, Jia ............................................... Disclosed no confl ict of interest. Mao, Liqun ........................................... Disclosed no confl ict of interest. Maran, Alberto ..................................... Disclosed no confl ict of interest. Marando, Alessandro ........................... Disclosed no confl ict of interest. Maranhão, Priscila A. ........................... Disclosed no confl ict of interest. Marathe, Chinmay S. ........................... Disclosed no confl ict of interest. Marceau, Lisa D. .................................. Disclosed no confl ict of interest. Marcelo, Marialuisa C. ........................ Employee: Eli Lilly and Company Marchetti, Piero ................................... Disclosed no confl ict of interest. Marcheva, Biliana ................................ Disclosed no confl ict of interest. Marchini, Julio S. ................................. Disclosed no confl ict of interest. Marchione, Stefania ............................ Disclosed no confl ict of interest. Marchisio, Marco ................................. Disclosed no confl ict of interest. Marcinak, John .................................... Employee: Takeda Global Research & Development Center, Inc. Marciniak, Anja .................................... Disclosed no confl ict of interest. Marcinkevage, Jessica ........................ Disclosed no confl ict of interest. Marcinkiewicz, Jadwiga ...................... Disclosed no confl ict of interest. Marcovecchio, Loredana ...................... Disclosed no confl ict of interest. Marcovina, Santica M. ......................... Disclosed no confl ict of interest. Marcucci, Melissa ................................ Disclosed no confl ict of interest. Marder, Thomas J. ............................... Disclosed no confl ict of interest. Mardock, Michelle ............................... Disclosed no confl ict of interest. Marechaud, Richard ............................. Disclosed no confl ict of interest. Marek, George ..................................... Disclosed no confl ict of interest. Marek, Peter J. ..................................... Disclosed no confl ict of interest. Marek-Trzonkowska, Natalia ............... Disclosed no confl ict of interest. Margaritidis, Charalampos .................. Disclosed no confl ict of interest. Margiotta, Elisa .................................... Disclosed no confl ict of interest. Margolis, Karen L. ................................ Disclosed no confl ict of interest. Mari, Andrea ........................................ Advisory Panel: Eli Lilly and Company; Research Support:

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company

Maria luisa, Fernandez-soto ................ Disclosed no confl ict of interest. Marin, Raffaella ................................... Disclosed no confl ict of interest. Marinelli Andreoli, Anna ...................... Disclosed no confl ict of interest. Mariotti, Luciana .................................. Disclosed no confl ict of interest. Mark, Laszlo ......................................... Disclosed no confl ict of interest. Mark, Michael ...................................... Employee: Boehringer Ingelheim GmbH & Co. KG Markan, Kathleen R. ............................ Disclosed no confl ict of interest. Markley, Brandon M. ............................ Disclosed no confl ict of interest.

Markmann, Eileen ................................ Disclosed no confl ict of interest. Marko, Limor ........................................ Disclosed no confl ict of interest. Markowitz, Jessica T. .......................... Other Relationship: Children With Diabetes Markowski, Todd W. ............................ Disclosed no confl ict of interest. Marks, Jennifer B. ................................ Advisory Panel: Amgen, Inc.; Research Support: Amylin Phar-

maceuticals, Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, Diamyd Medical AB, Eli Lilly and Company, Genentech, Macrogenics, Inc., Novartis Pharmaceuticals Corporation, Roche Pharmaceuticals, Sanofi

Marliss, Errol B. .................................... Disclosed no confl ict of interest. Marquardt, Erika .................................. Disclosed no confl ict of interest. Marra, Giampiero ................................. Employee: Novo Nordisk, Inc. Marrano, Nicola ................................... Disclosed no confl ict of interest. Marre, Michel ...................................... Disclosed no confl ict of interest. Marschke, Keith B. ............................... Employee: Ligand Pharmaceuticals; Stock/Shareholder: Ligand

Pharmaceuticals Marselli, Lorella ................................... Disclosed no confl ict of interest. Marsh, Stephen .................................... Disclosed no confl ict of interest. Marsh, William J. ................................ Disclosed no confl ict of interest. Marshall, Andrew ................................ Disclosed no confl ict of interest. Marshall, Sara L. .................................. Disclosed no confl ict of interest. Marso, Steven P. .................................. Disclosed no confl ict of interest. Marsolo, Keith ...................................... Disclosed no confl ict of interest. Martelli, Eugenio .................................. Disclosed no confl ict of interest. Martin, Alan A. ..................................... Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

Kline Martin, Catherine ................................. Disclosed no confl ict of interest. Martin, David ....................................... Disclosed no confl ict of interest. Martin, Guy .......................................... Stock/Shareholder: Metabolys Martin, Paula ........................................ Employee: AstraZeneca Pharmaceuticals LP Martin, Silas ......................................... Employee: Janssen Scientifi c Affairs, LLC Martin, Stephan ................................... Consultant: AstraZeneca Pharmaceuticals LP, Bristol-Myers

Squibb, Boehringer Ingelheim GmbH & Co. KG, Roche Di-agnostics; Research Support: Almased-Wellness-GmbH, Boehringer Ingelheim GmbH & Co. KG, gbo Medizintech-nik AG, Novartis Pharma GmbH

Martinez de la Escalera, Gonzalo ........ Disclosed no confl ict of interest. Martinez, Luc ........................................ Board Member: Novo Nordisk A/S Martinez, Mayra P. ............................... Disclosed no confl ict of interest. Martinez, Rachael ................................ Disclosed no confl ict of interest. Martin-Leyva, Ana ................................ Disclosed no confl ict of interest. Martino, Mikael M. .............................. Disclosed no confl ict of interest. Martins, Luis ........................................ Disclosed no confl ict of interest. Martucci, Ashley N. ............................. Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Marucci, Antonella ............................... Disclosed no confl ict of interest. Marullo, Letizia .................................... Disclosed no confl ict of interest. Maruthur, Nisa M. ................................ Disclosed no confl ict of interest. Marx, Nikolaus ..................................... Consultant: Boehringer Ingelheim GmbH & Co. KG Maryniuk, Melinda D. .......................... Disclosed no confl ict of interest. Marzban, Lucy ...................................... Disclosed no confl ict of interest. Marzorati, Simona ................................ Disclosed no confl ict of interest. Marzotti, Stefania ................................ Disclosed no confl ict of interest. Maser, Raelene E. ................................ Disclosed no confl ict of interest. Mashek, Douglas G. ............................. Disclosed no confl ict of interest. Mashek, Mara T. .................................. Disclosed no confl ict of interest. Mashitani, Tsuyoshi ............................. Disclosed no confl ict of interest. Mashoof, Sara ...................................... Disclosed no confl ict of interest. Masiello, Pellegrino ............................. Disclosed no confl ict of interest. Masierek, Malgorzata .......................... Employee: Bioton Masini, Matilde .................................... Disclosed no confl ict of interest. Mason, Clinton C. ................................. Disclosed no confl ict of interest. Mason, R.P. ........................................... Research Support: Bristol-Myers Squibb/AstraZeneca Mason, Rachael ................................... Disclosed no confl ict of interest. Masotti, Andrea ................................... Disclosed no confl ict of interest. Masquefa-Giraud, Pauline ................... Disclosed no confl ict of interest. Massa, Ornella ..................................... Disclosed no confl ict of interest. Massi-Benedetti, Massimo .................. Speaker’s Bureau: Nipro Diagnostics, Inc., Sanofi Massierer, Daniela ............................... Disclosed no confl ict of interest. Mast, Ruth ............................................ Disclosed no confl ict of interest. Mastaitis, Jason .................................. Disclosed no confl ict of interest. Mastick, Cynthia Corley ....................... Disclosed no confl ict of interest. Mastroiacovo, Pierpaolo ...................... Disclosed no confl ict of interest. Mastrototaro, John .............................. Employee: Medtronic Masubuchi, Yosuke .............................. Disclosed no confl ict of interest. Masuda, Daisaku ................................. Research Support: Boehringer Ingelheim GmbH & Co. KG Masuda, Izuru ....................................... Disclosed no confl ict of interest. Masuda, Takahiro ................................. Disclosed no confl ict of interest. Masuda, Yuichi ..................................... Disclosed no confl ict of interest. Masuzaki, Hiroaki ................................. Disclosed no confl ict of interest. Matfi n, Glenn ....................................... Consultant: Eli Lilly and Company Mather, Kieren J. ................................. Disclosed no confl ict of interest.

Dow



A877


AU

THO

R D

ISCL

OSU

RE

Matheson, Della ................................... Disclosed no confl ict of interest. Matheson, Don ..................................... Stock/Shareholder: Dose Safety Company Mathew, Elizabeth ............................... Disclosed no confl ict of interest. Mathews, Clayton E. ............................ Disclosed no confl ict of interest. Mathiesen, Elisabeth R. ....................... Consultant: Novo Nordisk A/S; Research Support: Novo

Nordisk A/S; Speaker’s Bureau: Aventis, Leo Pharma, Novo Nordisk A/S

Mathieu, Chantal ................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, MannKind Corpo-ration, Merck Sharp & Dohme Limited, Novartis Pharmaceuti-cals Corporation, Novo Nordisk, Inc., Pfi zer, Inc., Sanofi ; Research Support: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi

Mathis, Diane J. ................................... Disclosed no confl ict of interest. Matkovich, Scot J. ............................... Disclosed no confl ict of interest. Matoba, Keiichiro ................................. Disclosed no confl ict of interest. Matoulek, Martin ................................. Disclosed no confl ict of interest. Matschinsky, Franz M. ......................... Disclosed no confl ict of interest. Matsen, Miles E. .................................. Disclosed no confl ict of interest. Matskeplishvili, Simon ......................... Disclosed no confl ict of interest. Matsubara, Tatsuaki ............................ Disclosed no confl ict of interest. Matsubayashi, Yasuhiro ....................... Disclosed no confl ict of interest. Matsuda, Daisuke ................................ Disclosed no confl ict of interest. Matsuda, Masafumi ............................. Disclosed no confl ict of interest. Matsuhisa, Munehide .......................... Disclosed no confl ict of interest. Matsui, Jun .......................................... Disclosed no confl ict of interest. Matsuki, Kota ....................................... Disclosed no confl ict of interest. Matsumoto, Hideo ............................... Disclosed no confl ict of interest. Matsumoto, Hiroaki ............................. Disclosed no confl ict of interest. Matsumoto, Masahiko ......................... Employee: Chugai Research Institute for Medical Science, Inc. Matsumoto, Minori .............................. Disclosed no confl ict of interest. Matsumoto, Toshio .............................. Disclosed no confl ict of interest. Matsumura, Koki .................................. Disclosed no confl ict of interest. Matsumura, Takeshi ............................. Disclosed no confl ict of interest. Matsunaga, Satoshi ............................. Disclosed no confl ict of interest. Matsuo, Tomohito ................................ Disclosed no confl ict of interest. Matsuoka, Atsuko ................................ Disclosed no confl ict of interest. Matsuoka, Taka-aki .............................. Disclosed no confl ict of interest. Matsushita, Masayuki ......................... Disclosed no confl ict of interest. Matsuura, Minori ................................. Disclosed no confl ict of interest. Matsuyama, Akifumi ............................ Disclosed no confl ict of interest. Matsuyama, Rina ................................. Disclosed no confl ict of interest. Matsuyama, Yutaka ............................. Disclosed no confl ict of interest. Matsuzawa, Kazuhiko .......................... Disclosed no confl ict of interest. Matsuzawa, Yoko ................................. Disclosed no confl ict of interest. Mattaliano, Chiara ............................... Disclosed no confl ict of interest. Mattheus, Michaela ............................. Employee: Boehringer Ingelheim GmbH & Co. KG Matthews, David R. ............................. Advisory Panel: GlaxoSmithKline, Novo Nordisk, Inc., Janssen;

Research Support: Johnson & Johnson; Speaker’s Bureau: Novo Nordisk, Inc., Eli Lilly and Company, Boehringher Ingelheim Pharmaceuticals, Inc., AstraZeneca, SB Com-munications, Janssen Global, Merck, Takeda, Servier

Matthews, Jessica ............................... Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-Kline

Matti, Brenda ....................................... Disclosed no confl ict of interest. Mattison, Julie A. ................................ Disclosed no confl ict of interest. Mattsson Hultén, Lillemor ................... Disclosed no confl ict of interest. Matulewicz, Natalia ............................. Disclosed no confl ict of interest. Matveyenko, Aleksey V. ....................... Disclosed no confl ict of interest. Matzke, Daniela ................................... Disclosed no confl ict of interest. Mau, Marjorie L. .................................. Disclosed no confl ict of interest. Mauer, Michael .................................... Disclosed no confl ict of interest. Mauldin, Jill ......................................... Disclosed no confl ict of interest. Maulis, Matthew F. .............................. Disclosed no confl ict of interest. Maulny, Linda ....................................... Disclosed no confl ict of interest. Mauricio, Didac .................................... Disclosed no confl ict of interest. Maurizi, Annarita ................................. Disclosed no confl ict of interest. Maury, Elisa .......................................... Disclosed no confl ict of interest. Mauseth, Richard ................................. Stock/Shareholder: Dose Safety Company Mauvais-Jarvis, Franck ........................ Disclosed no confl ict of interest. Mavilio, Maria ...................................... Disclosed no confl ict of interest. Mavrogenis, Petros .............................. Employee: Novartis Pharmaceuticals Corporation Maxhera, Bujar ..................................... Disclosed no confl ict of interest. Maxwell, Alexander P. ......................... Disclosed no confl ict of interest. Maxwell, Michael ................................ Disclosed no confl ict of interest. May, Michelle ...................................... Other Relationship: Author, Eat What You Love, Love What

You Eat with Diabetes, Am I Hungry? Mindful Eating Workshops and Facilitator Training Program

May, Natalie B. .................................... Research Support: Bristol-Myers Squibb Company Mayberry, Lindsay S. ............................ Disclosed no confl ict of interest. Mayer-Davis, Elizabeth J. .................... Disclosed no confl ict of interest. Mayeux, Richard .................................. Disclosed no confl ict of interest. Mayhan, William G. ............................. Disclosed no confl ict of interest. Mayhew, Christopher N. ...................... Disclosed no confl ict of interest. Maynard, John D. ................................. Employee: VeraLight, Inc.; Other Relationship: VeraLight, Inc. Mayorga, Maria E. ............................... Disclosed no confl ict of interest. Mayorov, Alexander ............................. Speaker’s Bureau: Eli Lilly and Company, Lifescan Animas,

Inc., Novo Nordisk A/S, Roche Pharmaceuticals Mayoux, Eric ......................................... Employee: Boehringer Ingelheim GmbH & Co. KG Mayzel, Yulia ........................................ Employee: Integrity Applications, Ltd. Mazanderani, Adel B. ........................... Disclosed no confl ict of interest. Mazza, Carmen ..................................... Disclosed no confl ict of interest. Mazze, Roger ........................................ Research Support: Abbott Diabetes Care, Boehringer In-

gelheim Pharmaceuticals, Inc., CeQur, Ltd., Roche, Sanofi Mazzucco, María Belén ........................ Disclosed no confl ict of interest. Mbaezue, Nkechi ................................. Disclosed no confl ict of interest. McAdam-Marx, Carrie ......................... Disclosed no confl ict of interest. McAlister, Finlay A. .............................. Disclosed no confl ict of interest. McAullay, Daniel .................................. Disclosed no confl ict of interest. McBrien, Kerry ..................................... Disclosed no confl ict of interest. McCall, Kelly D. .................................... Disclosed no confl ict of interest. McCann, Jr., Thomas W. ...................... Employee: Animas Corporation; Stock/Shareholder: Johnson

& Johnson McCarthy, Marian ................................ Disclosed no confl ict of interest. McCarthy, Mark I. ................................. Disclosed no confl ict of interest. McClellan, Donald R. ........................... Disclosed no confl ict of interest. McCoin, Colin S. ................................... Disclosed no confl ict of interest. McConell, Glenn ................................... Disclosed no confl ict of interest. McCormick King, Megan L. .................. Disclosed no confl ict of interest. McCowen, Karen .................................. Disclosed no confl ict of interest. McCoy, Gregory A. ............................... Disclosed no confl ict of interest. McCoy, Rozalina G. .............................. Disclosed no confl ict of interest. McCrimmon, Rory J. ............................. Disclosed no confl ict of interest. McDaniel, Kristen ................................ Disclosed no confl ict of interest. McDermott, John H. ............................. Disclosed no confl ict of interest. McDermott, Michael ............................ Advisory Panel: Sanofi McDonald, Matthew W. ...................... Disclosed no confl ict of interest. McDonald, Timothy J. .......................... Disclosed no confl ict of interest. McDonald, William G. .......................... Employee: Metabolic Solutions Development Co.; Stock/

Shareholder: Metabolic Solutions Development Co. McDonell, Amanda .............................. Consultant: IMS Health, Inc. McDonnell, Kevin ................................. Disclosed no confl ict of interest. McDonnell, Marie E. ............................ Disclosed no confl ict of interest. McElduff, Patrick .................................. Disclosed no confl ict of interest. McElwee, Kevin ................................... Disclosed no confl ict of interest. McElwee, Molly ................................... Disclosed no confl ict of interest. McEwan, Philip C. ................................ Disclosed no confl ict of interest. McEwen, Laura N. ................................ Disclosed no confl ict of interest. McFann, Kim K. .................................... Disclosed no confl ict of interest. McGarrigle, James ............................... Disclosed no confl ict of interest. McGee, Paula ....................................... Disclosed no confl ict of interest. McGeoch, Susan C. .............................. Disclosed no confl ict of interest. McGill, Janet ........................................ Advisory Panel: Abbott Diabetes Care, Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, Merck, Novo Nordisk, Inc., Sanofi ; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc.

McGill, Margaret .................................. Disclosed no confl ict of interest. McGinnis, Lisa ...................................... Disclosed no confl ict of interest. McGinty, James ................................... Disclosed no confl ict of interest. McGovern, Andrew P. ........................... Disclosed no confl ict of interest. McGrath, Barbara ................................. Disclosed no confl ict of interest. McGrath, Kristine C. ............................. Disclosed no confl ict of interest. McGrew, Elizabeth ............................... Employee: VisionQuest Biomedical McGuinness, Owen .............................. Disclosed no confl ict of interest. McGuire, Brian E. ................................. Disclosed no confl ict of interest. McGuire, Catherine .............................. Disclosed no confl ict of interest. McHenry, Claire M. .............................. Disclosed no confl ict of interest. McIntosh, Angela C. ............................. Employee: Institute for Medical and Nursing Education, Inc. McIntyre, H. David ............................... Disclosed no confl ict of interest. McKay, Gareth J. .................................. Disclosed no confl ict of interest. McKeon, Katherine M. ......................... Disclosed no confl ict of interest. McKinlay, John B. ................................ Disclosed no confl ict of interest. McKnight, Amy J. ................................. Disclosed no confl ict of interest. McLean, Carrie G. ................................ Disclosed no confl ict of interest. McLean, Nellie ..................................... Disclosed no confl ict of interest. McLennan, Susan V. ............................. Disclosed no confl ict of interest. McManus, Meagan .............................. Disclosed no confl ict of interest. McMullen, Susan L. ............................. Employee: GlaxoSmithKline McNay, Ewan C. ................................... Disclosed no confl ict of interest. McNeely, Marguerite J. ....................... Disclosed no confl ict of interest.

Dow



A878


AU

THO

R D

ISCL

OSU

RE

McNeilly, Alison D. .............................. Disclosed no confl ict of interest. McNulty, Judi A. .................................. Disclosed no confl ict of interest. McPherson, Ruth .................................. Disclosed no confl ict of interest. McQueen, Robert B. ............................. Disclosed no confl ict of interest. McQueeney, Maureen .......................... Disclosed no confl ict of interest. McQuilling, John P. .............................. Disclosed no confl ict of interest. McTernan, Philip G. .............................. Disclosed no confl ict of interest. McVey, Elaine ....................................... Employee: Becton, Dickinson and Company; Research Support:

Becton, Dickinson and Company Mdingi, Colleen .................................... Disclosed no confl ict of interest. Meadows, Charles ............................... Disclosed no confl ict of interest. Meah, Wee Y. ....................................... Disclosed no confl ict of interest. Meah, Yunus A. .................................... Disclosed no confl ict of interest. Meda, Paolo ......................................... Disclosed no confl ict of interest. Mediavilla, José J. ............................... Disclosed no confl ict of interest. Medlej, Rita .......................................... Advisory Panel: Novartis Pharma AG; Other Relationship:

Sanofi -Aventis Meek, Thomas H. ................................. Disclosed no confl ict of interest. Meers, Grace M. .................................. Disclosed no confl ict of interest. Meerza, Dilnasheen ............................. Disclosed no confl ict of interest. Meguro, Shu ......................................... Disclosed no confl ict of interest. Mehaan, Rebecca ................................ Disclosed no confl ict of interest. Mehana, Amir E. .................................. Disclosed no confl ict of interest. Mehmood, Arshad ................................ Disclosed no confl ict of interest. Mehra, Maneesha ................................ Employee: Janssen Global Services, LLC Mehran, Arya E. ................................... Disclosed no confl ict of interest. Mehrotra, Rajeev ................................. Disclosed no confl ict of interest. Mehta, Deeksha ................................... Disclosed no confl ict of interest. Mehta, Disha ........................................ Disclosed no confl ict of interest. Mehta, Hemalkumar ............................ Other Relationship: Merck Mehta, Nozer M. .................................. Disclosed no confl ict of interest. Mehta, Paras ........................................ Disclosed no confl ict of interest. Mehta, Rucha J. ................................... Disclosed no confl ict of interest. Mehta, Sandhya ................................... Disclosed no confl ict of interest. Mehta, Sanjeev N. ............................... Disclosed no confl ict of interest. Mehta, Vinay ........................................ Employee: Merck; Stock/Shareholder: Merck Meier, Daniel T. .................................... Disclosed no confl ict of interest. Meier, Juris J. ...................................... Disclosed no confl ict of interest. Meigs, James B. .................................. Disclosed no confl ict of interest. Meijer, Rick I. ....................................... Disclosed no confl ict of interest. Meinardi, Simone ................................. Disclosed no confl ict of interest. Meinicke, Thomas ................................ Employee: Boehringer Ingelheim GmbH & Co. KG Meininger, Gary .................................... Employee: Janssen Research & Development, LLC Meirhaeghe, Aline ............................... Disclosed no confl ict of interest. Meisinger, Christa ................................ Disclosed no confl ict of interest. Meisinger, Markus ............................... Disclosed no confl ict of interest. Meissner, Victoria ................................ Disclosed no confl ict of interest. Mejia, Roberto ..................................... Disclosed no confl ict of interest. Melander, Christian .............................. Disclosed no confl ict of interest. Melish, John S. .................................... Disclosed no confl ict of interest. Melkozerov, Konstantin ........................ Disclosed no confl ict of interest. Mellado-Gil, José M. ........................... Disclosed no confl ict of interest. Mellati, Mahnaz ................................... Disclosed no confl ict of interest. Melling, C.W. James ............................ Disclosed no confl ict of interest. Melloul, Danielle .................................. Disclosed no confl ict of interest. Melton, Stephanie ............................... Disclosed no confl ict of interest. Meltzer, David O. .................................. Disclosed no confl ict of interest. Menard, Julie ....................................... Disclosed no confl ict of interest. Menchikova, Elizaveta V. ..................... Disclosed no confl ict of interest. Mendes, Eliana .................................... Disclosed no confl ict of interest. Mendes, Maria Carolina S. .................. Disclosed no confl ict of interest. Mendez, Armando ................................ Disclosed no confl ict of interest. Mendez, Carlos E. ................................ Disclosed no confl ict of interest. Mendonca, Christine ............................ Disclosed no confl ict of interest. Meneghini, Luigi F. ............................... Advisory Panel: Novo Nordisk A/S, Sanofi ; Consultant: Novo

Nordisk A/S, Sanofi ; Research Support: Biodel, Inc., Boeh-ringer Ingelheim GmbH & Co. KG, MannKind Corporation, Pfi zer, Inc.

Menéndez Torre, Edelmiro ................... Advisory Panel: Novo Nordisk A/S Meng, Chuchen .................................... Disclosed no confl ict of interest. Meng, Cong .......................................... Disclosed no confl ict of interest. Meng, Gina ........................................... Disclosed no confl ict of interest. Meng, Xi ............................................... Disclosed no confl ict of interest. Menghini, Rossella .............................. Disclosed no confl ict of interest. Mengos, April E. ................................... Disclosed no confl ict of interest. Menke, Andy ........................................ Disclosed no confl ict of interest. Menzaghi, Claudia ............................... Disclosed no confl ict of interest. Menzin, Joe .......................................... Research Support: Takeda Global Research & Development

Center, Inc. Merchant, Anwar T. ............................. Disclosed no confl ict of interest. Mercuri, Luana ..................................... Disclosed no confl ict of interest. Merecz, Anna ....................................... Disclosed no confl ict of interest.

Merenstein, Daniel .............................. Disclosed no confl ict of interest. Meric, Coskun ...................................... Disclosed no confl ict of interest. Merino, Maricruz .................................. Disclosed no confl ict of interest. Merino-Torres, Juan Francisco ............ Disclosed no confl ict of interest. Meriwether, David ............................... Disclosed no confl ict of interest. Merker, Ludwig .................................... Consultant: AstraZeneca Pharmaceuticals LP, Boehringer In-

gelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Roche Pharmaceuticals

Merlotti, Claudia .................................. Disclosed no confl ict of interest. Mermelstein, Robin .............................. Disclosed no confl ict of interest. Merovci, Aurora ................................... Disclosed no confl ict of interest. Merrill, Mary-Eliese ............................. Disclosed no confl ict of interest. Merrins, Matthew J. ............................ Disclosed no confl ict of interest. Merry, Peter .......................................... Disclosed no confl ict of interest. Merscher-Gomez, Sandra .................... Disclosed no confl ict of interest. Mersebach, Henriette .......................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Mesa, Jordi .......................................... Disclosed no confl ict of interest. Mesfum, Ertirea ................................... Disclosed no confl ict of interest. Mesznik, Shelley .................................. Other Relationship: Medtronics metayer, Laure ...................................... Disclosed no confl ict of interest. Metcalf, Brad S. ................................... Disclosed no confl ict of interest. Metcalf, Kristen M. .............................. Disclosed no confl ict of interest. Mete, Turkan ........................................ Disclosed no confl ict of interest. Metha, Nozer ....................................... Disclosed no confl ict of interest. Metzger, Boyd ...................................... Disclosed no confl ict of interest. Metzger, Daniel L. ................................ Disclosed no confl ict of interest. Metzger, Jesse ..................................... Disclosed no confl ict of interest. Mevi, Ashley A. .................................... Disclosed no confl ict of interest. Meyer Reigner, Sylvie .......................... Employee: F. Hoffmann-La Roche, Ltd., F. Hoffmann-La Roche,

Ltd. (Spouse/Partner) Meyer, Laurent ..................................... Disclosed no confl ict of interest. Meyramov, Gabit G. ............................. Disclosed no confl ict of interest. Meyramova, Aizhan G. ......................... Disclosed no confl ict of interest. Mezquita Raya, Pedro .......................... Advisory Panel: Bristol-Myers Squibb/AstraZeneca, FAES

Farma, Novo Nordisk; Research Support: Novo Nordisk, Inc.; Speaker’s Bureau: Bristol-Myers Squibb/AstraZen-eca, Esteve, FAES Farma, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc.

Mezza, Teresa ...................................... Disclosed no confl ict of interest. Mi, Zhen ............................................... Disclosed no confl ict of interest. Miao, Feng ........................................... Disclosed no confl ict of interest. Miao, Raymond .................................... Employee: Sanofi Miao, Shichang .................................... Employee: ChemoCentryx; Stock/Shareholder: ChemoCentryx Miao, Xiao ............................................ Disclosed no confl ict of interest. Miao, Xinyu .......................................... Disclosed no confl ict of interest. Miao, Zhenhua ..................................... Employee: ChemoCentryx; Stock/Shareholder: ChemoCentryx Miarka, Przemysław ............................. Disclosed no confl ict of interest. Miccoli, Roberto ................................... Disclosed no confl ict of interest. Michael, M. Dodson ............................. Employee: Eli Lilly and Company, Eli Lilly and Company


Michael, Mervyn D. .............................. Employee: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner); Stock/Shareholder: Eli Lilly and Com-pany, Eli Lilly and Company (Spouse/Partner)

Michaels, Jennifer ............................... Disclosed no confl ict of interest. Michail, Marios .................................... Disclosed no confl ict of interest. Michaliszyn, Sara F. ............................. Disclosed no confl ict of interest. Michaud, Camille ................................. Disclosed no confl ict of interest. Micheletto, Giancarlo .......................... Disclosed no confl ict of interest. Michels, Aaron ..................................... Research Support: Novartis Pharmaceuticals Corporation Michelson, Georg ................................. Disclosed no confl ict of interest. Middelbeek, Roeland J. ....................... Disclosed no confl ict of interest. Middleton, Tim ..................................... Disclosed no confl ict of interest. Midyett, L. Kurt .................................... Disclosed no confl ict of interest. Miehle, Konstanze ............................... Disclosed no confl ict of interest. Miele, Claudia ...................................... Disclosed no confl ict of interest. Mieler, William F. ................................. Consultant: Alcon Laboratories, Allergan, Inc., Genentech,

Novartis Pharmaceuticals Corporation, QLT; Other Relationship: Acucela, ThromboGenics; Speaker’s Bureau: Genentech

Mielke, Clinton ..................................... Disclosed no confl ict of interest. Miernik, Jadwiga ................................. Disclosed no confl ict of interest. Migita, Mika ......................................... Disclosed no confl ict of interest. Mihaescu, Grigore ................................ Disclosed no confl ict of interest. MiJeong, Kim ....................................... Disclosed no confl ict of interest. Mikeladze, Maia .................................. Disclosed no confl ict of interest. Miki, Tetsuro ........................................ Disclosed no confl ict of interest. Mikkelsen, Anders F. ............................ Disclosed no confl ict of interest. Mikkelsen, Kristian H. .......................... Stock/Shareholder: Lundbeck, Inc. Mikus, Catherine R. .............................. Disclosed no confl ict of interest.

Dow



A879


AU

THO

R D

ISCL

OSU

RE

Milan, Maria ........................................ Disclosed no confl ict of interest. Milata, Vlastimil ................................... Employee: Medtronic Milberg, William .................................. Disclosed no confl ict of interest. Milech, Adolpho ................................... Disclosed no confl ict of interest. Milicevic, Zvonko ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Miliou, Antigoni ................................... Disclosed no confl ict of interest. Miljkovic, Iva ........................................ Disclosed no confl ict of interest. Miller, Bernard V. .................................. Disclosed no confl ict of interest. Miller, Bryce ......................................... Employee: Genentech; Stock/Shareholder: Genentech Miller, Deborah .................................... Employee: Merck Sharp & Dohme Limited Miller, Edgar ......................................... Disclosed no confl ict of interest. Miller, Hadley ....................................... Disclosed no confl ict of interest. Miller, Jamee ....................................... Disclosed no confl ict of interest. Miller, Jason ........................................ Disclosed no confl ict of interest. Miller, Joshua D. .................................. Disclosed no confl ict of interest. Miller, Kellee M. .................................. Disclosed no confl ict of interest. Miller, Lupe R. ...................................... Employee: Lifescan Animas, Inc. Miller, Michael E. ................................. Disclosed no conflict of interest. Miller, Milissa ...................................... Disclosed no confl ict of interest. Miller, Rachel G. ................................... Disclosed no confl ict of interest. Miller, Richard ...................................... Disclosed no confl ict of interest. Miller, Shahar ....................................... Disclosed no confl ict of interest. Miller, Tracie L. ..................................... Disclosed no confl ict of interest. Miller-Lotan, Rachel ............................. Disclosed no confl ict of interest. Millot, Luc ............................................ Disclosed no confl ict of interest. Mills, Joseph L. .................................... Disclosed no confl ict of interest. Mills, Kevin .......................................... Disclosed no confl ict of interest. Milne, Ginger L. .................................... Disclosed no confl ict of interest. Milrad, Silvana ..................................... Disclosed no confl ict of interest. Mima, Akira .......................................... Disclosed no confl ict of interest. Mima, Yohei ......................................... Disclosed no confl ict of interest. Mimura, Makiyo ................................... Disclosed no confl ict of interest. Min, Danqing ........................................ Disclosed no confl ict of interest. Min, Kyong Pil ...................................... Disclosed no confl ict of interest. Min, Kyung Wan .................................. Disclosed no confl ict of interest. Min, Lillian ........................................... Disclosed no confl ict of interest. Min, Ren ............................................... Disclosed no confl ict of interest. Min, Sung Ah ....................................... Disclosed no confl ict of interest. Min, Zhang ........................................... Disclosed no confl ict of interest. Minagawa, Shinichi ............................. Disclosed no confl ict of interest. Minagawa, Shiniti ................................ Disclosed no confl ict of interest. Minang, Laura ...................................... Disclosed no confl ict of interest. Mindlova, Martina ............................... Disclosed no confl ict of interest. Mindubaeva, Farida A. ......................... Disclosed no confl ict of interest. Mine,Keiichiro ...................................... Disclosed no confl ict of interest. Mineoka, Yusuke .................................. Disclosed no confl ict of interest. Minervini, Gianmaria ........................... Employee: AstraZeneca Pharmaceuticals LP Minges, Karl E. ..................................... Disclosed no confl ict of interest. Mingomataj, Erli ................................... Disclosed no confl ict of interest. Minh, Timothy D. .................................. Disclosed no confl ict of interest. Minhas, Davneet S. .............................. Disclosed no confl ict of interest. Mini, G.K. ............................................. Disclosed no confl ict of interest. Minium, Judi ........................................ Disclosed no confl ict of interest. Minor, James M. .................................. Disclosed no confl ict of interest. Miragaya, Joanna ................................ Disclosed no confl ict of interest. Miranda, Danielle N. ............................ Disclosed no confl ict of interest. Miras, Alex D. ...................................... Disclosed no confl ict of interest. Mirmira, Raghavendra G. ..................... Disclosed no confl ict of interest. Misawa, Haruo ..................................... Disclosed no confl ict of interest. Misawa, Ryosuke ................................. Disclosed no confl ict of interest. Mishima, Takashi ................................. Disclosed no confl ict of interest. Mishra, Suruchi .................................... Disclosed no confl ict of interest. Misir, Akenath ...................................... Disclosed no confl ict of interest. Miska, Jason ........................................ Disclosed no confl ict of interest. Misra, Anoop ........................................ Research Support: Nestle, Inc. Misumi, Kazuo ...................................... Disclosed no confl ict of interest. Mitchell, Beth D. .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Mitchell, Braxton D. ............................. Disclosed no confl ict of interest. Mitchell, Grant A. ................................. Disclosed no confl ict of interest. Mitchell, Ryan K. .................................. Disclosed no confl ict of interest. Mithal, Alka .......................................... Disclosed no confl ict of interest. Mithal, Ambrish ................................... Consultant: Bristol-Myers Squibb Company, Eli Lilly and

Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi Aventis; Employee: Medanta Medicity; Research Support: Clinical Trials TECOS, ELIXA; Speaker’s Bureau: Clinical Trials TECOS, ELIXA

Mitidieri, Emma .................................... Disclosed no confl ict of interest. Mitnala, Sasikala ................................. Disclosed no confl ict of interest. Mitrea, Ioan L. ...................................... Disclosed no confl ict of interest.

Mitri, Michael ...................................... Disclosed no confl ict of interest. Mitsuhashi, Kaduteru ........................... Disclosed no confl ict of interest. Mitsui, Shinobu .................................... Disclosed no confl ict of interest. Mitsuishi, Masanori ............................. Disclosed no confl ict of interest. Mitsumatsu, Takako ............................. Disclosed no confl ict of interest. Mittal, Rajneesh ................................... Disclosed no confl ict of interest. Mitushima, Toru ................................... Disclosed no confl ict of interest. Miura, Junnosuke ................................ Disclosed no confl ict of interest. Miura, Katsuyuki .................................. Disclosed no confl ict of interest. Miura, Kyoko ........................................ Employee: Ajinomoto Group Mixson, Lori .......................................... Employee: Merck Sharp & Dohme Limited Miyagawa, Katsutoshi ......................... Disclosed no confl ict of interest. Miyahara, Fujiko ................................... Disclosed no confl ict of interest. Miyajima, Shin-ichi .............................. Disclosed no confl ict of interest. Miyakawa, Takaichi ............................. Disclosed no confl ict of interest. Miyamoto, Licht ................................... Disclosed no confl ict of interest. Miyamoto, Robin .................................. Disclosed no confl ict of interest. Miyano, Hiroshi .................................... Disclosed no confl ict of interest. Miyasato, Mai ...................................... Disclosed no confl ict of interest. Miyashita, Kazutoshi ............................ Disclosed no confl ict of interest. Miyatake, Han ...................................... Disclosed no confl ict of interest. Miyauchi, Masaaki ............................... Disclosed no confl ict of interest. Miyazaki, Shigeru ................................. Disclosed no confl ict of interest. Miyazaki, Takashi ................................. Disclosed no confl ict of interest. Miyoshi, Hideaki .................................. Disclosed no confl ict of interest. Mizukami, Hiroki .................................. Disclosed no confl ict of interest. Mizuno, Yukie ....................................... Employee: Sanwa Kagaku Kenkyusho Mizutani, Makoto ................................. Disclosed no confl ict of interest. Mkrtchyan, Hasmik .............................. Disclosed no confl ict of interest. Mlynarik, Vladimir ................................ Disclosed no confl ict of interest. Mlynarski, Wojciech ............................ Disclosed no confl ict of interest. Mmantovani, Alessandro ..................... Disclosed no confl ict of interest. Mo, Eun Young ..................................... Disclosed no confl ict of interest. Mo, Xiaoqing ........................................ Disclosed no confl ict of interest. Mo, Yifei ............................................... Disclosed no confl ict of interest. Moak, Shari L. ...................................... Disclosed no confl ict of interest. Moar, Yasmin ....................................... Disclosed no confl ict of interest. Mobini, Reza ........................................ Disclosed no confl ict of interest. Mochi, Nicola ....................................... Disclosed no confl ict of interest. Moeller, Niels ....................................... Disclosed no confl ict of interest. Moellering, Douglas R. ........................ Disclosed no confl ict of interest. Moffet, Howard H. ............................... Disclosed no confl ict of interest. Mogul, Sharon ...................................... Disclosed no confl ict of interest. Mohammed, Ali .................................... Disclosed no confl ict of interest. Mohammedi, Kamel ............................. Disclosed no confl ict of interest. Mohan, Arun V. ..................................... Disclosed no confl ict of interest. Mohan, Viswanathan ........................... Disclosed no confl ict of interest. Mohanty, Prasanna .............................. Disclosed no confl ict of interest. Moheet, Amir ....................................... Disclosed no confl ict of interest. Moinet, Gérard ..................................... Employee: Metabolys; Stock/Shareholder: Metabolys Mojiminiyi, Olusegun A. ....................... Disclosed no confl ict of interest. Mok, Ki-Tae .......................................... Disclosed no confl ict of interest. Mokhlesi, Babak ................................... Disclosed no confl ict of interest. Mokta, Jitender .................................... Disclosed no confl ict of interest. Mokta, Kiran K. .................................... Disclosed no confl ict of interest. Molano, R. Damaris ............................. Board Member: Converge Biotech, Inc. (Spouse/Partner),

NEVA Scientifi c, LLC (Spouse/Partner); Stock/Shareholder: Converge Biotech, Inc., Converge Biotech, Inc. (Spouse/Partner), NEVA Scientifi c, LLC (Spouse/Partner)

Molano, Ruth ........................................ Stock/Shareholder: Converge Biotech, Inc. Moldovan, Radu ................................... Disclosed no confl ict of interest. Moleda, Piotr ........................................ Disclosed no confl ict of interest. Molina, Fabiana ................................... Disclosed no confl ict of interest. Molinari, Claudia .................................. Disclosed no confl ict of interest. Molitch, Mark E. ................................... Advisory Panel: Corcept, IPSEN - Biomeasure Incorporated,

Janssen Pharmaceuticals, Novo Nordisk, Inc.; Consultant: Abbott Laboratories, Inc., Corcept, Novartis Pharmaceu-ticals Corporation; Research Support: Corcept, Eli Lilly and Company, IPSEN - Biomeasure Incorporated, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Reata Pharmaceuticals, Sanofi

Molitvoslovova, Natalya ...................... Disclosed no confl ict of interest. Molla, Michael ..................................... Disclosed no confl ict of interest. Møller Hansen, Ulla ............................. Disclosed no confl ict of interest. Moller, David ........................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Moller, Niels ......................................... Disclosed no confl ict of interest. Molnar, Gabor ...................................... Disclosed no confl ict of interest. Molnar, Gergo A. .................................. Disclosed no confl ict of interest. Molyneaux, Lynda ................................ Disclosed no confl ict of interest. Monciotti, Carlamaria .......................... Disclosed no confl ict of interest. Mondal, Ashis K. .................................. Disclosed no confl ict of interest.

Dow



A880


AU

THO

R D

ISCL

OSU

RE

Mondragon, Angeles ............................ Disclosed no confl ict of interest. Monks, Bobby ....................................... Disclosed no confl ict of interest. Monson, Gipper .................................... Employee: Sanofi Montanaro, Marc T. ............................. Disclosed no confl ict of interest. Montanya, Eduard ................................ Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Intarcia

Therapeutics, Inc., Novo Nordisk A/S; Employee: Almirall (Spouse/Partner); Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S

Monte, Scott V. .................................... Disclosed no confl ict of interest. Monti, Sara M. ..................................... Disclosed no confl ict of interest. Monticelli, Antonella ........................... Disclosed no confl ict of interest. Montosa, Abmaridel ............................ Disclosed no confl ict of interest. Montoya, Lucy ...................................... Disclosed no confl ict of interest. Monyak, John ....................................... Employee: AstraZeneca Pharmaceuticals LP Moon, Hyun-Seuk ................................. Disclosed no confl ict of interest. Moon, Jun Sung ................................... Disclosed no confl ict of interest. Moon, Min Kyong ................................. Disclosed no confl ict of interest. Moon, Seong Su ................................... Disclosed no confl ict of interest. Moon, Sung Dae .................................. Disclosed no confl ict of interest. Moon, Yeo-Jin ...................................... Disclosed no confl ict of interest. Moonen-Kornips, Esther ...................... Disclosed no confl ict of interest. Moore, Ashley ...................................... Disclosed no confl ict of interest. Moore, David L. .................................... Disclosed no confl ict of interest. Moore, Kathryn .................................... Disclosed no confl ict of interest. Moore, Mary C. .................................... Disclosed no confl ict of interest. Moore, Patrick C. .................................. Disclosed no confl ict of interest. Moore, Thomas R. ................................ Disclosed no confl ict of interest. Moosabhoy, Mufadal ........................... Disclosed no confl ict of interest. Mootha, Vamsi ..................................... Disclosed no confl ict of interest. Morabito, Alberto ................................. Disclosed no confl ict of interest. Moraes Leao Peixoto, Eduardo ............ Disclosed no confl ict of interest. Morais, Jose A. .................................... Disclosed no confl ict of interest. Moralidis, Eustratios ............................ Disclosed no confl ict of interest. Moran, Antoinette ................................ Research Support: Merck Moran, Brett ......................................... Disclosed no confl ict of interest. Moran, Chris ......................................... Disclosed no confl ict of interest. Moran, John ......................................... Disclosed no confl ict of interest. Moreau, François ................................. Disclosed no confl ict of interest. Moreira-Cali, Patricia ........................... Research Support: sanofi -aventisMoreland, Elaine C. .............................. Disclosed no confl ict of interest. Morelli, Matthew ................................. Disclosed no confl ict of interest. Morello, Candis M. .............................. Disclosed no confl ict of interest. Morello, Remy ...................................... Disclosed no confl ict of interest. Moreno Vega, Aura Ileana ................... Disclosed no confl ict of interest. Moreno, Carolina ................................. Disclosed no confl ict of interest. Moreno-Santos, Inma .......................... Disclosed no confl ict of interest. morera, Julia ........................................ Disclosed no confl ict of interest. Morgan, Alexander A. .......................... Disclosed no confl ict of interest. Morgan, Christopher L. ........................ Consultant: Abbott Laboratories, Inc., Bristol-Myers Squibb

Company, Takeda Pharmaceutical Company, Ltd. Morgan, Mary K. .................................. Disclosed no confl ict of interest. Morgan, Noel ....................................... Disclosed no confl ict of interest. Morgantini, Cecilia ............................... Disclosed no confl ict of interest. Mori, Ana Paula ................................... Disclosed no confl ict of interest. Mori, Hisashi ........................................ Disclosed no confl ict of interest. Mori, Hitoe ........................................... Disclosed no confl ict of interest. Mori, Ichiro ........................................... Disclosed no confl ict of interest. Mori, Kanako ........................................ Disclosed no confl ict of interest. Mori, Katsuhito .................................... Disclosed no confl ict of interest. Mori, Marcelo ...................................... Disclosed no confl ict of interest. Mori, Yasumichi ................................... Disclosed no confl ict of interest. Mori, Yutaka ......................................... Disclosed no confl ict of interest. Morikawa, Yuko ................................... Disclosed no confl ict of interest. Morimoto, Aya ..................................... Disclosed no confl ict of interest. Morin, Philip ......................................... Disclosed no confl ict of interest. Morinaga, Rieko ................................... Disclosed no confl ict of interest. Morini, Eleonora ................................... Disclosed no confl ict of interest. Morino, Katsutaro ................................ Disclosed no confl ict of interest. Morioka, Tetsu ..................................... Disclosed no confl ict of interest. Morioka, Tomoaki ................................. Disclosed no confl ict of interest. Morisawa, Chioko ................................ Disclosed no confl ict of interest. Morita, Hiroshi ..................................... Disclosed no confl ict of interest. Morita, Hiroyuki ................................... Disclosed no confl ict of interest. Morita, Satoshi .................................... Disclosed no confl ict of interest. Morita, Shuhei ..................................... Disclosed no confl ict of interest. Morita, Tomoko .................................... Disclosed no confl ict of interest. Morita, Yoshifumi ................................. Disclosed no confl ict of interest. Moritz, Tom .......................................... Disclosed no confl ict of interest. Moriya, Rie ........................................... Disclosed no confl ict of interest. Moriya, Tatsumi ................................... Disclosed no confl ict of interest. Mørkrid, Kjersti .................................... Disclosed no confl ict of interest.

Moro, Cedric ......................................... Disclosed no confl ict of interest. Moroto, Lucia ....................................... Disclosed no confl ict of interest. Morran, Michael P. ............................... Disclosed no confl ict of interest. Morris, Andrew P. ................................. Disclosed no confl ict of interest. Morris, David L. .................................... Disclosed no confl ict of interest. Morris, E. Matthew .............................. Disclosed no confl ict of interest. Morris, Steve ........................................ Disclosed no confl ict of interest. Morrison, Clive ..................................... Disclosed no confl ict of interest. Morrison, Gill ....................................... Disclosed no confl ict of interest. Morrison, Ron F. ................................... Disclosed no confl ict of interest. Morrow, Darren .................................... Disclosed no confl ict of interest. Morrow, Linda A. .................................. Employee: Profi l Institute for Clinical Research, Inc.; Stock/

Shareholder: Profi l Institute for Clinical Research, Inc. Morrow, Ryan ....................................... Disclosed no confl ict of interest. Morse, Dawn ........................................ Disclosed no confl ict of interest. Morsi, Amr ........................................... Disclosed no confl ict of interest. Mortellaro, Mark .................................. Disclosed no confl ict of interest. Mortensen, Brynjulf ............................. Disclosed no confl ict of interest. Morton, Gregory J. ............................... Research Support: Novo Nordisk A/S Morton, Lori .......................................... Disclosed no confl ict of interest. Mortuza, Rokhsana .............................. Disclosed no confl ict of interest. Mosely, Kylie ........................................ Disclosed no confl ict of interest. Moses, Robert G. ................................. Disclosed no confl ict of interest. Mosior, Marian K. ................................ Disclosed no confl ict of interest. Mosnier-Pudar, Helen ........................... Disclosed no confl ict of interest. Moss, Dan ............................................ Disclosed no confl ict of interest. Mosser, Rockann E. .............................. Disclosed no confl ict of interest. Mostazir, Mohammod B. ...................... Disclosed no confl ict of interest. Mostrou, Dimitrios ............................... Disclosed no confl ict of interest. Mota, Maria ......................................... Disclosed no confl ict of interest. Motoshima, Hiroyuki ............................ Disclosed no confl ict of interest. Motoyama, Koka .................................. Disclosed no confl ict of interest. Motta, Cecilia ....................................... Disclosed no confl ict of interest. Mottalib, Adham .................................. Disclosed no confl ict of interest. Mottl, Amy K. ....................................... Disclosed no confl ict of interest. Moulik, Mousumi ................................. Disclosed no confl ict of interest. Moullé, Valentine S. ............................ Disclosed no confl ict of interest. Mounier, Chantal .................................. Disclosed no confl ict of interest. Moussa Ali, Habib ................................ Disclosed no confl ict of interest. Moustarah, Fady .................................. Disclosed no confl ict of interest. Moutschen, Michel .............................. Disclosed no confl ict of interest. Mouza, Eirini ........................................ Disclosed no confl ict of interest. Movassat, Jamileh ............................... Disclosed no confl ict of interest. Moyes, Simon A. .................................. Disclosed no confl ict of interest. Mozaffarian, Dariush ........................... Disclosed no confl ict of interest. Mozzi, Enrico ........................................ Disclosed no confl ict of interest. Mraz, Milos .......................................... Disclosed no confl ict of interest. Msallaty, Zaher .................................... Disclosed no confl ict of interest. Mseeh, Faika ........................................ Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Mu, Kaida ............................................. Disclosed no confl ict of interest. Mu, Panwei .......................................... Disclosed no confl ict of interest. Muchmore, Douglas B. ......................... Employee: Halozyme Therapeutics; Stock/Shareholder:

Halozyme Therapeutics Mudaliar, Sunder R. ............................. Consultant: Bristol-Myers Squibb/AstraZeneca, Roche

Pharmaceuticals; Research Support: Amgen, Inc., Amylin Pharmaceuticals, Inc., Sanofi

Mudie, Nadejda ................................... Employee: F. Hoffmann-La Roche, Ltd. Mueller, Heidi ....................................... Disclosed no confl ict of interest. Mueller, Karsten ................................... Disclosed no confl ict of interest. Muendlein, Axel ................................... Disclosed no confl ict of interest. Mugabo, Yves ...................................... Disclosed no confl ict of interest. Mugavero, Michael J. .......................... Research Support: Sanofi (Spouse/Partner) Mugellini, Amedeo ............................... Disclosed no confl ict of interest. Mugerfeld, Irina ................................... Disclosed no confl ict of interest. Mughal, Saima A. ................................ Disclosed no confl ict of interest. Muhamedagic, Cynthia A. .................... Disclosed no confl ict of interest. Mukai, Eri ............................................. Disclosed no confl ict of interest. Mukamal, Kenneth ............................... Disclosed no confl ict of interest. Mukerji, Geetha ................................... Disclosed no confl ict of interest. Mukherjee, Jayanti .............................. Employee: Bristol-Myers Squibb Company; Stock/Shareholder:

Bristol-Myers Squibb Company Mukhopadhyay, Bani ............................ Disclosed no confl ict of interest. Muktader, Liat ...................................... Disclosed no confl ict of interest. Mullan-Jensen, Christine ..................... Consultant: Novo Nordisk A/S Mullany, Britta ...................................... Disclosed no confl ict of interest. Müller, Achim J. ................................... Employee: Eysense GmbH; Stock/Shareholder: Eysense GmbH Muller, Ido ............................................ Disclosed no confl ict of interest. Muller, Yunhua ..................................... Disclosed no confl ict of interest. Müller-Wieland, Dirk ........................... Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Merck

Sharp & Dohme Limited; Consultant: Daiichi-Sankyo, Inc.; Speaker’s Bureau: Boehringer Ingelheim GmbH & Co. KG,

Dow



A881


AU

THO

R D

ISCL

OSU

RE

Bristol-Myers Squibb/AstraZeneca, Daiichi-Sankyo, Inc., Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation

Mulligan, Kimberly ............................... Disclosed no confl ict of interest. Mulnier, Henrietta ................................ Advisory Panel: Novo Nordisk, Inc.; Speaker’s Bureau: Eli Lilly

and Company Multani, Manish K. .............................. Disclosed no confl ict of interest. Mulvaney, Shelagh ............................... Disclosed no confl ict of interest. Mumby, Patricia ................................... Disclosed no confl ict of interest. Munch, Gerald ...................................... Disclosed no confl ict of interest. Mundel, Peter ....................................... Disclosed no confl ict of interest. Mündlein, Axel ..................................... Disclosed no confl ict of interest. Munera, Jorge ...................................... Disclosed no confl ict of interest. Munesue, Seiichi ................................. Disclosed no confl ict of interest. Muniappan, Latha ................................ Disclosed no confl ict of interest. Muniyappa, Ranganath ........................ Disclosed no confl ict of interest. Munns, Diane ....................................... Disclosed no confl ict of interest. Munoz, Elyse E. .................................... Disclosed no confl ict of interest. Muñoz, Francisco ................................. Disclosed no confl ict of interest. Munoz, Miguel ..................................... Disclosed no confl ict of interest. Muñoz, Oscar ....................................... Disclosed no confl ict of interest. Munro, Neil .......................................... Advisory Panel: Abbott Diabetes Care, AstraZeneca/Bristol-

Meyers Squibb, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: Abbott Diabetes Care, AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi

Munsell, Michael ................................. Research Support: Takeda Global Research & Development Center, Inc.

Munshi, Medha N. ............................... Research Support: Sanofi Münzel, Thomas ................................... Disclosed no confl ict of interest. Munzenmaier, Diane ............................ Disclosed no confl ict of interest. Muoio, Deborah M. .............................. Disclosed no confl ict of interest. Murakami, Hiroshi ................................ Disclosed no confl ict of interest. Murakami, Kazutoshi ........................... Disclosed no confl ict of interest. Murakami, Tomoyasu ........................... Disclosed no confl ict of interest. Muraki, Ayako ...................................... Disclosed no confl ict of interest. Murakoshi, Michiaki ............................ Disclosed no confl ict of interest. Muramatsu, Toshiya ............................. Disclosed no confl ict of interest. Muranaka, Kazuya ................................ Disclosed no confl ict of interest. Muraoka, Hironori ................................ Disclosed no confl ict of interest. Murase, Kunitaka ................................. Disclosed no confl ict of interest. Murase-Mishiba, Yuko ......................... Disclosed no confl ict of interest. Murata, Allison E. ................................ Disclosed no confl ict of interest. Murata, Ayumi ..................................... Disclosed no confl ict of interest. Murata, Glen H. .................................... Disclosed no confl ict of interest. Murata, Hideho .................................... Disclosed no confl ict of interest. Murchison, Rachel ............................... Disclosed no confl ict of interest. Murff, Harvey ....................................... Disclosed no confl ict of interest. Murphree, Paul ..................................... Disclosed no confl ict of interest. Murphy, Helen R. .................................. Advisory Panel: Medtronic MiniMed, Inc.; Speaker’s Bureau:

Medtronic MiniMed, Inc., Novo Nordisk A/S, Roche Pharmaceuticals

Murphy, Kathryn M. ............................. Disclosed no confl ict of interest. Murphy, Louise ..................................... Disclosed no confl ict of interest. Murphy, Mary Beth .............................. Disclosed no confl ict of interest. Murphy, Matthew ................................ Disclosed no confl ict of interest. Murr, Michel ......................................... Disclosed no confl ict of interest. Murray, Alexander V. ............................ Research Support: Amylin Pharmaceuticals, Inc., Bristol-Myers

Squibb Company, Eli Lilly and Company, Johnson & John-son, Merck, Novo Nordisk, Inc., Roche Pharmaceuticals

Musat, Madalina .................................. Disclosed no confl ict of interest. Muscelli, Elza ....................................... Disclosed no confl ict of interest. Muscogiuri, Giovanna .......................... Disclosed no confl ict of interest. Musen, Gail .......................................... Disclosed no confl ict of interest. Musholt, Petra B. ................................. Speaker’s Bureau: Sanofi Musi, Nicolas ....................................... Disclosed no confl ict of interest. Müssig, Karsten ................................... Disclosed no confl ict of interest. Mustafa, Georgiana ............................. Disclosed no confl ict of interest. Muthukumaran, Parthiban ................... Disclosed no confl ict of interest. Muthutantri, Anushini .......................... Consultant: IMS Health, Inc. Muto, Tetsuya ...................................... Disclosed no confl ict of interest. Myers, Jonathan .................................. Disclosed no confl ict of interest. Myers, Martin G. .................................. Disclosed no confl ict of interest. Mylopoulos, Christos ........................... Disclosed no confl ict of interest. Mysliwiec, Malgorzata ........................ Disclosed no confl ict of interest. Mysliwska, Jolanta .............................. Disclosed no confl ict of interest. Nabeta, Tomohiro ................................. Disclosed no confl ict of interest. Nabrdalik, Katarzyna ............................ Disclosed no confl ict of interest. Nada, Elisa ........................................... Disclosed no confl ict of interest. Nadeau, Joseph H. ............................... Disclosed no confl ict of interest.

Nadeau, Kristen J. ............................... Disclosed no confl ict of interest. Naderali, E.K. ....................................... Disclosed no confl ict of interest. Naderi, Ramin ...................................... Disclosed no confl ict of interest. Nadkarni, Mohan ................................. Research Support: Bristol-Myers Squibb Company Nadler, Jerry L. ..................................... Disclosed no confl ict of interest. Nadolski, Lee E. .................................... Disclosed no confl ict of interest. Nagafuchi, Seiho .................................. Disclosed no confl ict of interest. Nagai, Yoshinori ................................... Disclosed no confl ict of interest. Nagai, Yoshio ....................................... Disclosed no confl ict of interest. Nagalla, Srinivasa R. ............................ Employee: DiabetOmics; Stock/Shareholder: DiabetOmics Nagamatsu, Shinya .............................. Disclosed no confl ict of interest. Nagao, Kenji ......................................... Disclosed no confl ict of interest. Nagaoka, Taiji ...................................... Disclosed no confl ict of interest. Nagar, Ron ............................................ Board Member: Insuline Medical; Employee: Insuline Medical;

Stock/Shareholder: Insuline Medical Nagasawa, Kaoru ................................. Disclosed no confl ict of interest. Nagasawa, Masahiro ........................... Disclosed no confl ict of interest. Nagasawa, Shin-ya .............................. Disclosed no confl ict of interest. Nagashima, Kazuaki ............................. Disclosed no confl ict of interest. Nagashima, Yuki .................................. Disclosed no confl ict of interest. Nagashimada, Mayumi ........................ Disclosed no confl ict of interest. Nagata, Naoto ...................................... Disclosed no confl ict of interest. Nagayama, Takahiro ............................ Employee: Daiichi-Sankyo, Inc. Nagl, Katrin .......................................... Disclosed no confl ict of interest. Nahill, Chelsea M. ............................... Disclosed no confl ict of interest. Naidis, Eugene ..................................... Employee: Integrity Applications, Ltd. Naik, Sarita .......................................... Disclosed no confl ict of interest. Nair, Anup ............................................ Disclosed no confl ict of interest. Nair, Indu .............................................. Disclosed no confl ict of interest. Nair, K. Sreekumaran ........................... Disclosed no confl ict of interest. Nair, Kavita V. ....................................... Disclosed no confl ict of interest. Nair, Sandhya R. ................................... Disclosed no confl ict of interest. Nair, Sreejayan ..................................... Disclosed no confl ict of interest. Nair, Sunil ............................................. Disclosed no confl ict of interest. Nairz, Manfred ..................................... Disclosed no confl ict of interest. Naji, Ali ................................................ Disclosed no confl ict of interest. Najjar, Mejdi ........................................ Disclosed no confl ict of interest. Nakadaira, Ikue .................................... Disclosed no confl ict of interest. Nakagami, Tomoko ............................... Disclosed no confl ict of interest. Nakagawa, Fumiyuki ............................ Disclosed no confl ict of interest. Nakagawa, Hideaki .............................. Disclosed no confl ict of interest. Nakagawa, Takashi .............................. Disclosed no confl ict of interest. Nakagawa, Yuko .................................. Disclosed no confl ict of interest. Nakagawachi, Reiko ............................ Disclosed no confl ict of interest. Nakai, Masuo ....................................... Disclosed no confl ict of interest. Nakai, Naoko ........................................ Employee: Daiichi-Sankyo, Inc. Nakajima, Takehiro .............................. Disclosed no confl ict of interest. Nakajima, Yukari .................................. Disclosed no confl ict of interest. Nakamura, Akinobu .............................. Disclosed no confl ict of interest. Nakamura, Jiro ..................................... Disclosed no confl ict of interest. Nakamura, Katherine ........................... Employee: Dexcom, Inc. Nakamura, Koshi .................................. Disclosed no confl ict of interest. Nakamura, Masato .............................. Disclosed no confl ict of interest. Nakamura, Naoto ................................. Disclosed no confl ict of interest. Nakamura, Nobuhisa ........................... Disclosed no confl ict of interest. Nakamura, Riyo .................................... Disclosed no confl ict of interest. Nakamura, Takaaki ............................... Disclosed no confl ict of interest. Nakamura, Takao ................................. Disclosed no confl ict of interest. Nakamura, Yasuhiko ............................ Disclosed no confl ict of interest. Nakamura, Yoshihiko ........................... Disclosed no confl ict of interest. Nakamura, Yuki .................................... Disclosed no confl ict of interest. Nakao, Honami ..................................... Disclosed no confl ict of interest. Nakao, Keiko ........................................ Disclosed no confl ict of interest. Nakaoka, Hajime .................................. Disclosed no confl ict of interest. Nakatani, Kazuhiro ............................... Disclosed no confl ict of interest. Nakatani, Shinya .................................. Disclosed no confl ict of interest. Nakatsuji, Hideaki ................................ Disclosed no confl ict of interest. Nakatsuka, Atsuko ............................... Disclosed no confl ict of interest. Nakaya, Yutaka .................................... Disclosed no confl ict of interest. Nakayama, Hitomi ................................ Disclosed no confl ict of interest. Nakazaki, Mitsuhiro ............................. Disclosed no confl ict of interest. Nakazawa, Masato .............................. Disclosed no confl ict of interest. Nakhoul, Farid ...................................... Disclosed no confl ict of interest. Nalini, Ramaswami .............................. Disclosed no confl ict of interest. Nallala, Deepika ................................... Disclosed no confl ict of interest. Nalls, Michael A. ................................. Disclosed no confl ict of interest. Nam, Deokhwa ..................................... Disclosed no confl ict of interest. Nam, Ji Sun .......................................... Disclosed no confl ict of interest. Nam, Joo Young ................................... Disclosed no confl ict of interest. Nam, Moon Suk ................................... Disclosed no confl ict of interest. Namata-Elengwe, Irue ......................... Disclosed no confl ict of interest. Nam-Goong, Il Sung ............................. Disclosed no confl ict of interest.

Dow



A882


AU

THO

R D

ISCL

OSU

RE

Namiki, Atsushi .................................... Disclosed no confl ict of interest. Nammo, Takao ..................................... Disclosed no confl ict of interest. Nan, Bin ................................................ Disclosed no confl ict of interest. Nan, Jessica ......................................... Disclosed no confl ict of interest. Nan, Raluca .......................................... Disclosed no confl ict of interest. Nanayakkara, Natalie .......................... Disclosed no confl ict of interest. Nanayakkara, Prabath .......................... Disclosed no confl ict of interest. Nanda, Kriti .......................................... Disclosed no confl ict of interest. Nanduri, Jayasri ................................... Disclosed no confl ict of interest. Nanhwan, Manjyot .............................. Disclosed no confl ict of interest. Nanjo, Kishio ........................................ Disclosed no confl ict of interest. Nanjo, Shuuji ........................................ Disclosed no confl ict of interest. Nanto, Shinsuke ................................... Disclosed no confl ict of interest. Napierala, Malgorzata U. ..................... Disclosed no confl ict of interest. Naples, Mark ........................................ Disclosed no confl ict of interest. Narain, Niven R. ................................... Disclosed no confl ict of interest. Narayan, K.M.Venkat ........................... Disclosed no confl ict of interest. Narui, Koji ............................................ Disclosed no confl ict of interest. Naruse, Keiko ....................................... Disclosed no confl ict of interest. Naruse, Rika ......................................... Disclosed no confl ict of interest. Naruse, Yuchi ....................................... Disclosed no confl ict of interest. Narva, Andrew S. ................................. Disclosed no confl ict of interest. Nasir, Khurram ..................................... Disclosed no confl ict of interest. Nasteska, Daniela ................................ Disclosed no confl ict of interest. Natali, Andrea ...................................... Disclosed no confl ict of interest. Natalicchio, Annalisa ........................... Disclosed no confl ict of interest. Natarajan, Jaya .................................... Employee: Janssen Research & Development Natarajan, Rama .................................. Disclosed no confl ict of interest. Nathan, Aviva G. .................................. Disclosed no confl ict of interest. Nathan, Brandon .................................. Disclosed no confl ict of interest. Nathan, David M. ................................. Disclosed no confl ict of interest. Natividad, Luis A. ................................. Disclosed no confl ict of interest. Nauck, Michael A. ................................ Advisory Panel: Amylin Pharmaceuticals, Inc., Berlin Chemie

AG, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, GlaxoSmithKline, Hoffman La Roche, Intarcia Therapeutics, Inc., Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi , Versartis, Inc.; Consultant: Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Berlin Chemie AG, Boehringer Ingelheim GmbH & Co. KG, Diartis Pharmaceuticals, Eli Lilly and Company, GlaxoS-mithKline, Hoffman La Roche, Intarcia Therapeutics, Inc., Janssen Global Services, LLC, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi , Versartis, Inc.; Other Relationship: Diabate/Boehringer Ingelheim, Incretin Expert Program/Lilly Deutschland GmbH, Medscape, LLC, Merck Sharp & Dohme Limited; Research Support: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, GlaxoSmithKline, Merck Sharp & Dohme Limited, Metacure, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Roche Pharmaceuticals, ToleRx; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Berlin Chemie AG, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Roche Pharmaceuticals

Navarro, Guadalupe ............................. Disclosed no confl ict of interest. Navarro, Virtu C. ................................... Disclosed no confl ict of interest. Nawroth, Peter P. ................................. Disclosed no confl ict of interest. Naylor, Rochelle N. .............................. Disclosed no confl ict of interest. Nazaré, José ........................................ Disclosed no confl ict of interest. Nazaret, Rémi ....................................... Employee: Metabolys Nazarian, Arbi ...................................... Disclosed no confl ict of interest. Neal, Bruce ........................................... Advisory Panel: Roche, Takeda; Consultant: Roche, Takeda;

Research Support: Australian Food and Grocery Council, Bupa Australia, Johnson & Johnson, Merck Schering Plough, Roche, Servier, United Healthcare Group, Bupa; Speaker’s Bureau: Abbott, Amgen, AstraZeneca, Glaxo-SmithKline, Novartis, Pepsico, Pfi zer, Pharmacy Guild of Australia, Roche, Sanofi Aventis, Servier, Tanabe

Neal, Doss W. ...................................... Disclosed no confl ict of interest. Neasham, David ................................... Research Support: Eli Lilly and Company Neault, Nicole ...................................... Disclosed no confl ict of interest. Neculaescu, Cristian ............................ Disclosed no confl ict of interest. Nedel, Bárbara ..................................... Disclosed no confl ict of interest. Nederveen, Aart J. ............................... Disclosed no confl ict of interest. Neerup, Trine S. ................................... Employee: Zealand Pharma A/S; Research Support: Zealand

Pharma A/S; Stock/Shareholder: Zealand Pharma A/S Nees, Margaret .................................... Disclosed no confl ict of interest. Negri, Carlo .......................................... Disclosed no confl ict of interest. Neira, Iraida ......................................... Disclosed no confl ict of interest. Nellemann, Birgitte .............................. Disclosed no confl ict of interest.

Nelson, Belinda .................................... Disclosed no confl ict of interest. Nelson, Bryce A. ................................... Disclosed no confl ict of interest. Nelson, David L. ................................... Disclosed no confl ict of interest. Nelson, David R. ................................... Employee: Eli Lilly and Company Nelson, James E. ................................. Disclosed no confl ict of interest. Nelson, Michael B. ............................... Disclosed no confl ict of interest. Nelson, Patrick ..................................... Disclosed no confl ict of interest. Nelson, Robert G. ................................. Disclosed no confl ict of interest. Nemetz, Peter N. .................................. Disclosed no confl ict of interest. Neremberg, Kara .................................. Disclosed no confl ict of interest. Neri, Anna ............................................ Disclosed no confl ict of interest. Nero, Damion ....................................... Research Support: Novo Nordisk, Inc. Nesher, Rafael ...................................... Disclosed no confl ict of interest. Neshewat, Gina M. .............................. Disclosed no confl ict of interest. Neslusan, Cheryl .................................. Employee: Janssen Global Services, LLC Nestler, John E. .................................... Disclosed no confl ict of interest. Neubacher, Dietmar ............................. Employee: Boehringer Ingelheim GmbH & Co. KG Neubauer, Katharina M. ....................... Disclosed no confl ict of interest. Neufeld, Naomi .................................... Disclosed no confl ict of interest. Neufer, P. Darrell .................................. Disclosed no confl ict of interest. Neufi eld, Naomi ................................... Disclosed no confl ict of interest. Neuper, Christine ................................. Disclosed no confl ict of interest. Neuschäfer-Rube, Frank ....................... Disclosed no confl ict of interest. Neutel, Joel .......................................... Disclosed no confl ict of interest. Neves, Rodrigo X. ................................. Disclosed no confl ict of interest. Newby, Brittney N. ............................... Disclosed no confl ict of interest. Newczas, Monika ................................. Disclosed no confl ict of interest. Newfi eld, Ron S. .................................. Disclosed no confl ict of interest. Newgard, Christopher B. ...................... Disclosed no confl ict of interest. Newman, Anne .................................... Disclosed no confl ict of interest. Newman, Julie ..................................... Employee: Bristol-Myers Squibb Company Newman, Laura .................................... Disclosed no confl ict of interest. Newnes, Lindsey .................................. Disclosed no confl ict of interest. Newsom, Sean A. ................................ Disclosed no confl ict of interest. Newsome, Philip N. ............................. Disclosed no confl ict of interest. Newswanger, Brett J. .......................... Disclosed no confl ict of interest. Newton, Christopher A. ....................... Consultant: Sanofi ; Research Support: Sanofi Newton, Katherine M. ......................... Disclosed no confl ict of interest. Nezamis, James P. ............................... Employee: MannKind Corporation; Stock/Shareholder: Mann-

Kind Corporation Nezu, Uru .............................................. Disclosed no confl ict of interest. Ng, Enders K. ........................................ Disclosed no confl ict of interest. Ng, Huei L. ............................................ Disclosed no confl ict of interest. Ng, Jason M. ........................................ Disclosed no confl ict of interest. Ng, Maggie C. ...................................... Disclosed no confl ict of interest. Ng, Vanessa ......................................... Disclosed no confl ict of interest. Ng-Mak, Daisy ..................................... Employee: Allergan, Inc. Nguyen, Dan ......................................... Disclosed no confl ict of interest. Nguyen, Denis ...................................... Disclosed no confl ict of interest. Nguyen, Ha ........................................... Disclosed no confl ict of interest. Nguyen, Huong-Lan .............................. Disclosed no confl ict of interest. Nguyen, Joseph ................................... Disclosed no confl ict of interest. Nguyen, Linda M. ................................. Disclosed no confl ict of interest. Nguyen, Matt ....................................... Employee: Valeritas, LLC; Stock/Shareholder: Valeritas, LLC Nguyen, Minh Tuan .............................. Disclosed no confl ict of interest. Nguyen, Nhung .................................... Disclosed no confl ict of interest. Nguyen, Thien-Son ............................... Disclosed no confl ict of interest. Ni, David ............................................... Disclosed no confl ict of interest. Ni, Jie ................................................... Disclosed no confl ict of interest. Ni, Yinhua ............................................. Disclosed no confl ict of interest. Nicholas, Jennifer A. ........................... Disclosed no confl ict of interest. Nichols, Colin G. ................................... Disclosed no confl ict of interest. Nichols, Gregory A. .............................. Research Support: AstraZeneca/Bristol-Meyers Squibb, Glaxo-

SmithKline, Novartis Pharmaceuticals Corporation Nicholson, Wanda ................................ Disclosed no confl ict of interest. Nichter, Mark ....................................... Disclosed no confl ict of interest. Nicolle, Lindsay E. ................................ Consultant: Janssen; Research Support: Janssen Nicolucci, Antonio ................................ Advisory Panel: Merck Sharp & Dohme Limited, Novartis

Pharmaceuticals Corporation; Consultant: Novo Nordisk, Inc.; Research Support: Lifescan Animas, Inc., Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi

Nicotra, Alessia .................................... Disclosed no confl ict of interest. Nicoziani, Paolo .................................... Employee: Novo Nordisk, Inc. Nie, Qing .............................................. Employee: GlaxoSmithKline Nielsen, Jens S. ................................... Disclosed no confl ict of interest. Nielsen, Martin N. ............................... Disclosed no confl ict of interest. Nielsen, Morten F. ................................ Disclosed no confl ict of interest. Nielsen, Roni ........................................ Disclosed no confl ict of interest. Nielsen, Soren ...................................... Disclosed no confl ict of interest. Niemeyer, Marcus ................................ Employee: Novo Nordisk A/S Nieto Iglesias, Javier ........................... Other Relationship: Eli Lilly and Company, Novartis, Johnson

& Johnson, Takeda, Reata; Research Support: Abbott

Dow



A883


AU

THO

R D

ISCL

OSU

RE

Nieto, Ramfi s E. .................................... Disclosed no confl ict of interest. Niewczas, Monika A. ........................... Disclosed no confl ict of interest. Nightingale, Peter G. ............................ Disclosed no confl ict of interest. Nigro, Cecilia ........................................ Disclosed no confl ict of interest. Nijpels, Giel .......................................... Disclosed no confl ict of interest. Nikitina, Irina ........................................ Disclosed no confl ict of interest. Nikolaidis, Athanasios ......................... Disclosed no confl ict of interest. Nikolaidou, Barbara ............................. Disclosed no confl ict of interest. Nikolajuk, Agnieszka ............................ Disclosed no confl ict of interest. Nikolopoulos, Athanasios .................... Disclosed no confl ict of interest. Nimri, Revital ....................................... Disclosed no confl ict of interest. Ning, Guang ......................................... Disclosed no confl ict of interest. Ning, Yun .............................................. Disclosed no confl ict of interest. Nishi, Masahiro .................................... Disclosed no confl ict of interest. Nishibata, Izumi ................................... Disclosed no confl ict of interest. Nishida, Makoto ................................... Disclosed no confl ict of interest. Nishida, Susumu .................................. Disclosed no confl ict of interest. Nishida, Tomoyo ................................... Disclosed no confl ict of interest. Nishida, Wataru ................................... Disclosed no confl ict of interest. Nishihara, Harumi ................................ Disclosed no confl ict of interest. Nishikawa, Tetsuo ................................ Disclosed no confl ict of interest. Nishikawa, Toru ................................... Disclosed no confl ict of interest. Nishimiya, Tatsuya ............................... Disclosed no confl ict of interest. Nishimura, Akihiro ............................... Disclosed no confl ict of interest. Nishimura, Erica ................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Nishimura, Masataka ........................... Disclosed no confl ict of interest. Nishimura, Rimei .................................. Disclosed no confl ict of interest. Nishimura, Wataru ............................... Disclosed no confl ict of interest. Nishino, Hoyoku ................................... Disclosed no confl ict of interest. Nishino, Takayoshi ............................... Disclosed no confl ict of interest. Nishio, Naomi ...................................... Disclosed no confl ict of interest. Nishio, Yoshihiko .................................. Disclosed no confl ict of interest. Nissen, Steven E. ................................. Consultant: Orexigen Therapeutics, Inc., Vivus, Inc. Nissim, Ahuva ...................................... Disclosed no confl ict of interest. Niswender, Kevin ................................. Disclosed no confl ict of interest. Nitabach, Michael N. ........................... Disclosed no confl ict of interest. Nitsch, Mario A. ................................... Consultant: Novartis Pharmaceuticals Corporation; Other Rela-

tionship: Medtronic; Research Support: Takeda Global Research and Development, Inc.; Speaker’s Bureau: Abbott Nutrition

Nitta, Kosaku ........................................ Disclosed no confl ict of interest. Nitz, Marlies ......................................... Disclosed no confl ict of interest. Niwa, Yasuhiro ..................................... Disclosed no confl ict of interest. Noble, Earl G. ....................................... Disclosed no confl ict of interest. Noble, Jason ........................................ Disclosed no confl ict of interest. Nochioka, Katsunori ............................. Disclosed no confl ict of interest. Noda, Hiroyuki ...................................... Disclosed no confl ict of interest. Noda, Mitsuhiko ................................... Disclosed no confl ict of interest. Nodale, Marianna ................................ Disclosed no confl ict of interest. Noe, Adele ........................................... Employee: Novartis Institutes for BioMedical Research;

Stock/Shareholder: Novartis Institutes for BioMedical Research

Noe, Joshua ......................................... Disclosed no confl ict of interest. Noel, Christian ..................................... Disclosed no confl ict of interest. Noguchi, Toshihide ............................... Disclosed no confl ict of interest. Noguchi, Yasushi .................................. Disclosed no confl ict of interest. Noguchi, Yukiko .................................... Disclosed no confl ict of interest. Nogueira, Keith .................................... Employee: Medtronic Noh, Tae Woong .................................. Disclosed no confl ict of interest. Noh, Yun-Hee ....................................... Disclosed no confl ict of interest. Noike, Hirofumi .................................... Disclosed no confl ict of interest. Nolan, Christopher J. ........................... Disclosed no confl ict of interest. Nolan, John J. ...................................... Employee: Steno Diabetes Center A/S; Stock/Shareholder:

Novo Nordisk A/S Nolido, Nyryan V. .................................. Disclosed no confl ict of interest. Noll, Christophe ................................... Disclosed no confl ict of interest. Nomi, Yukinobu .................................... Disclosed no confl ict of interest. Nomiyama, Takashi .............................. Disclosed no confl ict of interest. Nomoto, Koji ........................................ Disclosed no confl ict of interest. Nomura, Mitsuru .................................. Disclosed no confl ict of interest. Nomura, Yoshio .................................... Disclosed no confl ict of interest. Norby, Barbara ..................................... Disclosed no confl ict of interest. Nørgaard, Kirsten ................................. Research Support: Medtronic Norgaisse, Melissa .............................. Disclosed no confl ict of interest. Norjavaara, Ensio ................................. Employee: AstraZeneca Pharmaceuticals LP Norman, Robert .................................... Disclosed no confl ict of interest. Noronha, Renata .................................. Disclosed no confl ict of interest. Norouzi, Parviz ...................................... Disclosed no confl ict of interest. Nørregaard, Pia .................................... Employee: Zealand Pharma A/S; Research Support: Zealand

Pharma A/S Norris, Jill M. ....................................... Disclosed no confl ict of interest.

Norrman, Mathias ................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo Nordisk A/S

Norton, Luke ......................................... Disclosed no confl ict of interest. Nosaka, Mizuho ................................... Disclosed no confl ict of interest. Nosek, Leszek ....................................... Disclosed no confl ict of interest. Nosikov, Valeriy .................................... Disclosed no confl ict of interest. Noso, Shinsuke .................................... Disclosed no confl ict of interest. Nosratola, Vaziri D. .............................. Disclosed no confl ict of interest. Nouira, Semir ....................................... Disclosed no confl ict of interest. Nouwen, Arie ....................................... Disclosed no confl ict of interest. Novak, Lucia ......................................... Disclosed no confl ict of interest. Novak, Peter ......................................... Disclosed no confl ict of interest. Novak, Vera .......................................... Disclosed no confl ict of interest. Novelli, Michela ................................... Disclosed no confl ict of interest. Nowak, Krzysztof W. ............................ Disclosed no confl ict of interest. Nowak, Stefanie .................................. Disclosed no confl ict of interest. Nowicki, Maren .................................... Disclosed no confl ict of interest. Nowotny, Bettina ................................. Disclosed no confl ict of interest. Nowotny, Peter J. ................................. Disclosed no confl ict of interest. Nowrouzi, Azin ..................................... Disclosed no confl ict of interest. Ntasiopoulou, Chrysanthi ..................... Disclosed no confl ict of interest. Ntatsaki, Eleana ................................... Disclosed no confl ict of interest. Ntemka, Alexandra .............................. Disclosed no confl ict of interest. Numaguchi, Ryutaro ............................. Disclosed no confl ict of interest. Nundy, Shantanu .................................. Other Relationship: mHealth Solutions Núñez, Maria-Zunilda .......................... Disclosed no confl ict of interest. Nunn, Jennifer M. ................................ Disclosed no confl ict of interest. Nuotio, Marja-Liisa .............................. Disclosed no confl ict of interest. Nuttall, Frank Q. ................................... Disclosed no confl ict of interest. Nwankwo, Nneamaka .......................... Disclosed no confl ict of interest. Nygaard, Eva B. .................................... Research Support: Novo Nordisk A/S Nyhan, Kristine C. ................................ Disclosed no confl ict of interest. Nyirjesy, Paul ........................................ Consultant: Janssen Research & Development Nylen, Eric S. ........................................ Disclosed no confl ict of interest. Nyman, Elisabeth ................................. Employee: AstraZeneca Pharmaceuticals LP O’Connell, Jeffrey R. ............................ Disclosed no confl ict of interest. Oba, Kazuhito ....................................... Disclosed no confl ict of interest. Obara, Akio ........................................... Disclosed no confl ict of interest. Obara, Shinji ......................................... Disclosed no confl ict of interest. Obata, Atsushi ...................................... Disclosed no confl ict of interest. Obata, Toshiyuki ................................... Disclosed no confl ict of interest. Obayashi, Hiroshi ................................. Disclosed no confl ict of interest. Obendorf, Florian .................................. Disclosed no confl ict of interest. Oberholzer, José ................................... Disclosed no confl ict of interest. Obermaier, Karin .................................. Employee: Roche Diagnostics GmbH Obermayer-Pietsch, Barbara ................ Disclosed no confl ict of interest. Obregon-Henao, Andres ....................... Disclosed no confl ict of interest. O’Brien, Phillipe D. ............................... Disclosed no confl ict of interest. O’Brien, Sarah ...................................... Disclosed no confl ict of interest. O’Brien, Tracy P. .................................... Disclosed no confl ict of interest. Ocampo Francisco, Ann Marie ............. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Occhipinti, Margherita ......................... Disclosed no confl ict of interest. Ochi, Akinobu ....................................... Disclosed no confl ict of interest. Ochiai, Masahiko ................................. Disclosed no confl ict of interest. Ochoa Contreras, Daniel ...................... Disclosed no confl ict of interest. O’Connell, Jean .................................... Disclosed no confl ict of interest. O’Connell, Phillip .................................. Disclosed no confl ict of interest. O’Connell, Susan .................................. Disclosed no confl ict of interest. O’Connell, Thomas ............................... Employee: LipoScience O’Connor, Kevin .................................... Disclosed no confl ict of interest. O’Connor, Michelle Y. ........................... Disclosed no confl ict of interest. O’Connor, Patrick J. .............................. Disclosed no confl ict of interest. O’Connor-Semmes, Robin .................... Employee: GlaxoSmithKline Oda, Yoshie .......................................... Disclosed no confl ict of interest. Odawara, Masato ................................ Advisory Panel: Sanofi ; Research Support: Sanofi O’Dea, Angela ...................................... Disclosed no confl ict of interest. Odegaard, Andrew O. ........................... Disclosed no confl ict of interest. O’Dell, Laura E. ..................................... Disclosed no confl ict of interest. Odisho, Tanya ....................................... Disclosed no confl ict of interest. O’Donnell, J. Michael .......................... Disclosed no confl ict of interest. Odori, Shinji .......................................... Disclosed no confl ict of interest. Oelze, Matthias .................................... Disclosed no confl ict of interest. Oerskov, Lotte ....................................... Disclosed no confl ict of interest. O’Flynn, Dearbhail ................................ Disclosed no confl ict of interest. Ofstad, Anne Pernille ........................... Disclosed no confl ict of interest. Ogasawara, Saori ................................. Disclosed no confl ict of interest. Ogata, Hidetada ................................... Disclosed no confl ict of interest. Ogata, Makiko ...................................... Disclosed no confl ict of interest. Ogata, Nahoko ..................................... Disclosed no confl ict of interest. Ogawa, Daisuke ................................... Disclosed no confl ict of interest. Ogawa, Fumihiro .................................. Disclosed no confl ict of interest.

Dow



A884


AU

THO

R D

ISCL

OSU

RE

Ogawa, Shimpei ................................... Employee: Ajinomoto Group Ogbaa, Ike ............................................ Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Ogihara, Takeshi ................................... Disclosed no confl ict of interest. Ogilvie, Kathleen .................................. Disclosed no confl ict of interest. Ogino, Jun ............................................ Disclosed no confl ict of interest. Ogle, Graham ....................................... Disclosed no confl ict of interest. O’Gorman, Donal J. .............................. Disclosed no confl ict of interest. O’Grady, Tony ....................................... Disclosed no confl ict of interest. Oguma, Yuko ........................................ Disclosed no confl ict of interest. Ogunnowo-Bada, Emmanuel O. ........... Disclosed no confl ict of interest. Ogura, Kasane ...................................... Disclosed no confl ict of interest. Ogura, Masahito .................................. Disclosed no confl ict of interest. Oguz, Aytekin ....................................... Disclosed no confl ict of interest. Oh, Jee-Young ...................................... Disclosed no confl ict of interest. Oh, Ki Won ........................................... Disclosed no confl ict of interest. Oh, Kyubeom ........................................ Disclosed no confl ict of interest. Oh, Min Young ...................................... Disclosed no confl ict of interest. Oh, Sang Su .......................................... Disclosed no confl ict of interest. Oh, Su Jin ............................................. Disclosed no confl ict of interest. Oh, Tae Jung ........................................ Disclosed no confl ict of interest. Oh, Tae Keun ........................................ Disclosed no confl ict of interest. Ohama, Tohru ....................................... Disclosed no confl ict of interest. Ohara-Imaizumi, Mica .......................... Disclosed no confl ict of interest. Ohashi, Akiko ....................................... Disclosed no confl ict of interest. Ohashi, Ken .......................................... Disclosed no confl ict of interest. Ohashi, Shinichiro ................................ Disclosed no confl ict of interest. Ohashi, Yasuo ....................................... Disclosed no confl ict of interest. Ohata, Yoko .......................................... Disclosed no confl ict of interest. Ohhashi, Kennosuke ............................. Disclosed no confl ict of interest. Ohki, Tsuyoshi ...................................... Disclosed no confl ict of interest. Ohkura, Hiroko ...................................... Disclosed no confl ict of interest. Ohkura, Tsuyoshi .................................. Disclosed no confl ict of interest. Ohminami, Hirokazu ............................. Disclosed no confl ict of interest. Ohn, Jung Hun ...................................... Disclosed no confl ict of interest. Ohno, Norikazu ..................................... Disclosed no confl ict of interest. Ohri, Anupam ....................................... Disclosed no confl ict of interest. Ohsawa, Masahiro ............................... Disclosed no confl ict of interest. Ohshige, Toshihiko ............................... Disclosed no confl ict of interest. Ohsugi, Mitsuru .................................... Disclosed no confl ict of interest. Ohsumi, Jun ......................................... Employee: Daiichi-Sankyo, Inc. Ohta, Akio ............................................. Disclosed no confl ict of interest. Ohyama, Yasuo ..................................... Disclosed no confl ict of interest. Oikarinen, Maarit ................................. Disclosed no confl ict of interest. Oikarinen, Sami .................................... Disclosed no confl ict of interest. Oikawa, Shinichi .................................. Disclosed no confl ict of interest. Oiso, Yutaka ......................................... Disclosed no confl ict of interest. Ok, Chang-Ok ........................................ Disclosed no confl ict of interest. Okada, Hideyuki ................................... Disclosed no confl ict of interest. Okada, Hiroshi ...................................... Disclosed no confl ict of interest. Okada, Hisayuki .................................... Disclosed no confl ict of interest. Okada, Minoru ...................................... Disclosed no confl ict of interest. Okada, Rina .......................................... Disclosed no confl ict of interest. Okada, Takeshi ..................................... Disclosed no confl ict of interest. Okada-Iwabu, Miki ............................... Disclosed no confl ict of interest. Okahata, Sumie .................................... Disclosed no confl ict of interest. Okamoto, Ai .......................................... Disclosed no confl ict of interest. Okamoto, Masayuki ............................. Employee: Sanwa Kagaku Kenkyusho Okamoto, Ryuji ..................................... Employee: Sanwa Kagaku Kenkyusho Okamura, Shintaro ............................... Disclosed no confl ict of interest. Okamura, Tadashi ................................. Disclosed no confl ict of interest. Okamura, Tomio ................................... Disclosed no confl ict of interest. Okawa, Tetsuji ...................................... Disclosed no confl ict of interest. Okayama, Naotsuka ............................. Disclosed no confl ict of interest. Okazaki, Kentaro .................................. Disclosed no confl ict of interest. Okazaki, Yukiko ..................................... Disclosed no confl ict of interest. Okby, Rania ........................................... Disclosed no confl ict of interest. Oken, Emily ........................................... Disclosed no confl ict of interest. Oki, Yutaka ........................................... Disclosed no confl ict of interest. Okihiro, May ......................................... Disclosed no confl ict of interest. Okizaki, Shinichiro ................................ Disclosed no confl ict of interest. Okopien, Boguslaw .............................. Disclosed no confl ict of interest. Okouchi, Masahiro ............................... Disclosed no confl ict of interest. Okubo, Minoru ...................................... Disclosed no confl ict of interest. Okumura, Ryota .................................... Disclosed no confl ict of interest. Okunieff, Paul ....................................... Disclosed no confl ict of interest. Okunji, Priscilla O. ................................ Research Support: NIH Olasz, Lajos .......................................... Disclosed no confl ict of interest. Olausson, Josefi n ................................. Disclosed no confl ict of interest. Oler, Angie ............................................ Disclosed no confl ict of interest. Oleson, Bryndon J. ............................... Disclosed no confl ict of interest. Olimpico, Francesco ............................. Disclosed no confl ict of interest.

Oliveira, Ana Luisa ............................... Disclosed no confl ict of interest. Oliveira, Ana Mayra ............................. Disclosed no confl ict of interest. Oliveira, Atila ....................................... Disclosed no confl ict of interest. Oliver, Stacy R. ..................................... Disclosed no confl ict of interest. Oliyarnyk, Olena ................................... Disclosed no confl ict of interest. Olsen, Anne Helene ............................. Employee: Novo Nordisk A/S Olsen, Sjurdur ....................................... Disclosed no confl ict of interest. Olshaker, Jonathan .............................. Disclosed no confl ict of interest. Olsofka, John ....................................... Disclosed no confl ict of interest. Olson, Beth A. ...................................... Disclosed no confl ict of interest. Olson, Byron ......................................... Employee: VeraLight, Inc. Olson, Darin E. ...................................... Research Support: Amylin Pharmaceuticals, Inc., Eli Lilly and

Company, Novo Nordisk, Inc., PhaseBio, Roche Pharma-ceuticals, Sanofi

Olsson, Anders H. ................................. Disclosed no confl ict of interest. Olsson, Tommy ..................................... Disclosed no confl ict of interest. Oltulu, Yasemin .................................... Disclosed no confl ict of interest. Olver, T. Dylan ....................................... Disclosed no confl ict of interest. Olympios, George ................................. Advisory Panel: Novartis Pharmaceuticals Corporation; Other

Relationship: Novartis Pharmaceuticals Corporation Omae, Tsuneaki .................................... Disclosed no confl ict of interest. Omar, Bilal ............................................ Disclosed no confl ict of interest. Omer, Abdulkadir .................................. Disclosed no confl ict of interest. Omer, Beyhan ....................................... Disclosed no confl ict of interest. Omi, Maiko ........................................... Disclosed no confl ict of interest. Omidfar, Kobra ..................................... Disclosed no confl ict of interest. Omran, Dima ........................................ Disclosed no confl ict of interest. Omura, Chiaki ....................................... Disclosed no confl ict of interest. Omura, Masao ...................................... Disclosed no confl ict of interest. Omura, Yasushi .................................... Disclosed no confl ict of interest. Onda, Yoshiko ....................................... Disclosed no confl ict of interest. O’Neill, Ciaran ...................................... Disclosed no confl ict of interest. O’Neill, Edward A. ................................ Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited O’Neill, James ...................................... Disclosed no confl ict of interest. Ong, Siew Hwa .................................... Employee: Novartis Pharmaceuticals Corporation Onishi, Shunichiro ................................ Disclosed no confl ict of interest. Onishi, Yukiko ....................................... Research Support: Eli Lilly and Company, Novartis Pharmaceu-

ticals Corporation, Sanofi Ono, Hideki ........................................... Disclosed no confl ict of interest. Ono, Kaoru ............................................ Disclosed no confl ict of interest. Onuma, Hirohisa ................................... Disclosed no confl ict of interest. Onuma, Hiroshi ..................................... Disclosed no confl ict of interest. Opara, Emmanuel C. ............................. Disclosed no confl ict of interest. Opgenorth, Andrea ............................... Disclosed no confl ict of interest. Opstrup, Ulla K. .................................... Disclosed no confl ict of interest. Oram, Richard A. .................................. Disclosed no confl ict of interest. Orbay, Ekrem ........................................ Disclosed no confl ict of interest. Orchard, Trevor J. ................................. Consultant: Aegerion Pharmaceuticals, Inc., Gilead Sciences,

Inc.; Stock/Shareholder: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company (Spouse/Partner)

Orcun, Asuman ..................................... Disclosed no confl ict of interest. Ordelheide, Anna-Maria ...................... Disclosed no confl ict of interest. Ordway, Diane ...................................... Disclosed no confl ict of interest. Orent, Will ............................................ Disclosed no confl ict of interest. Orime, Kazuki ....................................... Disclosed no confl ict of interest. O’Riordan, Stephen M. ......................... Disclosed no confl ict of interest. Orlandi, Cesare ..................................... Employee: TransTech Pharma Orlando, Lori ......................................... Disclosed no confl ict of interest. Orlando, Maura R. ................................ Disclosed no confl ict of interest. Orlov, Steven ........................................ Disclosed no confl ict of interest. Orme, Ian .............................................. Disclosed no confl ict of interest. Orozco-Beltran, Domingo ..................... Advisory Panel: Eli Lilly and Company, Merck Sharp & Dohme

Limited, Novo Nordisk, Inc.; Consultant: Novo Nordisk, Inc.; Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi

Orr, Suvi ................................................ Employee: Pfi zer, Inc. Orr-Walker, Brandon ............................. Other Relationship: Sanofi Orsak, Beverly ...................................... Disclosed no confl ict of interest. Ørskov, Cathrine ................................... Employee: Novo Nordisk A/S Orszag, Andrej ...................................... Disclosed no confl ict of interest. Ortega Lamocea, Ximena ..................... Disclosed no confl ict of interest. Ortega, Emilio ....................................... Disclosed no confl ict of interest. Ortiz-Lopez, Carolina ............................ Disclosed no confl ict of interest. Orton, Matthew T. ................................ Disclosed no confl ict of interest. Oruk, Gonca .......................................... Disclosed no confl ict of interest. Orvik, Elsa ............................................. Disclosed no confl ict of interest. Osaki, Aya ............................................ Disclosed no confl ict of interest. Osawa, Haruhiko .................................. Disclosed no confl ict of interest. Osawa, Ikue .......................................... Disclosed no confl ict of interest. Osawa, Mari ......................................... Disclosed no confl ict of interest. Osawa, Taeko ....................................... Disclosed no confl ict of interest.

Dow



A885


AU

THO

R D

ISCL

OSU

RE

Osborn, Chandra Y. ............................... Disclosed no confl ict of interest. Osborne, Danielle M. ........................... Disclosed no confl ict of interest. Osborne, Lucy ....................................... Disclosed no confl ict of interest. Oscarrson, Jan ..................................... Employee: AstraZeneca Pharmaceuticals LP Osei, Kwame ........................................ Research Support: American Diabetes Association, NIH Oseid, Elizabeth .................................... Disclosed no confl ict of interest. Osenenko, Katherine M. ...................... Disclosed no confl ict of interest. O’Shea, Daniel ..................................... Disclosed no confl ict of interest. O’Shea, Donal ...................................... Disclosed no confl ict of interest. Oshima, Itsuki ....................................... Disclosed no confl ict of interest. Oshima, Yoshitake ................................ Disclosed no confl ict of interest. Oshitani, Natsuko ................................. Disclosed no confl ict of interest. Osmark, Peter ....................................... Disclosed no confl ict of interest. Osonoi, Sho .......................................... Disclosed no confl ict of interest. Östenson, Claes-Göran ........................ Disclosed no confl ict of interest. Osterhoff, Martin ................................. Disclosed no confl ict of interest. Østerlund, Torben ................................. Employee: Zealand Pharma A/S; Research Support: Zealand

Pharma A/S; Stock/Shareholder: Zealand Pharma A/S Østoft, Signe H. .................................... Speaker’s Bureau: Merck Sharp & Dohme Limited Ostrov, David ........................................ Disclosed no confl ict of interest. O’Sullivan, Eoin P. ................................. Disclosed no confl ict of interest. O’Sullivan, Esther ................................. Disclosed no confl ict of interest. O-Sullivan, InSug .................................. Disclosed no confl ict of interest. Ota, Hiroyo ........................................... Disclosed no confl ict of interest. Ota, Hitoshi .......................................... Disclosed no confl ict of interest. Ota, Tsuguhito ...................................... Disclosed no confl ict of interest. Ota, Yoshie ........................................... Disclosed no confl ict of interest. Otabe, Shuichi ...................................... Disclosed no confl ict of interest. Othman, Noorani .................................. Disclosed no confl ict of interest. Otlivanchik, Oleg .................................. Disclosed no confl ict of interest. Otsuka, Yuichiro ................................... Disclosed no confl ict of interest. Otsuki, Shingo ...................................... Disclosed no confl ict of interest. Otten, Julia ........................................... Disclosed no confl ict of interest. Ottosen, Ida A. ..................................... Disclosed no confl ict of interest. Otvos, James ........................................ Employee: LipoScience; Stock/Shareholder: LipoScience Otvos, Laszlo ........................................ Employee: Johnson & Johnson (Spouse/Partner) Ou, Dawei ............................................. Disclosed no confl ict of interest. Ou, Horng-Yih ....................................... Disclosed no confl ict of interest. Ouchi, Hiromi ........................................ Disclosed no confl ict of interest. Out, Mattijs .......................................... Disclosed no confl ict of interest. Ouwens, Margriet ................................ Disclosed no confl ict of interest. Ovalle, Fernando .................................. Disclosed no confl ict of interest. Overcash, Rachael T. ............................ Disclosed no confl ict of interest. Owczuk, Radoslaw ............................... Disclosed no confl ict of interest. Owen, Katharine R. .............................. Disclosed no confl ict of interest. Owens, David R. ................................... Disclosed no confl ict of interest. Owston, Michael .................................. Disclosed no confl ict of interest. Oya, Junko ............................................ Disclosed no confl ict of interest. Oyadomari, Seiichi ............................... Disclosed no confl ict of interest. Oyer, David S. ....................................... Advisory Panel: Novo Nordisk A/S; Speaker’s Bureau: Amylin

Pharmaceuticals, Inc., Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Novo Nordisk A/S

Öz, Gulin ............................................... Disclosed no confl ict of interest. Oza-Frank, Reena ................................. Disclosed no confl ict of interest. Ozaki, Noriyuki ..................................... Disclosed no confl ict of interest. Ozaki, Risa ............................................ Disclosed no confl ict of interest. Ozawa, Sachihiko ................................. Disclosed no confl ict of interest. Ozawa, Shogo ...................................... Disclosed no confl ict of interest. Ozkan, Banu .......................................... Disclosed no confl ict of interest. Ozon, Alev ............................................ Disclosed no confl ict of interest. Paccagnella, Agostino .......................... Disclosed no confl ict of interest. Pace, Fernanda ..................................... Disclosed no confl ict of interest. Pace, Wilson D. .................................... Research Support: Sanofi US, Shire; Stock/Shareholder:

Merck, Novartis Pharmaceuticals Corporation, Pfi zer, Inc. Pachatz, Joerg ...................................... Other Relationship: CeQur, Ltd. Pacifi ci, Francesca ................................ Disclosed no confl ict of interest. Pacini, Giovanni .................................... Disclosed no confl ict of interest. Pacut, Crystal ....................................... Disclosed no confl ict of interest. Paczkowski, Rosirene ........................... Employee: Eli Lilly and Company, Eli Lilly and Company


Padgett, Lindsey E. ............................... Disclosed no confl ict of interest. Pados, Gyula ......................................... Disclosed no confl ict of interest. Paez, Ana M ......................................... Disclosed no confl ict of interest. Paez, Kathryn ........................................ Disclosed no confl ict of interest. Page, Evaren E. ..................................... Disclosed no confl ict of interest. Page, Kathleen A. ................................. Disclosed no confl ict of interest. Paglia, Valentina .................................. Disclosed no confl ict of interest. Pagnini, Maria C. .................................. Disclosed no confl ict of interest. Pagnotti, Gabriel .................................. Disclosed no confl ict of interest. Paiva, Isabel ......................................... Disclosed no confl ict of interest. Pajewski, Nicholas ............................... Disclosed no confl ict of interest.

Pakiz, Bilge ........................................... Disclosed no confl ict of interest. Palacios, Cristina .................................. Disclosed no confl ict of interest. Palakiko, Donna-Marie ......................... Disclosed no confl ict of interest. Palanjian, Maral ................................... Disclosed no confl ict of interest. Palanki, Moorthy S. .............................. Disclosed no confl ict of interest. Palau Collazo, Miladys M. ................... Disclosed no confl ict of interest. Palena, Antonio .................................... Disclosed no confl ict of interest. Palermo, Andrea ................................... Disclosed no confl ict of interest. Paley, Carole ......................................... Disclosed no confl ict of interest. Palmer, James ...................................... Disclosed no confl ict of interest. Palmer, Jerry P. ..................................... Consultant: DiabetOmics Palmer, Julie R. .................................... Disclosed no confl ict of interest. Palmer, Nicholette D. ........................... Disclosed no confl ict of interest. Palming, Jenny ..................................... Disclosed no confl ict of interest. Paloma, Diane ...................................... Disclosed no confl ict of interest. Palta, Mari ............................................ Disclosed no confl ict of interest. Palumbo, Pasquale J. ........................... Disclosed no confl ict of interest. Pambianco, Georgia ............................. Disclosed no confl ict of interest. Pan, Changyu ........................................ Consultant: Takeda Global Research & Development Center,

Inc. Pan, Chunping ...................................... Disclosed no confl ict of interest. Pan, Chunshen ...................................... Consultant: Sanofi Pan, Jiaqi ............................................. Disclosed no conflict of interest. Pan, Qianqian ....................................... Disclosed no confl ict of interest. Pan, Xiaoping ....................................... Disclosed no confl ict of interest. Pan, Xiaoyu ........................................... Disclosed no confl ict of interest. Panagiotopoulos, Constadina .............. Disclosed no confl ict of interest. Panagopoulos, Periklis ......................... Disclosed no confl ict of interest. Panazzolo, Diogo G. .............................. Disclosed no confl ict of interest. Panda, Satchidananda ......................... Disclosed no confl ict of interest. Pandey, Ravindra M. ............................ Disclosed no confl ict of interest. Pandolfi , Assunta ................................. Disclosed no confl ict of interest. Pang, Chi Nam Ignatius ........................ Disclosed no confl ict of interest. Paniagua-Morgan, Francisco J. ........... Disclosed no confl ict of interest. Pankow, James S. ................................ Disclosed no confl ict of interest. Panneerseelan, Leena .......................... Disclosed no confl ict of interest. Pannu, Varinderpal ............................... Disclosed no confl ict of interest. Panosian, Jennifer ............................... Disclosed no confl ict of interest. Panza, Elisabetta .................................. Disclosed no confl ict of interest. Panzhinskiy, Evgeniy ............................. Disclosed no confl ict of interest. Papadogiannis, Dimitris ....................... Disclosed no confl ict of interest. Papadopoulou, Despina ....................... Disclosed no confl ict of interest. Papadopoulou, Maria ........................... Disclosed no confl ict of interest. Papageorgiou, Athanasios ................... Disclosed no confl ict of interest. Papageorgiou, Nikolaos ....................... Disclosed no confl ict of interest. Papaoikonomou, Stavroula .................. Disclosed no confl ict of interest. Papazafi ropoulou, Athanasia ............... Disclosed no confl ict of interest. Pappa, Maria ........................................ Disclosed no confl ict of interest. Pappas, Stavros .................................... Disclosed no confl ict of interest. Pappo, Jacques .................................... Disclosed no confl ict of interest. Paquot, Nicolas .................................... Disclosed no confl ict of interest. Parab, Prajakta ..................................... Disclosed no confl ict of interest. Paragh, György ..................................... Disclosed no confl ict of interest. Paranjape, Sachin A. ............................ Disclosed no confl ict of interest. Parazzoli, Susan ................................... Disclosed no confl ict of interest. Pardiwalla, Behram .............................. Disclosed no confl ict of interest. Pardo, Scott .......................................... Employee: Bayer Health Care, LLC Parekh, Vishal ....................................... Disclosed no confl ict of interest. Parente, Alexis ..................................... Disclosed no confl ict of interest. Parikh, Neha ......................................... Employee: Medtronic Parikh, Pathik M. .................................. Disclosed no confl ict of interest. Parikh, Shamik J. .................................. Employee: AstraZeneca Pharmaceuticals LP; Stock/Share-

holder: AstraZeneca Pharmaceuticals LP Park, Bo-Yoon ....................................... Disclosed no confl ict of interest. Park, Chan Sung ................................... Disclosed no confl ict of interest. Park, Chang .......................................... Disclosed no confl ict of interest. Park, Cheol Young ................................ Disclosed no confl ict of interest. Park, Hyeongkyu ................................... Disclosed no confl ict of interest. Park, Jae Yeo ........................................ Disclosed no confl ict of interest. Park, Jeong Hyun ................................. Disclosed no confl ict of interest. Park, Jong Suk ...................................... Disclosed no confl ict of interest. Park, Joong Yeol ................................... Disclosed no confl ict of interest. Park, Keon Jae ..................................... Disclosed no confl ict of interest. Park, Keun-Gyu ..................................... Disclosed no confl ict of interest. Park, Kyong Soo ................................... Disclosed no confl ict of interest. Park, Kyoungmin ................................... Disclosed no confl ict of interest. Park, Leejin ........................................... Disclosed no confl ict of interest. Park, Peter J. ........................................ Disclosed no confl ict of interest. Park, SeEun .......................................... Disclosed no confl ict of interest. Park, Shin-young .................................. Disclosed no confl ict of interest. Park, So-Young ..................................... Disclosed no confl ict of interest. Park, Sung-Jun ..................................... Disclosed no confl ict of interest.

Dow



A886


AU

THO

R D

ISCL

OSU

RE

Park, SungWoo ..................................... Disclosed no confl ict of interest. Park, Sunmin ........................................ Disclosed no confl ict of interest. Park, Tae Sun ........................................ Disclosed no confl ict of interest. Park, Yong Soo ..................................... Disclosed no confl ict of interest. Park, Yong-Moon .................................. Disclosed no confl ict of interest. Park, Yongsoo ....................................... Disclosed no confl ict of interest. Park, Yoo Jin ......................................... Disclosed no confl ict of interest. Park, Yoon Jeong .................................. Disclosed no confl ict of interest. Park, Young Jin ..................................... Disclosed no confl ict of interest. Park, Young Mi ..................................... Disclosed no confl ict of interest. Parker, Cherelle .................................... Disclosed no confl ict of interest. Parker, David ........................................ Other Relationship: Sanofi Parker, Emily ......................................... Disclosed no confl ict of interest. Parker, Kathryn ..................................... Disclosed no confl ict of interest. Parkes, Joan Lee .................................. Employee: Bayer Health Care, LLC Parkin, Christopher G. .......................... Consultant: Dexcom, Inc., Roche Diagnostics, Sanofi Parkinson, Jo ........................................ Disclosed no confl ict of interest. Parks, Elizabeth .................................... Disclosed no confl ict of interest. Parpala, Cristina ................................... Disclosed no confl ict of interest. Parrino, Cristina .................................... Disclosed no confl ict of interest. Parsons, Bruce ...................................... Employee: Pfi zer, Inc.; Stock/Shareholder: Pfi zer, Inc. Partke, Hans-Joachim .......................... Disclosed no confl ict of interest. Parton, Elaine ....................................... Disclosed no confl ict of interest. Partridge, Helen ................................... Disclosed no confl ict of interest. Parveen, Meher .................................... Disclosed no confl ict of interest. Parvin, Masuma ................................... Disclosed no confl ict of interest. Parvu, Valentin ..................................... Employee: Becton, Dickinson and Company Pascual, Eider ....................................... Disclosed no confl ict of interest. Pasko, Dorota ....................................... Disclosed no confl ict of interest. Pasquel, Francisco ................................ Disclosed no confl ict of interest. Passi, Rebecca ..................................... Disclosed no confl ict of interest. Pastellas, Christos ................................ Advisory Panel: Novartis Pharmaceuticals Corporation; Other

Relationship: Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi

Pasterkamp, Gerard .............................. Disclosed no confl ict of interest. Pastor, Rebecca .................................... Disclosed no confl ict of interest. Pastore, Ashley .................................... Disclosed no confl ict of interest. Pastore, Donatella ................................ Disclosed no confl ict of interest. Patek, Renata ....................................... Disclosed no confl ict of interest. Patel, Anita ........................................... Disclosed no confl ict of interest. Patel, Mahesh J. .................................. Consultant: LipoScience Patel, Neel R. ....................................... Speaker’s Bureau: LipoScience Patel, Neesha R. ................................... Disclosed no confl ict of interest. Patel, Nick ............................................ Research Support: Novo Nordisk, Inc. Patel, Nishita ........................................ Disclosed no confl ict of interest. Patel, Payal R. ...................................... Disclosed no confl ict of interest. Patel, Pinakin ........................................ Disclosed no confl ict of interest. Patel, Puja ............................................ Disclosed no confl ict of interest. Patel, Reema ........................................ Disclosed no confl ict of interest. Patel, Roshni ........................................ Disclosed no confl ict of interest. Patel, Sanjay ........................................ Employee: Boehringer Ingelheim GmbH & Co. KG Patel, Shailendra .................................. Disclosed no confl ict of interest. Patel, Sunil ........................................... Consultant: Allergan, Inc., Genentech, Ophthotech; Research

Support: Alcon Laboratories, Alimera, Allergan, Inc., Genentech, Ophthotech, Pfi zer, Inc., Regeneron Pharma-ceuticals, Inc.; Speaker’s Bureau: Alcon Laboratories; Stock/Shareholder: Ophthotech

Patel, Vihitaben S. ................................ Disclosed no confl ict of interest. Patel, Yasin ........................................... Disclosed no confl ict of interest. Patera, Ippolita P. ................................. Disclosed no confl ict of interest. Paterson, Andrew D. ............................ Disclosed no confl ict of interest. Päth, Günter ......................................... Disclosed no confl ict of interest. Pathan, Faruque M. .............................. Advisory Panel: Novartis Pharma AG, Novo Nordisk, Inc.,

Sanofi ; Board Member: Eli Lilly and Company; Consultant: IBRAHIM General Hospital and College; Employee: IBRAHIM General Hospital; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Novartis, Novo Nordisk, Inc., Sanofi

Pathe-Neuschäfer-Rube, Andrea ......... Disclosed no confl ict of interest. Patil, Deepak P. ..................................... Disclosed no confl ict of interest. Patrakeeva, Evgenya M. ....................... Disclosed no confl ict of interest. Patrick, Alan L. ..................................... Disclosed no confl ict of interest. Patrick, Amanda R. ............................... Research Support: Eli Lilly and Company Patrick, Shannon .................................. Disclosed no confl ict of interest. Patsouras, Konstantinos ...................... Disclosed no confl ict of interest. Patte, Caroline ...................................... Employee: Roche Diagnostics GmbH Patterson, Bruce ................................... Disclosed no confl ict of interest. Patterson, Christa ................................. Disclosed no confl ict of interest. Patterson, Christopher C. ..................... Disclosed no confl ict of interest. Patterson, Jaclyn K. ............................. Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Patti, Mary-Elizabeth ............................ Disclosed no confl ict of interest.

Patton, Susana R. ................................. Disclosed no confl ict of interest. Pattou, François .................................... Disclosed no confl ict of interest. Pauer, Jozsef ........................................ Disclosed no confl ict of interest. Paul, Sanjoy K. ..................................... Advisory Panel: Novo Nordisk A/S; Consultant: Amylin

Pharmaceuticals, Inc.; Research Support: Amylin Pharma-ceuticals, Inc.

Paulsen, Sarah ..................................... Research Support: Boehringer Ingelheim GmbH & Co. KG Paulsson, Mats ..................................... Disclosed no confl ict of interest. Pavkov, Meda E. ................................... Disclosed no confl ict of interest. Pavletich, Scott .................................... Disclosed no confl ict of interest. Pavlidis, Athinodoros ........................... Disclosed no confl ict of interest. Pawlowska, Monika ............................. Disclosed no confl ict of interest. Pawlowski, Maciej ............................... Disclosed no confl ict of interest. Pawlowsky, Sarah B. ............................ Disclosed no confl ict of interest. Payan, Marisa ...................................... Disclosed no confl ict of interest. Payter, Katelyn ..................................... Disclosed no confl ict of interest. Paz, Veronica P. ..................................... Disclosed no confl ict of interest. Paz-Pacheco, Elizabeth ......................... Disclosed no confl ict of interest. Peaceman, Alan ................................... Disclosed no confl ict of interest. Peacock, Nadine ................................... Disclosed no confl ict of interest. Peairs, Abigail ...................................... Disclosed no confl ict of interest. Pearsall, Melanie ................................. Disclosed no confl ict of interest. Pearson, Donald W. .............................. Disclosed no confl ict of interest. Pearson, Ewan R. ................................. Disclosed no confl ict of interest. Pearson-Leary, Jiah .............................. Disclosed no confl ict of interest. Pechhold, Susanne ............................... Disclosed no confl ict of interest. Pechtner, Valeria .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Peckett, Ashley ..................................... Disclosed no confl ict of interest. Pedersen, Bente K. ............................... Disclosed no confl ict of interest. Pedersen, Brian .................................... Disclosed no confl ict of interest. Pedersen, Kim B. .................................. Disclosed no confl ict of interest. Pedersen, Nancy L. ............................... Disclosed no confl ict of interest. Pedersen, Oluf ...................................... Stock/Shareholder: Novo Nordisk A/S Pedersen, Steen B. ............................... Disclosed no confl ict of interest. Pedersen-Bjergaard, Ulrik .................... Advisory Panel: Novo Nordisk A/S; Other Relationship:

Medtronics, Novo Nordisk A/S Peek, Monica E. .................................... Disclosed no confl ict of interest. Pei, Dee ................................................ Disclosed no confl ict of interest. Pei, Yu ................................................... Disclosed no confl ict of interest. Peiró, Concepción ................................. Disclosed no confl ict of interest. Peled, Dana .......................................... Employee: Andromeda Biotech, Ltd. Pelikanova, Terezie ............................... Disclosed no confl ict of interest. Pellegrini, Fabio .................................... Disclosed no confl ict of interest. Pelletier, Marie-Josee .......................... Disclosed no confl ict of interest. Pemberton, Janine ............................... Disclosed no confl ict of interest. Pencek, Richard .................................... Employee: Amylin Pharmaceuticals, LLC Penckofer, Sue ...................................... Disclosed no confl ict of interest. Pender, John R. .................................... Research Support: Johnson & Johnson Pender, Siobhan ................................... Disclosed no confl ict of interest. Pendrith, Ciara ...................................... Disclosed no confl ict of interest. Penfornis, Alfred .................................. Board Member: Novo Nordisk A/S Peng, Jian ............................................. Disclosed no confl ict of interest. Peng, Limin ........................................... Disclosed no confl ict of interest. Peng, Mingli ......................................... Disclosed no confl ict of interest. Peng, Shih-Jung ................................... Disclosed no confl ict of interest. Peng, Tiffany ......................................... Disclosed no confl ict of interest. Peng, Xuejun ........................................ Employee: Takeda Global Research & Development Center,

Inc. Peng, Yanhua ........................................ Disclosed no confl ict of interest. Pénicaud, Luc ....................................... Disclosed no confl ict of interest. Pennathur, Subramaniam ..................... Disclosed no confl ict of interest. Penno, Giuseppe .................................. Disclosed no confl ict of interest. Penrod, Leah V. ..................................... Disclosed no confl ict of interest. Perakakis, Nikolaos .............................. Disclosed no confl ict of interest. Peralta, Jorge G. .................................. Disclosed no confl ict of interest. Perazzo, Paula ...................................... Disclosed no confl ict of interest. Perdomo, German ................................. Disclosed no confl ict of interest. Pereira, Andrea Z. ................................ Disclosed no confl ict of interest. Pereira, Maria J. .................................. Disclosed no confl ict of interest. Pereira, Mark A. ................................... Disclosed no confl ict of interest. Pereira, Sandra ..................................... Disclosed no confl ict of interest. Perelis, Mark ........................................ Disclosed no confl ict of interest. Peremislov, Diana ................................. Advisory Panel: Bayer Health Care, LLC; Research Support: BD

Medical Diabetes Care Peres, Ricardo B. .................................. Disclosed no confl ict of interest. Peres, Sidney B. ................................... Disclosed no confl ict of interest. Pérez, Antonio ...................................... Advisory Panel: Almirall Perez, Cynthia M. ................................. Disclosed no confl ict of interest. Perez, Yendri ......................................... Disclosed no confl ict of interest. Pérez-Gandia, Carmen .......................... Disclosed no confl ict of interest. Perez-Polo, Jose R. ............................... Disclosed no confl ict of interest.

Dow



A887


AU

THO

R D

ISCL

OSU

RE

Perkins, Amanda G. .............................. Disclosed no confl ict of interest. Perkins, Bruce A. .................................. Advisory Panel: Neurometric, Inc.; Consultant: Novo Nordisk

A/S; Research Support: Boehringer Ingelheim GmbH & Co. KG, Medtronic MiniMed, Inc.; Speaker’s Bureau: Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Medtronic MiniMed, Inc., Novo Nordisk A/S, Roche Pharmaceuticals

Perkovic, Vlado ..................................... Advisory Panel: Abbott, Astellas, Baxter, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen, Pfi zer, Inc.; Speaker’s Bureau: Merck, Servier

Perlmuter, Lawrence C. ........................ Disclosed no confl ict of interest. Perls, Thomas T. ................................... Disclosed no confl ict of interest. Perlstein, Itay ....................................... Employee: Bristol-Myers Squibb Company Pernía, Olga .......................................... Disclosed no confl ict of interest. Perola, Markus ..................................... Disclosed no confl ict of interest. Perona, Rosario .................................... Disclosed no confl ict of interest. Peroni, Odile D. .................................... Disclosed no confl ict of interest. Perrard, Jerry L. .................................... Disclosed no confl ict of interest. Perrard, Xiaoyuan ................................. Disclosed no confl ict of interest. Perrea, Despoina .................................. Disclosed no confl ict of interest. Perreault, Mylene ................................. Employee: Pfi zer, Inc. Perren, Aurel ........................................ Advisory Panel: Novartis Pharmaceuticals Corporation;

Speaker’s Bureau: IPSEN - Formulation Innovation, Novartis Pharmaceuticals Corporation

Perrild, Hans ......................................... Disclosed no confl ict of interest. Perrin, Nancy A. ................................... Disclosed no confl ict of interest. Perrini, Sebastio ................................... Disclosed no confl ict of interest. Perrino, Brian A. ................................... Disclosed no confl ict of interest. Perrone, Tiziano .................................... Disclosed no confl ict of interest. Perry, Caroline R. .................................. Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

Kline Perry, Christopher G. ............................ Disclosed no confl ict of interest. Perry, Daniel J. ..................................... Disclosed no confl ict of interest. Perry, John R. ....................................... Disclosed no confl ict of interest. Perry, Rachel J. ..................................... Disclosed no confl ict of interest. Pers, Tune H. ........................................ Disclosed no confl ict of interest. Persson, A. Erik G. ................................ Disclosed no confl ict of interest. Persson, Xuan-Mai ............................... Disclosed no confl ict of interest. Perz, Siegfried ...................................... Disclosed no confl ict of interest. Pesau, Gerfried ..................................... Disclosed no confl ict of interest. Peshavaria, Mina ................................. Disclosed no confl ict of interest. Peshdary, Vian ...................................... Disclosed no confl ict of interest. Peter, Andreas ...................................... Disclosed no confl ict of interest. Peters, Anne L. ..................................... Consultant: Abbott Diabetes Care, Amylin/Eli Lilly, BD Medical

Diabetes Care, Janssen Pharmaceuticals, Medscape, LLC, Roche Pharmaceuticals, Sanofi , Takeda Pharmaceuticals U.S.A., Inc.; Speaker’s Bureau: Amylin/Eli Lilly, Novo Nordisk, Inc.

Peters, Annette .................................... Disclosed no confl ict of interest. Peters, Catherine J. .............................. Disclosed no confl ict of interest. Peters, Michael J. ................................ Disclosed no confl ict of interest. Peters, Ron ........................................... Disclosed no confl ict of interest. Petersen, Bettina .................................. Employee: Roche Diagnostics GmbH Peterson, Charlotte A. .......................... Disclosed no confl ict of interest. Peterson, Courtney M. ......................... Employee: McKinsey & Company (Spouse/Partner) Peterson, Daniel A. .............................. Disclosed no confl ict of interest. Peterson, Ninoska ................................ Disclosed no confl ict of interest. Peterson, Richard ................................. Disclosed no confl ict of interest. Petersson, Magnus .............................. Employee: AstraZeneca Pharmaceuticals LP; Stock/Share-

holder: AstraZeneca Pharmaceuticals LP Petersson, Stine J. ............................... Disclosed no confl ict of interest. Petidis, Konstantinos ........................... Disclosed no confl ict of interest. Petit, Catherine .................................... Disclosed no confl ict of interest. Petit, Marie-Hélène .............................. Disclosed no confl ict of interest. Petocz, Peter ......................................... Disclosed no confl ict of interest. Petrella, Robert J. ................................ Disclosed no confl ict of interest. Petropoulos, Ioannis N ......................... Disclosed no confl ict of interest. Petrovski, Goran ................................... Disclosed no confl ict of interest. Petten, Michael V. ................................ Disclosed no confl ict of interest. Pettis, Ronald J. ................................... Employee: Becton, Dickinson and Company, Becton, Dickinson

and Company (Spouse/Partner); Research Support: Bec-ton, Dickinson and Company; Stock/Shareholder: Becton, Dickinson and Company

Pettitt, David J. .................................... Disclosed no confl ict of interest. Petzold, Cathleen ................................. Disclosed no confl ict of interest. Peyot, Marie-Line ................................. Disclosed no confl ict of interest. Peyrot, Mark F. ...................................... Advisory Panel: Nordic Bioscience A/S, Tethys; Consultant:

Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Genentech, Novo Nordisk A/S; Research Support: Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Genentech, Novo Nordisk A/S; Speaker’s Bureau: Novo Nordisk A/S

Peyser, Thomas A. ................................ Employee: Dexcom, Inc.; Stock/Shareholder: Dexcom, Inc.

Pezzolesi, Marcus ................................. Disclosed no confl ict of interest. Pfaff, Emily R. ....................................... Disclosed no confl ict of interest. Pfefferkorn, Jeffrey A. .......................... Employee: Pfi zer, Inc.; Research Support: Pfi zer, Inc.; Stock/

Shareholder: Pfi zer, Inc. Pfeifer, Marija ...................................... Disclosed no confl ict of interest. Pfeiffer, Andreas F. ............................... Disclosed no confl ict of interest. Pfi ster, Frederick ................................... Disclosed no confl ict of interest. Pfützner, Andreas ................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Insuline

Medical, Novo Nordisk A/S, Sanofi , Unomedical; Board Member: GlucoMetrics AG; Consultant: AstraZeneca/Bristol-Meyers Squibb, Daiichi-Sankyo, Inc., Eli Lilly and Company, Lifescan Animas, Inc., Novo Nordisk, Inc., Sanofi ; Research Support: AstraZeneca/Bristol-Meyers Squibb, Boehringer Ingelheim GmbH & Co. KG, Cellnovo, CeQur, Ltd., Glenmark Pharmaceuticals, Ltd., ICON, Insuline Medical, Janssen Pharmaceuticals, Novo Nordisk A/S, Sanofi , Unomedical

Pfützner, Anke ...................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb (Spouse/Partner), Daiichi-Sankyo, Inc. (Spouse/Partner), Insuline Medical (Spouse/Partner), Novo Nordisk A/S (Spouse/Partner), Sanofi (Spouse/Partner), Unomedical (Spouse/Partner); Board Member: GlucoMetrix AG (Spouse/Partner); Consultant: AstraZeneca/Bristol-Meyers Squibb (Spouse/Partner), Insuline Medical (Spouse/Partner), Novo Nordisk A/S (Spouse/Partner), Sanofi (Spouse/Partner), Unomedical (Spouse/Partner)

Pham, Thi Minh Nguyet ....................... Disclosed no confl ict of interest. Pham-Short, Anna ................................ Disclosed no confl ict of interest. Phan, Thanh .......................................... Disclosed no confl ict of interest. Pharisien, Isabelle ................................ Disclosed no confl ict of interest. Phielix, Esther ....................................... Disclosed no confl ict of interest. Philippe, Erwann .................................. Disclosed no confl ict of interest. Philippe, Jacques ................................. Disclosed no confl ict of interest. Philipson, Louis .................................... Advisory Panel: Amylin Pharmaceuticals, Inc., Takeda Pharma-

ceutical Company, Ltd.; Research Support: Merck, Novo Nordisk, Inc.; Speaker’s Bureau: Merck

Philis-Tsimikas, Athena ........................ Advisory Panel: Merck, Novo Nordisk A/S, Sanofi ; Research Support: Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Merck, Novo Nordisk A/S, Pfi zer, Inc., Sankyo USA, Sanofi , Takeda

Phillip, Moshe ...................................... Advisory Panel: Animas Corporation, AstraZeneca Pharmaceuticals LP, Bayer Health Care, LLC, Medtronic MiniMed, Inc., Sanofi ; Board Member: CGM3 Ltd; Consultant: Andromeda Biotech, Ltd., Bristol-Myers Squibb Company, D-medical Industries Ltd, Ferring Pharmaceuticals, Inc.; Research Support: Abbott Diabetes Care, Andromeda Biotech, Ltd., Animas Corporation, Dexcom, Inc., Eli Lilly and Company, Insulet Corporation, Macrogenics, Inc., Medtronic MiniMed, Inc., Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi ; Speaker’s Bureau: Novo Nordisk, Inc., Pfi zer, Inc., Roche Pharmaceuticals, Sanofi ; Stock/Shareholder: CGM3 Ltd, D-Medical Industries

Phillips, Lawrence S. ............................ Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.; Employee: Veterans Administration; Other Relationship: Centers for Medicare and Medicaid Services; Research Support: Amylin Pharmaceuticals, Inc., Cystic Fibrosis Foundation, Eli Lilly and Company, Merck, Novo Nordisk, Inc., PhaseBio, Roche Pharmaceuticals, Sanofi

Phillips, Penny ...................................... Disclosed no confl ict of interest. Phillips, Victoria ................................... Research Support: Sanofi Phoenix, Serge ..................................... Disclosed no confl ict of interest. Phung, Olivia J. .................................... Research Support: Merck Piaggesi, Alberto .................................. Disclosed no confl ict of interest. Piatt, Gretchen A. ................................. Consultant: Johnson & Johnson Picard, Martin ....................................... Disclosed no confl ict of interest. Piccinini, Francesca .............................. Disclosed no confl ict of interest. Piccoli, Vanessa ................................... Disclosed no confl ict of interest. Piccolo, Carmela ................................... Employee: Novartis Pharma AG Piccolo, Rebecca .................................. Disclosed no confl ict of interest. Pichiri, Isabella ..................................... Disclosed no confl ict of interest. Pichu, Sivakamasundari ....................... Disclosed no confl ict of interest. Pickersgill, Linda .................................. Disclosed no confl ict of interest. Picolos, Michalis .................................. Other Relationship: Novartis Pharmaceuticals Corporation Picton, Peter ......................................... Disclosed no confl ict of interest. Pieber, Thomas R. ................................. Consultant: Carnegie Bank, Infi neon, Novo Nordisk A/S, Roche

Diagnostics; Speaker’s Bureau: Novo Nordisk A/S Piecewicz, Stephanie M. ...................... Disclosed no confl ict of interest. Piepel, Simon ....................................... Disclosed no confl ict of interest. Pierce, Susan M. .................................. Disclosed no confl ict of interest. Pierpont, Bridget .................................. Disclosed no confl ict of interest. pierreisnard, Audrey ............................. Disclosed no confl ict of interest.

Dow



A888


AU

THO

R D

ISCL

OSU

RE

Pietilä, Arto .......................................... Disclosed no confl ict of interest. Pietropaolo, Massimo .......................... Disclosed no confl ict of interest. Pietrzycka, Agata .................................. Disclosed no confl ict of interest. Piette, Jacques ..................................... Disclosed no confl ict of interest. Piganelli, Jon ........................................ Disclosed no confl ict of interest. Pihlajamäki, Jussi ................................ Disclosed no confl ict of interest. Pihoker, Catherine ................................ Disclosed no confl ict of interest. Pileggi, Antonello ................................. Board Member: Converge Biotech, Inc., NEVA Scientifi c, LLC;

Research Support: ATRM, Extended Delivery, LLC, Pfi zer, Inc., Positive ID Corporation, LLC; Stock/Shareholder: Converge Biotech, Inc., Converge Biotech, Inc. (Spouse/Partner), NEVA Scientifi c, LLC

Pillai, Pradeep Babu S. ......................... Disclosed no confl ict of interest. Pillarisetti, Sivaram .............................. Disclosed no confl ict of interest. Pillon, Nicolas J. .................................. Disclosed no confl ict of interest. Pilorget, Valerie .................................... Employee: Sanofi Pilz, Ingo ............................................... Disclosed no confl ict of interest. Pineda, Marco ...................................... Disclosed no confl ict of interest. Pinelli, Michele .................................... Disclosed no confl ict of interest. Pinelli, Nicole R. ................................... Disclosed no confl ict of interest. Piner, Lucy W. ....................................... Disclosed no confl ict of interest. Ping, Chen Z. ........................................ Disclosed no confl ict of interest. Ping, Fan ............................................... Disclosed no confl ict of interest. Pinhas-Hamiel, Orit .............................. Disclosed no confl ict of interest. Pinkney, Jonathan ................................ Disclosed no confl ict of interest. Pinkston, Beverly .................................. Disclosed no confl ict of interest. Pinnola, Silvia ....................................... Disclosed no confl ict of interest. Pintaudi, Basilio ................................... Disclosed no confl ict of interest. Pinto, Eduardo H. .................................. Disclosed no confl ict of interest. Piotrowski, David W. ............................ Employee: Pfi zer, Inc. Pipkin, Joseph A. .................................. Disclosed no confl ict of interest. Pisani, Graziéle D. ................................ Disclosed no confl ict of interest. Piskarov, Julia ...................................... Disclosed no confl ict of interest. Pistrosch, Frank .................................... Speaker’s Bureau: Novartis Pharmaceuticals Corporation Pi-Sunyer, F. Xavier ............................... Disclosed no confl ict of interest. Pitocco, Dario ....................................... Disclosed no confl ict of interest. Piya, Anil .............................................. Disclosed no confl ict of interest. Piya, Milan K. ....................................... Disclosed no confl ict of interest. Pizot, Cecile .......................................... Disclosed no confl ict of interest. Place, Jerome ....................................... Disclosed no confl ict of interest. Plamboeck, Astrid ................................ Disclosed no confl ict of interest. Plank, Johannes ................................... Speaker’s Bureau: Novo Nordisk A/S Platonov, Vadim V. ................................ Disclosed no confl ict of interest. Platten, Isabel ...................................... Disclosed no confl ict of interest. Pleger, Burkhard ................................... Disclosed no confl ict of interest. Pleus, Stefan ........................................ Disclosed no confl ict of interest. Plews-Ogan, Margaret ......................... Research Support: Bristol-Myers Squibb Company Pliszka, Justyna .................................... Disclosed no confl ict of interest. Plourde, Charles-Etienne ...................... Disclosed no confl ict of interest. Plummer, Elena V. ................................. Disclosed no confl ict of interest. Plunkett, Cynthia .................................. Disclosed no confl ict of interest. Pocai, Alessandro ................................. Employee: Merck Pochat, Armelle .................................... Disclosed no confl ict of interest. Podell, Brendan K. ................................ Disclosed no confl ict of interest. Poderoso, Juan J. ................................. Disclosed no confl ict of interest. Podgorski, Michal ................................. Disclosed no confl ict of interest. Podolnikova, Nataly P. .......................... Disclosed no confl ict of interest. Podpryatov, Sergij ................................ Disclosed no confl ict of interest. Pogach, Leonard M. ............................. Disclosed no confl ict of interest. Pohl, Roderike ...................................... Employee: Biodel, Inc. Poitout, Florence .................................. Disclosed no confl ict of interest. Poitout, Vincent .................................... Disclosed no confl ict of interest. Pokala, Naveen .................................... Disclosed no confl ict of interest. Policardo, Laura .................................... Disclosed no confl ict of interest. Polidori, David ...................................... Employee: Janssen Research & Development Polin, Ashley ......................................... Disclosed no confl ict of interest. Polinski, Jennifer M. ............................ Research Support: Eli Lilly and Company Polk, Phebe ........................................... Disclosed no confl ict of interest. Pollak, Sarah ........................................ Disclosed no confl ict of interest. Pollard, Cecil R. .................................... Disclosed no confl ict of interest. Pollard, Nicole E. .................................. Disclosed no confl ict of interest. Pollin, Toni I. ......................................... Disclosed no confl ict of interest. Pollock, Richard .................................... Research Support: Eli Lilly and Company Polónia, Jorge ...................................... Disclosed no confl ict of interest. Polonsky, Kenneth S. ............................ Research Support: NIH Poneleit, Boris ...................................... Disclosed no confl ict of interest. Pongrac Barlovic, Drazenka .................. Disclosed no confl ict of interest. Ponirakis, Georgios .............................. Disclosed no confl ict of interest. Pons, Belén ........................................... Disclosed no confl ict of interest. pontiroli, Antonio E. ............................. Disclosed no confl ict of interest. Poole, Chris D. ...................................... Consultant: Abbott Laboratories, Inc., Bristol-Myers Squibb

Company, Takeda Pharmaceutical Company, Ltd.

Poon, Wenny ........................................ Disclosed no confl ict of interest. Popa, Simona Georgiana G. ................. Disclosed no confl ict of interest. Pop-Busui, Rodica ................................ Research Support: Amylin Pharmaceuticals, Inc. Pope, Richard ....................................... Research Support: VeraLight, Inc. Popescu, Horatiu .................................. Disclosed no confl ict of interest. Popescu, Miro ...................................... Disclosed no confl ict of interest. Popescu, Simona .................................. Disclosed no confl ict of interest. Poplawska-Kita, Anna .......................... Disclosed no confl ict of interest. Porcellati, Francesca ............................ Other Relationship: Bristol-Myers Squibb Company, Eli Lilly

and Company, Merck Sharp & Dohme Limited, Sanofi Pories, Walter J. .................................. Research Support: Johnson & Johnson Porneala, Bianca .................................. Disclosed no confl ict of interest. Portha, Bernard .................................... Disclosed no confl ict of interest. Porzio, Ottavia ...................................... Disclosed no confl ict of interest. Posgai, Amanda ................................... Disclosed no confl ict of interest. Pothier, Claire E. ................................... Disclosed no confl ict of interest. Pothos, Emmanuel N. ........................... Disclosed no confl ict of interest. Potier, Louis .......................................... Disclosed no confl ict of interest. Potts, Tiffany M. ................................... Disclosed no confl ict of interest. Pouloukas, Stavros ............................... Other Relationship: Novartis Pharmaceuticals Corporation Poulsen, Niels K. .................................. Disclosed no confl ict of interest. Poulsen, Per L. ...................................... Disclosed no confl ict of interest. Poulsen, Pernille ................................... Employee: Novo Nordisk A/S; Speaker’s Bureau: Novo Nordisk

A/S Pound, Lynley D. ................................... Disclosed no confl ict of interest. Pourfarjam, Yasin ................................. Disclosed no confl ict of interest. Pourfarzib, Ray ..................................... Employee: LipoScience Pouwer, Frans ....................................... Advisory Panel: Novo Nordisk A/S Powell, A. Blair ..................................... Disclosed no confl ict of interest. Powell, David ....................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Powell, Roberta .................................... Disclosed no confl ict of interest. Powell, Winter ..................................... Disclosed no confl ict of interest. Power, Thomas P. ................................. Disclosed no confl ict of interest. Powers, Alvin C. ................................... Disclosed no confl ict of interest. Powers, Benjamin J. ............................ Consultant: Daiichi-Sankyo, Inc.Powers, Jay P. ...................................... Employee: ChemoCentryx Powers, Margaret A. ............................ Disclosed no confl ict of interest. Powers, Scott W. .................................. Disclosed no confl ict of interest. Powers, William J. ............................... Disclosed no confl ict of interest. Poznik, Gabriel D. ................................. Disclosed no confl ict of interest. Pozzi, Ambra ......................................... Disclosed no confl ict of interest. Pozzilli, Paolo ........................................ Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Eli

Lilly and Company, Novartis Pharmaceuticals Corporation, Sanofi ; Research Support: Andromeda Biotech, Ltd., Medtronic, Roche Diagnostics

Pozzoli, Marina ..................................... Disclosed no confl ict of interest. Prabhakar, Nanduri R. .......................... Disclosed no confl ict of interest. Prada, Patricia O. .................................. Disclosed no confl ict of interest. Pradhan, Sangeeta ............................... Disclosed no confl ict of interest. Prado de Nitsch, Fabiola ...................... Other Relationship: Bayer Health Care, LLC (Spouse/Part-

ner), Medtronic, Novartis Pharmaceuticals Corporation (Spouse/Partner), Bayer Guatemala (Spouse/Partner); Research Support: Takeda Global Research and Develop-ment, Inc. (Spouse/Partner); Speaker’s Bureau: Abbott Nutrition

Prager, Sonja G. .................................... Disclosed no confl ict of interest. Pramanik, Barnali ................................. Employee: Merck Sharp & Dohme Limited Prapavessis, Harry ................................ Disclosed no confl ict of interest. Prasad B., Rashmi ................................ Disclosed no confl ict of interest. Prasadan, Krishna ................................ Disclosed no confl ict of interest. Prasannarong, Mujalin ......................... Disclosed no confl ict of interest. Prat, Annik ............................................ Disclosed no confl ict of interest. Pratley, Richard E. ................................ Advisory Panel: GlaxoSmithKline; Consultant: GlaxoSmith-

Kline; Research Support: GlaxoSmithKline Pratt, Elizabeth S. ................................. Disclosed no confl ict of interest. Pravodelov, Vassiliki ............................. Disclosed no confl ict of interest. Prazny, Martin ...................................... Advisory Panel: Eli Lilly and Company, Medtronic; Speaker’s

Bureau: Abbott Diabetes Care, Dexcom, Inc., Medtronic, Novo Nordisk, Inc., Roche Pharmaceuticals

Prefontaine, Annick .............................. Disclosed no confl ict of interest. Prehn, Jochen H. .................................. Disclosed no confl ict of interest. Preissl, Hubert ...................................... Disclosed no confl ict of interest. Premilovac, Dino .................................. Disclosed no confl ict of interest. Prentki, Marc ........................................ Disclosed no confl ict of interest. Presley, Larraine ................................... Disclosed no confl ict of interest. Presswala, Lubaina S. .......................... Disclosed no confl ict of interest. Presti, Pamela ...................................... Disclosed no confl ict of interest. Prestrelski, Steven J. ........................... Disclosed no confl ict of interest. Preti, Paola ........................................... Disclosed no confl ict of interest. prevost, Gaetan .................................... Disclosed no confl ict of interest. Prévost, Gilles ...................................... Disclosed no confl ict of interest.

Dow



A889


AU

THO

R D

ISCL

OSU

RE

Price, David A. ...................................... Employee: Dexcom, Inc.; Stock/Shareholder: Dexcom, Inc. Price, Julie C. ....................................... Disclosed no confl ict of interest. Price, Karen L. ...................................... Disclosed no conflict of interest. Price, R. Arlen ....................................... Disclosed no confl ict of interest. Prietl, Barbara ...................................... Disclosed no confl ict of interest. Prigeon, Ronald L. ................................ Disclosed no confl ict of interest. Prince, Melvin J. .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Printz, Richard L. ................................... Disclosed no confl ict of interest. Prior, Sarah L. ....................................... Disclosed no confl ict of interest. Proença, André R. ................................. Disclosed no confl ict of interest. Proença, Neli L. .................................... Disclosed no confl ict of interest. Prohaska, Thomas ................................ Disclosed no confl ict of interest. Proietti Pannunzi, Laura ....................... Disclosed no confl ict of interest. Proietto, Joe ......................................... Disclosed no confl ict of interest. Prokopenko, Inga .................................. Disclosed no confl ict of interest. Protasio, Joan ...................................... Employee: KineMed, Inc. Proto, Vittoria ....................................... Disclosed no confl ict of interest. Provenzano, Vincenzo ........................... Disclosed no confl ict of interest. Province, Michael A. ............................ Disclosed no confl ict of interest. Provisor, Joseph ................................... Disclosed no confl ict of interest. Prudente, Sabrina ................................. Disclosed no confl ict of interest. Prud’homme, Denis .............................. Disclosed no confl ict of interest. Pruett, Timothy L. ................................. Disclosed no confl ict of interest. Prusty, Vinay ......................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Pruszynska-Oszmalek, Ewa .................. Disclosed no confl ict of interest. Pruzanski, Mark .................................... Disclosed no confl ict of interest. Ptacek, Peggy ....................................... Disclosed no confl ict of interest. Ptaszynska, Agata ................................ Employee: Bristol-Myers Squibb Company; Stock/Shareholder:

Bristol-Myers Squibb Company Pucci, Laura .......................................... Disclosed no confl ict of interest. Puckett, Curtiss .................................... Disclosed no confl ict of interest. Puelles, Jorge ....................................... Employee: Takeda Global Research and Development, Inc. Pugliese, Alberto .................................. Disclosed no confl ict of interest. Puhi, Desiree ........................................ Disclosed no confl ict of interest. Pujanek, Malgorzata ............................ Disclosed no confl ict of interest. Pujante, Pedro ...................................... Disclosed no confl ict of interest. Pulinilkunnil, Thomas C. ....................... Disclosed no confl ict of interest. Pulliam, Lindsay ................................... Disclosed no confl ict of interest. Puranik, Amrutesh S. ............................ Disclosed no confl ict of interest. Purewal, Tejpal S. ................................ Advisory Panel: Sanofi ; Speaker’s Bureau: AstraZeneca/

Bristol-Meyers Squibb, Boehringer Ingelheim Pharmaceu-ticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk, Inc.

Purnell, Jonathan Q. ............................. Disclosed no confl ict of interest. Purohit, Ashish ..................................... Disclosed no confl ict of interest. Purschke, Werner G. ............................ Employee: Noxxon Purwana, Indri ...................................... Disclosed no confl ict of interest. Püschel, Gerhard P. ............................... Disclosed no confl ict of interest. Puskas, Laszlo G. .................................. Disclosed no confl ict of interest. Pyatak, Beth ......................................... Disclosed no confl ict of interest. Pyatak, Elizabeth A. .............................. Disclosed no confl ict of interest. Pyle, Laura ............................................ Disclosed no confl ict of interest. Pyrlis, Felicity ....................................... Disclosed no confl ict of interest. Qatami, Lara ......................................... Employee: Bristol-Myers Squibb Company Qi, Jian Shen ........................................ Employee: Janssen Research & Development Qi, Weier .............................................. Disclosed no confl ict of interest. Qi, Yajuan ............................................. Disclosed no confl ict of interest. Qi, Yong ................................................ Employee: GlaxoSmithKline Qi, Zhan ................................................ Disclosed no confl ict of interest. Qian, Chunhua ...................................... Disclosed no confl ict of interest. Qian, Chunlin ........................................ Employee: Daiichi-Sankyo, Inc.; Stock/Shareholder: Daiichi-

Sankyo, Inc. Qian, Jingyi .......................................... Disclosed no confl ict of interest. Qian, Liu ............................................... Disclosed no confl ict of interest. Qian, Wei-Jun ...................................... Disclosed no confl ict of interest. Qian, Yuewei ........................................ Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Com-pany

Qiao, Yue .............................................. Disclosed no confl ict of interest. Qin, Bolin .............................................. Disclosed no confl ict of interest. Qin, Tairan ............................................ Disclosed no confl ict of interest. Qin, Zhaoyi ........................................... Disclosed no confl ict of interest. Qing, Sun L. .......................................... Disclosed no confl ict of interest. Qiu, Liru ................................................ Disclosed no confl ict of interest. Qiu, Ni .................................................. Disclosed no confl ict of interest. Qiu, Rose .............................................. Employee: Janssen Research & Development Qiu, Xinmin ........................................... Disclosed no confl ict of interest. Qiu, Yawei ............................................ Disclosed no confl ict of interest. Qiu, Ying ............................................... Employee: Merck Qu, Shen ............................................... Disclosed no confl ict of interest.

Qu, Yongming ....................................... Employee: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner); Stock/Shareholder: Eli Lilly and Com-pany, Eli Lilly and Company (Spouse/Partner)

Quandt, Sara ........................................ Disclosed no confl ict of interest. Quasney, Michael W. ........................... Disclosed no confl ict of interest. Queally, Michelle ................................. Disclosed no confl ict of interest. Quesenberry, Charles P. ........................ Disclosed no confl ict of interest. Qui, Weiyu ............................................ Disclosed no confl ict of interest. Quimbo, Ralph ...................................... Disclosed no confl ict of interest. Quinn, Lauretta T. ................................. Disclosed no confl ict of interest. Quinn, Laurie ........................................ Disclosed no confl ict of interest. Quinn, Martha K. .................................. Disclosed no confl ict of interest. Quintana, Laura .................................... Disclosed no confl ict of interest. Quintanilla, Wendolyn ......................... Disclosed no confl ict of interest. Quintero, Cecilia ................................... Disclosed no confl ict of interest. Quintin, Delphine ................................. Disclosed no confl ict of interest. Quon, Michael J. .................................. Speaker’s Bureau: Merck Qureshi, Fareeha .................................. Disclosed no confl ict of interest. Rabbani, M.U. ...................................... Disclosed no confl ict of interest. Rabbone, Ivana ..................................... Disclosed no confl ict of interest. Raccah, Denis ....................................... Advisory Panel: Bristol-Myers Squibb Company, Eli Lilly and

Company, Medtronic, Merck, MSD, Novartis Pharmaceu-ticals Corporation, Novo Nordisk, Inc., Sanofi ; Speaker’s Bureau: Bristol-Myers Squibb Company, Eli Lilly and Com-pany, Medtronic, Merck, MSD, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi

Rachmiel, Marianna ............................. Disclosed no confl ict of interest. Raciti, Gregory Alexander .................... Disclosed no confl ict of interest. Racketa, Jill .......................................... Employee: AstraZeneca Pharmaceuticals LP Radcliff, Zachary .................................. Disclosed no confl ict of interest. Radha, Venkatesan .............................. Disclosed no confl ict of interest. Radian, Serban ..................................... Disclosed no confl ict of interest. Radican, Larry ....................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Radloff, Katrin ...................................... Disclosed no confl ict of interest. Radom-Aizik, Shlomit ........................... Disclosed no confl ict of interest. Radtke, Jared ....................................... Disclosed no confl ict of interest. Radu, Irina ............................................ Disclosed no confl ict of interest. Radulian, Gabriela ................................ Disclosed no confl ict of interest. Radwan, Salma .................................... Disclosed no confl ict of interest. Rady, Brian ........................................... Disclosed no confl ict of interest. Radziuk, Jerry ....................................... Disclosed no confl ict of interest. Raebel, Marsha A. ............................... Disclosed no confl ict of interest. Raether, Brian ....................................... Employee: Arena Pharmaceuticals, Inc. Raffel, Leslie J. .................................... Disclosed no confl ict of interest. Rafi q, Meena ........................................ Disclosed no confl ict of interest. Rafkin, Lisa ........................................... Disclosed no confl ict of interest. Ragazzi, Eugenio .................................. Disclosed no confl ict of interest. Raghavan, Pooja ................................... Disclosed no confl ict of interest. Ragolia, Louis ....................................... Disclosed no confl ict of interest. Ragot, Stephanie .................................. Disclosed no confl ict of interest. Rahmouni, Kamal ................................. Disclosed no confl ict of interest. Rahnenführer, Jan ................................ Disclosed no confl ict of interest. Raikwar, Sudhanshu P. ......................... Disclosed no confl ict of interest. Raisch, Dennis ...................................... Disclosed no confl ict of interest. Rajamani, Sridharan ............................. Employee: Gilead Sciences, Inc. Rajan, Kumar B. .................................... Disclosed no confl ict of interest. Rajan, Mangala .................................... Disclosed no confl ict of interest. Rajan, Rajeswari .................................. Disclosed no confl ict of interest. Rajan, Sindhu ....................................... Disclosed no confl ict of interest. Rajaram, Rama ..................................... Disclosed no confl ict of interest. Rajaraman, Srinivasan ......................... Disclosed no confl ict of interest. Rajlakshmi, F.N.U. ................................ Disclosed no confl ict of interest. Rajpal, Aman ........................................ Disclosed no confl ict of interest. Rajpal, Deepak ..................................... Employee: GlaxoSmithKline Rajpal, Neetu ....................................... Employee: GlaxoSmithKline Rajpathak, Swapnil N. ......................... Employee: Merck Rakita, Steven ...................................... Disclosed no confl ict of interest. Raleigh, Daniel P. ................................. Disclosed no confl ict of interest. Ramakrishnan, Usha ............................ Disclosed no confl ict of interest. Ramanadham, Sasanka ........................ Disclosed no confl ict of interest. Ramasamy, Ravichandran .................... Disclosed no confl ict of interest. Ramchandani, Neesha ......................... Disclosed no confl ict of interest. Ramirez de Arellano, Antonio .............. Employee: Novo Nordisk Pharma S.A. Ramirez, Maricela R. ............................ Research Support: Daiichi-Sankyo, Inc. Ramljak, Sanja ..................................... Disclosed no confl ict of interest. Ramnanan, Christopher J. .................... Disclosed no confl ict of interest. Ramón Frias, Teresa ............................. Disclosed no confl ict of interest. Ramos, Gladys A. ................................. Disclosed no confl ict of interest. Ramos-Prol, Agustín ............................. Disclosed no confl ict of interest. Ramsauer, Markus ............................... Employee: Hoffman La Roche Ramsay, Joanne ................................... Disclosed no confl ict of interest.

Dow



A890


AU

THO

R D

ISCL

OSU

RE

Ramsey, Kathryn M. ............................. Disclosed no confl ict of interest. Ramsey, Michael W. ............................ Disclosed no confl ict of interest. Ramsey, Natalie L. ............................... Disclosed no confl ict of interest. Ramshaw, Hayley S. ............................. Disclosed no confl ict of interest. Rana, Azhar .......................................... Employee: Novo Nordisk A/S Randeva, Harpal S. ............................... Disclosed no confl ict of interest. Randoll, Randee A. ............................... Employee: Lifescan Animas, Inc. Randolph, John F. ................................. Disclosed no confl ict of interest. Ranetti, Aurelian .................................. Disclosed no confl ict of interest. Rao, G.V. ............................................... Disclosed no confl ict of interest. Rao, Paturi V. ........................................ Stock/Shareholder: DiabetOmics Raquel, Barba ....................................... Disclosed no confl ict of interest. Raravikar, Kalyani ................................. Disclosed no confl ict of interest. Raschke, Silja ....................................... Disclosed no confl ict of interest. Raskin, Philip ........................................ Advisory Panel: Amgen, Inc., AstraZeneca Pharmaceuticals LP;

Speaker’s Bureau: Novo Nordisk, Inc. Rask-Madsen, Christian ....................... Disclosed no confl ict of interest. Rasmussen, Benjamin S. ...................... Disclosed no confl ict of interest. Rasmussen, Signe S. ............................ Disclosed no confl ict of interest. Rasmussen, Søren ................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Rasmussen-Torvik, Laura J. ................. Disclosed no confl ict of interest. Rasouli, Neda ....................................... Disclosed no confl ict of interest. Raspovic, Katherine M. ........................ Disclosed no confl ict of interest. rastaldi, Maria Pia ................................ Disclosed no confl ict of interest. Rathmann, Wolfgang ........................... Disclosed no confl ict of interest. Ratnasiri, Kalani S. ............................... Disclosed no confl ict of interest. Ratner, Robert E. .................................. Disclosed no confl ict of interest. Rattigan, Stephen ................................ Disclosed no confl ict of interest. Rattunde, Henning ............................... Employee: Boehringer Ingelheim GmbH & Co. KG Ratzinger, Michaela ............................. Employee: Novartis Pharma GmbH Rauh, Anna Christina ........................... Disclosed no confl ict of interest. Raum, Jeffrey C. ................................... Disclosed no confl ict of interest. Raun, Kirsten ........................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Rauwerda, Jan A. ................................. Board Member: Institutional Ethics Review Board Raval, Amit ........................................... Research Support: Sanofi Raverdy, Violetta .................................. Disclosed no confl ict of interest. Ravindran, Anindita .............................. Disclosed no confl ict of interest. Ravussin, Eric ....................................... Consultant: Amylin Pharmaceuticals, Inc., GlaxoSmithKline,

Medical Weight Loss, Merck, Pfi zer, Inc., Sanofi ; Research Support: Ethicon EndoSurgery, Inc.

Rawlings, David J. ............................... Disclosed no confl ict of interest. Rawlins, David ..................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Rawlinson, William D. ......................... Disclosed no confl ict of interest. Ray, Joel ............................................... Disclosed no confl ict of interest. Raymond, Jennifer K. ........................... Disclosed no confl ict of interest. Raymond, Neil T. .................................. Disclosed no confl ict of interest. Rayner, Christopher K. .......................... Research Support: Eli Lilly and Company, Merck Raz, Itamar ........................................... Advisory Panel: Insuline Medical; Consultant: Insuline Medical Rea, Delphine ....................................... Other Relationship: Bristol-Myers Squibb Company, Novartis

Pharmaceuticals Corporation, Teva Pharmaceuticals Reach, Gérard ....................................... Advisory Panel: Lifescan Animas, Inc.; Speaker’s Bureau: Abbott

Diabetes Care, Bayer Health Care, LLC, Eli Lilly and Com-pany, Lifescan Animas, Inc., Menarini, Merck, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi

Reaney, Matthew ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company

Reaven, Gerald ..................................... Disclosed no confl ict of interest. Reaven, Peter D. ................................... Advisory Panel: Aastrom Biosciences, Inc.; Board Member:

Bristol-Myers Squibb Company; Research Support: Amylin Pharmaceuticals, Inc.; Speaker’s Bureau: Merck

Rebelos, Eleni ....................................... Disclosed no confl ict of interest. Rebuffat, Sandra .................................. Disclosed no confl ict of interest. Rechenberg, Kaitlyn ............................. Disclosed no confl ict of interest. Rector, R. Scott ..................................... Disclosed no confl ict of interest. Reda, Domenic ..................................... Disclosed no confl ict of interest. Reddy, D.N. ........................................... Disclosed no confl ict of interest. Reddy, Narendra L. ............................... Disclosed no confl ict of interest. Reddy, Srinivasa T. ............................... Other Relationship: Bruin Pharmaceuticals Reddy, Vanessa S. ................................ Employee: Genentech; Stock/Shareholder: Genentech Redgrave, Jamie .................................. Disclosed no confl ict of interest. Redman, Leanne ................................... Disclosed no confl ict of interest. Redondo, Maria J. ................................ Disclosed no confl ict of interest. Reece, E. Albert .................................... Disclosed no confl ict of interest. Reece, Melanie S. ................................ Disclosed no confl ict of interest. Reed, Kathryne ..................................... Disclosed no confl ict of interest. Reed, Laurence J. ................................. Disclosed no confl ict of interest. Reed, Melissa A. .................................. Disclosed no confl ict of interest. Rees, Sandra ........................................ Disclosed no confl ict of interest.

Reeves, David ....................................... Disclosed no confl ict of interest. Regazzi, Romano .................................. Disclosed no confl ict of interest. Regensteiner, Judith G. ........................ Research Support: Amylin Pharmaceuticals, Inc. Regier, Michael .................................... Disclosed no confl ict of interest. Regittnig, Werner ................................. Disclosed no confl ict of interest. Reiber, István ........................................ Disclosed no confl ict of interest. Reichert, Dorothea ............................... Disclosed no confl ict of interest. Reichetzeder, Christoph ....................... Disclosed no confl ict of interest. Reichman, Brian ................................... Disclosed no confl ict of interest. Reid, Anna ............................................ Disclosed no confl ict of interest. Reid, Darcy ........................................... Disclosed no confl ict of interest. Reid, Raymond ..................................... Disclosed no confl ict of interest. Reid, Timothy ........................................ Consultant: Amylin/Bristol-Myers Squibb, Novo Nordisk,

Inc., Sanofi ; Speaker’s Bureau: Amylin/ Bristol-Myers Squibb, Novo Nordisk, Inc., Sanofi

Reifel Miller, Anne ............................... Employee: Eli Lilly and Company Reilly, Muredach P. ............................... Disclosed no confl ict of interest. Rein, Philipp ......................................... Disclosed no confl ict of interest. Reinbeck, Anna Lena ............................ Disclosed no confl ict of interest. Reingold, Jason S. ............................... Speaker’s Bureau: LipoScience Reinhardt, Rickey ................................. Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

KlineReinick, Christina L. .............................. Disclosed no confl ict of interest. Reis, André ........................................... Disclosed no confl ict of interest. Reisenbigler, Emily ............................... Disclosed no confl ict of interest. Reiser, Jochen ...................................... Disclosed no confl ict of interest. Remedi, Maria S. ................................. Disclosed no confl ict of interest. Remonti, Luciana R. ............................. Disclosed no confl ict of interest. Remus, Kerstin ..................................... Disclosed no confl ict of interest. Remvig, Line S. ..................................... Employee: HypoSafe A/S Ren, Decheng ....................................... Disclosed no confl ict of interest. Ren, Jimmy ........................................... Employee: Janssen Research & Development Ren, Jun ............................................... Disclosed no confl ict of interest. Ren, Luping ........................................... Disclosed no confl ict of interest. Ren, Qian .............................................. Disclosed no confl ict of interest. Ren, Sidney .......................................... Disclosed no confl ict of interest. Ren, Wei ............................................... Disclosed no confl ict of interest. Ren, Yan ............................................... Disclosed no confl ict of interest. Ren, Yuelan .......................................... Disclosed no confl ict of interest. Ren, Zhuozhuo ...................................... Disclosed no confl ict of interest. Renard, Eric .......................................... Advisory Panel: Abbott Diabetes Care, Cellnovo, Dexcom, Inc.,

Menarini; Consultant: Eli Lilly and Company, Johnson & Johnson, Medtronic, Novo Nordisk, Inc., Roche Pharma-ceuticals, Sanofi ; Research Support: Dexcom, Inc., Insulet Corporation, Roche Pharmaceuticals

Reno, Candace M. ................................ Disclosed no confl ict of interest. Ress, Claudia ........................................ Disclosed no confl ict of interest. Retnakaran, Ravi .................................. Advisory Panel: Merck, Novo Nordisk, Inc.; Consultant: Merck,

Novo Nordisk, Inc.; Research Support: Merck, Novo Nordisk, Inc.

Retterath, Adam ................................... Disclosed no confl ict of interest. Rettig, Ingo ........................................... Disclosed no confl ict of interest. Retting, Kelsey ..................................... Disclosed no confl ict of interest. Reusch, Jane E. .................................... Advisory Panel: GlaxoSmithKline; Research Support: Amylin

Pharmaceuticals, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline

Reuschel, William B. ............................ Disclosed no confl ict of interest. Reutrakul, Sirimon ................................ Disclosed no confl ict of interest. Rewers, Arleta B. ................................. Disclosed no confl ict of interest. Rewers, Marian J. ................................ Disclosed no confl ict of interest. Rey, Chloe ............................................. Disclosed no confl ict of interest. Rey, Mariano ........................................ Disclosed no confl ict of interest. Reyes, David ......................................... Disclosed no confl ict of interest. Reynolds, Jenna ................................... Disclosed no confl ict of interest. Reynolds, Kristi .................................... Disclosed no confl ict of interest. Reynolds, Nichole ................................ Disclosed no confl ict of interest. Reynolds, Regina .................................. Disclosed no confl ict of interest. Reznik, Yves ......................................... Advisory Panel: Medtronic; Board Member: Abbott, Eli Lilly

and Company Rhee, Chanhaeng ................................. Disclosed no confl ict of interest. Rhee, Eun Jung .................................... Disclosed no confl ict of interest. Rhee, Mary K. ....................................... Research Support: Merck, Sankyo USA Rhee, Nicolai A. ................................... Disclosed no confl ict of interest. Rhein, Kathleen .................................... Employee: Animas Corporation; Stock/Shareholder: Johnson

& Johnson Rhinehart, Andrew S. ........................... Advisory Panel: Amylin Pharmaceuticals, Inc., Sanofi;

Board Member: Appalachian Diabetes Foundation; Consultant: Sanofi; Speaker’s Bureau: Abbott Labora-tories, Inc., Amylin Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Forest Pharmaceuticals, Inc., Novo Nordisk, Inc., Sanofi

Rhodes, Christopher J. ......................... Disclosed no confl ict of interest.

Dow



A891


AU

THO

R D

ISCL

OSU

RE

Riaz, Imran ............................................ Disclosed no confl ict of interest. Ribeiro, Rogerio S. ............................... Disclosed no confl ict of interest. Ribel, Ulla ............................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Riber, Ditte ........................................... Employee: Zealand Pharma A/S; Research Support: Zealand

Pharma A/S; Stock/Shareholder: Zealand Pharma A/S Ribnicky, David ..................................... Disclosed no confl ict of interest. Riboli, Elio ............................................ Disclosed no confl ict of interest. Riccardi, Gabriele ................................. Disclosed no confl ict of interest. Rice, Madeline M. ................................ Disclosed no confl ict of interest. Richard, Denis ...................................... Disclosed no confl ict of interest. Richards, Catrina .................................. Consultant: IMS Health, Inc. Richards, Jennifer P. ............................. Disclosed no confl ict of interest. Richards, Stephen M. ........................... Disclosed no confl ict of interest. Richardson, Andrew ............................. Disclosed no confl ict of interest. Richardson, Lisa ................................... Disclosed no confl ict of interest. Richardson, Sarah J. ............................ Disclosed no confl ict of interest. Riches, Christine .................................. Disclosed no confl ict of interest. Richey, Joyce M. .................................. Disclosed no confl ict of interest. Richter, Judit ........................................ Disclosed no confl ict of interest. Richter, Sara ......................................... Disclosed no confl ict of interest. Rickels, Karl .......................................... Disclosed no confl ict of interest. Rickels, Michael R. ............................... Consultant: Longevity Biotech Rickey, Leslie ........................................ Disclosed no confl ict of interest. Ricks, Madia ......................................... Disclosed no confl ict of interest. Ricordi, Camillo .................................... Board Member: Converge Biotech, Inc., NEVA Scientifi c, LLC,

Ophysio Riddle, Matthew C. .............................. Consultant: Amylin Pharmaceuticals, Inc., Elcelyx Thera-

peutics, Inc., Eli Lilly and Company, Hoffman La Roche, Sanofi , Valeritas, LLC; Research Support: Amylin Pharma-ceuticals, Inc., Eli Lilly and Company, Elcelyx Therapeu-tics, Inc., Sanofi , Valeritas, LLC; Speaker’s Bureau: Amylin Pharmaceuticals, Inc., Elcelyx Therapeutics, Inc., Eli Lilly and Company, Hoffman La Roche, Sanofi , Valeritas, LLC

Rideout, Drew ...................................... Disclosed no confl ict of interest. Ridley, Derrick E. .................................. Disclosed no confl ict of interest. Ried, Janina S. ..................................... Disclosed no confl ict of interest. Riedl, Margaret .................................... Research Support: NIH, Sanofi Rieger, Cosima C. ................................. Employee: Roche Diagnostics GmbH Rifas-Shiman, Sheryl L. ........................ Disclosed no confl ict of interest. Rigalleau, Vincent ................................ Disclosed no confl ict of interest. Riggs, Arthur D. .................................... Disclosed no confl ict of interest. Rigla, Mercedes ................................... Advisory Panel: Novo Nordisk, Inc.; Research Support: Roche

Pharmaceuticals Rigolon, Riccardo ................................. Disclosed no confl ict of interest. Riiff, Tim ............................................... Employee: KineMed, Inc. Rijnsburger, Merel ................................ Disclosed no confl ict of interest. Riley, Kevin ........................................... Disclosed no confl ict of interest. Rinaldi, Maria Elena ............................. Disclosed no confl ict of interest. Rink, Linda ............................................ Disclosed no confl ict of interest. Rinker, Joanne K. ................................. Disclosed no confl ict of interest. Rios, Hernan C. ..................................... Disclosed no confl ict of interest. Ripatti, Samuli ...................................... Disclosed no confl ict of interest. Ritholz, Marilyn D. ................................ Disclosed no confl ict of interest. Ritov, Vladimir B. .................................. Disclosed no confl ict of interest. Rittig, Kilian .......................................... Disclosed no confl ict of interest. Rittig, Søren ......................................... Disclosed no confl ict of interest. Ritzén, Hanna ....................................... Employee: Mercodia Rivellese, Angela A. ............................. Disclosed no confl ict of interest. Rivera-Vega, Michelle .......................... Disclosed no confl ict of interest. Rizell, Magnus ...................................... Disclosed no confl ict of interest. Rizvi, S. Aijaz Abbas ............................. Disclosed no confl ict of interest. Rizza, Robert A. .................................... Disclosed no confl ict of interest. Rizza, Stefano ....................................... Disclosed no confl ict of interest. Rizzo, Loredana .................................... Disclosed no confl ict of interest. Rizzo, Manfredi .................................... Disclosed no confl ict of interest. Rizzo, Mark A. ...................................... Disclosed no confl ict of interest. Rizzo, Paola .......................................... Disclosed no confl ict of interest. Robell, Nick J. ...................................... Disclosed no confl ict of interest. Roberson, Paula K. ............................... Disclosed no confl ict of interest. Roberts, Charles T. ............................... Stock/Shareholder: DiabetOmics Robertson, Chris ................................... Disclosed no confl ict of interest. Robertson, Dawn .................................. Disclosed no confl ict of interest. Robertson, M.D. ................................... Research Support: EFSD, National Starch Food Innovation Robertson, Neil .................................... Disclosed no confl ict of interest. Robertson, R. Paul ................................ Speaker’s Bureau: Merck Robinson, Cynthia ................................ Employee: Bayer Health Care, LLC Robinson, Matthew M. ........................ Disclosed no confl ict of interest. Robinson, Tom ...................................... Disclosed no confl ict of interest. Robker, Rebecca ................................... Disclosed no confl ict of interest. Robles, Lourdes .................................... Disclosed no confl ict of interest. Robusto, Fabio ...................................... Disclosed no confl ict of interest.

Rocca, Liliana ....................................... Disclosed no confl ict of interest. Roche, Béatrice .................................... Disclosed no confl ict of interest. Rocheleau, Jonathan V. ........................ Disclosed no confl ict of interest. Rock, Cheryl L. ...................................... Disclosed no confl ict of interest. Rod, Anne ............................................. Disclosed no confl ict of interest. Rodacki, Melanie ................................. Disclosed no confl ict of interest. Rodbard, David ..................................... Advisory Panel: Amylin Pharmaceuticals, Inc. (Spouse/

Partner), Bayer Health Care, LLC (Spouse/Partner), Bristol-Myers Squibb/AstraZeneca (Spouse/Partner), Merck (Spouse/Partner), Novo Nordisk, Inc. (Spouse/Partner); Consultant: Amylin Pharmaceuticals, Inc., Ha-lozyme Therapeutics, Lifescan Animas, Inc., MannKind Corporation, Merck, Merck (Spouse/Partner), Novo Nordisk, Inc. (Spouse/Partner), Roche Pharmaceuticals, Roche Pharmaceuticals (Spouse/Partner); Research Support: Amylin Pharmaceuticals, Inc. (Spouse/Partner), AstraZeneca/Bristol-Meyers Squibb (Spouse/Partner), Bristol-Myers Squibb Company (Spouse/Part-ner), Merck (Spouse/Partner), Novartis Pharmaceuti-cals Corporation (Spouse/Partner), Novo Nordisk, Inc. (Spouse/Partner), Sanofi (Spouse/Partner); Speaker’s Bureau: Amylin Pharmaceuticals, Inc. (Spouse/Partner), Bristol-Myers Squibb/AstraZeneca (Spouse/Part-ner), Eli Lilly and Company (Spouse/Partner), Merck (Spouse/Partner), Merck Sharp & Dohme Limited (Spouse/Partner), Novartis Pharmaceuticals Corpora-tion (Spouse/Partner), Novo Nordisk, Inc. (Spouse/Partner), Sanofi (Spouse/Partner)

Rodbard, Helena W. ............................. Advisory Panel: Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Bayer Health Care, LLC, Biodel, Inc., Novo Nordisk A/S, Roche Diagnostics, Sanofi ; Consultant: Biodel, Inc., Roche Diagnostics; Research Support: AstraZeneca Pharmaceuticals LP, Biodel, Inc., Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Roche Diagnostics, Sanofi ; Speaker’s Bureau: Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck, Novo Nordisk A/S

Roden, Michael .................................... Advisory Panel: Eli Lilly and Company, Takeda Pharmaceuti-cal Company, Ltd.; Board Member: Eli Lilly and Company, Takeda Pharmaceutical Company, Ltd.; Consultant: sanofi -aventis; Other Relationship: Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Novartis Phar-maceuticals Corporation; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk, Inc., Takeda Pharmaceutical Company, Ltd.

Rodgers, Ann ........................................ Disclosed no confl ict of interest. Rodier, Michel ...................................... Disclosed no confl ict of interest. Rodig, Scott J. ...................................... Disclosed no confl ict of interest. Rodnick, K. ............................................ Disclosed no confl ict of interest. Rodriguez, Beatriz ................................ Disclosed no confl ict of interest. Rodriguez, Henry .................................. Board Member: American Diabetes Association; Consultant:

Eli Lilly and Company, Roche Diagnostics; Other Relation-ship: Roche Pharmaceuticals (Spouse/Partner); Research Support: Bristol-Myers Squibb Company, Daiichi-Sankyo, Inc., Merck, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc.

Rodriguez, Luisa M. .............................. Disclosed no confl ict of interest. Rodríguez-Herrero, Agustin .................. Disclosed no confl ict of interest. Roe, Michael W. ................................... Disclosed no confl ict of interest. Roe, Nathan D. ..................................... Disclosed no confl ict of interest. Roeder, Hilary A. .................................. Disclosed no confl ict of interest. Roehrig, Karin ....................................... Disclosed no confl ict of interest. Roepstorff, Carsten .............................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Rofani, Cristina ..................................... Disclosed no confl ict of interest. Roger, Veronique L. .............................. Disclosed no confl ict of interest. Rogers, Ann .......................................... Disclosed no confl ict of interest. Rogers, Helen ....................................... Disclosed no confl ict of interest. Rogers, Pamela M. ............................... Disclosed no confl ict of interest. Rogers, Anne ........................................ Disclosed no confl ict of interest. Roglic, Gojka ........................................ Disclosed no confl ict of interest. Roh, Eun ............................................... Disclosed no confl ict of interest. Roh, Gu Seob ........................................ Disclosed no confl ict of interest. Rohde, Ulrich ........................................ Disclosed no confl ict of interest. Rohrs, Henry ......................................... Disclosed no confl ict of interest. Rohwedder, Katja ................................. Employee: AstraZeneca Pharmaceuticals LP Rojo, Gemma ........................................ Disclosed no confl ict of interest. Rokeya, Begum ..................................... Disclosed no confl ict of interest. Rokutan, Mariyo ................................... Disclosed no confl ict of interest.

Dow



A892


AU

THO

R D

ISCL

OSU

RE

Rolph, Timothy P. .................................. Employee: Pfi zer, Inc.; Research Support: Pfi zer, Inc.; Stock/Shareholder: Pfi zer, Inc.

Romacho, Tania .................................... Disclosed no confl ict of interest. Romacho-Romero, Tania ...................... Disclosed no confl ict of interest. Román, Carolina L. ............................... Disclosed no confl ict of interest. Romanatto, Talita ................................. Disclosed no confl ict of interest. Romano, Davide ................................... Disclosed no confl ict of interest. Romanova, Natalia N. .......................... Disclosed no confl ict of interest. Romenskaia, Irina ................................. Disclosed no confl ict of interest. Romero, Ana ......................................... Disclosed no confl ict of interest. Romero, Enrique ................................... Disclosed no confl ict of interest. Romero, Gracia ..................................... Employee: Sanofi Romero, Odile ....................................... Disclosed no confl ict of interest. Romero-Talamas, Hector ...................... Disclosed no confl ict of interest. Rong, Ying ............................................ Disclosed no confl ict of interest. Rönn, Tina ............................................. Disclosed no confl ict of interest. Rood, Jennifer ...................................... Disclosed no confl ict of interest. Ros, Oliana ........................................... Disclosed no confl ict of interest. Rosales, Ana G. .................................... Disclosed no confl ict of interest. Rosario, Rosa ....................................... Disclosed no confl ict of interest. Rosario, Wilfredo ................................. Disclosed no confl ict of interest. Rose, Michael A. .................................. Disclosed no confl ict of interest. Rose, Paulina ........................................ Disclosed no confl ict of interest. Rosen, Daniel J. ................................... Disclosed no confl ict of interest. Rosen, Evan .......................................... Disclosed no confl ict of interest. Rosenberg, Lynn ................................... Disclosed no confl ict of interest. Rosenfeld, Cheryl ................................. Consultant: Valeritas, LLC; Research Support: Valeritas, LLC Rosenfeld, Nora ................................... Disclosed no confl ict of interest. Rosenstock, Julio ................................. Advisory Panel: Amylin Pharmaceuticals, Inc., Eli Lilly and

Company, GlaxoSmithKline, Hoffman La Roche, Intarcia Therapeutics, Inc., Novo Nordisk, Inc., Sanofi ; Consultant: Amylin Pharmaceuticals, Inc., Eli Lilly and Company, GlaxoSmithKline, Hoffman La Roche, Intarcia Therapeu-tics, Inc., Novo Nordisk A/S, Sanofi ; Research Support: Sanofi , , Eli Lilly and Company, Novo Nordisk, Inc.

Rosenthal, Miranda .............................. Disclosed no confl ict of interest. Rosenzweig, James L. .......................... Disclosed no confl ict of interest. Ross, Glynis P. ...................................... Disclosed no confl ict of interest. Ross, Joseph S. .................................... Research Support: Medtronic Ross, Judith L. ...................................... Disclosed no confl ict of interest. Ross, Mike ............................................ Employee: Novartis Pharmaceuticals Corporation Ross, Stuart A. ..................................... Disclosed no confl ict of interest. Ross, Trenton T. .................................... Employee: Pfi zer, Inc. Ross-Degnan, Dennis ........................... Disclosed no confl ict of interest. Rossetti, Paolo ..................................... Disclosed no confl ict of interest. Rossi, Chiara ........................................ Disclosed no confl ict of interest. Rossi, Maria Chiara .............................. Disclosed no confl ict of interest. Rotberg, Britt ........................................ Disclosed no confl ict of interest. Roth, Christina L. .................................. Disclosed no confl ict of interest. Roth, Jesse ........................................... Disclosed no confl ict of interest. Rothberg, Amy E. .................................. Disclosed no confl ict of interest. Rothenberg, Paul .................................. Employee: Janssen Research & Development Rothman, Douglas L. ............................ Disclosed no confl ict of interest. Rothman, Russell ................................. Consultant: Abbott Diabetes Care Rotter, Jerome I. ................................... Disclosed no confl ict of interest. Rouch, Claude ...................................... Disclosed no confl ict of interest. Roumie, Christianne ............................. Disclosed no confl ict of interest. Round, Elizabeth ................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Round, Rachel A. .................................. Disclosed no confl ict of interest. Rountree, Austin .................................. Disclosed no confl ict of interest. Roush, Nicole ....................................... Employee: Pfi zer, Inc. Roushan, Cyrus A. ................................ Employee: Medtronic Rousseau, Michel F. ............................. Disclosed no confl ict of interest. Roussel, Ronan ..................................... Advisory Panel: Eli Lilly and Company, Lifescan Animas,

Inc., Medtronics, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi , Servier; Consultant: Eli Lilly and Company, Lifescan Animas, Inc., Medtronic, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi , Servier

Rowan-Martin, Megan ......................... Disclosed no confl ict of interest. Roy, Anirban ......................................... Employee: Medtronic; Stock/Shareholder: MedtronicRoy, Marie-Claude ................................ Disclosed no confl ict of interest. Roy, Sayon ............................................ Disclosed no confl ict of interest. Roy, Tapash .......................................... Disclosed no confl ict of interest. Roy-Duval, Christine ............................. Employee: Sanofi Rozansky, Hallie ................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Rozsa, Marton ...................................... Disclosed no confl ict of interest. Rrong, Zhou X. ...................................... Disclosed no confl ict of interest. Ruan, Hai-Bin ....................................... Disclosed no confl ict of interest. Ruan, Ting ............................................. Disclosed no confl ict of interest.

Ruas, Luísa ........................................... Disclosed no confl ict of interest. Rubin, Clinton T. ................................... Disclosed no confl ict of interest. Rubin, Daniel J. .................................... Disclosed no conflict of interest. Rubin, Deborah C. ................................ Disclosed no confl ict of interest. Rubin, Paul ........................................... Employee: XOMA Corporation Rubin, Richard R. .................................. Disclosed no confl ict of interest. Rubio, Claudia P. ................................... Disclosed no confl ict of interest. Rubio-Almanza, Matilde ...................... Disclosed no confl ict of interest. Rucci, Enzo ........................................... Disclosed no confl ict of interest. Rucker, Lisa .......................................... Disclosed no confl ict of interest. Ruderman, Neil B. ................................ Disclosed no confl ict of interest. Rudnisky, Chris ..................................... Disclosed no confl ict of interest. Ruedy, Katrina J. .................................. Disclosed no confl ict of interest. Ruelas, Valerie ..................................... Disclosed no confl ict of interest. Ruetten, Hartmut .................................. Employee: Sanofi Ruggiero, Laurie ................................... Disclosed no confl ict of interest. Rui, Liangyou ........................................ Disclosed no confl ict of interest. Rui, Xuefei ............................................ Disclosed no confl ict of interest. Ruige, Johannes ................................... Disclosed no confl ict of interest. Ruiz Morosini, Maria L. ........................ Disclosed no confl ict of interest. Ruiz, Justo ............................................ Disclosed no confl ict of interest. Ruiz, Monica ......................................... Disclosed no confl ict of interest. Ruiz-Narvaez, Edward A. ...................... Disclosed no confl ict of interest. Rukstalis, Michael ................................ Employee: Pfi zer, Inc. Rungby, Jørgen ..................................... Disclosed no confl ict of interest. Run-min, Guo ........................................ Disclosed no confl ict of interest. Rupnow, Marcia F. ................................ Employee: Janssen Scientifi c Affairs, LLC Ruppert, Kristine .................................. Research Support: Sanofi Rusavy, Zdenek ..................................... Disclosed no confl ict of interest. Rush, Jonathan .................................... Disclosed no confl ict of interest. Rusnak, James M. ................................ Employee: Pfi zer, Inc.; Research Support: Pfi zer, Inc.; Stock/

Shareholder: Pfi zer, Inc. Russell, Steven J. ................................. Research Support: Abbott Diabetes Care, Dexcom, Inc.,

Insulet Corporation, International Biomedical, Medtronic MiniMed, Inc.

Russell-Jones, David L. ........................ Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc.

Russo, Eleonora .................................... Disclosed no confl ict of interest. Russo, Rossella .................................... Disclosed no confl ict of interest. Rust, Keith F. ......................................... Disclosed no confl ict of interest. Rustan, Arild C. .................................... Disclosed no confl ict of interest. Rusu, Emilia .......................................... Disclosed no confl ict of interest. Rusu, Florin ........................................... Disclosed no confl ict of interest. Rutlin, Jerrel ......................................... Disclosed no confl ict of interest. Rutter, Guy A. ....................................... Disclosed no confl ict of interest. Rutter, Martin ....................................... Disclosed no confl ict of interest. Ryan, Amy T. ......................................... Disclosed no confl ict of interest. Ryan, Courtney ..................................... Disclosed no confl ict of interest. Ryan, Donna H. ..................................... Advisory Panel: Eisai, Inc., Novo Nordisk, Inc., Vivus, Inc.;

Consultant: Eisai, Inc., Novo Nordisk, Inc., Scientifi c Intake, Vivus, Inc.

Rybak, Iwona E. .................................... Disclosed no confl ict of interest. Rydén, Lars E. ....................................... Disclosed no confl ict of interest. Ryder, Jacqueline ................................. Disclosed no confl ict of interest. Ryder, Justin ......................................... Disclosed no confl ict of interest. Ryder, R.E.J. ......................................... Disclosed no confl ict of interest. Ryoichi, Misaka .................................... Disclosed no confl ict of interest. Rytter, Dorte ......................................... Disclosed no confl ict of interest. Ryu, Ohk Hyun ...................................... Disclosed no confl ict of interest. Rzeszotarski, Jacek .............................. Disclosed no confl ict of interest. Sá, João R. ........................................... Disclosed no confl ict of interest. Saad, Mario J. ...................................... Disclosed no confl ict of interest. Saaddine, Jinan B. ............................... Disclosed no confl ict of interest. Sabatino, Francesco ............................. Disclosed no confl ict of interest. Sabico, Shaun ...................................... Disclosed no confl ict of interest. Sabourin, Kristin J. ............................... Disclosed no confl ict of interest. Sacco, Jennifer .................................... Disclosed no confl ict of interest. Sacks, David A. .................................... Disclosed no confl ict of interest. Sadagurski, Marianna .......................... Disclosed no confl ict of interest. Saddi-Rosa, Pedro ................................ Disclosed no confl ict of interest. Sadosky, Alesia .................................... Employee: Pfi zer, Inc.; Stock/Shareholder: Pfi zer, Inc. Saeed, Mujahid .................................... Disclosed no confl ict of interest. Saely, Christoph H. ............................... Disclosed no confl ict of interest. Saengsirisuwan, Vitoon ....................... Disclosed no confl ict of interest. Saey, Jean ............................................ Disclosed no confl ict of interest. Safe, Stephen ....................................... Disclosed no confl ict of interest. Saffery, Richard .................................... Disclosed no confl ict of interest. Safi khan, Nooshin ................................ Disclosed no confl ict of interest. Safranow, Krzysztof .............................. Disclosed no confl ict of interest. Sagarra, Ramon .................................... Disclosed no confl ict of interest. Sagawa, Norimasa ............................... Disclosed no confl ict of interest.

Dow



A893


AU

THO

R D

ISCL

OSU

RE

Saglam, Kenan ..................................... Disclosed no confl ict of interest. Saglio, Giuseppe .................................. Consultant: Bristol-Myers Squibb Company, Novartis Phar-

maceuticals Corporation, Pfi zer, Inc.; Speaker’s Bureau: Bristol-Myers Squibb Company, Novartis Pharmaceuticals Corporation

Sagnard, Luc ......................................... Employee: Sanofi Sagrilla, Colleen ................................... Disclosed no confl ict of interest. Sagum, Jonathan S. ............................. Disclosed no confl ict of interest. Saha, Asish K. ...................................... Disclosed no confl ict of interest. Saha, Jharna ........................................ Disclosed no confl ict of interest. Sahu, Subhshri ..................................... Disclosed no confl ict of interest. Sahyouni, Elie ....................................... Disclosed no confl ict of interest. Saibene, Alessandro ............................ Disclosed no confl ict of interest. Said, Abdurahman ................................ Disclosed no confl ict of interest. Said, Nabil A. ....................................... Employee: Daiichi-Sankyo, Inc.; Stock/Shareholder: Daiichi-

Sankyo, Inc. Sairenchi, Toshimi ................................ Disclosed no confl ict of interest. Saisho, Yoshifumi ................................. Disclosed no confl ict of interest. Saito, Hidehito ..................................... Disclosed no confl ict of interest. Saito, Isao ............................................ Disclosed no confl ict of interest. Saito, Jun ............................................. Disclosed no confl ict of interest. Saito, Kazumi ....................................... Disclosed no confl ict of interest. Saito, Masayuki ................................... Disclosed no confl ict of interest. Sajan, Mini P. ....................................... Disclosed no confl ict of interest. Sakada, Michinori ................................ Disclosed no confl ict of interest. Sakagami, Hidemitsu ........................... Disclosed no confl ict of interest. Sakai, Chieko ........................................ Disclosed no confl ict of interest. Sakai, Kentaro ...................................... Disclosed no confl ict of interest. Sakai, Takenori ..................................... Disclosed no confl ict of interest. Sakamoto, Kenichi ............................... Disclosed no confl ict of interest. Sakamoto, Kentaro ............................... Disclosed no confl ict of interest. Sakamoto, Luciano H. .......................... Disclosed no confl ict of interest. Sakamoto, Masashi ............................. Employee: Nippon Boehringer Ingelheim Co., Ltd. Sakamoto, Masaya .............................. Disclosed no confl ict of interest. Sakamoto, Rika .................................... Disclosed no confl ict of interest. Sakane, Naoki ...................................... Disclosed no confl ict of interest. Sakaue, Hiroshi .................................... Disclosed no confl ict of interest. Sakinada, Hironori ................................ Disclosed no confl ict of interest. Sakuma, Yukie ...................................... Disclosed no confl ict of interest. Sakurada, Masaya ............................... Disclosed no confl ict of interest. Sakurada, Meiko .................................. Disclosed no confl ict of interest. Sakurai, Kenichi ................................... Disclosed no confl ict of interest. Sakurai, Masaru ................................... Disclosed no confl ict of interest. Sakurai, Shintarou ................................ Disclosed no confl ict of interest. Sakurai, Yoshitaka ................................ Disclosed no confl ict of interest. Sakurai, Yuko ........................................ Disclosed no confl ict of interest. Sakuramoto-Tsuchida, Sumiyo ............. Disclosed no confl ict of interest. Salam, G. .............................................. Disclosed no confl ict of interest. Salam, Muhammad .............................. Disclosed no confl ict of interest. Salamati, Sarah .................................... Disclosed no confl ict of interest. Salandini, Sophie ................................. Disclosed no confl ict of interest. Salas, Tiffanie ...................................... Disclosed no confl ict of interest. Saldana, Santiago ................................ Disclosed no confl ict of interest. Saleem, Moin ....................................... Disclosed no confl ict of interest. Saleh Hassan, Lina ............................... Disclosed no confl ict of interest. Salehi, Albert ....................................... Disclosed no confl ict of interest. Salehi, Marzieh .................................... Disclosed no confl ict of interest. Salem, Esam ......................................... Disclosed no confl ict of interest. Sales, Vicencia ..................................... Disclosed no confl ict of interest. Saletsky, Ronald ................................... Disclosed no confl ict of interest. Salihu, Hamisu ..................................... Disclosed no confl ict of interest. Salinitri, Francine D. ............................. Disclosed no confl ict of interest. Salles, Joao .......................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly

and Company, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi

Salomaa, Veikko ................................... Disclosed no confl ict of interest. Saltamentova, Svetlana ....................... Disclosed no confl ict of interest. Saltiel, Alan .......................................... Disclosed no confl ict of interest. Saltz, Joel ............................................. Research Support: Sanofi Saluja, Manoj ....................................... Disclosed no confl ict of interest. Salvador, Javier .................................... Disclosed no confl ict of interest. Salvati, Antonio .................................... Disclosed no confl ict of interest. Salvemini, Lucia ................................... Disclosed no confl ict of interest. Samadfam, Rana .................................. Disclosed no confl ict of interest. Samarasekera, Tanya ........................... Disclosed no confl ict of interest. Samat, Aashish .................................... Disclosed no confl ict of interest. Sambamoorthi, Usha ............................ Research Support: Sanofi Sambataro, Maria ................................ Disclosed no confl ict of interest. Samoa, Raynald ................................... Disclosed no confl ict of interest. Samp, Jennifer ..................................... Employee: Takeda Pharmaceutical Company, Ltd.

Sampanis, Christos .............................. Disclosed no confl ict of interest. Sampol, Gabriel .................................... Disclosed no confl ict of interest. Samra, Abdul Abou .............................. Disclosed no confl ict of interest. Samson, Pierre ..................................... Disclosed no confl ict of interest. Samson, Willis ..................................... Disclosed no confl ict of interest. Samuel, Stuart ..................................... Consultant: Novartis Pharmaceuticals Corporation, Roche

Pharmaceuticals Sanal, Geethu ....................................... Disclosed no confl ict of interest. Sanchez, Humberto .............................. Disclosed no confl ict of interest. Sanchez, Matilde ................................. Employee: Arena Pharmaceuticals, Inc. Sanchez, Milva ..................................... Disclosed no confl ict of interest. Sánchez-Ferrer, Carlos F. ...................... Disclosed no confl ict of interest. Sanchez-Infanted, David ...................... Disclosed no confl ict of interest. Sanchez-Lasheras, Carmen .................. Disclosed no confl ict of interest. Sancho Bornez, Veronica ..................... Disclosed no confl ict of interest. Sandbaek, Annelli ................................ Disclosed no confl ict of interest. Sandberg, Monica ................................ Disclosed no confl ict of interest. Sandhu, Sartaj ...................................... Disclosed no confl ict of interest. Sandhu-Minhas, Jasjeet K. .................. Disclosed no confl ict of interest. Sandoval, Sandra ................................. Disclosed no confl ict of interest. Sandoval, Sergio .................................. Disclosed no confl ict of interest. Sands, Arthur ....................................... Board Member: Lexicon Pharmaceuticals, Inc.; Employee:

Lexicon Pharmaceuticals, Inc.; Stock/Shareholder: Lexicon Pharmaceuticals, Inc.

Sandu, Oana ......................................... Disclosed no confl ict of interest. Sango, Kazunori ................................... Disclosed no confl ict of interest. Sankar, Adithya .................................... Disclosed no confl ict of interest. Sankar, Krishana S. .............................. Disclosed no confl ict of interest. Sanke, Tokio ......................................... Disclosed no confl ict of interest. Sanlioglu, Ahter Dilsad ........................ Disclosed no confl ict of interest. anlioglu, Salih ..................................... Disclosed no confl ict of interest. Sano, Hironari ...................................... Disclosed no confl ict of interest. Sano, Yoshiko ....................................... Disclosed no confl ict of interest. Santamaria, Pere .................................. Disclosed no confl ict of interest. Santin, Angela ...................................... Disclosed no confl ict of interest. Santini, Eleonora .................................. Disclosed no confl ict of interest. Santoro, Nicola .................................... Disclosed no confl ict of interest. Santos, Braulio ..................................... Disclosed no confl ict of interest. Santos, Fernando R. ............................. Disclosed no confl ict of interest. Santos, Laila R. .................................... Disclosed no confl ict of interest. Santos, Manoella ................................. Disclosed no confl ict of interest. Sappenfi eld, William ............................ Disclosed no confl ict of interest. Saraiva, Joana ..................................... Disclosed no confl ict of interest. Sarangarajan, Rangaprasad ................. Disclosed no confl ict of interest. Sarangi, Rutuparna .............................. Disclosed no confl ict of interest. Saravanan, Ponnusamy ........................ Disclosed no confl ict of interest. Sardana, Raj ......................................... Disclosed no confl ict of interest. Saremi, Aramesh .................................. Disclosed no confl ict of interest. Sargin, Mehmet ................................... Disclosed no confl ict of interest. Sarin, Antti-Pekka ................................ Disclosed no confl ict of interest. Sarlak, Hakan ....................................... Disclosed no confl ict of interest. Sarma, Aruna ....................................... Disclosed no confl ict of interest. Sarma, P.S. ........................................... Disclosed no confl ict of interest. Sarosiek, Konrad .................................. Disclosed no confl ict of interest. Sartore, Giovanni ................................. Disclosed no confl ict of interest. Sartorelli, Patricia ................................ Disclosed no confl ict of interest. Saruhashi, Tatiana ............................... Disclosed no confl ict of interest. Saryusz-Wolska, Malgorzata ............... Disclosed no confl ict of interest. Sasaki, Hideyuki ................................... Disclosed no confl ict of interest. Sasaki, Hiroyuki .................................... Disclosed no confl ict of interest. Sasaki, Kazuki ...................................... Disclosed no confl ict of interest. Sasaki, Kazuo ....................................... Disclosed no confl ict of interest. Sasaki, Tsutomu ................................... Disclosed no confl ict of interest. Sasaki, Yousuke ................................... Disclosed no confl ict of interest. Sasako, Takayoshi ................................ Disclosed no confl ict of interest. Sathananthan, Airani ........................... Disclosed no confl ict of interest. Sathananthan, Matheni ....................... Disclosed no confl ict of interest. Satin, Leslie .......................................... Disclosed no confl ict of interest. Satish, Basanthi ................................... Disclosed no confl ict of interest. Satman, Ilhan ....................................... Disclosed no confl ict of interest. Sato, Asako .......................................... Disclosed no confl ict of interest. Sato, Daisuke ....................................... Disclosed no confl ict of interest. Sato, Hiroki ........................................... Disclosed no confl ict of interest. Sato, Hiroyuki ....................................... Disclosed no confl ict of interest. Sato, Juichi .......................................... Disclosed no confl ict of interest. Sato, Junko .......................................... Disclosed no confl ict of interest. Sato, Kyoko K. ...................................... Disclosed no confl ict of interest. Sato, Shinji ........................................... Disclosed no confl ict of interest. Sato, Takehito ...................................... Disclosed no confl ict of interest. Sato, Teruko ......................................... Disclosed no confl ict of interest. Sato, Yasunori ...................................... Disclosed no confl ict of interest. Sato, Yuichi .......................................... Disclosed no confl ict of interest.

Dow



A894


AU

THO

R D

ISCL

OSU

RE

Sato, Yuka ............................................ Disclosed no confl ict of interest. Satoh, Hiroaki ....................................... Disclosed no confl ict of interest. Satoh, Kumi .......................................... Disclosed no confl ict of interest. Satoh, Shinobu ..................................... Disclosed no confl ict of interest. Satoh-Asahara, Noriko ......................... Disclosed no confl ict of interest. Sato-Horiguchi, Chikage ...................... Disclosed no confl ict of interest. Satoor, Sarang N. ................................. Disclosed no confl ict of interest. Satra, Ankita ........................................ Disclosed no confl ict of interest. Saudek, Frantisek ................................. Disclosed no confl ict of interest. Sauder, Sue .......................................... Disclosed no confl ict of interest. Sauer, Igor M. ....................................... Disclosed no confl ict of interest. Saul, Nora ............................................ Disclosed no confl ict of interest. Sauliner, Pierre-Jean ............................ Disclosed no confl ict of interest. Saura, Gabriella ................................... Disclosed no confl ict of interest. Sautin, Yuri ........................................... Disclosed no confl ict of interest. Savage, David A. .................................. Disclosed no confl ict of interest. Savastio, Silvia ..................................... Disclosed no confl ict of interest. Saveleva, Svetlana ............................... Disclosed no confl ict of interest. Savin, Katie .......................................... Disclosed no confl ict of interest. Savopoulos, Christos ............................ Disclosed no confl ict of interest. Savu, Anamaria .................................... Disclosed no confl ict of interest. Sawai, Mizuki ....................................... Disclosed no confl ict of interest. Sawaki, Hideaki ................................... Disclosed no confl ict of interest. Saydah, Sharon H. ................................ Disclosed no confl ict of interest. Sayegh, Mohamed H. ........................... Disclosed no confl ict of interest. Sbraccia, Paolo ..................................... Disclosed no confl ict of interest. Scatena, Fabrizio .................................. Disclosed no confl ict of interest. Scavone, Giuseppe ............................... Disclosed no confl ict of interest. Schaaf, Patricia .................................... Disclosed no confl ict of interest. Schaaf, Richard .................................... Disclosed no confl ict of interest. Schaan, Beatriz D. ................................ Disclosed no confl ict of interest. Schaart, Gert ........................................ Disclosed no confl ict of interest. Schachner, Holly C. .............................. Employee: Bayer Health Care, LLC Schade, David S. .................................. Disclosed no confl ict of interest. Schafer, Gerald L. ................................. Disclosed no confl ict of interest. Schafers, Stephen J. ............................ Disclosed no confl ict of interest. Schalkwijk, Casper G. .......................... Disclosed no confl ict of interest. Schall, Thomas J. ................................. Board Member: ChemoCentryx; Employee: ChemoCentryx;

Stock/Shareholder: ChemoCentryx Schaller, Hans-Eberhard ....................... Disclosed no confl ict of interest. Schaper, Frank ...................................... Disclosed no confl ict of interest. Schatz, Desmond A. ............................. Disclosed no confl ict of interest. Schauer, Irene E. .................................. Disclosed no confl ict of interest. Schauer, Philip ...................................... Advisory Panel: Ethicon EndoSurgery, Inc.; Research Support:

Ethicon EndoSurgery, Inc. Schaupp, Lukas .................................... Disclosed no confl ict of interest. Schechter, Clyde B. .............................. Disclosed no confl ict of interest. Scheen, Andre ...................................... Disclosed no confl ict of interest. Scheer, Marsel ..................................... Disclosed no confl ict of interest. Scheftner, Douglas A. .......................... Disclosed no confl ict of interest. Scheijen, Jean L. .................................. Disclosed no confl ict of interest. Scheja, Ludger ...................................... Disclosed no confl ict of interest. Scheler, Mika ....................................... Disclosed no confl ict of interest. Scheper, Nikolaus ................................ Disclosed no confl ict of interest. Scherbaum, Werner ............................. Disclosed no confl ict of interest. Scherer, Philipp E. ................................ Disclosed no confl ict of interest. Scherneck, Stephan ............................. Disclosed no confl ict of interest. Schernthaner, Gerit-Holger .................. Disclosed no confl ict of interest. Schernthaner, Guntram ........................ Disclosed no confl ict of interest. Schettini, Marcele ................................ Disclosed no confl ict of interest. Scheurer, Danielle B. ............................ Disclosed no confl ict of interest. Schiavon, Michele ................................ Disclosed no confl ict of interest. Schick, Fritz .......................................... Disclosed no confl ict of interest. Schipper, Christina ............................... Disclosed no confl ict of interest. Schleger, Franziska ............................... Disclosed no confl ict of interest. Schlensak, Matthias ............................ Disclosed no confl ict of interest. Schloegl, Haiko .................................... Disclosed no confl ict of interest. Schloot, Nanette C. .............................. Disclosed no confl ict of interest. Schluckebier, Gerd ............................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Schmelzeisen-Redeker, Guenther ........ Employee: Roche Diagnostics GmbH Schmid, Jasmin .................................... Disclosed no confl ict of interest. Schmid, Marlene .................................. Disclosed no confl ict of interest. Schmidt, Ann Marie ............................. Disclosed no confl ict of interest. Schmidt, Kristen ................................... Disclosed no confl ict of interest. Schmidt, Ronald ................................... Employee: Sanofi Schmidt, Signe ..................................... Disclosed no confl ict of interest. Schmidt, Ulrike ..................................... Disclosed no confl ict of interest. Schmidt, Virginia .................................. Disclosed no confl ict of interest. Schmidttdiel, Julie A. ........................... Disclosed no confl ict of interest. Schmitt, Patricia ................................... Disclosed no confl ict of interest. Schmitz, Carrie ..................................... Disclosed no confl ict of interest.

Schneider, Lindsay ............................... Disclosed no confl ict of interest. Schneider, Michael .............................. Employee: Boehringer Ingelheim Pharma GmbH & Co. KG Schnell, Kerstin .................................... Disclosed no confl ict of interest. Schnell, Oliver ...................................... Speaker’s Bureau: Bayer Health Care, LLC Schnell, Santiago ................................. Disclosed no confl ict of interest. Schnipper, Jeffrey L. ............................ Research Support: Sanofi Schoemaker, Michael ........................... Employee: Roche Diagnostics GmbH Schoiswohl, Gabriele ........................... Disclosed no confl ict of interest. Schoner, Constanze .............................. Disclosed no confl ict of interest. Schram, Miranda T. .............................. Disclosed no confl ict of interest. Schrauwen, Patrick .............................. Disclosed no confl ict of interest. Schreiber, Renata ................................. Disclosed no confl ict of interest. Schreiner, Birgit .................................... Disclosed no confl ict of interest. Schreiner, Pamela J. ............................ Disclosed no confl ict of interest. Schubert, Markus ................................. Disclosed no confl ict of interest. Schuck, Sarah ....................................... Disclosed no confl ict of interest. Schuler, Kathryn L. ............................... Disclosed no confl ict of interest. Schulman, Kathleen ............................. Disclosed no confl ict of interest. Schultes, Bernd .................................... Disclosed no confl ict of interest. Schultz, Alan T. ..................................... Disclosed no confl ict of interest. Schultz, James ..................................... Disclosed no confl ict of interest. Schultz, Ninna S. .................................. Disclosed no confl ict of interest. Schulz, Eberhard ................................... Disclosed no confl ict of interest. Schulz, Tim J. ....................................... Disclosed no confl ict of interest. Schumann, Beatrix ............................... Disclosed no confl ict of interest. Schumm-Draeger, Petra-Maria ............ Advisory Panel: Eli Lilly and Company, Novo Nordisk, Inc.,

Sanofi ; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi

Schürmann, Annette ............................ Disclosed no confl ict of interest. Schurmans, Stephane .......................... Disclosed no confl ict of interest. Schurr, Daniel ....................................... Research Support: Oramed Pharmaceuticals Schuster, Dara ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Schwahn, U. ......................................... Employee: Sanofi Schwartz, Eric A. .................................. Disclosed no confl ict of interest. Schwartz, Frank L. ................................ Research Support: Medtronic MiniMed, Inc. Schwartz, Michael W. .......................... Disclosed no confl ict of interest. Schwarz, Jean-Marc ............................ Disclosed no confl ict of interest. Schwarz, Peter E. ................................. Disclosed no confl ict of interest. Schweiger, Chaya ................................. Disclosed no confl ict of interest. Schweitzer, George G. .......................... Disclosed no confl ict of interest. Schweitzer, Jamie I. ............................. Disclosed no confl ict of interest. Schweitzer, Matthias A. ....................... Employee: Roche Diagnostics GmbH Schweizer, Anja .................................... Employee: Novartis Pharma AG; Stock/Shareholder: Novartis

Pharma AG Schwenk, Robert W. ............................. Disclosed no confl ict of interest. Schwenke, Dawn C. ............................. Disclosed no confl ict of interest. Schwiep, Frances ................................. Disclosed no confl ict of interest. Scism-Bacon, Jamie ............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Scoggins, John ..................................... Disclosed no confl ict of interest. Scolaro, Laura ...................................... Disclosed no confl ict of interest. Sconocchia, Giuseppe .......................... Disclosed no confl ict of interest. Scorsone, Alessandro .......................... Disclosed no confl ict of interest. Scott, Nancy L. ..................................... Disclosed no confl ict of interest. Scott, William M. ................................. Disclosed no confl ict of interest. Scranton, Richard E. ............................. Employee: VeroScience Seah, Darren ........................................ Disclosed no confl ict of interest. Seale, Patrick ....................................... Disclosed no confl ict of interest. Seaquist, Elizabeth ............................... Disclosed no confl ict of interest. Seay, Howard R. ................................... Disclosed no confl ict of interest. Seborg, Dale E. ..................................... Research Support: NIH Secchi, Antonio .................................... Disclosed no confl ict of interest. Seck, Thomas ....................................... Employee: Boehringer Ingelheim GmbH & Co. KG Seeger, John D. .................................... Research Support: Eli Lilly and Company Seelaender, Marilia .............................. Disclosed no confl ict of interest. Seewaldt-Becker, Elke ......................... Employee: Boehringer Ingelheim GmbH & Co. KG Segal, Alissa R. .................................... Disclosed no confl ict of interest. Segal, Mark S. ...................................... Disclosed no confl ict of interest. Seganfreddo, Elena .............................. Disclosed no confl ict of interest. Seggelke, Stacey .................................. Disclosed no confl ict of interest. Seghieri, Giuseppe ............................... Disclosed no confl ict of interest. Seghieri, Marta .................................... Disclosed no confl ict of interest. Segundo, Carmen ................................. Disclosed no confl ict of interest. Sehgal, Amrita ..................................... Disclosed no confl ict of interest. Seid, Michael ....................................... Disclosed no confl ict of interest. Seidah, Nabil G. ................................... Disclosed no confl ict of interest. Seidman, Daniel ................................... Disclosed no confl ict of interest. Seielstad, Mark .................................... Disclosed no confl ict of interest. Seino, Yusuke ....................................... Disclosed no confl ict of interest. Seino, Yutaka ....................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Eli Lilly and Company, GlaxoSmithKline, Johnson & John-

Dow



A895


AU

THO

R D

ISCL

OSU

RE

son, Novo Nordisk A/S, Otsuka Pharmaceutical Group, Sanofi , Taisho, Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi , Taisho, Takeda Pharmaceutical Company, Ltd.

Seissler, Jochen ................................... Disclosed no confl ict of interest. Sejling, Anne-Sophie ........................... Research Support: HypoSafe A/S Sekhar, Rajagopal V. ............................. Disclosed no confl ict of interest. Sekine, Osamu ..................................... Disclosed no confl ict of interest. Selck, Claudia ....................................... Disclosed no confl ict of interest. Selen, Daryl J. ...................................... Disclosed no confl ict of interest. Seley, Jane Jeffrie ............................... Disclosed no confl ict of interest. Sell, Henrike ......................................... Disclosed no confl ict of interest. Sell, Simone ......................................... Employee: Noxxon Sellers, Elizabeth A. ............................. Disclosed no confl ict of interest. Seltmann, Anne-Cathrin ....................... Disclosed no confl ict of interest. Selvarajah, Dinesh ............................... Disclosed no confl ict of interest. Selvin, Elizabeth ................................... Disclosed no confl ict of interest. Semenza, Gregg L. ............................... Disclosed no confl ict of interest. Sen Gupta, Piya .................................... Disclosed no confl ict of interest. Sen, Sabyasachi ................................... Disclosed no confl ict of interest. Senda, Satoko ...................................... Disclosed no confl ict of interest. Sener, Irfan ........................................... Disclosed no confl ict of interest. Sener, Selcuk Y. .................................... Disclosed no confl ict of interest. Senior, Peter A. .................................... Advisory Panel: Bayer Health Care, LLC, Eli Lilly and Company,

Medtronic, Novo Nordisk A/S; Other Relationship: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk A/S, Sanofi

Senmaru, Takafumi .............................. Disclosed no confl ict of interest. Senoo, Akira ......................................... Disclosed no confl ict of interest. Senthilselvan, A ................................... Disclosed no confl ict of interest. Seo, Chiaki ........................................... Disclosed no confl ict of interest. Seo, Dongju .......................................... Disclosed no confl ict of interest. Seo, Hyun-Ae ....................................... Disclosed no confl ict of interest. Seo, Ji A. .............................................. Disclosed no confl ict of interest. Seok, Hannah ....................................... Disclosed no confl ict of interest. Seok, Su Jin ......................................... Disclosed no confl ict of interest. Séquaris, Gilles .................................... Disclosed no confl ict of interest. Sequeira, Paola A. ................................ Research Support: Sanofi Serafi nceanu, Cristian .......................... Disclosed no confl ict of interest. Seraglia, Roberta ................................. Disclosed no confl ict of interest. Serb, Liviu ............................................. Disclosed no confl ict of interest. Sereika, Susan M. ................................ Disclosed no confl ict of interest. Serlie, Mireille J. ................................. Disclosed no confl ict of interest. Sermer, Mathew .................................. Disclosed no confl ict of interest. Serné, Erik H. ........................................ Disclosed no confl ict of interest. Serre, David .......................................... Disclosed no confl ict of interest. Sert, Caroline ....................................... Employee: Novo Nordisk A/S Sertié, Rogério A. ................................. Disclosed no confl ict of interest. Seshiah, Veeraswamy .......................... Consultant: Boehringer Ingelheim GmbH & Co. KG Sessa, Fausto ....................................... Disclosed no confl ict of interest. Sethi, Bipin ........................................... Consultant: Sanofi Seufert, Jochen .................................... Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Bayer

Health Care, LLC, Berlin Chemie AG, Eli Lilly and Com-pany, Ipsen, Janssen Biotech, Inc., Lifescan Inc, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Cor-poration, Novo Nordisk A/S, Pfi zer, Inc., Roche Pharma-ceuticals, Sanofi , Takeda Pharmaceutical Company, Ltd.; Research Support: Ipsen, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Pfi zer, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: AstraZeneca/Bristol-Meyers Squibb, Bayer Health Care, LLC, Berlin Chemie AG, Eli Lilly and Company, Ipsen, Jans-sen Pharmaceuticals, Lifescan, Inc., Merck, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Pfi zer, Inc., Roche Pharmaceuticals, Sanofi , Takeda Pharmaceutical Company, Ltd.

Severo, Mateus D. ............................... Disclosed no confl ict of interest. Seyoum, Berhane ................................. Disclosed no confl ict of interest. Sezaki, Kazunori ................................... Disclosed no confl ict of interest. Sha, Jin ................................................ Disclosed no confl ict of interest. Sha, Sue ............................................... Employee: Janssen Research & Development Shackleford, Angela M. ....................... Disclosed no confl ict of interest. Shafi q, Umber ....................................... Disclosed no confl ict of interest. Shaginian, Rimma ................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Shah, Amil ............................................ Disclosed no confl ict of interest. Shah, Amy S. ........................................ Disclosed no confl ict of interest. Shah, Arti ............................................. Disclosed no confl ict of interest.

Shah, Asha N. ...................................... Disclosed no confl ict of interest. Shah, Avni ............................................ Disclosed no confl ict of interest. Shah, Baiju R. ....................................... Disclosed no confl ict of interest. Shah, Bhavik P. ..................................... Disclosed no confl ict of interest. Shah, H. ................................................ Disclosed no confl ict of interest. Shah, Hetal S. ...................................... Disclosed no confl ict of interest. Shah, Jayendra H. ................................ Disclosed no confl ict of interest. Shah, Maitreyee ................................... Disclosed no confl ict of interest. Shah, Meera ......................................... Disclosed no confl ict of interest. Shah, Nilay D. ...................................... Disclosed no confl ict of interest. Shah, Nina ............................................ Disclosed no confl ict of interest. Shah, Payal S. ...................................... Disclosed no confl ict of interest. Shah, Rachana ..................................... Disclosed no confl ict of interest. Shah, Rajiv ........................................... Employee: Medtronic Shah, Ramila ........................................ Disclosed no confl ict of interest. Shah, Shreepal ..................................... Disclosed no confl ict of interest. Shah, Siddharth N. ............................... Advisory Panel: Novo Nordisk A/S Shaheen, Zach ...................................... Disclosed no confl ict of interest. Shahzad, Fatima G. .............................. Disclosed no confl ict of interest. Shaibi, Gabriel Q. ................................. Disclosed no confl ict of interest. Shaikh, Ayesha ..................................... Disclosed no confl ict of interest. Shakher, Jayadave ............................... Disclosed no confl ict of interest. Shaltout, Inass ..................................... Advisory Panel: Novartis Pharma AG Shamblott, Michael .............................. Disclosed no confl ict of interest. Shamiss, Ari ......................................... Disclosed no confl ict of interest. Shamkhalova, Minara .......................... Disclosed no confl ict of interest. Shamsuri, Nur Hidayah ........................ Disclosed no confl ict of interest. Shan, Kevin .......................................... Employee: Amylin Pharmaceuticals, LLC Shan, Zhilei .......................................... Disclosed no confl ict of interest. Shan, Zhongyan .................................... Disclosed no confl ict of interest. Shanahan, William R. .......................... Employee: Arena Pharmaceuticals, Inc.; Stock/Shareholder:

Arena Pharmaceuticals, Inc. Shang, Deya ......................................... Disclosed no confl ict of interest. Shankar, Anoop .................................... Disclosed no confl ict of interest. Shankar, Arun ....................................... Disclosed no confl ict of interest. Shankar, R. Ravi ................................... Employee: Merck Sharp & Dohme Limited, Merck Sharp &

Dohme Limited (Spouse/Partner) Shankar, Sudha S. ................................ Employee: Merck Sharp & Dohme Limited, Merck Sharp &

Dohme Limited (Spouse/Partner) Shanmugham, Prashanth ..................... Disclosed no confl ict of interest. Shanmugham, Satya ............................ Disclosed no confl ict of interest. Shannon, Richard P. .............................. Disclosed no confl ict of interest. Shanthi Rani, Coimbatore Subramaniam .. Disclosed no confl ict of interest. Shan-ying, Liu ....................................... Disclosed no confl ict of interest. Shao, Chun Hong .................................. Disclosed no confl ict of interest. Shao, Linlin ........................................... Disclosed no confl ict of interest. Shao, Shiying ....................................... Disclosed no confl ict of interest. Shao, Weijuan ...................................... Disclosed no confl ict of interest. Shapiro, James .................................... Disclosed no confl ict of interest. Shapiro, Jerry ....................................... Disclosed no confl ict of interest. Shapiro, Sheree .................................... Disclosed no confl ict of interest. Shara, Nawar ....................................... Disclosed no confl ict of interest. Sharkey, John ....................................... Disclosed no confl ict of interest. Sharma, Andrea ................................... Disclosed no confl ict of interest. Sharma, Hari ........................................ Consultant: Daiichi-Sankyo, Inc. Sharma, Mukti ...................................... Disclosed no confl ict of interest. Sharma, Neeraj K. ................................ Disclosed no confl ict of interest. Sharma, Rohit ....................................... Disclosed no confl ict of interest. Sharp, Mark .......................................... Disclosed no confl ict of interest. Shatskaya, Olga ................................... Research Support: Novo Nordisk A/S Shaw, James ........................................ Disclosed no confl ict of interest. Shaw, Jonathan E. ............................... Disclosed no confl ict of interest. Shaw, Wayne ....................................... Employee: Janssen Research & Development Shay, Christina M. ................................ Disclosed no confl ict of interest. Shayani, Steven ................................... Disclosed no confl ict of interest. Shea, Jacqueline .................................. Disclosed no confl ict of interest. Shearer, Jane ....................................... Disclosed no confl ict of interest. Sheetz, Matthew J. .............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Sheffi eld, Val C. .................................... Disclosed no confl ict of interest. Shehab, Nadine .................................... Disclosed no confl ict of interest. Shehadeh, Naim ................................... Advisory Panel: Eli Lilly and Company, Merck Sharp & Dohme

Limited, Novo Nordisk, Inc., Sanofi ; Research Support: Novo Nordisk, Inc.; Speaker’s Bureau: Eli Lilly and Com-pany, Merck Sharp & Dohme Limited, Novo Nordisk, Inc., Sanofi

Sheiner, Eyal ......................................... Disclosed no confl ict of interest. Shen, Bern ............................................ Stock/Shareholder: HealthCrowd Shen, Biing-Jiun ................................... Disclosed no confl ict of interest. Shen, Dongqian .................................... Disclosed no confl ict of interest. Shen, Hong ........................................... Disclosed no confl ict of interest. Shen, Jianguo ...................................... Disclosed no confl ict of interest.

Dow



A896


AU

THO

R D

ISCL

OSU

RE

Shen, Jie .............................................. Disclosed no confl ict of interest. Shen, Jing ............................................ Disclosed no confl ict of interest. Shen, Jingshi ........................................ Disclosed no confl ict of interest. Shen, Larry ........................................... Employee: Amylin Pharmaceuticals, LLC Shen, Shanmei ..................................... Disclosed no confl ict of interest. Shen, Xiaolan ....................................... Employee: Merck Shen, You-Tang .................................... Disclosed no confl ict of interest. Shen, Yunfeng ...................................... Disclosed no confl ict of interest. Sheng, Chunjun .................................... Disclosed no confl ict of interest. Sheng, Hui ............................................ Disclosed no confl ict of interest. Sheng, Liang ......................................... Disclosed no confl ict of interest. Shentu, Yue .......................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Shepard, Jaclyn .................................... Disclosed no confl ict of interest. Shepherd, John A. ................................ Disclosed no confl ict of interest. Sheriff, Helen ....................................... Disclosed no confl ict of interest. Sherman, Arthur ................................... Disclosed no confl ict of interest. Sherr, Jennifer ...................................... Research Support: Medtronic MiniMed, Inc. Sherwin, Robert S. ............................... Consultant: Amylin Pharmaceuticals, Inc., Bristol-Myers

Squibb Company, CureDM, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Johnson & Johnson, MannKind Corporation, McKinsey & Company, Merck, Novartis Phar-maceuticals Corporation, Pfi zer, Inc.; Stock/Shareholder: Insulet Corporation

Sherwood, Nancy E. ............................. Disclosed no confl ict of interest. Shestakova, Marina ............................. Consultant: Merck, Novartis, Novo Nordisk AS; Speaker’s

Bureau: Merck, Novartis, Novo Nordisk AS Shetty, Raman V. .................................. Employee: Novo Nordisk India Private Limited Sheu, Wayne H. ................................... Advisory Panel: Novo Nordisk, Inc.MSD; Speaker’s Bureau:

Bayer Sheu, Yahtyng ...................................... Disclosed no confl ict of interest. Shi, Juan .............................................. Disclosed no confl ict of interest. Shi, Lintao ............................................ Disclosed no confl ict of interest. Shi, Lizheng .......................................... Research Support: Bristol-Myers Squibb Company Shi, Qian ............................................... Disclosed no confl ict of interest. Shi, Wentao ......................................... Disclosed no confl ict of interest. Shi, Xialian ........................................... Disclosed no confl ict of interest. Shi, Yun ................................................ Disclosed no confl ict of interest. Shiau, Ming-Yuh ................................... Disclosed no confl ict of interest. Shiba, Teruo ......................................... Disclosed no confl ict of interest. Shibata, Hiroshi .................................... Disclosed no confl ict of interest. Shibata, Tomohito ................................ Disclosed no confl ict of interest. Shibue, Kimitaka .................................. Disclosed no confl ict of interest. Shibuya, Kenji ...................................... Disclosed no confl ict of interest. Shichiri, Masayoshi .............................. Disclosed no confl ict of interest. Shida, Cláudio S. .................................. Disclosed no confl ict of interest. Shidham, Shubhangi G. ........................ Disclosed no confl ict of interest. Shields, Adele ...................................... Disclosed no confl ict of interest. Shigemoto, Satomi ............................... Disclosed no confl ict of interest. Shigeta, Masayuki ............................... Disclosed no confl ict of interest. Shikama, Yosuke .................................. Disclosed no confl ict of interest. Shimabukuro, Michio ........................... Disclosed no confl ict of interest. Shimano, Hitoshi .................................. Disclosed no confl ict of interest. Shimatsu, Akira .................................... Disclosed no confl ict of interest. Shimizu, Hiroyuki .................................. Disclosed no confl ict of interest. Shimizu, Tomoaki ................................. Speaker’s Bureau: Astellas Pharma US, Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuti-cals, Inc., Eli Lilly and Company, Kissei Pharmaceutical Co., Ltd., Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd.

Shimizu, Yuuki ...................................... Disclosed no confl ict of interest. Shimoda, Masashi ............................... Disclosed no confl ict of interest. Shimoda, Seiya .................................... Disclosed no confl ict of interest. Shimohiro, Hisashi ............................... Disclosed no confl ict of interest. Shimomaeda, Kevin ............................. Disclosed no confl ict of interest. Shimomaeda, Lisa ................................ Disclosed no confl ict of interest. Shimomura, Hiroaki .............................. Disclosed no confl ict of interest. Shimomura, Iichiro ............................... Disclosed no confl ict of interest. Shimony, Joshua .................................. Disclosed no confl ict of interest. Shimoyama, Kimie ............................... Disclosed no confl ict of interest. Shimoyama, Mary ................................ Disclosed no confl ict of interest. Shimpuku, Mayumi .............................. Disclosed no confl ict of interest. Shimura, Kanako .................................. Disclosed no confl ict of interest. Shin, Chang-Sung ................................. Disclosed no confl ict of interest. Shin, Chol ............................................. Disclosed no confl ict of interest. Shin, Jang Yel ...................................... Disclosed no confl ict of interest. Shin, Jeong Ah ..................................... Disclosed no confl ict of interest. Shin, John ............................................ Employee: Medtronic Shin, Sanghoon .................................... Disclosed no confl ict of interest. Shin, Sehyun ........................................ Disclosed no confl ict of interest. Shin, Shyi J. ......................................... Disclosed no confl ict of interest.

Shin, Yu-Kyong ..................................... Disclosed no confl ict of interest. Shinde, S. ............................................. Disclosed no confl ict of interest. Shinjyo, Takamichi ............................... Disclosed no confl ict of interest. Shinoda, Junji ...................................... Disclosed no confl ict of interest. Shiochi, Hideki ..................................... Disclosed no confl ict of interest. Shioshita, Gerald .................................. Employee: Janssen Research & Development Shiota, Chiyo ........................................ Disclosed no confl ict of interest. Shiota, Masakazu ................................. Research Support: Pfi zer, Inc. Shirai, Kohji .......................................... Disclosed no confl ict of interest. Shirakawa, Jun .................................... Disclosed no confl ict of interest. Shisheva, Assia .................................... Disclosed no confl ict of interest. Shiu, S.W.M. ........................................ Disclosed no confl ict of interest. Shlyakhto, Evgenya V. .......................... Disclosed no confl ict of interest. Shockley, Travis .................................... Disclosed no confl ict of interest. Shoelson, Steven E. ............................. Disclosed no confl ict of interest. Shoemaker, Kevin J. ............................. Disclosed no confl ict of interest. Shojaee-Moradie, Fariba ..................... Disclosed no confl ict of interest. Shoji, Shigeichi .................................... Disclosed no confl ict of interest. Shoji, Tetsuo ......................................... Disclosed no confl ict of interest. Shore, Jay H. ........................................ Disclosed no confl ict of interest. Shrank, William H. ............................... Research Support: Eli Lilly and Company Shrestha, Deepika ................................ Disclosed no confl ict of interest. Shrestha, Sundar S. ............................. Disclosed no confl ict of interest. Shroyer, Noah F. ................................... Disclosed no confl ict of interest. Shu, Chen ............................................. Disclosed no confl ict of interest. Shu, David H. ........................................ Advisory Panel: Amgen, Inc., Boehringer Ingelheim Pharma-

ceuticals, Inc., Eli Lilly and Company; Other Relationship: Merck, Novartis Pharmaceuticals Corporation; Research Support: Novo Nordisk A/S; Speaker’s Bureau: Amgen, Inc., Amgen, Inc. (Spouse/Partner), Animas Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk A/S, Sanofi , Takeda Pharmaceuti-cal Company, Ltd. (Spouse/Partner)

Shu, Hua ............................................... Disclosed no confl ict of interest. Shu, Jiong ............................................ Disclosed no confl ict of interest. Shubrook, Jay H. .................................. Research Support: Medtronic MiniMed, Inc., Sanofi Shuldiner, Alan R. ................................. Disclosed no confl ict of interest. Shulman, Gerald I. ................................ Disclosed no confl ict of interest. Shum, Kenny ........................................ Consultant: Janssen Scientifi c Affairs, LLC, Novartis Pharma-

ceuticals Corporation, Orexigen Therapeutics, Inc., Roche Pharmaceuticals

Shungin, Dmitry .................................... Disclosed no confl ict of interest. Shurzinske, Linda ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company, Pfi zer, Inc. Siaw, Melanie ...................................... Disclosed no confl ict of interest. Sibomana, Laurien ............................... Disclosed no confl ict of interest. Siddiqi, Ferhan ..................................... Disclosed no confl ict of interest. Sidney, Stephen ................................... Disclosed no confl ict of interest. Sieber, Jochen ...................................... Employee: Sanofi Siegel-Axel, Dorothea I. ....................... Disclosed no confl ict of interest. Siegmund, Thorsten ............................. Advisory Panel: Eli Lilly and Company, Novo Nordisk, Inc.,

Sanofi ; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk, Inc., Sanofi

Siewko, Katarzyna ................................ Disclosed no confl ict of interest. Siffel, Csaba ......................................... Disclosed no confl ict of interest. Sigal, Ronald J. .................................... Disclosed no confl ict of interest. Silbermann, Laura ................................ Disclosed no confl ict of interest. Silecchia, Gianfranco ........................... Disclosed no confl ict of interest. Sill, Jordan ........................................... Disclosed no confl ict of interest. Silva, Camilo ........................................ Disclosed no confl ict of interest. Silva, Flávia M. ..................................... Disclosed no confl ict of interest. Silva, Frances ....................................... Disclosed no confl ict of interest. Silva, Pamuditha N. .............................. Disclosed no confl ict of interest. Silva, Paolo A. ...................................... Research Support: Optos Silva, Pedro M. ..................................... Disclosed no confl ict of interest. Silver, Kristi .......................................... Disclosed no confl ict of interest. Silver, Lynn D. ....................................... Disclosed no confl ict of interest. Silverstein, Janet ................................. Research Support: Daiichi-Sankyo, Inc., Novo Nordisk, Inc. Sim, Xueling ......................................... Disclosed no confl ict of interest. Simeonov, Anton .................................. Disclosed no confl ict of interest. Siminerio, Linda M. .............................. Research Support: Sanofi Simionato, Dulcinéia ............................ Disclosed no confl ict of interest. Simmons, David ................................... Advisory Panel: Novo Nordisk, Inc.; Speaker’s Bureau: Bristol-

Myers Squibb Company Simmons, Debra ................................... Disclosed no confl ict of interest. Simmons, Elizabeth B. .......................... Employee: Cardinal Health (Spouse/Partner) Simmons, Jeffrey D. ............................. Disclosed no confl ict of interest. Simmons, Jill H. ................................... Disclosed no confl ict of interest. Simmons, Rebecca A. .......................... Disclosed no confl ict of interest. Simó, Rafael ......................................... Disclosed no confl ict of interest. Simon, Celeste ..................................... Disclosed no confl ict of interest. Simonds, Amanda ................................ Employee: Novo Nordisk A/S

Dow



A897


AU

THO

R D

ISCL

OSU

RE

Simonson, Donald C. ............................ Disclosed no confl ict of interest. Simpson, Daniel ................................... Consultant: Novo Nordisk A/S Simpson, Peter ..................................... Employee: Dexcom, Inc. Simpson, Pippa ..................................... Disclosed no confl ict of interest. Simpson, Ronda ................................... Disclosed no confl ict of interest. Simpson, Scot H. .................................. Disclosed no confl ict of interest. Sims, Emily K. ....................................... Disclosed no confl ict of interest. Sims, Shannon A. ................................. Disclosed no confl ict of interest. Sims-Robinson, Catrina ........................ Disclosed no confl ict of interest. Sinaiko, Alan R. .................................... Disclosed no confl ict of interest. Sinclair, David A. .................................. Disclosed no confl ict of interest. Singh, Ajaypal ...................................... Disclosed no confl ict of interest. Singh, Balraj ......................................... Disclosed no confl ict of interest. Singh, Devendra P. ............................... Disclosed no confl ict of interest. Singh, Gurkirpal .................................... Research Support: Takeda Pharmaceutical Company, Ltd. Singh, Harsimran .................................. Disclosed no confl ict of interest. Singh, Jay P. ......................................... Disclosed no confl ict of interest. Singh, Sandeep .................................... Disclosed no confl ict of interest. Singh, Vikesh K. ................................... Disclosed no confl ict of interest. Singhal, Sangeeta ................................ Disclosed no confl ict of interest. Singham, Stephanie ............................. Disclosed no confl ict of interest. Singhvi, Ajay ........................................ Disclosed no confl ict of interest. Sinha, Anushua .................................... Disclosed no confl ict of interest. Sinha, Kundan ...................................... Disclosed no confl ict of interest. Sinha, Manasi ...................................... Disclosed no confl ict of interest. Sinha, Naina ......................................... Disclosed no confl ict of interest. Sinha, Rajita ......................................... Disclosed no confl ict of interest. Sinha, Vikram P. .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Sinha-Hikim, Amiya P. .......................... Disclosed no confl ict of interest. Sinha-Hikim, Indrani ............................. Disclosed no confl ict of interest. Sinnott, Margaret ................................. Disclosed no confl ict of interest. Sippl, Rachel M. ................................... Disclosed no confl ict of interest. Siraj, Elias S. ........................................ Advisory Panel: Sanofi; Consultant: Corcept; Speaker’s

Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Merck

Siscovick, David ................................... Disclosed no confl ict of interest. Sissoko, Aicha ...................................... Disclosed no confl ict of interest. Sissoko, Henriette ................................ Disclosed no confl ict of interest. Sisson, Stephen ................................... Disclosed no confl ict of interest. Sitnick, Mitch T. ................................... Disclosed no confl ict of interest. Sittadjody, Sivanandane ...................... Disclosed no confl ict of interest. Sivakumar, Kavitha ............................... Disclosed no confl ict of interest. Sivitz, William I. ................................... Research Support: GlaxoSmithKline Sjögren, Lovisa ..................................... Disclosed no confl ict of interest. Skallos, Patracia ................................... Disclosed no confl ict of interest. Skare, Sharon ....................................... Employee: Elcelyx Therapeutics, Inc. Skärstrand, Hanna ................................ Disclosed no confl ict of interest. Skarulis, Monica .................................. Disclosed no confl ict of interest. Skinner, Sandra S. ................................ Disclosed no confl ict of interest. Skorodok, Julia ..................................... Disclosed no confl ict of interest. Skoutas, Dimitrios ................................ Disclosed no confl ict of interest. Skov, Jeppe .......................................... Employee: Novo Nordisk A/S Skovlund, Soren Eik .............................. Employee: Novo Nordisk A/S Skowron, Monika ................................. Disclosed no confl ict of interest. Skrepnek, Grant H. ............................... Disclosed no confl ict of interest. Skrha, Jan ............................................ Advisory Panel: Eli Lilly and Company, Novo Nordisk, Inc. Skrivanek, Zachary ............................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Skrobek, Boris ...................................... Disclosed no confl ict of interest. Skupien, Jan ......................................... Disclosed no confl ict of interest. Skyggebjerg, Ole .................................. Disclosed no confl ict of interest. Skyler, Jay ............................................ Advisory Panel: BD Medical Diabetes Care, Cebix, Inc., Gilead

Sciences, Inc., Ideal Life, Merck, Sanofi , Takeda Pharma-ceutical Company, Ltd., Valeritas, LLC; Board Member: Dexcom, Inc., Moerae Matrix, Inc.; Research Support: Bayhill Therapeutics, Inc., Halozyme Therapeutics, Osiris Therapeutics, Inc.

Skytt, Dorte .......................................... Disclosed no confl ict of interest. Slabaugh, S. Lane ................................ Research Support: Novo Nordisk, Inc. Slabu, Hannah ...................................... Disclosed no confl ict of interest. Slentz, Cris A. ....................................... Disclosed no confl ict of interest. Slentz, Dorothy ..................................... Disclosed no confl ict of interest. Sletner, Line ......................................... Disclosed no confl ict of interest. Sliwinska, Agnieszka ........................... Disclosed no confl ict of interest. Sliwka, Ireneusz ................................... Disclosed no confl ict of interest. Slover, Robert ....................................... Research Support: Medtronic Sluimer, Judith ..................................... Disclosed no confl ict of interest. Sluss, Patrick ........................................ Disclosed no confl ict of interest. Slyne, Christine .................................... Disclosed no confl ict of interest. Smagala, Agnes ................................... Disclosed no confl ict of interest. Smart, Carmel E. .................................. Disclosed no confl ict of interest.

Smeeding, Jim E. ................................. Consultant: Genentech Smiles, Adam M. .................................. Disclosed no confl ict of interest. Smiley, Dawn ....................................... Research Support: Merck, Sanofi Smillie, Sarah J. ................................... Disclosed no conflict of interest. Smiris, Konstantinos ............................ Disclosed no confl ict of interest. Smith, Allan .......................................... Disclosed no confl ict of interest. Smith, Andrea L. ................................... Disclosed no confl ict of interest. Smith, Carin Y. ...................................... Research Support: Abbott Laboratories, Inc. Smith, Cody .......................................... Disclosed no confl ict of interest. Smith, Dave M. .................................... Employee: AstraZeneca Pharmaceuticals LP, AstraZeneca/

Bristol-Meyers Squibb Smith, Diarmuid ................................... Disclosed no confl ict of interest. Smith, Eric ............................................ Disclosed no confl ict of interest. Smith, Jacquelyn M. ............................ Disclosed no confl ict of interest. Smith, Jennifer R. ................................ Disclosed no confl ict of interest. Smith, Jessica ...................................... Disclosed no confl ict of interest. Smith, Leanne ...................................... Disclosed no confl ict of interest. Smith, Lewis ......................................... Disclosed no confl ict of interest. Smith, Marta S. .................................... Disclosed no confl ict of interest. Smith, Melinda ..................................... Employee: Lexicon Pharmaceuticals, Inc. Smith, Nicholas L. ................................ Disclosed no confl ict of interest. Smith, Richard ...................................... Disclosed no confl ict of interest. Smith, Steven A. .................................. Disclosed no confl ict of interest. Smith, Steven R. ................................... Consultant: Arena Pharmaceuticals, Inc. Smith, Susan Y. .................................... Disclosed no confl ict of interest. Smulders, Yvo M. ................................. Disclosed no confl ict of interest. Smyth, Joshua M. ................................ Disclosed no confl ict of interest. Snell, Helen J. ...................................... Disclosed no confl ict of interest. Snell-Bergeon, Janet K. ....................... Disclosed no confl ict of interest. Snider, Julia ......................................... Employee: Precision Health Economics Snider, Kara .......................................... Disclosed no confl ict of interest. Snijder, Marieke ................................... Disclosed no confl ict of interest. Snoek, Frank J. ..................................... Advisory Panel: Eli Lilly and Company, Roche Pharmaceuticals;

Research Support: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Lifescan Animas, Inc., Nordic Biosci-ence A/S

Snow, Jennifer ..................................... Disclosed no confl ict of interest. Snow, Kenneth ..................................... Employee: NeuroMetrix; Stock/Shareholder: NeuroMetrix Snyder, Caryn A. ................................... Employee: DiabetOmics So, Wing-Yee ....................................... Disclosed no confl ict of interest. Sobel, Jack ........................................... Consultant: Janssen Sobieraj, Diana M. ............................... Disclosed no confl ict of interest. Soda, Satoshi ....................................... Disclosed no confl ict of interest. Soejima, Eri .......................................... Disclosed no confl ict of interest. Soenen, Stijn ........................................ Disclosed no confl ict of interest. Soewondo, Pradana ............................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer

Ingelheim Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation; Board Member: Novo Nordisk A/S, Sanofi

Sofer, Sigal ........................................... Disclosed no confl ict of interest. Sohler, Nancy ....................................... Disclosed no confl ict of interest. Sohn, Tae Seo ...................................... Disclosed no confl ict of interest. Sojka, Sandra ....................................... Disclosed no confl ict of interest. Sola-Morales, Oriol .............................. Disclosed no confl ict of interest. Solano, Francis ..................................... Stock/Shareholder: Amgen, Inc., Johnson & Johnson Solberg Woods, Leah C. ....................... Disclosed no confl ict of interest. Soldatos, Georgia ................................. Disclosed no confl ict of interest. Soldatova, Tat’yana .............................. Disclosed no confl ict of interest. Soleymanlou, Nima .............................. Employee: Boehringer Ingelheim GmbH & Co. KG Soliman, Ahmed Z. ............................... Disclosed no confl ict of interest. Solini, Anna .......................................... Board Member: Boehringer Ingelheim Pharmaceuticals, Inc.,

Bristol-Myers Squibb/AstraZeneca; Research Support: Bristol-Myers Squibb/AstraZeneca

Solis-Herrera, Carolina ......................... Disclosed no confl ict of interest. Soliz, Peter ........................................... Employee: VisionQuest Biomedical; Stock/Shareholder:

VisionQuest Biomedical Solomon, Marla C. ............................... Disclosed no confl ict of interest. Solomon, Scott D. ................................ Disclosed no confl ict of interest. Solomon, Thomas P. ............................. Disclosed no confl ict of interest. Somal, Vikram S. .................................. Disclosed no confl ict of interest. Somani, Shrikant S. .............................. Disclosed no confl ict of interest. Somineni, Hari Krishna ........................ Disclosed no confl ict of interest. Sommerfeld, Mark ............................... Employee: Sanofi Son, Dong Ok ........................................ Disclosed no confl ict of interest. Son, Ho Young ...................................... Disclosed no confl ict of interest. Son, Hyun Shik ..................................... Disclosed no confl ict of interest. Son, Jang Won ..................................... Disclosed no confl ict of interest. Son, JeeWoong .................................... Disclosed no confl ict of interest. Søndergaard, Esben ............................. Disclosed no confl ict of interest. Sone, Hirohito ...................................... Disclosed no confl ict of interest. Soneja, Hemi ........................................ Disclosed no confl ict of interest. Song, Ci ................................................ Disclosed no confl ict of interest. Song, Fei ............................................... Disclosed no confl ict of interest.

Dow



A898


AU

THO

R D

ISCL

OSU

RE

Song, Gi Ho .......................................... Disclosed no confl ict of interest. Song, Guangyao ................................... Disclosed no confl ict of interest. Song, Jianxiao ...................................... Disclosed no confl ict of interest. Song, Kexiu .......................................... Disclosed no confl ict of interest. Song, Ki-Ho .......................................... Disclosed no confl ict of interest. Song, Min ............................................. Employee: Eli Lilly and Company Song, Qianqian ..................................... Disclosed no confl ict of interest. Song, Sun Ok ........................................ Disclosed no confl ict of interest. Song, Yingxiang ................................... Disclosed no confl ict of interest. Song, Young Duk .................................. Disclosed no confl ict of interest. Song, Yuh-Min ...................................... Disclosed no confl ict of interest. Songer, Thomas J. ................................ Disclosed no confl ict of interest. Sonne, David P. ..................................... Disclosed no confl ict of interest. Sonnweber, Thomas ............................. Disclosed no confl ict of interest. Sono, Yoko ............................................ Disclosed no confl ict of interest. Soon, Danny K. ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Sopher, Heather ................................... Disclosed no confl ict of interest. Soprovich, Allison ................................ Disclosed no confl ict of interest. Sørensen, Anders R. ............................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Sørensen, Henrik T. .............................. Disclosed no confl ict of interest. Sørensen, Lars Peter ............................ Disclosed no confl ict of interest. Sørensen, Thorkild ............................... Disclosed no confl ict of interest. Sorice, Gian Pio .................................... Disclosed no confl ict of interest. Sorisky, Alexander ................................ Disclosed no confl ict of interest. Soroka, Orysya ..................................... Disclosed no confl ict of interest. Sorter, Michael ..................................... Disclosed no confl ict of interest. Sosenko, Jay M. ................................... Disclosed no confl ict of interest. Sosner, Philippe .................................... Disclosed no confl ict of interest. Sost, Mônica ........................................ Disclosed no confl ict of interest. Sotiropoulos, Alexios ........................... Disclosed no confl ict of interest. Soto, Jamie .......................................... Disclosed no confl ict of interest. Soukhatcheva, Galina .......................... Disclosed no confl ict of interest. Soupal, Jan .......................................... Other Relationship: Medtronic; Speaker’s Bureau: Sanofi Sourris, Karly ........................................ Disclosed no confl ict of interest. South, Mark A. ..................................... Disclosed no confl ict of interest. Souza, Heraldo P. .................................. Disclosed no confl ict of interest. Souza, Maria das Graças C. ................. Disclosed no confl ict of interest. Sowers, James R. ................................ Board Member: Merck; Research Support: Takeda Pharmaceu-

tical Company, Ltd. Spadafranca, Angela ............................ Disclosed no confl ict of interest. Spaic, Tamara ....................................... Consultant: Sanofi Spain, C. Victor ..................................... Disclosed no confl ict of interest. Spanakis, Elias ..................................... Disclosed no confl ict of interest. Spandole, Sonia ................................... Disclosed no confl ict of interest. Spano, Lucia ......................................... Disclosed no confl ict of interest. Spanou, Marianna ................................ Disclosed no confl ict of interest. Sparks, Lauren M. ................................ Disclosed no confl ict of interest. Spat, Stephan ....................................... Disclosed no confl ict of interest. Speer, Heather ..................................... Disclosed no confl ict of interest. Speier, Stephan .................................... Disclosed no confl ict of interest. Speight, Jane ....................................... Advisory Panel: Roche Pharmaceuticals; Consultant: Abbott

Diabetes Care, Roche Pharmaceuticals; Other Relation-ship: Medtronic, Sanofi

Spelman, Susan ................................... Disclosed no confl ict of interest. Spence, Jason R. .................................. Disclosed no confl ict of interest. Spencer, Michael ................................. Disclosed no confl ict of interest. Sperl, Bianca ........................................ Disclosed no confl ict of interest. Sperl-Hillen, JoAnn .............................. Board Member: SimCare Health; Research Support: Abbott

Diabetes Care, GlaxoSmithKline Spiegelman, Bruce M. .......................... Disclosed no confl ict of interest. Spinas, Giatgen .................................... Advisory Panel: Eli Lilly and Company, MDS, Inc., Medtronics,

Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Roche Pharmaceuticals, Sanofi ; Research Support: Novo Nordisk A/S; Stock/Shareholder: Roche Pharmaceuticals

Spiro, Kim ............................................. Disclosed no confl ict of interest. Spoonamore, James ............................ Disclosed no confl ict of interest. Sprague, Randy S. ................................ Disclosed no confl ict of interest. Spruijt-Metz, Donna ............................. Disclosed no confl ict of interest. Spyrantis, Andreas ............................... Disclosed no confl ict of interest. Spyridaki, Athina .................................. Disclosed no confl ict of interest. Spyridonidou, Christina ........................ Disclosed no confl ict of interest. Squires, Leah L. .................................... Disclosed no confl ict of interest. Sreenan, Seamus ................................. Disclosed no confl ict of interest. Srestha, Anshu ..................................... Employee: Precision Health Economics Sridhar, Sneha ...................................... Disclosed no confl ict of interest. Srikanth, Velandai ................................ Disclosed no confl ict of interest. Srinivasan, Gayathri ............................. Disclosed no confl ict of interest. Srivastava, Anand K. ............................ Disclosed no confl ict of interest. Srivastava, Shweta .............................. Disclosed no confl ict of interest. St. Clair, Chris ....................................... Disclosed no confl ict of interest.

Stabler, Cherie ...................................... Stock/Shareholder: Converge Biotech, Inc. Stacy, Jane ........................................... Employee: Novo Nordisk, Inc. Stager, William .................................... Employee: Sanofi Ståhl, Fredrik ........................................ Disclosed no confl ict of interest. Stahl, Remick ....................................... Disclosed no confl ict of interest. Stahr, Anna ........................................... Disclosed no confl ict of interest. Staiger, Harald ..................................... Disclosed no confl ict of interest. Staiger, Katrin ...................................... Disclosed no confl ict of interest. Stain, Steven C. .................................... Disclosed no confl ict of interest. Stamateris, Rachel E. ........................... Disclosed no confl ict of interest. Stamm, Paul ......................................... Disclosed no confl ict of interest. Stancampiano, Marianna R. ................ Disclosed no confl ict of interest. Standfi eld, Scott ................................... Disclosed no confl ict of interest. Standiford, Debra A. ............................ Disclosed no confl ict of interest. Stanescu, Diana E. ............................... Disclosed no confl ict of interest. Stanford, Kristin I. ................................ Disclosed no confl ict of interest. Stang, Paul E. ....................................... Employee: Janssen Research & Development; Stock/Share-

holder: Janssen Research & Development Stanhope, Kimber L. ............................. Disclosed no confl ict of interest. Stanley, Ed ............................................ Disclosed no confl ict of interest. Stanojevic, Violeta ............................... Disclosed no confl ict of interest. Stanton, Rachel .................................... Disclosed no confl ict of interest. Stanton, Robert C. ................................ Disclosed no confl ict of interest. Starks, Rachel D. .................................. Disclosed no confl ict of interest. Staten, Myrlene ................................... Disclosed no confl ict of interest. Stathopoulos, Maria ............................ Disclosed no confl ict of interest. Staudte, Ronny ..................................... Disclosed no confl ict of interest. Steck, Andrea K. ................................... Disclosed no confl ict of interest. Steensgaard, Dorte B. .......................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Stefan, Norbert .................................... Disclosed no confl ict of interest. Stefanadis, Christodoulos .................... Disclosed no confl ict of interest. Stefanczyk, Ludomir ............................. Disclosed no confl ict of interest. Stefanovic-Racic, Maja ........................ Disclosed no confl ict of interest. Stefanovski, Darko ............................... Disclosed no confl ict of interest. Stefanowicz, Magdalena ..................... Disclosed no confl ict of interest. Steffen, Amy T. ..................................... Disclosed no confl ict of interest. Steffes, Michael W. ............................. Disclosed no confl ict of interest. Stehouwer, Coen D. ............................. Disclosed no confl ict of interest. Stein, Hayley ........................................ Disclosed no confl ict of interest. Stein, Peter ........................................... Employee: Janssen Research & Development Stein, Roland ........................................ Disclosed no confl ict of interest. Steinbach, Rita ..................................... Disclosed no confl ict of interest. Steinberg, Helmut O. ............................ Employee: Merck Sharp & Dohme Limited Steinberger, Julia ................................. Disclosed no confl ict of interest. Steiner, Donald F. ................................. Disclosed no confl ict of interest. Steiner, Juliane .................................... Disclosed no confl ict of interest. Steinert, Robert E. ................................ Disclosed no confl ict of interest. Stellhorn, Robert .................................. Employee: Janssen Global Services, LLC Stemann-Andersen, Marianne ............. Disclosed no confl ict of interest. Stender, Monika ................................... Disclosed no confl ict of interest. Stengelin, S .......................................... Employee: Sanofi Stenger, Patricia ................................... Employee: Bayer Health Care, LLC Stenkula, Karin ..................................... Disclosed no confl ict of interest. Stenlöf, Kaj ........................................... Disclosed no confl ict of interest. Stentz, Frankie B. ................................. Disclosed no confl ict of interest. Stephen, Thomas M. ............................ Disclosed no confl ict of interest. Stephens, Jacqueline M. ..................... Disclosed no confl ict of interest. Stephens, Jeffrey W. ........................... Disclosed no confl ict of interest. Stephenson, Alan H. ............................ Disclosed no confl ict of interest. St pniewski, Marek .............................. Disclosed no confl ict of interest. Steposz, Arkadiusz ............................... Disclosed no confl ict of interest. Stern, William ...................................... Disclosed no confl ict of interest. Sternfeld, Barbara ................................ Disclosed no confl ict of interest. Sternlof, Steve A. ................................. Disclosed no confl ict of interest. Steven, Sarah ....................................... Disclosed no confl ict of interest. Stevens, Martin J. ................................ Disclosed no confl ict of interest. Stevens, Robert D. ............................... Disclosed no confl ict of interest. Steverson, Dennis ................................ Disclosed no confl ict of interest. Steward, Earl ........................................ Disclosed no confl ict of interest. Stewart, John ....................................... Employee: Sanofi , Canada Stewart, Murray ................................... Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

Kline Stichert, Monika ................................... Disclosed no confl ict of interest. Stidsen, Jacob V. .................................. Disclosed no confl ict of interest. Stirban, Alin ......................................... Disclosed no confl ict of interest. Stoch, S. Aubrey ................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Stoecklein, Katrin ................................. Disclosed no confl ict of interest. Stoehr, Oliver ........................................ Disclosed no confl ict of interest. Stoehr, Robert ...................................... Disclosed no confl ict of interest. Stoffers, Doris A. .................................. Disclosed no confl ict of interest.

Dow



A899


AU

THO

R D

ISCL

OSU

RE

Stoian, Gheorghe ................................. Disclosed no confl ict of interest. Stoico, Vincenzo ................................... Disclosed no confl ict of interest. Stoimenis, Dimitris ............................... Disclosed no confl ict of interest. Stone, Michael H. ................................ Disclosed no confl ict of interest. Storer, Thomas W. ................................ Disclosed no confl ict of interest. Storey, Robert F. ................................... Disclosed no confl ict of interest. Storlien, Len H. ..................................... Employee: AstraZeneca Pharmaceuticals LP; Research Sup-

port: AstraZeneca Pharmaceuticals LP Storrs, Richard ...................................... Disclosed no confl ict of interest. Stovitz, Steven D. ................................. Disclosed no confl ict of interest. Straczkowski, Marek ............................ Disclosed no confl ict of interest. Stram, Daniel O. ................................... Disclosed no confl ict of interest. Strange, Poul ........................................ Consultant: Valeritas, LLC Stranjford, Sarah .................................. Disclosed no confl ict of interest. Stranks, Stephen .................................. Consultant: Novo Nordisk A/S; Speaker’s Bureau: Novo

Nordisk A/S Strassburger, Klaus .............................. Disclosed no confl ict of interest. Stratton, Irene M. ................................. Disclosed no confl ict of interest. Strauch, Konstantin .............................. Disclosed no confl ict of interest. Strauss, Holger M. ............................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Strauss, Kenneth .................................. Employee: BD Medical Diabetes Care; Stock/Shareholder:

Becton, Dickinson and Company Strawbridge, Rona J. ........................... Disclosed no confl ict of interest. Straznicky, Nora ................................... Disclosed no confl ict of interest. Streisand, Randi ................................... Disclosed no confl ict of interest. Stricker-Krongrad, Alain ....................... Disclosed no confl ict of interest. Strickland-Hedgpeth, Angela B. ........... Disclosed no confl ict of interest. Striker, Gary .......................................... Advisory Panel: Sanofi ; Research Support: Sanofi Strindberg, Lena ................................... Disclosed no confl ict of interest. Strobel, Eric .......................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Strock, Ellie .......................................... Consultant: Abbott Diabetes Care, Roche Pharmaceuticals,

Sanofi ; Research Support: Abbott Diabetes Care, BD Medical Diabetes Care, Roche Pharmaceuticals, Sanofi

Strollo, Rocky ....................................... Disclosed no confl ict of interest. Strom, Rachel ....................................... Disclosed no confl ict of interest. Stronks, Karien ..................................... Disclosed no confl ict of interest. Strowski, Mathias Z. ............................ Disclosed no confl ict of interest. Strozik, Agnieszka ................................ Disclosed no confl ict of interest. Strutt, Brenda J. ................................... Disclosed no confl ict of interest. Stuart, Charles A. ................................. Disclosed no confl ict of interest. Stuart, Ella ............................................ Disclosed no confl ict of interest. Stubbe, Scott ........................................ Employee: Arena Pharmaceuticals, Inc. Stubblefi eld, Tianna M. ........................ Disclosed no confl ict of interest. Stuck, Rodney ....................................... Disclosed no confl ict of interest. Stuckey, Heather L. .............................. Advisory Panel: Novo Nordisk A/S; Speaker’s Bureau: Novo

Nordisk A/S Stuckey, Melanie I. ............................... Disclosed no confl ict of interest. Stumvoll, Michael ................................ Disclosed no confl ict of interest. Stylianou, Andreas ............................... Other Relationship: Novartis Pharmaceuticals Corporation Su, Benli ............................................... Disclosed no confl ict of interest. Su, Bin .................................................. Disclosed no confl ict of interest. Su, Chang ............................................. Disclosed no confl ict of interest. Su, Haoran ............................................ Disclosed no confl ict of interest. Su, Junlei ............................................. Disclosed no confl ict of interest. Su, Lizhong ........................................... Disclosed no confl ict of interest. Su, Qing ................................................ Disclosed no confl ict of interest. Su, Yi .................................................... Disclosed no confl ict of interest. Suarez, Maria de Los Angeles ............. Disclosed no confl ict of interest. Subauste, Angela ................................. Disclosed no confl ict of interest. Subías, David ....................................... Disclosed no confl ict of interest. Suchindran, Sunil ................................. Disclosed no confl ict of interest. Suda, Masei ......................................... Disclosed no confl ict of interest. Sugawara, Ayumi ................................. Disclosed no confl ict of interest. Sugaya, Yoshiyuki ................................ Disclosed no confl ict of interest. Sugden, Mary C. ................................... Disclosed no confl ict of interest. Sugg, Jennifer E. .................................. Employee: AstraZeneca Pharmaceuticals LP; Stock/Share-

holder: AstraZeneca Pharmaceuticals LP Sugi, Kaoru ........................................... Disclosed no confl ict of interest. Sugiyama, Takashi ............................... Disclosed no confl ict of interest. Suh, Kyoil ............................................. Disclosed no confl ict of interest. Suh, Sang Hoon .................................... Disclosed no confl ict of interest. Suh, Young Ju ...................................... Disclosed no confl ict of interest. Sui, Yi ................................................... Disclosed no confl ict of interest. Suleiman, Mara .................................... Disclosed no confl ict of interest. Sullivan, Ashley .................................... Employee: Medtronic Sullivan, Christina L. ............................ Disclosed no confl ict of interest. Sullivan, Kelli A. ................................... Disclosed no confl ict of interest. Sullivan, Mark ...................................... Disclosed no confl ict of interest. Sullivan, Timothy .................................. Employee: ChemoCentryx; Stock/Shareholder: ChemoCentryx Sułowicz, Władysław ........................... Disclosed no confl ict of interest.

Sultan, Ariane ...................................... Disclosed no confl ict of interest. Sumi, Keisuke ....................................... Disclosed no confl ict of interest. Summerfi eld, Belinda ........................... Disclosed no confl ict of interest. Sumner, Anne E. ................................... Disclosed no confl ict of interest. Sun, Cheuk-Kwan ................................. Disclosed no confl ict of interest. Sun, Jennifer K. .................................... Advisory Panel: Abbott Laboratories, Inc.; Consultant: Novartis

Pharmaceuticals Corporation; Research Support: Boston Micromachines, Genentech

Sun, Juan ............................................. Disclosed no confl ict of interest. Sun, Lian Q. .......................................... Disclosed no confl ict of interest. Sun, Liao ............................................... Disclosed no confl ict of interest. Sun, Min ............................................... Disclosed no confl ict of interest. Sun, Ruo-Qiong .................................... Disclosed no confl ict of interest. Sun, Ruqiong ........................................ Disclosed no confl ict of interest. Sun, Wanjie .......................................... Disclosed no confl ict of interest. Sun, Wei ............................................... Disclosed no confl ict of interest. Sun, Weixia .......................................... Disclosed no confl ict of interest. Sun, Xiao Jian ...................................... Disclosed no confl ict of interest. Sun, Xiaoyan ........................................ Disclosed no confl ict of interest. Sun, Xiuqin ........................................... Disclosed no confl ict of interest. Sun, Ying .............................................. Disclosed no confl ict of interest. Sun, Yongning ...................................... Disclosed no confl ict of interest. Sunagawa, Sumito ............................... Disclosed no confl ict of interest. Sundararajan, Krishnaswamy .............. Disclosed no confl ict of interest. Sundararajan, Pragalath ...................... Disclosed no confl ict of interest. Sung, Yeon-Ah ...................................... Disclosed no confl ict of interest. Sunkari, Vivekananda Gupta ................ Disclosed no confl ict of interest. Sunyer, Berta ........................................ Disclosed no confl ict of interest. Superville, Reah ................................... Disclosed no confl ict of interest. Surakka, Ida .......................................... Disclosed no confl ict of interest. Suri, Vipin ............................................. Employee: GlaxoSmithKline Surmacz, Eva ........................................ Employee: Novo Nordisk, Inc. (Spouse/Partner); Research

Support: Novo Nordisk A/S Sutton, Beth ......................................... Disclosed no confl ict of interest. Sutton-Tyrrell, Kim ............................... Disclosed no confl ict of interest. Suwa, Satoru ........................................ Disclosed no confl ict of interest. Suwanai, Hirotsugu .............................. Disclosed no confl ict of interest. Suzuki, Akiko ........................................ Disclosed no confl ict of interest. Suzuki, Daisuke .................................... Disclosed no confl ict of interest. Suzuki, Hikari ........................................ Disclosed no confl ict of interest. Suzuki, Hiroaki ...................................... Disclosed no confl ict of interest. Suzuki, Hirofumi ................................... Disclosed no confl ict of interest. Suzuki, Hiromi ...................................... Disclosed no confl ict of interest. Suzuki, Jun ........................................... Disclosed no confl ict of interest. Suzuki, Kazuyo ...................................... Disclosed no confl ict of interest. Suzuki, Kiyoshi ..................................... Disclosed no confl ict of interest. Suzuki, Masayuki ................................. Employee: Chugai Pharmaceutical Co., Ltd. Suzuki, Noriyuki .................................... Disclosed no confl ict of interest. Suzuki, Sadao ....................................... Disclosed no confl ict of interest. Suzuki, Tatsuhiko .................................. Disclosed no confl ict of interest. Suzuki, Tatsuro ..................................... Disclosed no confl ict of interest. Suzuki, Yoshifumi ................................. Disclosed no confl ict of interest. Suzuki, Yoshiki ...................................... Disclosed no confl ict of interest. Suzuki, Yoshiyuki .................................. Employee: Chugai Pharmaceutical Co., Ltd. Suzuki, Yuki .......................................... Disclosed no confl ict of interest. Svacina, Stepan ................................... Disclosed no confl ict of interest. Svehlikova, Eva .................................... Disclosed no confl ict of interest. Svendsen, Anne Louise ........................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Svendsen, Claus B. ............................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Svensson, Maria K. .............................. Disclosed no confl ict of interest. Svensson, Per-Arne .............................. Disclosed no confl ict of interest. Svetkey, Laura ...................................... Disclosed no confl ict of interest. Swallow, Ros ........................................ Employee: Boehringer Ingelheim UK Ltd Swamy, Shobha .................................... Disclosed no confl ict of interest. Swanepoel, Mandy .............................. Disclosed no confl ict of interest. Swarts, Steve ....................................... Disclosed no confl ict of interest. Swartz, Melody A. ................................ Disclosed no confl ict of interest. Sweenie, Rachel .................................. Disclosed no confl ict of interest. Sweet, Ian R. ........................................ Disclosed no confl ict of interest. Sweeting, Arianne N. ........................... Disclosed no confl ict of interest. Syed, Farooq ......................................... Disclosed no confl ict of interest. Syed, Ismail .......................................... Disclosed no confl ict of interest. Syed, Samreen K. ................................. Employee: Eli Lilly and Company Sykes, Mark .......................................... Disclosed no confl ict of interest. Symons, J. David .................................. Disclosed no confl ict of interest. Syvänen, Ann-Christine ........................ Disclosed no confl ict of interest. Szabo, Shelagh M. ............................... Disclosed no confl ict of interest. Szadkowska, Agnieszka ....................... Disclosed no confl ict of interest. Szanda, Gergo ...................................... Disclosed no confl ict of interest. Szczepaniak, Edward ............................ Disclosed no confl ict of interest.

Dow



A900


AU

THO

R D

ISCL

OSU

RE

Szczepaniak, Lidia ................................ Disclosed no confl ict of interest. Szczesniak, Rhonda .............................. Disclosed no confl ict of interest. Sze, Cathy ............................................. Disclosed no confl ict of interest. Szeinbach, Sheryl L. ............................. Consultant: Sanofi Szelachowska, Malgorzata .................. Disclosed no confl ict of interest. Szendrödi, Julia .................................... Disclosed no confl ict of interest. Szeto, Angela ....................................... Disclosed no confl ict of interest. Szeto, Linda .......................................... Disclosed no confl ict of interest. Szopa, Magdalena ............................... Disclosed no confl ict of interest. Szyllo, Natalia ...................................... Disclosed no confl ict of interest. Szymanska-Garbacz, Elektra ................ Disclosed no confl ict of interest. ‘t Hart, Leen M. .................................... Disclosed no confl ict of interest. T’joen, Caroline L. ................................ Employee: Bristol-Myers Squibb Company Tabák, Adam G. .................................... Disclosed no confl ict of interest. Tabara, Yasuharu .................................. Disclosed no confl ict of interest. Taborsky Jr., Gerald J. .......................... Disclosed no confl ict of interest. Tachibana, Hiromi ................................ Disclosed no confl ict of interest. Tade, Jameson ..................................... Disclosed no confl ict of interest. Tadkase, Akshaya ................................. Disclosed no confl ict of interest. Tadler, Friedrich .................................... Disclosed no confl ict of interest. Tagawa, Hirotsune ............................... Disclosed no confl ict of interest. Tagett, Rebecca .................................... Disclosed no confl ict of interest. Tagliabue, Anna ................................... Disclosed no confl ict of interest. Taguchi, Koichiro .................................. Disclosed no confl ict of interest. Tahara, Yumiko ..................................... Disclosed no confl ict of interest. Taheri, Shahrad .................................... Research Support: Allergan, Inc., Novo Nordisk A/S; Speaker’s

Bureau: AstraZeneca/Bristol-Meyers Squibb, Novo Nordisk, Inc.

Tahrani, Abd A. ..................................... Disclosed no confl ict of interest. Tahsin, Bettina ..................................... Disclosed no confl ict of interest. Tai, E. Shyong ....................................... Disclosed no confl ict of interest. Tai, Joseph ........................................... Disclosed no confl ict of interest. Taira, Shin-ichiro .................................. Disclosed no confl ict of interest. Tajima, Kanako ..................................... Disclosed no confl ict of interest. Tajima, Naoko ...................................... Disclosed no confl ict of interest. Tajima, Ryoko ....................................... Disclosed no confl ict of interest. Tajiri, Yuji .............................................. Disclosed no confl ict of interest. Takaguri, Akira ..................................... Disclosed no confl ict of interest. Takahara, Noriko .................................. Disclosed no confl ict of interest. Takahashi, Hirokazu ............................. Disclosed no confl ict of interest. Takahashi, Kaoru .................................. Disclosed no confl ict of interest. Takahashi, Kazunori ............................. Disclosed no confl ict of interest. Takahashi, Kazuto ................................ Disclosed no confl ict of interest. Takahashi, Mao .................................... Disclosed no confl ict of interest. Takahashi, Noriko ................................. Disclosed no confl ict of interest. Takahashi, Shigeo ................................ Disclosed no confl ict of interest. Takahashi, Takuya ................................ Disclosed no confl ict of interest. Takaike, Hiroko ..................................... Disclosed no confl ict of interest. Takamura, Hiroshi ................................ Disclosed no confl ict of interest. Takamura, Toshinari ............................. Disclosed no confl ict of interest. Takamura, Yusuke ................................ Disclosed no confl ict of interest. Takasawa, Shin .................................... Disclosed no confl ict of interest. Takashi, Yuichi ...................................... Disclosed no confl ict of interest. Takata, Yasunori ................................... Disclosed no confl ict of interest. Takatani, Tomozumi .............................. Disclosed no confl ict of interest. Takatsu, Kiyoshi ................................... Disclosed no confl ict of interest. Takayama, Chitoshi .............................. Disclosed no confl ict of interest. Takayanagi, Miwa ................................ Disclosed no confl ict of interest. Takayanagi, Takeshi ............................. Disclosed no confl ict of interest. Takbou, Karim ....................................... Disclosed no confl ict of interest. Take, Kazumi ........................................ Disclosed no confl ict of interest. Takebayashi, Kohzo .............................. Disclosed no confl ict of interest. Takeda, Eiji ........................................... Disclosed no confl ict of interest. Takeda, Jun .......................................... Disclosed no confl ict of interest. Takeda, Koji .......................................... Disclosed no confl ict of interest. Takeda, Satoru ..................................... Disclosed no confl ict of interest. Takeda, Yoshiyu .................................... Disclosed no confl ict of interest. Takemoto, Minoru ................................ Disclosed no confl ict of interest. Taketani, Yutaka ................................... Disclosed no confl ict of interest. Takeuchi, Mitsuaki ............................... Employee: Sanwa Kagaku Kenkyusho Takeuchi, Tatsuo ................................... Disclosed no confl ict of interest. Takeuchi, Toru ...................................... Disclosed no confl ict of interest. Taki, Iman ............................................. Disclosed no confl ict of interest. Takihata, Masahiro .............................. Disclosed no confl ict of interest. Takikawa, Akiko ................................... Disclosed no confl ict of interest. Takiyama, Yumi .................................... Disclosed no confl ict of interest. Takizawa, Miho .................................... Disclosed no confl ict of interest. Talahalli, Ramaprasad .......................... Disclosed no confl ict of interest. Talavera, Gregory ................................. Disclosed no confl ict of interest. Talton, Jennifer W. ............................... Disclosed no confl ict of interest. Talukdar, Saswata ................................ Disclosed no confl ict of interest. Tam, Charmaine S. ............................... Disclosed no confl ict of interest.

Tam, Claudia H. .................................... Disclosed no confl ict of interest. Tam, Yossi ............................................ Disclosed no confl ict of interest. Tamaki, Masanori ................................. Disclosed no confl ict of interest. Tamaki, Motoyuki ................................. Disclosed no confl ict of interest. Tamaki, Yuka ........................................ Disclosed no confl ict of interest. Tamanaha, Tamiko ............................... Disclosed no confl ict of interest. Tamarina, Natalia A. ............................ Disclosed no confl ict of interest. Tamarit-Rodriguez, Jorge ..................... Disclosed no confl ict of interest. Tamas, Gabor ....................................... Disclosed no confl ict of interest. Tamas, Margery J. ............................... Employee: Institute for Medical and Nursing Education, Inc. Tamasawa, Naoki ................................. Disclosed no confl ict of interest. Tamborlane, William V. ........................ Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.,

Halozyme Therapeutics, Insuline Medical, Lifescan Animas, Inc., Medtronic, Novo Nordisk, Inc., Unomedical; Speaker’s Bureau: Novo Nordisk, Inc.

Tamir, Merana ...................................... Employee: Andromeda Biotech, Ltd. Tamminen, Ilkka ................................... Employee: Boehringer Ingelheim GmbH & Co. KG Tammone, Antonio ............................... Disclosed no confl ict of interest. Tamura, Haruka .................................... Disclosed no confl ict of interest. Tamura, Miyuki ..................................... Employee: Sanwa Kagaku Kenkyusho Tamura, Yasushi ................................... Disclosed no confl ict of interest. Tamura, Yoshifumi ................................ Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc.,

Eli Lilly and Company, MSD, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi , Takeda Pharma-ceutical Company, Ltd.

Tan, Chengyu ........................................ Disclosed no confl ict of interest. Tan, Jielin ............................................. Disclosed no confl ict of interest. Tan, K.C.B. ............................................ Disclosed no confl ict of interest. Tan, Qin ................................................ Disclosed no confl ict of interest. Tan, Yi ................................................... Disclosed no confl ict of interest. Tan, Yingying ........................................ Disclosed no confl ict of interest. Tanabe, Jutaro ..................................... Disclosed no confl ict of interest. Tanaka, Ayako ...................................... Disclosed no confl ict of interest. Tanaka, Eitaro ....................................... Disclosed no confl ict of interest. Tanaka, Hideaki .................................... Disclosed no confl ict of interest. Tanaka, Jun .......................................... Employee: Daiichi-Sankyo, Inc. Tanaka, Kayo ........................................ Disclosed no confl ict of interest. Tanaka, Kumiko .................................... Disclosed no confl ict of interest. Tanaka, Nobue ..................................... Disclosed no confl ict of interest. Tanaka, Sachiko ................................... Disclosed no confl ict of interest. Tanaka, Shiro ........................................ Disclosed no confl ict of interest. Tanaka, Shunichi .................................. Disclosed no confl ict of interest. Tanaka, Takayuki .................................. Disclosed no confl ict of interest. Tanaka, Tomoko .................................... Disclosed no confl ict of interest. Tanaka, Toshiaki ................................... Disclosed no confl ict of interest. Tanaka, Yasuhiro .................................. Disclosed no confl ict of interest. Tanaka, Yasushi .................................... Disclosed no confl ict of interest. Tanaka, Yoshinobu ............................... Disclosed no confl ict of interest. Tanaka, Yuki ......................................... Disclosed no confl ict of interest. Tanano, Ichiro ....................................... Disclosed no confl ict of interest. Taneera, Jalal ....................................... Disclosed no confl ict of interest. Tanenbaum, Molly L. ............................ Disclosed no confl ict of interest. Tang, Anna ........................................... Disclosed no confl ict of interest. Tang, Joyce W. ..................................... Disclosed no confl ict of interest. Tang, Jun L. .......................................... Disclosed no confl ict of interest. Tang, Junling ........................................ Disclosed no confl ict of interest. Tang, Shiue-Cheng ............................... Disclosed no confl ict of interest. Tang, Tao .............................................. Disclosed no confl ict of interest. Tang, Tricia ........................................... Disclosed no confl ict of interest. Tang, Wei ............................................. Disclosed no confl ict of interest. Tang, Xi-Xiang ...................................... Disclosed no confl ict of interest. Tang, Yong ............................................ Disclosed no confl ict of interest. Tani, Mizuki .......................................... Disclosed no confl ict of interest. Tanigawa, Takeshi ................................ Disclosed no confl ict of interest. Taniguchi, Atsushi ................................ Employee: Nippon Boehringer Ingelheim Co., Ltd. Taniguchi, Cullen .................................. Disclosed no confl ict of interest. Taniguchi, Shinichi ............................... Disclosed no confl ict of interest. Taniguchi, Yukiko .................................. Disclosed no confl ict of interest. Tanimoto, Mayumi ............................... Disclosed no confl ict of interest. Tanner, Keith ........................................ Disclosed no confl ict of interest. Tansey, Michael ................................... Consultant: Daiichi-Sankyo, Inc.Tao, Ben ................................................ Employee: Daiichi-Sankyo, Inc. Tao, Caroline ........................................ Disclosed no confl ict of interest. Tapscott, Ed .......................................... Disclosed no confl ict of interest. Tarasova, Valentina D. ......................... Disclosed no confl ict of interest. Targher, Giovanni ................................. Disclosed no confl ict of interest. Tarkun, Ilhan ......................................... Disclosed no confl ict of interest. Tarnoki, Adam D. .................................. Disclosed no confl ict of interest. Tarnoki, David L. ................................... Disclosed no confl ict of interest. Tarnow, Lise ......................................... Employee: Novo Nordisk A/S Tasali, Esra ........................................... Disclosed no confl ict of interest. Tasiopoulou, Dimitra ............................ Disclosed no confl ict of interest.

Dow



A901


AU

THO

R D

ISCL

OSU

RE

Tasyurek, Hale ...................................... Disclosed no confl ict of interest. Tate, Donna B. ...................................... Disclosed no confl ict of interest. Tatosian, Daniel ................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Tatsuoka, Hisato ................................... Disclosed no confl ict of interest. Tauschmann, Martin ............................ Disclosed no confl ict of interest. Tavakkolizadeh, Ali ............................... Disclosed no confl ict of interest. Tavakoli, Mitra ..................................... Disclosed no confl ict of interest. Tavernier, Geneviève ............................ Disclosed no confl ict of interest. Tawaramoto, Kazuhito ......................... Disclosed no confl ict of interest. Taylor, Alex ........................................... Disclosed no confl ict of interest. Taylor, Ann ............................................ Employee: Novartis Institutes for BioMedical Research, Inc.;

Stock/Shareholder: Novartis Institutes for BioMedical Research, Inc.

Taylor, David ......................................... Disclosed no confl ict of interest. Taylor, Jared ......................................... Disclosed no confl ict of interest. Taylor, Kenneth S. ................................ Disclosed no confl ict of interest. Taylor, Kent D. ...................................... Disclosed no confl ict of interest. Taylor, Kristin ........................................ Employee: Orexigen Therapeutics, Inc.; Stock/Shareholder:

Orexigen Therapeutics, Inc. Taylor, Roy ............................................ Disclosed no confl ict of interest. Taylor-Fishwick, David A. ..................... Disclosed no confl ict of interest. Tchernof, Andre .................................... Disclosed no confl ict of interest. Te, Jerez ............................................... Disclosed no confl ict of interest. Techmanska, Ilona ................................ Disclosed no confl ict of interest. Tecilazich, Francesco ............................ Disclosed no confl ict of interest. Tedeschi, Anna ..................................... Disclosed no confl ict of interest. Teff, Karen L. ........................................ Disclosed no confl ict of interest. Tehrani, Sara ........................................ Disclosed no confl ict of interest. Teich, Trevor ......................................... Disclosed no confl ict of interest. Teichert, Lenore .................................... Employee: Sanofi Teigland, Christie ................................. Disclosed no confl ict of interest. Tekce, Mustafa ..................................... Disclosed no confl ict of interest. Tekin, Buket .......................................... Disclosed no confl ict of interest. Tekin, Sakin .......................................... Disclosed no confl ict of interest. Tekumalla, Poornima K. ........................ Disclosed no confl ict of interest. Telejko, Beata ....................................... Disclosed no confl ict of interest. Telila, Tesfaye ...................................... Disclosed no confl ict of interest. Temizhan, Ahmet .................................. Disclosed no confl ict of interest. Temple, Karla A. ................................... Disclosed no confl ict of interest. Templeman, Nicole M. ......................... Disclosed no confl ict of interest. Templin, Andrew T. ............................... Disclosed no confl ict of interest. Temprosa, Marinella ............................ Disclosed no confl ict of interest. ten Kulve, Jennifer S. ........................... Disclosed no confl ict of interest. Tenayuca, John .................................... Disclosed no confl ict of interest. Teng, Weiping ...................................... Disclosed no confl ict of interest. Tennagels, Norbert ............................... Employee: Employee, Sanofi Tennen, Howard ................................... Disclosed no confl ict of interest. Tentolouris, Nikolaos ........................... Other Relationship: Eli Lilly and Company, Merck Teo, Adrian K. ....................................... Research Support: AstraZeneca Pharmaceuticals LP, AstraZen-

eca/Bristol-Meyers Squibb Teo, Yik Ying ......................................... Disclosed no confl ict of interest. Teodori, Marsha F. ................................ Disclosed no confl ict of interest. Terami, Naoto ....................................... Disclosed no confl ict of interest. Terami, Takahiro ................................... Disclosed no confl ict of interest. Terano, Takashi .................................... Disclosed no confl ict of interest. Terasaki, Jungo .................................... Disclosed no confl ict of interest. Terasawa, Tomoko ............................... Disclosed no confl ict of interest. Terauchi, Yasuo .................................... Disclosed no confl ict of interest. Terawaki, Yuichi ................................... Disclosed no confl ict of interest. Terpstra, Melissa ................................. Disclosed no confl ict of interest. Terry, J.G. ............................................. Disclosed no confl ict of interest. Tersey, Sarah A. ................................... Disclosed no confl ict of interest. Tesfaye, Solomon ................................. Disclosed no confl ict of interest. Teshima, Miho ...................................... Disclosed no confl ict of interest. Teslovich, Tanya M. .............................. Disclosed no confl ict of interest. Testa, Marcia A. ................................... Consultant: Eli Lilly and Company, Sanofi Tesz, Gregory J. .................................... Employee: Pfi zer, Inc. Teutsch, Charlott-Amélie ..................... Disclosed no confl ict of interest. Tezza, Sara ........................................... Disclosed no confl ict of interest. Tfayli, Hala ........................................... Disclosed no confl ict of interest. Thabit, Hood ......................................... Disclosed no confl ict of interest. Thai, Ah C. ............................................ Disclosed no confl ict of interest. Thai, Kerri ............................................. Disclosed no confl ict of interest. Thaker, Hatim ....................................... Disclosed no confl ict of interest. Thaler, Joshua P. .................................. Disclosed no confl ict of interest. Thankappan, K.R. ................................. Disclosed no confl ict of interest. Thayer, Deborah ................................... Disclosed no confl ict of interest. Theander, Julie ..................................... Employee: Medtronic Thearle, Margaret ................................ Disclosed no confl ict of interest. Thedens, Daniel ................................... Disclosed no confl ict of interest. Thein, Shermaine ................................. Disclosed no confl ict of interest.

Theinert, Stephan ................................. Employee: Eyesense GmbH Therapontos, Christina ......................... Employee: Novartis Pharmaceuticals Corporation Thies, Frank .......................................... Disclosed no confl ict of interest. Thimme, Robert .................................... Disclosed no confl ict of interest. Thiruchelvam, Dhan ............................. Disclosed no confl ict of interest. Thiviege, Carole ................................... Disclosed no confl ict of interest. Thomakos, Petros ................................. Disclosed no confl ict of interest. Thomas, Abraham ................................ Disclosed no confl ict of interest. Thomas, Avis J. .................................... Disclosed no confl ict of interest. Thomas, Cecil ....................................... Advisory Panel: Amylin/Eli Lilly Thomas, Francine ................................. Disclosed no confl ict of interest. Thomas, G.N. ........................................ Disclosed no confl ict of interest. Thomas, Helen E. ................................. Disclosed no confl ict of interest. Thomas, Joan ....................................... Disclosed no confl ict of interest. Thomas, John F. .................................... Disclosed no confl ict of interest. Thomas, Leo ......................................... Disclosed no confl ict of interest. Thomas, Merlin .................................... Disclosed no confl ict of interest. Thomas, Nina ....................................... Employee: Bristol-Myers Squibb Company Thomas, Rebecca L. ............................. Disclosed no confl ict of interest. Thomas, Stephen M. ............................ Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S;

Speaker’s Bureau: Sanofi Thomason, Darren ................................ Consultant: Daiichi-Sankyo, Inc. Thompson, Andrea ............................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Thompson, Bithika ................................ Disclosed no confl ict of interest. Thompson, Christopher J. .................... Disclosed no confl ict of interest. Thompson, David .................................. Disclosed no confl ict of interest. Thompson, James ................................ Disclosed no confl ict of interest. Thompson, Jennifer W. ........................ Disclosed no confl ict of interest. Thompson, Joanice A. .......................... Research Support: Sanofi US Thompson, Kyle .................................... Disclosed no confl ict of interest. Thompson, Rebecca J. ......................... Disclosed no confl ict of interest. Thompson, Theodore J. ........................ Disclosed no confl ict of interest. Thomsen, Reimar W. ............................ Disclosed no confl ict of interest. Thomson, Erin ....................................... Disclosed no confl ict of interest. Thong, Ken Y. ........................................ Disclosed no confl ict of interest. Thorand, Barbara .................................. Disclosed no confl ict of interest. Thorens, Bernard .................................. Disclosed no confl ict of interest. Thorleifsson, Gudmar ........................... Disclosed no confl ict of interest. Thorndike, Anne ................................... Disclosed no confl ict of interest. Thorpe, Jerill ........................................ Disclosed no confl ict of interest. Thorsteinsson, Birger ........................... Advisory Panel: Eli Lilly and Company Thrysøe, Samuel ................................... Disclosed no confl ict of interest. Thulaseedharan, N.K. ........................... Disclosed no confl ict of interest. Thuma, Jean R. .................................... Disclosed no confl ict of interest. Thurber, Brian W. ................................. Disclosed no confl ict of interest. Thuren, Tom .......................................... Employee: Novartis Pharmaceuticals Corporation; Stock/

Shareholder: Novartis Pharmaceuticals Corporation Thurheimer, Jennifer L. ........................ Disclosed no confl ict of interest. Thurman, Janet P. ................................. Research Support: Sanofi US Thurmond, Debbie C. ............................ Disclosed no confl ict of interest. Thurnheer, Martin ................................ Disclosed no confl ict of interest. Thurston, Gavin .................................... Disclosed no confl ict of interest. Thyagarajan, Bharat ............................. Disclosed no confl ict of interest. Thyfault, John P. ................................... Disclosed no confl ict of interest. Tian, Hao Ming ..................................... Disclosed no confl ict of interest. Tian, Hui ............................................... Disclosed no confl ict of interest. Tian, Ling .............................................. Disclosed no confl ict of interest. Tiao, Janice .......................................... Disclosed no confl ict of interest. Tichansky, David ................................... Disclosed no confl ict of interest. Tichy, Eileen M. .................................... Disclosed no confl ict of interest. Tideman, Ann M. .................................. Employee: Bayer Health Care, LLC Tien, Thomas ........................................ Disclosed no confl ict of interest. Tierney, Edward .................................... Disclosed no confl ict of interest. Tildesley, Hamish G. ............................. Disclosed no confl ict of interest. Tildesley, Hugh D. ................................. Disclosed no confl ict of interest. Tillner, Joachim .................................... Employee: Sanofi Tilves, Debra ......................................... Disclosed no confl ict of interest. Timar, Bogdan ....................................... Disclosed no confl ict of interest. Timar, Romulus ..................................... Disclosed no confl ict of interest. Timm, Derek ......................................... Disclosed no confl ict of interest. Tinahones, Francisco J. ........................ Disclosed no confl ict of interest. Tinelli, Carmine .................................... Disclosed no confl ict of interest. Tinetti, Matias ...................................... Disclosed no confl ict of interest. Tinnes, Kai ............................................ Disclosed no confl ict of interest. Tio, Fermin ............................................ Disclosed no confl ict of interest. Tirosh, Amir .......................................... Disclosed no confl ict of interest. Tirosh, Oren .......................................... Disclosed no confl ict of interest. Tirrell, Lee S. ........................................ Disclosed no confl ict of interest. Tisch, Ulrike .......................................... Disclosed no confl ict of interest. Tiwari, Hemant ..................................... Disclosed no confl ict of interest. Tobe, Kazuyuki ...................................... Disclosed no confl ict of interest.

Dow



A902


AU

THO

R D

ISCL

OSU

RE

Tobias, Deirdre K. ................................. Disclosed no confl ict of interest. Tobin, Garry S. ...................................... Advisory Panel: Roche Pharmaceuticals; Speaker’s Bureau:

Amylin Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Dexcom, Inc., Eli Lilly and Company, Medtronic MiniMed, Inc., Novo Nordisk, Inc.

Tobin-Hess, Aviva ................................. Disclosed no confl ict of interest. Tocaci, Georgiana ................................. Disclosed no confl ict of interest. Tochiya, Mayu ...................................... Disclosed no confl ict of interest. Toda, Akiko ........................................... Disclosed no confl ict of interest. Toda, Eiichi ........................................... Disclosed no confl ict of interest. Toda, Kyoko .......................................... Disclosed no confl ict of interest. Todd, John ............................................ Disclosed no confl ict of interest. Todorov, Ivan ........................................ Disclosed no confl ict of interest. Tofe Povedano, Santiago ..................... Consultant: Eli Lilly and Company, Novartis Pharmaceuticals

Corporation, Novo Nordisk A/S; Research Support: Eli Lilly and Company, Takeda Pharmaceutical Company, Ltd.

Togashi, Yu ........................................... Disclosed no confl ict of interest. Toh, Hong B. ......................................... Disclosed no confl ict of interest. Toh, Matthias ....................................... Disclosed no confl ict of interest. Tohooloo, Bhavna ................................. Disclosed no confl ict of interest. Tojo, Katsuyoshi ................................... Disclosed no confl ict of interest. Tokar, Esra ............................................ Disclosed no confl ict of interest. Tokudome, Takuto ................................ Employee: Bristol-Myers Squibb Company Toledo, Frederico G. ............................. Disclosed no confl ict of interest. Toledo-Corral, Claudia M. .................... Disclosed no confl ict of interest. Toma, Mihai ......................................... Disclosed no confl ict of interest. Tomao, Enrico ....................................... Disclosed no confl ict of interest. Tomas, Eva ........................................... Disclosed no confl ict of interest. Tomaselli, Alfredo G. ............................ Consultant: Metabolic Solutions Development Co. Tomas-Falco, Eva .................................. Disclosed no confl ict of interest. Tomcalova, Jana .................................. Disclosed no confl ict of interest. Tomei, Alice A. ..................................... Disclosed no confl ict of interest. Tomida, Yosuke .................................... Disclosed no confl ict of interest. Tominaga, Ayako .................................. Disclosed no confl ict of interest. Tominaga, Yoichi .................................. Disclosed no confl ict of interest. Tomolo, Anne ....................................... Disclosed no confl ict of interest. Tomuta, Nora ........................................ Disclosed no confl ict of interest. Tonelli, Marcello .................................. Disclosed no confl ict of interest. Tong, Cindy ........................................... Employee: Janssen Research & Development Tong, Guoyu .......................................... Disclosed no confl ict of interest. Tong, Jenny .......................................... Disclosed no confl ict of interest. Tong, Nanwei ....................................... Disclosed no confl ict of interest. Tong, Peter ........................................... Disclosed no confl ict of interest. Tooze, Janet ......................................... Disclosed no confl ict of interest. Topolcan, Ondrej .................................. Disclosed no confl ict of interest. Topp, Brian G. ....................................... Employee: Eli Lilly and Company Torenholt, Rikke .................................... Other Relationship: Novo Nordisk A/S Torrence, Stephanie ............................. Disclosed no confl ict of interest. Torres, Ivan ........................................... Disclosed no confl ict of interest. Torres, Oscar V. ..................................... Disclosed no confl ict of interest. Tortosa, Federica .................................. Disclosed no confl ict of interest. Toscano, Vincenzo ................................ Disclosed no confl ict of interest. Tosh, David ........................................... Disclosed no confl ict of interest. Toti, Florence ........................................ Disclosed no confl ict of interest. Totomirova, Tzvetelina ......................... Disclosed no confl ict of interest. Toufexis, Costas ................................... Other Relationship: Novartis Pharmaceuticals Corporation Tousoulis, Dimitris ................................ Disclosed no confl ict of interest. Tovilla Zarate, Carlos ........................... Disclosed no confl ict of interest. Townsend, Claire M. ............................ Disclosed no confl ict of interest. Townsend, Kristy L. .............................. Disclosed no confl ict of interest. Toyoda, Masao ..................................... Disclosed no confl ict of interest. Toyofuku, Yukiko ................................... Disclosed no confl ict of interest. Toyoji, Yosihumi ................................... Disclosed no confl ict of interest. Trachta, Pavel ....................................... Disclosed no confl ict of interest. Trahair, Laurence G. ............................. Disclosed no confl ict of interest. Traldi, Pietro ......................................... Disclosed no confl ict of interest. Tran, Duy A. .......................................... Disclosed no confl ict of interest. Tran, Len ............................................... Disclosed no confl ict of interest. Trapp, Caroline ..................................... Disclosed no confl ict of interest. Trast, Jeniece ....................................... Disclosed no confl ict of interest. Trautmann, Michael ............................. Advisory Panel: Merck; Consultant: Amylin Pharmaceuticals,

LLC, Bristol-Myers Squibb Company; Stock/Shareholder: Eli Lilly and Company

Traylor, Louise ...................................... Employee: Bristol-Myers Squibb Company (Spouse/Partner), Sanofi

Treebak, Jonas T. .................................. Disclosed no confl ict of interest. Treiber, Gerlies ..................................... Speaker’s Bureau: Novo Nordisk A/S Trentani, Claudia .................................. Disclosed no confl ict of interest. Tressler, Michael C. .............................. Disclosed no confl ict of interest. Triantafyllou, Areti ............................... Disclosed no confl ict of interest. Triantafyllou, George ............................ Disclosed no confl ict of interest. Tribler, Siri ............................................ Disclosed no confl ict of interest.

Triebel, Jakob ....................................... Disclosed no confl ict of interest. Trief, Paula M. ...................................... Disclosed no confl ict of interest. Trigo, Enrique ....................................... Disclosed no confl ict of interest. Trikola, Artemis .................................... Disclosed no confl ict of interest. Tripathi, Gyanendra .............................. Disclosed no confl ict of interest. Tripathi, Kamlakar ................................ Disclosed no confl ict of interest. Tripathi, Richik ...................................... Disclosed no confl ict of interest. Tripathy, Devjit ..................................... Advisory Panel: Health Diagnostics Lab Tripathy, Purnima .................................. Disclosed no confl ict of interest. Triplitt, Curtis ........................................ Disclosed no confl ict of interest. Trischitta, Vincenzo .............................. Disclosed no confl ict of interest. Trivedi, Nitin ......................................... Disclosed no confl ict of interest. Trivedi, Prerak ....................................... Disclosed no confl ict of interest. Trogdon, Justin ..................................... Disclosed no confl ict of interest. Trojak, Aleksandra ................................ Disclosed no confl ict of interest. Trombetta, Maddalena ......................... Disclosed no confl ict of interest. Troupin, Barbara ................................... Employee: Vivus, Inc.; Stock/Shareholder: Vivus, Inc. Trower, Nicole ...................................... Disclosed no confl ict of interest. Trubitsyna, Yelena ................................ Employee: VeroScience Trucco, Massimo .................................. Disclosed no confl ict of interest. Truitt, Kenneth E. .................................. Employee: Daiichi-Sankyo, Inc. Trujillo, Gloria M. ................................. Disclosed no confl ict of interest. Trujillo, Jennifer ................................... Disclosed no confl ict of interest. Trznadel-Morawska, Iwona .................. Disclosed no confl ict of interest. Trzonkowski, Piotr ................................ Disclosed no confl ict of interest. Tsai, Adam G. ....................................... Research Support: Sanofi US, Nutrisystem, Inc. Tsai, Ailin .............................................. Disclosed no confl ict of interest. Tsai, Linus ............................................. Disclosed no confl ict of interest. Tsai, Max .............................................. Employee: Takeda Global Research & Development Center,

Inc. Tsai, Sue ............................................... Disclosed no confl ict of interest. Tsaih, Shirng-Wern ............................... Disclosed no confl ict of interest. Tsalikian, Eva ........................................ Disclosed no confl ict of interest. Tsalta, Danai ........................................ Disclosed no confl ict of interest. Tsang, Chiu Chi ..................................... Disclosed no confl ict of interest. Tsang, Ellen .......................................... Employee: KineMed, Inc. Tsang, John .......................................... Disclosed no confl ict of interest. Tsang, Man Wo .................................... Research Support: Johnson & Johnson Tsang, Philip ......................................... Research Support: Johnson & Johnson Tsao, Chang-Hui ................................... Disclosed no confl ict of interest. Tschannen, Michael ............................. Disclosed no confl ict of interest. Tschirhart, Holly ................................... Disclosed no confl ict of interest. Tschöp, Matthias .................................. Disclosed no confl ict of interest. Tse, Hubert M. ...................................... Disclosed no confl ict of interest. Tse, Hung Fat ........................................ Disclosed no confl ict of interest. Tseng, Chin-Lin ..................................... Disclosed no confl ict of interest. Tseng, Li-Nien ...................................... Disclosed no confl ict of interest. Tseng, Tzu-Ling ..................................... Disclosed no confl ict of interest. Tseng, Yu-Hua ...................................... Disclosed no confl ict of interest. Tsioli, Christiana ................................... Disclosed no confl ict of interest. Tsitouridis, Ioannis ............................... Disclosed no confl ict of interest. Tsitsilianos, Andrew V. ......................... Disclosed no confl ict of interest. Tsitsilianos, Nicholas ........................... Disclosed no confl ict of interest. Tsodikov, Alexander ............................. Disclosed no confl ict of interest. Tsosie, Gerilene .................................... Disclosed no confl ict of interest. Tsougranis, George H. .......................... Disclosed no confl ict of interest. Tsuboi, Kentaro .................................... Disclosed no confl ict of interest. Tsuchiya, Ken ....................................... Disclosed no confl ict of interest. Tsuchiya, Koichiro ................................ Disclosed no confl ict of interest. Tsuchiya, Mariko .................................. Disclosed no confl ict of interest. Tsuchiya, Masanobu ............................ Disclosed no confl ict of interest. Tsuchiya, Takafumi ............................... Disclosed no confl ict of interest. Tsuda, Masahiro ................................... Disclosed no confl ict of interest. Tsui, Circe W. ....................................... Disclosed no confl ict of interest. Tsui, Stephen K. ................................... Disclosed no confl ict of interest. Tsuji, Ken .............................................. Disclosed no confl ict of interest. Tsujii, Satoru ........................................ Disclosed no confl ict of interest. Tsujikawa, Muneo ................................ Disclosed no confl ict of interest. Tsujinaka, Hiroki ................................... Disclosed no confl ict of interest. Tsujino, Daisuke ................................... Disclosed no confl ict of interest. Tsukagoshi, Chihiro .............................. Disclosed no confl ict of interest. Tsukamoto, Katsura .............................. Employee: Sanwa Kagaku Kenkyusho Tsukamoto, Masami ............................. Disclosed no confl ict of interest. Tsun, J.G.S. .......................................... Disclosed no confl ict of interest. Tsunekawa, Shin .................................. Disclosed no confl ict of interest. Tsuneyama, Koichi ............................... Disclosed no confl ict of interest. Tsuprykov, Oleg .................................... Disclosed no confl ict of interest. Tsuriya, Daisuke ................................... Disclosed no confl ict of interest. Tsutsumi, Chiharu ................................. Disclosed no confl ict of interest. Tsutsumi, Shuichi ................................. Disclosed no confl ict of interest. Tsutsumi, Yoko ..................................... Disclosed no confl ict of interest. Tsuzaki, Kokoro ..................................... Disclosed no confl ict of interest.

Dow



A903


AU

THO

R D

ISCL

OSU

RE

Tsuzuku, Shigeki ................................... Disclosed no confl ict of interest. Tu, Li Chuan .......................................... Research Support: Sanofi Tu, Ling-Hsien ....................................... Disclosed no confl ict of interest. Tu, Meihua ........................................... Employee: Pfi zer, Inc. Tu, Wanzhu ........................................... Disclosed no confl ict of interest. Tugeeva, Elvina .................................... Disclosed no confl ict of interest. Tulloch, Heather ................................... Disclosed no confl ict of interest. Tumerdem Calik, Burcu ........................ Disclosed no confl ict of interest. Tumini, Stefano .................................... Disclosed no confl ict of interest. Tunceli, Kaan ........................................ Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Tunceli, Ozgur ....................................... Disclosed no confl ict of interest. Tunekawa, Shin .................................... Disclosed no confl ict of interest. Tuomilehto, Jaakko .............................. Disclosed no confl ict of interest. Tura, Andrea ......................................... Disclosed no confl ict of interest. Tura, Bernardo ...................................... Disclosed no confl ict of interest. Turco, Lucia .......................................... Disclosed no confl ict of interest. Turcotte, Eric E. .................................... Disclosed no confl ict of interest. Turek, Sara J. ....................................... Disclosed no confl ict of interest. Turgunova, Ludmila G. .......................... Disclosed no confl ict of interest. Turk, John ............................................. Disclosed no confl ict of interest. Turkbey, Evrim B. .................................. Disclosed no confl ict of interest. Turksoy, Kamuran ................................. Disclosed no confl ict of interest. Turner, Cindy ......................................... Employee: Arena Pharmaceuticals, Inc. Turner, Nigel ......................................... Disclosed no confl ict of interest. Turner, Paul D. ...................................... Disclosed no confl ict of interest. Turner, Scott ......................................... Employee: KineMed, Inc. Turner, Tamela J. .................................. Research Support: Sanofi US Turpcu, Adam ....................................... Employee: Genentech; Stock/Shareholder: Genentech Tütüncüoglu, Aliye P. ............................ Disclosed no confl ict of interest. Tütüncüoglu, Pelin ................................ Disclosed no confl ict of interest. Tvede, Michael ..................................... Disclosed no confl ict of interest. Twig, Gilad ........................................... Disclosed no confl ict of interest. Twigg, Stephen M. ............................... Disclosed no confl ict of interest. Tyrrell, Jessica S. ................................. Disclosed no confl ict of interest. Tzarou, Kanella ..................................... Disclosed no confl ict of interest. Tzekov, Anatoly .................................... Disclosed no confl ict of interest. Tzemos, Kostas .................................... Employee: VeraLight, Inc. Tziomalos, Konstantinos ...................... Disclosed no confl ict of interest. Tzur, Dorit ............................................. Disclosed no confl ict of interest. Uberti, Mariano G. ............................... Disclosed no confl ict of interest. Uchida, Daigaku ................................... Disclosed no confl ict of interest. Uchida, Toyoyoshi ................................ Disclosed no confl ict of interest. Uchigata, Yasuko .................................. Disclosed no confl ict of interest. Uchizono, Yuji ....................................... Disclosed no confl ict of interest. Udagawa, Haruhide ............................. Disclosed no confl ict of interest. Ueda, Eri ............................................... Disclosed no confl ict of interest. Ueda, Minoru ....................................... Disclosed no confl ict of interest. Ueda, Naohiko ...................................... Disclosed no confl ict of interest. Ueda, Otoya .......................................... Employee: Chugai Pharmaceutical Co., Ltd. Ueda, Rei .............................................. Disclosed no confl ict of interest. Uehara, Shinichiro ................................ Disclosed no confl ict of interest. Ueki, Akio ............................................. Disclosed no confl ict of interest. Ueki, Kohjiro ......................................... Disclosed no confl ict of interest. Ueland, Thor ......................................... Disclosed no confl ict of interest. Uemura, Yasuyuki ................................. Disclosed no confl ict of interest. Uenishi, Eita ......................................... Disclosed no confl ict of interest. Ueno, Hideki ......................................... Disclosed no confl ict of interest. Ueshima, Kenji ..................................... Disclosed no confl ict of interest. Ueyama, Minoru ................................... Disclosed no confl ict of interest. Ugarova, Tatiana P. ............................... Disclosed no confl ict of interest. Ugel, Eunice ......................................... Disclosed no confl ict of interest. Ugi, Satoshi .......................................... Disclosed no confl ict of interest. Ugnat, Anne-Marie .............................. Disclosed no confl ict of interest. Ukai, Yasuhiro ...................................... Disclosed no confl ict of interest. Ulbrecht, Jan S. .................................... Disclosed no confl ict of interest. Ullrich, Axel .......................................... Disclosed no confl ict of interest. Ullrich, Susanne ................................... Disclosed no confl ict of interest. Ulrichsen, Sinna P. ................................ Disclosed no confl ict of interest. Umapathy, Dhamodharan ..................... Disclosed no confl ict of interest. Umapathysivam, Mahesh M. ............... Disclosed no confl ict of interest. Umeda, Luciana M. .............................. Disclosed no confl ict of interest. Umehara, Toshihiro .............................. Disclosed no confl ict of interest. Umezono, Tomoya ................................ Disclosed no confl ict of interest. Umpierre, Daniel .................................. Disclosed no confl ict of interest. Umpierrez, Guillermo E. ....................... Research Support: Merck, Sanofi Umpleby, A.M. ...................................... Disclosed no confl ict of interest. Umpleby, Margot .................................. Disclosed no confl ict of interest. Umrani, Malati R. ................................. Disclosed no confl ict of interest. Un, Ozge ............................................... Disclosed no confl ict of interest. Underwood, Patricia ............................. Disclosed no confl ict of interest. Unger-Hu, Kirsten ................................. Disclosed no confl ict of interest.

Unni, Sudhir .......................................... Disclosed no confl ict of interest. Unnikrishnan, A.G. ............................... Disclosed no confl ict of interest. Uno, Yoshihiro ...................................... Disclosed no confl ict of interest. Unterman, Terry G. ............................... Disclosed no confl ict of interest. Upadhyay, Jagriti ................................. Disclosed no confl ict of interest. Upala, Sikarin ....................................... Disclosed no confl ict of interest. Upson, Marcia B. .................................. Other Relationship: Naturally Slim Urata, Hiromi ........................................ Disclosed no confl ict of interest. Urbancic Rovan, Vilma ......................... Disclosed no confl ict of interest. Urbanova, Monika ................................ Disclosed no confl ict of interest. Urbanowska, Teresa ............................. Employee: F. Hoffmann-La Roche, Ltd. Urbina, Elaine M. ................................. Disclosed no confl ict of interest. Uribarri, Jaime ..................................... Disclosed no confl ict of interest. Uribe-Bruce, Liliana .............................. Employee: Novartis Pharmaceuticals Corporation (Spouse/

Partner) Urschitz, Martina .................................. Disclosed no confl ict of interest. Usiskin, Keith ....................................... Employee: Janssen Research & Development, LLC Uslan, Mark .......................................... Disclosed no confl ict of interest. Ussar, Siegfried .................................... Disclosed no confl ict of interest. Usui, Isao .............................................. Disclosed no confl ict of interest. Usui, Ryota ........................................... Disclosed no confl ict of interest. Usui, Taro ............................................. Disclosed no confl ict of interest. Usukura, Mikiya ................................... Disclosed no confl ict of interest. Utsunomiya, Kazunori .......................... Disclosed no confl ict of interest. Utzschneider, Kristina M. ..................... Disclosed no confl ict of interest. Uzu, Takashi ......................................... Disclosed no confl ict of interest. Vaag, Allan A. ...................................... Consultant: Novo Nordisk A/S; Speaker’s Bureau: Eli Lilly and

Company; Stock/Shareholder: Novo Nordisk A/S Vaca, Pilar ............................................ Disclosed no confl ict of interest. Vaca-Sanchez, Pilar .............................. Disclosed no confl ict of interest. Vaccaro, Nicole .................................... Employee: Janssen Research & Development Vaccaro, Olga ....................................... Disclosed no confl ict of interest. Vach, Werner ........................................ Disclosed no confl ict of interest. Vaeggemose, Michael ......................... Disclosed no confl ict of interest. Vafai, Scott B. ...................................... Disclosed no confl ict of interest. Vagner, Josef ........................................ Disclosed no confl ict of interest. Vajda, Eric G. ........................................ Employee: Ligand Pharmaceuticals; Stock/Shareholder: Ligand

Pharmaceuticals Vajda, Karen ......................................... Disclosed no confl ict of interest. Vakilipour, Amin ................................... Disclosed no confl ict of interest. Vakilynejad, Majid ............................... Employee: Takeda Global Research & Development Center,

Inc. Valcarce, Carmen ................................. Employee: TransTech Pharma Valdez, Ivan .......................................... Disclosed no confl ict of interest. Valensi, Paul ......................................... Consultant: Boehringer Ingelheim GmbH & Co. KG, Bristol-

Myers Squibb/AstraZeneca, Kowa Pharmaceuticals, Merck Sharp & Dohme Limited, Novo Nordisk A/S

Valentine, Rudy J. ................................ Disclosed no confl ict of interest. Valentine, Virginia ................................ Speaker’s Bureau: Amylin Pharmaceuticals, Inc. Valentine, William ............................... Research Support: Eli Lilly and Company Valentini, Alessia ................................. Disclosed no confl ict of interest. Valentini, Umberto ............................... Disclosed no confl ict of interest. Valeros, Katherine A. ........................... Disclosed no confl ict of interest. Valeur, Anders ...................................... Employee: Zealand Pharma A/S; Research Support: Zealand

Pharma A/S Valgardson, Joshua .............................. Disclosed no confl ict of interest. Valiente, Cindy ..................................... Disclosed no confl ict of interest. Vallejo, Susana .................................... Disclosed no confl ict of interest. Vallejo-Ortega, Jorge ........................... Disclosed no confl ict of interest. Vallerie, Sara ........................................ Disclosed no confl ict of interest. Vallis, Michael ..................................... Advisory Panel: Novo Nordisk A/S; Consultant: Abbott

Products Operations AG, Merck, Sanofi; Other Rela-tionship: Novo Nordisk A/S; Research Support: Abbott Diabetes Care, AstraZeneca/Bristol-Meyers Squibb, GlaxoSmithKline, Merck, Novo Nordisk A/S, Pfizer, Inc., Sanofi

Vallon, Volker ....................................... Consultant: Roche Pharmaceuticals; Employee: Roche Pharma-ceuticals; Research Support: Amylin Pharmaceuticals, Inc., Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb/AstraZeneca, Takeda Pharmaceuticals U.S.A., Inc.

Van Bloemendaal, Liselotte ................. Disclosed no confl ict of interest. Van Brunt, Kate .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Van Cauter, Eve .................................... Disclosed no confl ict of interest. Van der Heijden, Amber A. .................. Disclosed no confl ict of interest. Van der Plasse, Geoffrey ...................... Disclosed no confl ict of interest. Van deWeijer, Tineke ........................... Disclosed no confl ict of interest. Van Dijk, Jan-Willem ........................... Disclosed no confl ict of interest. Van Duijn, Cornelia M. ......................... Disclosed no confl ict of interest. Van Duinkerken, Eelco ......................... Research Support: Novo Nordisk A/S Van Eijk, M.C. ....................................... Disclosed no confl ict of interest. Van Eupen, Marcelle G. ....................... Disclosed no confl ict of interest.

Dow



A904


AU

THO

R D

ISCL

OSU

RE

Van Gaal, Luc F. .................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Janssen Pharmaceuticals, Johnson & Johnson, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Research Support: National Research Funds (Belgium); Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Janssen Pharmaceuticals, Johnson & Johnson, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi

Van Hinsbergh, Victor W. ..................... Disclosed no confl ict of interest. Van Leeuwen, Nienke .......................... Disclosed no confl ict of interest. Van Loon, Luc J. ................................... Disclosed no confl ict of interest. Van Mechelen, Willem ........................ Disclosed no confl ict of interest. Van Megen, Kayleigh M. ..................... Disclosed no confl ict of interest. Van Obberghen, Emmanuel .................. Disclosed no confl ict of interest. Van Poelgeest, Erik M. ......................... Disclosed no confl ict of interest. Van Schaik, Ron H. ............................... Disclosed no confl ict of interest. Van ‘t Riet, Esther ................................ Disclosed no confl ict of interest. Van Valkengoed, Irene ......................... Disclosed no confl ict of interest. Van Walleghem, Norma ....................... Disclosed no confl ict of interest. Vandebrouck, Tom ................................ Employee: Novo Nordisk A/S Vanderwood, Karl K. ............................ Disclosed no confl ict of interest. VanEssen, Darla J. ............................... Disclosed no confl ict of interest. Vangen, Siri .......................................... Disclosed no confl ict of interest. VanPelt, Rachael E. .............................. Disclosed no confl ict of interest. Vantyghem, Marie-Christine ................ Disclosed no confl ict of interest. Varady, Krista A. ................................... Disclosed no confl ict of interest. Vardeny, Orly ........................................ Disclosed no confl ict of interest. Vardi, Moshe ........................................ Disclosed no confl ict of interest. Varela, Maria C. ................................... Disclosed no confl ict of interest. Varma, Rohit ......................................... Consultant: Allergan, Inc., AqueSys, Genentech, Merck,

Replenish, Inc.; Research Support: Genentech, Replenish, Inc.

Varma, Swarna ..................................... Consultant: Novo Nordisk, Inc., Amylin; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Sanofi , Lilly, Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Merck, Ama-rin, Kowa, Astra Zeneca, Bristol-Meyers Squibb, Warner Chilcotte

Varughese, Rincy .................................. Disclosed no confl ict of interest. Vasquez, Erida ...................................... Disclosed no confl ict of interest. Vatansever Tekin, Buket ....................... Disclosed no confl ict of interest. Vater, Axel ............................................ Employee: Noxxon Vatish, Manu ........................................ Disclosed no confl ict of interest. Vaughn, Daniel E. ................................. Employee: Halozyme Therapeutics; Stock/Shareholder:

Halozyme Therapeutics Vavrova, Ema ........................................ Disclosed no confl ict of interest. Vaz, Cherie ........................................... Disclosed no confl ict of interest. Vaziri Sani, Fariba ................................ Disclosed no confl ict of interest. Vaziri, Nosratola D. .............................. Disclosed no confl ict of interest. Vaziri-Sani, Fariba ................................ Disclosed no confl ict of interest. Vazquez Membrillo, Miguel ................. Disclosed no confl ict of interest. Vedovato, Monica ................................ Disclosed no confl ict of interest. Vedtofte, Louise ................................... Disclosed no confl ict of interest. Veedfald, Simon ................................... Disclosed no confl ict of interest. Velayoudom, Fritz Line ......................... Disclosed no confl ict of interest. Velho, Gilberto ..................................... Disclosed no confl ict of interest. Velichkova, Violeta K. ........................... Disclosed no confl ict of interest. Vella, Adrian ......................................... Disclosed no confl ict of interest. Velluto, Diana ....................................... Disclosed no confl ict of interest. Velsor-Friedrich, Barbara ...................... Disclosed no confl ict of interest. Veltman, Dick J. ................................... Disclosed no confl ict of interest. Vendelbo, Mikkel H. ............................. Disclosed no confl ict of interest. Venditti, Elizabeth M. ........................... Disclosed no confl ict of interest. Venema, Maarten ................................ Disclosed no confl ict of interest. Venesmaa, Sari .................................... Disclosed no confl ict of interest. Veneza, Lorena ..................................... Disclosed no confl ict of interest. Venkat Narayan, K.M. .......................... Disclosed no confl ict of interest. Venn, Alison ......................................... Disclosed no confl ict of interest. Ventura, Adriana .................................. Disclosed no confl ict of interest. Venturi, Elena ....................................... Disclosed no confl ict of interest. Venugopalan, Ramakrishna ................. Employee: Animas Corporation; Stock/Shareholder: Johnson

& Johnson Verberne, Hein ..................................... Disclosed no confl ict of interest. Verchere, C. Bruce ................................ Disclosed no confl ict of interest. Vercruysse, Frank ................................. Employee: Janssen Research & Development Veresiu, Ioan A. .................................... Disclosed no confl ict of interest. Vergani, Andrea ................................... Disclosed no confl ict of interest. Vergidou, Paraskevi .............................. Disclosed no confl ict of interest. Verlinden, Matthew ............................. Disclosed no confl ict of interest. Vernon, Ashley ..................................... Research Support: Covidien

Verny, Christiane .................................. Consultant: Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi ; Research Support: Merck, Novo Nordisk, Inc.

Veronelli, Annamaria ........................... Disclosed no confl ict of interest. Verrijken, An ......................................... Disclosed no confl ict of interest. Vespasiani, Giacomo ............................ Disclosed no confl ict of interest. Vesper, Iris ............................................ Employee: Roche Diagnostics GmbH Vestergaard, Henrik ............................. Disclosed no confl ict of interest. Vetrani, Claudia .................................... Disclosed no confl ict of interest. Veves, Aristidis .................................... Disclosed no confl ict of interest. Vezzulli, Paolo ...................................... Disclosed no confl ict of interest. Viaplana Masclans, Judith .................. Disclosed no confl ict of interest. Viberti, Giancarlo ................................. Advisory Panel: Abbott Laboratories, Inc., Eli Lilly and

Company, Mitsubishi Tanabe Pharmaceutical Corpora-tion; Board Member: GlaxoSmithKline, Novartis Pharmaceuticals Corporation; Speaker’s Bureau: Eli Lilly and Company

Vichaiwong, Kanokwan ........................ Disclosed no confl ict of interest. Vickers, Steven ..................................... Disclosed no confl ict of interest. Victor, Timothy W. ................................ Consultant: Novartis Pharma AG; Employee: Kantar Health Vidal, Josep .......................................... Disclosed no confl ict of interest. Vidyasagar, Sadasivan ......................... Disclosed no confl ict of interest. Vidyasagar, Sudha ................................ Disclosed no confl ict of interest. Vieira, Pedro M. ................................... Disclosed no confl ict of interest. Vienberg, Sara ...................................... Disclosed no confl ict of interest. Viener, Hilla Lee ................................... Disclosed no confl ict of interest. Vierra, Nicholas C. ............................... Disclosed no confl ict of interest. Vietri, Jeffrey ....................................... Research Support: Kantar Health Vigersky, Robert ................................... Advisory Panel: Bayer, Medtronic, Sanofi ; Research Support:

DexCom Viggiani, Maria T. ................................. Employee: Bayer Health Care, LLC Vigil, Diana ........................................... Disclosed no confl ict of interest. Vignati, Laila ........................................ Disclosed no confl ict of interest. Vignati, Louis ........................................ Consultant: Cebix, Inc., Constant Biotechnology, Immuneworks Vigneri, Riccardo .................................. Disclosed no confl ict of interest. Vigueira, Patrick A. ............................... Disclosed no confl ict of interest. Vijapurkar, Ujjwala ............................... Employee: Janssen Research & Development Vijayakumar, G ..................................... Disclosed no confl ict of interest. Vikram, Naval ....................................... Disclosed no confl ict of interest. Vikulova, Olga ...................................... Disclosed no confl ict of interest. Vila, Isabelle K. .................................... Disclosed no confl ict of interest. Vileikyte, Loretta .................................. Disclosed no confl ict of interest. Villa, Chiara .......................................... Disclosed no confl ict of interest. Villadsen, Gerda ................................... Disclosed no confl ict of interest. Villafl or, Ciriaco .................................... Disclosed no confl ict of interest. Villalobos, Laura A. .............................. Disclosed no confl ict of interest. Villamaina, Elisabetta .......................... Disclosed no confl ict of interest. Villarreal, Rodrigo ................................ Disclosed no confl ict of interest. Villringer, Arno ..................................... Disclosed no confl ict of interest. Vilmann, Peter ...................................... Disclosed no confl ict of interest. Vilsbøll, Tina ......................................... Advisory Panel: Bristol-Myers Squibb Company, Merck Sharp

& Dohme Limited, Novo Nordisk A/S, Sanofi ; Board Member: Bristol-Myers Squibb Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi ; Consultant: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi , Zealand Pharma A/S; Research Support: Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi , Zealand Pharma A/S

Vimalananda, Varsha G. ....................... Disclosed no confl ict of interest. Vinaixa, Maria ...................................... Disclosed no confl ict of interest. Vincent, Marie-Pascale ........................ Disclosed no confl ict of interest. Vinciguerra, Federica ........................... Disclosed no confl ict of interest. Vind, Birgitte F. ..................................... Disclosed no confl ict of interest. Vines, Latoya ........................................ Disclosed no confl ict of interest. Vinet, Laurent ....................................... Disclosed no confl ict of interest. Viollet, Benoit ....................................... Disclosed no confl ict of interest. Virella, Gabe ......................................... Disclosed no confl ict of interest. Virella, Gabriel ..................................... Disclosed no confl ict of interest. Visco, Virginia E. .................................. Disclosed no confl ict of interest. Vishnudas, Vivek .................................. Disclosed no confl ict of interest. Visiedo, Francisco M. ........................... Research Support: Amylin Pharmaceuticals, Inc. Vissing, Kristian ................................... Disclosed no confl ict of interest. Vistisen, Dorte ...................................... Employee: Steno Diabetes Center A/S; Stock/Shareholder:

Novo Nordisk A/S Vistoli, Fabio ......................................... Disclosed no confl ict of interest. Viswambharan, Hema .......................... Disclosed no confl ict of interest. Viswanathan, Prabhakar ...................... Employee: Takeda Global Research & Development Center,

Inc.; Stock/Shareholder: Takeda Global Research & Development Center, Inc.

Dow



A905


AU

THO

R D

ISCL

OSU

RE

Viswanathan, Vijay .............................. Disclosed no confl ict of interest. Vitai, Marta .......................................... Disclosed no confl ict of interest. Vitale, Marilena ................................... Disclosed no confl ict of interest. Vitolins, Mara Z. ................................... Disclosed no confl ict of interest. Vitolo, Edoardo ..................................... Disclosed no confl ict of interest. Vivekanandan-Giri, Anuradha .............. Disclosed no confl ict of interest. Vivekananhan, Aravindan .................... Disclosed no confl ict of interest. Vlajnic, Aleksandra .............................. Employee: Sanofi US, Inc. Vlassara, Helen .................................... Disclosed no confl ict of interest. Vlasuk, George P. .................................. Employee: GlaxoSmithKline Vlodarchyk, Coreen .............................. Disclosed no confl ict of interest. Vo, Lien ................................................. Employee: Janssen Scientifi c Affairs, LLC Voelker, James R. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Vogel, Claudia ...................................... Consultant: Roche Diagnostics Vogel, Heike ......................................... Disclosed no confl ict of interest. Volchuk, Allen ...................................... Disclosed no confl ict of interest. Volkening, Lisa K. ................................. Disclosed no confl ict of interest. Volkov, Petr ........................................... Disclosed no confl ict of interest. Vollbrecht, Jill E. .................................. Disclosed no confl ict of interest. Vollmers, Christopher ........................... Disclosed no confl ict of interest. Vølund, Aage ........................................ Stock/Shareholder: Novo Nordisk A/S Von Eynatten, Maximilian .................... Employee: Boehringer Ingelheim GmbH & Co. KG Von Frankenberg, Anize D. ................... Disclosed no confl ict of interest. Von Gall, Charlotte ............................... Disclosed no confl ict of interest. Von Kleist-Retzow, Jürgen-Christoph .. Disclosed no confl ict of interest. Von Loeffelholz, Christian .................... Disclosed no confl ict of interest. Von Websky, Karoline .......................... Disclosed no confl ict of interest. Vonbank, Alexander ............................. Disclosed no confl ict of interest. Vonberg, Andrew ................................. Disclosed no confl ict of interest. Vora, Jiten ............................................ Advisory Panel: Abbott Diabetes Care, Eli Lilly and Company,

Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Research Support: Eli Lilly and Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: Abbott Diabetes Care, Boehringer Ingelheim GmbH & Co. KG, Eli Lilly and Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi

Vorderstrasse, Allison .......................... Disclosed no confl ict of interest. Voruganti, V.S. ...................................... Disclosed no confl ict of interest. Voskanyan, Gayane .............................. Employee: Medtronic Voss, Andreas ...................................... Disclosed no confl ict of interest. Vrang, Niels .......................................... Research Support: Boehringer Ingelheim GmbH & Co. KG Vranic, Mladen ..................................... Disclosed no confl ict of interest. Vrzalova, Jindra .................................... Disclosed no confl ict of interest. Vu, Calvin ............................................. Disclosed no confl ict of interest. Waagepetersen, Helle S. ..................... Disclosed no confl ict of interest. Waalen, Jill .......................................... Disclosed no confl ict of interest. Wachal, Angela .................................... Disclosed no confl ict of interest. Wactawski-Wende, Jean .................... Disclosed no confl ict of interest. Wada, Hiromichi .................................. Disclosed no confl ict of interest. Wada, Jun ............................................ Disclosed no confl ict of interest. Wada, Naoko A. ................................... Employee: Chugai Pharmaceutical Co., Ltd. Wada, Nobuhiko .................................. Disclosed no confl ict of interest. Wada, Norio ......................................... Disclosed no confl ict of interest. Wada, Yoshiharu .................................. Disclosed no confl ict of interest. Wadhwa, Navneet ............................... Employee: Ranbaxy Laboratories Limited Wadwa, R. Paul .................................... Research Support: Eli Lilly and Company, Novo Nordisk, Inc. Waeckel, Ludovic ................................. Disclosed no confl ict of interest. Wagatsuma, Kenji ................................ Disclosed no confl ict of interest. Wagenknecht, Lynne E. ........................ Disclosed no confl ict of interest. Wagers, Amy J. .................................... Disclosed no confl ict of interest. Wägner, Ana ........................................ Disclosed no confl ict of interest. Wagner, Bridget K. ............................... Disclosed no confl ict of interest. Wagner, Connie .................................... Disclosed no confl ict of interest. Wagner, David ...................................... Disclosed no confl ict of interest. Wagner, John A. .................................. Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Wagner, Julie A. .................................. Disclosed no confl ict of interest. Wagner, Rebecca ................................. Disclosed no confl ict of interest. Wagner, Robert .................................... Disclosed no confl ict of interest. Wagner, Robin S. ................................. Employee: Roche Diagnostics GmbH Wago, Takehiko .................................... Disclosed no confl ict of interest. Wahed, Abdus ...................................... Disclosed no confl ict of interest. Wahid, Farheen .................................... Disclosed no confl ict of interest. Wainstein, Julio ................................... Consultant: Andromeda Biotech, Ltd. Waitman, Jorge ................................... Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Janssen

Pharmaceuticals, Novo Nordisk A/S; Speaker’s Bureau: Bristol-Myers Squibb/AstraZeneca, Novartis Pharmaceuti-cals Corporation, Novo Nordisk A/S

Wajs, Ewa ............................................ Employee: Janssen Research & Development

Wakabayashi, Tadamasa ..................... Disclosed no confl ict of interest. Wakamatsu, Sadako ............................ Disclosed no confl ict of interest. Waki, Hironori ...................................... Disclosed no confl ict of interest. Wakimoto, Satoko ................................ Employee: Daiichi-Sankyo, Inc. Walders-Abramson, Natalie ................ Consultant: Daiichi-Sankyo, Inc. Waldo, Dan .......................................... Consultant: Dexcom, Inc. Waldron, Sheridan ............................... Disclosed no confl ict of interest. Walia, Palak ......................................... Disclosed no confl ict of interest. Walilko, Ewa ........................................ Disclosed no confl ict of interest. Walker, Ashby F. ................................... Disclosed no confl ict of interest. Walker, Elizabeth A. ............................. Disclosed no confl ict of interest. Walker, Karen ....................................... Disclosed no confl ict of interest. Walker, Susan ...................................... Disclosed no confl ict of interest. Walker, Tomas ...................................... Research Support: Amylin/Eli Lilly, Dexcom, Inc.; Speaker’s

Bureau: Amylin/Eli Lilly, Dexcom, Inc. Walker, William ................................... Disclosed no confl ict of interest. Walkinshaw, Emma .............................. Disclosed no confl ict of interest. Walkinshaw, Steve A. .......................... Disclosed no confl ict of interest. Wallace, Douglas ................................. Disclosed no confl ict of interest. Wallén, Håkan ...................................... Disclosed no confl ict of interest. Wallia, Amisha ..................................... Research Support: Corcept, Reata Pharmaceuticals Wallis, Diane ........................................ Disclosed no confl ict of interest. Wallston, Kenneth A. ........................... Disclosed no confl ict of interest. Walsh, Brandon .................................... Employee: Orexigen Therapeutics, Inc.; Stock/Shareholder:

Orexigen Therapeutics, Inc. Walsh, Cathal ....................................... Disclosed no confl ict of interest. Walsh, Kenneth .................................... Disclosed no confl ict of interest. Walters, Matthew J. ............................ Employee: ChemoCentryx Walton, James ..................................... Disclosed no confl ict of interest. Walton, R. Grace .................................. Disclosed no confl ict of interest. Walus-Miarka, Malgorzata .................. Disclosed no confl ict of interest. Wan, Xuesi ........................................... Disclosed no confl ict of interest. Wang, Aihong ...................................... Disclosed no confl ict of interest. Wang, Aileen X. ................................... Disclosed no confl ict of interest. Wang, Bingdi ........................................ Disclosed no confl ict of interest. Wang, Bo .............................................. Employee: Merck Wang, Cecilia C. ................................... Disclosed no confl ict of interest. Wang, Changjiang ................................ Disclosed no confl ict of interest. Wang, Changzheng .............................. Disclosed no confl ict of interest. Wang, Chao .......................................... Disclosed no confl ict of interest. Wang, Chen .......................................... Disclosed no confl ict of interest. Wang, Chengshi ................................... Disclosed no confl ict of interest. Wang, Dan ........................................... Disclosed no confl ict of interest. Wang, Di .............................................. Disclosed no confl ict of interest. Wang, Edward ...................................... Employee: Sanofi Wang, Fang .......................................... Disclosed no confl ict of interest. Wang, Fei ............................................. Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Wang, Feifei ......................................... Disclosed no confl ict of interest. Wang, Feng .......................................... Disclosed no confl ict of interest. Wang, Gary .......................................... Disclosed no confl ict of interest. Wang, Haiping ..................................... Disclosed no confl ict of interest. Wang, Hao ........................................... Disclosed no confl ict of interest. Wang, Hong ......................................... Disclosed no confl ict of interest. Wang, Hsun-Fan ................................... Disclosed no confl ict of interest. Wang, Hui ............................................ Disclosed no confl ict of interest. Wang, Hye Jin ...................................... Disclosed no confl ict of interest. Wang, Jianbo ....................................... Disclosed no confl ict of interest. Wang, Jie ............................................. Disclosed no confl ict of interest. Wang, Jijiao ......................................... Disclosed no confl ict of interest. Wang, Jing ........................................... Disclosed no confl ict of interest. Wang, Jingying .................................... Disclosed no confl ict of interest. Wang, Jinju .......................................... Disclosed no confl ict of interest. Wang, Jinping ...................................... Disclosed no confl ict of interest. Wang, Jiun-Ling ................................... Disclosed no confl ict of interest. Wang, Jiying ........................................ Disclosed no confl ict of interest. Wang, Josh J. ...................................... Disclosed no confl ict of interest. Wang, Jun-Sing ................................... Disclosed no confl ict of interest. Wang, Kai ............................................. Disclosed no confl ict of interest. Wang, Kun ............................................ Disclosed no confl ict of interest. Wang, Lei ............................................. Disclosed no confl ict of interest. Wang, Li ............................................... Disclosed no confl ict of interest. Wang, Lijun .......................................... Disclosed no confl ict of interest. Wang, Ling-jia ...................................... Disclosed no confl ict of interest. Wang, Liya ........................................... Disclosed no confl ict of interest. Wang, Manman ................................... Disclosed no confl ict of interest. Wang, Nae-Yuh .................................... Disclosed no confl ict of interest. Wang, Nan ........................................... Disclosed no confl ict of interest. Wang, Niansong .................................. Disclosed no confl ict of interest. Wang, Ning .......................................... Disclosed no confl ict of interest. Wang, Paulus S. ................................... Disclosed no confl ict of interest. Wang, Peili ........................................... Disclosed no confl ict of interest. Wang, Pei-Wen .................................... Disclosed no confl ict of interest.

Dow



A906


AU

THO

R D

ISCL

OSU

RE

Wang, Pin ............................................. Disclosed no confl ict of interest. Wang, Ping ........................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Wang, Ping H. ...................................... Disclosed no confl ict of interest. Wang, Qian .......................................... Disclosed no confl ict of interest. Wang, Qinghua .................................... Disclosed no confl ict of interest. Wang, Qiong A. .................................... Disclosed no confl ict of interest. Wang, Rennian ..................................... Disclosed no confl ict of interest. Wang, Rong .......................................... Disclosed no confl ict of interest. Wang, Rui ............................................. Disclosed no confl ict of interest. Wang, Shaohua .................................... Disclosed no confl ict of interest. Wang, Shean-Sheng ............................ Employee: Janssen Research & Development Wang, Shihong ..................................... Disclosed no confl ict of interest. Wang, Shu Pei ...................................... Disclosed no confl ict of interest. Wang, Shulin ........................................ Employee: TransTech Pharma Wang, Songyan .................................... Disclosed no confl ict of interest. Wang, Suzanne .................................... Disclosed no confl ict of interest. Wang, Tianyuan ................................... Disclosed no confl ict of interest. Wang, Weiqing .................................... Disclosed no confl ict of interest. wang, Wen hui ..................................... Disclosed no confl ict of interest. Wang, WenFang .................................. Disclosed no confl ict of interest. Wang, Xiaodan ..................................... Disclosed no confl ict of interest. Wang, Xiaojie ....................................... Disclosed no confl ict of interest. Wang, Xiaojun ...................................... Disclosed no confl ict of interest. Wang, Xiaoli ......................................... Disclosed no confl ict of interest. Wang, Xiaolin ....................................... Disclosed no confl ict of interest. Wang, Xiaoxin ...................................... Disclosed no confl ict of interest. Wang, Xiaoyun ..................................... Disclosed no confl ict of interest. Wang, Xin ............................................. Employee: Pfi zer, Inc.; Research Support: Pfi zer, Inc.; Stock/

Shareholder: Pfi zer, Inc. Wang, Xujing ........................................ Disclosed no confl ict of interest. Wang, Yangwei .................................... Disclosed no confl ict of interest. Wang, Ying ........................................... Disclosed no confl ict of interest. Wang, Yiting ........................................ Employee: Janssen Research & Development Wang, Yi-Xin (Jim) ............................... Disclosed no confl ict of interest. Wang, Yong .......................................... Disclosed no confl ict of interest. Wang, Yu Qing ..................................... Disclosed no confl ict of interest. wang, Yuehui ........................................ Disclosed no confl ict of interest. Wang, Yujie .......................................... Disclosed no confl ict of interest. Wang, Yun ............................................ Disclosed no confl ict of interest. Wang, Yuxia ......................................... Disclosed no confl ict of interest. Wang, Yuzhen ...................................... Disclosed no confl ict of interest. Wang, Zhanjian .................................... Disclosed no confl ict of interest. Wang, Zhaohong .................................. Disclosed no confl ict of interest. Wang, ZhiXiao ...................................... Disclosed no confl ict of interest. Wang, Zhong Q. ................................... Disclosed no confl ict of interest. Wang, Zilian ......................................... Disclosed no confl ict of interest. Wangnoo, Subhash K. .......................... Disclosed no confl ict of interest. Wanjihia, Violet W. .............................. Disclosed no confl ict of interest. Wanner, Christoph ............................... Consultant: Boehringer Ingelheim GmbH & Co. KG Warchal-Windham, Mary E. ................ Employee: Bayer Health Care, LLC Ward, Glenn ......................................... Disclosed no confl ict of interest. Ward, Kirsty L. ...................................... Disclosed no confl ict of interest. Ward, Sarah ......................................... Employee: Eli Lilly and Company Ward, W. Kenneth ................................ Advisory Panel: Xeris Pharmaceuticals; Consultant: Echo

Therapeutics, Inc.; Research Support: Novo Nordisk A/S; Stock/Shareholder: iSense Corporation

Warmus, Joseph .................................. Employee: Pfi zer, Inc. Warner, Jay .......................................... Employee: CeQur, Ltd. Warnock, Garth L. ................................ Disclosed no confl ict of interest. Warram, James D. ............................... Disclosed no confl ict of interest. Warren, Laura ...................................... Disclosed no confl ict of interest. Warton, E. Margaret ............................ Disclosed no confl ict of interest. Waseem, Muhammad .......................... Disclosed no confl ict of interest. Washko, George ................................... Disclosed no confl ict of interest. Wasim, Hanif ....................................... Disclosed no confl ict of interest. Wasserfall, Clive H. ............................. Disclosed no confl ict of interest. Wasserman, David H. .......................... Disclosed no confl ict of interest. Waszczeniuk, Magdalena .................... Disclosed no confl ict of interest. Watada, Hirotaka ................................. Advisory Panel: Astellas Pharma US, Inc., Boehringer Ingelheim

Pharmaceuticals, Inc., Daiichi-Sankyo, Inc., Mitsubishi Tanabe Pharmaceutical Corporation, Sanofi ; Research Support: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo, Inc., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly and Company, MSD, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfi zer, Inc., Sanofi , Sanwakagaku, Shionogi, Inc., Takeda Pharmaceutical Company, Ltd.; Speaker’s Bureau: Bayer Health Care, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo, Inc., Eli Lilly and Company, MSD, Novo Nordisk, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd.

Watanabe, Atsushi .............................. Disclosed no confl ict of interest.

Watanabe, Hirohumi ............................ Disclosed no confl ict of interest. Watanabe, Hiroshi ............................... Disclosed no confl ict of interest. Watanabe, Jonathan H. ....................... Disclosed no confl ict of interest. Watanabe, Koin ................................... Disclosed no confl ict of interest. Watanabe, Richard M. ......................... Disclosed no confl ict of interest. Watanabe, Takayuki ............................. Disclosed no confl ict of interest. Watanabe, Tsuyoshi ............................. Disclosed no confl ict of interest. Watanabe, Yuko ................................... Disclosed no confl ict of interest. Watkins, Elaine .................................... Disclosed no confl ict of interest. Watson, Sara ....................................... Disclosed no confl ict of interest. Watson, Sydeaka ................................. Disclosed no confl ict of interest. Watson-Williams, Phyllis ..................... Disclosed no confl ict of interest. Watt, Barbara ....................................... Disclosed no confl ict of interest. Watt, Matthew .................................... Disclosed no confl ict of interest. Watterson, Kenneth R. ......................... Disclosed no confl ict of interest. Wattjes, Mike P. ................................... Disclosed no confl ict of interest. Watts, Ann ........................................... Disclosed no confl ict of interest. Waugh, Kathleen C. ............................. Disclosed no confl ict of interest. Wautlet, Arnaud ................................... Disclosed no confl ict of interest. Wawrusiewicz-Kurylonek, Natalia ...... Disclosed no confl ict of interest. Way, James .......................................... Employee: GlaxoSmithKline Ways, Kirk ............................................ Employee: Janssen Research & Development, LLC Wayte, Sarah C. ................................... Disclosed no confl ict of interest. Weaver, Jessica R. ............................... Disclosed no confl ict of interest. Webb, Amy ........................................... Disclosed no confl ict of interest. Webber, Jonathan ................................ Disclosed no confl ict of interest. Weber, Dietmar .................................... Disclosed no confl ict of interest. Weber, Sonja ........................................ Employee: Boehringer Ingelheim GmbH & Co. KG Webster, Zoe ........................................ Disclosed no conflict of interest. Weedon, Michael N. ............................ Disclosed no confl ict of interest. Wei, Fengjiang ..................................... Disclosed no confl ict of interest. Wei, Kevin ............................................ Disclosed no confl ict of interest. Wei, Limin ............................................ Disclosed no confl ict of interest. Wei, Qian ............................................. Disclosed no confl ict of interest. Wei, Qiong ........................................... Disclosed no confl ict of interest. Wei, Wenhui ........................................ Employee: Sanofi ; Stock/Shareholder: Sanofi , Sanofi (Spouse/

Partner) Wei, Xiaowei ........................................ Disclosed no confl ict of interest. Wei, Xiuqing ......................................... Disclosed no confl ict of interest. Wei, Ying .............................................. Disclosed no confl ict of interest. Weidenbach, Kelly N. .......................... Disclosed no confl ict of interest. Weigensberg, Marc J. ......................... Disclosed no confl ict of interest. Weigert, Cora ....................................... Disclosed no confl ict of interest. Weikel, Karen A. .................................. Disclosed no confl ict of interest. Weimer, Marc ...................................... Employee: Boehringer Ingelheim GmbH & Co. KG Weimer, Sandra ................................... Disclosed no confl ict of interest. Weiner, Lauren S. ................................. Disclosed no confl ict of interest. Weinger, Katie ..................................... Disclosed no confl ict of interest. Weinman, Steven A. ............................ Employee: Institute for Medical and Nursing Education, Inc. Weinstein, Eleanor M. ......................... Disclosed no confl ict of interest. Weinstein, Rachel ................................ Employee: Janssen Research & Development; Stock/Share-

holder: Janssen Research & Development Weinzimer, Stuart A. ............................ Advisory Panel: Insuline Medical; Consultant: Animas Corpora-

tion, BD Medical Diabetes Care; Speaker’s Bureau: Eli Lilly and Company

Weir, Daniala L. .................................... Disclosed no confl ict of interest. Weir, Gordon ........................................ Disclosed no confl ict of interest. Weir, Matthew R. ................................. Consultant: Janssen Weiss, Guenter .................................... Disclosed no confl ict of interest. Weiss, Ram .......................................... Disclosed no confl ict of interest. Weiss, Robert ....................................... Disclosed no confl ict of interest. Weissmann, Lais .................................. Disclosed no confl ict of interest. Weitzman, Elissa R. ............................. Disclosed no confl ict of interest. Wellenstein, Kerry ............................... Disclosed no confl ict of interest. Wells, Ellen M. ..................................... Research Support: Swetland Center for Environmental Health Wells, George A. .................................. Disclosed no confl ict of interest. Wells, James M. .................................. Disclosed no confl ict of interest. Welsh, John B. ..................................... Employee: Medtronic Weltman, Arthur L. ............................... Disclosed no confl ict of interest. Welton, Nicky ....................................... Disclosed no confl ict of interest. Wen, Junping ....................................... Disclosed no confl ict of interest. Wen, Li ................................................. Disclosed no confl ict of interest. Wen, Tianyang ..................................... Disclosed no confl ict of interest. Wendel, Christopher S. ........................ Disclosed no confl ict of interest. Wendt Andrae, Jaime .......................... Disclosed no confl ict of interest. Weng, Jianping .................................... Research Support: Bayer Health Care, LLC, Eli Lilly and Com-

pany, Novo Nordisk, Inc. Weng, Shao-Wen ................................. Disclosed no confl ict of interest. Wen-Ming, Xu ...................................... Disclosed no confl ict of interest. Wens, Johan ........................................ Advisory Panel: AstraZeneca/Bristol-Meyers Squibb, Eli Lilly

and Company; Board Member: Novo Nordisk A/S; Other Relationship: Novo Nordisk A/S

Dow



A907


AU

THO

R D

ISCL

OSU

RE

Wentworth, Charles ............................. Research Support: Eli Lilly and Company Wenzel, Philip ...................................... Disclosed no confl ict of interest. Werner, Ulrich ...................................... Employee: Sanofi Weslati, Chaker .................................... Disclosed no confl ict of interest. Wesley, David ...................................... Disclosed no confl ict of interest. Wesorick, David H. ............................... Disclosed no confl ict of interest. Wessel, Jennifer .................................. Disclosed no confl ict of interest. Wessels, Hunter ................................... Disclosed no confl ict of interest. West, Amy ............................................ Disclosed no confl ict of interest. Weston, Philip J. .................................. Disclosed no confl ict of interest. Westwell-Roper, Clara ......................... Disclosed no confl ict of interest. Wewalka, Marlene .............................. Disclosed no confl ict of interest. Wexler, Deborah J. .............................. Disclosed no confl ict of interest. Weyman, Kate ...................................... Disclosed no confl ict of interest. Whaley-Connell, Adam ........................ Disclosed no confl ict of interest. Wharam, James F. ............................... Disclosed no confl ict of interest. Wheatcroft, Stephen B. ....................... Disclosed no confl ict of interest. Wheeler, David ..................................... Disclosed no confl ict of interest. Wheeler, Eleanor .................................. Disclosed no confl ict of interest. Wheeler, Jean S. .................................. Employee: Metabolic Solutions Development Co. Wheeler, Stephanie ............................. Disclosed no confl ict of interest. Whellan, David ..................................... Consultant: Pozen, Inc. White, Adam S. .................................... Disclosed no confl ict of interest. White, Andrew P .................................. Disclosed no confl ict of interest. White, David ........................................ Disclosed no confl ict of interest. White, Emma ........................................ Disclosed no confl ict of interest. White, Kathryn E. ................................. Disclosed no confl ict of interest. White, Neil H. ...................................... Disclosed no confl ict of interest. White, Wendy ...................................... Employee: GlaxoSmithKline Whitehurst, Todd .................................. Disclosed no confl ict of interest. Whitmore, Harry ................................... Disclosed no confl ict of interest. Whitmore, Jennifer .............................. Disclosed no confl ict of interest. Whittemore, Mary S. ........................... Disclosed no confl ict of interest. Whittemore, Robin ............................... Disclosed no confl ict of interest. Wice, Burton M. ................................... Disclosed no confl ict of interest. Wickham, Edmond P. ............................ Disclosed no confl ict of interest. Wicksteed, Barton ................................ Disclosed no confl ict of interest. Wiegand, Stanley ................................. Disclosed no confl ict of interest. Wiersch, John ...................................... Disclosed no confl ict of interest. Wierup, Nils ......................................... Disclosed no confl ict of interest. Wiesner, Rudolf J. ................................ Disclosed no confl ict of interest. Wiinberg, Niels .................................... Stock/Shareholder: Novo Nordisk A/S Wijesejara, Nadeeja ............................ Disclosed no confl ict of interest. Wijesinghe, Dayanjan .......................... Disclosed no confl ict of interest. Wilding, John P. ................................... Consultant: Astellas, AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Bristol-Myers Squibb, Janssen/Johnson & Johnson, Eli Lilly and Company, Merck Sharpe & Dohme, Novo Nordisk, Inc.; Research Sup-port: AstraZeneca, Boehringer Ingelheim Pharmaceu-ticals, Inc., Bristol-Myers Squibb, Novo Nordisk, Inc., Merck Sharpe & Dohme, Janssen/Johnson & Johnson, Sanofi

Wilhelm, Kenneth ................................ Employee: Genentech Wilhite, Abigail .................................... Disclosed no confl ict of interest. Wilinska, Malgorzata E. ....................... Consultant: Becton, Dickinson and Company Wilk, Juliusz ......................................... Disclosed no confl ict of interest. Wilkin, Terence J. ................................ Disclosed no confl ict of interest. Wilkins, Gianna .................................... Disclosed no confl ict of interest. Wilkins, Marc R. ................................... Disclosed no confl ict of interest. Wilkinson, Iain D. ................................. Disclosed no confl ict of interest. Willaing, Ingrid ..................................... Employee: Steno Diabetes Center Willard, Joshua R. ................................ Disclosed no confl ict of interest. Willems, Sara M. ................................. Disclosed no confl ict of interest. Willi, Steven M. ................................... Disclosed no confl ict of interest. Williams, Ann S. .................................. Disclosed no confl ict of interest. Williams, Ashley S. .............................. Disclosed no confl ict of interest. Williams, Desmond E. .......................... Disclosed no confl ict of interest. Williams, Kevin J. ................................ Disclosed no confl ict of interest. Williams, Michael ................................ Disclosed no confl ict of interest. Williams, Phillip ................................... Disclosed no confl ict of interest. Williams, Priscilla ................................ Disclosed no confl ict of interest. Williams, Robert C. .............................. Disclosed no confl ict of interest. Williams, Shelley ................................. Research Support: NIH, Sanofi Willig, James H. ................................... Disclosed no confl ict of interest. Willis, Leslie H. .................................... Disclosed no confl ict of interest. Willis, Michael ..................................... Consultant: Janssen; Research Support: Janssen Willis, Wayne T. ................................... Disclosed no confl ict of interest. Willmes, Diana ..................................... Disclosed no confl ict of interest. Wills, Stephen L. .................................. Disclosed no confl ict of interest. Wilms, Britta ........................................ Disclosed no confl ict of interest. Wilson, Amy R. ..................................... Disclosed no confl ict of interest. Wilson, Bryan R. ................................... Employee: Biodel, Inc.; Stock/Shareholder: Biodel, Inc.

Wilson, Craig ........................................ Employee: Takeda Global Research & Development Center, Inc.

Wilson, Darrell M. ................................ Disclosed no confl ict of interest. Wilson, Hoyt G. .................................... Disclosed no confl ict of interest. Wilson, Joseph P. ................................. Disclosed no confl ict of interest. Wilson, Justine .................................... Disclosed no confl ict of interest. Wilson, Peter ........................................ Disclosed no confl ict of interest. Wilson, Rebecca .................................. Disclosed no confl ict of interest. Win, Khin .............................................. Employee: Profi l Institute for Clinical Research, Inc. Winchester, Bryan ................................ Disclosed no confl ict of interest. Windmueller, Rebecca ......................... Research Support: AstraZeneca Pharmaceuticals LP, AstraZen-

eca/Bristol-Meyers Squibb Winegar, Deborah ................................ Employee: LipoScience Winhofer, Yvonne ................................. Disclosed no confl ict of interest. Winkler, Helga ...................................... Disclosed no confl ict of interest. Winkler, Thomas W. ............................. Disclosed no confl ict of interest. Winnay, Jonathon ................................ Disclosed no confl ict of interest. Winnier, Deidre .................................... Disclosed no confl ict of interest. Winocour, Peter .................................... Disclosed no confl ict of interest. Winstead-Derlega, Christopher ........... Research Support: Bristol-Myers Squibb Company Wintfeld, Neil S. .................................. Employee: Novo Nordisk, Inc. Wise, Joyce .......................................... Disclosed no confl ict of interest. Wise, Lauren A. .................................... Disclosed no confl ict of interest. Wissam, Anteer ................................... Disclosed no confl ict of interest. Witek, Przemysław ............................... Disclosed no confl ict of interest. Witherell, Ingrid C. ............................... Consultant: Pozen, Inc. Witkowski, Piotr ................................... Disclosed no confl ict of interest. Witsch, Michael ................................... Disclosed no confl ict of interest. Witte, Daniel R. .................................... Stock/Shareholder: Novo Nordisk A/S Wittert, Gary ........................................ Disclosed no confl ict of interest. Wittmann, Istvan .................................. Disclosed no confl ict of interest. Wittrup, Minna ..................................... Other Relationship: Novo Nordisk A/S Wiza, Claudia ....................................... Disclosed no confl ict of interest. Woerdeman, Jorn ................................ Disclosed no confl ict of interest. Woerle, Hans J. ................................... Employee: Boehringer Ingelheim GmbH & Co. KG Wohlfart, Paulus .................................. Employee: Sanofi Wojtaszewski, Jørgen F. ...................... Disclosed no confl ict of interest. Wolden, Michael L. .............................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S Wolfe, Bruce ........................................ Disclosed no confl ict of interest. Wolfe, Cindy L. ..................................... Employee: Metabolic Solutions Development Co. Wolfe, Gary S. ...................................... Disclosed no confl ict of interest. Wolfe, Pamela ...................................... Disclosed no confl ict of interest. Wolff, Kathleen L. ................................ Consultant: Abbott Diabetes Care Wolffenbuttel, Bruce ............................ Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S;

Consultant: Amylin Pharmaceuticals, LLC, Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S; Research Support: Eli Lilly and Company, IPSEN - Formulation Innovation, Novo Nordisk A/S, Pfi zer, Inc.

Wolford, Angela ................................... Employee: Pfi zer, Inc. Wolfram von Wolmar, Carolin .............. Employee: Boehringer Ingelheim Pharma GmbH & Co. KG Wollheim, Claes ................................... Disclosed no confl ict of interest. Wolski, Kathy ....................................... Disclosed no confl ict of interest. Won, Kyu Chang ................................... Disclosed no confl ict of interest. Wong, Chang H. ................................... Disclosed no confl ict of interest. Wong, F. Susan ..................................... Disclosed no confl ict of interest. Wong, Jencia ....................................... Disclosed no confl ict of interest. Wong, Jenise ....................................... Disclosed no confl ict of interest. Wong, Kari E. ....................................... Disclosed no confl ict of interest. Wong, Randall ...................................... Disclosed no confl ict of interest. Wong, Rebecca .................................... Disclosed no confl ict of interest. Wong, Simon K. ................................... Research Support: Metacure Wong, Y. ............................................... Disclosed no confl ict of interest. Woo, Jeong-Taek ................................. Disclosed no confl ict of interest. Woo, Vincent C. ................................... Advisory Panel: Abbott Diabetes Care, AstraZeneca Phar-

maceuticals LP, Boehringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Merck, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi ; Speaker’s Bureau: Abbott Diabetes Care, AstraZeneca Pharmaceuticals LP, Boeh-ringer Ingelheim GmbH & Co. KG, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Merck, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi

Woo, Yu Cho ......................................... Disclosed no confl ict of interest. Wood, Gina .......................................... Disclosed no confl ict of interest. Wood, Jamie R. .................................... Disclosed no confl ict of interest. Wood, Michael H. ................................ Disclosed no confl ict of interest. Woodle, E. Steve .................................. Disclosed no confl ict of interest. Woodruff, Trent .................................... Disclosed no confl ict of interest. Woods, Lorna ....................................... Disclosed no confl ict of interest. Woods, Mark ........................................ Disclosed no confl ict of interest.

Dow



A908


AU

THO

R D

ISCL

OSU

RE

Woolcott, Orison O. .............................. Disclosed no confl ict of interest. Woolf, Adrian S. .................................. Disclosed no conflict of interest. Workalemahu, Tsegaselassie .............. Disclosed no confl ict of interest. Worm, Dorte ......................................... Disclosed no confl ict of interest. Worsham, Chris .................................... Disclosed no confl ict of interest. Worthey, Elizabeth A. ........................... Disclosed no confl ict of interest. Worthington, Roberta .......................... Disclosed no confl ict of interest. Wouters, Kristiaan ............................... Disclosed no confl ict of interest. Wozniak, Lisa ....................................... Disclosed no confl ict of interest. Wozniakiewicz, Ewa ............................ Disclosed no confl ict of interest. Wressnegger, Alexander ...................... Disclosed no confl ict of interest. Wright, Alice ........................................ Disclosed no confl ict of interest. Wright, Anthony M. ............................. Disclosed no confl ict of interest. Wright, Kathryn A. ............................... Disclosed no confl ict of interest. Wroblewski, Kristen E. ......................... Disclosed no confl ict of interest. Wronkowitz, Nina ................................ Disclosed no confl ict of interest. Wu, Bingcao ......................................... Disclosed no confl ict of interest. Wu, Chung-Ze ...................................... Disclosed no confl ict of interest. Wu, Di .................................................. Disclosed no confl ict of interest. Wu, Donghong ..................................... Disclosed no confl ict of interest. Wu, Eric Q. ........................................... Consultant: Daiichi-Sankyo, Inc., Sanofi ; Research Support:

Takeda Pharmaceutical Company, Ltd. Wu, Guoyao .......................................... Disclosed no confl ict of interest. Wu, Hongju .......................................... Disclosed no confl ict of interest. Wu, Hongyu .......................................... Disclosed no confl ict of interest. Wu, Hsien-Tsai ..................................... Disclosed no confl ict of interest. Wu, Huaizhu ......................................... Disclosed no confl ict of interest. Wu, I-Hsien .......................................... Disclosed no confl ict of interest. Wu, Jian ............................................... Disclosed no confl ict of interest. Wu, Jing ............................................... Disclosed no confl ict of interest. Wu, Jun ................................................ Disclosed no confl ict of interest. Wu, Li-Chiu ........................................... Disclosed no confl ict of interest. Wu, Linda ............................................. Disclosed no confl ict of interest. Wu, Mian ............................................. Disclosed no confl ict of interest. Wu, Pengfei .......................................... Disclosed no confl ict of interest. Wu, Qiang ............................................ Disclosed no confl ict of interest. Wu, Stephanie C. ................................. Disclosed no confl ict of interest. Wu, Ted ................................................ Disclosed no confl ict of interest. Wu, Wei ............................................... Disclosed no confl ict of interest. Wu, Wei Kelly ...................................... Disclosed no confl ict of interest. Wu, Wudelehu ..................................... Disclosed no confl ict of interest. Wu, Xiangdong ..................................... Disclosed no confl ict of interest. Wu, Xiwei ............................................. Disclosed no confl ict of interest. Wu, Yangfeng ....................................... Disclosed no confl ict of interest. Wu, Ying ............................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/Share-

holder: AstraZeneca Pharmaceuticals LP Wu, Yizhen ........................................... Disclosed no confl ict of interest. Wu, Yueh-Chu ...................................... Disclosed no confl ict of interest. Wu, Zhanhong ...................................... Disclosed no confl ict of interest. Wu, Zhixiang ........................................ Disclosed no confl ict of interest. Wukich, Dane K. ................................... Disclosed no confl ict of interest. Wutoh, Anthony W. .............................. Research Support: NIH Wygant, Gail D. .................................... Employee: Bristol-Myers Squibb/AstraZeneca Wymer, David ....................................... Disclosed no confl ict of interest. Wysham, Carol H. ................................ Research Support: Amylin Pharmaceuticals, Inc., Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Johnson & Johnson, Merck, Novo Nordisk, Inc., sanofi -aventis

Wysocki, Timothy T. ............................. Disclosed no confl ict of interest. Xi, Joan Q. ............................................ Disclosed no confl ict of interest. Xi, Min X. .............................................. Disclosed no confl ict of interest. Xia, Jing ............................................... Disclosed no confl ict of interest. Xia, Qianghua ....................................... Disclosed no confl ict of interest. Xia, Wenqing ........................................ Disclosed no confl ict of interest. Xiang, Anny H. ...................................... Disclosed no confl ict of interest. Xiang, Hongding ................................... Disclosed no confl ict of interest. Xiang, Kunsan ...................................... Disclosed no confl ict of interest. Xiang, Li ................................................ Disclosed no confl ict of interest. Xiang, Yufei .......................................... Disclosed no confl ict of interest. Xiao, Changting .................................... Disclosed no confl ict of interest. Xiao, Feng ............................................. Disclosed no confl ict of interest. Xiao, Haipeng ....................................... Disclosed no confl ict of interest. Xiao, Jianzhong .................................... Disclosed no confl ict of interest. Xiao, Jie ............................................... Disclosed no confl ict of interest. Xiao, Jing ............................................. Disclosed no confl ict of interest. Xiao, Ting .............................................. Disclosed no confl ict of interest. Xiao, Xiang ........................................... Disclosed no confl ict of interest. Xiao, Xiangwei ..................................... Disclosed no confl ict of interest. Xiao, Xinhua ......................................... Disclosed no confl ict of interest. Xie, Changqing ..................................... Disclosed no confl ict of interest. Xie, Cheng ............................................ Employee: Gilead Sciences, Inc. Xie, Fei .................................................. Disclosed no confl ict of interest.

Xie, Li .................................................... Disclosed no confl ict of interest. Xie, Weiliang ........................................ Disclosed no confl ict of interest. Xie, Xitao .............................................. Disclosed no confl ict of interest. Xin, Ying ............................................... Disclosed no confl ict of interest. Xin, Zhong ............................................ Disclosed no confl ict of interest. Xing, Dongyuan .................................... Disclosed no confl ict of interest. Xing, XiaoHuan ..................................... Disclosed no confl ict of interest. Xing, Xiaoyan ....................................... Disclosed no confl ict of interest. Xing, Yubo ............................................ Disclosed no confl ict of interest. Xing-yun, Hu ......................................... Disclosed no confl ict of interest. Xingzhe, Zhang ..................................... Disclosed no confl ict of interest. Xiong, Yan ............................................ Disclosed no confl ict of interest. Xu, Aimin .............................................. Disclosed no confl ict of interest. Xu, Dong-chuan .................................... Disclosed no confl ict of interest. Xu, Fangzheng ...................................... Disclosed no confl ict of interest. Xu, Fei ................................................... Disclosed no confl ict of interest. Xu, Fen .................................................. Disclosed no confl ict of interest. Xu, HaiXia ............................................. Disclosed no confl ict of interest. Xu, Jia .................................................. Disclosed no confl ict of interest. Xu, Jian ................................................ Disclosed no confl ict of interest. Xu, Jianzhao ......................................... Disclosed no confl ict of interest. Xu, Jing ................................................ Disclosed no confl ict of interest. Xu, June ............................................... Employee: Janssen Research & Development Xu, Lei ................................................... Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Xu, Liangzhi .......................................... Disclosed no confl ict of interest. Xu, Lijuan .............................................. Disclosed no confl ict of interest. Xu, Lu .................................................... Disclosed no confl ict of interest. Xu, Mengjing ........................................ Disclosed no confl ict of interest. Xu, Mingtong ........................................ Disclosed no confl ict of interest. Xu, Tianshu ........................................... Disclosed no confl ict of interest. Xu, Wen ................................................ Disclosed no confl ict of interest. Xu, Xianmin .......................................... Disclosed no confl ict of interest. Xu, Xiaojing .......................................... Disclosed no confl ict of interest. Xu, Xihui ............................................... Disclosed no confl ict of interest. Xu, Yaping ............................................ Employee: Genentech; Stock/Shareholder: Genentech Xu, Yihua .............................................. Research Support: Novo Nordisk, Inc. Xu, Yingxin ........................................... Consultant: AstraZeneca Pharmaceuticals LP, Bristol-Myers

Squibb Company, Novo Nordisk, Inc., Sanofi Xu, Yong ............................................... Disclosed no confl ict of interest. Xu, Yun ................................................. Disclosed no confl ict of interest. Xu, Yunlu .............................................. Disclosed no confl ict of interest. Xu, Zhangrong ...................................... Disclosed no confl ict of interest. Xu, Zihui ............................................... Disclosed no confl ict of interest. Xue, Ruidan .......................................... Disclosed no confl ict of interest. Xue, Wenqiong ..................................... Disclosed no confl ict of interest. Xun, Pengcheng .................................... Disclosed no confl ict of interest. Xxun, Zhang M. .................................... Disclosed no confl ict of interest. Xy, Ding ................................................ Disclosed no confl ict of interest. Yabe, Daisuke ....................................... Speaker’s Bureau: Bayer Health Care, LLC, Eli Lilly and

Company, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd.

Yabiku, Kouichi ..................................... Disclosed no confl ict of interest. Yachi, Yoko ........................................... Disclosed no confl ict of interest. Yada, Toshihiko .................................... Disclosed no confl ict of interest. Yadav, Santosh K. ................................. Disclosed no confl ict of interest. Yadava, Nagendra ................................ Disclosed no confl ict of interest. Yadrihinskaya, Maya ............................ Research Support: Novo Nordisk, Inc. Yaegashi, Nobuo .................................. Disclosed no confl ict of interest. Yaghootkar, Hanieh .............................. Disclosed no confl ict of interest. Yagihashi, Soroku ................................. Research Support: Novartis Pharmaceuticals Corporation Yajnik, Chittaranjan S. .......................... Disclosed no confl ict of interest. Yakubovich, Natalia ............................. Research Support: Sanofi Yalcin, Funda ........................................ Disclosed no confl ict of interest. Yalcin, Yavuz ......................................... Disclosed no confl ict of interest. Yale, Jean-Francois .............................. Advisory Panel: Novo Nordisk, Inc., Eli Lilly and Company,

Sanofi , Merck, Bristol-Myers Squibb, Astra Zeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen, Takeda; Research Support: Novo Nordisk, Inc., Eli Lilly and Company, Takeda, Merck, Sanofi , Bristol-Myers Squibb, Astra Zeneca, Janssen; Speaker’s Bureau: Novo Nordisk, Inc., Eli Lilly and Company, Sanofi , Merck, Bristol-Myers Squibb, Astra Zeneca, Boehringer Ingelheim Pharmaceuti-cals, Inc., Janssen, Takeda

Yamada, Ayako ..................................... Disclosed no confl ict of interest. Yamada, Kentaro .................................. Disclosed no confl ict of interest. Yamada, Nobuhiro ................................ Disclosed no confl ict of interest. Yamada, Satoru .................................... Disclosed no confl ict of interest. Yamada, Shinsuke ................................ Disclosed no confl ict of interest. Yamada, Syu ......................................... Disclosed no confl ict of interest. Yamada, Takaho ................................... Disclosed no confl ict of interest.

Dow



A909


AU

THO

R D

ISCL

OSU

RE

Yamada, Takatsugu .............................. Disclosed no confl ict of interest. Yamada, Tomohide ............................... Disclosed no confl ict of interest. Yamada, Yoshifumi ............................... Disclosed no confl ict of interest. Yamagishi, Sho-ichi .............................. Disclosed no confl ict of interest. Yamaguchi, Miyuki ............................... Disclosed no confl ict of interest. Yamaguchi, Suguru .............................. Disclosed no confl ict of interest. Yamaguchi, Yu ...................................... Employee: Sanwa Kagaku Kenkyusho Yamahara, Kosuke ................................ Disclosed no confl ict of interest. Yamakado, Minoru ............................... Disclosed no confl ict of interest. Yamakage, Hajime ............................... Disclosed no confl ict of interest. Yamakawa, Ken .................................... Disclosed no confl ict of interest. Yamamori, Ikuo ..................................... Disclosed no confl ict of interest. Yamamoto, Akihito ............................... Disclosed no confl ict of interest. Yamamoto, Eriko .................................. Disclosed no confl ict of interest. Yamamoto, Hironori ............................. Disclosed no confl ict of interest. Yamamoto, Hiroshi ............................... Disclosed no confl ict of interest. Yamamoto, Hirotaka ............................. Disclosed no confl ict of interest. Yamamoto, Kazuhiro ............................ Disclosed no confl ict of interest. Yamamoto, Magda T. ........................... Disclosed no confl ict of interest. Yamamoto, Masahiko .......................... Disclosed no confl ict of interest. Yamamoto, Masahiro ........................... Disclosed no confl ict of interest. Yamamoto, Naoya ................................ Disclosed no confl ict of interest. Yamamoto, Noriyuki ............................. Employee: Bayer Healthcare Company Ltd Yamamoto, Risako ................................ Disclosed no confl ict of interest. Yamamoto, Shohei ............................... Disclosed no confl ict of interest. Yamamoto, Tetsuya .............................. Disclosed no confl ict of interest. Yamamoto, Toshikazu ........................... Disclosed no confl ict of interest. Yamamoto, Yasuhiko ............................ Disclosed no confl ict of interest. Yamamura, Shigeo ............................... Disclosed no confl ict of interest. Yamana, Akiko ...................................... Disclosed no confl ict of interest. Yamanaka, Mayumi .............................. Disclosed no confl ict of interest. Yamanaka-Okumura, Hisami ................ Disclosed no confl ict of interest. Yamane, Megumi ................................. Disclosed no confl ict of interest. Yamane, Shunsuke ............................... Disclosed no confl ict of interest. Yamano, Gen ........................................ Disclosed no confl ict of interest. Yamaoka, Tomomi ................................ Disclosed no confl ict of interest. Yamashina, Shohei ............................... Disclosed no confl ict of interest. Yamashiro, Yuichiro .............................. Disclosed no confl ict of interest. Yamashita, Kaoru ................................. Disclosed no confl ict of interest. Yamashita, Maki .................................. Disclosed no confl ict of interest. Yamashita, Shizuya .............................. Disclosed no confl ict of interest. Yamato, Shiho ...................................... Disclosed no confl ict of interest. Yamauchi, Akiyo ................................... Disclosed no confl ict of interest. Yamauchi, Keishi .................................. Disclosed no confl ict of interest. Yamauchi, Toshimasa ........................... Disclosed no confl ict of interest. Yamauchi, Yuichiro ............................... Disclosed no confl ict of interest. Yamazaki, Junichi ................................. Disclosed no confl ict of interest. Yamazaki, Katsuya ............................... Disclosed no confl ict of interest. Yamazaki, Kota ..................................... Disclosed no confl ict of interest. Yamazaki, Masahiro ............................. Disclosed no confl ict of interest. Yamazaki, Satoru .................................. Disclosed no confl ict of interest. Yamazaki, Yuko ..................................... Disclosed no confl ict of interest. Yan, Alice F. .......................................... Disclosed no confl ict of interest. Yan, Chaofeng ...................................... Disclosed no confl ict of interest. Yan, JinHua .......................................... Disclosed no confl ict of interest. Yan, Jinhua ........................................... Disclosed no confl ict of interest. Yan, Li ................................................... Disclosed no confl ict of interest. Yan, Qingyun ........................................ Employee: Pfi zer, Inc. Yan, Shi Fang ........................................ Disclosed no confl ict of interest. Yan, Yang .............................................. Disclosed no confl ict of interest. Yanagimachi, Tsuyoshi ......................... Disclosed no confl ict of interest. Yanagisawa, Katsuyuki ........................ Disclosed no confl ict of interest. Yanase, Toshihiko ................................. Disclosed no confl ict of interest. Yang, Cai-Xian ...................................... Disclosed no confl ict of interest. Yang, Chijiao ........................................ Disclosed no confl ict of interest. Yang, Daizhi .......................................... Disclosed no confl ict of interest. Yang, Fred ............................................. Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

Kline Yang, Fuhua .......................................... Disclosed no confl ict of interest. Yang, Gangyi ........................................ Disclosed no confl ict of interest. Yang, Guang ......................................... Disclosed no confl ict of interest. Yang, Hae Kyung .................................. Disclosed no confl ict of interest. Yang, Hsiu-Chiung ................................ Disclosed no confl ict of interest. Yang, Huijie .......................................... Disclosed no confl ict of interest. Yang, Jiao ............................................. Employee: Takeda Pharmaceuticals U.S.A., Inc. Yang, Jin-Kui ........................................ Consultant: Takeda Global Research & Development Center,

Inc. Yang, Jisin ............................................ Employee: AstraZeneca Pharmaceuticals LP Yang, Jui-Chen ..................................... Employee: RTI Health Solutions; Research Support: Merck

Sharp & Dohme Limited Yang, Lichaun ....................................... Disclosed no confl ict of interest. Yang, Liu ............................................... Disclosed no confl ict of interest.

Yang, Maojun ....................................... Disclosed no confl ict of interest. Yang, Ming ........................................... Employee: Gilead Sciences, Inc. Yang, Peixin .......................................... Disclosed no confl ict of interest. Yang, Peng ............................................ Disclosed no confl ict of interest. Yang, Qiong .......................................... Disclosed no confl ict of interest. Yang, Qiulan ......................................... Disclosed no confl ict of interest. Yang, Rong ........................................... Disclosed no confl ict of interest. Yang, Shanmin ..................................... Disclosed no confl ict of interest. Yang, Shuyu .......................................... Disclosed no confl ict of interest. Yang, Sundy N. ..................................... Disclosed no confl ict of interest. Yang, Tao .............................................. Disclosed no confl ict of interest. Yang, Wenjing ...................................... Disclosed no confl ict of interest. Yang, Wenying ..................................... Disclosed no confl ict of interest. Yang, Wulin .......................................... Disclosed no confl ict of interest. Yang, Xiaohua ...................................... Disclosed no confl ict of interest. Yang, Xiaoyong ..................................... Disclosed no confl ict of interest. Yang, Xilin ............................................ Disclosed no confl ict of interest. Yang, Yan .............................................. Disclosed no confl ict of interest. Yang, Yemen ......................................... Disclosed no confl ict of interest. Yang, Yi-Sun ......................................... Disclosed no confl ict of interest. Yang, Yu Hsuan Carol ........................... Disclosed no confl ict of interest. Yang, Yue .............................................. Disclosed no confl ict of interest. Yang, Yuzhi ........................................... Disclosed no confl ict of interest. Yanik, Brandon M. ................................ Disclosed no confl ict of interest. Yaniv, Gal .............................................. Disclosed no confl ict of interest. Yankey, Jon W. ..................................... Disclosed no confl ict of interest. Yan-ling, Wei ........................................ Disclosed no confl ict of interest. Yao, Bin ................................................ Disclosed no confl ict of interest. Yao, Jianhua ......................................... Disclosed no confl ict of interest. Yaochite, Juliana U. ............................. Disclosed no confl ict of interest. Yaqoob, Mohammad M. ....................... Disclosed no confl ict of interest. Yaroslavceva, Marianna ....................... Disclosed no confl ict of interest. Yasbeck, Cynthia F. ............................... Disclosed no confl ict of interest. Yassa, Laura ......................................... Consultant: Novo Nordisk A/S Yasuda, Kazuki ..................................... Disclosed no confl ict of interest. Yasuda, Patrice ..................................... Disclosed no confl ict of interest. Yasuda, Tetsuyuki ................................. Disclosed no confl ict of interest. Yasuda, Yoshinori ................................. Disclosed no confl ict of interest. Yasuno, Shinji ....................................... Disclosed no confl ict of interest. Yau, Linda ............................................. Employee: Genentech Yavuz, Dilek .......................................... Disclosed no confl ict of interest. Yazawa, Masako .................................. Disclosed no confl ict of interest. Yazdi, Puya ........................................... Disclosed no confl ict of interest. Yazici, Dilek .......................................... Disclosed no confl ict of interest. Ycoub, Fady .......................................... Disclosed no confl ict of interest. Yd, Peng ............................................... Disclosed no confl ict of interest. Yderstraede, Knud ................................ Disclosed no confl ict of interest. Ye, Chang ............................................. Disclosed no confl ict of interest. Ye, Chianping ....................................... Disclosed no confl ict of interest. Ye, Gui-lan ............................................ Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Ye, Honggang ....................................... Disclosed no confl ict of interest. Ye, Jianping .......................................... Research Support: NIDDK Ye, Ji-Ming ........................................... Disclosed no confl ict of interest. Ye, June ................................................ Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

Kline Ye, Kaitai .............................................. Disclosed no confl ict of interest. Ye, Li ..................................................... Disclosed no confl ict of interest. Ye, Mingliang ....................................... Disclosed no confl ict of interest. Ye, Xiangyang ....................................... Disclosed no confl ict of interest. Ye, Xiao ................................................ Disclosed no confl ict of interest. Ye, Xin .................................................. Employee: Daiichi-Sankyo, Inc.; Stock/Shareholder: Daiichi-

Sankyo, Inc. Ye, Yumei .............................................. Research Support: Amylin Pharmaceuticals, Inc., AstraZeneca

Pharmaceuticals LP, Forest Pharmaceuticals, Inc., Merck, Roche Pharmaceuticals

Yechoor, Vijay K. ................................... Disclosed no confl ict of interest. Yee, Jacqueline .................................... Employee: Janssen Research & Development Yeh, Helen ............................................ Employee: AstraZeneca Pharmaceuticals LP Yeh, Hsin-Chieh .................................... Disclosed no confl ict of interest. Yeh, Matthew Y. ................................... Disclosed no confl ict of interest. Yengo, Loïc ........................................... Disclosed no confl ict of interest. Yeo, Charles ......................................... Disclosed no confl ict of interest. Yeo, Dong Wook ................................... Disclosed no confl ict of interest. Yeo, Yen C. ........................................... Disclosed no confl ict of interest. Yerauchi, Yasuo .................................... Disclosed no confl ict of interest. Yeung, Chun Yip ................................... Disclosed no confl ict of interest. Yeung, Roseanne O. ............................. Disclosed no confl ict of interest. Yevdokymova, Natalya ......................... Disclosed no confl ict of interest. Yew, Tong W. ........................................ Disclosed no confl ict of interest. Yfanti, Christina ................................... Disclosed no confl ict of interest. Yi, Chin-ok ............................................ Disclosed no confl ict of interest.

Dow



A910


AU

THO

R D

ISCL

OSU

RE

Yi, Sang-A ............................................ Disclosed no confl ict of interest. Yi, Shuang-Qin ..................................... Disclosed no confl ict of interest. Yi, Zhengping ....................................... Disclosed no confl ict of interest. Yi-Frazier, Joyce ................................... Disclosed no confl ict of interest. Yılmaz, Didem ...................................... Disclosed no confl ict of interest. Yilmaz, M. Temel .................................. Disclosed no confl ict of interest. Yim, Jung Hyeun .................................. Disclosed no confl ict of interest. Yiming, Mu ........................................... Disclosed no confl ict of interest. Yin, Guo-shu ......................................... Disclosed no confl ict of interest. Yin, Jinhua ........................................... Disclosed no confl ict of interest. Yin, Liangjie .......................................... Disclosed no confl ict of interest. Yin, Wenling ......................................... Disclosed no confl ict of interest. Yin, Xueyao .......................................... Disclosed no confl ict of interest. Yin, Zhaohui ......................................... Disclosed no confl ict of interest. Ying, Wei .............................................. Disclosed no confl ict of interest. Ying, Zha .............................................. Disclosed no confl ict of interest. Ylitalo, Kelly R. ..................................... Disclosed no confl ict of interest. Yoda, Koichiro ...................................... Disclosed no confl ict of interest. Yoda, Maki ........................................... Disclosed no confl ict of interest. Yoder, Stephanie M. ............................. Disclosed no confl ict of interest. Yogi-Morren, Divya .............................. Disclosed no confl ict of interest. Yoko, Ohata .......................................... Disclosed no confl ict of interest. Yokoh, Hidetaka ................................... Disclosed no confl ict of interest. Yokoi, Hiroyoshi .................................... Disclosed no confl ict of interest. Yokota, Tamotsu ................................... Disclosed no confl ict of interest. Yokote, Kotaro ...................................... Disclosed no confl ict of interest. Yokote, Koutaro .................................... Disclosed no confl ict of interest. Yoneda, Chihiro .................................... Disclosed no confl ict of interest. Yoneda, Takashi ................................... Disclosed no confl ict of interest. Yong, Gu ............................................... Disclosed no confl ict of interest. Yoo, Hye Jin ......................................... Disclosed no confl ict of interest. Yoo, Hyung Joon .................................. Disclosed no confl ict of interest. Yoo, Jeong Seon .................................. Disclosed no confl ict of interest. Yoo, Myunghi ....................................... Disclosed no confl ict of interest. Yoo, Seung Hyun .................................. Disclosed no confl ict of interest. Yoo, Soon-Jib ....................................... Disclosed no confl ict of interest. Yoo, So-Yeon ........................................ Disclosed no confl ict of interest. Yoo, Tae ................................................ Disclosed no confl ict of interest. Yoon, Ja Young ..................................... Disclosed no confl ict of interest. Yoon, Ji Sung ....................................... Disclosed no confl ict of interest. Yoon, Ji Won ........................................ Disclosed no confl ict of interest. Yoon, Kun Ho ........................................ Disclosed no confl ict of interest. Yoon, So Yoon ...................................... Disclosed no confl ict of interest. Yore, Mark M. ...................................... Disclosed no confl ict of interest. Yoshida, Akitoshi .................................. Disclosed no confl ict of interest. Yoshida, Eiko ........................................ Disclosed no confl ict of interest. Yoshida, Kumi ....................................... Disclosed no confl ict of interest. Yoshida, Masashi ................................. Disclosed no confl ict of interest. Yoshida, Taro ........................................ Disclosed no confl ict of interest. Yoshifuji, Ayumu .................................. Disclosed no confl ict of interest. Yoshihara, Tomoaki .............................. Disclosed no confl ict of interest. Yoshikawa, Yuichiro ............................. Disclosed no confl ict of interest. Yoshimoto, Sakiya ................................ Disclosed no confl ict of interest. Yoshimura, Masayuki ........................... Disclosed no confl ict of interest. Yoshimura, Toru .................................... Disclosed no confl ict of interest. Yoshimura, Yukio .................................. Disclosed no confl ict of interest. Yoshino, Gen ........................................ Disclosed no confl ict of interest. Yoshita, Katsushi .................................. Disclosed no confl ict of interest. Yoshizaki, Takeshi ................................ Disclosed no confl ict of interest. Yoshizawa, Sakiko ................................ Disclosed no confl ict of interest. Yosten, Gina ......................................... Disclosed no confl ict of interest. You, Young-Hye .................................... Disclosed no confl ict of interest. Young, Andrew A. ................................ Employee: GlaxoSmithKline Young, Cheryl ....................................... Disclosed no confl ict of interest. Young, Edwin ........................................ Disclosed no confl ict of interest. Young, Heather ..................................... Disclosed no confl ict of interest. Young, Kim ........................................... Disclosed no confl ict of interest. Young, Laura ......................................... Disclosed no confl ict of interest. Young, Lawrence .................................. Disclosed no confl ict of interest. Young, Malcolm A. ............................... Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

Kline Young, Martin E. ................................... Disclosed no confl ict of interest. Young, Mary ......................................... Disclosed no confl ict of interest. Younk, Lisa M. ...................................... Disclosed no confl ict of interest. Yu, Edward ........................................... Disclosed no confl ict of interest. Yu, Hao Yong ........................................ Disclosed no confl ict of interest. Yu, Jae Myung ..................................... Disclosed no confl ict of interest. Yu, Ji Hee ............................................. Disclosed no confl ict of interest. Yu, Jing ................................................. Disclosed no confl ict of interest. Yu, Lili ................................................... Disclosed no confl ict of interest. Yu, Liping .............................................. Disclosed no confl ict of interest. Yu, Ping ................................................. Disclosed no confl ict of interest.

Yu, Shan ............................................... Disclosed no confl ict of interest. Yu, Shawn ............................................ Employee: Takeda Pharmaceuticals U.S.A., Inc.; Stock/

Shareholder: Takeda Pharmaceuticals U.S.A., Inc. Yu, Shengsheng .................................... Employee: Merck Yu, Shijia .............................................. Disclosed no confl ict of interest. Yu, Shujie ............................................. Disclosed no confl ict of interest. Yu, Wen Qin ......................................... Disclosed no confl ict of interest. Yu, Xuefeng .......................................... Advisory Panel: Bristol-Myers Squibb Company, Novartis

Pharmaceuticals Corporation Yu, Yerong ............................................ Disclosed no confl ict of interest. Yu, Yinghua .......................................... Disclosed no confl ict of interest. Yu, Yongmei .......................................... Disclosed no confl ict of interest. Yuan, Chao-Xing ................................... Disclosed no confl ict of interest. Yuan, Deborah ...................................... Disclosed no confl ict of interest. Yuan, Ding H. ........................................ Disclosed no confl ict of interest. Yuan, Jenny .......................................... Disclosed no confl ict of interest. Yuan, Jian-Min ..................................... Disclosed no confl ict of interest. Yuan, Ming-Xia ..................................... Disclosed no confl ict of interest. Yuan, Tao .............................................. Disclosed no confl ict of interest. Yuan, Xiaohong .................................... Disclosed no confl ict of interest. Yuan, Xiaolan ....................................... Disclosed no confl ict of interest. Yuan, Yujia ............................................ Disclosed no confl ict of interest. Yuan, Zhong .......................................... Employee: Janssen Research & Development; Stock/Share-

holder: Janssen Research & Development Yubero-Serrano, Elena M. .................... Disclosed no confl ict of interest. Yucel, Nihal .......................................... Disclosed no confl ict of interest. Yudkin, John S. ..................................... Disclosed no confl ict of interest. Yue, Dennis K. ...................................... Disclosed no confl ict of interest. Yue, Jessica T. ...................................... Disclosed no confl ict of interest. Yue, Kevin K. ........................................ Disclosed no confl ict of interest. Yufeng, Jiang ....................................... Disclosed no confl ict of interest. Yumoto, Kazuhiko ................................. Disclosed no confl ict of interest. Yun, Hye Ryoung .................................. Disclosed no confl ict of interest. Yun, Jae-Seung .................................... Disclosed no confl ict of interest. Yun, Mijin ............................................. Disclosed no confl ict of interest. Yun, Yu Jung ......................................... Disclosed no confl ict of interest. Yung, Ken K. ......................................... Disclosed no confl ict of interest. Yung, S. ................................................ Disclosed no confl ict of interest. Yup, Kang ............................................. Disclosed no confl ict of interest. Yushkina, Yana ..................................... Disclosed no confl ict of interest. Yusuf, Salim ......................................... Research Support: Sanofi Zabetian, Azadeh ................................. Disclosed no confl ict of interest. Zadala, Mouslech ................................. Disclosed no confl ict of interest. Zagar, Anthony ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company Zagarins, Sofi ja E. ................................ Disclosed no confl ict of interest. Zagrodzki, Paweł .................................. Disclosed no confl ict of interest. Zaharieva, Dessi P. ............................... Disclosed no confl ict of interest. Zaheer, M. Shoaib ................................ Disclosed no confl ict of interest. Zaheer, Sarah N. .................................. Disclosed no confl ict of interest. Zahiragic, Lejla ..................................... Disclosed no confl ict of interest. Zahr-Akrawi, Elsie ................................ Disclosed no confl ict of interest. Zai, Adrian ............................................ Disclosed no confl ict of interest. Zajdenverg, Lenita ................................ Disclosed no confl ict of interest. Zakaria, Ahmed .................................... Disclosed no confl ict of interest. Zaldivar, Frank P. ................................... Disclosed no confl ict of interest. Zaletel, Jelka ........................................ Disclosed no confl ict of interest. Zalevskaya, Alsu G. .............................. Disclosed no confl ict of interest. Zambrowicz, Brian ................................ Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc. Zandavalli, Rafaela .............................. Disclosed no confl ict of interest. Zanella, Maria T. .................................. Disclosed no confl ict of interest. Zang, Mengwei .................................... Disclosed no confl ict of interest. Zanolin, Daniela ................................... Disclosed no confl ict of interest. Zantidis, Anestis .................................. Disclosed no confl ict of interest. Zapatero, Antonio ................................ Disclosed no confl ict of interest. Zapletalova, Jana ................................. Disclosed no confl ict of interest. Zarra, Emanuela ................................... Disclosed no confl ict of interest. Zarrinpar, Amir ..................................... Disclosed no confl ict of interest. Zavazava, Nicholas .............................. Disclosed no confl ict of interest. Zayed, Hany .......................................... Disclosed no confl ict of interest. Zecchini, Barbara ................................. Disclosed no confl ict of interest. Zechner, Rudolf .................................... Disclosed no confl ict of interest. Zeitler, Philip S. .................................... Consultant: Bristol-Myers Squibb Company, Daiichi-Sankyo,

Inc., Gilead Sciences, Inc., Janssen Pharmaceuticals, Merck

Zelaya, Fernando O. ............................. Disclosed no confl ict of interest. Zelihic, Edin .......................................... Disclosed no confl ict of interest. Zelisko, Andrea .................................... Disclosed no confl ict of interest. Zeng, Chunping .................................... Disclosed no confl ict of interest. Zeng, Hui .............................................. Disclosed no confl ict of interest. Zeng, Jiaoe ........................................... Consultant: Takeda Global Research & Development Center, Inc.

Dow



A911


AU

THO

R D

ISCL

OSU

RE

Zeng, Long-Yi ....................................... Disclosed no confl ict of interest. Zeng, Xiao-Yi ........................................ Disclosed no confl ict of interest. Zeng, Yingjuan ..................................... Disclosed no confl ict of interest. Zenia, Amel .......................................... Disclosed no confl ict of interest. Zeppieri, Richard .................................. Disclosed no confl ict of interest. Zgibor, Janice C. ................................... Research Support: Sanofi Zgorski, Melinda .................................. Disclosed no confl ict of interest. Zhan, Chenyu ........................................ Disclosed no confl ict of interest. Zhang, Amy .......................................... Disclosed no confl ict of interest. Zhang, Bo ............................................. Disclosed no confl ict of interest. Zhang, Cheng ....................................... Disclosed no confl ict of interest. Zhang, Chi ............................................ Disclosed no confl ict of interest. Zhang, Cuilin ........................................ Disclosed no confl ict of interest. Zhang, Dan ........................................... Disclosed no confl ict of interest. Zhang, Danyi ........................................ Disclosed no confl ict of interest. Zhang, Dongmei ................................... Disclosed no confl ict of interest. Zhang, Dongyan ................................... Disclosed no confl ict of interest. Zhang, Fan ............................................ Disclosed no confl ict of interest. Zhang, Fang .......................................... Employee: Novo Nordisk A/S Zhang, Guangxiang .............................. Disclosed no confl ict of interest. Zhang, Guochao ................................... Disclosed no confl ict of interest. Zhang, Hong ......................................... Disclosed no confl ict of interest. Zhang, Hongbin .................................... Disclosed no confl ict of interest. Zhang, Huashi ...................................... Disclosed no confl ict of interest. Zhang, Jiajia ......................................... Disclosed no confl ict of interest. Zhang, Jialiang ..................................... Disclosed no confl ict of interest. Zhang, Jian L. ....................................... Disclosed no confl ict of interest. Zhang, Jianwei ..................................... Disclosed no confl ict of interest. Zhang, Jie ............................................. Disclosed no confl ict of interest. Zhang, Jifeng ....................................... Disclosed no confl ict of interest. Zhang, Jin ............................................. Disclosed no confl ict of interest. Zhang, Jun ............................................ Disclosed no confl ict of interest. Zhang, Kebin ........................................ Disclosed no confl ict of interest. Zhang, Kehao ....................................... Disclosed no confl ict of interest. Zhang, Kezhong .................................... Disclosed no confl ict of interest. Zhang, Lei ............................................. Disclosed no confl ict of interest. Zhang, Lihua ......................................... Disclosed no confl ict of interest. Zhang, Liling ......................................... Disclosed no confl ict of interest. Zhang, Lina ........................................... Disclosed no confl ict of interest. Zhang, Linbo ......................................... Disclosed no confl ict of interest. Zhang, Lingxiao .................................... Disclosed no confl ict of interest. Zhang, Lurong ....................................... Disclosed no confl ict of interest. Zhang, Mary X. ..................................... Disclosed no confl ict of interest. Zhang, Mei ........................................... Disclosed no confl ict of interest. Zhang, Ning .......................................... Disclosed no confl ict of interest. Zhang, Ping ........................................... Disclosed no confl ict of interest. Zhang, Puhong ...................................... Disclosed no confl ict of interest. Zhang, Qi .............................................. Disclosed no confl ict of interest. Zhang, Qiu ............................................ Disclosed no confl ict of interest. Zhang, Quan-Jiang ............................... Disclosed no confl ict of interest. Zhang, Rong ......................................... Disclosed no confl ict of interest. Zhang, Rui ............................................ Disclosed no confl ict of interest. Zhang, Saifei ........................................ Disclosed no confl ict of interest. Zhang, Sarah X. .................................... Disclosed no confl ict of interest. Zhang, Sheng ....................................... Disclosed no confl ict of interest. Zhang, Shun ......................................... Disclosed no confl ict of interest. Zhang, Simin ........................................ Disclosed no confl ict of interest. Zhang, Steven B. .................................. Disclosed no confl ict of interest. Zhang, Ting ........................................... Disclosed no confl ict of interest. Zhang, Wei ........................................... Disclosed no confl ict of interest. Zhang, Wencan .................................... Employee: Takeda Global Research & Development Center, Inc. Zhang, Wenwei .................................... Disclosed no confl ict of interest. Zhang, Wenzheng ................................ Disclosed no confl ict of interest. Zhang, Xian H. ...................................... Disclosed no confl ict of interest. Zhang, Xiang Yang ............................... Disclosed no confl ict of interest. Zhang, Xiangmin .................................. Disclosed no confl ict of interest. Zhang, Xian-Man .................................. Disclosed no confl ict of interest. Zhang, Xiao Juan ................................. Disclosed no confl ict of interest. Zhang, Xiaojun ..................................... Disclosed no confl ict of interest. Zhang, Xiaoke ....................................... Disclosed no confl ict of interest. Zhang, Xiaoming .................................. Disclosed no confl ict of interest. Zhang, Xiuying ...................................... Disclosed no confl ict of interest. Zhang, Xiuzhen ..................................... Disclosed no confl ict of interest. Zhang, Xuanping .................................. Disclosed no confl ict of interest. Zhang, Yahong ...................................... Employee: VeroScience Zhang, Yanqing ..................................... Disclosed no confl ict of interest. Zhang, Ye .............................................. Disclosed no confl ict of interest. Zhang, Yi .............................................. Disclosed no confl ict of interest. Zhang, Yifei .......................................... Disclosed no confl ict of interest. Zhang, Ying .......................................... Employee: Pozen, Inc. Zhang, Ying-Jian .................................. Disclosed no confl ict of interest. Zhang, Yingmei .................................... Disclosed no confl ict of interest.

Zhang, Yiping ....................................... Disclosed no confl ict of interest. Zhang, Yong-jun ................................... Disclosed no confl ict of interest. Zhang, Yu .............................................. Disclosed no confl ict of interest. Zhang, Yun ............................................ Disclosed no confl ict of interest. Zhang, Yuying ....................................... Disclosed no confl ict of interest. Zhang, Zhenhuan .................................. Disclosed no confl ict of interest. Zhang, Zhijia ......................................... Disclosed no confl ict of interest. Zhangrong, Xu ...................................... Disclosed no confl ict of interest. Zhao, Aihua .......................................... Disclosed no confl ict of interest. Zhao, Changgeng ................................. Employee: Merck Sharp & Dohme Limited; Stock/Shareholder:

Merck Sharp & Dohme Limited Zhao, Chen ........................................... Disclosed no confl ict of interest. Zhao, Chunhui ...................................... Disclosed no confl ict of interest. Zhao, Dong ........................................... Disclosed no confl ict of interest. Zhao, Jiuming ....................................... Disclosed no confl ict of interest. Zhao, Libo ............................................. Disclosed no confl ict of interest. Zhao, Lina ............................................. Disclosed no confl ict of interest. Zhao, Luping ......................................... Disclosed no confl ict of interest. Zhao, Mingming ................................... Disclosed no confl ict of interest. Zhao, Niky ............................................ Employee: ChemoCentryx Zhao, Shangang ................................... Disclosed no confl ict of interest. Zhao, Shuyuan ...................................... Employee: Janssen Research & Development Zhao, Tingbao ....................................... Disclosed no confl ict of interest. Zhao, Weigang ..................................... Disclosed no confl ict of interest. Zhao, Weijing ....................................... Disclosed no confl ict of interest. Zhao, Wenhui ....................................... Disclosed no confl ict of interest. Zhao, Xiaojuan ..................................... Disclosed no confl ict of interest. Zhao, Yingnamn ................................... Research Support: Bristol-Myers Squibb Company Zhao, Yingnan ...................................... Disclosed no confl ict of interest. Zhao, Yong ............................................ Board Member: Tianhe Stem Cell Biotechnologies Inc; Stock/

Shareholder: Tianhe Stem Cell Biotechnologies Inc Zhao, Yuguang ...................................... Disclosed no confl ict of interest. Zhao, Zhigang ....................................... Disclosed no confl ict of interest. Zhao, Zhiyong ....................................... Disclosed no confl ict of interest. Zhao, Zhiyuan ....................................... Disclosed no confl ict of interest. Zhaohui, L.V. ......................................... Disclosed no confl ict of interest. Zheleznyakova, Anna ........................... Disclosed no confl ict of interest. Zhen, Yan Feng ..................................... Disclosed no confl ict of interest. Zheng, Fenping ..................................... Disclosed no confl ict of interest. Zheng, Hui ............................................ Disclosed no confl ict of interest. Zheng, Jenny ........................................ Disclosed no confl ict of interest. Zheng, Qinlong ..................................... Employee: Nordic Bioscience A/S Zheng, Shao Xiong ............................... Disclosed no confl ict of interest. Zheng, Tai Shan .................................... Disclosed no confl ict of interest. Zheng, Xiaowei .................................... Disclosed no confl ict of interest. Zheng, Yang .......................................... Disclosed no confl ict of interest. Zhi, Degui ............................................. Disclosed no confl ict of interest. Zhi, Hui ................................................. Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmith-

Kline Zhi, Lin .................................................. Employee: Ligand Pharmaceuticals; Stock/Shareholder: Ligand

Pharmaceuticals Zhong, Guoquan ................................... Disclosed no confl ict of interest. Zhong, Wenze ...................................... Disclosed no confl ict of interest. Zhou, Alyssa ......................................... Disclosed no confl ict of interest. Zhou, Bei .............................................. Disclosed no confl ict of interest. Zhou, Beiyan ......................................... Disclosed no confl ict of interest. Zhou, Dajin ........................................... Disclosed no confl ict of interest. Zhou, Dajing ......................................... Disclosed no confl ict of interest. Zhou, Dong Hao .................................... Disclosed no confl ict of interest. Zhou, Jian ............................................. Disclosed no confl ict of interest. Zhou, Jian-Ying .................................... Disclosed no confl ict of interest. Zhou, Jiaojiao ....................................... Disclosed no confl ict of interest. Zhou, Jiaqiang ...................................... Disclosed no confl ict of interest. Zhou, Kaixin .......................................... Disclosed no confl ict of interest. Zhou, Ligang ......................................... Disclosed no confl ict of interest. Zhou, Maggie ....................................... Disclosed no confl ict of interest. Zhou, Meijian ....................................... Research Support: GlaxoSmithKline Zhou, Mi ............................................... Disclosed no confl ict of interest. Zhou, Ming ........................................... Employee: Amylin Pharmaceuticals, LLC Zhou, Qiao ............................................ Disclosed no confl ict of interest. Zhou, Qiaoling ...................................... Disclosed no confl ict of interest. Zhou, Rong ........................................... Disclosed no confl ict of interest. Zhou, Steve .......................................... Employee: Sanofi Zhou, Tianyi .......................................... Disclosed no confl ict of interest. Zhou, Xianghai ..................................... Disclosed no confl ict of interest. Zhou, Xiu .............................................. Disclosed no confl ict of interest. Zhou, Xueqin ........................................ Disclosed no confl ict of interest. Zhou, Yi ................................................ Disclosed no confl ict of interest. Zhou, Yiming ........................................ Disclosed no confl ict of interest. Zhou, Yingjiang .................................... Employee: Pfi zer, Inc. Zhou, Zhiguang ..................................... Disclosed no confl ict of interest. Zhu, Dalong .......................................... Disclosed no confl ict of interest.

Dow



A912


AU

THO

R D

ISCL

OSU

RE

Zhu, Dan ............................................... Disclosed no confl ict of interest. Zhu, Hao ............................................... Disclosed no confl ict of interest. Zhu, Jiaan ............................................. Disclosed no confl ict of interest. Zhu, Li ................................................... Disclosed no confl ict of interest. Zhu, Meili ............................................. Disclosed no confl ict of interest. Zhu, Min ............................................... Disclosed no confl ict of interest. Zhu, Na ................................................. Disclosed no confl ict of interest. Zhu, Qinglei .......................................... Disclosed no confl ict of interest. Zhu, Wanling ........................................ Disclosed no confl ict of interest. Zhu, Xiaoyun ......................................... Disclosed no confl ict of interest. Zhu, Xinkai ............................................ Disclosed no confl ict of interest. Zhu, Yanhua .......................................... Disclosed no confl ict of interest. Zhu, Yimin ............................................ Employee: Pfi zer, Inc. Zhu, Yunxia ........................................... Disclosed no confl ict of interest. Zhu, Yusheng ........................................ Disclosed no confl ict of interest. Zhu, Zhenxin ......................................... Disclosed no confl ict of interest. Zhuang, Guoqing .................................. Disclosed no confl ict of interest. Zhuang, Langen .................................... Disclosed no confl ict of interest. Zhuang, Xiaoming ................................ Disclosed no confl ict of interest. Zhuge, Fen ............................................ Disclosed no confl ict of interest. Zhuo, Xiaohui ....................................... Disclosed no confl ict of interest. Zibar, Karin ........................................... Disclosed no confl ict of interest. Ziegenfuss, Jeanette Y. ........................ Disclosed no confl ict of interest. Ziegler, Anette-G .................................. Disclosed no confl ict of interest. Ziegler, Dan .......................................... Disclosed no confl ict of interest. Ziegler, Ralph ....................................... Consultant: Roche Diagnostics Zielinski, Mark C. ................................. Disclosed no confl ict of interest. Ziemer, David C. ................................... Research Support: Sanofi Zigman, Jeffrey M. ............................... Disclosed no confl ict of interest. Zikri-Ditch, Meital ................................ Disclosed no confl ict of interest. Zilov, Alexey V. ..................................... Consultant: Merck, Novartis, Novo Nordisk AS; Speaker’s

Bureau: Merck, Novartis, Novo Nordisk AS Zimmerberg, Joshua ............................ Disclosed no confl ict of interest.

Zimmerman, Miriam B. ........................ Disclosed no confl ict of interest. Zimmerman, Paul ................................. Disclosed no confl ict of interest. Zinman, Bernard ................................... Advisory Panel: Amylin Pharmaceuticals, Inc., Boehringer

Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Merck, Novo Nordisk, Inc., Sanofi , Takeda Pharmaceutical Company, Ltd.; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Merck, Novo Nordisk, Inc.

Zinn, Kelly K. ........................................ Disclosed no confl ict of interest. Zinßius, Elena ....................................... Disclosed no confl ict of interest. Zisser, Howard C. ................................. Advisory Panel: Animas Corporation, MannKind Corporation;

Consultant: Roche Pharmaceuticals; Research Support: Dexcom, Inc., Eli Lilly and Company, Insulet Corporation, Lifescan Animas, Inc., Medtronic MiniMed, Inc., Novo Nordisk, Inc.

Zivehe, Fariba ....................................... Disclosed no confl ict of interest. Zmuda, Joseph M. ............................... Disclosed no confl ict of interest. Zobairi, Fatiha ...................................... Disclosed no confl ict of interest. Zografou, Ioanna .................................. Disclosed no confl ict of interest. Zonenberg, Anna .................................. Disclosed no confl ict of interest. Zoppi, Annalisa .................................... Disclosed no confl ict of interest. Zoppini, Giacomo ................................. Disclosed no confl ict of interest. Zou, Dajin ............................................. Disclosed no confl ict of interest. Zou, Fang .............................................. Disclosed no confl ict of interest. Zou, Lingling ......................................... Disclosed no confl ict of interest. Zoupas, Christos ................................... Disclosed no confl ict of interest. Zrebiec, John F. .................................... Disclosed no confl ict of interest. Zschornack, Eva .................................... Disclosed no confl ict of interest. Zubair, Mohammad .............................. Disclosed no confl ict of interest. Zucchini, Stefano ................................. Disclosed no confl ict of interest. Zulli, Anthony ....................................... Disclosed no confl ict of interest. Zuqian, Lu ............................................. Disclosed no confl ict of interest. Zzhang, Xiuying .................................... Disclosed no confl ict of interest.

Dow



Documents

db13-dualityinfo.pdf - American Diabetes Association